Document and Entity Information
Document and Entity Information | 12 Months Ended |
Dec. 31, 2021shares | |
Entity [Table] | |
Entity registrant name | UBS Group AG |
Entity central index key | 0001610520 |
Entity current reporting status | Yes |
Entity voluntary filers | No |
Current fiscal year end date | --12-31 |
Entity filer category | Large Accelerated Filer |
Entity well known seasoned issuer | No |
Entity common stock shares outstanding | 3,702,422,995 |
Document type | 20-F |
Document period end date | Dec. 31, 2021 |
Amendment flag | false |
Document fiscal year focus | 2021 |
Document fiscal period focus | FY |
Entity emerging growth company | false |
Entity shell company | false |
Entity interactive data current | Yes |
Auditor name | Ernst & Young Ltd |
Auditor firm ID | 1460 |
Auditor location | Basel, Switzerland |
Icfr auditor attestation flag | true |
Contact Personnel Name | David Kelly |
Document Accounting Standard | International Financial Reporting Standards |
Entity File Number | 1-36764 |
Entity Incorporation State Country Code | V8 |
Document Registration Statement | false |
Document Annual Report | true |
Document Transition Report | false |
Document Shell Company Report | false |
Business Contact [Member] | |
Entity [Table] | |
Entity Address Address Line 1 | Bahnhofstrasse 45 |
Entity Address City Or Town | Zurich |
Entity Address Postal Zip Code | CH-8001 |
Entity Address Country | CH |
City Area Code | 203 |
Local Phone Number | 719 3000 |
UBS AG | |
Entity [Table] | |
Entity registrant name | UBS AG |
Entity central index key | 0001114446 |
Entity current reporting status | Yes |
Entity voluntary filers | No |
Current fiscal year end date | --12-31 |
Entity filer category | Non-accelerated Filer |
Entity well known seasoned issuer | No |
Entity common stock shares outstanding | 3,858,408,466 |
Document type | 20-F |
Document period end date | Dec. 31, 2021 |
Amendment flag | false |
Document fiscal year focus | 2021 |
Document fiscal period focus | FY |
Entity emerging growth company | false |
Entity shell company | false |
Entity interactive data current | Yes |
Auditor name | Ernst & Young Ltd |
Auditor firm ID | 1460 |
Auditor location | Basel, Switzerland |
Icfr auditor attestation flag | true |
Contact Personnel Name | David Kelly |
Document Accounting Standard | International Financial Reporting Standards |
Entity File Number | 1-15060 |
Entity Incorporation State Country Code | V8 |
Document Registration Statement | false |
Document Annual Report | true |
Document Transition Report | false |
Document Shell Company Report | false |
UBS AG | Business Contact [Member] | |
Entity [Table] | |
Entity Address Address Line 1 | Bahnhofstrasse 45 |
Entity Address City Or Town | Zurich |
Entity Address Postal Zip Code | CH-8001 |
Entity Address Country | CH |
City Area Code | 203 |
Local Phone Number | 719 3000 |
Consolidated Income Statement
Consolidated Income Statement - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | $ 8,533 | $ 8,810 | $ 10,684 |
Interest expense from financial instruments measured at amortized cost | (3,259) | (4,247) | (7,194) |
Net interest income from financial instruments measured at fair value through profit or loss | 1,431 | 1,299 | 1,011 |
Net interest income | 6,705 | 5,862 | 4,501 |
Other net income from financial instruments measured at fair value through profit or loss | 5,850 | 6,960 | 6,842 |
Credit loss (expense) / release | 148 | (694) | (78) |
Fee and commission income | 24,372 | 20,961 | 19,110 |
Fee and commission expense | (1,985) | (1,775) | (1,696) |
Net fee and commission income | 22,387 | 19,186 | 17,413 |
Other income | 452 | 1,076 | 212 |
Total operating income | 35,542 | 32,390 | 28,889 |
Personnel expenses | 18,387 | 17,224 | 16,084 |
General and administrative expenses | 5,553 | 4,885 | 5,288 |
Depreciation, amortization and impairment of non-financial assets | 2,118 | 2,126 | 1,940 |
Total operating expenses | 26,058 | 24,235 | 23,312 |
Operating profit / (loss) before tax | 9,484 | 8,155 | 5,577 |
Tax expense / (benefit) | 1,998 | 1,583 | 1,267 |
Net profit / (loss) | 7,486 | 6,572 | 4,310 |
Net profit / (loss) attributable to non-controlling interests | 29 | 15 | 6 |
Net profit / (loss) attributable to shareholders | $ 7,457 | $ 6,557 | $ 4,304 |
Earnings per share | |||
Basic | $ 2.14 | $ 1.83 | $ 1.17 |
Diluted | $ 2.06 | $ 1.77 | $ 1.14 |
UBS AG | |||
Entity [Table] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | $ 8,534 | $ 8,816 | $ 10,703 |
Interest expense from financial instruments measured at amortized cost | (3,366) | (4,333) | (7,303) |
Net interest income from financial instruments measured at fair value through profit or loss | 1,437 | 1,305 | 1,015 |
Net interest income | 6,605 | 5,788 | 4,415 |
Other net income from financial instruments measured at fair value through profit or loss | 5,844 | 6,930 | 6,833 |
Credit loss (expense) / release | 148 | (695) | (78) |
Fee and commission income | 24,422 | 20,982 | 19,156 |
Fee and commission expense | (1,985) | (1,775) | (1,696) |
Net fee and commission income | 22,438 | 19,207 | 17,460 |
Other income | 941 | 1,549 | 677 |
Total operating income | 35,976 | 32,780 | 29,307 |
Personnel expenses | 15,661 | 14,686 | 13,801 |
General and administrative expenses | 9,476 | 8,486 | 8,586 |
Depreciation, amortization and impairment of non-financial assets | 1,875 | 1,909 | 1,751 |
Total operating expenses | 27,012 | 25,081 | 24,138 |
Operating profit / (loss) before tax | 8,964 | 7,699 | 5,169 |
Tax expense / (benefit) | 1,903 | 1,488 | 1,198 |
Net profit / (loss) | 7,061 | 6,211 | 3,971 |
Net profit / (loss) attributable to non-controlling interests | 29 | 15 | 6 |
Net profit / (loss) attributable to shareholders | $ 7,032 | $ 6,196 | $ 3,965 |
Consolidated Statement of Compr
Consolidated Statement of Comprehensive Income - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | $ 7,486 | $ 6,572 | $ 4,310 |
Defined benefit plans | |||
Gains / (losses) on defined benefit plans, before tax | 2 | (327) | |
Total comprehensive income | |||
Total other comprehensive income | (2,367) | 1,740 | 781 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (2,393) | 2,230 | 1,363 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 26 | (490) | (582) |
Total comprehensive income | 5,119 | 8,312 | 5,091 |
Comprehensive income attributable to shareholders | |||
Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 7,457 | 6,557 | 4,304 |
Foreign currency translation | |||
Foreign currency translation movements related to net assets of foreign operations, before tax | (1,076) | 2,103 | 200 |
Effective portion of changes in fair value of hedging instruments designated as net investment hedges, before tax | 498 | (936) | (134) |
Foreign currency translation differences on foreign operations reclassified to the income statement | (2) | (7) | 52 |
Effective portion of changes in fair value of hedging instruments designated as net investment hedge reclassified to the income statement | 10 | 2 | (14) |
Income tax relating to foreign currency translations, including the effect of net investment hedges | 35 | (67) | 0 |
Subtotal foreign currency translation, net of tax | (535) | 1,095 | 104 |
Financial assets measured at fair value through other comprehensive income | |||
Net unrealized gains / (losses), before tax | (203) | 223 | 189 |
Net realized gains / (losses) reclassified to the income statement from equity | (9) | (40) | (31) |
Income tax relating to net unrealized gains / (losses) | 55 | (48) | (41) |
Subtotal financial assets measured at fair value through other comprehensive income, net of tax | (157) | 136 | 117 |
Cash flow hedges of interest rate risk | |||
Effective portion of changes in fair value of hedging instruments recognized in OCI | (992) | 2,012 | 1,571 |
Net (gains) / losses reclassified to the income statement from equity | (1,073) | (770) | (175) |
Income tax related to cash flow hedges | 390 | (231) | (253) |
Subtotal cash flow hedges, net of tax | (1,675) | 1,011 | 1,143 |
Cost of hedging | |||
Cost of hedging, before tax | (32) | (13) | |
Income tax relating to cost of hedging | 6 | 0 | |
Subtotal cost of hedging, net of tax | (26) | (13) | |
Defined benefit plans | |||
Gains / (losses) on defined benefit plans, before tax | 2 | (327) | (146) |
Income tax relating to defined benefit plans | (7) | 109 | (41) |
Subtotal defined benefit plans, net of tax | (5) | (218) | (186) |
Own credit on financial liabilities designated at fair value | |||
Gains / (losses) from own credit on financial liabilities designated at fair value, before tax | 46 | (293) | (400) |
Income tax relating to own credit on financial liabilities designated at fair value | 0 | 0 | 8 |
Subtotal own credit on financial liabilities designated at fair value, net of tax | 46 | (293) | (392) |
Total comprehensive income | |||
Total other comprehensive income | (2,351) | 1,719 | 785 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (2,393) | 2,230 | 1,363 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 42 | (511) | (578) |
Total comprehensive income | 5,106 | 8,276 | 5,089 |
Comprehensive income attributable to non-controlling interests | |||
Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 29 | 15 | 6 |
Total comprehensive income | |||
Total other comprehensive income | (16) | 21 | (4) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (16) | 21 | (4) |
Total comprehensive income | 13 | 36 | 2 |
UBS AG | |||
Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 7,061 | 6,211 | 3,971 |
Defined benefit plans | |||
Gains / (losses) on defined benefit plans, before tax | 133 | (222) | |
Total comprehensive income | |||
Total other comprehensive income | (2,235) | 1,759 | 785 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (2,368) | 2,165 | 1,351 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 132 | (406) | (566) |
Total comprehensive income | 4,826 | 7,970 | 4,756 |
UBS AG | Comprehensive income attributable to shareholders | |||
Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 7,032 | 6,196 | 3,965 |
Foreign currency translation | |||
Foreign currency translation movements related to net assets of foreign operations, before tax | (1,046) | 2,040 | 199 |
Effective portion of changes in fair value of hedging instruments designated as net investment hedges, before tax | 492 | (938) | (144) |
Foreign currency translation differences on foreign operations reclassified to the income statement | (1) | (7) | 52 |
Effective portion of changes in fair value of hedging instruments designated as net investment hedge reclassified to the income statement | 10 | 2 | (14) |
Income tax relating to foreign currency translations, including the effect of net investment hedges | 35 | (67) | (1) |
Subtotal foreign currency translation, net of tax | (510) | 1,030 | 92 |
Financial assets measured at fair value through other comprehensive income | |||
Net unrealized gains / (losses), before tax | (203) | 223 | 189 |
Net realized gains / (losses) reclassified to the income statement from equity | (9) | (40) | (31) |
Income tax relating to net unrealized gains / (losses) | 55 | (48) | (41) |
Subtotal financial assets measured at fair value through other comprehensive income, net of tax | (157) | 136 | 117 |
Cash flow hedges of interest rate risk | |||
Effective portion of changes in fair value of hedging instruments recognized in OCI | (992) | 2,012 | 1,571 |
Net (gains) / losses reclassified to the income statement from equity | (1,073) | (770) | (175) |
Income tax related to cash flow hedges | 390 | (231) | (253) |
Subtotal cash flow hedges, net of tax | (1,675) | 1,011 | 1,143 |
Cost of hedging | |||
Cost of hedging, before tax | (32) | (13) | |
Income tax relating to cost of hedging | 6 | 0 | |
Subtotal cost of hedging, net of tax | (26) | (13) | |
Defined benefit plans | |||
Gains / (losses) on defined benefit plans, before tax | 133 | (222) | (129) |
Income tax relating to defined benefit plans | (31) | 88 | (41) |
Subtotal defined benefit plans, net of tax | 102 | (134) | (170) |
Own credit on financial liabilities designated at fair value | |||
Gains / (losses) from own credit on financial liabilities designated at fair value, before tax | 46 | (293) | (400) |
Income tax relating to own credit on financial liabilities designated at fair value | 0 | 0 | 8 |
Subtotal own credit on financial liabilities designated at fair value, net of tax | 46 | (293) | (392) |
Total comprehensive income | |||
Total other comprehensive income | (2,220) | 1,738 | 789 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (2,368) | 2,165 | 1,351 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 148 | (427) | (562) |
Total comprehensive income | 4,813 | 7,934 | 4,754 |
UBS AG | Comprehensive income attributable to non-controlling interests | |||
Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 29 | 15 | 6 |
Total comprehensive income | |||
Total other comprehensive income | (16) | 21 | (4) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (16) | 21 | (4) |
Total comprehensive income | $ 13 | $ 36 | $ 2 |
Consolidated Statement of Com_2
Consolidated Statement of Comprehensive Income (Parenthetical) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Statement Of Comprehensive Income [Table] | ||
Gains / (losses) on defined benefit plans, before tax | $ 2 | $ (327) |
Major plans | ||
Statement Of Comprehensive Income [Table] | ||
Gains / (losses) on defined benefit plans, before tax | (27) | (323) |
Swiss pension plan | ||
Statement Of Comprehensive Income [Table] | ||
Gains / (losses) on defined benefit plans, before tax | (336) | (276) |
Additional employer contributions paid to employees retirement assets | 254 | 235 |
UK pension plan | ||
Statement Of Comprehensive Income [Table] | ||
Gains / (losses) on defined benefit plans, before tax | 207 | (61) |
UBS AG | ||
Statement Of Comprehensive Income [Table] | ||
Gains / (losses) on defined benefit plans, before tax | 133 | (222) |
UBS AG | Major plans | ||
Statement Of Comprehensive Income [Table] | ||
Gains / (losses) on defined benefit plans, before tax | 102 | (219) |
UBS AG | Swiss pension plan | ||
Statement Of Comprehensive Income [Table] | ||
Gains / (losses) on defined benefit plans, before tax | (207) | (172) |
Additional employer contributions paid to employees retirement assets | 152 | 143 |
UBS AG | UK pension plan | ||
Statement Of Comprehensive Income [Table] | ||
Gains / (losses) on defined benefit plans, before tax | $ 207 | $ (61) |
Consolidated Balance Sheet
Consolidated Balance Sheet - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 |
Assets | ||
Cash and balances at central banks | $ 192,817,000,000 | $ 158,231,000,000 |
Loans and advances to banks | 15,480,000,000 | 15,444,000,000 |
Receivables from securities financing transactions | 75,012,000,000 | 74,210,000,000 |
Cash collateral receivables on derivative instruments | 30,514,000,000 | 32,737,000,000 |
Loans and advances to customers | 397,761,000,000 | 379,528,000,000 |
Other financial assets measured at amortized cost | 26,209,000,000 | 27,194,000,000 |
Total financial assets measured at amortized cost | 737,794,000,000 | 687,345,000,000 |
Financial assets at fair value held for trading | 130,821,000,000 | 125,397,000,000 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 43,397,000,000 | 47,098,000,000 |
Derivative financial instruments | 118,142,000,000 | 159,617,000,000 |
Brokerage receivables | 21,839,000,000 | 24,659,000,000 |
Financial assets at fair value not held for trading | 60,080,000,000 | 80,364,000,000 |
Total financial assets measured at fair value through profit or loss | 330,882,000,000 | 390,037,000,000 |
Financial assets measured at fair value through other comprehensive income | 8,844,000,000 | 8,258,000,000 |
Investments in associates | 1,243,000,000 | 1,557,000,000 |
Property, equipment and software | 12,888,000,000 | 13,109,000,000 |
Goodwill and intangible assets | 6,378,000,000 | 6,480,000,000 |
Deferred tax assets | 8,876,000,000 | 9,212,000,000 |
Other non-financial assets | 10,277,000,000 | 9,768,000,000 |
Total assets | 1,117,182,000,000 | 1,125,765,000,000 |
Liabilities | ||
Amounts due to banks | 13,101,000,000 | 11,050,000,000 |
Payables from securities financing transactions | 5,533,000,000 | 6,321,000,000 |
Cash collateral payables on derivative instruments | 31,798,000,000 | 37,312,000,000 |
Customer deposits | 542,007,000,000 | 524,605,000,000 |
Debt issued measured at amortized cost | 139,155,000,000 | 139,232,000,000 |
Other financial liabilities measured at amortized cost | 9,001,000,000 | 9,729,000,000 |
Total financial liabilities measured at amortized cost | 740,595,000,000 | 728,250,000,000 |
Financial liabilities at fair value held for trading | 31,688,000,000 | 33,595,000,000 |
Derivative financial instruments | 121,309,000,000 | 161,102,000,000 |
Brokerage payables designated at fair value | 44,045,000,000 | 38,742,000,000 |
Debt issued designated at fair value | 73,799,000,000 | 61,243,000,000 |
Other financial liabilities designated at fair value | 30,074,000,000 | 30,387,000,000 |
Total financial liabilities measured at fair value through profit or loss | 300,916,000,000 | 325,069,000,000 |
Provisions | 3,518,000,000 | 2,828,000,000 |
Other non-financial liabilities | 11,151,000,000 | 9,854,000,000 |
Total liabilities | 1,056,180,000,000 | 1,066,000,000,000 |
Equity | ||
Share capital | 322,000,000 | 338,000,000 |
Share premium | 15,928,000,000 | 16,753,000,000 |
Treasury shares | (4,675,000,000) | (4,068,000,000) |
Retained earnings | 43,851,000,000 | 38,776,000,000 |
Other comprehensive income recognized directly in equity, net of tax | 5,236,000,000 | 7,647,000,000 |
Equity attributable to shareholders | 60,662,000,000 | 59,445,000,000 |
Equity attributable to non-controlling interests | 340,000,000 | 319,000,000 |
Total equity | 61,002,000,000 | 59,765,000,000 |
Total liabilities and equity | 1,117,182,000,000 | 1,125,765,000,000 |
UBS AG | ||
Assets | ||
Cash and balances at central banks | 192,817,000,000 | 158,231,000,000 |
Loans and advances to banks | 15,360,000,000 | 15,344,000,000 |
Receivables from securities financing transactions | 75,012,000,000 | 74,210,000,000 |
Cash collateral receivables on derivative instruments | 30,514,000,000 | 32,737,000,000 |
Loans and advances to customers | 398,693,000,000 | 380,977,000,000 |
Other financial assets measured at amortized cost | 26,236,000,000 | 27,219,000,000 |
Total financial assets measured at amortized cost | 738,632,000,000 | 688,717,000,000 |
Financial assets at fair value held for trading | 131,033,000,000 | 125,492,000,000 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 43,397,000,000 | 47,098,000,000 |
Derivative financial instruments | 118,145,000,000 | 159,618,000,000 |
Brokerage receivables | 21,839,000,000 | 24,659,000,000 |
Financial assets at fair value not held for trading | 59,642,000,000 | 80,038,000,000 |
Total financial assets measured at fair value through profit or loss | 330,659,000,000 | 389,808,000,000 |
Financial assets measured at fair value through other comprehensive income | 8,844,000,000 | 8,258,000,000 |
Investments in associates | 1,243,000,000 | 1,557,000,000 |
Property, equipment and software | 11,712,000,000 | 11,958,000,000 |
Goodwill and intangible assets | 6,378,000,000 | 6,480,000,000 |
Deferred tax assets | 8,839,000,000 | 9,174,000,000 |
Other non-financial assets | 9,836,000,000 | 9,374,000,000 |
Total assets | 1,116,145,000,000 | 1,125,327,000,000 |
Liabilities | ||
Amounts due to banks | 13,101,000,000 | 11,050,000,000 |
Payables from securities financing transactions | 5,533,000,000 | 6,321,000,000 |
Cash collateral payables on derivative instruments | 31,801,000,000 | 37,313,000,000 |
Customer deposits | 544,834,000,000 | 527,929,000,000 |
Funding from UBS Group AG | 57,295,000,000 | 53,979,000,000 |
Debt issued measured at amortized cost | 82,432,000,000 | 85,351,000,000 |
Other financial liabilities measured at amortized cost | 9,765,000,000 | 10,421,000,000 |
Total financial liabilities measured at amortized cost | 744,762,000,000 | 732,364,000,000 |
Financial liabilities at fair value held for trading | 31,688,000,000 | 33,595,000,000 |
Derivative financial instruments | 121,309,000,000 | 161,102,000,000 |
Brokerage payables designated at fair value | 44,045,000,000 | 38,742,000,000 |
Debt issued designated at fair value | 71,460,000,000 | 59,868,000,000 |
Other financial liabilities designated at fair value | 32,414,000,000 | 31,773,000,000 |
Total financial liabilities measured at fair value through profit or loss | 300,916,000,000 | 325,080,000,000 |
Provisions | 3,452,000,000 | 2,791,000,000 |
Other non-financial liabilities | 8,572,000,000 | 7,018,000,000 |
Total liabilities | 1,057,702,000,000 | 1,067,254,000,000 |
Equity | ||
Share capital | 338,000,000 | 338,000,000 |
Share premium | 24,653,000,000 | 24,580,000,000 |
Retained earnings | 27,912,000,000 | 25,251,000,000 |
Other comprehensive income recognized directly in equity, net of tax | 5,200,000,000 | 7,585,000,000 |
Equity attributable to shareholders | 58,102,000,000 | 57,754,000,000 |
Equity attributable to non-controlling interests | 340,000,000 | 319,000,000 |
Total equity | 58,442,000,000 | 58,073,000,000 |
Total liabilities and equity | $ 1,116,145,000,000 | $ 1,125,327,000,000 |
Consolidated Statement of Chang
Consolidated Statement of Changes in Equity ฿ in Millions, $ in Millions | THB (฿) | USD ($) | Share capitalUSD ($) | Share premiumUSD ($) | Treasury sharesUSD ($) | Retained earningsUSD ($) | Other comprehensive income recognized directly in equity, net of taxUSD ($) | of which: foreign currency translationUSD ($) | of which: financial assets at fair value through other comprehensive incomeUSD ($) | of which: cash flow hedgesUSD ($) | of which: cost of hedgingUSD ($) | Total equity attributable to shareholdersUSD ($) | Non-controlling interestsUSD ($) | UBS AGUSD ($) | UBS AGShare capitalUSD ($) | UBS AGShare premiumUSD ($) | UBS AGRetained earningsUSD ($) | UBS AGOther comprehensive income recognized directly in equity, net of taxUSD ($) | UBS AGof which: foreign currency translationUSD ($) | UBS AGof which: financial assets at fair value through other comprehensive incomeUSD ($) | UBS AGof which: cash flow hedgesUSD ($) | UBS AGof which: cost of hedgingUSD ($) | UBS AGTotal equity attributable to shareholdersUSD ($) | UBS AGNon-controlling interestsUSD ($) |
Statement Of Changes In Equity [Table] | ||||||||||||||||||||||||
Balance before the adoption of IFRIC 23 | $ 53,071 | $ 338 | $ 20,843 | $ (2,631) | $ 30,416 | $ 3,930 | $ 3,924 | $ (103) | $ 109 | $ 52,896 | $ 176 | $ 52,400 | $ 338 | $ 24,655 | $ 23,285 | $ 3,946 | $ 3,940 | $ (103) | $ 109 | $ 52,224 | $ 176 | |||
Balance at Dec. 31, 2018 | 53,060 | 338 | 20,843 | (2,631) | 30,405 | 3,930 | 3,924 | (103) | 109 | 52,885 | 176 | 52,389 | 338 | 24,655 | 23,274 | 3,946 | 3,940 | (103) | 109 | 52,213 | 176 | |||
Statement Of Changes In Equity [Table] | ||||||||||||||||||||||||
Acquisition of treasury shares | (1,771) | (1,771) | (1,771) | |||||||||||||||||||||
Delivery of treasury shares under share-based compensation plans | 97 | (886) | 983 | 97 | ||||||||||||||||||||
Other disposal of treasury shares | 92 | (2) | 94 | 92 | ||||||||||||||||||||
Premium on shares issued and warrants exercised | 29 | 29 | 29 | 0 | 0 | 0 | ||||||||||||||||||
Share-based compensation expensed in the income statement | 619 | 619 | 619 | |||||||||||||||||||||
Tax (expense) / benefit | 11 | 11 | 11 | 11 | 11 | 11 | ||||||||||||||||||
Dividends | (2,552) | (2,544) | (9) | (2,544) | (8) | (3,258) | (3,250) | (3,250) | (8) | |||||||||||||||
Translation effects recognized directly in retained earnings | 0 | 9 | 0 | 9 | 0 | 0 | (9) | 9 | 0 | 9 | 0 | |||||||||||||
New consolidations / (deconsolidations) and other increases / (decreases) | (1) | (6) | (6) | 5 | (3) | (7) | (7) | 5 | ||||||||||||||||
Total comprehensive income for the year | 5,091 | 3,726 | 1,363 | 104 | 117 | 1,143 | 5,089 | 2 | 4,756 | 3,403 | 1,351 | 92 | 117 | 1,143 | 4,754 | 2 | ||||||||
of which: net profit / (loss) | 4,310 | 4,304 | 4,304 | 6 | 3,971 | 3,965 | 3,965 | 6 | ||||||||||||||||
of which: OCI, net of tax | 781 | (578) | 1,363 | 104 | 117 | 1,143 | 785 | (4) | 785 | (562) | 1,351 | 92 | 117 | 1,143 | 789 | (4) | ||||||||
Balance at Dec. 31, 2019 | 54,675 | 338 | 18,064 | (3,326) | 34,122 | 5,303 | 4,028 | 14 | 1,260 | 54,501 | 174 | 53,896 | 338 | 24,659 | 23,419 | 5,306 | 4,032 | 14 | 1,260 | 53,722 | 174 | |||
Statement Of Changes In Equity [Table] | ||||||||||||||||||||||||
Acquisition of treasury shares | ฿ (1,584) | (1,584) | (1,584) | |||||||||||||||||||||
Delivery of treasury shares under share-based compensation plans | 90 | (628) | 719 | 90 | ||||||||||||||||||||
Other disposal of treasury shares | 112 | (11) | 123 | 112 | ||||||||||||||||||||
Premium on shares issued and warrants exercised | (4) | (4) | (4) | |||||||||||||||||||||
Share-based compensation expensed in the income statement | 691 | 691 | 691 | |||||||||||||||||||||
Tax (expense) / benefit | 18 | 18 | 18 | 1 | 1 | 1 | ||||||||||||||||||
Dividends | (2,613) | (1,304) | (1,304) | (2,607) | (6) | (3,854) | (3,848) | (3,848) | (6) | |||||||||||||||
Translation effects recognized directly in retained earnings | 0 | (49) | 49 | 0 | 49 | 0 | 0 | (49) | 49 | 0 | 49 | 0 | ||||||||||||
Share of changes in retained earnings of associates and joint ventures | (40) | (40) | (40) | (40) | (40) | (40) | ||||||||||||||||||
New consolidations / (deconsolidations) and other increases / (decreases) | 103 | (76) | 65 | 65 | (12) | 115 | 103 | (76) | 65 | 65 | (12) | 115 | ||||||||||||
Total comprehensive income for the year | 8,312 | 6,046 | 2,230 | 1,095 | 136 | 1,011 | $ (13) | 8,276 | 36 | 7,970 | 5,769 | 2,165 | 1,030 | 136 | 1,011 | $ (13) | 7,934 | 36 | ||||||
of which: net profit / (loss) | 6,572 | 6,557 | 6,557 | 15 | 6,211 | 6,196 | 6,196 | 15 | ||||||||||||||||
of which: OCI, net of tax | 1,740 | (511) | 2,230 | 1,095 | 136 | 1,011 | (13) | 1,719 | 21 | 1,759 | (427) | 2,165 | 1,030 | 136 | 1,011 | (13) | 1,738 | 21 | ||||||
Balance at Dec. 31, 2020 | 59,765 | 338 | 16,753 | (4,068) | 38,776 | 7,647 | 5,188 | 151 | 2,321 | (13) | 59,445 | 319 | 58,073 | 338 | 24,580 | 25,251 | 7,585 | 5,126 | 151 | 2,321 | (13) | 57,754 | 319 | |
Statement Of Changes In Equity [Table] | ||||||||||||||||||||||||
Acquisition of treasury shares | (3,521) | (3,521) | (3,521) | |||||||||||||||||||||
Delivery of treasury shares under share-based compensation plans | 114 | (675) | 789 | 114 | ||||||||||||||||||||
Other disposal of treasury shares | 88 | 7 | 81 | 88 | ||||||||||||||||||||
Cancelation of treasury shares related to the 2018-2021 share repurchase program | 0 | (16) | (236) | 2,044 | (1,792) | 0 | ||||||||||||||||||
Premium on shares issued and warrants exercised | (7) | (7) | (7) | |||||||||||||||||||||
Share-based compensation expensed in the income statement | 643 | 643 | 643 | |||||||||||||||||||||
Tax (expense) / benefit | (88) | (88) | (88) | (102) | (102) | (102) | ||||||||||||||||||
Dividends | (1,305) | (651) | (651) | (1,301) | (4) | (4,542) | (4,539) | (4,539) | (4) | |||||||||||||||
Equity classified as obligation to purchase own shares | (7) | (7) | (7) | |||||||||||||||||||||
Translation effects recognized directly in retained earnings | 0 | 18 | (18) | 0 | (18) | 0 | 0 | 0 | 18 | (18) | 0 | (18) | 0 | 0 | ||||||||||
Share of changes in retained earnings of associates and joint ventures | 1 | 1 | 1 | 1 | 1 | 1 | ||||||||||||||||||
New consolidations / (deconsolidations) and other increases / (decreases) | 193 | 182 | 182 | 12 | 193 | 182 | 182 | 12 | ||||||||||||||||
Total comprehensive income for the year | 5,119 | 7,499 | (2,393) | (535) | (157) | (1,675) | (26) | 5,106 | 13 | 4,826 | 7,180 | (2,368) | (510) | (157) | (1,675) | (26) | 4,813 | 13 | ||||||
of which: net profit / (loss) | 7,486 | 7,457 | 7,457 | 29 | 7,061 | 7,032 | 7,032 | 29 | ||||||||||||||||
of which: OCI, net of tax | (2,367) | 42 | (2,393) | (535) | (157) | (1,675) | (26) | (2,351) | (16) | (2,235) | 148 | (2,368) | (510) | (157) | (1,675) | (26) | (2,220) | (16) | ||||||
Balance at Dec. 31, 2021 | $ 61,002 | $ 322 | $ 15,928 | $ (4,675) | $ 43,851 | $ 5,236 | $ 4,653 | $ (7) | $ 628 | $ (39) | $ 60,662 | $ 340 | $ 58,442 | $ 338 | $ 24,653 | $ 27,912 | $ 5,200 | $ 4,617 | $ (7) | $ 628 | $ (39) | $ 58,102 | $ 340 |
Consolidated Statement of Cha_2
Consolidated Statement of Changes in Equity (Parenthetical) $ in Millions | Jan. 01, 2019USD ($) | Dec. 31, 2021USD ($)$ / sharesshares | Dec. 31, 2020USD ($)$ / shares | Dec. 31, 2019SFr / shares |
Entity [Table] | ||||
Effect of adoption of IFRIC 23 | $ (11) | |||
Retained earnings | $ 43,851 | $ 38,776 | ||
Compensation-related liabilities | 7,257 | 7,468 | ||
Deferred tax assets | $ 8,876 | $ 9,212 | ||
Ordinary cash dividends paid, ordinary shares per share | (per share) | $ 0.37 | $ 0.73 | SFr 0.70 | |
Maximum percentage of dividends that may be paid from capital contribution reserves | 50.00% | |||
New consolidations / (deconsolidations) and other increases / (decreases) | $ 193 | $ 103 | ||
Own shares purchased and cancelled as part of 2018-2021 share repurchase program | shares | 156,632,400 | |||
Minimum percentage of the total capital reduction amount exceeding the nominal value by which captal contribution reserves are reduced upon cancellation of the shares | 50.00% | |||
UBS Brasil Servicos | ||||
Entity [Table] | ||||
Decrease in proportion of ownership in subsidiaries that do not result in loss of control | 49.99% | |||
Share premium | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | $ 182 | $ (76) | ||
Retained earnings | ||||
Entity [Table] | ||||
Effect of adoption of IFRIC 23 | (11) | |||
Other comprehensive income recognized directly in equity, net of tax | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | 65 | |||
of which: foreign currency translation | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | 65 | |||
Total equity attributable to shareholders | ||||
Entity [Table] | ||||
Effect of adoption of IFRIC 23 | (11) | |||
New consolidations / (deconsolidations) and other increases / (decreases) | 182 | (12) | ||
Non-controlling interests | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | 12 | 115 | ||
Non-controlling interests | UBS Brasil Servicos | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | 115 | |||
UBS AG | ||||
Entity [Table] | ||||
Effect of adoption of IFRIC 23 | (11) | |||
Retained earnings | 27,912 | 25,251 | ||
Compensation-related liabilities | 4,795 | 4,776 | ||
Deferred tax assets | 8,839 | 9,174 | ||
New consolidations / (deconsolidations) and other increases / (decreases) | 193 | $ 103 | ||
UBS AG | UBS Brasil Servicos | ||||
Entity [Table] | ||||
Decrease in proportion of ownership in subsidiaries that do not result in loss of control | 49.99% | |||
UBS AG | Share premium | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | 182 | $ (76) | ||
UBS AG | Retained earnings | ||||
Entity [Table] | ||||
Effect of adoption of IFRIC 23 | (11) | |||
UBS AG | Other comprehensive income recognized directly in equity, net of tax | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | 65 | |||
UBS AG | of which: foreign currency translation | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | 65 | |||
UBS AG | Total equity attributable to shareholders | ||||
Entity [Table] | ||||
Effect of adoption of IFRIC 23 | $ (11) | |||
New consolidations / (deconsolidations) and other increases / (decreases) | 182 | (12) | ||
UBS AG | Non-controlling interests | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | $ 12 | 115 | ||
UBS AG | Non-controlling interests | UBS Brasil Servicos | ||||
Entity [Table] | ||||
New consolidations / (deconsolidations) and other increases / (decreases) | $ 115 |
Share information and earnings
Share information and earnings per share - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Shares issued | |||
Balance at the beginning of the year | 3,859,055,395 | 3,859,055,395 | 3,855,634,749 |
Issuance / (canceled) of shares | (156,632,400) | 3,420,646 | |
Balance at the end of the year | 3,702,422,995 | 3,859,055,395 | 3,859,055,395 |
Treasury shares | |||
Balance at the beginning of the year | 307,477,002 | 243,021,296 | 166,467,802 |
Acquisitions | 214,270,175 | 128,372,257 | 146,876,692 |
Disposals | (62,299,449) | (63,916,551) | (70,323,198) |
Cancellation of second trading line treasury shares | (156,632,400) | ||
Balance at the end of the year | 302,815,328 | 307,477,002 | 243,021,296 |
Shares outstanding | 3,399,607,667 | 3,551,578,393 | 3,616,034,099 |
Basic and diluted earnings | |||
Net profit / (loss) attributable to shareholders | $ 7,457 | $ 6,557 | $ 4,304 |
Less: (profit) / loss on own equity derivative contracts | 0 | (1) | 0 |
Net profit / (loss) attributable to shareholders for diluted EPS | $ 7,457 | $ 6,556 | $ 4,304 |
Weighted average shares outstanding | |||
Weighted average shares outstanding for basic EPS | 3,482,963,682 | 3,583,176,189 | 3,663,278,238 |
Effect of dilutive potential shares resulting from notional shares, in-the-money options and warrants outstanding | 144,277,693 | 123,852,137 | 103,881,600 |
Weighted average shares outstanding for diluted EPS | 3,627,241,375 | 3,707,028,326 | 3,767,159,838 |
Earnings per share | |||
Basic | $ 2.14 | $ 1.83 | $ 1.17 |
Diluted | $ 2.06 | $ 1.77 | $ 1.14 |
Potentially dilutive instruments | |||
Employee share-based compensation awards | 5,886,945 | 2,536,789 | |
Other equity derivative contracts | 6,553,051 | 11,414,728 | 21,632,879 |
Total | 12,439,996 | 13,951,517 | 21,632,879 |
UBS AG | |||
Shares issued | |||
Balance at the beginning of the year | 3,858,408,466 | ||
Balance at the end of the year | 3,858,408,466 | 3,858,408,466 | |
Basic and diluted earnings | |||
Net profit / (loss) attributable to shareholders | $ 7,032 | $ 6,196 | $ 3,965 |
Consolidated Statement of Cash
Consolidated Statement of Cash Flows - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Cash flow from / (used in) operating activities | |||
Net profit / (loss) | $ 7,486 | $ 6,572 | $ 4,310 |
Non-cash items included in net profit and other adjustments: | |||
Credit loss expense / (release) | (148) | 694 | 78 |
Share of net profits of associates and joint ventures and impairment related to associates | (105) | (84) | (45) |
Deferred tax expense / (benefit) | 434 | 352 | 477 |
Net loss / (gain) from investing activities | (230) | (698) | 220 |
Net loss / (gain) from financing activities | 100 | 3,246 | 6,493 |
Other net adjustments | 3,802 | (8,076) | 854 |
Depreciation, amortization and impairment of non-financial assets | 2,118 | 2,126 | 1,940 |
Net change in operating assets and liabilities: | |||
Loans and advances to banks and amounts due to banks | 2,148 | 3,586 | (4,336) |
Securities financing transactions | (2,316) | 9,588 | 8,678 |
Cash collateral on derivative instruments | (3,312) | (3,487) | 2,839 |
Loans and advances to customers | (27,460) | (33,656) | (3,128) |
Customer deposits | 29,825 | 51,805 | 23,217 |
Financial assets and liabilities at fair value held for trading and derivative financial instruments | (10,516) | 11,259 | (18,829) |
Brokerage receivables and payables | 8,115 | (5,199) | (2,347) |
Financial assets at fair value not held for trading, other financial assets and liabilities | 19,609 | 320 | 33 |
Provisions, other non-financial assets and liabilities | 3,010 | (387) | 55 |
Income taxes paid, net of refunds | (1,134) | (1,002) | (804) |
Net cash flow from / (used in) operating activities | 31,425 | 36,958 | 19,705 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (1) | (46) | (26) |
Disposal of subsidiaries, associates and intangible assets | 593 | 674 | 114 |
Purchase of property, equipment and software | (1,841) | (1,854) | (1,584) |
Disposal of property, equipment and software | 295 | 366 | 11 |
Purchase of financial assets measured at fair value through other comprehensive income | (5,802) | (6,290) | (3,424) |
Disposal and redemption of financial assets measured at fair value through other comprehensive income | 5,052 | 4,530 | 3,913 |
Net (purchase) / redemption of debt securities measured at amortized cost | (415) | (4,166) | (562) |
Net cash flow from / (used in) investing activities | (2,119) | (6,785) | (1,558) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | (3,093) | 23,845 | (17,149) |
Net movements in treasury shares and own equity derivative activity | (3,341) | (1,387) | (1,559) |
Distributions paid on UBS shares | (1,301) | (2,607) | (2,544) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 98,272 | 80,255 | 65,047 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (79,909) | (87,098) | (68,883) |
Net cash flows from other financing activities | (282) | (575) | (526) |
Net cash flow from / (used in) financing activities | 10,345 | 12,432 | (25,614) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 173,531 | 119,873 | 126,079 |
Net cash flow from / (used in) operating, investing and financing activities | 39,651 | 42,605 | (7,467) |
Effects of exchange rate differences on cash and cash equivalents | (5,307) | 11,052 | 1,261 |
Cash and cash equivalents at the end of the year | 207,875 | 173,531 | 119,873 |
Net cash flow from / (used in) operating activities includes: | |||
Interest received in cash | 11,163 | 11,915 | 15,315 |
Interest paid in cash | 4,707 | 6,320 | 10,769 |
Dividends on equity investments, investment funds and associates received in cash | 2,531 | 1,901 | 3,145 |
UBS AG | |||
Cash flow from / (used in) operating activities | |||
Net profit / (loss) | 7,061 | 6,211 | 3,971 |
Non-cash items included in net profit and other adjustments: | |||
Credit loss expense / (release) | (148) | 695 | 78 |
Share of net profits of associates and joint ventures and impairment related to associates | (105) | (84) | (45) |
Deferred tax expense / (benefit) | 432 | 355 | 460 |
Net loss / (gain) from investing activities | (230) | (698) | 220 |
Net loss / (gain) from financing activities | 100 | 3,246 | 6,506 |
Other net adjustments | 3,790 | (8,061) | 862 |
Depreciation, amortization and impairment of non-financial assets | 1,875 | 1,909 | 1,751 |
Net change in operating assets and liabilities: | |||
Loans and advances to banks and amounts due to banks | 2,148 | 3,586 | (4,336) |
Securities financing transactions | (2,316) | 9,588 | 8,678 |
Cash collateral on derivative instruments | (3,311) | (3,486) | 2,842 |
Loans and advances to customers | (26,943) | (33,897) | (3,205) |
Customer deposits | 29,349 | 52,831 | 23,399 |
Financial assets and liabilities at fair value held for trading and derivative financial instruments | (10,635) | 11,326 | (18,873) |
Brokerage receivables and payables | 8,115 | (5,199) | (2,347) |
Financial assets at fair value not held for trading, other financial assets and liabilities | 19,793 | 392 | 126 |
Provisions, other non-financial assets and liabilities | 2,617 | (1,213) | (537) |
Income taxes paid, net of refunds | (1,026) | (919) | (741) |
Net cash flow from / (used in) operating activities | 30,563 | 36,581 | 18,805 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (1) | (46) | (26) |
Disposal of subsidiaries, associates and intangible assets | 593 | 674 | 114 |
Purchase of property, equipment and software | (1,581) | (1,573) | (1,401) |
Disposal of property, equipment and software | 295 | 364 | 11 |
Purchase of financial assets measured at fair value through other comprehensive income | (5,802) | (6,290) | (3,424) |
Disposal and redemption of financial assets measured at fair value through other comprehensive income | 5,052 | 4,530 | 3,913 |
Net (purchase) / redemption of debt securities measured at amortized cost | (415) | (4,166) | (562) |
Net cash flow from / (used in) investing activities | (1,860) | (6,506) | (1,374) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | (3,093) | 23,845 | (17,149) |
Distributions paid on UBS shares | (4,539) | (3,848) | (3,250) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 98,619 | 80,153 | 65,047 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (79,799) | (87,099) | (68,883) |
Net cash flows from other financing activities | (261) | (553) | (504) |
Net cash flow from / (used in) financing activities | 10,927 | 12,498 | (24,738) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 173,430 | 119,804 | 125,853 |
Net cash flow from / (used in) operating, investing and financing activities | 39,630 | 42,573 | (7,307) |
Effects of exchange rate differences on cash and cash equivalents | (5,306) | 11,053 | 1,258 |
Cash and cash equivalents at the end of the year | 207,755 | 173,430 | 119,804 |
Net cash flow from / (used in) operating activities includes: | |||
Interest received in cash | 11,170 | 11,929 | 15,344 |
Interest paid in cash | 4,802 | 6,414 | 10,800 |
Dividends on equity investments, investment funds and associates received in cash | $ 2,531 | $ 1,901 | $ 3,145 |
Consolidated Statement ot Cash
Consolidated Statement ot Cash Flows (Parenthetical) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Restricted cash and cash equivalents | $ 3,408 | $ 3,828 | $ 3,192 |
Cash and balances at central banks classified as cash equivalents | 192,706 | 158,088 | 106,957 |
Loans and advances to banks classified as cash equivalents | 13,942 | 14,028 | 11,386 |
Money market paper classified as cash equivalents | 1,227 | 1,415 | 1,530 |
Disposal of subsidiaries, associates and intangible assets | 593 | 674 | 114 |
UBS AG | |||
Entity [Table] | |||
Restricted cash and cash equivalents | 3,408 | 3,828 | 3,192 |
Cash and balances at central banks classified as cash equivalents | 192,706 | 158,088 | 106,957 |
Loans and advances to banks classified as cash equivalents | 13,822 | 13,928 | 11,317 |
Money market paper classified as cash equivalents | 1,227 | 1,415 | 1,530 |
Disposal of subsidiaries, associates and intangible assets | $ 593 | $ 674 | $ 114 |
Changes in liabilities arising
Changes in liabilities arising from financing activities - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | $ 15,270 | $ 17,002 | |
Non-cash changes | (2,724) | 6,207 | |
of which: foreign currency translation | (4,857) | 6,824 | |
of which: fair value changes | 4,106 | (1,946) | |
of which: other | (1,972) | 1,328 | |
Balance | 215,082 | 202,535 | $ 179,327 |
Debt issued measured at amortized cost | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 5,070 | 22,428 | |
Non-cash changes | (5,148) | 6,308 | |
of which: foreign currency translation | (3,175) | 4,980 | |
of which: other | (1,972) | 1,328 | |
Balance | 139,155 | 139,232 | 110,497 |
of which: short-term | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | (3,093) | 23,845 | |
Non-cash changes | (475) | 984 | |
of which: foreign currency translation | (475) | 984 | |
Balance | 43,098 | 46,666 | 21,837 |
of which: long-term | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 8,163 | (1,417) | |
Non-cash changes | (4,673) | 5,324 | |
of which: foreign currency translation | (2,700) | 3,995 | |
of which: other | (1,972) | 1,328 | |
Balance | 96,057 | 92,566 | 88,660 |
Debt issued designated at fair value | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 10,076 | (5,420) | |
Non-cash changes | 2,480 | (146) | |
of which: foreign currency translation | (1,617) | 1,764 | |
of which: fair value changes | 4,097 | (1,909) | |
Balance | 73,799 | 61,243 | 66,809 |
Over-the-counter debt instruments | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 124 | (6) | |
Non-cash changes | (56) | 44 | |
of which: foreign currency translation | (65) | 81 | |
of which: fair value changes | 9 | (37) | |
Balance | 2,128 | 2,060 | 2,022 |
UBS AG | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 15,727 | 16,899 | |
Non-cash changes | (2,705) | 6,203 | |
of which: foreign currency translation | (4,857) | 6,825 | |
of which: fair value changes | 4,104 | (1,946) | |
of which: other | (1,953) | 1,324 | |
Balance | 215,655 | 202,633 | 179,531 |
UBS AG | Debt issued measured at amortized cost | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | (550) | 18,722 | |
Non-cash changes | (2,369) | 3,794 | |
of which: foreign currency translation | (1,841) | 3,589 | |
of which: other | (528) | 205 | |
Balance | 82,432 | 85,351 | 62,835 |
UBS AG | of which: short-term | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | (3,093) | 23,845 | |
Non-cash changes | (475) | 984 | |
of which: foreign currency translation | (475) | 984 | |
Balance | 43,098 | 46,666 | 21,837 |
UBS AG | of which: long-term | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 2,543 | (5,123) | |
Non-cash changes | (1,894) | 2,810 | |
of which: foreign currency translation | (1,366) | 2,605 | |
of which: other | (528) | 205 | |
Balance | 39,334 | 38,685 | 40,998 |
UBS AG | Debt issued designated at fair value | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 9,075 | (6,423) | |
Non-cash changes | 2,516 | (301) | |
of which: foreign currency translation | (1,611) | 1,760 | |
of which: fair value changes | 4,127 | (2,061) | |
Balance | 71,460 | 59,868 | 66,592 |
UBS AG | Over-the-counter debt instruments | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 126 | (6) | |
Non-cash changes | (58) | 44 | |
of which: foreign currency translation | (65) | 82 | |
of which: fair value changes | 7 | (38) | |
Balance | 2,128 | 2,060 | 2,022 |
UBS AG | Funding from UBS Group AG and its subsidiaries | |||
Disclosure Of Reconciliation Of Liabilities Arising From Financing Activities [Table] | |||
Cash flows | 7,076 | 4,606 | |
Non-cash changes | (2,795) | 2,666 | |
of which: foreign currency translation | (1,340) | 1,395 | |
of which: fair value changes | (30) | 152 | |
of which: other | (1,425) | 1,119 | |
Balance | $ 59,635 | $ 55,354 | $ 48,083 |
Share information; Earnings per
Share information; Earnings per share | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Share capital | Ordinary share capital As 3,702,422,995 issued shares 0.10 a share 370,242,299.50 . Shares by 157 16 2021, as the 156,632,400 share reduction, General Meeting. Conditional share capital As of 31 December 2021, the was available to UBS Group AG’s Board of Directors (BoD): – A 38,000,000 380,000,000 of 0.10 mandatory granted financial markets. This conditional the Extraordinary 26 November Annual General Meeting (AGM) of UBS The BoD has not made use of such allowance. A maximum 12,170,583 121,705,830 fully paid 0.10 each, stock appreciation rights issued to employees and members of the subsidiaries. This by the shareholders at the same EGM in 2014. Authorized share capital UBS 31 December 2021 . |
Share repurchase program | Share repurchase programs In March to CHF 2 repurchas ed 8 million res for USD 112 31 acquisition cost of USD 364 The 2018–2021 and the 156,632,400 repurchase reduction, General Meeting. In repurchase program 4 UBS repurchased 153 cost of USD 2,500 2,294 |
UBS AG | |
Entity [Table] | |
Share capital | Ordinary share capital As 3,858,408,466 shares 3,858,408,466 nominal 0.10 CHF 385,840,846.60 . UBS Group AG. Conditional share capital As of 31 December 2021, the following was available to UBS AG’s Board of Directors (BoD): – A of 38,000,000 380,000,000 of 0.10 mandatory granted financial markets. This conditional the Annual General Meeting of UBS BoD has not made use of such allowance. Authorized share capital UBS 31 December 2021. Earnings per share In Exchange and the New York Stock Exchange. As of 31 December 2021, 100% of UBS AG’s issued shares AG and therefore were not publicly traded. Accordingly, earnings per share information is not provided for UBS AG. |
Material accounting policies
Material accounting policies | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Material accounting policies | Note 1 Material accounting policies This Note describes the preparation of the Statements) Group). authorized for issue by the Board of Directors. Basis of accounting The Financial Statements have been prepared in accordance with International Financial Reporting International presented in US dollars (USD). Disclosures and funding, integral part of the Financial to requirements Financial Instruments: , and Presentation , and repeated in this section. The applied consistently in all years presented unless otherwise stated in Note 1b. Critical accounting estimates and judgments Preparation of these Financial to apply amounts contingent time they are made. Such available such estimates assumptions, which future and other pertinent factors, to determine their continuing relevance based on current conditions, estimates and Statements. Furthermore, actual results may differ significantly from UBS’s estimates, was anticipated The judgment Financial Statements: – expected credit loss measurement (refer to item 2g in this Note and to Note 20); – fair value measurement (refer to item 2f in this Note – income taxes (refer to item 6 in this Note and to Note – provisions and contingent liabilities (refer to item 9 Note 18); – post-employment benefit 27); – goodwill (refer to item 8 in this Note and to Note – consolidation of structured entities (refer to Note 29). 1) Consolidation The Financial Statements comprise the parent company as ; intercompany balances have been it when (ii) exposure to use its power to affect its own returns. Consideration determine whether the Group has the current ability decisions about those activities need to be made. Subsidiaries, when control control ceases. and circumstances indicate that there is a change to one or more elements required to establish that control is present. Business combinations are accounted for using the acquisition method. The amount of any non-controlling at acquiree’s identifiable net assets. › Refer to Note 29 for more information Critical accounting estimates and judgments Each aforementioned consolidation principles. complex determining whether extent of UBS’s involvement is unique for each entity, consolidation outcome consolidated while assessment, judgment circumstances, including the the substance of voting and similar rights. › Refer to Note 29 for more information 2) Financial instruments a. Recognition UBS recognizes financial instruments when it contractual date derivative financial instruments. In transactions the financial the transferor, UBS does not recognize the transferred as its asset. UBS also acts in a fiduciary capacity, which results in it holding or benefit plans and definition they are income is excluded from the Financial Statements. Client execution through neither obtains benefits from nor controls such cash balances. b. Classification, measurement and presentation Financial assets All financial instruments value through through . For financial subsequently measured at amortized cost or value is adjusted for directly attributable transaction costs. Where the flows that are the the is classified business model that has collect business with the objective being achieved collecting contractual cash flows and selling financial assets. All those except for derivatives case hedge accounting requirements apply (refer Note for more information). Business model assessment and contractual cash flow characteristics UBS determines the way financial assets are managed to achieve a particular business objective. In Group asset contain a contractual cash flows arising over the life of the instrument. Financial liabilities Financial liabilities measured at amortized cost Debt capital instruments containing the principal amounts equity upon either breach the Swiss Supervisory Authority (FINMA) that a viability event has occurred. Such contractual provisions are not is deemed to be a non-financial variable specific to a party to contract. If a debt a future the difference between any equity issued recognized in the income statement. A gain or loss is recognized in Other income is subsequently repurchased A reissuance of debt. Financial liabilities measured at fair value through profit or loss UBS liabilities at fair value financial instruments managed on a fair information), derivative including issuance of certain structured debt instruments. Measurement and presentation After initial recognition, UBS financial described in the table on the following pages. Classification, measurement and presentation Classification, measurement and presentation Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – cash and balances at central banks; – loans and advances to banks; – receivables from securities financing transactions; – cash collateral receivables on derivative instruments; – residential and commercial mortgages; – corporate loans; – secured loans, including Lombard loans, and unsecured loans; – loans to financial advisors; – debt securities held as high-quality liquid (HQLA). Measured at amortized cost using the effective interest method less allowances for expected credit losses (refer to items 2d and 2g in this Note for more information). The following items are recognized in the income statement: – interest income, which is accounted for in accordance with item 2d – ECL and reversals; – foreign exchange (FX) translation gains and losses. When a financial asset at amortized cost is derecognized, the gain or loss is recognized in the income statement. For amounts arising from settlement of certain derivatives, refer to the next page. Measured at FVOCI Debt instruments measured at FVOCI This classification primarily includes debt securities certain asset-backed securities held as HQLA. Measured at fair value, reported in Other comprehensive income, net of applicable income taxes, until such investments are derecognized. Upon derecognition, any accumulated balances in Other comprehensive income are reclassified to the income statement and reported within Other income. The following items, which are determined on the basis as for financial assets measured at amortized cost, recognized in the income statement: – interest income, which is accounted for in accordance with item 2d – ECL and reversals; – FX translation gains and losses. Financial assets classification Significant items included Measurement and presentation Measured at FVTPL Held for trading Financial assets held for trading include: – all derivatives with a positive replacement value, those that are designated and effective hedging instruments; and – other financial assets acquired principally for the purpose of selling or repurchasing in the near term, or that are part of a portfolio of identified financial instruments that are managed together and for there is evidence of a recent actual pattern of short-term profit taking. Included in this category are debt instruments (including those in the form of money market paper, loans) and equity instruments. Measured at fair value, income statement. Derivative assets (including derivatives that and effective hedging instruments) are generally presented as Derivative financial instruments , except those exchange-traded (ETD) and over-the-counter cleared derivatives that are legally settled on a daily or in substance net settled on a daily basis, presented within Cash collateral receivables on derivative instruments. Changes in fair value, initial transaction costs, and gains and losses arising on disposal or redemption recognized in Other net income from financial instruments measured at fair value through , except interest income on instruments other than derivatives (refer to item 2d in this Note), interest on derivatives designated as hedging instruments of interest rate risk and forward points on certain short- and long-duration FX contracts acting as economic hedges, which are reported in Net interest income. Changes in the fair value of derivatives that designated and effective hedging instruments are presented either in the income statement or Other comprehensive income , depending on the type of hedge relationship (refer to item 2j in this Note for more information). Mandatorily measured at FVTPL – Other This classification includes financial assets measured at FVTPL that are not held for trading, as follows: – certain structured loans, certain commercial loans, and receivables from securities financing transactions are managed on a fair value basis; – loans managed on a fair value basis, including those hedged with credit derivatives; – certain debt securities held as HQLA and fair value basis; – certain investment fund holdings and assets hedge delivery obligations related to cash-settled employee compensation plans; – brokerage receivables, for which contractual cash flows do not meet the SPPI criterion because the aggregate balance is accounted for as a single unit of with interest being calculated on the individual components; – auction rate securities, for which contractual cash do not meet the SPPI criterion because interest may reset at rates that contain leverage; – equity – assets held under unit-linked investment contracts. Financial liabilities classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – demand and time deposits; – retail savings / deposits; – payables – non-structured fixed-rate bonds; – subordinated debt; – certificates of deposit and covered bonds; and – cash collateral payables on derivative instruments. Measured at amortized cost using the effective interest method. When a financial liability at amortized cost is derecognized, the gain or loss is recognized in the income statement. Measured at fair value through profit or loss Held for trading Financial liabilities held for trading include: – all derivatives with a negative replacement value (including certain loan commitments), that are designated and effective hedging instruments; and – obligations to deliver financial instruments, debt and equity instruments, that UBS has third parties but does not own (short positions). Measurement and presentation of financial liabilities classified at FVTPL follow the same principles financial assets classified at FVTPL, except that of change in the fair value of a financial liability designated at FVTPL that is attributable to changes UBS’s own credit risk is presented in Other comprehensive income Retained earnings and is never reclassified to the income statement. Derivative liabilities (including derivatives that designated and effective hedging instruments) generally presented as Derivative financial instruments , except those exchange-traded and OTC-cleared derivatives that are legally settled on a daily basis substance net settled on a daily basis, which presented within Cash collateral payables on derivative instruments. Designated at FVTPL UBS designates liabilities: – issued hybrid debt instruments that primarily equity-linked, credit-linked and rates-linked bonds notes; – issued debt instruments managed on a fair basis; – certain payables from securities financing transactions; – amounts due under unit-linked investment contracts the cash flows of which are linked to financial measured at FVTPL and eliminate an accounting mismatch; – brokerage payables, which arise in conjunction with brokerage receivables and are measured at FVTPL to achieve measurement consistency. c. Loan commitments and financial guarantees Loan defined terms and classified value through profit fair measured at Financial guarantee that holder make specified debt instrument. d. Interest income and expense Interest statement based the effective method . calculating instruments UBS estimates future cash flows considering all contractual terms of applied to the gross carrying amount of the financial asset amortized cost asset income is determined by the adjusted for any credit loss allowance. Upfront measured at fair value where a loan is expected to be issued, and direct financial recognized over the expected EIR. Fees related to be issued, as well as loan syndication fees where UBS does not retain a portion of a comparable risk as other participants, are included in Net fee and commission and commitment or when syndication occurs. › Refer to item 3 in this Note for more information Interest included in interest income when positive and in interest expense when negative. excluding derivatives, is interest rates are income. › Refer to item 2b 3 e. Derecognition Financial assets UBS derecognizes financial asset, risks and rewards of the asset or rewards asset. Where similar transferred if the counterparty has received the contractual rights to the cash flows of for example, In transfers where control over the financial asset is retained, UBS continues involvement, determined changes transfer. Certain futures counterparties and daily basis, basis derecognition of the associated derivatives. › Refer to Note 22 and 23 Financial liabilities UBS derecognizes a financial liability when when canceled exchanged for a different substantially modified, the original new carrying amounts recognized in the income statement. f. Fair value of financial instruments UBS accounts at fair value. Fair value is the price on the measurement date that would be liability in the principal market, absence of a principal market. › Refer to Note 21 for more information Critical accounting estimates and judgments The use unobservable market requires recorded heavily on unobservable a higher that market close-out costs, which are presented in Note 21d. UBS‘s governance framework over in Note 21b, arising from instruments to reasonably possible alternative › Refer to Note 21 for more information ECL cost, receivables, , and not measured at portion which include UBS’s credit as ability before mitigation actions. Recognition of expected credit losses ECL are recognized on the following basis: – Stage 1 instruments: Maximum 12-month from initial recognition, shortfalls that would after occurring. – Stage 2 significant an SICR) subsequent lifetime default events over the expected life of a financial instrument, weighted by no longer observed, the instrument will move back to stage 1. – Stage 3 credit-impaired occurrence of one or more loss events, by estimating cash recovery strategy. - impaired allowance has been recognized, for example because they are expected to be fully recoverable through collateral held. – Changes recognized for impaired (POCI). POCI financial instruments include those that are purchased defaulted counterparty; they derecognition. All uncollectible or forgiven. of a losses. Recoveries, in part or in full, of off are generally credited to Credit loss (expense) / release . ECL Credit (expense) / release . A corresponding ECL allowance is reported as a decrease in the carrying amount of financial assets measured at amortized cost on the balance sheet. measured at accumulated Other income . credit lines, provisions for ECL are presented in Provisions. Default and credit impairment UBS management counterparty qualitative criteria. › Refer to “Credit policies for distressed assets” management and control” section of this report for information Measurement of expected credit losses IFRS based method factors: probability exposure on an the overdrafts derives an average LGDs used in the ECL calculation are point-in-time (PIT)-based for key portfolios and consider both current conditions and expected cyclical PDs determined for treated as scenario independent. For the UBS leverages its are also used in determining expected loss (EL) and risk-weighted assets under Adjustments have been made to these models and IFRS 9-related models structure and of the fact that PDs and LGDs used in the ECL calculation are PIT- based, cycle (TTC) parameters. expected credit oversight processes. Probability of default: PD represents the over probability of lifetime remaining lifetime of PDs and scenario forecasts. client scenario dependencies and client-idiosyncratic information. Exposure EAD exposure to credit risk considering accruals, discounted at considered reflective characteristics of the respective portfolios. Loss given LGD represents time of a potential future cash expected claims and, where applicable, time to realization of collateral and the seniority of EAD. Estimation of expected credit losses Number of scenarios and estimation of scenario weights Determination of probability range especially assumptions about macroeconomic factors on the estimate. To economic . Each represented considering the exposure of key portfolios to economic risks, and for determined. The estimation scenarios based on a conditions, takes severity economic variables. The respective that macroeconomic variables will materialize. Macroeconomic and other factors The modeled historical information is key factors. information cycle-sensitive PD and LGD determination purposes, UBS projects the relevant reverting, over a specified period, to longer-term projections. Factors relevant Regional into considering UBS’s key ECL-relevant portfolios. For variables represent the most relevant factors for ECL calculation: – GDP growth rates, given performance; – unemployment clients’ ability to meet contractual obligations; – house price indices, given their collateral valuations; – interest rates, abilities to service debt; – consumer companies’ and economic stability; and – equity indices, corporate rating tools. Scenario generation, review process and governance A develop involvement from a broad range of experts. The other Scenario Sounding Sessions and ECL Management Forum, which include senior management from Group Risk and Group Finance. Important aspects particular credit addressed systematically and stage allocation and ECL allowance. The Committee , as authority under UBS’s decisions taken by the ECL Management Forum. › Refer to Note 20 for more information ECL measurement period The period for which lifetime ECL are determined is based on the maximum taking prepayment financial guarantee contracts, the maximum contractual period for which to extend credit. Additionally, demand loan and contractual credit risk ability to actions. In such cases UBS is required to estimate which it is exposed to credit risk. This applies to UBS’s credit card limits, which do not have a callable components are managed as one exposure. from UBS’s credit a portfolio level, past due. for credit card as a proxy for the period that UBS is exposed to credit risk. Customary market commitments. monitoring trends combination events trigger additional informed credit are not subject a management practices and formal credit re-origination measurement types of facilities as UBS is exposed to credit risk, with 12 months also back SICR, always reporting date. Significant increase in credit risk Financial ongoing maximum assessment initial quantitative Primarily, default forward-looking instrument determined at two different dates: – at the reporting date; and – at inception of the instrument. If, based on UBS’s a instrument is transferred to stage 2 with lifetime ECL recognized The threshold quality of the borrower, instruments based on PD changes A high-level the downgrades, The actual SICR level by interpolating between the values shown in the table. Internal rating at origination of the instrument Rating downgrades / SICR trigger 0–3 3 4–8 2 9–13 1 Irrespective probabilities, credit increased for an instrument if the contractual payments are more than specifically criterion instruments are transferred to stage 2 due criterion, transfer Personal & Region Switzerland but applied before a transfer back to stage 1 can be triggered. Additionally, indicators, economic list, which is used as a Exception management is further applied, and collective adjustments risk characteristics not otherwise fully reflected. In apply certain other asset-based management processes with strict margining. If margin calls are not satisfied, a position exceptional stage 2 may be made to take account of specific facts. Credit risk SICR, from mainly arises because instrument-specific, exposures stage 2 will actual holistic counterparty risk at any given date may be warranted. › Refer to the “ Risk management and control ” section of this report for more information Critical accounting estimates and judgments The calculation of ECL requires management and make estimates and assumptions to the timing and amount of ECL recognized. Determination of a significant increase in IFRS 9 does assessment considering qualitative and quantitative criteria. An IFRS 9 ECL Management Forum results. Scenarios, scenario weights and macroeconomic ECL determines selects variables conditions. IFRS Management scenario selection and weights, post-model adjustments are required that may significantly ECL measurement period Lifetime ECL are of the transaction, Swiss callable determine the period over period is positions, and a 12-month period applied for Modeling and post-model adjustments A number ECL, significantly affect controls and GMGC) . - model are ECL Management Forum and endorsed by the A sensitivity covering , weights and SICR trigger points 20f. › Refer to Note 20 for more information h. Restructured and modified financial assets When payment default is expected, occurred, difficulties that business, such as modifying subordination, granted, each case generally classified as will preferential granted preferential conditions no longer exceed UBS’s risk tolerance. Modifications result in an alteration of future contractual cash flows and can occur within UBS’s normal risk tolerance or as part of difficulties. The could lead resulting in the new does modified contractual cash the existing recognized in the i. Offsetting UBS net if (i) it has a legally enforceable right to set amounts realize positions include, for example, certain derivatives and repurchase and reverse exchanges and clearing houses. In assessing whether or emphasis is placed on the effectiveness of operational settlement mechanics exposure offsetting on the balance financial assets and liabilities, even enforceable netting arrangements. securities extent insignificant, receivables and payables in a single settlement process or cycle. › Refer to Note 22 for more information . Hedge accounting The Group stated otherwise hedge meets discontinued. Voluntary permitted under Fair value hedges of interest rate risk related to debt instruments and loan assets The fair value change risk is hedged item, and recognized the change Fair value hedges of portfolio interest rate risk related to loans designated under IAS 39 Prior to discontinuation in December 2021, the fair value change of the Other or Other financial liabilities measured and recognized in the income statement the hedging instrument. Fair value hedges of FX risk related to debt instruments The hedged risk and recognized in the fair value of basis derivatives is excluded from the designation and a cost of hedging with Other comprehensive income Equity . These amounts are released statement over the term of the hedged item. Discontinuation of fair value hedges Discontinuations item amortized to the income statement over the remaining life of the hedged is derecognized, cost of statement Cash flow hedges of forecast transactions Fair value gains derivatives designated as cash risk are recognized initially in Other comprehensive income within Equity when including discontinued expected expected to reclassified to the income statement. Hedges of net investments in foreign operations Gains or losses on the hedging portion of a hedge are recognized Other comprehensive income Equity, while ineffective element statement. the cumulative Equity associated is reclassified Other income . Interest Rate Benchmark Reform UBS uncertainty before existing interest rate benchmarks are replaced with can exist, probable with little no consequential impact replacement risk-free apply the requirements of Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (Interest Rate Benchmark Reform – Phase 2). › Refer to Note 1b for more information 3) Fee and commission income and expenses UBS provides to its categories: certain custody from contingent (e.g., s execution recognizes fully requires on a systematic basis over the life of the agreement. Consideration identifiable performance nature performance obligations are typically those that include time management consequence, UBS is not allocating performance obligations. Point-in-time dependent on trade performance recognized on Custodial reference to the size of the customer portfolio. However, generally customer’s portfolio and period. management beyond UBS’s control until such uncertainties are resolved. UBS’s fees are generally a result, UBS’s contracts do result in the assets. contracts, UBS has not capitalized any material costs to obtain or fulfill liabilities. UBS presents expenses primarily in line with their nature in the income directly obligations associated with the generally Total Fee commission , general and administrative expenses, Total operating . For services (where UBS fees in the not recognized the associated income collected from the given client. › Refer to Note 4 for more information, including disaggregation of revenues 4) Share-based and other deferred compensation plans UBS recognizes expenses for deferred compensation awards over the become shortened, restructuring programs or recognition date. Where no who are eligible for length-of-service criteria, the services are presumed to have been received performance year or, in the case of off-cycle awards, immediately on the grant date. Share-based compensation plans Share-based compensation the taking award, restrictions in effect and non-vesting conditions. For equity-settled the incremental increase in value. Expenses tranche basis, over the service period based number reflect the actual outcomes of service or performance conditions. For breach of to adjustment to the share-based compensation expense. For cash-settled at each reporting equals the cash distributed. Other deferred compensation plans Compensation expense for other deferred recognized on a the nature of on the the cumulative expense of respective financial instruments distributed. › Refer to Note 28 5) Post-employment benefit plans Defined benefit plans Defined plans employee factors, defined present value the projected unit assets remeasurements Other income . present value of the the resulting net asset is limited to the present value of economic benefits reductions in future net specific employee and is calculated independent qualified actuaries. Critical accounting estimates and judgment The net defined benefit liability or asset at the balance sheet date and the related personnel expense provided, assumptions. assumptions could and pension expense life expectancy, discount rate, expected salary increases, pension increases and analysis for reasonable possible movements in each significant for UBS‘s post-employment obligations is provided › Refer for more information A separate entity are paid. UBS amounts if employees the benefits relating and prior periods. Compensation expense employees have rendered This is generally in the year of contribution. Prepaid contributions are recognized reduction in future payments is available. 6) Income taxes UBS is subject to the income tax laws the non-Swiss jurisdictions in which UBS has business operations. The Group’s provision for income and deferred paid or refunded for the current period or previous periods. Deferred between liabilities that will periods and are measured using the applicable tax rates and laws that have been reporting period and that are expected to reverse. Deferred significant being: used against profits in future years; and (ii) temporary differences that Deferred tax assets that sufficient taxable profits will be differences can be of extent there are is convincing available against which the unused tax losses can be utilized. Deferred tax liabilities between balance sheet give rise to taxable income in future periods. Deferred and current tax assets and (i) they arise in the same tax authority; (iii) are intended to be settled net or realized simultaneously. Current benefit and deferred taxes recognized in relation to: a subsidiary (for which such amounts would goodwill arising from the acquisition); (ii) gains sale of directly Equity ); instruments that are classified at of remeasurements currency translations points above are Other comprehensive income Equity . UBS reflects which acceptance by probable using either depending on which method is deemed a basis resolved. Critical accounting estimates and judgments Tax application of such UBS historical forecasts and other factors when evaluating the recoverability of its period, and its period profitability particularly sensitive to future economic, Forecasts are reviewed times, if required. If recent losses have been incurred, convincing evidence is required to prove there is sufficient future profitability given the UBS’s deferred tax through the income statement. In uncertain interpretation of tax laws, and litigation. › Refer to Note 8 for more information Property, is measured at accumulated reciation . Software development measured reliably and it is will begins straight line basis over an asset’s estimated useful life. Property, impairment cash - generating alongside goodwill and intangible assets as described in item 8 in this Note. the below . The recoverable amounts of such assets, other than property that has a market price, approach required by a market participant to replace the service capacity the individually for impairment. › Refer to Note 12 for more information 8) Goodwill Goodwill represents the value acquired amortized, reporting period, goodwill for impairment annually, any indication An impairment charge the carrying Critical accounting estimates and judgments UBS‘s methodology for that earnings available to shareholders in years one to three; (ii) changes in the discount rates; and (iii) changes in the long-term Earnings available results, Directors. external information, and external analysts and the view of management. The each cash-generating unit are tested for sensitivity by applying reasonably possible changes to those assumptions. › Refer to Notes 2 and Provisions generally recognized in 37, Provisions, Contingent Liabilities and Contingent Assets , when: (i) UBS has a present obligation as a an outflow and (iii) a reliable estimate made. The majority of UBS’s provisions and Restructuring consequence of scope including employee sabbatical measurement principles set out in item 4 UBS presents Provisions they relate to a loan commitment, a revolving revocable credit line. IAS 37 provisions are of the the balance sheet date. When conditions required a outflow disclosed for existence events not wholly within the control of UBS. Critical accounting estimates and judgments Recognition of provisions the past estimating the This which, due to their nature, outcome The amount of any provision used particular matter. Management regularly reviews such criteria for provisions have been satisfied and to determine the timing and amount of any potential outflows . › Refer to Note 18 Transactions into exchange rate date, all monetary liabilities denominated in foreign currency functional currency differences Other instruments measured at fair value through profit or loss . Non-monetary items measured at historical cost are translated at the exchange rate on the date of the transaction. Upon consolidation, assets and liabilities of are translated into US closing exchange rate expense items and other comprehensive income are translated at the translation differences are recognized in Equity the entirety, foreign operation. Share translated the historic of Share premium. Other comprehensive income in es measured at FVOCI are translated at the closing exchange rate as of the through Retained earnings . › Refer to Note 33 for more information 11) Equity, treasury shares and contracts on UBS Group AG shares UBS Group AG shares held (treasury shares) UBS purchased Equity as Treasury at deducted Equity difference and their weighted average cost (net of tax, if any) Share premium . Net cash settlement contracts Contracts involving settlement, or provide the counterparty or UBS with a settlement option that includes a choice of settling net in cash, are classified as derivatives held for trad |
UBS AG | |
Entity [Table] | |
Material accounting policies | Note 1 Material accounting policies This Note describes the preparation of the Statements) AG ). On 24 February 2022, issue by the Board of Directors. Basis of accounting The Financial Statements have been prepared in accordance with International Financial Reporting International presented in US dollars (USD). Disclosures and funding, integral part of the Financial to requirements Financial Instruments: , and Presentation , and repeated in this section. The applied consistently in all years presented unless otherwise stated in Note 1b. Critical accounting estimates and judgments Preparation of these Financial to apply amounts contingent time they are made. Such available AG regularly such estimates assumptions, which future and other pertinent factors, to determine their continuing relevance based on current conditions, estimates and Statements. estimates, which could result in significant was anticipated The judgment Financial Statements: – expected credit loss measurement (refer to item 2g in this Note and to Note 20); – fair value measurement (refer to item 2f in this Note – income taxes (refer to item 6 in this Note and to Note – provisions and contingent liabilities (refer to item 9 Note 18); – post-employment benefit 27); – goodwill (refer to item 8 in this Note and to Note – consolidation of structured entities (refer to Note 29). 1) Consolidation The UBS AG intercompany UBS structured entities over the relevant activities of variable returns; own returns. Consideration determine whether the current ability decisions about those activities need to be made. Subsidiaries, when control control ceases. and circumstances indicate that there is a change to one or more elements required to establish that control is present. Business combinations are accounted for using the acquisition method. The amount of any non-controlling at acquiree’s identifiable net assets. › Refer to Note 29 for more information Critical accounting estimates and judgments Each aforementioned consolidation principles. complex determining whether extent uniform consolidation be consolidated while assessment, judgment circumstances, including the the substance of voting and similar rights. › Refer to Note 29 for more information 2) Financial instruments a. Recognition UBS AG recognizes financial to an instrument. AG applies settlement date accounting to all standard purchases and non-derivative financial instruments. In extent the financial derecognition by transferred instrument as its asset. UBS holding retirement benefit plans and meet satisfied, they are not recognized on UBS AG’s balance sheet and the related income is excluded from the Financial Statements. Client execution through neither obtains benefits from nor controls such cash balances. b. Classification, measurement and presentation Financial assets All financial instruments value through through . For financial subsequently measured at amortized cost or value is adjusted for directly attributable transaction costs. Where the flows that are the the is classified business model that has collect business with the objective being achieved collecting contractual cash flows and selling financial assets. All those except for derivatives case hedge accounting requirements apply (refer Note for more information). Business model assessment and contractual cash flow characteristics UBS AG determines the business objective. In assessing whether considers contain contractual cash flows arising over the life of the instrument. Financial liabilities Financial liabilities measured at amortized cost Financial liabilities Debt issued measured Funding , which has received from AG scope of consolidation. instruments issued cont ain ing contractual provisions down or equity tier 1 (CET1) Financial event Such derivatives, variable specific to a party to the contract. If a debt a future the difference between any equity issued recognized in the income statement. A gain or loss is recognized in Other income is subsequently repurchased A reissuance of debt. Financial liabilities measured at fair value through profit or loss UBS liabilities at fair value financial instruments managed on a fair information), derivative including issuance of certain structured debt instruments. Measurement and presentation After initial recognition, UBS AG its described in the table on the following pages. Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – cash and balances at central banks; – loans and advances to banks; – receivables from securities financing transactions; – cash collateral receivables on derivative instruments; – residential and commercial mortgages; – corporate loans; – secured loans, including Lombard loans, and unsecured loans; – loans to financial advisors; – debt securities held as high-quality liquid (HQLA). Measured at amortized cost using the effective interest method less allowances for expected credit losses (refer to items 2d and 2g in this Note for more information). The following items are recognized in the income statement: – interest income, which is accounted for in accordance with item 2d – ECL and reversals; – foreign exchange (FX) translation gains and losses. When a financial asset at amortized cost is derecognized, the gain or loss is recognized in the income statement. For amounts arising from settlement of certain derivatives, refer to the next page. Measured at FVOCI Debt instruments measured at FVOCI This classification primarily includes debt securities certain asset-backed securities held as HQLA. Measured at fair value, reported in Other comprehensive income, net of applicable income taxes, until such investments are derecognized. Upon derecognition, any accumulated balances in Other comprehensive income are reclassified to the income statement and reported within Other income. The following items, which are determined on the basis as for financial assets measured at amortized recognized in the income statement: – interest income, which is accounted for in accordance with item 2d – ECL and reversals; – FX translation gains and losses. Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at FVTPL Held for trading Financial assets held for trading include: – all derivatives with a positive replacement value, those that are designated and effective hedging instruments; and – other financial assets acquired principally for the purpose of selling or repurchasing in the near term, or that are part of a portfolio of identified financial instruments that are managed together and for there is evidence of a recent actual pattern of short-term profit taking. Included in this category are debt instruments (including those in the form of money market paper, loans) and equity instruments. Measured at fair value, income statement. Derivative assets (including derivatives that and effective hedging instruments) are generally presented as Derivative financial instruments , except those exchange-traded (ETD) and over-the-counter cleared derivatives that are legally settled on a daily or in substance net settled on a daily basis, presented within Cash collateral receivables on derivative instruments. Changes in fair value, initial transaction costs, and gains and losses arising on disposal or redemption recognized in Other net income from financial instruments measured at fair value through , except interest income on instruments other than derivatives (refer to item 2d in this Note), interest on derivatives designated as hedging instruments of interest rate risk and forward points on certain short- and long-duration FX contracts acting as economic hedges, which are reported in Net interest income. Changes in the fair value of derivatives that designated and effective hedging instruments are presented either in the income statement or Other comprehensive income , depending on the type of hedge relationship (refer to item 2j in this Note for more information). Mandatorily measured at FVTPL – Other This classification includes financial assets measured at FVTPL that are not held for trading, as follows: – certain structured loans, certain commercial loans, and receivables from securities financing transactions are managed on a fair value basis; – loans managed on a fair value basis, including those hedged with credit derivatives; – certain debt securities held as HQLA and fair value basis; – certain investment fund holdings and assets hedge delivery obligations related to cash-settled employee compensation plans; – brokerage receivables, for which contractual cash flows do not meet the SPPI criterion because the aggregate balance is accounted for as a single unit of with interest being calculated on the individual components; – auction rate securities, for which contractual cash do not meet the SPPI criterion because interest may reset at rates that contain leverage; – equity instruments; – assets held under unit-linked investment contracts. Classification, measurement and presentation Financial liabilities classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – demand and time deposits; – retail savings / deposits; – payables – non-structured fixed-rate bonds; – subordinated debt; – certificates of deposit and covered bonds; – obligations against funding from UBS Group AG; – cash collateral payables on derivative instruments. Measured at amortized cost using the effective interest method. When a financial liability at amortized cost is derecognized, the gain or loss is recognized in the income statement. Measured at fair value through profit or loss Held for trading Financial liabilities held for trading include: – all derivatives with a negative replacement value (including certain loan commitments), that are designated and effective hedging instruments; and – obligations to deliver financial instruments, debt and equity instruments, that UBS AG has sold third parties but does not own (short positions). Measurement and presentation of financial liabilities classified at FVTPL follow the same principles financial assets classified at FVTPL, except that of change in the fair value of a financial liability designated at FVTPL that is attributable to changes AG’s own credit risk is presented in Other comprehensive income Retained earnings and is never reclassified to the income statement. Derivative liabilities (including derivatives that designated and effective hedging instruments) generally presented as Derivative financial instruments , except those exchange-traded and OTC-cleared derivatives that are legally settled on a daily basis substance net settled on a daily basis, which presented within Cash collateral payables on derivative instruments. Designated at FVTPL UBS AG designates liabilities: – issued hybrid debt instruments that primarily include equity-linked, credit-linked and rates-linked bonds notes; – issued debt instruments managed on a fair basis; – certain payables from securities financing transactions; – amounts due under unit-linked investment contracts the cash flows of which are linked to financial measured at FVTPL and eliminate an accounting mismatch; – brokerage payables, which arise in conjunction with brokerage receivables and are measured at FVTPL to achieve measurement consistency. c. Loan commitments and financial guarantees Loan defined terms and classified value through profit fair measured at Financial guarantee that require UBS AG holder make specified debt instrument. d. Interest income and expense Interest statement based the method . calculating instruments UBS terms of the instrument, EIR applied to the gross the financial interest income is cost amount adjusted for any credit loss allowance. Upfront measured at fair value where a loan is expected to be issued, and direct financial recognized over the expected EIR. Fees related to be issued, as well as loan syndication fees where UBS AG does not retain a portion retain a portion of the syndicated loan at the same effective yield for comparable risk Net fee and commission income and either recognized over the commitment or when syndication occurs. › Refer to item 3 in this Note for more information Interest included in interest income when positive and in interest expense when negative. excluding derivatives, is interest rates are income. › Refer to item 2b 3 e. Derecognition Financial assets UBS AG derecognizes a transferred financial asset, or a financial asset, if the purchaser has received substantially all the risks and rewards of the asset or rewards asset. Where similar transferred if the counterparty has received the contractual rights to the cash flows of for example, In transfers where control over the financial asset is retained, UBS AG continues to involvement, determined changes transfer. Certain futures counterparties daily basis, basis derecognition of the associated derivatives. › Refer to Note 22 and Note 23 for more information Financial liabilities UBS AG derecognizes i.e., when canceled exchanged for a different substantially modified, the original new carrying amounts recognized in the income statement. f. Fair value of financial instruments UBS AG accounts liabilities at fair value. Fair date transfer participants in the principal market, or in the most advantageous market in the absence of a principal market. › Refer to Note 21 for more information Critical accounting estimates and judgments The use unobservable market requires recorded heavily on unobservable a higher that market close-out costs, which are presented in Note 21d. UBS AG ‘ s described in estimated effects arising from changing significant unobservable inputs in Level 3 financial instruments in Note 21g. › Refer to Note 21 for more information ECL cost, receivables, , and not measured at portion which AG ’s facilities, as UBS has the ability to risk mitigation actions. Recognition of expected credit losses ECL are recognized on the following basis: – Stage 1 instruments: Maximum 12-month from initial recognition, shortfalls that would after occurring. – Stage 2 significant an SICR) subsequent lifetime default events over the expected life of a financial instrument, weighted by no longer observed, the instrument will move back to stage 1. – Stage 3 credit-impaired occurrence of one or more loss events, by estimating cash recovery strategy. - impaired allowance has been recognized, for example because they are expected to be fully recoverable through collateral held. – Changes recognized for impaired (POCI). POCI financial instruments include those that are purchased defaulted counterparty; they derecognition. All uncollectible or forgiven. of a losses. Recoveries, in part or in full, of off are generally credited to Credit loss (expense) / release . ECL Credit (expense) / release . A corresponding ECL allowance is reported as a decrease in the carrying amount of financial assets measured at amortized cost on the balance sheet. measured at accumulated Other income . credit lines, provisions for ECL are presented in Provisions. Default and credit impairment UBS AG applies management counterparty qualitative criteria. › Refer to “Credit policies for distressed assets’’ in the ‘’Risk management and control” section of this report for information Measurement of expected credit losses IFRS based method factors: probability exposure on an the overdrafts derives an average LGDs used in the ECL calculation are point-in-time (PIT)-based for key portfolios and consider both current conditions and expected cyclical determined for treated as scenario independent. For the UBS AG that weighted assets loss models. IFRS complexity, take calculation Basel III through-the-cycle relevant for AG’s model validation and oversight processes. Probability of default: PD represents the over probability of lifetime remaining lifetime of PDs and scenario forecasts. client scenario dependencies and client-idiosyncratic information. Exposure EAD exposure to credit risk considering accruals, discounted at considered reflective characteristics of the respective portfolios. Loss given LGD represents time of a potential future cash expected claims and, where applicable, time to realization of collateral and the seniority of EAD. Estimation of expected credit losses Number of scenarios and estimation of scenario weights Determination of probability range especially assumptions about macroeconomic factors on the estimate. To requirement, AG uses economic . Each represented considering the exposure of key portfolios to economic risks, and for determined. The estimation scenarios based on a conditions, takes severity economic variables. The respective that macroeconomic variables will materialize. Macroeconomic and other factors The modeled historical information is key factors. information cycle - sensitive nd AG projects the relevant economic factors for a period before reverting, over LGD for longer-term projections. Factors relevant Regional into considering UBS AG’s key ECL-relevant portfolios. For variables represent the most relevant factors for ECL calculation: – GDP growth rates, given performance; – unemployment clients’ ability to meet contractual obligations; – house price indices, given their collateral valuations; – interest rates, abilities to service debt; – consumer companies’ and economic stability; and – equity indices, corporate rating tools. Scenario generation, review process and governance A develop involvement from a broad range of experts. The other Scenario Sounding Sessions and ECL Management Forum, which include senior management from Group Risk and Group Finance. Important aspects particular credit addressed systematically and stage allocation and ECL allowance. The Committee , as authority under UBS the decisions taken by the ECL Management Forum. › Refer to Note 20 for more information ECL measurement period The period for which lifetime ECL are determined is based on the maximum risk, taking prepayment financial guarantee contracts, the AG has obligation to extend credit. Additionally, demand loan and contractual cancellation right credit risk abi lity AG can - mitigating actions. the period UBS AG ’s contractual maturity date, are callable on demand and where the drawn and undrawn components are managed as The significant and is managed at a portfolio level, with credit actions triggered period of seven years months for AG is exposed to credit risk. Customary market commitments. monitoring trends combination events trigger additional informed credit are not subject a management practices and formal credit re-origination measurement types of facilities as UBS AG is look-back reporting date. Significant increase in credit risk Financial ongoing maximum assessment initial quantitative Primarily, UBS default forward-looking instrument determined at two different dates: – at the reporting date; and – at inception of the instrument. If, exceeds a set threshold, an SICR is deemed to have occurred and the recognized. The threshold quality of the borrower, instruments based on PD changes A high-level the downgrades, The actual SICR level by interpolating between the values shown in the table. Internal rating at origination of the instrument Rating downgrades / SICR trigger 0–3 3 4–8 2 9–13 1 Irrespective probabilities, credit increased for an instrument if the contractual payments are more than specifically criterion instruments are transferred to stage 2 due criterion, transfer Personal & Region Switzerland but applied before a transfer back to stage 1 can be triggered. Additionally, indicators, economic list, which is used as a Exception management is further applied, and collective adjustments risk characteristics not otherwise fully reflected. In apply certain other asset-based management processes with strict margining. If margin calls are not satisfied, a position exceptional stage 2 may be made to take account of specific facts. Credit risk SICR, from mainly arises because instrument-specific, exposures stage 2 will actual holistic counterparty risk at any given date may be warranted. › Refer to the “ Risk management and control ” section of this report for more information Critical accounting estimates and judgments The calculation of ECL requires management and make estimates and assumptions to the timing and amount of ECL recognized. Determination of a significant increase in IFRS 9 does not include a definition of what constitutes an SICR, with UBS AG’s assessment considering ECL Management Forum has SICR results. Scenarios, scenario weights and macroeconomic ECL reflect an unbiased and probability-weighted amount, which UBS AG determines selects variables conditions. IFRS Management scenario selection and weights, post-model adjustments are required that may significantly ECL measurement period Lifetime ECL are of the transaction, Swiss callable master determine the period over period is positions, and a 12-month period applied for Modeling and post-model adjustments A number ECL, significantly validation Committee (the GMGC). ECL Management Forum and endorsed by the A sensitivity covering , weights and SICR trigger points 20f. › Refer to Note 20 for more information h. Restructured and modified financial assets When payment default is expected, occurred, UBS AG difficulties that business, such as modifying subordination, granted, each case generally classified as will preferential granted preferential conditions no longer exceed UBS AG’s risk tolerance. Modifications result in an alteration of future contractual cash flows and can occur part of a difficulties. The could lead resulting in the new does modified contractual cash the existing recognized in the i. Offsetting UBS AG net if (i) it has a legally enforceable right to set amounts realize positions include, for example, certain derivatives and repurchase and reverse exchanges and clearing houses. In assessing whether UBS basis, or to realize the asset and settle the liability simultaneously, emphasis is placed on the effectiveness of operational settlement mechanics exposure offsetting on AG’s subject R epurchase arrangements and securities financing transactions are presented net only to the extent that the settlement mechanism or results the cycle. › Refer to Note 22 for more information j. Hedge accounting UBS AG applies stated otherwise hedge meets discontinued. Voluntary permitted under Fair value hedges of interest rate risk related to debt instruments and loan assets The fair value change risk is hedged item, and recognized the change Fair value hedges of portfolio interest rate risk related to loans designated under IAS 39 Prior to discontinuation in December 2021, the fair value change of the Other or Other financial liabilities measured and recognized in the income statement the hedging instrument. Fair value hedges of FX risk related to debt instruments The hedged risk and recognized in the fair value of basis derivatives is excluded from the designation and a cost of hedging with Other comprehensive income Equity . These amounts are released statement over the term of the hedged item. Discontinuation of fair value hedges Discontinuations item amortized to the income statement over the remaining life of the hedged is derecognized, cost of statement Cash flow hedges of forecast transactions Fair value gains derivatives designated as cash risk are recognized initially in Other comprehensive income within Equity when including discontinued expected expected to reclassified to the income statement. Hedges of net investments in foreign operations Gains or losses on the hedging portion of a hedge are recognized Other comprehensive income Equity, while ineffective element statement. the cumulative Equity associated is reclassified Other income . Interest Rate Benchmark Reform UBS uncertainty before existing interest rate benchmarks are replaced with alternative can exist, probable d with little no consequential replacement risk-free interest rates expected in 2021 and beyond, UBS apply the requirements of Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (Interest Rate Benchmark Reform – Phase 2). › Refer to Note 1b for more information 3) Fee and commission income and expenses UBS provides to its categories: certain custody from contingent (e.g., securities recognizes fully requires on a systematic basis over the life of the agreement. Consideration identifiable performance nature performance obligations are typically those that include time management consequence, AG is judgment various performance obligations. Point-in-time dependent on trade performance recognized on Custodial reference to the size of the customer portfolio. However, generally customer’s portfolio and period. UBS management beyond UBS AG’s control until such uncertainties are resolved. UBS AG’s fees are generally earned from short-term contracts. As AG ’s component or or prepayment assets. Furthermore, due to the short-term nature of such contracts, to obtain or fulfill a contract assets or liabilities. UBS AG presents expenses primarily in line with their nature the income statement, differentiating between expenses that are directly obligations associated with the generally Total Fee commission , general and administrative expenses, Total operating . For services (where UBS AG specific fees in the income parties against the associated income collected from the given client. › Refer to Note 4 for more information, including disaggregation of revenues 4) Share-based and other deferred compensation plans UBS AG over the to shortened, restructuring programs or recognition date. Where no who are eligible for length-of-service criteria, the services are presumed to have been received performance year or, in the case of off-cycle awards, immediately on the grant date. Share-based compensation plans UBS Group settle employees of awards payment transactions. UBS granted Group AG’s account including, where effect vesting conditions. For equity-settled the incremental increase in value. Expenses tranche basis, over the service period based number reflect the actual outcomes of service or performance conditions. For breach of to adjustment to the share-based compensation expense. For cash-settled at each reporting equals the cash distributed. Other deferred compensation plans Compensation expense for other deferred recognized on a the nature of on the the cumulative expense of respective financial instruments distributed. › Refer to Note 28 5) Post-employment benefit plans Defined benefit plans Defined plans employee factors, defined present value the projected unit assets remeasurements Other income . present value of the the resulting net asset is limited to the present value of economic benefits reductions in future net specific employee and is calculated independent qualified actuaries. Critical accounting estimates and judgments The net defined benefit liability or asset at the balance sheet date and the related personnel expense provided, assumptions. assumptions could and pension expense life expectancy, discount rate, expected salary increases, pension increases and analysis for reasonable possible movements in each significant for UBS AG‘s post-employment obligations is . › Refer to Note 27 for more information Defined contribution plans A separate entity are paid. further amounts if the plan does not hold sufficient assets employees the benefits relating and prior periods. Compensation expense employees have rendered This is generally in the year of contribution. Prepaid contributions are recognized reduction in future payments is available. 6) Income taxes UBS AG is of operations. UBS and deferred paid or refunded for the current period or previous periods. Deferred between liabilities that will periods and are measured using the applicable tax rates and laws that have been reporting period and that are expected to reverse. Deferred significant being: used against profits in future years; and (ii) temporary differences that Deferred tax assets that sufficient taxable profits will be differences can be of extent there are is convincing available against which the unused tax losses can be utilized. Deferred tax liabilities between balance sheet give rise to taxable income in future periods. Deferred and current tax assets and (i) they arise in the same tax authority; (iii) are intended to be settled net or realized simultaneously. Current benefit and deferred taxes recognized in relation to: a subsidiary (for which such amounts would goodwill arising from the acquisition); (ii) gains sale of directly Equity ); instruments that are classified at of remeasurements currency translations points above are Other comprehensive income Equity . UBS AG reflects the for considered applicable, using either the most likely amount or expected value methods, depending deemed a predictor , and , the uncertainty will be resolved. Critical accounting estimates and judgments Tax application of such UBS AG historical forecasts and other factors when evaluating the recoverability of its period, and its period profitability particularly sensitive to future economic, Forecasts are reviewed times, if required. If recent losses have been incurred, convincing evidence is required to prove there is sufficient future profitability given the UBS AG ’s e , primarily recognized through the income statement. In uncertain interpretation of tax laws, and litigation. › Refer to Note 8 Property, is measured at accumulated reciation . Software development measured reliably and it is will begins straight line basis over an asset’s estimated useful life. Property, impairment cash - generating alongside goodwill and intangible assets as described in item 8 in this Note. the below . The recoverable amounts of such assets, other than property that has a market price, approach required by a market participant to replace the service capacity the individually for impairment. › Refer to Note 12 for more information 8) Goodwill Goodwill represents the value acquired amortized, reporting period, tests there is any An impairment charge the carrying Critical accounting estimates and judgments UBS model that is most sensitive to the following key assumptions: (i) forecasts of earnings available to shareholders the discount rates; and (iii) changes in the Earnings available results, Directors. external information, and external analysts and the view of management. The each cash-generating unit are tested for sensitivity by applying reasonably possible changes to those assumptions. › Refer to Notes 2 and Provisions generally recognized in 37, Provisions, Contingent , has a that obligation; obligation can be made. The AG ’s ns regulatory benefits. consequence of scope including employee sabbatical measurement principles set out in item 4 UBS AG presents Provisions if they relate to a loan commitment, financial or a revolving revocable credit line. IAS 37 provisions are of the the balance sheet date. When conditions required a outflow disclosed for existence events not wholly within the control of UBS AG. Critical accounting estimates and judgments Recognition of provisions the past estimating the This which, due to their nature, outcome difficult to predict. The amount of any provision used particular matter. Management regularly reviews such criteria for provisions have been satisfied and to determine the timing and amount of any potential outflows. › Refer to Note 18 Transactions into exchange rate date, all monetary liabilities denominated in foreign currency functional currency differences Other instruments measured at fair value through profit or loss . Non-monetary items measured at historical cost are translated at the exchange rate on the date of the transaction. Upon consolidation, assets and liabilities of are translated into US the closing exchange rate on the balance sheet date, and income and expense at the translation differences are recognized in Equity the income statement entirety, the foreign foreign operation. Share translated the historic of Share premium. Other comprehensive income in measured at FVOCI are translated at the closing exchange rate as of the through Retained earnings . › Refer to Note 33 for more information 11) Net cash settlement contracts Contracts involving settlement, AG with settlement option are classified as derivatives held for trading. |
Changes in accounting policies,
Changes in accounting policies, comparability and adjustments | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Changes in accounting policies, comparability and adjustments | Changes in accounting policies, comparability and other adjustments Amendments to IAS 1, Presentation of Financial Statements , and IFRS Practice Statement 2, Making Materiality Judgements Effective from 1 January IAS 1, Presentation , Statement 2, Making , issued February 2021. Note 1a has been refined through adopting these amendments. Amendments to IAS 39, IFRS 9 and IFRS 7 ( Interest Rate Benchmark Reform – Phase 2 ) On Interest Reform – Phase and IFRS 16) , addressing a number of issues in financial reporting areas that arise or replaced. permits instruments alternative prospectively by rate consequence determining the contractual cash to the had no material effect on the Group’s financial statements. T he also provide reliefs, with the following adopted by UBS: – D esignate an ARR - contractually component, even if it is when it that it will meet designation and the risk component is reliably of designated as rate risk related to debt instruments, mortgages and hedges Financing (SARON) and the Sterling Overnight Index Average (SONIA). – Amend interest hedged risk changed due to requirements of the phase 2 amendment. – The francs with accumulated in based on the ARR on which the hedged future cash be based. when the forecast ARR or are no longer expected to occur. The requirements transition reporting date financial instruments because of the transition. |
IFRSs and interpretations to be adopted and other adjustments | International Financial Reporting Standards and Interpretations to be adopted in 2022 and later and other changes IFRS 17, In May 2017, the IASB issued Insurance Contracts , which sets out obligations reinsurance 2023. have a material effect on the Group’s financial statements. |
UBS AG | |
Entity [Table] | |
Changes in accounting policies, comparability and adjustments | Changes in accounting policies, comparability and other adjustments Amendments to IAS 1, Presentation of Financial Statements , and IFRS Practice Statement 2, Making Materiality Judgements Effective amendments to IAS 1, Presentation of Financial , and IFRS Practice Statement 2, Making Materiality Judgements , issued by IASB policies amendments. Amendments to IAS 39, IFRS 9 and IFRS 7 ( Interest Rate Benchmark Reform – Phase 2 ) On Interest Reform – Phase and IFRS 16) , addressing a number of issues in financial reporting areas that arise or replaced. permits instruments alternative prospectively by rate consequence determining the contractual cash to which had no material effect on UBS AG’s financial statements. T he also provide reliefs, with the following adopted by UBS AG: – D esignate an ARR - contractually component, even if it is when expect that it will meet the requirements the measurable. As of 31 December 2021, the principal ARRs that UBS AG has designated as the of interest rate cash Overnight the Swiss Average Overnight (SARON) and (SONIA). – Amend interest hedged risk changed due AG to continue the hedge relationship in accordance with the requirements of the phase 2 amendment. – The francs with accumulated in based on the ARR on which the hedged future cash be based. when the forecast ARR or are no longer expected to occur. The requirements regarding to date instruments because of the transition. |
IFRSs and interpretations to be adopted and other adjustments | International Financial Reporting Standards and Interpretations to be adopted in 2022 and later and other changes IFRS 17, In May 2017, the IASB issued Insurance Contracts , which sets out obligations reinsurance 2023. UBS AG is assessing the standard, but have a material effect on UBS AG’s financial statements. |
Segment reporting
Segment reporting | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Entitys Reportable Segments Explanatory | Note 2a UBS’s divisions: Banking, business divisions as Together with Group Functions, the four business divisions reflect the management structure of the Group. – Global provides advice and solutions to private clients, in particular in the ultra high ranges from corporate management managed globally across the regions. – Personal & Corporate Banking and s ’ , from basic retirement, financing, in , through channels. – Asset asset across all major traditional as and wealth management clients globally. – The Investment provides institutional, globally, invest and manage risks. Its offering includes advisory services, facilitating clients raising debt private and capital trading across equities and fixed income, – Group Group rvices ( which Technology, Corporate Services, Human , Finance, Legal, Compliance, Branding and Group and Non-core and Legacy Portfolio. Financial Group Functions is presented reports considered IFRS 8, Operating Segments . UBS’s internal accounting policies, accounting policies revenues segment. carried operating agreements reportable involved in the value for the Group are immaterial, as the majority allocated agreements. consolidated equity is allocated to the reportable on and liabilities of the reportable segments are funded invested reflected in the results of each reportable segment. Segment include intercompany reporting to the external transaction together with another operating segment or Group Functions, the segment that a addressed by the transaction and which segment is providing the funding same principles. Non-current represent assets that are expected months after the reporting deferred tax assets and post-employment benefits. USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS For the year ended 31 December 2021 Net interest income 4,244 2,120 (15) 481 (127) 6,705 Non-interest income 15,175 2,143 2,632 8,972 (233) 28,689 Income 19,419 4,263 2,617 9,454 (359) 35,393 Credit loss (expense) / release 29 86 (1) 34 0 148 Total operating income 19,449 4,349 2,616 9,488 (360) 35,542 Total operating expenses 14,665 2,618 1,586 6,858 330 26,058 Operating profit / (loss) before tax 4,783 1,731 1,030 2,630 (689) 9,484 Tax expense / (benefit) 1,998 Net profit / (loss) 7,486 Additional information Total assets 395,235 225,370 25,639 346,431 124,507 1,117,182 Additions to non-current assets 56 16 1 30 1,989 2,091 USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS For the year ended 31 December 2020 Net interest income 4,027 2,049 (17) 284 (481) 5,862 Non-interest income 1 13,107 1,858 2,993 9,235 30 27,222 Income 17,134 3,908 2,975 9,519 (452) 33,084 Credit loss (expense) / release (88) (257) (2) (305) (42) (694) Total operating income 17,045 3,651 2,974 9,214 (494) 32,390 Total operating expenses 13,026 2,392 1,519 6,732 567 24,235 Operating profit / (loss) before tax 4,019 1,259 1,455 2,482 (1,060) 8,155 Tax expense / (benefit) 1,583 Net profit / (loss) 6,572 Additional information Total assets 367,714 231,657 28,589 369,683 128,122 1,125,765 Additions to non-current assets 5 12 385 150 2,294 2,847 USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS For the year ended 31 December 2019 Net interest income 3,947 1,992 (25) (669) (744) 4,501 Non-interest income 12,426 1,744 1,962 7,968 367 24,467 Income 16,373 3,736 1,938 7,299 (378) 28,967 Credit loss (expense) / release (20) (21) 0 (30) (7) (78) Total operating income 16,353 3,715 1,938 7,269 (385) 28,889 Total operating expenses 12,955 2,274 1,406 6,485 192 23,312 Operating profit / (loss) before tax 3,397 1,441 532 784 (577) 5,577 Tax expense / (benefit) 1,267 Net profit / (loss) 4,310 Additional information Total assets 309,766 209,405 34,565 315,855 102,603 972,194 Additions to non-current assets 68 10 0 1 5,217 5,297 1 Includes a USD 631 571 60 recognized in Global Wealth Management. The the regional management of with, performance is and judgments that may structure. The that client attributed to the country where the attribution Presidents. and Legacy Portfolio in level. These revenues are included in the Global The geographic analysis location of the entity in which the given assets are recorded. For the year ended 31 December 2021 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 14.5 41 9.0 44 of which: USA 13.5 38 8.5 41 Asia Pacific 6.5 18 1.5 7 Europe, Middle East and Africa (excluding Switzerland) 7.0 20 2.9 14 Switzerland 7.9 22 7.1 35 Global (0.3) (1) 0.0 0 Total 35.5 100 20.5 100 For the year ended 31 December 2020 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 13.0 40 9.0 42 of which: USA 11.7 36 8.4 40 Asia Pacific 6.0 18 1.5 7 Europe, Middle East and Africa (excluding Switzerland) 6.5 20 3.0 14 Switzerland 6.9 21 7.6 36 Global 0.1 0 0.0 0 Total 32.4 100 21.1 100 For the year ended 31 December 2019 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 12.0 42 8.9 44 of which: USA 10.9 38 8.5 42 Asia Pacific 4.7 16 1.4 7 Europe, Middle East and Africa (excluding Switzerland) 5.8 20 3.0 15 Switzerland 6.7 23 7.1 35 Global (0.3) (1) 0.0 0 Total 28.9 100 20.3 100 |
UBS AG | |
Entity [Table] | |
Disclosure Of Entitys Reportable Segments Explanatory | Note 2a UBS divisions: Banking, business divisions as Together with Group Functions, the four business divisions reflect the management structure of UBS AG. – Global pr ovides advice and solutions to private clients, in particular in the ultra high ranges from corporate management managed globally across the regions. – Personal & Corporate Banking and s ’ , from basic retirement, financing, in , through channels. – Asset asset across all major traditional as and wealth management clients globally. – The Investment provides institutional, globally, invest and manage risks. Its offering includes advisory services, facilitating clients raising debt private and capital trading across equities and fixed income, – Group Group ( which Technology, Corporate Services, Human , Finance, Legal, k Compliance, Branding and Group and Non-core and Legacy Portfolio. Financial Group Functions is presented reports operating Operating Segments . UBS management determine the revenues and reportable segments reflected Revenue-sharing agreements revenues segments intersegment revenues for UBS of revenue-sharing managing reportable currency segments are funded and reportable segment. Segment include intercompany reporting to in segment or Group Functions, additional criteria are considered to determine the segment that will report the associated will are providing the follows the same principles. Non-current represent assets that are expected months after the reporting date, deferred tax assets and post-employment benefits. USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS AG For the year ended 31 December 2021 Net interest income 4,244 2,120 (15) 481 (226) 6,605 Non-interest income 15,175 2,144 2,632 8,978 294 29,222 Income 19,419 4,264 2,617 9,459 68 35,828 Credit loss (expense) / release 29 86 (1) 34 0 148 Total operating income 19,449 4,350 2,616 9,493 68 35,976 Total operating expenses 14,743 2,623 1,593 6,902 1,151 27,012 Operating profit / (loss) before tax 4,706 1,726 1,023 2,592 (1,083) 8,964 Tax expense / (benefit) 1,903 Net profit / (loss) 7,061 Additional information Total assets 395,235 225,425 25,202 346,641 123,641 1,116,145 Additions to non-current assets 56 16 1 30 1,689 1,791 USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS AG For the year ended 31 December 2020 Net interest income 4,027 2,049 (17) 284 (555) 5,788 Non-interest income 1 13,107 1,859 2,993 9,224 504 27,686 Income 17,134 3,908 2,975 9,508 (52) 33,474 Credit loss (expense) / release (88) (257) (2) (305) (42) (695) Total operating income 17,046 3,651 2,974 9,203 (94) 32,780 Total operating expenses 13,080 2,390 1,520 6,762 1,329 25,081 Operating profit / (loss) before tax 3,965 1,261 1,454 2,441 (1,423) 7,699 Tax expense / (benefit) 1,488 Net profit / (loss) 6,211 Additional information Total assets 367,714 231,710 28,266 369,778 127,858 1,125,327 Additions to non-current assets 5 12 385 150 1,971 2,524 USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS AG For the year ended 31 December 2019 Net interest income 3,947 1,993 (25) (669) (831) 4,415 Non-interest income 12,426 1,745 1,962 7,967 869 24,970 Income 16,373 3,737 1,938 7,298 38 29,385 Credit loss (expense) / release (20) (21) 0 (30) (7) (78) Total operating income 16,353 3,717 1,938 7,268 31 29,307 Total operating expenses 13,018 2,274 1,407 6,515 925 24,138 Operating profit / (loss) before tax 3,335 1,443 531 753 (893) 5,169 Tax expense / (benefit) 1,198 Net profit / (loss) 3,971 Additional information Total assets 309,766 209,512 34,565 316,058 102,028 971,927 Additions to non-current assets 68 10 0 1 4,935 5,014 1 Includes a USD 631 571 60 recognized in Global Wealth Management. The the regional management structure of UBS AG. The operating income to these regions the basis on which is judgments may structure. The that client attributed to the country where the attribution Presidents. and Legacy Portfolio in level. These revenues are included in the Global The geographic analysis location of the entity in which the given assets are recorded. For the year ended 31 December 2021 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 14.5 40 9.0 47 of which: USA 13.5 38 8.5 44 Asia Pacific 6.5 18 1.4 7 Europe, Middle East and Africa (excluding Switzerland) 7.0 19 2.6 13 Switzerland 7.9 22 6.3 33 Global 0.1 0 0.0 0 Total 36.0 100 19.3 100 For the year ended 31 December 2020 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 13.0 40 9.0 45 of which: USA 11.7 36 8.4 42 Asia Pacific 6.0 18 1.4 7 Europe, Middle East and Africa (excluding Switzerland) 6.5 20 2.7 14 Switzerland 6.9 21 6.9 34 Global 0.5 2 0.0 0 Total 32.8 100 20.0 100 For the year ended 31 December 2019 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 12.0 41 8.9 46 of which: USA 10.9 37 8.5 44 Asia Pacific 4.7 16 1.3 7 Europe, Middle East and Africa (excluding Switzerland) 5.8 20 2.6 13 Switzerland 6.7 23 6.5 34 Global 0.1 0 0.0 0 Total 29.3 100 19.3 100 |
Net interest income and other n
Net interest income and other net income from fair value changes on financial instruments | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Net Interest Income And Other Net Income From Financial Instruments Measured At Fair Value Through Profit Or Loss Explanatory | Note 3 For the year ended USD million 31.12.21 31.12.20 31.12.19 Net interest income from financial instruments measured 1,431 1,299 1,011 Other net income from financial instruments measured 5,850 6,960 6,842 of which: net gains / (losses) from financial liabilities designated 1 (6,582) 1,509 (8,748) Total net income from financial instruments measured at fair value through profit or loss 7,281 8,259 7,853 Net interest income Interest income from loans and deposits 2 6,488 6,690 8,008 Interest income from securities financing transactions 3 513 862 2,005 Interest income from other financial instruments measured 284 335 364 Interest income from debt instruments measured at fair 115 101 120 Interest income from derivative instruments designated as cash 1,133 822 188 Total interest income from financial instruments measured at amortized cost and fair 8,533 8,810 10,684 Interest expense on loans and deposits 4 523 1,031 2,634 Interest expense on securities financing transactions 5 1,102 870 1,152 Interest expense on debt issued 1,533 2,237 3,285 Interest expense on lease liabilities 102 110 122 Total interest expense from financial instruments measured at amortized cost 3,259 4,247 7,194 Total net interest income from financial instruments measured at amortized cost and fair 5,274 4,563 3,490 Total net interest income from financial instruments measured at fair value through profit or loss 1,431 1,299 1,011 Total net interest income 6,705 5,862 4,501 1 Excludes fair value changes of hedges related to financial liabilities designated at fair value and foreign currency translation effects arising from translating foreign currency transactions into the respective functional currency, both of which are reported within Other net income from financial instruments measured at fair value through profit or loss. 2,068 72 USD 1,830 USD 2,068 72 1,830 through profit or loss not as well as negative interest on amounts due to banks, customer deposits, and cash collateral payables on derivative negative interest, including deposits, as well as negative securities financing transactions and negative interest, including fees, on receivables from securities |
UBS AG | |
Entity [Table] | |
Disclosure Of Net Interest Income And Other Net Income From Financial Instruments Measured At Fair Value Through Profit Or Loss Explanatory | Note 3 For the year ended USD million 31.12.21 31.12.20 31.12.19 Net interest income from financial instruments measured 1,437 1,305 1,015 Other net income from financial instruments measured 5,844 6,930 6,833 of which: net gains / (losses) from financial liabilities designated 1 (6,457) 1,625 (8,748) Total net income from financial instruments measured at fair value through profit or loss 7,281 8,235 7,848 Net interest income Interest income from loans and deposits 2 6,489 6,696 8,026 Interest income from securities financing transactions 3 513 862 2,005 Interest income from other financial instruments measured 284 335 364 Interest income from debt instruments measured at fair 115 101 120 Interest income from derivative instruments designated as cash 1,133 822 188 Total interest income from financial instruments measured at amortized cost and fair 8,534 8,816 10,703 Interest expense on loans and deposits 4 1,655 2,440 4,541 Interest expense on securities financing transactions 5 1,102 870 1,152 Interest expense on debt issued 512 918 1,491 Interest expense on lease liabilities 98 105 118 Total interest expense from financial instruments measured at amortized cost 3,366 4,333 7,303 Total net interest income from financial instruments measured at amortized cost and fair 5,168 4,483 3,400 Total net interest income from financial instruments measured at fair value through profit or loss 1,437 1,305 1,015 Total net interest income 6,605 5,788 4,415 1 Excludes fair value changes currency, both of which 2,068 72 and USD 1,830 of USD 2,068 72 1,830 through profit or instruments, as well as negative transactions and negative interest, including fees, customer deposits, and funding from UBS Group AG, Includes interest expense on payables from securities financing transactions and negative interest, including fees, |
Net fee and commission income
Net fee and commission income | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Fee And Commission Income Expense Explanatory | Note 4 For the year ended USD million 31.12.21 31.12.20 31.12.19 Fee and commission income Underwriting fees 1,463 1,085 741 M&A and corporate finance fees 1,102 736 774 Brokerage fees 4,382 4,132 3,248 Investment fund fees 5,790 5,289 4,858 Portfolio management and related services 9,762 8,009 7,656 Other 1,874 1,710 1,832 Total fee and commission income 1 24,372 20,961 19,110 of which: recurring 15,410 13,009 12,544 of which: transaction-based 8,692 7,491 6,402 of which: performance-based 269 461 163 Fee and commission expense Brokerage fees paid 259 274 310 Distribution fees paid 611 589 590 Other 1,115 912 797 Total fee and commission expense 1,985 1,775 1,696 Net fee and commission income 22,387 19,186 17,413 of which: net brokerage fees 4,123 3,858 2,938 1 For the 14,545 1,644 3,337 million for Asset 4,814 33 12,475 USD 1,426 3,129 3,882 49 2019: USD 11,694 1,307 2,659 3,355 94 million for Group Functions). |
UBS AG | |
Entity [Table] | |
Disclosure Of Fee And Commission Income Expense Explanatory | Note 4 For the year ended USD million 31.12.21 31.12.20 31.12.19 Fee and commission income Underwriting fees 1,512 1,104 784 M&A and corporate finance fees 1,102 736 774 Brokerage fees 4,383 4,132 3,248 Investment fund fees 5,790 5,289 4,859 Portfolio management and related services 9,762 8,009 7,656 Other 1,874 1,712 1,836 Total fee and commission income 1 24,422 20,982 19,156 of which: recurring 15,410 13,010 12,545 of which: transaction-based 8,743 7,512 6,449 of which: performance-based 269 461 163 Fee and commission expense Brokerage fees paid 259 274 310 Distribution fees paid 611 589 590 Other 1,115 911 796 Total fee and commission expense 1,985 1,775 1,696 Net fee and commission income 22,438 19,207 17,460 of which: net brokerage fees 4,124 3,858 2,938 1 For the 14,545 1,645 3,337 million for Asset Management, USD 4,863 33 12,475 1,427 3,129 3,901 50 USD 11,694 1,307 2,659 3,397 98 for Group Functions). |
Other income
Other income | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Other Operating Income Explanatory | Note 5 For the year ended USD million 31.12.21 31.12.20 31.12.19 Associates, joint ventures and subsidiaries Net gains / (losses) from acquisitions and disposals of 1 (11) 635 2 (36) Net gains / (losses) from disposals of investments in associates 41 0 4 Share of net profits of associates and joint ventures 105 84 46 Impairments related to associates 0 0 (1) Total 135 719 13 Net gains / (losses) from disposals of financial assets measured 9 40 31 Income from properties 3 23 26 27 Net gains / (losses) from properties held for sale 100 4 76 5 (19) Other 185 6 216 7 160 Total other income 452 1,076 212 1 Includes foreign exchange gains 631 stake in Fondcenter AG 140 sale-and-leaseback transactions, primarily 100 from the sale of 215 Bloomberg Commodity Index family. |
UBS AG | |
Entity [Table] | |
Disclosure Of Other Operating Income Explanatory | Note 5 For the year ended USD million 31.12.21 31.12.20 31.12.19 Associates, joint ventures and subsidiaries Net gains / (losses) from acquisitions and disposals of 1 (11) 635 2 (36) Net gains / (losses) from disposals of investments in associates 41 0 4 Share of net profits of associates and joint ventures 105 84 46 Impairments related to associates 0 0 (1) Total 134 719 13 Net gains / (losses) from disposals of financial assets measured 9 40 31 Income from properties 3 22 25 27 Net gains / (losses) from properties held for sale 100 4 76 5 (19) Income from shared services provided to UBS Group AG or its subsidiaries 451 422 464 Other 224 6 267 7 161 Total other income 941 1,549 677 1 Includes foreign exchange gains 631 stake in Fondcenter AG 140 sale-and-leaseback transactions, primarily 100 from the sale of UBS AG's domestic wealth management business in Austria. Refer to Note 30 for more 215 Bloomberg Commodity Index family. |
Personnel expenses
Personnel expenses | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Employee Benefits Explanatory | Note 6 For the year ended USD million 31.12.21 31.12.20 31.12.19 Salaries 1 7,339 7,023 6,518 Variable compensation – performance awards 2 3,190 3,209 3 2,755 Variable compensation – other 2 229 220 246 Financial advisor compensation 2,4 4,860 4,091 4,043 Contractors 381 375 381 Social security 978 899 3 799 Post-employment benefit plans 5 833 6 845 787 of which: defined benefit plans 470 502 461 of which: defined contribution plans 363 343 326 Other personnel expenses 576 561 3 555 Total personnel expenses 18,387 17,224 16,084 1 Includes role-based allowances. employees, resulting in an 280 240 20 20 million within compensation calculated on the basis the time of 80 obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities. |
UBS AG | |
Entity [Table] | |
Disclosure Of Employee Benefits Explanatory | Note 6 For the year ended USD million 31.12.21 31.12.20 31.12.19 Salaries 1 5,723 5,535 5,183 Variable compensation – performance awards 2 2,916 2,953 3 2,545 Variable compensation – other 2 196 201 225 Financial advisor compensation 2,4 4,860 4,091 4,043 Contractors 142 138 147 Social security 762 704 3 627 Post-employment benefit plans 5 582 6 597 569 of which: defined benefit plans 280 306 of which: defined contribution plans 303 291 278 Other personnel expenses 479 466 3 461 Total personnel expenses 15,661 14,686 13,801 1 Includes role-based allowances. employees, resulting in an 270 240 20 10 million within compensation calculated on the basis the time of 49 obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities. |
General and administrative expe
General and administrative expenses | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of General And Administrative Expense Explanatory | Note 7 For the year ended USD million 31.12.21 31.12.20 31.12.19 Outsourcing costs 893 951 1,072 IT expenses 1,055 949 860 Consulting, legal and audit fees 540 646 850 Real estate and logistics costs 634 671 662 Market data services 417 413 414 Marketing and communication 242 217 270 Travel and entertainment 72 84 298 Litigation, regulatory and similar matters 2 911 197 165 Other 788 757 696 of which: UK and German bank levies 3 58 55 41 Total general and administrative expenses 5,553 4,885 5,288 1 In 2021, UBS changed expenses. of USD 1 3 11 22 38 30 USD 16 27 31 |
UBS AG | |
Entity [Table] | |
Disclosure Of General And Administrative Expense Explanatory | Note 7 For the year ended USD million 31.12.21 31.12.20 31.12.19 Outsourcing costs 426 466 551 IT expenses 490 449 448 Consulting, legal and audit fees 465 566 753 Real estate and logistics costs 530 563 559 Market data services 367 361 364 Marketing and communication 171 162 191 Travel and entertainment 66 77 272 Litigation, regulatory and similar matters 2 910 197 165 Other 6,051 5,646 5,283 of which: shared services costs charged by UBS Group AG or its subsidiaries 5,321 4,939 4,621 of which: UK and German bank levies 3 58 55 41 Total general and administrative expenses 9,476 8,486 8,586 1 In administrative expenses. from third parties of USD 1 3 11 22 38 30 included a credit of USD 16 27 31 |
Income taxes
Income taxes | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Income Tax Explanatory | Note 8 For the year ended USD million 31.12.21 31.12.20 31.12.19 Tax expense / (benefit) Swiss Current 680 482 365 Deferred 34 116 265 Total Swiss 714 598 630 Non-Swiss Current 884 749 426 Deferred 400 236 211 Total non-Swiss 1,284 985 637 Total income tax expense / (benefit) recognized in the income statement 1,998 1,583 1,267 |
Financial assets at amortized c
Financial assets at amortized cost and other positions in scope of expected credit loss measurement | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Provision Matrix Explanatory | Note 9 The financial expected segments or “ECL segments” are aggregated portfolios based on shared methods below. › Refer to Note 20 for more information about loss measuremen Segment Segment description Description of credit risk sensitivity Business division / Group Functions Private clients with mortgages Lending to private clients secured by owner-occupied real estate and personal account overdrafts of those clients Sensitive to the interest rate environment, unemployment values and other regional aspects – Personal & Corporate Banking – Global Wealth Management Real estate financing Rental or income-producing real estate financing to private and corporate clients secured by real estate Sensitive to unemployment interest rate environment, real estate collateral values and other regional aspects – Personal & Corporate Banking – Global Wealth Management – Investment Bank Large corporate clients Lending to large corporate and multi- national clients Sensitive to GDP developments, unemployment levels, business cycles and collateral values (diverse collateral, and other collateral types) – Personal & Corporate Banking – Investment Bank SME clients Lending to small and medium-sized corporate clients Sensitive to GDP developments, unemployment levels, the interest rate environment and, to some extent, seasonality, values (diverse collateral, estate and other collateral types) – Personal & Corporate Banking Lombard Loans secured by pledges of marketable securities, guarantees and other forms of collateral Sensitive to equity and debt markets changes in collateral values) – Global Wealth Management Credit cards Credit card solutions in Switzerland and the US Sensitive to unemployment levels – Personal & Corporate Banking – Global Wealth Management Commodity trade finance Working capital financing of commodity traders, generally extended on a self- liquidating transactional basis Sensitive primarily to the strength of individual transaction structures and collateral values (price volatility of commodities), debt service is directly linked to the shipments financed – Personal & Corporate Banking Financial intermediaries and hedge funds Lending to financial institutions and pension funds, including exposures to broker-dealers and clearing houses Sensitive to GDP development, the interest rate environment, price and volatility risks in financial markets, and regulatory and political risk – Personal & Corporate Banking – Investment Bank Refer to Note 20f for more details regarding sensitivity The instruments and certain non-financial instruments that are subject to ECL. Coverage taking ECL amount of sum of Loans and Loans to advisors . These ratios are influenced by the following key factors: – Lombard loans in lending policies minimal under most circumstances; – mortgage loans to private clients and controlled by to-value ratios and strong debt service capabilities; – the amount of unsecured retail lending (including credit cards) is insignificant; lending in Switzerland includes loans; – contractual maturities in the loan portfolio, which in the lending months or and 3 years in Switzerland with longer US and loan commitments up to 4 years; and – write-offs of when all forgiven, reduces the coverage ratios |
UBS AG | |
Entity [Table] | |
Disclosure Of Provision Matrix Explanatory | Note 9 The financial expected credit loss (ECL) requirements segments or “ECL segments” are aggregated portfolios based on shared methods below. › Refer to Note 20 for more information about loss measurement Segment Segment description Description of credit risk sensitivity Business division / Group Functions Private clients with mortgages Lending to private clients secured by owner-occupied real estate and personal account overdrafts of those clients Sensitive to the interest rate environment, unemployment levels, real estate collateral values – Personal & Corporate Banking – Global Wealth Management Real estate financing Rental or income-producing real estate financing to private and corporate clients secured by real estate Sensitive to unemployment levels, the interest rate environment, collateral values aspects – Personal & Corporate Banking – Global Wealth Management – Investment Bank Large corporate clients Lending to large corporate and multi- national clients Sensitive to GDP developments, unemployment levels, business cycles and collateral values (diverse collateral, and other collateral types) – Personal & Corporate Banking – Investment Bank SME clients Lending to small and medium-sized corporate clients Sensitive to GDP developments, unemployment levels, environment and, to some extent, seasonality, values (diverse collateral, estate and other collateral types) – Personal & Corporate Banking Lombard Loans secured by pledges of marketable securities, guarantees and other forms of collateral Sensitive to equity and debt markets changes in collateral values) – Global Wealth Management Credit cards Credit card solutions in Switzerland and the US Sensitive to unemployment levels – Personal & Corporate Banking – Global Wealth Management Commodity trade finance Working capital financing of commodity traders, generally extended on a self- liquidating transactional basis Sensitive primarily to the strength of individual transaction structures and collateral values (price volatility of commodities), debt service is directly linked to the shipments financed – Personal & Corporate Banking Financial intermediaries and hedge funds Lending to financial institutions and pension funds, including exposures to broker-dealers and clearing houses Sensitive to GDP development, the interest rate environment, price and volatility risks in financial markets, and regulatory and political risk – Personal & Corporate Banking – Investment Bank Refer to Note 20f for more details regarding sensitivity The instruments and certain non-financial instruments that are subject to ECL. USD million 31.12.21 Carrying amount 1 ECL allowances Financial instruments measured at amortized Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Cash and balances at central banks 192,817 192,817 0 0 0 0 0 0 Loans and advances to banks 15,360 15,333 26 1 (8) (7) (1) 0 Receivables from securities financing transactions 75,012 75,012 0 0 (2) (2) 0 0 Cash collateral receivables on derivative instruments 30,514 30,514 0 0 0 0 0 0 Loans and advances to customers 398,693 381,496 15,620 1,577 (850) (126) (152) (572) of which: Private clients with mortgages 152,479 143,505 8,262 711 (132) (28) (71) (33) of which: Real estate financing 43,945 40,463 3,472 9 (60) (19) (40) 0 of which: Large corporate clients 13,990 12,643 1,037 310 (170) (22) (16) (133) of which: SME clients 14,004 12,076 1,492 436 (259) (19) (15) (225) of which: Lombard 149,283 149,255 0 27 (33) (6) 0 (28) of which: Credit cards 1,716 1,345 342 29 (36) (10) (9) (17) of which: Commodity trade finance 3,813 3,799 7 7 (114) (6) 0 (108) Other financial assets measured at amortized cost 26,236 25,746 302 189 (109) (27) (7) (76) of which: Loans to financial advisors 2,453 2,184 106 163 (86) (19) (3) (63) Total financial assets measured at amortized cost 738,632 720,917 15,948 1,767 (969) (161) (160) (647) Financial assets measured at fair value through other comprehensive income 8,844 8,844 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 747,477 729,762 15,948 1,767 (969) (161) (160) (647) Total exposure ECL provisions Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Guarantees 20,972 19,695 1,127 150 (41) (18) (8) (15) of which: Large corporate clients 3,464 2,567 793 104 (6) (3) (3) 0 of which: SME clients 1,353 1,143 164 46 (8) (1) (1) (7) of which: Financial intermediaries and hedge funds 9,575 9,491 84 0 (17) (13) (4) 0 of which: Lombard 2,454 2,454 0 0 (1) 0 0 (1) of which: Commodity trade finance 3,137 3,137 0 0 (1) (1) 0 0 Irrevocable loan commitments 39,478 37,097 2,335 46 (114) (72) (42) 0 of which: Large corporate clients 23,922 21,811 2,102 9 (100) (66) (34) 0 Forward starting reverse repurchase and securities borrowing agreements 1,444 1,444 0 0 0 0 0 0 Committed unconditionally revocable credit lines 42,373 39,802 2,508 63 (38) (28) (10) 0 of which: Real estate financing 7,328 7,046 281 0 (5) (4) (1) 0 of which: Large corporate clients 5,358 4,599 736 23 (7) (4) (3) 0 of which: SME clients 5,160 4,736 389 35 (15) (11) (3) 0 of which: Lombard 8,670 8,670 0 0 0 0 0 0 of which: Credit cards 9,466 9,000 462 4 (6) (5) (2) 0 of which: Commodity trade finance 117 117 0 0 0 0 0 0 Irrevocable committed prolongation of existing loans 5,611 5,527 36 48 (3) (3) 0 0 Total off-balance sheet financial instruments and credit lines 109,878 103,565 6,006 307 (196) (121) (60) (15) Total allowances and provisions (1,165) (282) (220) (662) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective USD million 31.12.20 Carrying amount 1 ECL allowances Financial instruments measured at amortized Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Cash and balances at central banks 158,231 158,231 0 0 0 0 0 0 Loans and advances to banks 15,344 15,160 184 0 (16) (9) (5) (1) Receivables from securities financing transactions 74,210 74,210 0 0 (2) (2) 0 0 Cash collateral receivables on derivative instruments 32,737 32,737 0 0 0 0 0 0 Loans and advances to customers 380,977 358,396 20,341 2,240 (1,060) (142) (215) (703) of which: Private clients with mortgages 148,175 138,769 8,448 959 (166) (35) (93) (39) of which: Real estate financing 43,429 37,568 5,838 23 (63) (15) (44) (4) of which: Large corporate clients 15,161 12,658 2,029 474 (279) (27) (40) (212) of which: SME clients 14,872 11,990 2,254 628 (310) (19) (23) (268) of which: Lombard 133,850 133,795 0 55 (36) (5) 0 (31) of which: Credit cards 1,558 1,198 330 30 (38) (11) (11) (16) of which: Commodity trade finance 3,269 3,214 43 12 (106) (5) 0 (101) Other financial assets measured at amortized cost 27,219 26,401 348 469 (133) (34) (9) (90) of which: Loans to financial advisors 2,569 1,982 137 450 (108) (27) (5) (76) Total financial assets measured at amortized cost 688,717 665,135 20,873 2,709 (1,211) (187) (229) (795) Financial assets measured at fair value through other comprehensive income 8,258 8,258 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 696,976 673,394 20,873 2,709 (1,211) (187) (229) (795) Total exposure ECL provisions Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Guarantees 17,081 14,687 2,225 170 (63) (14) (15) (34) of which: Large corporate clients 3,710 2,048 1,549 113 (20) (4) (5) (12) of which: SME clients 1,310 936 326 48 (13) (1) (1) (11) of which: Financial intermediaries and hedge funds 7,637 7,413 224 0 (17) (7) (9) 0 of which: Lombard 641 633 0 8 (2) 0 0 (2) of which: Commodity trade finance 1,441 1,416 25 0 (2) (1) 0 0 Irrevocable loan commitments 41,372 36,894 4,374 104 (142) (74) (68) 0 of which: Large corporate clients 24,209 20,195 3,950 64 (121) (63) (58) 0 Forward starting reverse repurchase and securities borrowing agreements 3,247 3,247 0 0 0 0 0 0 Committed unconditionally revocable credit lines 42,077 37,176 4,792 108 (50) (29) (21) 0 of which: Real estate financing 6,328 5,811 517 0 (12) (5) (7) 0 of which: Large corporate clients 4,909 2,783 2,099 27 (9) (2) (7) 0 of which: SME clients 5,827 4,596 1,169 63 (16) (12) (4) 0 of which: Lombard 9,671 9,671 0 0 0 (1) 0 0 of which: Credit cards 8,661 8,220 430 11 (8) (6) (2) 0 of which: Commodity trade finance 242 242 0 0 0 0 0 0 Irrevocable committed prolongation of existing loans 3,282 3,277 5 0 (2) (2) 0 0 Total off-balance sheet financial instruments and credit lines 107,059 95,281 11,396 382 (257) (119) (104) (34) Total allowances and provisions (1,468) (306) (333) (829) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the Coverage taking ECL amount of sum of Loans and Loans to advisors . These ratios are influenced by the following key factors: – Lombard loans in lending policies minimal under most circumstances; – mortgage loans to private clients and controlled by to-value ratios and strong debt service capabilities; – the amount of unsecured retail lending (including credit cards) is insignificant; lending in Switzerland includes government backed loans; – contractual maturities in the loan portfolio, which in the lending months or and 3 years in Switzerland with longer US and loan commitments up to 4 years; – write-offs of when all or part of a financial asset is deemed forgiven, reduces the coverage ratios Coverage ratios for core loan portfolio 31.12.21 Gross carrying amount (USD million) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Private clients with mortgages 152,610 143,533 8,333 744 9 2 85 446 Real estate financing 44,004 40,483 3,512 10 14 5 114 231 Large corporate clients 14,161 12,665 1,053 443 120 18 148 2,997 SME clients 14,263 12,095 1,507 661 182 16 103 3,402 Lombard 149,316 149,261 0 55 2 0 0 5,026 Credit cards 1,752 1,355 351 46 204 72 255 3,735 Commodity trade finance 3,927 3,805 7 115 290 15 3 9,388 Other loans and advances to customers 19,510 18,425 1,010 75 23 9 15 3,730 Loans to financial advisors 2,539 2,203 109 226 338 88 303 2,791 Total 1 402,081 383,825 15,882 2,374 23 4 98 2,673 Gross exposure (USD million) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Private clients with mortgages 9,123 8,798 276 49 3 3 9 15 Real estate financing 8,766 8,481 285 0 9 7 88 0 Large corporate clients 32,748 28,981 3,630 136 34 25 110 1 SME clients 8,077 7,276 688 114 38 19 151 585 Lombard 14,438 14,438 0 0 1 0 0 0 Credit cards 9,466 9,000 462 4 7 5 34 0 Commodity trade finance 3,262 3,262 0 0 4 4 0 0 Financial intermediaries and hedge funds 13,747 13,379 369 0 13 10 120 0 8,806 8,507 296 4 15 6 30 0 Total 2 108,434 102,121 6,006 307 18 12 100 486 1 Includes Loans and 399,543 2,539 2 Excludes Forward starting reverse repurchase and securities borrowing agreements. Coverage ratios for core loan portfolio 31.12.20 Gross carrying amount (USD million) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Private clients with mortgages 148,341 138,803 8,540 998 11 2 108 390 Real estate financing 43,492 37,583 5,883 27 15 4 75 1,414 Large corporate clients 15,440 12,684 2,069 686 181 21 192 3,089 SME clients 15,183 12,010 2,277 896 204 16 101 2,991 Lombard 133,886 133,800 0 86 3 0 0 3,592 Credit cards 1,596 1,209 342 46 240 91 333 3,488 Commodity trade finance 3,375 3,219 43 113 315 16 2 8,939 Other loans and advances to customers 20,722 19,229 1,402 91 29 13 25 3,563 Loans to financial advisors 2,677 2,009 142 526 404 135 351 1,446 Total 1 384,714 360,547 20,697 3,470 30 5 106 2,247 Gross exposure (USD million) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Private clients with mortgages 6,285 6,083 198 3 7 6 16 197 Real estate financing 7,056 6,576 481 0 21 9 185 0 Large corporate clients 32,828 25,026 7,598 205 46 27 92 565 SME clients 9,121 7,239 1,734 148 40 19 63 779 Lombard 14,178 14,170 0 8 2 1 0 1,941 Credit cards 8,661 8,220 430 11 9 8 44 0 Commodity trade finance 1,683 1,658 25 0 10 8 15 8,279 Financial intermediaries and hedge funds 7,690 7,270 448 0 26 13 248 166 16,309 15,792 482 8 12 6 11 12,414 Total 2 103,812 92,034 11,396 382 25 13 91 894 1 Includes Loans and 382,036 2,677 2 Excludes Forward starting reverse repurchase and securities borrowing agreements. |
Derivative instruments
Derivative instruments | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Derivative Financial Instruments Explanatory | Note 10 Overview Over-the-counter under Association counterparties. Terms and the contracts have industry-standard settlement mechanisms prescribed clearing houses, in particular interest rate swaps a which cash collateral exchanged legally various requiring variation margins on bearing brought - 19 , the Securities completion of the final phase-in of margin requirements for non- centrally cleared derivatives, Other amounts regulated exchange-traded derivatives (ETD) contracts. benefits of pricing transparency, changes in value and, consequently, Most of the Group’s derivative transactions relate to sales and market-making activity. Sales activities marketing of derivative products to customers to take, transfer, modify or making aims to client activity, market participants with spread The Group also instruments for hedging purposes. › Refer to Notes 16 and 21 for more information instruments › Refer to Note 26 for more information about designated in hedge accounting relationships Risks of derivative instruments The derivative financial assets shown on the an however, the counterparty credit exposure in This is generally the case because, on the one hand, replacement values can on the master netting agreements and bilateral collateral Both control regulators reflect these additional factors. › Refer to Note 22 for more information about assets and liabilities after consideration allowed under enforceable netting arrangements › Refer to the “Risk management and control” report for more information about the risks arising derivative instruments Derivative instruments 31.12.21 31.12.20 USD billion Derivative financial assets Notional amounts related to derivative financial assets 2,3 Derivative financial liabilities Notional amounts related to derivative financial liabilities 2,3 Other notional amounts 2,4 Derivative financial assets Notional amounts related to derivative financial assets 2,3 Derivative financial liabilities Notional amounts related to derivative financial liabilities 2,3 Other notional amounts 2,4 Interest rate contracts 33.2 991.2 28.7 943.1 8,675.1 50.9 928.0 43.9 880.4 11,291.5 of which: forward contracts (OTC) 1 0.1 29.4 0.2 28.6 443.6 0.0 19.8 0.4 21.9 2,602.5 of which: swaps (OTC) 26.4 394.3 19.2 344.1 7,549.4 40.8 407.0 30.9 364.8 8,105.2 of which: options (OTC) 6.6 545.2 9.2 553.6 10.1 447.5 12.5 460.5 of which: futures (ETD) 525.0 480.6 of which: options (ETD) 0.0 22.4 0.0 16.8 157.1 0.0 53.6 0.0 33.1 103.3 Credit derivative contracts 1.4 44.7 1.8 46.3 2.4 57.6 2.9 64.8 of which: credit default swaps (OTC) 1.3 39.4 1.6 44.1 2.2 53.6 2.6 62.3 of which: total return swaps (OTC) 0.1 1.3 0.2 1.7 0.1 1.9 0.3 2.5 Foreign exchange contracts 53.3 3,030.8 54.1 2,938.8 1.2 68.7 2,951.1 70.5 2,820.4 1.4 of which: forward contracts (OTC) 23.8 1,008.9 23.8 1,043.2 27.3 779.1 29.0 853.3 of which: swaps (OTC) 24.3 1,606.3 24.9 1,480.3 34.3 1,727.3 34.4 1,567.3 of which: options (OTC) 5.2 412.6 5.3 408.6 7.1 440.9 7.1 394.7 Equity contracts 28.2 456.9 34.9 603.9 80.1 34.8 449.6 41.2 581.3 91.3 of which: swaps (OTC) 4.7 105.7 9.3 154.8 6.4 89.4 9.8 108.4 of which: options (OTC) 4.6 61.4 6.5 102.3 7.0 87.1 10.9 146.2 of which: futures (ETD) 71.2 67.9 of which: options (ETD) 10.2 289.6 9.8 346.3 8.8 10.7 273.1 11.3 326.8 23.5 of which: client-cleared transactions (ETD) 8.6 9.4 10.7 9.1 Commodity contracts 1.6 57.8 1.6 56.4 14.7 2.2 57.8 2.0 49.7 10.1 of which: swaps (OTC) 0.5 19.9 0.8 25.4 0.5 17.7 0.8 18.0 of which: options (OTC) 0.4 14.0 0.2 10.4 1.0 23.5 0.7 17.8 of which: futures (ETD) 13.9 9.3 of which: forward contracts (ETD) 18.1 15.2 8.0 6.3 of which: client-cleared transactions (ETD) 0.6 0.4 0.5 0.3 Loan commitments measured at FVTPL (OTC) 0.8 0.0 8.2 0.0 10.2 Unsettled purchases of non-derivative financial instruments 5 0.1 13.3 0.2 10.6 0.3 18.3 0.2 10.0 Unsettled sales of non-derivative financial instruments 5 0.2 18.2 0.1 9.4 0.2 17.2 0.3 12.9 Total derivative instruments, based on IFRS netting 6 118.1 4,613.8 121.3 4,616.6 8,771.1 159.6 4,479.5 161.1 4,429.7 11,394.4 1 Includes certain forward starting repurchase and reverse repurchase agreements that derivative financial instruments amounts of client-cleared ETD and OTC cleared through either a central counterparty or an exchange. The fair value instruments and Cash collateral trade date and settlement date right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency or to realize the asset and settle the liability simultaneously. Refer to Note 22 for more information on On a notional amount basis, 40 % of OTC interest rate contracts held as of contractual underlying to interest rate contracts decreased 2.6 with which alternative reference rates, and maturities. |
UBS AG | |
Entity [Table] | |
Disclosure Of Derivative Financial Instruments Explanatory | Note 10 Overview Over-the-counter under a Association counterparties. Terms and the contracts have industry-standard settlement mechanisms prescribed clearing houses, in particular interest rate swaps a which cash collateral exchanged legally various requiring margins on bearing brought - 19 , the Securities completion of the final phase-in of margin requirements for non- centrally cleared derivatives, Other amounts regulated exchange-traded derivatives (ETD) contracts. benefits of pricing transparency, changes in value and, consequently, Most market-making activity. Sales activities marketing of derivative products to customers to take, transfer, modify or making aims to client activity, market participants with spread UBS also instruments for hedging purposes. › Refer to Notes 16 and 21 for more information instruments › Refer to Note 26 for more information about designated in hedge accounting relationships Risks of derivative instruments The derivative financial assets shown on the an important component of UBS AG ’s credit exposure; however, the counterparty are rarely an adequate reflection of UBS AG’s credit exposure in its derivatives business with that generally the case because, on the one hand, replacement values can increase other hand, netting the exposure measures risk these additional factors. › Refer to Note 22 for more information about assets and liabilities after consideration allowed under enforceable netting arrangements › Refer to the “Risk management and control” report for more information about the risks arising derivative instruments Derivative instruments 31.12.21 31.12.20 USD billion Derivative financial assets Notional amounts related to derivative financial assets 2,3 Derivative financial liabilities Notional amounts related to derivative financial liabilities 2,3 Other notional amounts 2,4 Derivative financial assets Notional amounts related to derivative financial assets 2,3 Derivative financial liabilities Notional amounts related to derivative financial liabilities 2,3 Other notional amounts 2,4 Interest rate contracts 33.2 991.2 28.7 943.1 8,675.1 50.9 928.0 43.9 880.4 11,291.5 of which: forward contracts (OTC) 1 0.1 29.4 0.2 28.6 443.6 0.0 19.8 0.4 21.9 2,602.5 of which: swaps (OTC) 26.4 394.3 19.2 344.1 7,549.4 40.8 407.0 30.9 364.8 8,105.2 of which: options (OTC) 6.6 545.2 9.2 553.6 10.1 447.5 12.5 460.5 of which: futures (ETD) 525.0 480.6 of which: options (ETD) 0.0 22.4 0.0 16.8 157.1 0.0 53.6 0.0 33.1 103.3 Credit derivative contracts 1.4 44.7 1.8 46.3 2.4 57.6 2.9 64.8 of which: credit default swaps (OTC) 1.3 39.4 1.6 44.1 2.2 53.6 2.6 62.3 of which: total return swaps (OTC) 0.1 1.3 0.2 1.7 0.1 1.9 0.3 2.5 Foreign exchange contracts 53.3 3,031.0 54.1 2,938.8 1.2 68.7 2,951.2 70.5 2,820.4 1.4 of which: forward contracts (OTC) 23.8 1,009.1 23.8 1,043.2 27.3 779.2 29.0 853.3 of which: swaps (OTC) 24.3 1,606.4 24.9 1,480.3 34.3 1,727.3 34.4 1,567.3 of which: options (OTC) 5.2 412.6 5.3 408.6 7.1 440.9 7.1 394.7 Equity contracts 28.2 456.9 34.9 603.9 80.1 34.8 449.6 41.2 581.3 91.3 of which: swaps (OTC) 4.7 105.7 9.3 154.8 6.4 89.4 9.8 108.4 of which: options (OTC) 4.6 61.4 6.5 102.3 7.0 87.1 10.9 146.2 of which: futures (ETD) 71.2 67.9 of which: options (ETD) 10.2 289.6 9.8 346.3 8.8 10.7 273.1 11.3 326.8 23.5 of which: client-cleared transactions (ETD) 8.6 9.4 10.7 9.1 Commodity contracts 1.6 57.8 1.6 56.4 14.7 2.2 57.8 2.0 49.7 10.1 of which: swaps (OTC) 0.5 19.9 0.8 25.4 0.5 17.7 0.8 18.0 of which: options (OTC) 0.4 14.0 0.2 10.4 1.0 23.5 0.7 17.8 of which: futures (ETD) 13.9 9.3 of which: forward contracts (ETD) 0.0 18.1 0.0 15.2 0.0 8.0 0.0 6.3 of which: client-cleared transactions (ETD) 0.6 0.4 0.5 0.3 Loan commitments measured at FVTPL (OTC) 0.8 0.0 8.2 0.0 10.2 Unsettled purchases of non-derivative financial instruments 5 0.1 13.3 0.2 10.6 0.3 18.3 0.2 10.0 Unsettled sales of non-derivative financial instruments 5 0.2 18.2 0.1 9.4 0.2 17.2 0.3 12.9 Total derivative instruments, based on IFRS netting 6 118.1 4,614.0 121.3 4,616.6 8,771.1 159.6 4,479.6 161.1 4,429.7 11,394.4 1 Includes certain forward starting repurchase and reverse repurchase agreements that are classified as measured derivative financial instruments amounts of client-cleared ETD and OTC cleared through either a central counterparty or an exchange. The instruments and Cash collateral trade date and enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of the entity and all of the counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously. Refer to Note 22 for more information On a notional amount basis, 40 % of OTC interest rate contracts held as of 31 December 2021 (31 December 50 %) mature 36 % (31 30 %) within one to 25 % (31 December 20 %) after five years. Notional either settled Other amounts above buckets underlying to interest rate contracts 2.6 with which alternative reference rates, and maturities. |
Financial assets measured at fa
Financial assets measured at fair value through OCI | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Financial Assets Measured At Fair Value Through Other Comprehensive Income Explanatory | Note 11 USD million 31.12.21 31.12.20 Financial assets measured at fair value through other comprehensive income 1 Debt instruments Governments and government agencies 8,522 8,155 of which: USA 7,507 7,727 Banks 322 103 Total financial assets measured at fair value through other comprehensive income 8,844 8,258 Unrealized gains / (losses) recognized in Other comprehensive Unrealized gains, before tax 67 204 Unrealized (losses), before tax (80) (4) Net unrealized gains / (losses), before tax (13) 200 Net unrealized gains / (losses), after tax (7) 151 1 Refer to Note 21c for more information about product type and fair value hierarchy categorization. Refer also to Note 9 and |
UBS AG | |
Entity [Table] | |
Financial Assets Measured At Fair Value Through Other Comprehensive Income Explanatory | Note 11 USD million 31.12.21 31.12.20 Financial assets measured at fair value through other comprehensive income 1 Debt instruments Governments and government agencies 8,522 8,155 of which: USA 7,507 7,727 Banks 322 103 Total financial assets measured at fair value through other comprehensive income 8,844 8,258 Unrealized gains / (losses) recognized in Other comprehensive Unrealized gains, before tax 67 204 Unrealized (losses), before tax (80) (4) Net unrealized gains / (losses), before tax (13) 200 Net unrealized gains / (losses), after tax (7) 151 1 Refer to Note 21c for more information about product type and fair value hierarchy categorization. Refer |
Property, equipment and softwar
Property, equipment and software | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of property, equipment and software [text block] | Note 12 At historical cost less accumulated depreciation USD million Owned properties and equipment 1 Leased properties and equipment 2 Software Projects in progress 2021 2020 Historical cost Balance at the beginning of the year 13,185 4,249 7,768 1,036 26,238 24,431 Additions 273 213 228 1,376 2,090 2,312 Disposals / write-offs 3 (430) (223) (98) 0 (751) (990) Reclassifications 4 323 0 808 (1,149) (18) (590) Foreign currency translation (303) (66) (64) (12) (445) 1,074 Balance at the end of the year 13,048 4,174 8,642 1,250 27,113 26,238 Accumulated depreciation Balance at the beginning of the year 8,060 1,082 3,987 0 13,129 11,628 Depreciation 635 498 945 0 2,078 1,997 Impairment 5 9 1 0 0 10 72 Disposals / write-offs 3 (424) (215) (98) 0 (737) (855) Reclassifications 4 (12) 0 0 0 (12) (328) Foreign currency translation (196) (20) (28) 0 (243) 616 Balance at the end of the year 8,072 1,346 4,807 0 14,225 13,129 Net book value Net book value at the beginning of the year 5,126 3,167 3,780 1,036 13,109 12,804 Net book value at the end of the year 4,976 2,828 3,835 1,250 6 12,888 13,109 1 Includes leasehold relation to real estate, including 657 679 within Interest expense from There were no material gains 140 respective periods represents net reclassifications recoverable amount based on a value in use approach was determined to be zero. 1,087 163 |
UBS AG | |
Entity [Table] | |
Disclosure of property, equipment and software [text block] | Note 12 At historical cost less accumulated depreciation USD million Owned properties and equipment 1 Leased properties and equipment 2 Software Projects in progress 2021 2020 Historical cost Balance at the beginning of the year 11,676 4,091 7,111 907 23,785 22,329 Additions 162 1 174 233 1,220 1,789 1,989 Disposals / write-offs 3 (345) (212) (75) 0 (632) (867) Reclassifications 4 267 0 703 (988) (18) (590) Foreign currency translation (266) (59) (48) (9) (381) 924 Balance at the end of the year 11,494 3,994 7,924 1,130 24,542 23,785 Accumulated depreciation Balance at the beginning of the year 7,188 1,019 3,621 0 11,827 10,503 Depreciation 507 474 854 0 1,835 1,779 Impairment 5 8 1 0 0 9 72 Disposals / write-offs 3 (341) (204) (75) 0 (619) (735) Reclassifications 4 (12) 0 0 0 (12) (328) Foreign currency translation (172) (18) (19) 0 (210) 535 Balance at the end of the year 7,178 1,272 4,380 0 12,830 11,827 Net book value Net book value at the beginning of the year 4,488 3,072 3,490 907 11,958 11,826 Net book value at the end of the year 4,316 2,722 3,544 1,130 6 11,712 11,958 1 Includes leasehold improvements and IT hardware. in relation to real estate, including offices, retail branches and sales offices. The 632 652 within Interest expense from There were no material gains 140 respective periods represents net reclassifications recoverable amount based on a value in use approach was determined to be zero. 1,009 121 |
Goodwill and intangible assets
Goodwill and intangible assets | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Intangible Assets And Goodwill Explanatory | Note 13 Introduction UBS annual basis or when indicators of impairment exist. UBS considers Asset Management, as it is reported in as a separate cash-generating unit (a which the is reviewed and amount of goodwill in Global Wealth Management relates to the PaineWebber Americas portion of monitored Wealth Wealth Management the International (consisting of EMEA, Asia Pacific and Global). The goodwill is on CGU. An impairment charge is recognized if the carrying amount exceeds the recoverable amount. As balance sheet 6.1 3.7 carried USD 1.2 Switzerland CGU , and 1.2 billion carried by methodology described below, balances not impaired. Methodology for goodwill impairment testing The recoverable amounts are determined using flow model, which has features of the banking The recoverable earnings attributable to shareholders from the first three forecast years and the terminal value, adjusted assumed to growth beyond periods forecast of third growth rate, as well as the implied perpetual capital growth. The carrying amount for each CGU is determined by reference to framework, funding, and balance sheet” section of this equity to the businesses on the basis of their risk-weighted assets and allocations from Group goodwill and related CET1 deduction primarily used for the Attributed equity is its approximation attributed planning process, the recoverable amounts of the respective CGU. › Refer to the “Capital, liquidity and funding, section of this report for more information about attribution framework Assumptions Valuation model information, applicable. The model used to determine the recoverable amount is most shareholders rates and long-term rates shareholders are estimated on the basis of forecast results, which are part of the business plan approved by the Board of Directors. The discount pricing model-based approach, and and T hey also take o regional differences in risk-free rates at CGUs. determined growth rate forecasts. Key assumptions of eac possible available 20 %, rates were changed by 1.5 growth rates were changed by 0.75 scenarios, not reported Wealth Management. If periods deviate attributable Wealth Management may losses in the income goodwill affect cash flows capital under expected on the Group’s capital ratios. Discount and growth rates Discount rates Growth rates In % 31.12.21 31.12.20 31.12.21 31.12.20 Global Wealth Management Americas 9.5 9.5 4.0 5.1 Global Wealth Management Switzerland and International 8.5 8.5 3.1 3.7 Asset Management 8.5 8.5 2.9 3.5 USD million Goodwill Intangible assets 1 2021 2020 Historical cost Balance at the beginning of the year 6,182 1,683 7,865 7,820 Additions 1 1 147 Disposals (3) (3) (158) Write-offs (41) (41) (35) Foreign currency translation (53) (30) (83) 91 Balance at the end of the year 6,126 1,612 7,739 7,865 Accumulated amortization and impairment Balance at the beginning of the year 1,385 1,385 1,351 Amortization 31 31 55 Impairment / (reversal of impairment) 2 (1) (1) 2 Disposals 0 0 Write-offs (41) (41) (35) Foreign currency translation (13) (13) 11 Balance at the end of the year 1,360 1,360 1,385 Net book value at the end of the year 6,126 252 6,378 6,480 of which: Global Wealth Management Americas 3,720 41 3,760 3,770 of which: Global Wealth Management Switzerland and International 1,204 72 1,276 1,320 of which: Asset Management 1,202 1,202 1,226 of which: Investment Bank 139 139 161 of which: Group Functions 0 4 1 Intangible 2 Impairment charges recorded in 5 2020). The table below presents estimated aggregated amortization expenses for intangible assets. USD million Intangible assets Estimated aggregated amortization expenses for: 2022 29 2023 27 2024 23 2025 23 2026 23 Thereafter 126 Not amortized due to indefinite useful life 2 Total 252 |
UBS AG | |
Entity [Table] | |
Disclosure Of Intangible Assets And Goodwill Explanatory | Note 13 Introduction UBS AG performs an impairment test on annual basis or when indicators of impairment exist. UBS AG considers Asset Management, 2a, as a separate cash-generating at goodwill) is reviewed and assessed by management. Given that a significant relates affected remains , despite formation goodwill for Global Wealth Management is for Switzerland and Global). The goodwill is on CGU. An impairment charge is recognized if the carrying amount exceeds the recoverable amount. As balance sheet 6.1 3.7 carried USD 1.2 Switzerland CGU , and 1.2 billion carried by methodology goodwill CGUs are not impaired. Methodology for goodwill impairment testing The recoverable amounts are determined using flow model, which has features of the banking The recoverable earnings attributable to shareholders from the first three forecast years and the terminal value, adjusted assumed to growth beyond periods forecast of third growth rate, as well as the implied perpetual capital growth. The carrying amount for each CGU is determined by reference to which balance sheet” section of this report, UBS attributes equity to the businesses on the basis of their risk-weighted assets and leverage ratio denominator (both metrics include Group their certain CET1 deduction the purpose of measuring the performance of the includes equal to the capital a CGU requires to conduct its business and is currently considered amount of applied in are used in calculating the recoverable amounts of the respective CGU. › Refer to the “Capital, liquidity and funding, section of this report for more information about attribution framework Assumptions Valuation model applicable. The model used to determine the recoverable amount is most shareholders rates and long-term rates shareholders are estimated on the basis of forecast results, which are part of the business plan approved by the Board of Directors. The discount pricing model-based approach, and and T hey also take regional differences in risk-free rates at CGUs. determined growth rate forecasts. Key assumptions of eac possible available 20 %, rates were changed by 1.5 growth rates were changed by 0.75 scenarios, not reported Wealth Management. If periods deviate attributable Wealth Management may losses in the income goodwill affect cash flows capital under expected on UBS AG’s capital ratios. Discount and growth rates Discount rates Growth rates In % 31.12.21 31.12.20 31.12.21 31.12.20 Global Wealth Management Americas 9.5 9.5 4.0 5.1 Global Wealth Management Switzerland and International 8.5 8.5 3.1 3.7 Asset Management 8.5 8.5 2.9 3.5 USD million Goodwill Intangible assets 1 2021 2020 Historical cost Balance at the beginning of the year 6,182 1,683 7,865 7,820 Additions 1 1 147 Disposals (3) (3) (158) Write-offs (41) (41) (35) Foreign currency translation (53) (30) (83) 91 Balance at the end of the year 6,126 1,612 7,739 7,865 Accumulated amortization and impairment Balance at the beginning of the year 1,385 1,385 1,351 Amortization 31 31 55 Impairment / (reversal of impairment) 2 (1) (1) 2 Disposals 0 0 Write-offs (41) (41) (35) Foreign currency translation (13) (13) 11 Balance at the end of the year 1,360 1,360 1,385 Net book value at the end of the year 6,126 252 6,378 6,480 of which: Global Wealth Management Americas 3,720 41 3,760 3,770 of which: Global Wealth Management Switzerland and International 1,204 72 1,276 1,320 of which: Asset Management 1,202 1,202 1,226 of which: Investment Bank 139 139 161 of which: Group Functions 0 4 1 Intangible assets mainly include customer relationships, contractual rights and the fully amortized branch 2 Impairment charges recorded in 2020 relate to assets for which the recoverable amount was determined considering their value 5 2020). The table below presents estimated aggregated amortization expenses for intangible assets. USD million Intangible assets Estimated aggregated amortization expenses for: 2022 29 2023 27 2024 23 2025 23 2026 23 Thereafter 126 Not amortized due to indefinite useful life 2 Total 252 |
Other financial and non-financi
Other financial and non-financial assets | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Other Financial And Non Financial Assets Explanatory [textblock] | Note 14 a) Other financial assets measured at amortized cost USD million 31.12.21 31.12.20 Debt securities 18,858 18,801 of which: government bills / bonds 9,833 9,789 Loans to financial advisors 2,453 2,569 Fee- 1,972 2,014 Finance lease receivables 1,356 1,447 Settlement and clearing accounts 455 614 Accrued interest income 520 591 Other 594 1,158 Total other financial assets measured at amortized cost 26,209 27,194 b) Other non-financial assets USD million 31.12.21 31.12.20 Precious metals and other physical commodities 5,258 6,264 Deposits and collateral provided in connection with litigation, 1 1,526 1,418 Prepaid expenses 1,108 1,081 VAT and other tax receivables 638 433 Properties and other non-current assets held for sale 32 246 Assets of disposal groups held for sale 2 1,093 Other 621 326 Total other non-financial assets 10,277 9,768 1 Refer to Note 18 for more information. |
UBS AG [Member] | |
Entity [Table] | |
Other Financial And Non Financial Assets Explanatory [textblock] | Note 14 a) Other financial assets measured at amortized cost USD million 31.12.21 31.12.20 Debt securities 18,858 18,801 of which: government bills / bonds 9,833 9,789 Loans to financial advisors 2,453 2,569 Fee- 1,966 2,014 Finance lease receivables 1,356 1,447 Settlement and clearing accounts 455 614 Accrued interest income 521 592 Other 627 1,182 Total other financial assets measured at amortized cost 26,236 27,219 b) Other non-financial assets USD million 31.12.21 31.12.20 Precious metals and other physical commodities 5,258 6,264 Deposits and collateral provided in connection with litigation, 1 1,526 1,418 Prepaid expenses 717 731 VAT and other tax receivables 591 392 Properties and other non-current assets held for sale 32 246 Assets of disposal groups held for sale 2 1,093 Other 618 323 Total other non-financial assets 9,836 9,374 1 Refer to Note 18 for more information. |
Amounts due to banks and custom
Amounts due to banks and customer deposits | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of due to banks and customers [text block] | Note 15 USD million 31.12.21 31.12.20 Amounts due to banks Customer deposits 542,007 524,605 of which: demand deposits 246,417 236,447 of which: retail savings / deposits 247,224 220,898 of which: time deposits 1 48,365 67,260 Total amounts due to banks and customer deposits 555,108 535,655 1 Includes customer deposits in UBS AG Jersey Branch placed by UBS Switzerland AG on behalf |
UBS AG | |
Entity [Table] | |
Disclosure of due to banks and customers [text block] | Note 15 a) Amounts due to banks and customer deposits USD million 31.12.21 31.12.20 Amounts due to banks 13,101 11,050 Customer deposits 544,834 527,929 of which: demand deposits 247,299 237,604 of which: retail savings / deposits 247,224 220,898 of which: time deposits 1 50,312 69,427 Total amounts due to banks and customer deposits 557,935 538,979 1 Includes customer deposits in UBS AG Jersey Branch placed by UBS Switzerland AG on behalf of its clients. b) Funding from UBS Group AG USD million 31.12.21 31.12.20 Senior unsecured debt that contributes to total loss-absorbing 38,984 36,611 Senior unsecured debt other than TLAC 4,471 2,939 High-trigger loss-absorbing additional tier 1 capital instruments 11,414 11,854 Low-trigger loss-absorbing additional tier 1 capital instruments 2,426 2,575 Total 1 57,295 53,979 1 UBS AG has also recognized funding from UBS Group AG that is designated at fair value. |
Debt issued designated at fair
Debt issued designated at fair value | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Financial Instruments Designated At Fair Value Through Profit Or Loss Explanatory | Note 16 USD million 31.12.21 31.12.20 Issued debt instruments Equity-linked 1 47,059 41,069 Rates-linked 16,369 11,038 Credit-linked 1,723 1,933 Fixed-rate 2,868 3,604 Commodity-linked 2,911 1,497 Other 2,868 2,101 of which: debt that contributes to total loss-absorbing capacity 2,136 1,190 Total debt issued designated at fair value 73,799 61,243 of which: issued by UBS AG with original maturity greater than one 2 57,967 46,427 of which: life-to-date own credit (gain) / loss 347 418 1 Includes investment fund unit-linked instruments issued. 100 % of the balance was unsecured (31 December 2020: 100 %). As of 31 December redemption amount at maturity value through profit or carrying amount. The table below shows the carrying between contractual features. Interest rate ranges for future interest to debt issued designated at fair value have the table below, structured are prevailing market conditions payment is made. › Refer to Note 24 for maturity information cash flow basis Contractual maturity of carrying amount USD million 2022 2023 2024 2025 2026 2027–2031 Thereafter Total 31.12.21 Total 31.12.20 UBS Group AG 1 Non-subordinated debt Fixed-rate 0 0 0 0 0 0 2,340 2,340 1,375 UBS AG 2 Non-subordinated debt Fixed-rate 4,296 1,658 716 495 226 273 1,732 9,397 9,409 Floating-rate 19,338 15,621 5,067 5,816 3,840 8,364 3,238 61,284 49,528 Subtotal 23,635 17,279 5,783 6,311 4,066 8,637 4,971 70,682 58,937 Other subsidiaries 3 Non-subordinated debt Fixed-rate 6 0 0 0 0 423 0 429 539 Floating-rate 150 47 145 0 0 0 7 349 392 Subtotal 156 47 145 0 0 423 7 778 931 Total 23,791 17,325 5,929 6,311 4,066 9,060 7,317 73,799 61,243 1 Consists of instruments issued by the legal entity UBS Group AG. |
UBS AG | |
Entity [Table] | |
Disclosure Of Financial Instruments Designated At Fair Value Through Profit Or Loss Explanatory | Note 16 USD million 31.12.21 31.12.20 Issued debt instruments Equity-linked 1 47,059 41,069 Rates-linked 16,369 11,038 Credit-linked 1,723 1,933 Fixed-rate 2,868 3,604 Commodity-linked 2,911 1,497 Other 529 726 Total debt issued designated at fair value 71,460 59,868 of which: issued by UBS AG with original maturity greater than one 2 57,967 46,427 of which: life-to-date own credit (gain) / loss 144 233 1 Includes investment fund unit-linked instruments issued. 100 % of the balance was unsecured (31 December 2020: 100 %). As of 31 December redemption amount at maturity value through profit or carrying amount. The table below shows the carrying between contractual features. Interest rate ranges for future interest to debt issued designated at fair value have the table below, structured are prevailing market conditions payment is made. › Refer to Note 24 for maturity information cash flow basis Contractual maturity of carrying amount USD million 2022 2023 2024 2025 2026 2027–2031 Thereafter Total 31.12.21 Total 31.12.20 UBS AG 1 Non-subordinated debt Fixed-rate 4,296 1,658 716 495 226 273 1,732 9,397 9,409 Floating-rate 19,338 15,621 5,067 5,816 3,840 8,364 3,238 61,284 49,528 Subtotal 23,635 17,279 5,783 6,311 4,066 8,637 4,971 70,682 58,937 Other subsidiaries 2 Non-subordinated debt Fixed-rate 6 0 0 0 0 423 0 429 539 Floating-rate 150 47 145 0 0 0 7 349 392 Subtotal 156 47 145 0 0 423 7 778 931 Total 23,791 17,325 5,929 6,311 4,066 9,060 4,977 71,460 59,868 1 Consists of instruments issued by the legal entity UBS AG. |
Debt issued held at amortized c
Debt issued held at amortized cost | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Debt Securities Explanatory | Note 17 USD million 31.12.21 31.12.20 Certificates of deposit and commercial paper 40,640 41,151 Other short-term debt 2,458 5,515 Short-term debt 1 43,098 46,666 Senior unsecured debt that contributes to total loss-absorbing 38,984 36,611 Senior unsecured debt other than TLAC 27,590 21,340 of which: issued by UBS AG with original maturity greater than one 2 23,307 18,464 Covered bonds 1,389 2,796 Subordinated debt 18,640 22,157 of which: high-trigger loss-absorbing additional tier 1 capital 11,052 11,837 of which: low-trigger loss-absorbing additional tier 1 capital 2,425 2,577 of which: low-trigger loss-absorbing tier 2 capital instruments 2,596 7,201 of which: non-Basel III-compliant tier 2 capital instruments 547 543 Debt issued through the Swiss central mortgage institutions 9,454 9,660 Other long-term debt 0 3 Long-term debt 3 96,057 92,566 Total debt issued measured at amortized cost 4 139,155 139,232 1 Debt with an original contractual maturity of 100 % of the balance was unsecured (31 December 2020: 100 %). redemption features. The Group uses interest manage amortized some cases, accounting for interest rate risk as discussed in item 2j in Note 1a and Note to-date adjustment to the carrying amount of debt issued was increase 478 increase of USD 2,401 changes in fair value due to interest rate movements. Subordinated debt consists of unsecured debt obligations that are present and future issuing All outstanding as of 31 December 2021 pay a fixed rate of interest. The table below shows the carrying floating-rate consider any early redemption rate issuances similar to below. Refer to Note 24 for maturity information cash flow basis Contractual maturity of carrying amount USD million 2022 2023 2024 2025 2026 2027–2031 Thereafter Total 31.12.21 Total 31.12.20 UBS Group AG 1 Non-subordinated debt Fixed-rate 3,769 4,027 5,145 5,052 6,748 12,534 3,294 40,569 33,578 Floating-rate 492 2,183 0 0 0 0 0 2,676 5,890 Subordinated debt Fixed-rate 0 0 0 0 0 0 13,477 13,477 14,413 Subtotal 4,261 6,211 5,145 5,052 6,748 12,534 16,771 56,722 53,881 UBS AG 2 Non-subordinated debt Fixed-rate 38,647 5,578 1,964 349 3,439 1,381 1,213 52,571 52,618 Floating-rate 9,807 2,093 1,922 907 508 0 0 15,238 15,299 Subordinated debt Fixed-rate 2,020 0 2,596 337 210 0 0 5,163 7,744 Subtotal 50,474 7,671 6,482 1,594 4,158 1,381 1,213 72,972 75,661 Other subsidiaries 3 Non-subordinated debt Fixed-rate 907 1,007 1,072 1,173 1,045 3,674 582 9,460 9,690 Subtotal 907 1,007 1,072 1,173 1,045 3,674 582 9,460 9,690 Total 55,642 14,889 12,698 7,818 11,951 17,590 18,566 139,155 139,232 1 Consists of debt issued by the legal entity UBS Group AG. |
UBS AG | |
Entity [Table] | |
Disclosure Of Debt Securities Explanatory | Note 17 USD million 31.12.21 31.12.20 Certificates of deposit and commercial paper 40,640 41,151 Other short-term debt 2,458 5,515 Short-term debt 1 43,098 46,666 Senior unsecured debt 23,328 18,483 of which: issued by UBS AG with original maturity greater than one 2 23,307 18,464 Covered bonds 1,389 2,796 Subordinated debt 5,163 7,744 of which: low-trigger loss-absorbing tier 2 capital instruments 2,596 7,201 of which: non-Basel III-compliant tier 2 capital instruments 547 543 Debt issued through the Swiss central mortgage institutions 9,454 9,660 Other long-term debt 0 3 Long-term debt 3 39,334 38,685 Total debt issued measured at amortized cost 4 82,432 85,351 1 Debt with an original contractual maturity of 100 % of the balance was unsecured (31 December 2020: 100 %). redemption features. UBS manage amortized cost. In some cases, UBS AG applies hedge accounting for interest 26. adjustment to the of USD 261 USD 761 fair value due to interest rate movements. Subordinated debt consists of unsecured debt obligations that are present and future issuing All rdinated outstanding as of 31 December 2021 pay a fixed rate of interest. The table below shows the carrying floating-rate consider any early redemption rate issuances similar to below. › Refer to Note 24 for maturity information cash flow basis Contractual maturity of carrying amount USD million 2022 2023 2024 2025 2026 2027–2031 Thereafter Total 31.12.21 Total 31.12.20 UBS AG 1 Non-subordinated debt Fixed-rate 38,647 5,578 1,964 349 3,439 1,381 1,213 52,571 52,618 Floating-rate 9,807 2,093 1,922 907 508 0 0 15,238 15,299 Subordinated debt Fixed-rate 2,020 0 2,596 337 210 0 0 5,163 7,744 Subtotal 50,474 7,671 6,482 1,594 4,158 1,381 1,213 72,972 75,661 Other subsidiaries 2 Non-subordinated debt Fixed-rate 907 1,007 1,072 1,173 1,045 3,674 582 9,460 9,690 Subtotal 907 1,007 1,072 1,173 1,045 3,674 582 9,460 9,690 Total 51,381 8,679 7,554 2,766 5,203 5,055 1,795 82,432 85,351 1 Consists of debt issued by the legal entity UBS AG. |
Provisions
Provisions | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Provisions Explanatory | Note 18 a) Provisions The table below presents an overview of total provisions. USD million 31.12.21 31.12.20 Provisions other than provisions for expected credit losses 3,322 2,571 Provisions for expected credit losses 196 257 Total provisions 3,518 2,828 The following table presents additional information for provisions other than provisions for expected credit losses. USD million Litigation, regulatory and similar matters 1 Restructuring Other 3 Total 2021 Balance at the beginning of the year 2,135 72 363 2,571 Increase in provisions recognized in the income statement 986 297 78 1,361 Release of provisions recognized in the income statement (74) (30) (32) (136) Provisions used in conformity with designated purpose (189) (165) (80) (434) Capitalized reinstatement costs 0 0 32 32 Foreign currency translation / unwind of discount (59) (3) (10) (72) Balance at the end of the year 2,798 172 2 352 3,322 1 Consists of provisions for losses 125 USD 18 47 49 operational risks. components, maintenance, when from sub-tenants. Information respect of included in Note associated with the other classes of provisions. |
UBS AG | |
Entity [Table] | |
Disclosure Of Provisions Explanatory | Note 18 a) Provisions The table below presents an overview of total provisions. USD million 31.12.21 31.12.20 Provisions other than provisions for expected credit losses 3,256 2,534 Provisions for expected credit losses 196 257 Total provisions 3,452 2,791 The following table presents additional information for provisions other than provisions for expected credit losses. USD million Litigation, regulatory and similar matters 1 Restructuring Other 3 Total 2021 Balance at the beginning of the year 2,135 67 332 2,534 Increase in provisions recognized in the income statement 986 228 73 1,286 Release of provisions recognized in the income statement (74) (25) (29) (128) Provisions used in conformity with designated purpose (189) (130) (76) (396) Capitalized reinstatement costs 0 0 30 30 Foreign currency translation / unwind of discount (59) (3) (9) (70) Balance at the end of the year 2,798 137 2 321 3,256 1 Consists of provisions for losses resulting from legal, liability and compliance risks. 90 USD 13 47 49 operational risks. Restructuring provisions personnel - related provisions and onerous contracts. Personnel-related restructuring provisions changes in amount may be reduces the and therefore the estimated are recognized components, maintenance, when from sub-tenants. Information respect of included in Note associated with the other classes of provisions. |
Litigation, regulatory and simi
Litigation, regulatory and similar matters | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Contingent Liabilities Explanatory | b) Litigation, regulatory and similar matters The exposes disputes and regulatory purposes of this Note more disputes and regulatory and criminal investigations. Such outcome and the particularly in the earlier where may occur in order or reputational implications of continuing to for exonerated. The the amount and with respect to which provisions have been established and other contingent matters brought against after seeking legal advice, has a events, it is and the are otherwise satisfied, a that nevertheless with similar asserted claims. If any of those conditions is not met, such matters obligation cannot be reliably estimated, recognized Accordingly, outflow significant. Developments relating to relevant statements, provision developments provide end reporting financial statements for the reporting period. Specific litigation, below, including be significance effects. The amount of or other information is provided where in order to assist exposures. In established a such disclosure of the amount of a provision to position with other what outflow, we subject disclosure. With respect to the matters for which we do not state whether we have established established a contingent liability (b) we have fact to matter outflow of resources to be probable and reliably estimable. With respect for which we have established provisions, we the expected timing of the expected outflows for those matters for which we are able to estimate and expected levels of liquidity over the relevant time periods. The and similar matters as a class in Note estimate matters as a class of contingent liabilities. Doing so would UBS proceedings theories, that have not yet been initiated or are at early adjudication, quantified provide a numerical estimate of the from litigation, the aggregate are provisions. Litigation, non-monetary conviction of, a crime could have material consequences for UBS. Resolution of waivers operations, may entitle regulatory authorities to limit, suspend or terminate licenses and regulatory authorizations, and may permit financial participation in such limitation, suspension or participations, could have material consequences for UBS. The risk of matters determining capital requirements purpose balance sheet” section of this report. Provisions for litigation, regulatory and similar matters 1 USD million Global Wealth Manage- ment Personal & Corporate Banking Manage- ment Investment Bank Group Functions Total 2021 Balance at the beginning of the year 861 115 0 227 932 2,135 Increase in provisions recognized in the income statement 754 84 9 107 32 986 Release of provisions recognized in the income statement (60) (11) 0 (4) 0 (74) Provisions used in conformity with designated purpose (175) (1) (1) (10) (2) (189) Foreign currency translation / unwind of discount (42) (6) 0 (11) 0 (59) Balance at the end of the year 1,338 181 8 310 962 2,798 1 Provisions, if any, Provisions, if any, for the matters described in items 1 and 6 of this Note are allocated between Global Wealth Management and 5 are allocated between the Investment Bank and Group Functions. 1. Inquiries regarding cross-border wealth management businesses Tax made employees located cross-border other financial institutions. of relating to rise to further inquiries in orders from the Swiss Federal information assistance in tax matters. The account numbers pertaining to based inform proceedings appeal. The requests authorities, who seized certain in shared additional countries to file similar requests. Since employees complicity regarding and financial solicitation with this to provide caution ”) of 1.1 to post 40 EUR 10 On verdict finding UBS AG guilty of unlawful French territory and aggravated laundering of fraud, unlawful solicitation and of laundering the proceeds of tax fraud. The court 3.7 and 800 damages to the French took place in Appeal aggravated ordered 3.75 EUR 1 EUR 800 the aiding and abetting of pay a fine of EUR 1.875 the enables UBS AG Appeal stakeholders. The fine Appeal are has been 99 deducted from the bail), subject to the result of UBS’s appeal. Our balance with 1.1 (USD 1.252 possible estimation uncertainty and of civil amount. In 2016, that it inculpé ”) regarding allegations of financial fraud. settlement with the Brussels 49 without banking serious tax fraud. The allegation of laundering of proceeds of tax fraud was dismissed. Our balance with respect to matters described UBS believes standard. established provisions, the of currently prove provision that we have recognized. 2. Claims related to sales of residential mortgage-backed securities and mortgages From 2002 through loan market, UBS was residential purchaser and seller of US residential mortgages. In November 2018, Court for unspecified Institutions related transactions complaint district court denied UBS’s motion to dismiss. Our balance sheet at with respect to matters described UBS believes standard. established provisions, the of currently prove provision that we have recognized. 3. Madoff In (BMIS) investment UBS subsidiaries regulators, Authority Surveillance du Secteur Financier. third-party funds established all established in exposure Luxembourg in establishing including promoter, members. In funds certain individuals, including current seeking 2.1 includes trustee for the liquidation of BMIS (BMIS Trustee). A against UBS relating been filed in test Luxembourg Court has dismissed a further appeal in one of the test cases. In the among others, in relation to the two Luxembourg funds and of defendants 2 2014, the US Supreme for leave to appeal decisions dismissing the 125 alleged to In 2016, the bankruptcy court dismissed UBS entities. In February 2019, the Court of Appeals reversed the dismissal Supreme Court subsequently denied a the Court the Bankruptcy Court for further proceedings. 4. Puerto Rico Declines since 2013 in the market prices of Puerto Rico municipal bonds and of co-managed distributed by UBS (UBS PR) 2015, led to settlements Financial Institutions US Securities Industry Regulatory Authority. Since then, Puerto Rico municipal bonds and/or assets complaints and arbitration demands seeking aggregate of USD 3.4 3.1 through Allegations include the funds and of the loans. A various UBS the funds, alleging hundreds the funds. In matter for USD 15 In 2011, the Employee Retirement Rico which consulting their connection 3 of USD 800 to defendants’ motion to denied plaintiffs’ motion for summary judgment. Beginning in 2015, certain the on certain federal oversee oversight creditors’ the supervision of a Federal District Judge. In Rico federal and municipal underwriting offerings. UBS 125 million in fees in the relevant offerings. In August insurance companies that insured issues of Puerto Rico municipal bonds municipal bonds seek 955 from defendants failed to the between 2002 and 2007, which plaintiffs argue they relied in agreeing to insure the contractual motions decisions are defendants’ ruling was reversed and the motion to dismiss was granted. Our balance with respect UBS believes standard. established provisions, the future of currently prove provisions that we have recognized. 5. Foreign exchange, LIBOR and benchmark rates, and other trading practices Foreign exchange-related regulatory matters: numerous possible manipulation of foreign metals prices. As a resolutions the conditional immunity by the in other jurisdictions violations businesses. Foreign exchange-related have jurisdictions against classes of persons with court class the exchange futures settlement agreement that provides for UBS of 141 classes. that settlement and have courts against UBS and other banks, alleging violations of US European competition laws and unjust enrichment. In against UBS and numerous other banks on behalf of persons and businesses in the the defendants In March motions to dismiss the complaint. The plaintiffs filed an amended complaint in August defendants’ motions to dismiss the amended complaint. LIBOR Numerous regarding potential improper attempts by UBS, manipulate UBS relating authorities. UBS immunity Antitrust Commission competition law violations related to certain has not reached a final settlement with WEKO, of WEKO has asserted LIBOR and of federal courts on benchmark-based derivatives. Also jurisdictions are a number of to various products whose other benchmarks, including and debt securities, bonds accounts, The certain TIBOR, Yen and compensatory and other damages under varying legal theories. USD LIBOR class and individual actions In 2013 and 2015, whole racketeering and appeal. In court’s dismissal in part and district court for further proceedings. The Second other things, and other one alleged States. Separately, in district plaintiffs’ claims and certain of In certification UBS, and plaintiffs sought permission to appeal that ruling to the Second petition to 2018 denied 2019, a putative class action Southern District banks directly instruments. defendants moved to 26 March 2020 the the complaint in In District alleging that the as USD LIBOR consumer the complaint in September 2021. Other benchmark class actions in the US: Yen In 2014, 2015 and 2017, the court in certain antitrust granted defendants’ dismissed the lone remaining claim in the action as impermissibly extraterritorial. dismissed entirety reversed the dismissal and in August 2020 plaintiffs filed granted in part and denied in part defendants’ motion to dismiss the amended complaint in remaining defendants have moved for reconsideration. CHF LIBOR on standing grounds and failure amended complaint, and the court granted a renewed motion to dismiss 2021, vacate the dismissal and EURIBOR the case as of personal jurisdiction. Plaintiffs have appealed. SIBOR / SOR action Plaintiffs renewed March 2021, filed an amended have moved to dismiss. BBSW lawsuit as to UBS and certain other personal jurisdiction. Plaintiffs 2019, February defendants’ August 2020, for 2021. GBP August 2019. Plaintiffs have appealed. Government bonds: 2015 in US federal courts against UBS and other banks on behalf of persons who since 2007. A consolidated complaint was filed District Court for the the banks colluded with Treasury securities asserting Defendants’ motions granted which actions have and other government In finding that antitrust bonds. The European 172 is appealing With encompassed our balance an applicable accounting for which resources in certainty based on may ultimately than the provision that we have recognized. 6. Swiss retrocessions The Federal Supreme Court of Switzerland case against distributing structured products must be who have the firm, absent to all Swiss has met affected clients. The result, potentially on a case-by-case basis. Considerations taken into account when assessing these cases of documentation distribution fees. Our balance sheet at with respect to matters described UBS believes standard. and the resolution thereof, factors that assess. Hence, as in the established provisions, the of currently prove provision that we have recognized. |
UBS AG | |
Entity [Table] | |
Disclosure Of Contingent Liabilities Explanatory | b) Litigation, regulatory and similar matters UBS operates in a legal and it and regulatory proceedings. As a result, UBS (which for purposes of subsidiaries, as applicable) proceedings, including criminal investigations. Such outcome and the particularly in the earlier where occur in reputational implications those matters for uncertainties inherent timing of any potential outflows for both matters with respect to which liabilities. UBS makes provisions for such matters brought against it when, in it constructive that an outflow of be reliably estimated. Where these factors a provision may asserted against UBS, but are nevertheless expected to be, on UBS’s conditions is not met, such matters result in contingent liabilities. If liability resources even matters could that issuance assessment example, existed at after the reporting in the financial statements for the reporting period. Specific litigation, below, including be significance effects. The amount of or other information is provided where in order to assist exposures. In established a such disclosure of the amount of a provision to position with other what outflow, we subject disclosure. With respect to the matters for which we do not state whether we have established established a contingent liability (b) we have fact to matter outflow of resources to be probable and reliably estimable. With respect for which we have established provisions, we the expected timing of the expected outflows for those matters for which we are able to estimate and expected levels of liquidity over the relevant time periods. The and similar matters as a class in Note estimate matters as a class of contingent liabilities. Doing so would UBS proceedings theories, that have not yet been initiated or are at early adjudication, quantified provide a numerical estimate of the from litigation, the aggregate are provisions. Litigation, non-monetary conviction of, a crime could have material consequences for UBS. Resolution of waivers operations, may entitle regulatory authorities to limit, suspend or terminate licenses and regulatory authorizations, and may permit financial participation in such limitation, suspension or participations, could have material consequences for UBS. The risk of matters determining capital requirements purpose balance sheet” section of this report. Provisions for litigation, regulatory and similar matters 1 USD million Global Wealth Manage- ment Personal & Corporate Banking Manage- ment Investment Bank Group Functions Total 2021 Balance at the beginning of the year 861 115 0 227 932 2,135 Increase in provisions recognized in the income statement 754 84 9 107 32 986 Release of provisions recognized in the income statement (60) (11) 0 (4) 0 (74) Provisions used in conformity with designated purpose (175) (1) (1) (10) (2) (189) Foreign currency translation / unwind of discount (42) (6) 0 (11) 0 (59) Balance at the end of the year 1,338 181 8 310 962 2,798 1 Provisions, if any, Provisions, if any, for the matters described in items 1 and 6 of this Note are allocated between Global Wealth Management and Personal & Corporate Banking, and provisions, if any, for the matters described in item 5 are allocated between the Investment Bank and Group Functions. 1. Inquiries regarding cross-border wealth management businesses Tax made employees located cross-border other financial institutions. of relating to rise to further inquiries in orders from the Swiss Federal information assistance in tax matters. The account numbers pertaining to based inform proceedings appeal. The requests authorities, who seized certain in shared additional countries to file similar requests. Since employees complicity regarding and financial solicitation with this to provide caution ”) of 1.1 to post 40 EUR 10 On verdict finding UBS AG guilty of unlawful French territory and aggravated laundering of fraud, unlawful solicitation and of laundering the proceeds of tax fraud. The court 3.7 and 800 damages to the French took place in Appeal aggravated ordered 3.75 EUR 1 EUR 800 the aiding and abetting of pay a fine of EUR 1.875 the enables UBS AG Appeal stakeholders. The fine Appeal are has been 99 deducted from the bail), subject to the result of UBS’s appeal. Our balance with 1.1 (USD 1.252 possible estimation uncertainty and of civil amount. In 2016, that it inculpé ”) regarding allegations of financial fraud. settlement with the Brussels 49 without banking serious tax fraud. The allegation of laundering of proceeds of tax fraud was dismissed. Our balance with respect to matters described UBS believes standard. established provisions, the of currently prove provision that we have recognized. 2. Claims related to sales of residential mortgage-backed securities and mortgages From 2002 through loan market, UBS was residential purchaser and seller of US residential mortgages. In November 2018, Court for unspecified Institutions related transactions complaint district court denied UBS’s motion to dismiss. Our balance sheet at with respect to matters described UBS believes standard. established provisions, the of currently prove provision that we have recognized. 3. Madoff In (BMIS) investment UBS branch) subsidiaries regulators, Authority Surveillance du Secteur Financier. third-party funds established all established in exposure Luxembourg establishing including promoter, members. In funds certain individuals, including current seeking 2.1 includes trustee for the liquidation of BMIS (BMIS Trustee). A against UBS relating been filed in test Luxembourg Court has dismissed a further appeal in one of the test cases. In the among others, in relation to the two Luxembourg funds and of defendants 2 2014, the US Supreme for leave to appeal decisions dismissing the 125 alleged to In 2016, the bankruptcy court dismissed UBS entities. In February 2019, the Court of Appeals reversed the dismissal Supreme Court subsequently denied a the Court the Bankruptcy Court for further proceedings. 4. Puerto Rico Declines since 2013 in the market prices of Puerto Rico municipal bonds and of co-managed distributed by UBS (UBS PR) 2015, led to settlements Financial Institutions US Securities Industry Regulatory Authority. Since then, Puerto Rico municipal bonds and/or assets complaints and arbitration demands seeking aggregate of USD 3.4 3.1 through claims . Allegations include the funds and of the loans. A various UBS the funds, alleging hundreds the funds. In matter for USD 15 In 2011, the Employee Retirement Rico which consulting their connection 3 of USD 800 to the defendants’ motion to denied plaintiffs’ motion for summary judgment. Beginning in 2015, certain the on certain federal oversee oversight creditors’ the supervision of a Federal District Judge. In Rico federal and municipal underwriting offerings. UBS 125 million in fees in the relevant offerings. In August insurance companies that insured issues of Puerto Rico municipal bonds municipal bonds seek 955 from defendants failed to the between 2002 and 2007, which plaintiffs argue they relied in agreeing to insure the contractual motions decisions are defendants’ ruling was reversed and the motion to dismiss was granted. Our balance with respect UBS believes standard. established provisions, the future of currently prove provisions that we have recognized. 5. Foreign exchange, LIBOR and benchmark rates, and other trading practices Foreign exchange-related regulatory matters: numerous possible manipulation of foreign metals prices. As a resolutions the immunity by the in other jurisdictions violations businesses. Foreign exchange-related have jurisdictions against classes of persons with court class the exchange futures settlement agreement that provides for UBS of 141 classes. that settlement and have courts against UBS and other banks, alleging violations of US European competition laws and unjust enrichment. In against UBS and numerous other banks on behalf of persons and businesses in the the defendants In March motions to dismiss the complaint. The plaintiffs filed an amended complaint in August defendants’ motions to dismiss the amended complaint. LIBOR - related matters: Numerous regarding potential improper attempts by UBS, manipulate UBS relating authorities. UBS immunity Antitrust Commission competition law violations related to certain has not reached a final settlement with WEKO, as of WEKO has asserted LIBOR and of federal courts on benchmark-based derivatives. Also jurisdictions are a number of to various products whose other benchmarks, including and debt securities, bonds accounts, The certain TIBOR, Yen and compensatory and other damages under varying legal theories. USD LIBOR class and individual actions In 2013 and 2015, whole racketeering and appeal. In court’s dismissal in part and district court for further proceedings. The Second other things, and other one alleged States. Separately, in district plaintiffs’ claims and certain of In certification UBS, and plaintiffs sought permission to appeal that ruling to the Second petition to 2018 denied 2019, a putative class action Southern District banks directly instruments. defendants moved to 26 March 2020 the the complaint in In District alleging that the as USD LIBOR consumer the complaint in September 2021. Other benchmark class actions in the US: Yen In 2014, 2015 and 2017, the court in certain antitrust granted defendants’ dismissed the lone remaining claim in the action as impermissibly extraterritorial. dismissed entirety reversed the dismissal and in August 2020 plaintiffs filed granted in part and denied in part defendants’ motion to dismiss the amended complaint in remaining defendants have moved for reconsideration. CHF LIBOR on standing grounds and failure amended complaint, and the court granted a renewed motion to dismiss 2021, vacate the dismissal and EURIBOR the case as of personal jurisdiction. Plaintiffs have appealed. SIBOR / SOR action Plaintiffs renewed March 2021, filed an amended have moved to dismiss. BBSW lawsuit as to UBS and certain other personal jurisdiction. Plaintiffs 2019, February defendants’ August 2020, for 2021. GBP August 2019. Plaintiffs have appealed. Government bonds: 2015 in US federal courts against UBS and other banks on behalf of persons who since 2007. A consolidated complaint was filed District Court for the the banks colluded with Treasury securities asserting Defendants’ motions granted which actions have and other government In finding that antitrust bonds. The European 172 is appealing With encompassed our balance an applicable accounting for which resources in certainty based on may ultimately than the provision that we have recognized. 6. Swiss retrocessions The Federal Supreme Court of Switzerland case distributing structured products must be who have the firm, absent to all Swiss has met affected clients. The result, potentially on a case-by-case basis. Considerations taken into account when assessing these cases of documentation a distribution fees. Our balance sheet at with respect to matters described UBS believes standard. and the resolution thereof, factors that assess. Hence, as in the established provisions, the of currently prove provision that we have recognized. |
Other financial and non-finan_2
Other financial and non-financial liabilities | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Other Financial And Non Financial Liabilities Explanatory | Note 19 a) Other financial liabilities measured at amortized cost USD million 31.12.21 31.12.20 Other accrued expenses 1,876 1,696 Accrued interest expenses 1,094 1,355 Settlement and clearing accounts 1,304 1,199 Lease liabilities 3,558 3,927 Other 1,167 1,553 Total other financial liabilities measured at amortized cost 9,001 9,729 b) Other financial liabilities designated at fair value USD million 31.12.21 31.12.20 Financial liabilities related to unit-linked investment contracts 21,466 20,975 Securities financing transactions 6,377 7,317 Over-the-counter debt instruments 2,128 2,060 Other 103 35 Total other financial liabilities designated at fair value 30,074 30,387 of which: life-to-date own credit (gain) / loss (32) (36) c) Other non-financial liabilities USD million 31.12.21 31.12.20 Compensation-related liabilities 7,257 7,468 of which: Deferred Contingent Capital Plan 1,628 1,858 of which: financial advisor compensation plans 1,512 1,500 of which: other compensation plans 2,846 2,740 of which: net defined benefit liability 633 722 of which: other compensation-related liabilities 1 638 648 Deferred tax liabilities 300 564 Current tax liabilities 1,398 1,009 VAT and other tax payables 590 523 Deferred income 240 228 Liabilities of disposal groups held for sale 2 1,298 Other 68 61 Total other non-financial liabilities 11,151 9,854 1 Includes liabilities for payroll taxes and untaken vacation. |
UBS AG | |
Entity [Table] | |
Other Financial And Non Financial Liabilities Explanatory | Note 19 a) Other financial liabilities measured at amortized cost USD million 31.12.21 31.12.20 Other accrued expenses 1,642 1,508 Accrued interest expenses 1,134 1,382 Settlement and clearing accounts 1,282 1,181 Lease liabilities 3,438 3,821 Other 2,269 2,530 Total other financial liabilities measured at amortized cost 9,765 10,421 b) Other financial liabilities designated at fair value USD million 31.12.21 31.12.20 Financial liabilities related to unit-linked investment contracts 21,466 20,975 Securities financing transactions 6,377 7,317 Over-the-counter debt instruments 2,128 2,060 Funding from UBS Group AG 2,340 1,375 Other 103 46 Total other financial liabilities designated at fair value 32,414 31,773 of which: life-to-date own credit (gain) / loss 172 148 c) Other non-financial liabilities USD million 31.12.21 31.12.20 Compensation-related liabilities 4,795 4,776 of which: financial advisor compensation plans 1,512 1,497 of which: other compensation plans 2,140 2,034 of which: net defined benefit liability 617 711 of which: other compensation-related liabilities 1 526 534 Deferred tax liabilities 297 558 Current tax liabilities 1,365 943 VAT and other tax payables 524 470 Deferred income 225 212 Liabilities of disposal groups held for sale 2 1,298 Other 68 61 Total other non-financial liabilities 8,572 7,018 1 Includes liabilities for payroll taxes and untaken vacation. |
Expected credit loss measuremen
Expected credit loss measurement | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Financial Assets Explanatory | Additional information Note 20 Total 148 reflecting 123 stage 1 and 2 25 related to credit-impaired (stage 3) positions. Stage 1 123 included 68 adjustment, macroeconomic 45 million changes and a residual USD 10 from remeasurements transactions, partially offset by expenses from new transactions . › Refer to Note 20b ECL model, scenarios, adjustment and to Note 20c for more information the development of ECL allowances and Stage 3 net releases of USD 25 a number of defaulted 24 in Personal & Corporate Banking. b) Changes to ECL models, scenarios, scenario weights and key inputs Credit loss (expense) / release USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions Total For the year ended 31.12.21 Stages 1 and 2 28 62 0 34 0 123 Stage 3 1 24 (1) 0 0 25 Total credit loss (expense) / release 29 86 (1) 34 0 148 For the year ended 31.12.20 Stages 1 and 2 (48) (129) 0 (88) 0 (266) Stage 3 (40) (128) (2) (217) (42) (429) Total credit loss (expense) / release (88) (257) (2) (305) (42) (694) For the year ended 31.12.19 Stages 1 and 2 3 23 0 (4) 0 22 Stage 3 (23) (44) 0 (26) (7) (100) Total credit loss (expense) / release (20) (21) 0 (30) (7) (78) Refer to expected credit loss key inputs applied. Governance Comprehensive processes scenario increases in credit risk resulted in stage transfers, to outputs adjustments. Model changes During 2021, the model review adjustments of (LGD) USD 45 25 Large corporate Investment Personal & Corporate Banking and Global Wealth Management. Scenario and key input updates During were updated by conditions more downturn, improved forecast starting level. The projections of the planning purposes, are broadly in line with external data, such as from International economic especially in the improvement assumes continued growth in 2022 in slower rate than expected to fall noticeably below the current levels. Interest rates are expected to pursued in the Eurozone and Switzerland, and any potential rises in the US would be are especially in Switzerland and, to a lesser degree, in the US. The which and assumes that, while decreased, the remain debt, following the to protectionism results central banks have limited consequence, under oriented demand macroeconomic highs and real estate sectors contract sharply. With effect and mild downside scenarios, which as attached, calculation. following outlook regarding a potential change in The following pent-up demand in certain interest rates prices rise significantly, but inflation rates are temporary and spare economic mean that the scenario. The rising concerns regarding inflationary trends from steepening of volatility. period under . remaining high, central a few impacting corporate period is the consequence. The table for the four scenarios applied as of 31 December 2021. Scenario weights and post-model adjustments With the weighting of the generally on distribution of 2021, 5 percentage points of the weight of the baseline scenario and 10 percentage redistributed to the upside scenario (10%), as shown in the table below. Although the scenarios and in passed its peak path, based experiences factors comprehensively reflect extraordinary events, such as a pandemic or a fundamental change in the world political order. Especially these generally accepted view that the effects of COVID-19 are abating may prove to be disappointed by of current between challenges, such distortion of energy markets. Such events could affect economies severely and change than and applying model and apply - model These adjustments were 2021 , when n et of 91 recognized, corresponding to one third of of assessment and judgment, and year-end 2021 reporting. The post-model adjustments relating to COVID-19 amounted to 224 (2020: USD 117 16 for uncertain). ECL scenario Assigned weights in % 31.12.21 31.12.20 Upside 5.0 0.0 Baseline 55.0 60.0 Mild downside 10.0 0.0 Severe downside 30.0 40.0 Scenario assumptions One year Three years cumulative 31.12.21 Upside Baseline Mild downside Severe downside Upside Baseline Mild downside Severe downside Real GDP growth (% change) United States 9.1 4.4 (0.1) (5.9) 17.8 10.1 1.8 (3.8) Eurozone 9.4 3.9 (0.1) (8.7) 17.3 7.5 0.9 (10.3) Switzerland 5.5 2.4 (0.9) (6.6) 13.1 5.8 (0.1) (5.7) Consumer price index (% change) United States 3.1 2.2 5.7 (1.2) 9.5 6.3 13.0 0.4 Eurozone 2.3 1.4 4.2 (1.3) 8.0 4.8 10.4 (1.7) Switzerland 1.8 0.3 3.5 (1.8) 6.1 1.7 9.0 (1.6) Unemployment rate (end-of-period level, %) United States 3.0 3.9 6.1 10.9 3.0 3.5 7.2 10.8 Eurozone 6.2 7.4 8.7 12.9 6.0 7.2 9.1 15.1 Switzerland 2.3 2.5 3.4 5.2 1.6 2.3 4.2 5.9 Fixed income: 10-year government bonds (change in yields, basis points) USD 50.0 16.5 259.2 (50.0) 170.0 41.2 329.2 (15.0) EUR 40.0 11.1 283.8 (35.0) 140.0 34.9 349.3 (25.0) CHF 50.0 12.1 245.5 (70.0) 150.0 34.4 307.3 (35.0) Equity indices (% change) S&P 500 12.0 14.1 (27.0) (50.2) 35.5 24.7 (21.8) (40.1) EuroStoxx 50 16.0 12.3 (23.4) (57.6) 41.6 20.7 (19.9) (50.4) SPI 14.0 12.1 (22.9) (53.6) 37.9 19.1 (19.6) (44.2) Swiss real estate (% change) Single-Family Homes 5.1 4.4 (4.3) (17.0) 15.5 7.4 (8.8) (30.0) Other real estate (% change) United States (S&P / Case-Shiller) 10.0 3.5 (2.3) (9.5) 21.7 7.1 (8.7) (26.3) Eurozone (House Price Index) 8.4 5.1 (4.0) (5.4) 17.8 9.6 (7.6) (10.8) Scenario assumptions One year Three years cumulative 31.12.20 Baseline Severe downside Baseline Severe downside Real GDP growth (% change) United States 2.7 (5.9) 9.1 (3.8) Eurozone 2.5 (8.7) 9.9 (10.3) Switzerland 3.3 (6.6) 9.0 (5.7) Consumer price index (% change) United States 1.7 (1.2) 5.5 0.4 Eurozone 1.4 (1.3) 3.9 (1.7) Switzerland 0.3 (1.8) 0.9 (1.6) Unemployment rate (end-of-period level, %) United States 5.5 12.1 4.5 9.9 Eurozone 9.5 14.1 8.0 16.4 Switzerland 3.8 6.1 3.2 6.8 Fixed income: 10-year government bonds (change in yields, basis points) USD 22.0 (50.0) 46.0 (15.0) EUR 4.0 (35.0) 21.0 (25.0) CHF 13.0 (70.0) 31.0 (35.0) Equity indices (% change) S&P 500 (2.9) (50.2) (1.7) (40.1) EuroStoxx 50 3.8 (57.6) 13.5 (50.4) SPI (0.8) (53.6) 5.8 (44.2) Swiss real estate (% change) Single-Family Homes 3.4 (17.0) 7.1 (30.0) Other real estate (% change) United States (S&P / Case-Shiller) 2.5 (15.3) 9.2 (28.7) Eurozone (House Price Index) 1.1 (22.9) 7.2 (35.4) c) Development of ECL allowances and provisions The ECL impacted by a variety of factors, such as: – origination of new instruments during the period; – effect of passage of time as the ECLs on an instrument for the remaining same); – discount value basis; – derecognition of instruments in the period; – change in individual asset quality of instruments; – effect respective weights; movements from a of stages 1 and 2; – movements status) when 100% (or vice versa); – changes in models or updates to model parameters; – write-off; and – foreign foreign currencies and other movements. The following table explains the changes in credit lines in page. Development of ECL allowances and USD million Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2020 (1,468) (306) (333) (829) Net movement from new and derecognized transactions 1 (59) (72) 13 0 of which: Private clients with mortgages (7) (10) 3 0 of which: Real estate financing (7) (11) 4 0 of which: Large corporate clients (13) (21) 7 0 of which: SME clients (8) (8) 0 0 of which: Other (24) (23) (2) 0 (21) (18) (4) 0 0 (1) 1 0 Remeasurements with stage transfers 2 (40) 8 0 (49) of which: Private clients with mortgages (9) 4 (13) 0 of which: Real estate financing (3) 1 (4) 0 of which: Large corporate clients 2 (2) 12 (8) of which: SME clients (27) 5 4 (36) of which: Other (3) 0 2 (4) 2 (1) 3 0 0 1 (1) 0 Remeasurements without stage transfers 3 203 55 74 74 of which: Private clients with mortgages 33 8 26 (1) of which: Real estate financing 30 13 13 3 of which: Large corporate clients 44 5 21 17 of which: SME clients 53 (1) 1 53 of which: Other 44 29 14 2 27 15 12 0 6 8 1 (3) Model changes 4 45 29 16 0 Movements with profit or loss impact 5 148 19 104 25 Movements without profit or loss impact (write-off, FX and other) 6 154 5 9 141 Balance as of 31 December 2021 (1,165) (282) (220) (662) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. methodology changes. uncollectible or forgiven and movements in foreign exchange rates. In 148 million from net credit loss releases impacting profit or loss: – a 59 transactions 72 increase lending portfolio, 13 stage 2 before their contractual maturity; – a USD 163 that resulted 203 remeasurements half of portion related to the partial release of a by USD 40 2 clients; – a USD 45 model changes. 25 Large corporate remainder related to various Banking and Global Wealth Management. In to allowances decreased by USD 154 137 million 18 million and other movements, both of which statement. Development of ECL allowances and USD million Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2019 (1,029) (181) (160) (688) Net movement from new and derecognized transactions 1 (28) (90) 17 46 of which: Private clients with mortgages (2) (3) 2 0 of which: Real estate financing (3) (5) 2 0 of which: Large corporate clients (32) (29) (4) 0 of which: SME clients (16) (14) (3) 0 of which: Other 26 (39) 20 46 32 (1) 15 17 9 (1) 9 0 23 (6) 0 29 (20) (15) (5) 0 Remeasurements with stage transfers 2 (427) 45 (134) (338) of which: Private clients with mortgages (19) (2) (17) 0 of which: Real estate financing (6) 3 (9) 0 of which: Large corporate clients (224) 34 (83) (175) of which: SME clients (43) (1) (11) (31) of which: Other (134) 11 (14) (131) (36) 0 (18) (19) (12) 7 (7) (11) (36) 0 0 (36) (59) 0 0 (59) Remeasurements without stage transfers 3 (271) (88) (47) (136) of which: Private clients with mortgages (34) (19) (8) (7) of which: Real estate financing (14) (4) (11) 1 of which: Large corporate clients (149) (53) (17) (79) of which: SME clients (13) 0 (7) (6) of which: Other (60) (11) (4) (44) (18) (12) (3) (3) (3) 6 0 (9) (12) 0 0 (12) Model changes 4 32 21 11 0 Movements with profit or loss impact 5 (694) (112) (154) (429) Movements without profit or loss impact (write-off, FX and other) 6 254 (14) (19) 287 Balance as of 31 December 2020 (1,468) (306) (333) (829) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. methodology changes. uncollectible or forgiven and movements in foreign exchange rates. As explained in Note in SICR ) considers quantitative between assessment considers changes in PD based economic counterparties that with payments that are at least 30 days past due. ECL stage 2 (“significant deterioration USD million Stage 2 of which: PD layer of which: watch list of which: ≥30 days past due On-and off-balance sheet (220) (158) (22) (39) of which: Private clients with mortgages (71) (54) 0 (17) of which: Real estate financing (43) (38) 0 (4) of which: Large corporate clients (55) (40) (15) 0 of which: SME clients (30) (19) (7) (4) of which: Financial intermediaries and hedge funds (6) (6) 0 0 of which: Loans to financial advisors (3) 0 0 (3) of which: Credit cards (11) 0 0 (11) of which: Other (1) (1) 0 0 d) Maximum exposure to credit risk The credit and mitigating credit risk for these classes of financial instruments. The amounts of financial subject sheet arrangements. presented at fair value. reasonable alternative as credit derivative contracts notional amounts. Both are capped at the maximum credit risk for which and control” section of this of credit risk and respects from the requirements of IFRS. Maximum exposure to credit risk 31.12.21 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD billion Maximum exposure to credit risk Cash collateral received Collateralized by securities Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 192.8 192.8 Loans and advances to banks 4 15.5 0.1 0.1 15.3 Receivables from securities financing transactions 75.0 0.0 68.0 6.9 0.0 Cash collateral receivables on derivative instruments 5,6 30.5 18.4 12.1 Loans and advances to customers 7 397.8 37.5 128.7 191.3 20.2 4.0 16.2 Other financial assets measured at amortized cost 26.2 0.2 0.1 1.3 24.6 Total financial assets measured at amortized cost 737.8 37.7 196.9 191.3 28.4 18.4 0.0 4.0 261.0 Financial assets measured at fair value through other comprehensive income – debt 8.8 8.8 Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL 746.6 37.7 196.9 191.3 28.4 18.4 0.0 4.0 269.8 Guarantees 8 20.9 1.3 6.5 0.2 2.5 2.3 8.1 Loan commitments 8 39.4 0.5 4.0 2.4 7.3 0.3 1.7 23.1 Forward starting transactions, reverse repurchase and securities borrowing agreements 1.4 1.4 0.0 Committed unconditionally revocable credit lines 40.7 0.3 9.0 6.2 3.9 0.5 20.9 Total maximum exposure to credit risk not reflected on the balance sheet, in scope of ECL 102.5 2.2 20.9 8.7 13.7 0.0 0.3 4.5 52.1 31.12.20 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD billion Maximum exposure to credit risk Cash collateral received Collateralized by securities Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 158.2 158.2 Loans and advances to banks 4 15.4 0.1 15.3 Receivables from securities financing transactions 74.2 0.0 67.1 7.0 0.0 Cash collateral receivables on derivative instruments 5,6 32.7 21.1 11.6 Loans and advances to customers 7 379.5 25.8 118.2 194.6 21.7 4.4 14.8 Other financial assets measured at amortized cost 27.2 0.1 0.2 1.3 25.5 Total financial assets measured at amortized cost 687.3 26.0 185.7 194.6 30.1 21.1 0.0 4.4 225.5 Financial assets measured at fair value through other comprehensive income – debt 8.3 8.3 Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL 695.6 26.0 185.7 194.6 30.1 21.1 0.0 4.4 233.7 Guarantees 8 17.0 0.7 5.0 0.2 1.7 2.5 7.0 Loan commitments 8 41.2 0.0 4.2 2.1 6.8 0.4 2.4 25.3 Forward starting transactions, reverse repurchase and securities borrowing agreements 3.2 3.2 0.0 Committed unconditionally revocable credit lines 40.1 0.1 10.3 6.2 2.7 0.0 20.7 Total maximum exposure to credit risk not reflected on the balance sheet, in scope of ECL 101.6 0.8 22.7 8.5 11.2 0.0 0.4 4.9 53.0 1 Of which: USD 1,443 1,983 130 (31 December 2020: USD 154 cash, securities, real estate and other collateral. UBS applies mortgage loans, gold and other commodities. clients. clients who retain the associated credit risk. the collateral allocation was updated cash, with an offsetting reduction in loans secured by real estate and loans secured by securities. e) Financial assets subject to credit risk by rating category The exposure to credit risk based on the Group’s internal credit rating system and year-end risk rating reflects the Group’s assessment default of amounts presented are gross of impairment allowances. › Refer to the “Risk management and control” report for more details system Financial assets subject to credit risk by rating USD million 31.12.21 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 191,015 1,802 0 0 0 0 192,817 0 192,817 of which: stage 1 191,015 1,802 0 0 0 0 192,817 0 192,817 Loans and advances to banks 407 12,623 1,171 795 490 1 15,488 (8) 15,480 of which: stage 1 407 12,623 1,146 795 488 0 15,460 (7) 15,453 of which: stage 2 0 0 24 0 2 0 27 (1) 26 of which: stage 3 0 0 0 0 0 1 1 0 1 Receivables from securities financing transactions 34,386 11,267 10,483 17,440 1,439 0 75,014 (2) 75,012 of which: stage 1 34,386 11,267 10,483 17,440 1,439 0 75,014 (2) 75,012 Cash collateral receivables on derivative instruments 7,466 13,476 5,878 3,647 47 0 30,514 0 30,514 of which: stage 1 7,466 13,476 5,878 3,647 47 0 30,514 0 30,514 Loans and advances to customers 5,295 232,233 67,620 69,892 21,423 2,148 398,611 (850) 397,761 of which: stage 1 5,295 231,153 65,084 62,796 16,362 0 380,690 (126) 380,564 of which: stage 2 0 1,080 2,536 7,096 5,061 0 15,773 (152) 15,620 of which: stage 3 0 0 0 0 0 2,148 2,148 (572) 1,577 Other financial assets measured at amortized cost 12,564 6,702 321 6,072 394 264 26,318 (109) 26,209 of which: stage 1 12,564 6,693 307 5,863 317 0 25,745 (27) 25,718 of which: stage 2 0 10 13 209 77 0 309 (7) 302 of which: stage 3 0 0 0 0 0 264 264 (76) 189 Total financial assets measured at amortized cost 251,133 278,103 85,472 97,846 23,793 2,414 738,762 (969) 737,794 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 3,996 4,771 0 77 0 0 8,844 0 8,844 Total on-balance sheet financial instruments 255,130 282,874 85,472 97,923 23,793 2,414 747,606 (969) 746,638 Off-balance sheet positions subject to expected USD million 31.12.21 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off - balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 4,457 7,064 4,535 3,757 1,009 150 20,972 (41) of which: stage 1 4,457 7,037 4,375 3,075 752 0 19,695 (18) of which: stage 2 0 27 160 682 258 0 1,127 (8) of which: stage 3 0 0 0 0 0 150 150 (15) Irrevocable loan commitments 2,797 14,183 7,651 8,298 6,502 46 39,478 (114) of which: stage 1 2,797 13,917 7,416 7,127 5,840 0 37,097 (72) of which: stage 2 0 266 235 1,171 663 0 2,335 (42) of which: stage 3 0 0 0 0 0 46 46 0 Forward starting reverse repurchase and securities borrowing agreements 0 0 55 1,389 0 0 1,444 0 Total off-balance sheet financial instruments 7,254 21,247 12,241 13,444 7,512 196 61,894 (155) Credit lines Committed unconditionally revocable credit lines 2,636 15,594 8,627 9,752 4,107 63 40,778 (38) of which: stage 1 2,636 15,250 8,304 8,346 3,671 0 38,207 (28) of which: stage 2 0 344 323 1,406 436 0 2,508 (10) of which: stage 3 0 0 0 0 0 63 63 0 Irrevocable committed prolongation of existing loans 17 2,438 1,422 1,084 602 48 5,611 (3) of which: stage 1 17 2,438 1,422 1,082 568 0 5,527 (3) of which: stage 2 0 0 0 1 34 0 36 0 of which: stage 3 0 0 0 0 0 48 48 0 Total credit lines 2,653 18,032 10,049 10,836 4,709 111 46,390 (41) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and Financial assets subject to credit risk by rating USD million 31.12.20 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 156,250 1,981 0 0 0 0 158,231 0 158,231 of which: stage 1 156,250 1,981 0 0 0 0 158,231 0 158,231 Loans and advances to banks 543 12,129 1,344 1,182 260 1 15,460 (16) 15,444 of which: stage 1 543 12,074 1,277 1,145 231 0 15,269 (9) 15,260 of which: stage 2 0 55 67 37 29 0 189 (5) 184 of which: stage 3 0 0 0 0 0 1 1 (1) 0 Receivables from securities financing transactions 22,998 16,009 15,367 17,995 1,842 0 74,212 (2) 74,210 of which: stage 1 22,998 16,009 15,367 17,995 1,842 0 74,212 (2) 74,210 Cash collateral receivables on derivative instruments 8,196 13,477 7,733 3,243 88 0 32,737 0 32,737 of which: stage 1 8,196 13,477 7,733 3,243 88 0 32,737 0 32,737 Loans and advances to customers 5,813 214,307 67,270 69,217 21,038 2,943 380,589 (1,060) 379,528 of which: stage 1 5,813 212,970 63,000 59,447 15,860 0 357,090 (142) 356,948 of which: stage 2 0 1,338 4,269 9,770 5,178 0 20,556 (215) 20,341 of which: stage 3 0 0 0 0 0 2,943 2,943 (703) 2,240 Other financial assets measured at amortized cost 15,404 4,018 280 6,585 481 560 27,327 (133) 27,194 of which: stage 1 15,404 4,015 269 6,334 389 0 26,410 (34) 26,377 of which: stage 2 0 3 11 251 91 0 357 (9) 348 of which: stage 3 0 0 0 0 0 560 560 (90) 469 Total financial assets measured at amortized cost 209,204 261,922 91,993 98,223 23,709 3,505 688,556 (1,211) 687,345 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 3,212 5,014 0 32 0 0 8,258 0 8,258 Total on-balance sheet financial instruments 212,417 266,936 91,993 98,255 23,709 3,505 696,815 (1,211) 695,603 Off-balance sheet positions subject to expected USD million 31.12.20 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off - balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 3,482 4,623 3,522 4,293 991 170 17,081 (63) of which: stage 1 3,482 4,219 2,688 3,558 739 0 14,687 (14) of which: stage 2 0 404 834 736 252 0 2,225 (15) of which: stage 3 0 0 0 0 0 170 170 (34) Irrevocable loan commitments 3,018 14,516 8,583 9,302 5,850 104 41,372 (142) of which: stage 1 3,018 13,589 6,873 8,739 4,676 0 36,894 (74) of which: stage 2 0 927 1,711 563 1,174 0 4,374 (68) of which: stage 3 0 0 0 0 0 104 104 0 Forward starting reverse repurchase and securities borrowing agreements 82 150 0 3,015 0 0 3,247 0 Total off-balance sheet financial instruments 6,583 19,289 12,105 16,610 6,840 273 61,700 (205) Credit lines Committed unconditionally revocable credit lines 574 13,505 5,958 8,488 11,501 108 40,134 (50) of which: stage 1 574 12,940 4,517 6,609 10,593 0 35,233 (29) of which: stage 2 0 565 1,441 1,879 908 0 4,792 (21) of which: stage 3 0 0 0 0 0 108 108 0 Irrevocable committed prolongation of existing loans 14 1,349 931 632 357 0 3,282 (2) of which: stage 1 14 1,349 930 630 355 0 3,277 (2) of which: stage 2 0 1 1 2 1 0 5 0 of which: stage 3 0 0 0 0 0 0 0 0 Total credit lines 588 14,854 6,889 9,119 11,858 109 43,416 (52) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and f) Sensitivity information As uncertainties at the time they are made. ECL model The models applied on correlate homogeneous ECL reporting 9. Forward-looking scenarios Depending on the scenario selection assumptions for the weighted interest rates, growth assumption rates rates narratives As forecasting models are complex, due to the combination multiple individual information macroeconomy. Portfolio factors would also not be meaningful, as potential compensatory effects indicate s some s if variable for the forecasting period is amended with all other factors remaining unchanged. Potential effect on stage 1 and stage 2 USD million Baseline Upside Mild downside Severe downside Weighted average Change in key parameters Fixed income: Government bonds (absolute change) –0.50% (1) 0 (29) (9) (4) +0.50% 1 1 39 11 5 +1.00% 4 2 88 23 14 Unemployment rate (absolute change) –1.00% (2) (2) (30) (48) (13) –0.50% (1) (1) (17) (27) (7) +0.50% 1 1 21 31 8 +1.00% 3 2 47 68 18 Real GDP growth (relative change) –2.00% 4 2 8 17 10 –1.00% 2 1 4 8 5 +1.00% (1) 0 (10) (8) (4) +2.00% (2) 0 (14) (16) (7) House Price Index (relative change) –5.00% 6 4 50 73 24 –2.50% 3 2 24 34 12 +2.50% (2) (1) (26) (31) (11) +5.00% (4) (3) (46) (31) (13) Equity (S&P500, EuroStoxx, SMI) (relative change) –10.00% 2 2 5 6 5 –5.00% 1 0 2 3 2 +5.00% (1) 0 (2) (3) (2) +10.00% (2) 0 (4) (6) (3) Sensitivities can be more meaningfully of macroeconomic factors. favorable and alternative changes stage 2 portfolios and disclosed for each scenario. The model-based thereafter. ECLs: horizon will lead to different LGD estimations. UBS, Switzerland, maturities that are within horizon. Scenario weights ECL narratives and baseline scenario, highlighting the non-linearity of credit losses. As shown for 387 million December USD 442 f USD 503 639 had weighted 130 % (31 December 2020: 145 %) of the baseline value. The effects of weighting table below. Stage allocation and SICR The n SICR management SICR trigger positions would be subject to lifetime ECLs under any scenario. The demonstrated ECL allowances would have been USD 1,060 across irrespective actual 503 million as Potential Maturity profile The maturity profile is an important driver for changes to transfers maturity profile of most lending books is relatively movement significant portion multi-purpose of time. For drawings under such agreements with a the respective term is applied for ECL calculations, of 12 months in stage 1. For unused credit lines and all that have no fixed applies a credit review policies, which require either of key indicators an annual products assumption. Actual ECL allowances and provisions, including staging (as per Note 9) Pro forma ECL allowances and provisions, assuming all positions being subject to lifetime ECL Scenarios Weighted average 100% Baseline 100% Upside 100% Mild downside 100% Severe downside Weighted average USD million, except where indicated Segmentation Private clients with mortgages (95) (53) (52) (119) (207) (277) Real estate financing (62) (50) (48) (101) (97) (118) Large corporate clients (150) (116) (107) (148) (244) (257) SME clients (65) (56) (55) (71) (91) (117) Other segments (130) (112) (108) (135) (166) (291) Total (503) (387) (370) (574) (806) (1,060) |
UBS AG | |
Entity [Table] | |
Disclosure Of Financial Assets Explanatory | Additional information Note 20 a) Expected credit losses in the period Total 148 reflecting 123 stage 1 and 2 25 related to credit-impaired (stage 3) positions. Stage 1 123 included 68 adjustment, macroeconomic 45 million changes a residual USD 10 from remeasurements transactions, partially offset by expenses from new transactions . › Refer to Note 20b ECL model, scenarios, adjustment and to Note 20c for more information development of ECL allowances and Stage 3 net releases of USD 25 a number of defaulted 24 in Personal & Corporate Banking. Credit loss (expense) / release USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions Total For the year ended 31.12.21 Stages 1 and 2 28 62 0 34 0 123 Stage 3 1 24 (1) 0 0 25 Total credit loss (expense) / release 29 86 (1) 34 0 148 For the year ended 31.12.20 Stages 1 and 2 (48) (129) 0 (88) 0 (266) Stage 3 (40) (128) (2) (217) (42) (429) Total credit loss (expense) / release (88) (257) (2) (305) (42) (695) For the year ended 31.12.19 Stages 1 and 2 3 23 0 (4) 0 22 Stage 3 (23) (44) 0 (26) (7) (100) Total credit loss (expense) / release (20) (21) 0 (30) (7) (78) b) Changes to ECL models, scenarios, scenario weights and key inputs Refer to expected credit loss key inputs applied. Governance Comprehensive processes scenario increases in credit risk resulted in stage transfers, to outputs adjustments. Model changes During 2021, the model review adjustments of (LGD) USD 45 25 Large corporate Investment Personal & Corporate Banking and Global Wealth Management. Scenario and key input updates During were updated by conditions more downturn, the - looking improved forecast starting level. The projections of the AG ’s business planning purposes, such as International economic especially in the improvement assumes continued growth in 2022 in slower rate than expected to fall noticeably below the current levels. Interest rates are expected to pursued in the Eurozone and Switzerland, and any potential rises in the US would be are especially in Switzerland and, to a lesser degree, in the US. The which and assumes that, while decreased, the remain debt, following the to protectionism results central banks have limited consequence, under oriented demand macroeconomic highs and real estate sectors contract sharply. With effect and mild downside scenarios, which as attached, calculation. following outlook regarding a potential change in The following pent-up demand in certain interest rates prices rise significantly, but inflation rates are temporary and spare economic mean that the scenario. The rising concerns regarding inflationary trends from steepening of volatility. period remaining high, central a few impacting corporate period is the consequence. The table for the four scenarios applied as of 31 December 2021. Scenario weights and post-model adjustments With the weighting of the generally on distribution of 2021, 5 percentage points of the weight of the baseline scenario and 10 percentage redistributed to the upside scenario (10%), as shown in the table below. Although the scenarios and in passed its peak path, based experiences factors comprehensively reflect extraordinary events, such as a pandemic or a fundamental change in the world political order. Especially these generally accepted view that the effects of COVID-19 are abating may prove to be disappointed by of current between challenges, such distortion of energy markets. Such events could affect economies severely and change than and applying model and apply - model These adjustments were 2021 , when net of 91 recognized, corresponding to one third of of assessment and judgment, and year-end 2021 reporting. The post-model adjustments relating to COVID-19 amounted to 224 (2020: USD 117 16 for uncertain). ECL scenario Assigned weights in % 31.12.21 31.12.20 Upside 5.0 0.0 Baseline 55.0 60.0 Mild downside 10.0 0.0 Severe downside 30.0 40.0 Scenario assumptions One year Three years cumulative 31.12.21 Upside Baseline Mild downside Severe downside Upside Baseline Mild downside Severe downside Real GDP growth (% change) United States 9.1 4.4 (0.1) (5.9) 17.8 10.1 1.8 (3.8) Eurozone 9.4 3.9 (0.1) (8.7) 17.3 7.5 0.9 (10.3) Switzerland 5.5 2.4 (0.9) (6.6) 13.1 5.8 (0.1) (5.7) Consumer price index (% change) United States 3.1 2.2 5.7 (1.2) 9.5 6.3 13.0 0.4 Eurozone 2.3 1.4 4.2 (1.3) 8.0 4.8 10.4 (1.7) Switzerland 1.8 0.3 3.5 (1.8) 6.1 1.7 9.0 (1.6) Unemployment rate (end-of-period level, %) United States 3.0 3.9 6.1 10.9 3.0 3.5 7.2 10.8 Eurozone 6.2 7.4 8.7 12.9 6.0 7.2 9.1 15.1 Switzerland 2.3 2.5 3.4 5.2 1.6 2.3 4.2 5.9 Fixed income: 10-year government bonds (change in yields, basis points) USD 50.0 16.5 259.2 (50.0) 170.0 41.2 329.2 (15.0) EUR 40.0 11.1 283.8 (35.0) 140.0 34.9 349.3 (25.0) CHF 50.0 12.1 245.5 (70.0) 150.0 34.4 307.3 (35.0) Equity indices (% change) S&P 500 12.0 14.1 (27.0) (50.2) 35.5 24.7 (21.8) (40.1) EuroStoxx 50 16.0 12.3 (23.4) (57.6) 41.6 20.7 (19.9) (50.4) SPI 14.0 12.1 (22.9) (53.6) 37.9 19.1 (19.6) (44.2) Swiss real estate (% change) Single-Family Homes 5.1 4.4 (4.3) (17.0) 15.5 7.4 (8.8) (30.0) Other real estate (% change) United States (S&P / Case-Shiller) 10.0 3.5 (2.3) (9.5) 21.7 7.1 (8.7) (26.3) Eurozone (House Price Index) 8.4 5.1 (4.0) (5.4) 17.8 9.6 (7.6) (10.8) Scenario assumptions One year Three years cumulative 31.12.20 Baseline Severe downside Baseline Severe downside Real GDP growth (% change) United States 2.7 (5.9) 9.1 (3.8) Eurozone 2.5 (8.7) 9.9 (10.3) Switzerland 3.3 (6.6) 9.0 (5.7) Consumer price index (% change) United States 1.7 (1.2) 5.5 0.4 Eurozone 1.4 (1.3) 3.9 (1.7) Switzerland 0.3 (1.8) 0.9 (1.6) Unemployment rate (end-of-period level, %) United States 5.5 12.1 4.5 9.9 Eurozone 9.5 14.1 8.0 16.4 Switzerland 3.8 6.1 3.2 6.8 Fixed income: 10-year government bonds (change in yields, basis points) USD 22.0 (50.0) 46.0 (15.0) EUR 4.0 (35.0) 21.0 (25.0) CHF 13.0 (70.0) 31.0 (35.0) Equity indices (% change) S&P 500 (2.9) (50.2) (1.7) (40.1) EuroStoxx 50 3.8 (57.6) 13.5 (50.4) SPI (0.8) (53.6) 5.8 (44.2) Swiss real estate (% change) Single-Family Homes 3.4 (17.0) 7.1 (30.0) Other real estate (% change) United States (S&P / Case-Shiller) 2.5 (15.3) 9.2 (28.7) Eurozone (House Price Index) 1.1 (22.9) 7.2 (35.4) c) Development of ECL allowances and provisions The ECL impacted by a variety of factors, such as: – origination of new instruments during the period; – effect of passage of time as the ECLs on an instrument for the remaining same); – discount value basis; – derecognition of instruments in the period; – change in individual asset quality of instruments; – effect respective weights; movements from a of stages 1 and 2; – movements status) when 100% (or vice versa); – changes in models or updates to model parameters; – write-off; and – foreign foreign currencies and other movements. The following table explains the changes in credit lines in page. Development of ECL allowances and USD million Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2020 (1,468) (306) (333) (829) Net movement from new and derecognized transactions 1 (59) (72) 13 0 of which: Private clients with mortgages (7) (10) 3 0 of which: Real estate financing (7) (11) 4 0 of which: Large corporate clients (13) (21) 7 0 of which: SME clients (8) (8) 0 0 of which: Other (24) (23) (2) 0 (21) (18) (4) 0 0 (1) 1 0 Remeasurements with stage transfers 2 (40) 8 0 (49) of which: Private clients with mortgages (9) 4 (13) 0 of which: Real estate financing (3) 1 (4) 0 of which: Large corporate clients 2 (2) 12 (8) of which: SME clients (27) 5 4 (36) of which: Other (3) 0 2 (4) 2 (1) 3 0 0 1 (1) 0 Remeasurements without stage transfers 3 203 55 74 74 of which: Private clients with mortgages 33 8 26 (1) of which: Real estate financing 30 13 13 3 of which: Large corporate clients 44 5 21 17 of which: SME clients 53 (1) 1 53 of which: Other 44 29 14 2 27 15 12 0 6 8 1 (3) Model changes 4 45 29 16 0 Movements with profit or loss impact 5 148 19 104 25 Movements without profit or loss impact (write-off, FX and other) 6 154 5 9 141 Balance as of 31 December 2021 (1,165) (282) (220) (662) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. methodology changes. uncollectible or forgiven and movements in foreign exchange rates. In 148 million from net credit loss releases impacting profit or loss: – a 59 transactions 72 increase lending portfolio, 13 stage 2 before their contractual maturity; – a USD 163 that 203 remeasurements half of portion related to the partial release of a by USD 40 2 clients; – a USD 45 model changes. 25 Large corporate remainder related to various Banking and Global Wealth Management. In to pacting allowances decreased by USD 154 137 million 18 million from and other movements, both of which statement. Development of ECL allowances and USD million Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2019 (1,029) (181) (160) (688) Net movement from new and derecognized transactions 1 (28) (90) 17 46 of which: Private clients with mortgages (2) (3) 2 0 of which: Real estate financing (3) (5) 2 0 of which: Large corporate clients (32) (29) (4) 0 of which: SME clients (16) (14) (3) 0 of which: Other 26 (39) 20 46 32 (1) 15 17 9 (1) 9 0 23 (6) 0 29 (20) (15) (5) 0 Remeasurements with stage transfers 2 (427) 45 (134) (338) of which: Private clients with mortgages (19) (2) (17) 0 of which: Real estate financing (6) 3 (9) 0 of which: Large corporate clients (224) 34 (83) (175) of which: SME clients (43) (1) (11) (31) of which: Other (134) 11 (14) (131) (36) 0 (18) (19) (12) 7 (7) (11) (36) 0 0 (36) (59) 0 0 (59) Remeasurements without stage transfers 3 (271) (88) (47) (136) of which: Private clients with mortgages (34) (19) (8) (7) of which: Real estate financing (14) (4) (11) 1 of which: Large corporate clients (149) (53) (17) (79) of which: SME clients (13) 0 (7) (6) of which: Other (60) (11) (4) (44) (18) (12) (3) (3) (3) 6 0 (9) (12) 0 0 (12) Model changes 4 32 21 11 0 Movements with profit or loss impact 5 (694) (112) (154) (429) Movements without profit or loss impact (write-off, FX and other) 6 254 (14) (19) 287 Balance as of 31 December 2020 (1,468) (306) (333) (829) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. methodology changes. uncollectible or forgiven and movements in foreign exchange rates. As explained in Note in SICR ) considers quantitative between assessment considers changes in PD based economic outlook. Additionally, UBS counterparties that with payments that are at least 30 days past due. ECL stage 2 ("significant deterioration USD million Stage 2 of which: PD layer of which: watch list of which: ≥30 days past due On-and off-balance sheet (220) (158) (22) (39) of which: Private clients with mortgages (71) (54) 0 (17) of which: Real estate financing (43) (38) 0 (4) of which: Large corporate clients (55) (40) (15) 0 of which: SME clients (30) (19) (7) (4) of which: Financial intermediaries and hedge funds (6) (6) 0 0 of which: Loans to financial advisors (3) 0 0 (3) of which: Credit cards (11) 0 0 (11) of which: Other (1) (1) 0 0 d) Maximum exposure to credit risk The tables below provide risk for financial instruments subject to ECL requirements and the respective credit risk for these classes of financial instruments. The amounts of financial subject sheet arrangements. presented at fair value. reasonable alternative as credit derivative contracts notional amounts. Both are capped at the maximum credit risk for which and control” section of this of credit risk and respects from the requirements of IFRS Maximum exposure to credit risk 31.12.21 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD billion Maximum exposure to credit risk Cash collateral received Collateralized by securities Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 192.8 192.8 Loans and advances to banks 4 15.4 0.1 0.1 15.1 Receivables from securities financing transactions 75.0 0.0 68.0 6.9 0.0 Cash collateral receivables on derivative instruments 5,6 30.5 18.4 12.1 Loans and advances to customers 7 398.7 38.2 128.7 191.3 20.2 4.0 16.4 Other financial assets measured at amortized cost 26.2 0.2 0.1 0.0 1.3 24.7 Total financial assets measured at amortized cost 738.6 38.4 196.9 191.3 28.4 18.4 0.0 4.0 261.1 Financial assets measured at fair value through other comprehensive income – debt 8.8 8.8 Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL 747.5 38.4 196.9 191.3 28.4 18.4 0.0 4.0 270.0 Guarantees 8 20.9 1.3 6.5 0.2 2.5 2.3 8.1 Loan commitments 8 39.4 0.5 4.0 2.4 7.3 0.3 1.7 23.1 Forward starting transactions, reverse repurchase and securities borrowing agreements 1.4 1.4 0.0 Committed unconditionally revocable credit lines 42.3 0.3 9.0 6.2 3.9 0.5 22.5 Total maximum exposure to credit risk not reflected on the balance sheet, in scope of ECL 104.1 2.2 20.9 8.7 13.7 0.0 0.3 4.5 53.7 31.12.20 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD billion Maximum exposure to credit risk Cash collateral received Collateralized by securities Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 158.2 158.2 Loans and advances to banks 4 15.3 0.1 15.2 Receivables from securities financing transactions 74.2 0.0 67.1 7.0 0.0 Cash collateral receivables on derivative instruments 5,6 32.7 21.1 11.6 Loans and advances to customers 7 381.0 27.0 118.2 194.6 21.7 0.0 4.4 15.1 Other financial assets measured at amortized cost 27.2 0.1 0.2 0.0 1.3 25.5 Total financial assets measured at amortized cost 688.7 27.2 185.7 194.6 30.1 21.1 0.0 4.4 225.6 Financial assets measured at fair value through other comprehensive income – debt 8.3 8.3 Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL 697.0 27.2 185.7 194.6 30.1 21.1 0.0 4.4 233.9 Guarantees 8 17.0 0.7 5.0 0.2 1.7 2.5 7.0 Loan commitments 8 41.2 0.0 4.2 2.1 6.8 0.4 2.4 25.3 Forward starting transactions, reverse repurchase and securities borrowing agreements 3.2 3.2 0.0 Committed unconditionally revocable credit lines 42.0 0.1 10.3 6.2 2.7 0.0 22.7 Total maximum exposure to credit risk not reflected on the balance sheet, in scope of ECL 103.5 0.8 22.7 8.5 11.2 0.0 0.4 4.9 54.9 1 Of which: USD 1,443 1,983 130 (31 December 2020: USD 154 cash, securities, real inventory, mortgage loans, gold and other commodities. by those clients. behalf information. increase in loans secured by cash, with an offsetting reduction in loans secured by real estate and loans secured by securities. e) Financial assets subject to credit risk by rating category The exposure to credit risk based on the Group’s internal credit rating system and year-end risk rating reflects the Group’s assessment of the probability of default amounts presented are gross of impairment allowances. › Refer to the “Risk management and control” report for more details system Financial assets subject to credit risk by rating USD million 31.12.21 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 191,015 1,802 0 0 0 0 192,817 0 192,817 of which: stage 1 191,015 1,802 0 0 0 0 192,817 0 192,817 Loans and advances to banks 407 12,552 1,123 795 490 1 15,368 (8) 15,360 of which: stage 1 407 12,552 1,098 795 488 0 15,340 (7) 15,333 of which: stage 2 0 0 24 0 2 0 27 (1) 26 of which: stage 3 0 0 0 0 0 1 1 0 1 Receivables from securities financing transactions 34,386 11,267 10,483 17,440 1,439 0 75,014 (2) 75,012 of which: stage 1 34,386 11,267 10,483 17,440 1,439 0 75,014 (2) 75,012 Cash collateral receivables on derivative instruments 7,466 13,476 5,878 3,647 47 0 30,514 0 30,514 of which: stage 1 7,466 13,476 5,878 3,647 47 0 30,514 0 30,514 Loans and advances to customers 5,295 232,663 67,620 70,394 21,423 2,148 399,543 (850) 398,693 of which: stage 1 5,295 231,583 65,083 63,298 16,362 0 381,622 (126) 381,496 of which: stage 2 0 1,080 2,536 7,096 5,061 0 15,773 (152) 15,620 of which: stage 3 0 0 0 0 0 2,148 2,148 (572) 1,577 Other financial assets measured at amortized cost 12,564 6,705 321 6,097 394 264 26,346 (109) 26,236 of which: stage 1 12,564 6,696 307 5,887 317 0 25,772 (27) 25,746 of which: stage 2 0 10 13 209 77 0 309 (7) 302 of which: stage 3 0 0 0 0 0 264 264 (76) 189 Total financial assets measured at amortized cost 251,133 278,465 85,424 98,372 23,793 2,414 739,601 (969) 738,632 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 3,996 4,771 0 77 0 0 8,844 0 8,844 Total on-balance sheet financial instruments 255,130 283,236 85,424 98,449 23,793 2,414 748,445 (969) 747,477 Off-balance sheet positions subject to expected USD million 31.12.21 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off - balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 4,457 7,064 4,535 3,757 1,009 150 20,972 (41) of which: stage 1 4,457 7,037 4,375 3,075 752 0 19,695 (18) of which: stage 2 0 27 160 682 258 0 1,127 (8) of which: stage 3 0 0 0 0 0 150 150 (15) Irrevocable loan commitments 2,797 14,183 7,651 8,298 6,502 46 39,478 (114) of which: stage 1 2,797 13,917 7,416 7,127 5,840 0 37,097 (72) of which: stage 2 0 266 235 1,171 663 0 2,335 (42) of which: stage 3 0 0 0 0 0 46 46 0 Forward starting reverse repurchase and securities borrowing agreements 0 0 55 1,389 0 0 1,444 0 Total off balance sheet financial instruments 7,254 21,247 12,241 13,444 7,512 196 61,894 (155) Credit lines Committed unconditionally revocable credit lines 2,636 16,811 8,627 10,130 4,107 63 42,373 (38) of which: stage 1 2,636 16,467 8,304 8,724 3,671 0 39,802 (28) of which: stage 2 0 344 323 1,406 436 0 2,508 (10) of which: stage 3 0 0 0 0 0 63 63 0 Irrevocable committed prolongation of existing loans 17 2,438 1,422 1,084 602 48 5,611 (3) of which: stage 1 17 2,438 1,422 1,082 568 0 5,527 (3) of which: stage 2 0 0 0 1 34 0 36 0 of which: stage 3 0 0 0 0 0 48 48 0 Total credit lines 2,653 19,249 10,049 11,214 4,709 111 47,984 (41) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and Financial assets subject to credit risk by rating USD million 31.12.20 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 156,250 1,981 0 0 0 0 158,231 0 158,231 of which: stage 1 156,250 1,981 0 0 0 0 158,231 0 158,231 Loans and advances to banks 543 12,029 1,344 1,182 260 1 15,360 (16) 15,344 of which: stage 1 543 11,974 1,277 1,145 231 0 15,170 (9) 15,160 of which: stage 2 0 55 67 37 29 0 189 (5) 184 of which: stage 3 0 0 0 0 0 1 1 (1) 0 Receivables from securities financing transactions 22,998 16,009 15,367 17,995 1,842 0 74,212 (2) 74,210 of which: stage 1 22,998 16,009 15,367 17,995 1,842 0 74,212 (2) 74,210 Cash collateral receivables on derivative instruments 8,196 13,477 7,733 3,243 88 0 32,737 0 32,737 of which: stage 1 8,196 13,477 7,733 3,243 88 0 32,737 0 32,737 Loans and advances to customers 5,813 215,755 67,270 69,217 21,038 2,943 382,036 (1,060) 380,977 of which: stage 1 5,813 214,418 63,000 59,447 15,860 0 358,538 (142) 358,396 of which: stage 2 0 1,338 4,269 9,770 5,178 0 20,556 (215) 20,341 of which: stage 3 0 0 0 0 0 2,943 2,943 (703) 2,240 Other financial assets measured at amortized cost 15,404 4,043 280 6,585 481 560 27,352 (133) 27,219 of which: stage 1 15,404 4,040 269 6,334 389 0 26,435 (34) 26,401 of which: stage 2 0 3 11 251 91 0 357 (9) 348 of which: stage 3 0 0 0 0 0 560 560 (90) 469 Total financial assets measured at amortized cost 209,204 263,295 91,993 98,223 23,709 3,505 689,929 (1,211) 688,717 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 3,212 5,014 0 32 0 0 8,258 0 8,258 Total on-balance sheet financial instruments 212,417 268,309 91,993 98,255 23,709 3,505 698,187 (1,211) 696,976 Off-balance sheet positions subject to expected USD million 31.12.20 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off - balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 3,482 4,623 3,522 4,293 991 170 17,081 (63) of which: stage 1 3,482 4,219 2,688 3,558 739 0 14,687 (14) of which: stage 2 0 404 834 736 252 0 2,225 (15) of which: stage 3 0 0 0 0 0 170 170 (34) Irrevocable loan commitments 3,018 14,516 8,583 9,302 5,850 104 41,372 (142) of which: stage 1 3,018 13,589 6,873 8,739 4,676 0 36,894 (74) of which: stage 2 0 927 1,711 563 1,174 0 4,374 (68) of which: stage 3 0 0 0 0 0 104 104 0 Forward starting reverse repurchase and securities borrowing agreements 82 150 0 3,015 0 0 3,247 0 Total off balance sheet financial instruments 6,583 19,289 12,105 16,610 6,840 273 61,700 (205) Credit lines Committed unconditionally revocable credit lines 574 15,448 5,958 8,488 11,501 108 42,077 (50) of which: stage 1 574 14,883 4,517 6,609 10,593 0 37,176 (29) of which: stage 2 0 565 1,441 1,879 908 0 4,792 (21) of which: stage 3 0 0 0 0 0 108 108 0 Irrevocable committed prolongation of existing loans 14 1,349 931 632 357 0 3,282 (2) of which: stage 1 14 1,349 930 630 355 0 3,277 (2) of which: stage 2 0 1 1 2 1 0 5 0 of which: stage 3 0 0 0 0 0 0 0 0 Total credit lines 588 16,797 6,889 9,119 11,858 109 45,359 (52) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and f) Sensitivity information As uncertainties at the time they are made. ECL model The models applied on correlate homogeneous ECL reporting 9. Forward-looking scenarios Depending on the scenario selection assumptions for the weighted interest rates, growth assumption rates rates narratives As forecasting models are complex, due to the combination multiple individual information macroeconomy. Portfolio factors would also not be meaningful, as potential compensatory effects indicate s some s if variable for the forecasting period is amended with all other factors remaining unchanged Potential effect on stage 1 and stage 2 USD million Baseline Upside Mild downside Severe downside Weighted average Change in key parameters Fixed income: Government bonds (absolute change) –0.50% (1) 0 (29) (9) (4) +0.50% 1 1 39 11 5 +1.00% 4 2 88 23 14 Unemployment rate (absolute change) –1.00% (2) (2) (30) (48) (13) –0.50% (1) (1) (17) (27) (7) +0.50% 1 1 21 31 8 +1.00% 3 2 47 68 18 Real GDP growth (relative change) –2.00% 4 2 8 17 10 –1.00% 2 1 4 8 5 +1.00% (1) 0 (10) (8) (4) +2.00% (2) 0 (14) (16) (7) House Price Index (relative change) –5.00% 6 4 50 73 24 –2.50% 3 2 24 34 12 +2.50% (2) (1) (26) (31) (11) +5.00% (4) (3) (46) (31) (13) Equity (S&P500, EuroStoxx, SMI) (relative change) –10.00% 2 2 5 6 5 –5.00% 1 0 2 3 2 +5.00% (1) 0 (2) (3) (2) +10.00% (2) 0 (4) (6) (3) Sensitivities can be more meaningfully of macroeconomic factors. favorable and alternative changes stage 2 portfolios and disclosed for each scenario. The model-based thereafter. ECLs: horizon will lead to different LGD estimations. UBS AG, Switzerland, maturities that are within horizon. As shown in the table on the bottom of this page, the ECL for stage 1 and 387 (31 December 2020: USD 442 503 (31 December USD 639 determined solely on ECL therefore amounts 130 % (31 December 2020: 145 %) of the scenarios 100% are shown in the table below. Stage allocation and SICR The n SICR management judgment, SICR trigger positions would be subject to lifetime ECLs under any scenario. The demonstrated in the table below with the indication that the ECL allowances and provisions have been USD 1,060 the portfolio had been their actual SICR and 503 31 December 2021. Potential Maturity profile The maturity profile is an important driver for changes to transfers maturity profile of most lending books is relatively movement significant portion multi-purpose of utilization but are unconditionally time. For drawings the respective term is applied for ECL calculations, of 12 months in stage 1. For unused credit lines and all that generally given the monitoring of positions or an annual formal review for any other for maturity assumption. Actual ECL allowances and provisions, including staging (as per Note 9) Pro forma ECL allowances and provisions, assuming all positions being subject to lifetime ECL Scenarios Weighted average 100% Baseline 100% Upside 100% Mild downside 100% Severe downside Weighted average USD million, except where indicated Segmentation Private clients with mortgages (95) (53) (52) (119) (207) (277) Real estate financing (62) (50) (48) (101) (97) (118) Large corporate clients (150) (116) (107) (148) (244) (257) SME clients (65) (56) (55) (71) (91) (117) Other segments (130) (112) (108) (135) (166) (291) Total (503) (387) (370) (574) (806) (1,060) |
Fair value measurement
Fair value measurement | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Fair Value Measurement Explanatory | Note 21 a) Valuation principles All disclosed at fair value are categorized into one of three hierarchy levels is based on the or liability as used to fair hierarchy within which an based on the lowest level input fair value measurement: – Level 1 identical assets and liabilities; – Level 2 – are, or are based on, observable market data; or – Level 3 – valuation techniques not based on observable market data. Fair markets for the liability technique, including be made to credit and funding the considered by market participants when establishing limitations considered in the determination liability account and UBS applies level, conditions are met, UBS may estimate the fair value of offsetting risk exposures on the basis of the net open risks. › Refer to Note 21d for more information b) Valuation governance UBS’s fair value measurement and model governance framework includes numerous controls and other procedural safeguards that are intended to reported in the financial statements. New products and valuation techniques must from the risk and finance control functions. Responsibility for the ongoing measurement of financial and non-financial instruments at fair value is with the business divisions. Fair control divisions. Independent through benchmarking the business divisions’ with observable market prices governance order to monitor used. determine groups within Finance and Risk a regular basis, as well as pricing. As a result of the valuation estimates of fair value to the relevant accounting standard. › Refer to Note 21d for more information c) Fair value hierarchy The table below provides financial and value. used (including significant valuation the the fair value hierarchy. Determination of fair values from quoted market 1 31.12.21 31.12.20 USD million Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial assets measured at fair value on a recurring basis Financial assets at fair value held for trading 113,697 14,825 2,299 130,821 107,507 15,553 2,337 125,397 of which: Equity instruments 97,958 1,090 149 99,197 90,307 1,101 171 91,579 Government bills / bonds 7,135 1,351 10 8,496 9,028 2,207 10 11,245 Investment fund units 7,843 1,364 21 9,229 7,374 1,794 23 9,192 Corporate and municipal bonds 708 7,604 556 8,868 789 8,356 817 9,961 Loans 0 3,099 1,443 4,542 0 1,860 1,134 2,995 Asset-backed securities 53 317 120 489 8 236 181 425 Derivative financial instruments 522 116,479 1,140 118,142 795 157,068 1,754 159,617 of which: Foreign exchange contracts 255 53,043 7 53,305 319 68,424 5 68,749 Interest rate contracts 0 32,747 494 33,241 0 50,353 537 50,890 Equity / index contracts 0 27,861 384 28,245 0 33,990 853 34,842 Credit derivative contracts 0 1,179 236 1,414 0 2,008 350 2,358 Commodity contracts 0 1,590 16 1,606 0 2,211 6 2,217 Brokerage receivables 0 21,839 0 21,839 0 24,659 0 24,659 Financial assets at fair value not held for trading 2 27,278 28,622 4,180 60,080 40,986 35,435 3,942 80,364 of which: Financial assets for unit-linked investment contracts 21,110 187 6 21,303 20,628 101 2 20,731 Corporate and municipal bonds 123 13,937 306 14,366 290 16,957 372 17,619 Government bills / bonds 5,624 3,236 0 8,860 19,704 3,593 0 23,297 Loans 0 4,982 892 5,874 0 7,699 862 8,561 Securities financing transactions 0 5,704 100 5,804 0 6,629 122 6,751 Auction rate securities 0 0 1,585 1,585 0 0 1,527 1,527 Investment fund units 338 574 117 1,028 278 447 105 831 Equity instruments 83 2 681 765 86 0 544 631 Other 0 0 495 495 0 10 408 418 Financial assets measured at fair value through other comprehensive income on Financial assets measured at fair value through other comprehensive 2 2,704 6,140 0 8,844 1,144 7,114 0 8,258 of which: Asset-backed securities 0 4,849 0 4,849 0 6,624 0 6,624 Government bills / bonds 2,658 27 0 2,686 1,103 47 0 1,150 Corporate and municipal bonds 45 1,265 0 1,310 40 444 0 485 Non-financial assets measured at fair value on a recurring basis Precious metals and other physical commodities 5,258 0 0 5,258 6,264 0 0 6,264 Non-financial assets measured at fair value on a non-recurring basis Other non-financial assets 3 0 0 26 26 0 1 245 246 Total assets measured at fair value 149,459 187,905 7,645 345,010 156,696 239,831 8,278 404,805 Determination of fair values from quoted market 1 31.12.21 31.12.20 USD million Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial liabilities measured at fair value on a recurring basis Financial liabilities at fair value held for trading 25,413 6,170 105 31,688 26,888 6,652 55 33,595 of which: Equity instruments 18,328 513 83 18,924 22,519 425 40 22,985 Corporate and municipal bonds 30 4,219 17 4,266 31 4,048 9 4,089 Government bills / bonds 5,883 826 0 6,709 3,642 1,036 0 4,678 Investment fund units 1,172 555 6 1,733 696 1,127 5 1,828 Derivative financial instruments 509 118,558 2,242 121,309 746 156,884 3,471 161,102 of which: Foreign exchange contracts 258 53,800 21 54,078 316 70,149 61 70,527 Interest rate contracts 0 28,398 278 28,675 0 43,389 527 43,916 Equity / index contracts 0 33,438 1,511 34,949 0 38,870 2,306 41,176 Credit derivative contracts 0 1,412 341 1,753 0 2,403 528 2,931 Commodity contracts 0 1,503 63 1,566 0 2,003 24 2,027 Financial liabilities designated at fair value on a recurring basis Brokerage payables designated at fair value 0 44,045 0 44,045 0 38,742 0 38,742 Debt issued designated at fair value 2 0 59,606 14,194 73,799 0 50,273 10,970 61,243 Other financial liabilities designated at fair value 2 0 29,258 816 30,074 0 29,671 716 30,387 of which: Financial liabilities related to unit-linked investment contracts 0 21,466 0 21,466 0 20,975 0 20,975 Securities financing transactions 0 6,375 2 6,377 0 7,317 0 7,317 Over-the-counter debt instruments 0 1,334 794 2,128 0 1,363 697 2,060 Total liabilities measured at fair value 25,922 257,637 17,357 300,916 27,635 282,222 15,212 325,069 1 Bifurcated embedded derivatives are presented on the same balance sheet lines 2 As of 31 December 2021, USD 17 21 8 8 fair value through other 36 16 1 1 liabilities designated at fair value are expected to be recovered or settled after 12 months. at the lower of their net carrying amount or fair value less costs to sell. Valuation techniques UBS uses widely recognized valuation techniques for determining the fair not valuation flows, relative value and option pricing methodologies. Discounted technique future these reflects the credit and for instruments with similar risk present future market standard cash flow projection the calculation are modeling techniques and models. Relative value models measure fair prices adjustments observed instrument and the instrument being valued. Option pricing models behavior of future asset or assets payoff for payoff is industry-standard The form analytical binomial tree or Monte Carlo simulation). Where available, assumptions and inputs. be derived recent observable based analogous instruments, derivation of input levels based on products with market conditions and valuation approaches. For using pricing services and relevant quotes. Consideration nature of recently consensus models, techniques and inputs rate curves, rates, bond rates, levels of market volatility and correlation. Refer to Note 21f for incorporate instruments Derivative instruments: valuation and classification in the fair value hierarchy The valuation associated instrument across interest derivatives are measured using rates currency for the respective counterparty collateral agreement. Product Valuation and classification in the fair value hierarchy Government bills and bonds Valuation – Generally valued using prices obtained directly – Instruments not priced directly using active-market data techniques that incorporate market data Fair value hierarchy – Generally traded in active markets with prices that can be obtained directly from these markets, resulting in classification as Level 1, Corporate and municipal bonds Valuation – Generally adjusted for seniority, maturity and liquidity. – When prices incorporating the credit spread of the – For convertible bonds model. Fair value hierarchy – Generally classified as Level 1 or Level 2, depending – Level 3 instruments have no suitable pricing information Traded loans and loans measured at fair value Valuation – Valued directly – Where no derived from debt instruments in comparable entities or different products in the same entity, or by using a credit default and interest approach based on rating agency guidelines. Fair value hierarchy – Instruments with suitably deep and liquid pricing – Positions requiring the use of depth, are classified as Level 3. Uncollateralized discounted equivalent) curve for the currency in 2 1 d , the collateralized adjustments CVA s) , debit DVA s) and funding valuation adjustments (FVAs), as estimation credit risk, and funding costs and benefits. › Refer to Note 10 for more information about instruments Derivative product Valuation and classification in the fair value hierarchy Interest rate contracts Valuation – Interest rate swap contracts flows using curves used to estimate future index curve models using interest rates associated with interest rate swap rates, forward rate agreement rates, short-term interest rate futures prices, spreads and inflation swap rates. – Interest rate option contracts include interest rate yield curves, inflation curves, – When the maturity quotes are observable for last observable point using standard assumptions parameter to represent a suitable proxy for that Fair value hierarchy – The majority of interest inputs for yield curve models are generally traded – Options are to active-market options and more exotic products. – Interest rate swap observable quotes. – Exotic options for market data are classified as Level 3. Credit derivative contracts Valuation – Credit derivative spreads, upfront pricing points and implied recovery rates. Where a derivative credit spread is not directly available, it may be derived from the price of – Asset-backed credit security with an adjustment to reflect Fair value hierarchy – Single-entity and recovery rates name(s) are not actively traded instruments, these contracts are classified – Asset-backed distributed across Level 2 and Level 3. Derivative product Valuation and classification in the fair value hierarchy Foreign exchange contracts Valuation – Open spot foreign exchange (FX) – Forward FX contracts are valued using the FX spot rate adjusted for forward pricing points observed from standard market-based sources. – Over-the-counter (OTC) FX The models used for shorter-dated options (i.e., maturities of those used for additional consideration of interest rate and FX – The valuation for observed FX volatilities for all relevant FX pairs. Fair value hierarchy – The therefore such FX contracts are generally classified – A significant proportion of from standard market contracts traded in – OTC FX option contracts where there is no active market Equity / index contracts Valuation – Equity forward models. The key inputs to the models are (which are implied discounted using market-standard discounted cash flow models using a rate that reflects the appropriate funding rate for they are related equity. – Equity option contracts are valued described between discounted appropriate funding rate not volatility data, or the equivalent data for Fair value hierarchy – As inputs are significant proportion of equity forward contracts – Equity option positions for which inputs are derived observable markets are also classified correlation inputs are not observable. Commodity contracts Valuation – Commodity forward forward levels on standard instruments. – Commodity commodity forward level for the volatility of the underlying or between different commodities or commodity Fair value hierarchy – Individual market data is available. Product Valuation and classification in the fair value hierarchy Investment fund units Valuation – Predominantly exchange-traded, with – Where market prices are not available, fair Fair value hierarchy – Listed units classification, while other positions are classified – Positions for which NAVs are not available Asset-backed securities (ABS) Valuation – For liquid securities, the valuation levels between the time of trading and the discounted expected Fair value hierarchy – Residential - backed , c ommercial - backed and generally classified as Level 2. However, data is not available, they are classified as Level Auction rate securities (ARS) Valuation – ARS emanating from the note coupon, credit risk attributable to the liquidity risk as a function of the level of trading volume in these positions, and extension risk, as ARS perpetual instruments that require an assumption Fair value hierarchy – Granular and liquid pricing information is generally not available for classified as Level 3. Equity instruments Valuation – Listed equity instruments are generally valued – Unlisted equity holdings, and are deemed to be impaired. Fair value hierarchy – The majority readily and regularly available, resulting in Level Financial assets for unit-linked investment contracts Valuation – The majority of assets are listed on exchanges Fair value hierarchy – Most assets are classified as Level 1 if actively traded, – Instruments for which prices are not readily available Securities financing transactions Valuation – These instruments are valued using discounted expected cash flow techniques. The discount rate applied is based on funding curves that are relevant Fair value hierarchy – Collateral funding curves for are classified as Level 2. – Where the collateral positions are classified as Level 3. Brokerage receivables and payables Valuation – Fair value is determined based on the value of Fair value hierarchy – Due to their on-demand nature, these receivables Amounts due under unit-linked investment contracts Valuation – The corresponding assets. Fair value hierarchy – The liabilities themselves are not actively traded, traded and are therefore classified as Level 2. d) Valuation adjustments and other items The output of a value result, valuations are adjusted, where appropriate and when such factors would be considered by market participants fair value, to valuation restrictions and other factors. The table below summarizes the recognized on the balance sheet. Details about each category are provided further below. Valuation adjustment reserves on the balance sheet As of Life-to-date gain / (loss), USD million 31.12.21 31.12.20 31.12.19 Deferred day-1 profit or loss reserves 418 269 146 Own credit adjustments on financial liabilities designated at fair value (315) (381) (88) CVAs, FVAs, (1,004) (959) (706) Deferred day-1 profit or loss reserves For measure fair on recognized differ where any such difference is deferred and not initially recognized in the income statement. Deferred Other net through profit or loss underlying s observable transaction is closed out. The profit or loss reserves during the respective period. Deferred day-1 profit or loss reserves USD million 2021 2020 2019 Reserve balance at the beginning of the year 269 146 255 Profit / (loss) deferred on new transactions 459 362 171 (Profit) / loss recognized in the income statement (308) (238) (278) Foreign currency translation (2) 0 (2) Reserve balance at the end of the year 418 269 146 Own credit Own option liabilities where valuation participants. Changes in fair recognized Other directly Retained with statement in future periods. increase an accounting mismatch in the Group does not hedge changes in own credit. Own curves, market-observed default swap spreads the value that are attributable as well other than credit spreads, such as redemptions, effects from time decay own credit is recognized unrealized OCA date. change since initial recognition. › Refer to Note 16 for more information about designated at fair value Own credit adjustments on financial liabilities Included in Other comprehensive income For the year ended USD million 31.12.21 31.12.20 31.12.19 Recognized during the period: Realized gain / (loss) (14) 2 8 Unrealized gain / (loss) 60 (295) (408) Total gain / (loss), before tax 46 (293) (400) As of USD million 31.12.21 31.12.20 31.12.19 Recognized on the balance sheet as of the end of the period: Unrealized life-to-date gain / (loss) (315) (381) (88) Credit valuation adjustments In order to measure including Financial assets at to instruments. This protection required instruments. considering dependent probabilities arrangements, , and contractual factors. Funding valuation adjustments FVAs uncollateralized and and moving flows from the ARR to OCA using the CVA framework, including the probability of counterparty default. collateralized derivative be sold or repledged. Debit valuation adjustments A DVA derivatives calculation being exposures collateral movements and UBS’s credit default spreads. Other valuation adjustments Instruments that are measured as part of a portfolio of combined long and short consistent liquidity valuation adjustment is or appropriate, reflecting current levels of market liquidity. offer spreads used in are obtained from market transactions and are updated periodically. Uncertainties of - based valuations through amounts valuations uncertainties in the relevant modeling assumptions, in the and market inputs used, or in the calibration to estimates, including how it uncertainties. Model reserves data other relevant sources. Other items In the first half of 2021, 861 a US-based unwinding of loss Other instruments measured at fair value through profit or loss . Valuation adjustments on financial instruments As of Life-to-date gain / (loss), USD million 31.12.21 31.12.20 Credit valuation adjustments 1 (44) (66) Funding valuation adjustments (49) (73) Debit valuation adjustments 2 0 Other valuation adjustments (913) (820) of which: liquidity (341) (340) of which: model uncertainty (571) (479) 1 Amounts do not include reserves against defaulted counterparties. e) Transfers between Level 1 and Level 2 Assets and liabilities transferred to Level 2 during 2021 were also not material. f) Level 3 instruments: valuation techniques and inputs The together value, considered significant as and a range of values for those unobservable inputs. The inputs not reflect the level of an assessment assumptions, but rather the different underlying the relevant will parameter each balance inputs may differ across other financial institutions, reflecting the diversity of the products in each firm’s inventory. Valuation techniques and inputs used in the fair value measurement Fair value Significant unobservable input(s) 1 Range of inputs Assets Liabilities Valuation technique(s) 31.12.21 31.12.20 USD billion 31.12.21 31.12.20 31.12.21 31.12.20 low high weighted average 2 low high weighted average 2 unit 1 Financial assets and liabilities at fair value held for trading and Financial assets at fair Corporate and municipal bonds 0.9 1.2 0.0 0.0 Relative value to market comparable Bond price equivalent 16 143 98 1 143 100 points Discounted expected cash flows Discount margin 434 434 268 268 basis points Traded loans, loans measured at fair value, loan commitments and guarantees 2.8 2.4 0.0 0.0 Relative value to market comparable Loan price equivalent 0 101 99 0 101 99 points Discounted expected cash flows Credit spread 175 800 436 190 800 398 basis points Market comparable and securitization model Credit spread 28 1,544 241 40 1,858 333 basis points Auction rate securities 1.6 1.5 Discounted expected cash flows Credit spread 115 197 153 100 188 140 basis points Investment fund units 3 0.1 0.1 0.0 0.0 Relative value to market comparable Net asset value Equity instruments 3 0.8 0.7 0.1 0.0 Relative value to market comparable Price Debt issued designated at fair value 4 14.2 11.0 Other financial liabilities designated at fair value 0.8 0.7 Discounted expected cash flows Funding spread 24 175 42 175 basis points Derivative financial instruments Interest rate contracts 0.5 0.5 0.3 0.5 Option model Volatility of interest rates 65 81 29 69 basis points Credit derivative contracts 0.2 0.3 0.3 0.5 Discounted expected cash flows Credit spreads 1 583 1 489 basis points Bond price equivalent 2 136 0 100 points Equity / index contracts 0.4 0.9 1.5 2.3 Option model Equity dividend yields 0 11 0 13 % Volatility of equity stocks, equity and other indices 4 98 4 100 % Equity-to-FX correlation (29) 76 (34) 65 % Equity-to-equity correlation (25) 100 (16) 100 % 1 The ranges of significant for most non-derivative financial liabilities designated at investments. linked notes, all of which have embedded derivative parameters that are considered to be unobservable. lines in this table. Significant unobservable inputs in Level 3 positions This section discusses the significant unobservable inputs that a change in each unobservable inputs have not been included Input Description Bond price equivalent – Where market similar instruments. Factors considered when the issuer. Fair value may be measured either by a direct price comparison or by conversion of (either as an outright yield or as a spread to – For corporate and municipal bonds, value. Bonds priced at 0 are distressed to the point that no recovery par measurement date. – For credit derivatives, the bond price range converted to an equivalent yield or credit Loan price equivalent – Where market prices are not available similar instruments. maturity and issuer-specific covenants. Fair value may be measured either by a direct price comparison instrument price used to expected, while a current price of 100 represents Credit spread – Valuation models for many credit derivatives the associated referenced security or reference rate, typically either US Treasury or ARR, (decrease) in credit credit derivative held. Credit spreads may calculated. A with the lower levels of credit risk. Discount margin – The discount margin (DM) spread represents the market return required for uncertainty in the index (e.g., Secured Overnight Financing DM in isolation would result in a higher / (lower) – The high end This indicates captured by the quality instruments. Funding spread – Structured financing transactions are valued using synthetic funding curves that best represent the assets that are pledged as collateral for the transactions. They are not representative estimate of where UBS can source and deploy secured funding with counterparties for a given type of collateral. The funding spreads are expressed in terms of basis points, – A small proportion of structured fair value had an exposure to funding spreads that Volatility – Volatility measures the variability of future prices a higher number reflects a more volatile instrument, for which future price movements are key input instrument. The effect is a reduced by option prices represents the effect of pricing options of – Volatilities of low interest rates tend to be much higher than volatilities of high interest rates. In addition, different currencies may have significantly different implied volatilities. Input Description Correlation – Correlation measures the interrelationship between the movements of two variables. It is expressed as a percentage between –100% and with a (meaning a movement of correlation on the measurement of fair value depends on the specific terms of the instruments being valued, reflecting the range of different payoff features within – Equity-to-FX correlation is important for equity options based on Equity-to-equity correlation is particularly important for complex options that incorporate, in some in the projected payoff. Equity dividend yields – The derivation of contracts and for measuring fair value using option pricing models. The relationship between the current stock price and forward price is based on a combination of expected future dividend levels and relevant funding rates applicable of the share price, and timing represent the forward price. The table classified unobservable inputs unfavorable significantly, does estimated Interdependencies between Level 1, 2 and 3 been relationships between the not a significant element of the valuation uncertainty. Sensitivity including market reasonably possible value measurement process. The sensitivity ranges are not always symmetrical valuations are not always precisely in and unfavorable range. Sensitivity data and Diversification different sensitivity results and, as such, would result in an overall sensitivity component diversification benefit is not significant to this analysis. Sensitivity of fair value measurements to changes 1 31.12.21 31.12.20 USD million Favorable changes Unfavorable changes Favorable changes Unfavorable changes Traded loans, loans designated at fair value, loan commitments and guarantees 19 (13) 29 (28) Securities financing transactions 41 (53) 40 (52) Auction rate securities 66 2 (66) 2 105 (105) Asset-backed securities 20 (20) 41 (41) Equity instruments 173 (146) 129 (96) Interest rate derivative contracts, net 29 (19) 11 (16) Credit derivative contracts, net 5 (8) 10 (14) Foreign exchange derivative contracts, net 19 (11) 20 (15) Equity / index derivative contracts, net 368 (335) 318 (294) Other 50 (73) 91 (107) Total 790 (744) 794 (768) 1 Sensitivity of issued and various parameters and a change in assumptions regarding the underlying statistical distribution. h) Level 3 instruments: movements during the period The movements in Level 3 assets and on a recurring basis, excluding any related hedging activity. Assets presented as the beginning of the year. Movements of Level 3 instruments Total gains / losses included in comprehensive income USD billion Balance as of 31 December 2019 Net gains / losses included in income 1 of which: related to Level 3 instruments held at the end of the reporting period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance as of 31 December 2020 Financial assets at fair value held for trading 1.8 (0.1) (0.1) 0.8 (1.4) 1.0 0.0 0.3 0.0 0.0 2.3 of which: Investment fund units 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Corporate and municipal bonds 0.5 0.0 0.0 0.7 (0.5) 0.0 0.0 0.1 0.0 0.0 0.8 Loans 0.8 0.0 (0.1) 0.0 (0.7) 1.0 0.0 0.1 0.0 0.0 1.1 Other 0.4 0.0 0.0 0.1 (0.3) 0.0 0.0 0.2 0.0 0.0 0.4 Derivative financial instruments – assets 1.3 0.3 0.4 0.0 0.0 0.7 (0.5) 0.1 (0.2) 0.1 1.8 of which: Interest rate contracts 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 Equity / index contracts 0.6 0.1 0.1 0.0 0.0 0.6 (0.3) 0.0 (0.1) 0.0 0.9 Credit derivative contracts 0.4 0.0 0.0 0.0 0.0 0.1 (0.2) 0.1 0.0 0.0 0.3 Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Financial assets at fair value not held for trading 4.0 0.0 0.1 0.8 (0.9) 0.0 0.0 0.1 0.0 0.0 3.9 of which: Loans 1.2 0.0 0.0 0.3 (0.7) 0.0 0.0 0.0 0.0 0.0 0.9 Auction rate securities 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 Equity instruments 0.5 0.0 0.0 0.1 (0.1) 0.0 0.0 0.0 0.0 0.0 0.5 Other 0.7 0.0 0.0 0.4 (0.2) 0.0 0.0 0.0 0.0 0.0 1.0 Derivative financial instruments – liabilities 2.0 1.3 1.2 0.0 0.0 1.2 (0.9) 0.4 (0.6) 0.1 3.5 of which: Interest rate contracts 0.1 0.3 0.3 0.0 0.0 0.3 (0.2) 0.2 (0.2) 0.0 0.5 Equity / index contracts 1.3 1.0 0.8 0.0 0.0 0.8 (0.6) 0.1 (0.2) 0.0 2.3 Credit derivative contracts 0.5 0.0 0.0 0.0 0.0 0.1 (0.1) 0.1 (0.2) 0.0 0.5 Other 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 Debt issued designated at fair value 9.9 0.2 0.0 0.0 0.0 7.6 (5.7) 0.5 (1.7) 0.2 11.0 Other financial liabilities designated at fair value 0.8 0.1 0.1 0.0 0.0 0.3 (0.5) 0.0 0.0 0.0 0.7 1 Net gains / losses Level 3 assets as of 31 December 2021 were USD 7.6 8.3 17.4 15.2 Total gains / losses included in comprehensive income Balance as of 31 December 2020 2 Net gains / losses included in income 1 of which: related to Level 3 instruments held at the end of the reporting period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance as of 31 December 2021 2 2.3 0.0 (0.1) 0.3 (1.6) 1.2 0.0 0.3 (0.3) 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 (0.4) 0.0 0.0 0.0 (0.1) 0.0 0.6 1.1 0.0 0.0 0.0 (0.8) 1.2 0.0 0.0 (0.2) 0.0 1.4 0.4 0.0 0.0 0.1 (0.4) 0.0 0.0 0.3 0.0 0.0 0.3 1.8 (0.2) (0.1) 0.0 0.0 0.5 (0.7) 0.1 (0.3) 0.0 1.1 0.5 0.1 0.1 0.0 0.0 0.1 (0.2) 0.0 (0.1) 0.0 0.5 0.9 (0.1) (0.1) 0.0 0.0 0.3 (0.4) 0.0 (0.2) 0.0 0.4 0.3 (0.1) (0.1) 0.0 0.0 0.0 (0.1) 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.1 1.0 (0.6) 0.0 0.0 0.1 (0.3) 0.0 4.2 0.9 0.0 0.0 0.6 (0.3) 0.0 0.0 0.0 (0.3) 0.0 0.9 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.1 0.1 0.1 (0.1) 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 (0.1) 0.3 (0.2) 0.0 0.0 0.0 0.0 0.0 1.0 3.5 0.2 0.0 0.0 0.0 0.9 (1.8) 0.0 (0.5) 0.0 2.2 0.5 (0.1) (0.1) 0.0 0.0 0.0 (0.1) 0.0 0.0 0.0 0.3 2.3 0.3 0.1 0.0 0.0 0.8 (1.5) 0.0 (0.4) 0.0 1.5 0.5 (0.1) (0.1) 0.0 0.0 0.0 0.0 0.0 (0.1) 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 (0.1) 0.0 0.0 0.0 0.1 11.0 0.7 0.6 0.0 0.0 8.0 (4.2) 0.2 (1.2) (0.2) 14.2 0.7 0.0 0.0 0.0 0.0 0.4 (0.2) 0.0 0.0 0.0 0.8 i) Maximum exposure to credit risk for financial instruments measured at fair value The credit risk for financial instruments respective credit risk for these classes of financial instruments. The amounts of financial subject sheet arrangements. presented at fair value. reasonable alternative as credit derivative contracts notional amounts. Both are capped at the maximum credit risk for which and control” section of this of credit risk and respects from the requirements of IFRS. Maximum exposure to credit risk 31.12.21 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD billion Cash collateral received Collateral- ized by securities Secured by real estate Other collateral Netting Credit derivative contracts Guarantees Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 22.4 22.4 Derivative financial instruments 4,5 118.1 4.2 103.2 10.7 Brokerage receivables 21.8 21.6 0.2 Financial assets at fair value not held for trading – debt instruments 6 37.0 11.2 25.7 Total financial assets measured at fair value 199.4 0.0 37.1 0.0 0.0 103.2 0.0 0.0 59.1 Guarantees 7 0.2 0.2 0.0 31.12.20 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD billion Cash collateral received Collateral- ized by securities Secured by real estate Other collateral Netting Credit derivative contracts Guarantees Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 24.6 24.6 Derivative financial instruments 4,5 159.6 6.0 138.4 15.2 Brokerage receivables 24.7 24.4 0.3 Financial assets at fair value not held for trading – debt instruments 6 58.2 13.2 45.0 Total financial assets measured at fair value 267.1 0.0 43.6 0.0 0.0 138.4 0.0 0.0 85.1 Guarantees 7 0.5 0.1 0.3 0.0 1 The maximum exposure to loss is generally equal to the carrying amount and subject the purpose of this disclosure, collateral 0 0 commitments and forward starting reverse repurchase agreements classified as derivatives. USD 27.8 21.9 8.2 0.8 9.4 billion, of which USD 0.8 balance sheet. Refer to agreements. j) Financial instruments not measured at fair value The table below provides the estimated fair values of financial instruments not measured at fair value. Financial instruments not measured at fair value 31.12.21 31.12.20 Carrying amount Fair value Carrying amount Fair value USD billion Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Assets 2 Cash and balances at central banks 192.8 192.7 0.1 0.0 0.0 192.8 158.2 158.1 0.1 0.0 0.0 158.2 Loans and advances to banks 15.5 14.8 0.0 0.7 0.0 15.5 15.4 14.7 0.0 0.6 0.1 15.4 Receivables from securities financing transactions 75.0 71.6 0.0 1.3 2.1 75.0 74.2 64.9 0.0 7.6 1.7 74.2 Cash collateral receivables on derivative instruments 30.5 30.5 0.0 0.0 0.0 30.5 32.7 32.7 0.0 0.0 0.0 32.7 Loans and advances to customers 397.8 163.1 0.0 43.8 190.1 396.9 379.5 172.0 0.0 34.2 174.6 380.8 Other financial assets measured at amortized cost 26.2 4.1 9.3 10.7 2.4 26.5 27.2 5.3 9.4 10.9 2.3 28.0 Liabilities 2 Amounts due to banks 13.1 9.1 0.0 4.0 0.0 13.1 11.0 8.5 0.0 2.6 0.0 11.0 Payables from securities financing transactions 5.5 4.1 0.0 1.5 0.0 5.5 6.3 6.0 0.0 0.3 0.0 6.3 Cash collateral payables on derivative instruments 31.8 31.8 0.0 0.0 0.0 31.8 37.3 37.3 0. |
UBS AG | |
Entity [Table] | |
Disclosure Of Fair Value Measurement Explanatory | Note 21 a) Valuation principles All disclosed at fair value are categorized into one of three hierarchy levels is based on the or liability as used to fair hierarchy within which an based on the lowest level input fair value measurement: – Level 1 identical assets and liabilities; – Level 2 – are, or are based on, observable market data; or – Level 3 – valuation techniques not based on observable market data. Fair markets for the liability technique, including be made to credit and funding the considered by market participants when establishing limitations considered in the determination liability account and UBS applies level, conditions are met, UBS may estimate the fair value of offsetting risk exposures on the basis of the net open risks. › Refer to Note 21d for more information b) Valuation governance UBS’s fair value measurement and model governance framework includes numerous controls and other procedural safeguards that are intended to reported in the financial statements. New products and valuation techniques must from the risk and finance control functions. Responsibility for the ongoing measurement of financial and non-financial instruments at fair value is with the business divisions. Fair control divisions. Independent through benchmarking the business divisions’ with observable market prices governance order to monitor used. determine groups within Finance and Risk a regular basis, as well as pricing. As a result of the valuation estimates of fair value to the relevant accounting standard. › Refer to Note 21d for more information c) Fair value hierarchy The table below provides financial and value. used (including significant valuation the the fair value hierarchy. Determination of fair values from quoted market 1 31.12.21 31.12.20 USD million Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial assets measured at fair value on a recurring basis Financial assets at fair value held for trading 113,722 15,012 2,299 131,033 107,526 15,630 2,337 125,492 of which: Equity instruments 97,983 1,090 149 99,222 90,327 1,101 171 91,599 Government bills / bonds 7,135 1,351 10 8,496 9,028 2,207 10 11,245 Investment fund units 7,843 1,364 21 9,229 7,374 1,794 23 9,192 Corporate and municipal bonds 708 7,791 556 9,055 789 8,432 817 10,038 Loans 0 3,099 1,443 4,542 0 1,860 1,134 2,995 Asset-backed securities 53 317 120 489 8 236 181 425 Derivative financial instruments 522 116,482 1,140 118,145 795 157,069 1,754 159,618 of which: Foreign exchange contracts 255 53,046 7 53,307 319 68,425 5 68,750 Interest rate contracts 0 32,747 494 33,241 0 50,353 537 50,890 Equity / index contracts 0 27,861 384 28,245 0 33,990 853 34,842 Credit derivative contracts 0 1,179 236 1,414 0 2,008 350 2,358 Commodity contracts 0 1,590 16 1,606 0 2,211 6 2,217 Brokerage receivables 0 21,839 0 21,839 0 24,659 0 24,659 Financial assets at fair value not held for trading 2 27,278 28,185 4,180 59,642 40,986 35,110 3,942 80,038 of which: Financial assets for unit-linked investment contracts 21,110 187 6 21,303 20,628 101 2 20,731 Corporate and municipal bonds 123 13,937 306 14,366 290 16,957 372 17,619 Government bills / bonds 5,624 3,236 0 8,860 19,704 3,593 0 23,297 Loans 0 4,982 892 5,874 0 7,699 862 8,561 Securities financing transactions 0 5,704 100 5,804 0 6,629 122 6,751 Auction rate securities 0 0 1,585 1,585 0 0 1,527 1,527 Investment fund units 338 137 117 591 278 121 105 505 Equity instruments 83 2 681 765 86 0 544 631 Other 0 0 495 495 0 10 408 418 Financial assets measured at fair value through other comprehensive income on Financial assets measured at fair value through other comprehensive 2 2,704 6,140 0 8,844 1,144 7,114 0 8,258 of which: Asset-backed securities 0 4,849 0 4,849 0 6,624 0 6,624 Government bills / bonds 2,658 27 0 2,686 1,103 47 0 1,150 Corporate and municipal bonds 45 1,265 0 1,310 40 444 0 485 Non-financial assets measured at fair value on a recurring basis Precious metals and other physical commodities 5,258 0 0 5,258 6,264 0 0 6,264 Non-financial assets measured at fair value on a non-recurring basis Other non-financial assets 3 0 0 26 26 0 1 245 246 Total assets measured at fair value 149,484 187,658 7,645 344,787 156,716 239,583 8,278 404,576 Determination of fair values from quoted market 1 31.12.21 31.12.20 USD million Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial liabilities measured at fair value on a recurring basis Financial liabilities at fair value held for trading 25,413 6,170 105 31,688 26,889 6,652 55 33,595 of which: Equity instruments 18,328 513 83 18,924 22,519 425 40 22,985 Corporate and municipal bonds 30 4,219 17 4,266 31 4,048 9 4,089 Government bills / bonds 5,883 826 0 6,709 3,642 1,036 0 4,678 Investment fund units 1,172 555 6 1,733 696 1,127 5 1,828 Derivative financial instruments 509 118,558 2,242 121,309 746 156,884 3,471 161,102 of which: Foreign exchange contracts 258 53,800 21 54,078 316 70,149 61 70,527 Interest rate contracts 0 28,398 278 28,675 0 43,389 527 43,916 Equity / index contracts 0 33,438 1,511 34,949 0 38,870 2,306 41,176 Credit derivative contracts 0 1,412 341 1,753 0 2,403 528 2,931 Commodity contracts 0 1,503 63 1,566 0 2,003 24 2,027 Financial liabilities designated at fair value on a recurring basis Brokerage payables designated at fair value 0 44,045 0 44,045 0 38,742 0 38,742 Debt issued designated at fair value 2 0 59,606 11,854 71,460 0 50,273 9,595 59,868 Other financial liabilities designated at fair value 2 0 29,258 3,156 32,414 0 29,682 2,091 31,773 of which: Financial liabilities related to unit-linked investment contracts 0 21,466 0 21,466 0 20,975 0 20,975 Securities financing transactions 0 6,375 2 6,377 0 7,317 0 7,317 Over-the-counter debt instruments 0 1,334 794 2,128 0 1,363 697 2,060 Total liabilities measured at fair value 25,922 257,637 17,357 300,916 27,635 282,233 15,212 325,080 1 Bifurcated embedded derivatives are presented on the same balance sheet lines 2 As of 31 December 2021, USD 16 20 8 8 fair value through other 33 15 3 3 liabilities designated at fair value are expected to be recovered or settled after 12 months. at the lower of their net carrying amount or fair value less costs to sell. Valuation techniques UBS uses widely recognized valuation techniques for determining the fair not valuation flows, relative value and option pricing methodologies. Discounted technique future these reflects the credit and for instruments with similar risk present future market standard cash flow projection the calculation are modeling techniques and models. Relative value models measure fair prices adjustments observed instrument and the instrument being valued. Option pricing models behavior of future asset or assets payoff for payoff is industry-standard The form analytical binomial tree or Monte Carlo simulation). Where available, assumptions and inputs. be derived recent observable based analogous instruments, derivation of input levels based on products with market conditions and valuation approaches. For using pricing services and relevant quotes. Consideration nature of recently consensus models, techniques and inputs rate curves, rates, bond rates, levels of market volatility and correlation. Refer to Note 21f for more the funding and credit characteristics they are applied. Financial instruments excluding derivatives: valuation and classification in the fair value hierarchy Product Valuation and classification in the fair value hierarchy Government bills and bonds Valuation – Generally valued using prices obtained directly – Instruments not priced directly using active-market data techniques that incorporate market data Fair value hierarchy – Generally traded in active markets with prices that can be obtained directly from these markets, resulting in classification as Level 1, Corporate and municipal bonds Valuation – Generally adjusted for seniority, maturity and liquidity. – When prices incorporating the credit spread of the – For convertible bonds model. Fair value hierarchy – Generally classified as Level 1 or Level 2, depending – Level 3 instruments have no suitable pricing information Traded loans and loans measured at fair value Valuation – Valued directly – Where no derived from debt instruments in comparable entities or different products in the same entity, or by using a credit default and interest approach based on rating agency guidelines. Fair value hierarchy – Instruments with suitably deep and liquid pricing – Positions requiring the use of depth, are classified as Level 3. Product Valuation and classification in the fair value hierarchy Investment fund units Valuation – Predominantly exchange-traded, with – Where market prices are not available, fair Fair value hierarchy – Listed units classification, while other positions are classified – Positions for which NAVs are not available Asset-backed securities (ABS) Valuation – For liquid securities, the valuation levels between the time of trading and the discounted expected Fair value hierarchy – Residential - backed , commercial mortgage - backed and generally classified as Level 2. However, data is not available, they are classified as Level Auction rate securities (ARS) Valuation – ARS emanating from the note coupon, credit risk attributable to the liquidity risk as a function of the level of trading volume in these positions, and extension risk, as ARS are perpetual instruments that require an assumption Fair value hierarchy – Granular and liquid pricing information is generally not available for classified as Level 3. Equity instruments Valuation – Listed equity instruments are generally valued – Unlisted equity holdings, and are deemed to be impaired. Fair value hierarchy – The majority readily and regularly available, resulting in Level Financial assets for unit-linked investment contracts Valuation – The majority of assets are listed on exchanges Fair value hierarchy – Most assets are classified as Level 1 if actively traded, – Instruments for which prices are not readily available Securities financing transactions Valuation – These instruments are valued using discounted expected cash flow techniques. The discount rate applied is based on funding curves that are relevant Fair value hierarchy – Collateral funding curves for are classified as Level 2. – Where the collateral positions are classified as Level 3. Brokerage receivables and payables Valuation – Fair value is determined based on the value of Fair value hierarchy – Due to their on-demand nature, these receivables Amounts due under unit-linked investment contracts Valuation – The corresponding assets. Fair value hierarchy – The liabilities themselves are not actively traded, traded and are therefore classified as Level 2. Derivative instruments: valuation and classification in the fair value hierarchy The valuation associated instrument across interest derivatives are measured using rates currency for the respective counterparty collateral agreement. Uncollateralized discounted equivalent) curve for the currency in 2 1 d , the collateralized adjustments CVA s) , debit DVA s) and funding valuation adjustments (FVAs), as estimation credit risk, and funding costs and benefits. › Refer to Note 10 for more information about instruments Derivative product Valuation and classification in the fair value hierarchy Interest rate contracts Valuation – Interest rate swap contracts flows using curves used to estimate future index curve models using interest rates associated with interest rate swap rates, forward rate agreement rates, short-term interest rate futures prices, spreads and inflation swap rates. – Interest rate option contracts include interest rate yield curves, inflation curves, – When the maturity quotes are observable for last observable point using standard assumptions parameter to represent a suitable proxy for that Fair value hierarchy – The majority of interest rate swaps are classified inputs for yield curve models are generally traded – Options are generally to active-market options and more exotic products. – Interest rate swap observable quotes. – Exotic options for market data are classified as Level 3. Credit derivative contracts Valuation – Credit derivative spreads, upfront pricing points and implied recovery rates. Where a derivative credit spread is not directly available, it may be derived from the price of – Asset-backed credit security with an adjustment to reflect Fair value hierarchy – Single-entity and recovery rates name(s) are not actively traded instruments, these contracts are classified – Asset-backed distributed across Level 2 and Level 3. Derivative product Valuation and classification in the fair value hierarchy Foreign exchange contracts Valuation – Open spot foreign exchange (FX) – Forward FX contracts are valued using the FX spot rate adjusted for forward pricing points observed from standard market-based sources. – Over-the-counter (OTC) The models used for shorter-dated options (i.e., maturities of those used for additional consideration of interest rate and FX – The valuation for observed FX volatilities for all relevant FX pairs. Fair value hierarchy – The therefore such FX contracts are generally classified – A significant proportion of from standard market contracts traded in – OTC FX option contracts where there is no active market Equity / index contracts Valuation – Equity forward models. The key inputs to the models are (which are implied discounted using market-standard discounted cash flow models using a rate that reflects the appropriate funding rate for they are related equity. – Equity option contracts are valued described between discounted appropriate funding rate not volatility data, or the equivalent data for Fair value hierarchy – As inputs are significant proportion of equity forward contracts – Equity option positions for which inputs are derived observable markets are also classified correlation inputs are not observable. Commodity contracts Valuation – Commodity forward forward levels on standard instruments. – Commodity commodity forward level for the volatility of the underlying or between different commodities or commodity Fair value hierarchy – Individual market data is available. d) Valuation adjustments and other items The output of a valuation technique is always an estimate of a fair value that cannot be result, valuations are adjusted, where appropriate and when such factors would be considered by market participants in estimating fair value, to reflect valuation restrictions and other factors. The table below summarizes the recognized on the balance sheet. Details about each category are provided further below. Valuation adjustment reserves on the balance sheet As of Life-to-date gain / (loss), USD million 31.12.21 31.12.20 31.12.19 Deferred day-1 profit or loss reserves 418 269 146 Own credit adjustments on financial liabilities designated at fair value (315) (381) (88) CVAs, FVAs, (1,004) (959) (706) Deferred day-1 profit or loss reserves For measure fair on recognized differ where any such difference is deferred and not initially recognized in the income statement. Deferred Other net through profit or loss underlying s observable transaction is closed out. The profit or loss reserves during the respective period. Deferred day-1 profit or loss reserves USD million 2021 2020 2019 Reserve balance at the beginning of the year 269 146 255 Profit / (loss) deferred on new transactions 459 362 171 (Profit) / loss recognized in the income statement (308) (238) (278) Foreign currency translation (2) 0 (2) Reserve balance at the end of the year 418 269 146 Own credit Own option liabilities where valuation participants. Changes in fair recognized Other directly Retained with statement in future periods. increase an does not hedge changes in own credit Own curves, market-observed default swap spreads the value that are attributable as well other than credit spreads, such as redemptions, effects from time decay own credit is recognized unrealized OCA date. change since initial recognition. › Refer to Note 16 for more information about designated at fair value Own credit adjustments on financial liabilities Included in Other comprehensive income For the year ended USD million 31.12.21 31.12.20 31.12.19 Recognized during the period: Realized gain / (loss) (14) 2 8 Unrealized gain / (loss) 60 (295) (408) Total gain / (loss), before tax 46 (293) (400) As of USD million 31.12.21 31.12.20 31.12.19 Recognized on the balance sheet as of the end of the period: Unrealized life-to-date gain / (loss) (315) (381) (88) Credit valuation adjustments In order to measure including Financial assets at to instruments. This protection required instruments. considering dependent probabilities arrangements, contractual factors. Funding valuation adjustments FVAs uncollateralized and and moving flows from the ARR to OCA using the CVA framework, including the probability of counterparty default. collateralized derivative be sold or repledged. Debit valuation adjustments A DVA derivatives calculation being exposures collateral movements and UBS’s credit default spreads. Other valuation adjustments Instruments that are measured as part of a portfolio of combined long and short consistent liquidity valuation adjustment is or appropriate, reflecting current levels of market liquidity. offer spreads used in are obtained from market transactions and are updated periodically. Uncertainties valuations through amounts that UBS estimates should be deducted from produced relevant modeling used, known considers a market reserves are transactions, sources. Other items In the first 861 as a US-based unwinding of loss Other instruments measured at fair value through profit or loss . Valuation adjustments on financial instruments As of Life-to-date gain / (loss), USD million 31.12.21 31.12.20 Credit valuation adjustments 1 (44) (66) Funding valuation adjustments (49) (73) Debit valuation adjustments 2 0 Other valuation adjustments (913) (820) of which: liquidity (341) (340) of which: model uncertainty (571) (479) 1 Amounts do not include reserves against defaulted counterparties. e) Transfers between Level 1 and Level 2 Assets and liabilities transferred to Level 2 during 2021 were also not material. f) Level 3 instruments: valuation techniques and inputs The together value, considered significant as and a range of values for those unobservable inputs. The inputs not reflect the level of an assumptions, but rather the different underlying the therefore vary from period to period and parameter to parameter based on characteristics sheet date. Furthermore, differ across other financial institutions, the products in each firm’s inventory. Valuation techniques and inputs used in the fair value measurement Fair value Significant unobservable input(s) 1 Range of inputs Assets Liabilities Valuation technique(s) 31.12.21 31.12.20 USD billion 31.12.21 31.12.20 31.12.21 31.12.20 low high weighted average 2 low high weighted average 2 unit 1 Financial assets and liabilities at fair value held for trading and Financial assets at fair Corporate and municipal bonds 0.9 1.2 0.0 0.0 Relative value to market comparable Bond price equivalent 16 143 98 1 143 100 points Discounted expected cash flows Discount margin 434 434 268 268 basis points Traded loans, loans measured at fair value, loan commitments and guarantees 2.8 2.4 0.0 0.0 Relative value to market comparable Loan price equivalent 0 101 99 0 101 99 points Discounted expected cash flows Credit spread 175 800 436 190 800 398 basis points Market comparable and securitization model Credit spread 28 1,544 241 40 1,858 333 basis points Auction rate securities 1.6 1.5 Discounted expected cash flows Credit spread 115 197 153 100 188 140 basis points Investment fund units 3 0.1 0.1 0.0 0.0 Relative value to market comparable Net asset value Equity instruments 3 0.8 0.7 0.1 0.0 Relative value to market comparable Price Debt issued designated at fair value 4 11.9 9.6 Other financial liabilities designated at fair value 3.2 2.1 Discounted expected cash flows Funding spread 24 175 42 175 basis points Derivative financial instruments Interest rate contracts 0.5 0.5 0.3 0.5 Option model Volatility of interest rates 65 81 29 69 basis points Credit derivative contracts 0.2 0.3 0.3 0.5 Discounted expected cash flows Credit spreads 1 583 1 489 basis points Bond price equivalent 2 136 0 100 points Equity / index contracts 0.4 0.9 1.5 2.3 Option model Equity dividend yields 0 11 0 13 % Volatility of equity stocks, equity and other indices 4 98 4 100 % Equity-to-FX correlation (29) 76 (34) 65 % Equity-to-equity correlation (25) 100 (16) 100 % 1 The ranges of significant for most non-derivative financial liabilities designated at investments. linked notes, all of which have embedded derivative parameters that are considered to be unobservable. lines in this table. Significant unobservable inputs in Level 3 positions This section discusses the significant unobservable inputs that a change in each unobservable inputs have not been included in the summary below. Input Description Bond price equivalent – Where market similar instruments. Factors considered when the issuer. Fair value may be measured either by a direct price comparison or by conversion of (either as an outright yield or as a spread to – For corporate and municipal bonds, value. Bonds priced at 0 are distressed to the point that no par measurement date. – For credit derivatives, the bond price range converted to an equivalent yield or credit Loan price equivalent – Where market prices are not available similar instruments. maturity and issuer-specific covenants. Fair value may be measured either by a direct price comparison instrument price used to expected, while a current price of 100 represents Credit spread – Valuation models for many credit derivatives the associated referenced security or reference rate, typically either US Treasury or ARR, (decrease) in credit credit derivative held. Credit spreads may calculated. A with the lower levels of credit risk. Discount margin – The discount margin (DM) spread represents the market return required for uncertainty in the index (e.g., Secured Overnight Financing DM in isolation would result in a higher / (lower) – The high end This indicates captured by the quality instruments. Funding spread – Structured financing transactions are valued using synthetic funding curves that best represent the assets that are pledged as collateral for the transactions. They are not representative estimate of where UBS can source and deploy secured funding with counterparties for a given type of collateral. The funding spreads are expressed in terms of basis points, – A small proportion of structured fair value had an exposure to funding spreads that Volatility – Volatility measures the variability of future prices a higher number reflects a more volatile instrument, for which future price movements are key input instrument. The effect is a reduced by option prices represents the effect of pricing options of – Volatilities of low interest rates tend to be much higher than volatilities of high interest rates. In addition, different currencies may have significantly different implied volatilities. Input Description Correlation – Correlation measures the interrelationship between the movements of two variables. It is expressed as a percentage between –100% and with a (meaning a movement of correlation on the measurement of fair value depends on the specific terms of the instruments being valued, reflecting the range of different payoff features within – Equity-to-FX correlation is important for equity options based on Equity-to-equity correlation is particularly important for complex options that incorporate, in some in the projected payoff. Equity dividend yields – The derivation of contracts and for measuring fair value using option pricing models. The relationship between the current stock price and forward price is based on a combination of expected future dividend levels and relevant funding rates applicable of the share price, and timing represent the forward price. g) Level 3 instruments: sensitivity to changes in unobservable input assumptions The table classified unobservable inputs unfavorable significantly, does Interdependencies between Level 1, 2 and 3 been relationships between the not a significant element of the valuation uncertainty. Sensitivity including market reasonably possible value measurement process. The sensitivity ranges are not always symmetrical valuations are not always precisely in and unfavorable range. Sensitivity data and Diversification different sensitivity results and, as such, would result in an overall sensitivity component diversification benefit is not significant to this analysis. Sensitivity of fair value measurements to changes 1 31.12.21 31.12.20 USD million Favorable changes Unfavorable changes Favorable changes Unfavorable changes Traded loans, loans designated at fair value, loan commitments and guarantees 19 (13) 29 (28) Securities financing transactions 41 (53) 40 (52) Auction rate securities 66 2 (66) 2 105 (105) Asset-backed securities 20 (20) 41 (41) Equity instruments 173 (146) 129 (96) Interest rate derivative contracts, net 29 (19) 11 (16) Credit derivative contracts, net 5 (8) 10 (14) Foreign exchange derivative contracts, net 19 (11) 20 (15) Equity / index derivative contracts, net 368 (335) 318 (294) Other 50 (73) 91 (107) Total 790 (744) 794 (768) 1 Sensitivity of issued and various parameters and a change in assumptions regarding the underlying statistical distribution. h) Level 3 instruments: movements during the period The movements in Level 3 assets and on a recurring basis, excluding any related hedging activity. Assets presented as the beginning of the year. Movements of Level 3 instruments Total gains / losses included in comprehensive income USD billion Balance as of 31 December 2019 Net gains / losses included in income 1 of which: related to Level 3 instruments held at the end of the reporting period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance as of 31 December 2020 Financial assets at fair value held for trading 1.8 (0.1) (0.1) 0.8 (1.4) 1.0 0.0 0.3 0.0 0.0 2.3 of which: Investment fund units 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Corporate and municipal bonds 0.5 0.0 0.0 0.7 (0.5) 0.0 0.0 0.1 0.0 0.0 0.8 Loans 0.8 0.0 (0.1) 0.0 (0.7) 1.0 0.0 0.1 0.0 0.0 1.1 Other 0.4 0.0 0.0 0.1 (0.3) 0.0 0.0 0.2 0.0 0.0 0.4 Derivative financial instruments – assets 1.3 0.3 0.4 0.0 0.0 0.7 (0.5) 0.1 (0.2) 0.1 1.8 of which: Interest rate contracts 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 Equity / index contracts 0.6 0.1 0.1 0.0 0.0 0.6 (0.3) 0.0 (0.1) 0.0 0.9 Credit derivative contracts 0.4 0.0 0.0 0.0 0.0 0.1 (0.2) 0.1 0.0 0.0 0.3 Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Financial assets at fair value not held for trading 4.0 0.0 0.1 0.8 (0.9) 0.0 0.0 0.1 0.0 0.0 3.9 of which: Loans 1.2 0.0 0.0 0.3 (0.7) 0.0 0.0 0.0 0.0 0.0 0.9 Auction rate securities 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 Equity instruments 0.5 0.0 0.0 0.1 (0.1) 0.0 0.0 0.0 0.0 0.0 0.5 Other 0.7 0.0 0.0 0.4 (0.2) 0.0 0.0 0.0 0.0 0.0 1.0 Derivative financial instruments – liabilities 2.0 1.3 1.2 0.0 0.0 1.2 (0.9) 0.4 (0.6) 0.1 3.5 of which: Interest rate contracts 0.1 0.3 0.3 0.0 0.0 0.3 (0.2) 0.2 (0.2) 0.0 0.5 Equity / index contracts 1.3 1.0 0.8 0.0 0.0 0.8 (0.6) 0.1 (0.2) 0.0 2.3 Credit derivative contracts 0.5 0.0 0.0 0.0 0.0 0.1 (0.1) 0.1 (0.2) 0.0 0.5 Other 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 Debt issued designated at fair value 9.6 0.0 (0.2) 0.0 0.0 6.6 (5.6) 0.5 (1.7) 0.2 9.6 Other financial liabilities designated at fair value 1.0 0.2 0.2 0.0 0.0 1.4 (0.6) 0.0 0.0 0.0 2.1 1 Net gains / losses Level 3 assets as of 31 December 2021 were USD 7.6 8.3 17.4 15.2 i) Maximum exposure to credit risk for financial instruments measured at fair value The tables below provide risk respective credit risk for these classes of financial instruments. The amounts of financial subject sheet arrangements. presented at fair value. reasonable alternative as credit derivative contracts notional amounts. Both are capped at the maximum credit risk for which and control” section of this of credit risk and respects from the requirements of IFRS. Maximum exposure to credit risk 31.12.21 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD billion Cash collateral received Collateral- ized by securities Secured by real estate Other collateral Netting Credit derivative contracts Guarantees Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 22.6 22.6 Derivative financial instruments 4,5 118.1 4.2 103.2 10.7 Brokerage receivables 21.8 0.0 21.6 0.2 Financial assets at fair value not held for trading – debt instruments 6 37.0 0.0 11.2 25.7 Total financial assets measured at fair value 199.5 0.0 37.1 0.0 0.0 103.2 0.0 0.0 59.2 Guarantees 7 0.2 0.0 0.2 0.0 31.12.20 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD billion Cash collateral received Collateral- ized by securities Secured by real estate Other collateral Netting Credit derivative contracts Guarantees Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 24.7 24.7 Derivative financial instruments 4,5 159.6 6.0 138.4 15.2 Brokerage receivables 24.7 24.4 0.3 Financial assets at fair value not held for trading – debt instruments 6 58.2 0.0 13.2 45.0 Total financial assets measured at fair value 267.2 0.0 43.6 0.0 0.0 138.4 0.0 0.0 85.2 Guarantees 7 0.5 0.1 0.3 0.0 1 The maximum exposure to loss is generally equal to the carrying amount and subject to change over time with market movements. the purpose of this disclosure, collateral and credit enhancements were 0 0 commitments and forward starting reverse repurchase of USD 27.8 21.9 8.2 0.8 9.4 billion, of which USD 0.8 balance sheet. Refer to Note 22 agreements. j) Financial instruments not measured at fair value The table below provides the estimated fair values of financial instruments not measured at fair value. Financial instruments not measured at fair value 31.12.21 31.12.20 Carrying amount Fair value Carrying amount Fair value USD billion Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Assets 2 Cash and balances at central banks 192.8 192.7 0.1 0.0 0.0 192.8 158.2 158.1 0.1 0.0 0.0 158.2 Loans and advances to banks 15.4 14.6 0.0 0.7 0.0 15.3 15.3 14.6 0.0 0.6 0.1 15.3 Receivables from securities financing transactions 75.0 71.6 0.0 1.3 2.1 75.0 74.2 64.9 0.0 7.6 1.7 74.2 Cash collateral receivables on derivative instruments 30.5 30.5 0.0 0.0 0.0 30.5 32.7 32.7 0.0 0.0 0.0 32.7 Loans and advances to customers 398.7 163.7 0.0 43.8 190.4 397.9 381.0 173.1 0.0 34.2 174.9 382.3 Other financial assets measured at amortized cost 26.2 4.1 9.3 10.7 2.4 26.5 27.2 5.4 9.4 10.9 2.3 28.0 Liabilities 2 Amounts due to banks 13.1 9.1 0.0 4.0 0.0 13.1 11.0 8.5 0.0 2.6 0.0 11.1 Payables from securities financing transactions 5.5 4.1 0.0 1.5 0.0 5.5 6.3 6.0 0.0 0.2 0.0 6.3 Cash collateral payables on derivative instruments 31.8 31.8 0.0 0.0 0.0 31.8 37.3 37.3 0.0 0.0 0.0 37.3 Customer deposits 544.8 537.6 0.0 7.3 0.0 544.8 527.9 521.8 0.0 6.2 0.0 528.0 Funding from UBS Group AG 57.3 2.8 0.0 56.0 0.0 58.8 54.0 0.0 0.0 55.6 0.0 55.6 Debt issued measured at amortized cost 82.4 13.0 0.0 69.8 0.0 82.8 85.4 16.4 0.0 70.0 0.0 86.3 Other financial liabilities measured at amortized cost 3 6.3 6.3 0.0 0.0 0.0 6.3 6.6 6.6 0.0 0.0 0.1 6.7 1 Includes certain financial instruments where the carrying amount is a reasonable with a remaining maturity (excluding 0 0 USD 0 0 1 1 175 2020: USD 163 19 20 1 0 of Amounts due to banks, 4 3 53 49 31 2020: USD 31 3 3 after 12 months. The fair for assumptions described below relate only financial instruments may estimations, necessarily be compared from The following principles estimates for financial instruments not measured at fair value: – For than three months, the market prices, if available. Where quoted market prices were were current instruments and estimates generally include risk or UBS’s own credit. – For short-term financial instruments with remaining maturities of three credit estimate of fair value. |
Offsetting financial assets and
Offsetting financial assets and financial liabilities | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Offsetting Of Financial Assets And Financial Liabilities Explanatory | Note 22 UBS manage the credit risks reverse repurchase transactions, over-the-counter These enable assets received event fulfill their contractual obligations. The tables on this page and the next page of enforceable master netting as well as exposures for these financial instruments. The mitigation arrangements. Therefore the net amounts presented in the on this page and the next page do not purport to actual credit risk exposure. Financial assets subject to offsetting, enforceable Assets subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Assets not subject to netting arrangements 4 Total assets As of 31.12.21, USD billion Gross assets before netting Netting with gross liabilities 2 Net assets recognized on the balance sheet Financial liabilities Collateral received Assets after consideration of netting potential Assets recognized on the balance sheet Total assets after consideration of netting potential Total assets recognized on the balance sheet Receivables from securities financing transactions 67.7 (13.8) 53.9 (2.9) (51.0) 0.0 21.1 21.1 75.0 Derivative financial instruments 116.0 (3.6) 112.4 (88.9) (18.5) 5.0 5.7 10.7 118.1 Cash collateral receivables on derivative instruments 1 29.4 0.0 29.4 (15.2) (3.3) 11.0 1.1 12.1 30.5 Financial assets at fair value not held for trading 93.1 (87.6) 5.5 (1.1) (4.4) 0.0 54.6 54.6 60.1 of which: reverse repurchase agreements 93.1 (87.6) 5.5 (1.1) (4.4) 0.0 0.3 0.3 5.8 Total assets 306.2 (105.0) 201.2 (108.1) (77.2) 15.9 82.6 98.5 283.7 As of 31.12.20, USD billion Receivables from securities financing transactions 70.3 (13.4) 57.0 (1.7) (55.3) 0.0 17.3 17.3 74.2 Derivative financial instruments 156.9 (5.0) 151.9 (117.2) (27.2) 7.5 7.7 15.2 159.6 Cash collateral receivables on derivative instruments 1 31.9 0.0 31.9 (19.6) (1.5) 10.8 0.8 11.6 32.7 Financial assets at fair value not held for trading 85.6 (79.1) 6.5 (0.8) (5.8) 0.0 73.9 73.9 80.4 of which: reverse repurchase agreements 85.6 (79.1) 6.5 (0.8) (5.8) 0.0 0.2 0.2 6.7 Total assets 344.8 (97.5) 247.3 (139.3) (89.8) 18.3 99.7 117.9 346.9 1 The net IAS 32 principles and exchange-traded directly to the amounts presented in the “Netting with gross assets” column in “Receivables from securities financing securities financing transactions” and “Other financial instruments and cash collateral table. Financial liabilities subject to offsetting, enforceable Liabilities subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Liabilities not subject to netting arrangements 4 Total liabilities As of 31.12.21, USD billion Gross liabilities before netting Netting with gross assets 2 Net liabilities recognized on the balance sheet Financial assets Collateral pledged Liabilities after consideration of netting potential Liabilities recognized on the balance sheet Total liabilities after consideration of netting potential Total liabilities recognized on the balance sheet Payables from securities financing transactions 16.9 (12.8) 4.1 (1.8) (2.3) 0.0 1.4 1.4 5.5 Derivative financial instruments 118.4 (3.6) 114.9 (88.9) (18.1) 7.9 6.4 14.3 121.3 Cash collateral payables on derivative instruments 1 30.4 0.0 30.4 (13.1) (3.3) 14.0 1.4 15.4 31.8 Other financial liabilities designated at fair value 94.8 (88.6) 6.2 (2.2) (3.8) 0.2 23.9 24.1 30.1 of which: repurchase agreements 94.6 (88.6) 6.0 (2.2) (3.8) 0.0 0.4 0.4 6.4 Total liabilities 260.6 (105.0) 155.6 (106.0) (27.5) 22.1 33.1 55.2 188.7 As of 31.12.20, USD billion Payables from securities financing transactions 18.2 (13.3) 4.9 (1.6) (3.3) 0.0 1.4 1.4 6.3 Derivative financial instruments 157.1 (5.0) 152.1 (117.2) (23.9) 10.9 9.0 19.9 161.1 Cash collateral payables on derivative instruments 1 35.6 0.0 35.6 (19.6) (2.1) 13.9 1.7 15.7 37.3 Other financial liabilities designated at fair value 87.0 (79.2) 7.8 (0.8) (6.3) 0.7 22.6 23.3 30.4 of which: repurchase agreements 86.2 (79.2) 7.0 (0.8) (6.3) 0.0 0.3 0.3 7.3 Total liabilities 297.8 (97.5) 200.3 (139.2) (35.5) 25.6 34.8 60.4 235.1 1 The net amount of Cash collateral payables on derivative instruments recognized on the balance sheet includes certain OTC derivatives that are net settled on a daily basis either legally or in substance under IAS 32 principles and exchange-traded derivatives that are economically settled on presented in the financing transactions” and “Other financial liabilities designated at fair value” transactions” and “Financial assets collateral presented have been liabilities not subject to enforceable netting arrangements and other out-of-scope items. |
UBS AG | |
Entity [Table] | |
Disclosure Of Offsetting Of Financial Assets And Financial Liabilities Explanatory | Note 22 UBS manage the credit risks reverse repurchase transactions, over-the-counter These enable assets received event fulfill their contractual obligations. The tables on this page and the next page of enforceable master netting as well as exposures for these financial instruments. UBS mitigation arrangements. Therefore, the on this page and the next page do not purport to actual credit risk exposure. Financial assets subject to offsetting, enforceable Assets subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Assets not subject to netting arrangements 4 Total assets As of 31.12.21, USD billion Gross assets before netting Netting with gross liabilities 2 Net assets recognized on the balance sheet Financial liabilities Collateral received Assets after consideration of netting potential Assets recognized on the balance sheet Total assets after consideration of netting potential Total assets recognized on the balance sheet Receivables from securities financing transactions 67.7 (13.8) 53.9 (2.9) (51.0) 0.0 21.1 21.1 75.0 Derivative financial instruments 116.0 (3.6) 112.4 (88.9) (18.5) 5.0 5.8 10.7 118.1 Cash collateral receivables on derivative instruments 1 29.4 0.0 29.4 (15.2) (3.3) 11.0 1.1 12.1 30.5 Financial assets at fair value not held for trading 93.1 (87.6) 5.5 (1.1) (4.4) 0.0 54.1 54.1 59.6 of which: reverse repurchase agreements 93.1 (87.6) 5.5 (1.1) (4.4) 0.0 0.3 0.3 5.8 Total assets 306.2 (105.0) 201.2 (108.1) (77.2) 15.9 82.1 98.1 283.3 As of 31.12.20, USD billion Receivables from securities financing transactions 70.3 (13.4) 57.0 (1.7) (55.3) 0.0 17.3 17.3 74.2 Derivative financial instruments 156.9 (5.0) 151.9 (117.2) (27.2) 7.5 7.7 15.2 159.6 Cash collateral receivables on derivative instruments 1 31.9 0.0 31.9 (19.6) (1.5) 10.8 0.8 11.6 32.7 Financial assets at fair value not held for trading 85.6 (79.1) 6.5 (0.8) (5.8) 0.0 73.5 73.5 80.0 of which: reverse repurchase agreements 85.6 (79.1) 6.5 (0.8) (5.8) 0.0 0.2 0.2 6.7 Total assets 344.8 (97.5) 247.3 (139.3) (89.8) 18.3 99.3 117.6 346.6 1 The net IAS 32 principles and exchange-traded directly to the amounts presented in the “Netting with gross assets” column in “Receivables from securities financing securities financing transactions” and “Other financial instruments and cash collateral table. Financial liabilities subject to offsetting, enforceable Liabilities subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Liabilities not subject to netting arrangements 4 Total liabilities As of 31.12.21, USD billion Gross liabilities before netting Netting with gross assets 2 Net liabilities recognized on the balance sheet Financial assets Collateral pledged Liabilities after consideration of netting potential Liabilities recognized on the balance sheet Total liabilities after consideration of netting potential Total liabilities recognized on the balance sheet Payables from securities financing transactions 16.9 (12.8) 4.1 (1.8) (2.3) 0.0 1.4 1.4 5.5 Derivative financial instruments 118.4 (3.6) 114.9 (88.9) (18.1) 7.9 6.4 14.3 121.3 Cash collateral payables on derivative instruments 1 30.4 0.0 30.4 (13.1) (3.3) 14.0 1.4 15.4 31.8 Other financial liabilities designated at fair value 94.8 (88.6) 6.2 (2.2) (3.8) 0.2 26.3 26.5 32.4 of which: repurchase agreements 94.6 (88.6) 6.0 (2.2) (3.8) 0.0 0.4 0.4 6.4 Total liabilities 260.6 (105.0) 155.6 (106.0) (27.5) 22.1 35.5 57.6 191.1 As of 31.12.20, USD billion Payables from securities financing transactions 18.2 (13.3) 4.9 (1.6) (3.3) 0.0 1.4 1.4 6.3 Derivative financial instruments 157.1 (5.0) 152.1 (117.2) (23.9) 10.9 9.0 19.9 161.1 Cash collateral payables on derivative instruments 1 35.6 0.0 35.6 (19.6) (2.1) 13.9 1.7 15.7 37.3 Other financial liabilities designated at fair value 87.0 (79.2) 7.8 (0.8) (6.3) 0.7 24.0 24.7 31.8 of which: repurchase agreements 86.2 (79.2) 7.0 (0.8) (6.3) 0.0 0.3 0.3 7.3 Total liabilities 297.8 (97.5) 200.3 (139.2) (35.5) 25.6 36.2 61.7 236.5 1 The net amount of Cash collateral payables on derivative instruments recognized on the balance sheet includes certain OTC derivatives that are net settled on a daily basis either legally or in substance under IAS 32 principles and exchange-traded derivatives that are economically settled on presented in the financing transactions” and “Other financial liabilities designated at fair value” transactions” and “Financial assets collateral presented have been liabilities not subject to enforceable netting arrangements and other out-of-scope items. |
Restricted financial assets
Restricted financial assets | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Restricted Assets Disclosure Text Block | Note 23 This Note provides assets that are received as collateral with the right to resell or repledge these assets (Note 23d). a) Restricted financial assets Restricted against an existing liability or contingent liability and other assets that are used to secure funding. Financial lending from issuance repurchase market collateral may be more or less than the fair value of the securities loaned, repurchase agreements, the fair value of the collateral sold under an borrowed. Pledged mortgage loans serve as collateral for existing liabilities existing 10,843 31 December 2021 (31 December 2020: USD 12,456 Other restricted financial assets include assets protected under client asset entities to back related liabilities to the policy holders, assets held in certain jurisdictions to maintenance requirements. The carrying associated with these other equal to the carrying amount of the assets, with the exception of assets held to comply with local asset maintenance requirements, for which the associated liabilities are greater. Restricted financial assets USD million 31.12.21 31.12.20 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties of which: mortgage loans 1 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties of which: mortgage loans 1 Financial assets pledged as collateral Financial assets at fair value held for trading 63,725 43,397 64,367 47,098 Loans and advances to customers 18,160 16,330 20,361 18,191 Financial assets at fair value not held for trading 961 961 2,140 2,140 Debt securities classified as Other financial assets measured cost 2,234 1,870 2,506 2,506 Financial assets measured at fair value through other comprehensive income 0 0 149 149 Total financial assets pledged as collateral 2 85,079 89,523 Other restricted financial assets Loans and advances to banks 3,408 3,730 Financial assets at fair value held for trading 392 741 Cash collateral receivables on derivative instruments 4,747 3,765 Loans and advances to customers 1,237 756 Financial assets at fair value not held for trading 22,765 23,243 Financial assets measured at fair value through other comprehensive income 894 0 Other 97 110 Total other restricted financial assets 33,540 32,345 Total financial assets pledged and other restricted financial assets 118,619 121,868 1 All related USD 2.7 2.7 requirements. 4.4 USD 1.3 In addition and requirements within authorities leverage Board ’s process, which the ability distributions of capital based on the results of those tests. Supervisory higher subsidiaries. Non-regulated requirements also be the result or country-specific arrangements and / or requirements. › Refer to the “Financial and regulatory key figures significant regulated subsidiaries and sub-groups” section report for financial information about significant subsidiaries of the Group |
UBS AG | |
Entity [Table] | |
Restricted Assets Disclosure Text Block | Note 23 This Note provides assets that are received as collateral with the right to resell or repledge these assets (Note 23d). a) Restricted financial assets Restricted against an existing liability or contingent liability and other assets that are used to secure funding. Financial lending from issuance generally repurchase market collateral may be more or less than the fair value of the securities loaned, repurchase agreements, the fair value of the collateral sold under an borrowed. Pledged mortgage loans serve as collateral for existing liabilities existing 10,843 31 December 2021 (31 December 2020: USD 12,456 Other restricted financial assets include assets protected under client asset segregation entities to back related liabilities to the policy holders, assets held in certain jurisdictions to maintenance requirements. The carrying associated with these other equal to the carrying amount of the assets, with the exception of assets held to comply with local asset maintenance requirements, for which the associated liabilities are greater. Restricted financial assets USD million 31.12.21 31.12.20 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties of which: mortgage loans 1 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties of which: mortgage loans 1 Financial assets pledged as collateral Financial assets at fair value held for trading 63,834 43,397 64,418 47,098 Loans and advances to customers 18,160 16,330 20,361 18,191 Financial assets at fair value not held for trading 961 961 2,140 2,140 Debt securities classified as Other financial assets measured cost 2,234 1,870 2,506 2,506 Financial assets measured at fair value through other comprehensive income 0 0 149 149 Total financial assets pledged as collateral 2 85,188 89,574 Other restricted financial assets Loans and advances to banks 3,408 3,730 Financial assets at fair value held for trading 392 741 Cash collateral receivables on derivative instruments 4,747 3,765 Loans and advances to customers 1,237 756 Financial assets at fair value not held for trading 22,328 22,917 Financial assets measured at fair value through other comprehensive income 894 0 Other 97 110 Total other restricted financial assets 33,104 32,019 Total financial assets pledged and other restricted financial assets 118,292 121,593 1 All related USD 2.7 2.7 requirements. 4.4 USD 1.3 In addition subsidiaries requirements within authorities leverage Board’s which the ability distributions of capital based on the results of those tests. Supervisory higher subsidiaries. Non-regulated requirements also be the result or country-specific arrangements and / or requirements. › Refer to the “Financial and regulatory key figures significant regulated subsidiaries and sub-groups” section report for financial information about significant subsidiaries of UBS AG |
Transferred financial assets th
Transferred financial assets that are not derecognized in their entirety | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Transfers Of Financial Assets Explanatory | b) Transferred financial assets that are not derecognized in their entirety The table below presents as well as recognized liabilities associated with those transferred assets. Transferred financial assets subject to continued recognition in full USD million 31.12.21 31.12.20 Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Financial assets at fair value held for trading that may be sold or repledged 43,397 17,687 47,098 18,874 relating to securities lending and repurchase agreements in 17,970 17,687 19,177 18,874 relating to securities lending agreements in exchange for securities 24,146 27,595 relating to other financial asset transfers 1,281 326 Financial assets at fair value not held for trading that may be sold or repledged counterparties 961 898 2,140 1,378 Debt securities classified as Other financial assets measured sold or repledged by counterparties 1,870 1,725 2,506 1,963 Financial assets measured at fair value through other comprehensive or repledged by counterparties 0 0 149 148 Total financial assets transferred 46,227 20,311 51,893 22,363 Transactions continue to be recognized include securities lending other financial asset arrangements are, market subject to UBS’s normal credit risk control processes. › Refer to Note 1a item 2e for more information and securities lending agreements As 31 , approximately 41 % of transferred held transferred recognized counterparties. For securities a 0 % 15 % transferred assets, carrying assets. The counterparties to the the table above have full recourse to UBS. In securities the receipt received UBS’s balance not received transaction, assets. Other transferred to carrying table above, a therefore collateral pledged and the associated liability. Transferred derecognition in of 31 December 2021 and as of 31 December 2020. |
UBS AG | |
Entity [Table] | |
Disclosure Of Transfers Of Financial Assets Explanatory | b) Transferred financial assets that are not derecognized in their entirety The table below presents as well as recognized liabilities associated with those transferred assets. Transferred financial assets subject to continued recognition in full USD million 31.12.21 31.12.20 Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Financial assets at fair value held for trading that may be sold or repledged 43,397 17,687 47,098 18,874 relating to securities lending and repurchase agreements in 17,970 17,687 19,177 18,874 relating to securities lending agreements in exchange for securities 24,146 27,595 relating to other financial asset transfers 1,281 326 Financial assets at fair value not held for trading that may be sold or repledged counterparties 961 898 2,140 1,378 Debt securities classified as Other financial assets measured sold or repledged by counterparties 1,870 1,725 2,506 1,963 Financial assets measured at fair value through other comprehensive or repledged by counterparties 0 0 149 148 Total financial assets transferred 46,227 20,311 51,893 22,363 Transactions continue to sheet well as lending standard agreements and counterparties processes. › Refer to Note 1a item 2e for more information and securities lending agreements As 31 , approximately 41 % of transferred transferred recognized counterparties. For securities a 0 % 15 % transferred assets, carrying assets. The counterparties to the the table above have full recourse to UBS AG. In securities the receipt received nor the obligation to return them AG’s balance sheet, as transferred received transaction, assets. Other transferred to carrying table above, a therefore collateral pledged and the associated liability. Transferred derecognition in of 31 December 2021 and as of 31 December 2020. |
Transferred financial assets _2
Transferred financial assets that are derecognized in their entirety with continuing involvement | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Continuing Involvement In Derecognised Financial Assets Explanatory | c) Transferred financial assets that are derecognized in their entirety with continuing involvement Continuing financial particular transfer agreement or from the counterparty or a third party, entered into in connection with the transfer. The involvement from and reported securitization remaining exposure |
UBS AG | |
Entity [Table] | |
Disclosure Of Continuing Involvement In Derecognised Financial Assets Explanatory | c) Transferred financial assets that are derecognized in their entirety with continuing involvement Continuing financial particular transfer agreement or from the counterparty or a third party, entered into in connection with the transfer. The involvement from transferred positions and reported securitization remaining exposure |
Off-balance sheet assets receiv
Off-balance sheet assets received | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Off Balance Sheet Assets Received Text Block | d) Off-balance sheet assets received The table below presents assets received from third parties that can sheet, but that are held as collateral, including amounts that have been sold or repledged. Off-balance sheet assets received USD million 31.12.21 31.12.20 Fair value of assets received that can be sold or repledged 497,828 500,689 received as collateral under reverse repurchase, securities borrowing and lending arrangements, derivative and other transactions 1 483,426 487,904 received in unsecured borrowings 14,402 12,785 Thereof sold or repledged 2 367,440 367,258 in connection with financing activities 319,176 315,603 to satisfy commitments under short sale transactions 31,688 33,595 in connection with derivative and other transactions 1 16,575 18,059 1 Includes securities received as initial margin from its clients that UBS is required to remit to central counterparties, 2 Does not include off-balance 12.7 18.9 settlement purposes for which there are no associated liabilities or contingent liabilities. |
UBS AG | |
Entity [Table] | |
Disclosure Of Off Balance Sheet Assets Received Text Block | d) Off-balance sheet assets received The table below presents assets received from third parties that can sheet, but that are held as collateral, including amounts that have been sold or repledged. Off-balance sheet assets received USD million 31.12.21 31.12.20 Fair value of assets received that can be sold or repledged 497,828 500,689 received as collateral under reverse repurchase, securities borrowing and lending arrangements, derivative and other transactions 1 483,426 487,904 received in unsecured borrowings 14,402 12,785 Thereof sold or repledged 2 367,440 367,258 in connection with financing activities 319,176 315,603 to satisfy commitments under short sale transactions 31,688 33,595 in connection with derivative and other transactions 1 16,575 18,059 1 Includes securities services. 12.7 18.9 clearing and settlement purposes for which there are no associated liabilities or contingent liabilities. |
Maturity analysis of financial
Maturity analysis of financial liabilities | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Measurement categories, credit risk and maturity analysis of financial instruments [text block] | Note 24 The trading financial liabilities the earliest date on which UBS could be contractually required to pay. band are also shown for 31 December 2020. and transactions, are assigned to the Due within 1 month , this trading activities. The over significantly longer periods. Maturity analysis of financial liabilities 31.12.21 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.7 2.4 3.5 0.6 13.1 Payables from securities financing transactions 3.8 0.3 1.6 0.0 5.7 Cash collateral payables on derivative instruments 31.8 31.8 Customer deposits 530.1 5.2 3.3 3.2 0.4 542.3 Debt issued measured at amortized cost 2 4.0 12.7 41.1 53.5 37.6 148.9 Other financial liabilities measured at amortized cost 4.5 0.1 0.5 1.8 1.6 8.4 0.1 0.1 0.5 1.8 1.6 4.0 Total financial liabilities measured at amortized cost 580.9 20.8 49.9 59.2 39.5 750.2 Financial liabilities at fair value held for trading 3,4 31.7 31.7 Derivative financial instruments 3,5 121.3 121.3 Brokerage payables designated at fair value 44.0 44.0 Debt issued designated at fair value 6 13.8 11.5 13.5 24.5 18.5 81.9 Other financial liabilities designated at fair value 28.1 0.4 0.5 0.4 1.1 30.5 Total financial liabilities measured at fair value through profit or loss 239.0 11.9 14.0 24.9 19.6 309.4 Total 819.8 32.7 63.9 84.1 59.1 1,059.6 Guarantees, commitments and forward starting transactions Loan commitments 7 38.3 0.5 0.7 0.0 39.5 Guarantees 21.2 0.0 21.2 Forward starting transactions, reverse repurchase and securities borrowing agreements 7 1.4 1.4 Total 60.9 0.5 0.7 0.0 0.0 62.1 31.12.20 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.1 2.4 2.1 0.5 0.0 11.1 Payables from securities financing transactions 5.6 0.4 0.3 0.0 0.0 6.3 Cash collateral payables on derivative instruments 37.3 37.3 Customer deposits 512.8 6.6 3.5 1.8 0.2 524.9 Debt issued measured at amortized cost 2 9.0 8.3 41.9 53.7 35.6 148.5 Other financial liabilities measured at amortized cost 4.5 0.1 0.5 2.0 1.8 8.9 0.1 0.1 0.5 2.0 1.8 4.5 Total financial liabilities measured at amortized cost 575.3 17.9 48.2 58.0 37.7 737.1 Financial liabilities at fair value held for trading 3,4 33.6 33.6 Derivative financial instruments 3,5 161.1 161.1 Brokerage payables designated at fair value 38.7 38.7 Debt issued designated at fair value 6 21.9 16.8 7.1 9.2 9.5 64.5 Other financial liabilities designated at fair value 27.9 0.6 0.6 0.7 1.1 30.9 Total financial liabilities measured at fair value through profit or loss 283.2 17.4 7.7 9.9 10.6 328.8 Total 858.5 35.3 56.0 67.9 48.3 1,065.9 Guarantees, commitments and forward starting transactions Loan commitments 7 40.5 0.5 0.4 0.0 41.4 Guarantees 17.5 17.5 Forward starting transactions, reverse repurchase and securities borrowing agreements 7 3.2 3.2 Total 61.3 0.5 0.4 0.0 0.0 62.2 1 Except for financial liabilities payments. that would have to be paid if these positions had to be settled or 30.8 USD 32.6 0.9 1.0 0 0 34 (31 December 2020: USD 32 full contractual committed amount of USD 36.0 31.3 by reference to the Excludes derivative loan commitments and forward starting reverse repurchase agreements measured at fair value |
UBS AG | |
Entity [Table] | |
Measurement categories, credit risk and maturity analysis of financial instruments [text block] | Note 24 The trading financial liabilities as the earliest date to pay. band are also shown for 31 December 2020. and transactions, are assigned to the Due within 1 month , this trading activities. The over significantly longer periods. Maturity analysis of financial liabilities 31.12.21 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.7 2.4 3.5 0.6 0.0 13.1 Payables from securities financing transactions 3.8 0.3 1.6 0.0 5.7 Cash collateral payables on derivative instruments 31.8 31.8 Customer deposits 531.0 6.6 3.3 3.9 0.4 545.1 Funding from UBS Group AG 2 0.2 3.3 2.3 28.8 30.6 65.3 Debt issued measured at amortized cost 2 3.8 9.4 38.8 25.1 7.6 84.7 Other financial liabilities measured at amortized cost 5.3 0.1 0.4 1.8 1.5 9.1 of which: lease liabilities 0.1 0.1 0.4 1.8 1.5 3.9 Total financial liabilities measured at amortized cost 582.6 22.1 49.9 60.2 40.1 754.8 Financial liabilities at fair value held for trading 3,4 31.7 31.7 Derivative financial instruments 3,5 121.3 121.3 Brokerage payables designated at fair value 44.0 44.0 Debt issued designated at fair value 6 13.8 11.5 13.5 24.5 12.5 75.9 Other financial liabilities designated at fair value 28.1 0.4 0.5 0.4 7.1 36.5 Total financial liabilities measured at fair value through profit or loss 239.0 11.9 14.0 24.9 19.6 309.4 Total 821.6 34.0 63.9 85.0 59.6 1,064.2 Guarantees, commitments and forward starting transactions Loan commitments 7 38.3 0.5 0.7 0.0 39.5 Guarantees 21.2 0.0 21.2 Forward starting transactions, reverse repurchase and securities borrowing agreements 7 1.4 1.4 Total 60.9 0.5 0.7 0.0 0.0 62.1 31.12.20 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.1 2.4 2.1 0.5 0.0 11.1 Payables from securities financing transactions 5.6 0.4 0.3 0.0 0.0 6.3 Cash collateral payables on derivative instruments 37.3 37.3 Customer deposits 514.0 7.8 3.5 2.8 0.2 528.2 Funding from UBS Group AG 2 0.1 0.3 6.2 29.1 24.8 60.5 Debt issued measured at amortized cost 2 8.8 7.8 38.2 24.5 8.9 88.2 Other financial liabilities measured at amortized cost 5.3 0.1 0.5 2.0 1.8 9.6 of which: lease liabilities 0.1 0.1 0.5 2.0 1.8 4.4 Total financial liabilities measured at amortized cost 577.2 18.9 50.7 58.8 35.8 741.3 Financial liabilities at fair value held for trading 3,4 33.6 33.6 Derivative financial instruments 3,5 161.1 161.1 Brokerage payables designated at fair value 38.7 38.7 Debt issued designated at fair value 6 21.9 16.8 7.1 9.2 6.0 61.0 Other financial liabilities designated at fair value 27.9 0.6 0.6 0.7 4.6 34.3 Total financial liabilities measured at fair value through profit or loss 283.2 17.4 7.7 9.8 10.6 328.8 Total 860.3 36.3 58.4 68.6 46.4 1,070.0 Guarantees, commitments and forward starting transactions Loan commitments 7 40.5 0.5 0.4 0.0 41.4 Guarantees 17.5 17.5 Forward starting transactions, reverse repurchase and securities borrowing agreements 7 3.2 3.2 Total 61.3 0.5 0.4 0.0 0.0 62.2 1 Except for financial liabilities at payments. that would have to be paid if these positions had to be settled 30.8 USD 32.6 0.9 1.0 0 0 34 (31 December 2020: USD 32 full contractual committed amount of USD 36.0 31.3 by reference 7 Excludes derivative loan commitments and forward starting reverse repurchase agreements measured at fair value |
Interest rate benchmark reform
Interest rate benchmark reform | 12 Months Ended |
Dec. 31, 2021 | |
Schedule Interest Rate Benchmark Reform [Table] | |
Disclosure of how entity is managing transition to alternative benchmark rates, its progress at reporting date and risks to which it is exposed arising from financial instruments because of transition [text block] | Note 25 Background A market-wide reform of major interest rate benchmarks is being undertaken FCA) announcing in Interbank Offered Rates (LIBORs) would cease after 31 December 2021 for two-month USD tenors will cease immediately after 30 June 2023. The majority of UBS’s IBOR exposure was linked and USD LIBOR. The LIBOR is the Swiss Average Rate Overnight (SARON). The ARR for USD addition, there are recommended ARRs for GBP LIBOR, JPY LIBOR and EUR LIBOR. The 2019, calculation are not considered throughout the rest of this Note. On 25 January 2021, the IBOR Fallbacks Fallbacks Derivatives Association (ISDA) derivatives to incorporate IBORs, non-cleared derivatives ISDA definitions adhered to the protocol in November 2020. UBS’s contracts via bi-lateral industry (e. g., the and through etc.). UBS of Furthermore, , UBS implemented IBORs. Governance over the transition to alternative benchmark rates UBS governance structure and complexity of by business divisions program each business division, each overseen monthly steering joint Audit and Risk with an increased US remaining USD LIBOR transition. Risks A core management reform and transition. These the following: – economic risks to UBS and its existing pricing information, market uncertainty or disruption; – accounting treatment, income statement volatility; – valuation risks arising from the variation between benchmarks that will cease instruments; – operational risks processes data sourcing and processing and bulk migration of contracts; and – legal clients products referencing benchmarks that will cease. Overall, the effort required to transition is affected by multiple factors, including multiple stakeholders listed – such - equivalent products – and a ARR transparency, oversight and operational preparedness to progress with the significant progress made as have and strategy Transition progress Non-derivative instruments UBS’s significant non-derivative exposures subject to IBOR reform primarily corporate and USD LIBOR-linked deposits to SARON. SARON-based mortgages and corporate loans based on all major ARRs in the US market. Throughout private remaining their first roll date in 2022. In addition, as transition of - linked non - derivative liabilities originated in the US, which transitioned In the UBS communication LIBOR, with the objective through the activation of existing fallbacks contractual terms where such mortgages were reduced to USD 21 mortgages automatically coupon roll date. The US urities - based to , amounting 37 the linked to USD LIBOR planned As of 3 equivalent of issued not called on their on fallback language and mechanics will and in and by UBS not those bonds in advance of their reset dates, with Swiss franc-denominated benchmark 2022. These debt instruments on the following page, given their current fixed-rate coupon. As of 5 of irrevocable commitments that may currencies with IBOR-linked interest relevant benchmark cessation 3 of LIBOR , and USD 2 of commitments retained a non - USD as of 31 December with transition extent non-USD IBOR-linked contracts, legislative solutions. Derivative instruments UBS holds derivatives those designated in hedge accounting relationships. A significant number legs that reform. The majority of derivatives in linked derivatives substantially completed had exchange - traded through activities by December 2021. For transacted exchanges, counterparties have adhered to the ISDA IBOR Fallbacks Protocol, which builds in had of transition time of cessation. Financial instruments yet to transition to alternative benchmarks The instrument has material transitioned to ARRs, and that: – contractually transition to an alternative benchmark; and – have contracts) after the agreed cessation dates. Contracts where penalty exposure to have not been included, impact on the transition process. In line with information provided parties includes the to the Group that are subject to interest rate benchmark reform: – gross instruments; – total trade count for derivative financial instruments. The s included in maximum rights, preferences and investment decisions. As of in transitioning LIBOR LIBOR-linked relate to derivatives that successfully transitioned in January 2022 and SARON on their first roll date in 2022. 31.12.21 LIBOR benchmark rates Measure CHF USD GBP EUR 1 JPY Carrying value of non-derivative financial instruments Total non-derivative financial assets USD million 21,616 2 65,234 3 45 4 1 0 Total non-derivative financial liabilities USD million 27 4 1,985 4 3 4 5 0 Trade count of derivative financial instruments Total derivative financial instruments Trade count 829 6 40,500 7 183 6 3,744 6 184 6 Off-balance sheet exposures Total irrevocable loan commitments USD million 0 11,863 8 0 0 0 1 Relates primarily to EUR LIBOR positions. and brokerage accounts, amounting to USD 37 5 1 credit lines, where IBOR transition efforts are complete, except for USD LIBOR. The remainder primarily relates to US mortgages and corporate lending. can reset to rates linked to transitioned in January 2022, and an insignificant amount of cleared derivatives, where the respective clearing houses’ organized transition happened in January 2022. 5,000 derivatives, of which approximately 500 swaps with an ARR leg 3 remaining and approximately USD 2 that can be drawn in US dollars only and will transition in 2022–2023. |
UBS AG | |
Schedule Interest Rate Benchmark Reform [Table] | |
Disclosure of how entity is managing transition to alternative benchmark rates, its progress at reporting date and risks to which it is exposed arising from financial instruments because of transition [text block] | Note 25 Background A market-wide reform of major interest rate benchmarks is being undertaken FCA) announcing in Interbank Offered Rates (LIBORs) would cease after 31 December 2021 for two-month USD tenors will cease immediately after 30 June 2023. The LIBOR and USD LIBOR. CHF LIBOR is for USD LIBOR is the Secured Overnight Financing Rate (SOFR); in addition, there are recommended ARRs for GBP LIBOR, JPY LIBOR and EUR LIBOR. The 2019, calculation are not considered throughout the rest of this Note. On 25 January 2021, the IBOR Fallbacks Fallbacks Derivatives Association (ISDA) derivatives to incorporate IBORs, non-cleared derivatives ISDA adhered to the protocol in November 2020. UBS AG’s focus throughout contracts via bi-lateral industry (e. g., the and through etc . ). UBS AG h as transition provisions. Furthermore, in line has implemented a framework to limit new contracts referencing IBORs. Governance over the transition to alternative benchmark rates UBS AG established - divisional, - functional governance structure and complexity of by business The program includes each business division, each overseen monthly steering joint Audit and Risk with an increased US remaining USD LIBOR transition. Risks A management reform and transition. These the following: – economic risks to UBS AG of existing contracts, reduced transparency and pricing information, market uncertainty or disruption; – accounting treatment, income statement volatility; – valuation risks arising from the variation between benchmarks that will cease instruments; – operational back e.g. , data contracts; and – legal and conduct risks relating to UBS AG’s engagement with clients products referencing benchmarks that will cease. Overall, the effort required to transition is affected by multiple factors, including multiple stakeholders listed – such - equivalent products – and a ARR market transparency, oversight and operational preparedness to progress with the significant have and strategy Transition progress Non-derivative instruments UBS reform primarily d to balances, corporate CHF and USD LIBORs. During 2020, UBS AG transitioned most of its CHF AG launched on mortgages in the US market. Throughout 2021, private remaining their first roll date in 2022. In addition, as the liabilities originated in the US, which transitioned In the cessation communication LIBOR, with the objective through the activation of existing fallbacks contractual terms where such mortgages were reduced to USD 21 mortgages automatically coupon roll date. The US - based to , amounting 37 the linked to USD LIBOR planned As of 3 billion funding from UBS Group AG that, if directly on IBOR calculation mechanics will be communicated as market standards formalize and US dollar - and Swiss - denominated contracts funding from IBORs, UBS AG aims dates, completed been current fixed-rate coupon. As of 5 billion of different currencies with IBOR-linked after ; approximately USD 3 except USD , and USD 2 commitments retained a with transition the these contracts, UBS AG will seek to renegotiate current terms or rely on legislative solutions. Derivative instruments UBS including those significant number of interest rate and cross-currency swaps floating legs to IBOR reform. The majority of derivatives in linked derivatives substantially completed AG had also completed the transition of all non-USD IBOR-linked exchange - traded through activities organized by December 2021. For exchanges, counterparties have adhered to the ISDA IBOR Fallbacks Protocol, which builds in had of transition time of cessation. Financial instruments yet to transition to alternative benchmarks The instrument UBS AG has material exposures subject not yet transitioned to ARRs, and that: – contractually transition to an alternative benchmark; and – have contracts) after the agreed cessation dates. Contracts where penalty s, exposure to have not been included, impact on the transition process. In line with information provided parties monitoring UBS AG’s includes the to UBS AG that are subject to interest rate benchmark reform: – gross instruments; – total trade count for derivative financial instruments. The s included in maximum rights, preferences and investment decisions. As AG ha d made progress in transitioning LIBOR exposures to ARRs. The remaining non-USD primarily o that successfully January 2022 transition to SARON on their first roll date in 2022. 31.12.21 LIBOR benchmark rates Measure CHF USD GBP EUR 1 JPY Carrying value of non-derivative financial instruments Total non-derivative financial assets USD million 21,616 2 65,234 3 45 4 1 0 Total non-derivative financial liabilities USD million 27 4 1,985 4 3 4 5 0 Trade count of derivative financial instruments Total derivative financial instruments Trade count 829 6 40,500 7 183 6 3,744 6 184 6 Off-balance sheet exposures Total irrevocable loan commitments USD million 0 11,863 8 0 0 0 1 Relates primarily to EUR LIBOR positions. and brokerage accounts, amounting to USD 37 5 1 credit lines, where IBOR transition efforts are complete, except for USD LIBOR. The remainder primarily relates to US mortgages and corporate lending. can reset to rates linked to transitioned in January 2022, and an insignificant amount of cleared derivatives, where the respective clearing houses’ organized transition happened in January 2022. 5,000 derivatives, of which approximately 500 swaps with an ARR leg 3 remaining and approximately USD 2 that can be drawn in US dollars only and will transition in 2022–2023. |
Hedge accounting
Hedge accounting | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of General Hedge Accounting Explanatory | Note 26 Derivatives designated in hedge accounting relationships The foreign exchange related to net investments in foreign operations. › Refer to “Market risk” in the “Risk management section of this report for more information about and how they are managed by the Group Hedging instruments and hedged risk Interest flow benchmark interest rates. are usually the largest component value of the hedged position in transaction currency. Cross-currency foreign exchange foreign operations. changes in spot foreign exchange rate. The notional the notional swaps are hedge sensitivity. Hedged items and hedge designation Fair value hedges of interest rate risk related to debt instruments and loan assets Fair value hedges of interest and loan assets involve the debt issued, assets francs formerly designated within “Fair interest floating cash flows by receive receive floating cash flows. Designations francs, Australian dollars, Japanese new hedging into in 2021 in these benchmark rate was the relevant alternative reference rate (ARR). Following the with 2021, yen designations was changed ARR with Interest IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16) . Fair designated under IAS 39 Prior to December 2021, the Group long-term fixed-rate mortgage loans in rate swaps that rate instruments were adjusted in month the designated. being originated or loans being repaid. Cash flow hedges of forecast transactions The assets expected movements future cash flows, representing are projected on the basis of factors, aggregate portfolios over time form the interest rate risk of the Group, which is hedged with interest rate swaps, forecasts ongoing basis, and are traded and designated, or are terminated resulting discontinuance. following sterling dollars, Swiss replaced with new ARR designations in December 2021. › Refer to Note 1b Fair value hedges of foreign exchange risk related to issued debt instruments Debt dollar exchange hedges convert debt denominated in currencies to 1 January requirements of IFRS 9, Financial Instruments, › Refer to Note 1b Hedges of net investments in foreign operations The Group applies in associates. Upon months, designations investments in foreign operations. Economic relationship between hedged item and hedging instrument For between determined based on In cases where hedge designation takes place after origination of the behavior of their respective terms is also performed. Prior to interest rate risk related to loans designated under IAS 39, hedge effectiveness was assessed by of designated benchmark value of the interest rate swaps. Sources of hedge ineffectiveness In from curves entering hedging derivative In hedge hedging instruments and undesignated risk components and of such discounting and risk components in the hedged items. In ineffectiveness is unlikely unless the hedged the designated hedged the foreign ineffectiveness. Hedge ineffectiveness from fair value through profit Other net income. Derivatives not designated in hedge accounting relationships Non-hedge accounted derivatives with Other financial instruments measured , even clearing. The short- economic hedges, which are reported in Net interest income. All hedges: designated hedging instruments As of or for the year ended 31.12.21 Carrying amount USD million Notional amount Derivative financial assets Derivative financial liabilities Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Interest rate risk Fair value hedges 89,525 0 7 (1,604) 1,602 (2) Cash flow hedges 79,573 12 1 (1,185) 990 (196) Foreign exchange risk Fair value hedges 2 27,875 87 261 (2,139) 2,181 42 Hedges of net investments in foreign operations 13,939 23 105 497 (497) 0 As of or for the year ended 31.12.20 Carrying amount USD million Notional amount Derivative financial assets Derivative financial liabilities Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Interest rate risk Fair value hedges 80,759 12 1,231 (1,247) (16) Cash flow hedges 72,732 18 2,213 (2,012) 201 Foreign exchange risk Fair value hedges 2 21,555 449 7 (1,735) 1,715 (20) Hedges of net investments in foreign operations 13,775 3 194 (937) 936 (2) 1 Amounts used accounting designation and accounted for as a cost of hedging with amounts deferred in Other comprehensive income within Equity. Fair value hedges: designated hedged items USD million 31.12.21 31.12.20 Interest rate risk FX risk Interest rate risk FX risk Debt issued measured at amortized cost Carrying amount of designated debt issued 74,700 27,875 70,429 21,555 478 2,401 Other financial assets measured at amortized cost – debt securities Carrying amount of designated debt securities 2,677 3,242 (7) (38) Loans and advances to customers 1 Carrying amount of designated loans 13,835 10,374 of which: accumulated amount of fair value hedge adjustment 2 (109) 100 of which: accumulated amount of fair value hedge adjustment subject portfolio that ceased to be part of hedge accounting 2 3 111 1 Prior to 31 December 2021, these amounts were designated in fair value hedges of portfolio interest rate risk under IAS 39. customers, whereas prior to 1 January 2021 amounts were presented within either Other financial assets Fair value hedges: profile of the timing of the 31.12.21 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 0 8 10 49 22 90 Cross-currency swaps 1 1 6 13 6 28 31.12.20 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 1 0 4 9 46 12 70 Cross-currency swaps 0 0 4 16 2 22 1 In accordance with IFRS 7 requirements, the fair value hedges of portfolio interest rate risk Cash flow hedge reserve on a pre-tax basis USD million 31.12.21 31.12.20 Amounts related to hedge relationships for which hedge 26 2,560 Amounts related to hedge relationships for which hedge 743 296 Total other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis 769 2,856 Foreign currency translation reserve on a pre-tax basis USD million 31.12.21 31.12.20 Amounts related to hedge relationships for which hedge (45) (559) Amounts related to hedge relationships for which hedge 262 268 Total other comprehensive income recognized directly in equity related to hedging instruments basis 217 (291) Interest rate benchmark reform The Group continues to apply the relief provided Interest Rate Benchmark published by the IASB in September 2019. The benchmark were LIBOR, JPY swaps and JPY LIBOR transitioned to ARRs transitioned remain available, but all such, designations as IBOR contracts mature. The Group’s hedge Inter-bank Offered Rate (EURIBOR), which to exist as a benchmark rate for the foreseeable future. Thus, the Group benchmark benchmark reform. Apart from fair value relationships following carrying relationships maturing after 31 December 2021, or 30 June 2023 for applicable interest rate benchmarks. Hedges affected by the amendments. › Refer to Note 1a item 2j for more information about the relief provided by the amendments to IFRS 9, IAS to interest rate benchmark reform › Refer to Note 25 Interest rate benchmark reform information about the transition progress Hedging instruments referencing LIBOR 31.12.21 31.12.20 Carrying amount Carrying amount USD million Notional amount Derivative financial assets Derivative financial liabilities Notional amount Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 23,367 0 0 37,146 1 (12) Cash flow hedges 10,803 0 0 11,179 0 0 |
UBS AG | |
Entity [Table] | |
Disclosure Of General Hedge Accounting Explanatory | Note 26 Hedge accounting Derivatives designated in hedge accounting relationships UBS AG applies hedge exchange risk including structural net investments in foreign operations. › Refer to “Market risk” in the “Risk management section of this report for more information about and how they are managed by UBS AG Hedging instruments and hedged risk Interest flow benchmark interest rates. are usually the largest value of the hedged position in transaction currency. Cross-currency foreign exchange foreign operations. changes in spot foreign exchange rate. The notional the notional swaps are hedge sensitivity. Hedged items and hedge designation Fair value hedges of interest rate risk related to debt instruments and loan assets Fair value hedges of interest and loan assets involve the debt issued, assets francs formerly designated within “Fair interest floating cash flows by receive receive floating cash flows. Designations francs, Australian dollars, Japanese new hedging into in 2021 in these benchmark rate was the Following the with 2021, yen designations was changed ARR with Interest Rate Benchmark Reform 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16) . Fair designated under IAS 39 Prior long-term fixed-rate mortgage loans in rate swaps that rate instruments were adjusted in month the designated. being originated or loans being repaid. Cash flow hedges of forecast transactions UBS assets expected movements future cash flows, representing are projected on the basis of factors, aggregate portfolios over time form the interest swaps, forecasts ongoing basis, and are traded and designated, or are terminated resulting discontinuance. following : US , sterling dollars, Swiss replaced with new ARR designations in December 2021. Fair value hedges of foreign exchange risk related to issued debt instruments Debt dollar are exchange hedges convert debt denominated in currencies to dollars . 1 January requirements of IFRS 9, Financial Instruments, › Refer to Note 1b Hedges of net investments in foreign operations UBS AG applies foreign , which associates. Upon months, hedge relationship designations investments in foreign operations. Economic relationship between hedged item and hedging instrument For between determined based on In cases where hedge designation takes place after origination of the behavior of their respective terms is also performed. Prior to interest rate risk related to loans designated under IAS 39, hedge effectiveness was assessed by of designated benchmark value of the interest rate swaps. Sources of hedge ineffectiveness In from curves entering hedging derivative In hedge hedging instruments and undesignated risk components and of such discounting and risk components in the hedged items. In ineffectiveness is unlikely unless the hedged the designated hedged the foreign ineffectiveness. Hedge ineffectiveness from fair value through profit Other net income. Derivatives not designated in hedge accounting relationships Non-hedge accounted derivatives with Other financial instruments measured , even clearing. The short- economic hedges, which are reported in Net interest income All hedges: designated hedging instruments As of or for the year ended 31.12.21 USD million Notional amount Carrying amount Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 89,525 0 7 (1,604) 1,602 (2) Cash flow hedges 79,573 12 1 (1,185) 990 (196) Foreign exchange risk Fair value hedges 2 27,875 87 261 (2,139) 2,181 42 Hedges of net investments in foreign operations 13,761 23 103 492 (491) 0 As of or for the year ended 31.12.20 USD million Notional amount Carrying amount Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 80,759 12 1,231 (1,247) (16) Cash flow hedges 72,732 18 2,213 (2,012) 201 Foreign exchange risk Fair value hedges 2 21,555 449 7 (1,735) 1,715 (20) Hedges of net investments in foreign operations 13,634 3 193 (939) 938 (2) 1 Amounts used accounting designation and accounted for as a cost of hedging with amounts deferred in Other comprehensive income within Equity. Fair value hedges: designated hedged items USD million 31.12.21 31.12.20 Interest rate risk FX risk Interest rate risk FX risk Debt issued measured at amortized cost Carrying amount of designated debt issued 21,653 11,392 24,247 10,889 261 761 Funding from UBS Group AG Carrying amount of designated debt instruments 53,047 16,483 46,182 10,666 218 1,640 Other financial assets measured at amortized cost – debt securities Carrying amount of designated debt securities 2,677 3,242 (7) (38) Loans and advances to customers 1 Carrying amount of designated loans 13,835 10,374 of which: accumulated amount of fair value hedge adjustment 2 (109) 100 of which: accumulated amount of fair value hedge adjustment subject portion of the portfolio that ceased to be part of hedge 2 3 111 1 Prior to 31 December 2021, these amounts were designated in fair value customers, whereas prior to 1 January 2021 amounts were presented within either Other financial assets Fair value hedges: profile of the timing of the 31.12.21 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 0 8 10 49 22 90 Cross-currency swaps 1 1 6 13 6 28 31.12.20 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 1 0 4 9 46 12 70 Cross-currency swaps 0 0 4 16 2 22 1 In accordance with IFRS 7 requirements, the fair value hedges of portfolio interest rate risk Cash flow hedge reserve on a pre-tax basis USD million 31.12.21 31.12.20 Amounts related to hedge relationships for which hedge 26 2,560 Amounts related to hedge relationships for which hedge 743 296 Total other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis 769 2,856 Foreign currency translation reserve on a pre-tax basis USD million 31.12.21 31.12.20 Amounts related to hedge relationships for which hedge (569) Amounts related to hedge relationships for which hedge 268 Total other comprehensive income recognized directly in equity related to hedging instruments basis 201 (302) Interest rate benchmark reform UBS Interest Benchmark published by the IASB in September 2019. The benchmark were LIBOR, JPY swaps and JPY LIBOR transitioned to ARRs transitioned remain available, but all such, designations as IBOR contracts mature. UBS Inter-bank Offered Rate (EURIBOR), which to exist as a benchmark rate for the foreseeable future. Thus, the Group benchmark benchmark reform. Apart from its fair hedge relationships where the following carrying relationships maturing after 31 December 2021, or 30 June 2023 for applicable interest rate benchmarks. Hedges affected by the amendments. › Refer to Note 1a item 2j for more information about the relief provided by the amendments to IFRS 9, IAS to interest rate benchmark reform › Refer to Note 25 Interest rate benchmark reform information about the transition progress Hedging instruments referencing LIBOR 31.12.21 31.12.20 Carrying amount Carrying amount USD million Notional amount Derivative financial assets Derivative financial liabilities Notional amount Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 23,367 0 0 37,146 1 (12) Cash flow hedges 10,803 0 0 11,179 0 0 |
Post-employment benefit plans
Post-employment benefit plans | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Post-employment benefit plans [text block] | Note 27 a) Defined benefit plans UBS various s in practices. US plan rules. Swiss pension plan The Swiss employees in Switzerland close minimum Swiss plan offers retirement, disability and survivor benefits governed by a this board are defined by Swiss pension law and the plan rules. Savings employer and employee. Depending on the age of the UBS pays 6.5 % and 27.5 % of contributory base salary 2.8 % and 9 % of contributory contributions that Employees can them, which vary between 2.5 % and 13.5 % of contributory base salary 0 % 9 % variable compensation, contribution category. The plan offers to 65 a choice between payment. Participants draw benefits 58 , employment and remain active members of 70 . purchases of benefits to fund early retirement benefits. The pension applying participant’s The balance is based on credited vested benefits transferred from previous employers, purchases of benefits, and the employer contributions that have retirement annual interest rate Pension Foundation Board at the end of each year. Although promise under Swiss pension law, it is accounted for as a defined benefit accrue and the payment of lifetime pension benefits. An actuarial valuation in accordance with Swiss pension law is performed basis occur, the Pension Foundation Board is required to necessary measures to be 10 plan pension contributions could be required. between employer and obliged to 50 % of required. As of funding 134.8 % (31 December 2020: 132.6 %). The investment strategy of the Swiss plan complies with Swiss pension diversification of plan assets, defined by the Pension performed asset and Foundation between assets and liabilities. As situation on plan’s USD 6,577 4,862 million). sheet to economic present present value of the estimated of estimated defined benefit asset was recognized on the balance sheet. Changes to the Swiss pension plan in 2019 The measures that long-term measures, among increased already in payment on 1 January 2019 were not affected. To mitigate the to 720 (USD 790 2021) installments of USD 235 254 and 2021 reduced OCI with no effect on the income statement. The third installment, CHF 193 212 closing exchange rate on 31 December 2021), will first made to the Swiss plan 491 UK pension plan The UK benefits increase normal retirement 60 . The plan provides guaranteed lifetime upon retirement. for more than accruing benefits for current or participate in the UK defined contribution plan. The governance the Pension to contributions, recent Pension Trustee and the plan funding contributions to the funding contributions of USD 46 The financial assets, which insurance hedge should mitigate volatility in the net defined As of 31 of USD 3 In 2019, arrangement whereby a collateral security for the of 31 December 2021 was USD 337 USD 347 related and . arrangement provides the to a pool of assets in the event of UBS’s insolvency a required deficit funding contribution. The benefit 5 regular funding reviews during the year. US pension plans There are two distinct major defined benefit plans in the US, a 65 . Both entrants employees have participated in a defined contribution plan. One of the in retirement credited annually the other defined the Former employees with vested benefits have the option to take a lump sum payment or a lifetime annuity. As fiduciaries governance of the plans. The portfolio s of ch responsible for the assets. The benefit plans in 2022 are estimated at USD 10 German pension plans There are two unfunded. The normal retirement age is 65 directly accrues The accumulated account an annual basis 5 %. The has been closed the amounts related to variable account balance is credited on an annual basis interest rate of 6 % for amounts accrued before 2010, of 4 % for amounts accrued 0.9 % for accrued law, whereby the responsibility to are payments is directly increased in line with price inflation. In June with interest returns 0 %. implemented for all eligible active participants Each savings account. The employer contributions benefit plans in 2022 are estimated at USD 12 Financial information by plan The movement sheet for defined benefit plans, as well as an analysis of amounts recognized in net profit and in Other comprehensive incom e. Defined benefit plans USD million Swiss pension plan UK pension plan US and German pension plans Total 2021 2020 2021 2020 2021 2020 2021 2020 Defined benefit obligation at the beginning of the year 27,728 24,496 4,162 3,654 1,905 1,820 33,795 29,970 Current service cost 494 447 0 0 6 6 500 453 Interest expense 58 72 58 73 30 45 147 190 Plan participant contributions 266 259 0 0 0 0 266 259 Remeasurements 837 1,279 71 449 (62) 105 846 1,832 of which: actuarial (gains) / losses due to changes in demographic 51 (164) 14 (14) 4 (34) 69 (212) of which: actuarial (gains) / losses due to changes in financial (678) 983 (3) 505 (78) 134 (759) 1,621 of which: experience (gains) / losses 1 1,464 460 59 (42) 12 5 1,535 423 Past service cost related to plan amendments 0 0 0 3 4 0 4 3 Curtailments (80) 0 0 0 0 0 (80) 0 Benefit payments (1,097) (1,153) (148) (148) (112) (108) (1,357) (1,409) Other movements 0 (4) 0 0 1 0 1 (4) Foreign currency translation (809) 2,333 (38) 132 (33) 37 (880) 2,501 Defined benefit obligation at the end of the year 27,398 27,728 4,105 4,162 1,740 1,905 33,242 33,795 of which: amounts owed to active members 14,333 13,765 150 159 222 245 14,705 14,169 of which: amounts owed to deferred members 0 0 1,593 1,879 669 743 2,262 2,622 of which: amounts owed to retirees 13,065 13,963 2,362 2,124 849 917 16,276 17,004 of which: funded plans 27,398 27,728 4,105 4,162 1,222 1,319 32,724 33,209 of which: unfunded plans 0 0 0 0 518 586 518 586 Fair value of plan assets at the beginning of the year 32,590 28,219 4,149 3,658 1,360 1,299 38,100 33,176 Return on plan assets excluding interest income 2,322 1,818 277 388 40 118 2,639 2,324 Interest income 74 84 58 73 26 38 159 196 Employer contributions 763 729 0 46 16 17 779 792 Plan participant contributions 266 259 0 0 0 0 266 259 Benefit payments (1,097) (1,153) (148) (148) (112) (108) (1,357) (1,409) Administration expenses, taxes and premiums paid (13) (13) 0 0 (4) (4) (17) (17) Other movements 0 0 0 0 1 0 1 0 Foreign currency translation (930) 2,647 (39) 132 0 0 (969) 2,779 Fair value of plan assets at the end of the year 33,975 32,590 4,297 4,149 1,329 1,360 39,601 38,100 Surplus / (deficit) 6,577 4,862 192 (13) (411) (545) 6,358 4,304 Asset ceiling effect at the beginning of the year 4,862 3,724 0 0 0 0 4,862 3,724 Interest expense on asset ceiling effect 15 12 0 0 0 0 15 12 Asset ceiling effect excluding interest expense and foreign currency asset ceiling effect 1,821 814 0 0 0 0 1,821 814 Foreign currency translation (121) 313 0 0 0 0 (121) 313 Asset ceiling effect at the end of the year 6,577 4,862 0 0 0 0 6,577 4,862 Net defined benefit asset / (liability) of major plans 0 0 192 (13) (411) (545) (219) (558) Net defined benefit asset / (liability) of remaining plans (112) (123) Total net defined benefit asset / (liability) (331) (680) of which: Net defined benefit asset 302 42 of which: Net defined benefit liability 2 (633) (722) 1 Experience (gains) / occurred. Income statement – expenses related to defined benefit plans 1 USD million Swiss pension plan UK pension plan US and German pension plans Total For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Current service cost 494 447 0 0 6 6 500 453 Interest expense related to defined benefit obligation 58 72 58 73 30 45 147 190 Interest income related to plan assets (74) (84) (58) (73) (26) (38) (159) (196) Interest expense on asset ceiling effect 15 12 0 0 0 0 15 12 Administration expenses, taxes and premiums paid 13 13 0 0 4 4 17 17 Past service cost related to plan amendments 0 0 0 3 4 0 4 3 Curtailments (80) 0 0 0 0 0 (80) 0 Net periodic expenses recognized in net profit for major plans 426 459 0 3 18 18 444 479 Net periodic expenses recognized in net profit for remaining plans 2 25 23 Total net periodic expenses recognized in net profit 470 502 1 Refer to Note 6. Other comprehensive income – gains / (losses) on defined benefit plans USD million Swiss pension plan UK pension plan US and German pension plans Total For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Remeasurement of defined benefit obligation (837) (1,279) (71) (449) 62 (105) (846) (1,832) of which: change in discount rate assumption 870 (777) 319 (504) 77 (141) 1,267 (1,421) of which: change in rate of salary increase assumption (3) (230) 0 0 0 0 (3) (230) of which: change in rate of pension increase assumption 0 0 (316) (1) (1) 1 (318) 0 of which: change in rate of interest credit on retirement savings (193) 26 0 0 (1) 24 (194) 50 of which: change in life expectancy 0 261 9 22 (3) 50 5 333 of which: change in other actuarial assumptions (47) (99) (23) (8) 2 (34) (68) (142) of which: experience gains / (losses) 1 (1,464) (460) (59) 42 (12) (5) (1,535) (423) Return on plan assets excluding interest income 2,322 1,818 277 388 40 118 2,639 2,324 Asset ceiling effect excluding interest expense and foreign currency (1,821) (814) 0 0 0 0 (1,821) (814) Total gains / (losses) recognized in other comprehensive income for major plans (336) (276) 207 (61) 103 14 (27) (323) Total gains / (losses) recognized in other comprehensive income for remaining plans 30 (4) Total gains / (losses) recognized in other comprehensive income 2 2 (327) 1 Experience (gains) / occurred. The table below provides information about the duration of the DBO and the timing for expected benefit payments. Swiss pension plan UK pension plan US and German pension plans 1 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Duration of the defined benefit obligation (in years) 15.1 15.7 18.8 19.0 9.5 10.2 Maturity analysis of benefits expected to be paid USD million Benefits expected to be paid within 12 months 1,312 1,293 110 114 123 122 Benefits expected to be paid between 1 and 3 years 2,636 2,630 248 232 237 235 Benefits expected to be paid between 3 and 6 years 3,824 3,839 418 406 338 346 Benefits expected to be paid between 6 and 11 years 6,220 6,166 743 744 495 532 Benefits expected to be paid between 11 and 16 years 5,572 5,646 751 758 392 413 Benefits expected to be paid in more than 16 years 18,092 18,884 3,028 3,206 519 541 1 The duration of the defined benefit obligation represents a weighted average across US and Actuarial assumptions The actuarial assumptions based on the economic conditions prevailing in the jurisdiction in which they are offered. Changes are most rate is based on the yield of high-quality corporate bonds quoted in decrease in reviews the actuarial assumptions used determine their continuing relevance. › Refer to Note 1a item 5 for a description for defined benefit plans The tables below show the significant actuarial assumptions used in calculating the DBO at the end of the year Significant actuarial assumptions Swiss pension plan UK pension plan US and German pension plans 1 In % 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Discount rate 0.34 0.10 1.82 1.42 2.10 1.62 Rate of salary increase 2.01 2.00 0.00 0.00 2.35 2.25 Rate of pension increase 0.00 0.00 3.32 2.89 1.80 1.70 Rate of interest credit on retirement savings 1.04 0.60 0.00 0.00 1.18 1.12 1 Represents weighted average assumptions across US and German plans. Mortality tables and life expectancies for Life expectancy at age 65 for a male member currently aged 65 aged 45 Country Mortality table 31.12.21 31.12.20 31.12.21 31.12.20 Switzerland BVG 2020 G with CMI 2019 projections 21.7 21.7 23.3 23.2 UK S3PA with CMI 2020 projections 1 23.4 23.4 24.5 24.6 USA Pri-2012 with MP-2021 projection scale 2 21.9 21.8 23.3 23.2 Germany Dr. K. Heubeck 2018 G 20.5 20.8 23.2 23.6 Life expectancy at age 65 for a female member currently aged 65 aged 45 Country Mortality table 31.12.21 31.12.20 31.12.21 31.12.20 Switzerland BVG 2020 G with CMI 2019 projections 23.4 23.4 25.0 24.9 UK S3PA with CMI 2020 projections 1 24.9 24.9 26.3 26.3 USA Pri-2012 with MP-2021 projection scale 2 23.3 23.2 24.7 24.5 Germany Dr. K. Heubeck 2018 G 23.9 24.3 26.1 26.5 1 In 2020, S3PA with CMI 2019 projections was used. Sensitivity analysis of significant actuarial assumptions The table below presents a sensitivity analysis for each significant actuarial affected were reasonably circumstances may arise, which could outside Caution should be used the DBO, as the sensitivities may not be linear. Sensitivity analysis of significant actuarial 1 Increase / (decrease) in defined benefit obligation Swiss pension plan UK pension plan US and German pension plans USD million 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Discount rate Increase by 50 basis points (1,695) (1,793) (361) (370) (78) (91) Decrease by 50 basis points 1,933 2,048 411 423 84 99 Rate of salary increase Increase by 50 basis points 109 117 – 2 – 2 0 1 Decrease by 50 basis points (104) (111) – 2 – 2 0 (1) Rate of pension increase Increase by 50 basis points 1,333 1,413 334 358 6 8 Decrease by 50 basis points – 3 – 3 (306) (316) (6) (7) Rate of interest credit on retirement savings Increase by 50 basis points 224 236 – 4 – 4 8 9 Decrease by 50 basis points (224) 5 (188) – 4 – 4 (7) (8) Life expectancy Increase in longevity by one additional year 915 1,061 184 182 56 60 1 The sensitivity analyses are based on a change in one assumption while holding all other assumptions constant, so that interdependencies between the assumptions are excluded. service, a change in assumption is not 0 % as of 31 December 2021 and as 4 As the UK plan does not provide interest 19 % of retirement savings were subject to a legal minimum 1.00 %. Fair value of plan assets The tables Composition and fair value of plan assets Swiss pension plan 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 187 0 187 1 219 0 219 1 Real estate / property Domestic 0 3,530 3,530 10 0 3,582 3,582 11 Foreign 0 580 580 2 0 331 331 1 Investment funds Equity Domestic 843 0 843 2 826 0 826 3 Foreign 6,213 2,652 8,865 26 6,284 1,958 8,242 25 Bonds 1 Domestic, AAA to BBB– 4,446 0 4,446 13 3,721 0 3,721 11 Foreign, AAA to BBB– 5,093 0 5,093 15 6,146 0 6,146 19 Foreign, below BBB– 1,314 0 1,314 4 1,303 0 1,303 4 Other 4,211 3,558 7,769 23 3,363 3,722 7,085 22 Other investments 668 682 1,349 4 663 473 1,136 3 Total fair value of plan assets 22,973 11,002 33,975 100 22,525 10,065 32,590 100 31.12.21 31.12.20 Total fair value of plan assets 33,975 32,590 of which: 2 Bank accounts at UBS 194 231 UBS debt instruments 28 34 UBS shares 25 24 Securities lent to UBS 3 1,079 1,416 Property occupied by UBS 93 96 Derivative financial instruments, counterparty UBS 3 128 149 1 The bond credit ratings from other rating positions disclosed in the table encompass both direct investments in UBS instruments and indirect investments, i.e., those made through funds that the pension fund invests in. financial instruments are amounted to USD 43 17 Composition and fair value of plan assets UK pension plan 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 147 0 147 3 195 0 195 5 Bonds 1 Domestic, AAA to BBB– 2,605 0 2,605 61 2,150 0 2,150 52 Foreign, AAA to BBB– 372 0 372 9 53 0 53 1 Foreign, below BBB– 4 0 4 0 0 0 0 0 Investment funds Equity Domestic 44 4 47 1 34 3 37 1 Foreign 921 0 921 21 1,077 0 1,077 26 Bonds 1 Domestic, AAA to BBB– 532 147 679 16 919 131 1,050 25 Domestic, below BBB– 12 0 12 0 47 0 47 1 Foreign, AAA to BBB– 179 0 179 4 149 0 149 4 Foreign, below BBB– 115 0 115 3 110 0 110 3 Real estate Domestic 110 12 122 3 98 16 114 3 Foreign 6 34 40 1 0 37 37 1 Other (313) 0 (313) (7) (86) 0 (86) (2) Insurance contracts 0 8 8 0 0 8 8 0 Derivatives 57 (3) 54 1 (3) 0 (3) 0 Asset-backed securities 0 11 11 0 0 6 6 0 Other investments 2 (717) 10 (707) (16) (803) 9 (794) (19) Total fair value of plan assets 4,074 223 4,297 100 3,940 209 4,149 100 1 The bond credit ratings from other rating agencies were used, these were converted to the equivalent rating in S&P’s US and German pension plans 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 11 0 11 1 38 0 38 3 Equity Domestic 79 0 79 6 0 0 0 0 Foreign 31 0 31 2 0 0 0 0 Bonds 1 Domestic, AAA to BBB– 486 0 486 37 490 0 490 36 Domestic, below BBB– 17 0 17 1 7 0 7 0 Foreign, AAA to BBB– 97 0 97 7 99 0 99 7 Foreign, below BBB– 6 0 6 0 1 0 1 0 Investment funds Equity Domestic 3 0 3 0 210 0 210 15 Foreign 56 0 56 4 169 0 169 12 Bonds 1 Domestic, AAA to BBB– 269 0 269 20 195 0 195 14 Domestic, below BBB– 147 0 147 11 34 0 34 2 Foreign, AAA to BBB– 11 0 11 1 19 0 19 1 Foreign, below BBB– 2 0 2 0 3 0 3 0 Real estate Domestic 0 9 9 1 0 14 14 1 Other 99 0 99 7 79 0 79 6 Insurance contracts 0 1 1 0 0 1 1 0 Other investments 5 0 5 0 0 0 0 0 Total fair value of plan assets 1,319 10 1,329 100 1,345 15 1,360 100 1 The bond credit ratings from other rating agencies were used, these were converted to the equivalent rating in S&P’s b) Defined contribution plans UBS sponsors most significant limited which and matching contributions. plans are recognized as an expense. Expenses related to defined contribution For the year ended USD million 31.12.21 31.12.20 31.12.19 US plan 198 190 173 UK plan 101 88 82 Remaining plans 64 65 71 Total 1 363 343 326 1 Refer to Note 6. c) Related-party disclosure UBS is fund of execute activities lending and borrowing UBS pension funds UBS. Also, UBS leases pension . December 202 1 , commitment leases USD 9 million (31 December 20 : USD 11 › Refer to the “Composition and fair value Note 27a for more information about fair value in UBS instruments held by the Swiss The following and to the post-employment benefit the UK, the US and arrangements. Related-party disclosure For the year ended USD million 31.12.21 31.12.20 31.12.19 Received by UBS Fees 39 34 34 Paid by UBS Rent 4 5 4 Dividends, capital repayments and interest 5 10 11 The transaction volumes in UBS shares and UBS debt instruments and the balances of UBS shares held were: Transaction volumes – UBS shares and UBS debt instruments For the year ended 31.12.21 31.12.20 Financial instruments bought by pension funds UBS shares (in thousands of shares) 907 1,758 UBS debt instruments (par values, USD million) 37 28 Financial instruments sold by pension funds or matured UBS shares (in thousands of shares) 1,688 2,605 UBS debt instruments (par values, USD million) 40 6 UBS shares held by post-employment benefit 31.12.21 31.12.20 Number of shares (in thousands of shares) 14,073 14,854 Fair value (USD million) 252 210 |
UBS AG | |
Entity [Table] | |
Post-employment benefit plans [text block] | Note 27 a) Defined benefit plans UBS AG has established defined various in egulations practices. US plan rules. Swiss pension plan The Swiss employees in Switzerland close minimum benefit requirements under Swiss pension law. In 2017, from UBS held pooled UBS AG and those transferred to AG UBS’s Swiss pension UBS defined benefit accounting, i.e., the net pension cost and the net pension proportionally between based obligations related to their employees. The Swiss and responsibilities of this board the plan rules. Savings employer and employee. Depending on the age of the UBS AG 6.5 % and 27.5 % of 2.8 % and 9 % of contributory variable compensation. UBS AG also pays contributions that Employees can them, which vary between 2.5 % and 13.5 % of contributory base salary 0 % 9 % variable compensation, and contribution category. The plan offers to 65 a choice between payment. Participants draw benefits 58 , employment and remain active members of 70 . purchases of benefits to fund early retirement benefits. The pension applying participant’s The balance is based on credited vested benefits transferred from previous employers, purchases of benefits, and the employer contributions that have retirement annual interest rate Pension Foundation Board at the end of each year Although promise under Swiss pension law, it is accounted for as a defined benefit accrue and the payment of lifetime pension benefits. An actuarial valuation in accordance with Swiss pension law is performed basis occur, the Pension Foundation Board is required to necessary measures to be 10 plan pension contributions could be required. between employer and obliged to 50 % of required. As of funding 134.8 % (31 December 2020: 132.6 %). The investment strategy of the Swiss plan complies with Swiss pension diversification of plan assets, defined by the Pension performed asset and Foundation between assets and liabilities. As situation on plan’s USD 3,716 2,739 million). sheet to economic present present value of the estimated of estimated defined benefit asset was recognized on the balance sheet. Changes to the Swiss pension plan in 2019 The Pension Foundation Board and UBS AG agreed to implement measures that long-term measures, among increased already in payment on 1 January 2019 were not affected. To for , AG committed to pay an 450 million 494 million at the on 31 December 2022. Two 143 152 paid in 2020 and statement. The third installment, CHF 116 127 closing exchange rate on 31 December 2021), will first made to the Swiss plan 277 UK pension plan The UK benefits increase normal retirement 60 . The plan provides guaranteed lifetime upon retirement. for more than accruing benefits for current or participate in the UK defined contribution plan. The governance the AG . contributions funding contributions, which most recent actuarial Pension Trustee Board and UBS AG recovery plan within no deficit funding contributions to the UK plan. In 2020, UBS AG made deficit funding contributions of USD 46 The financial assets, which insurance hedge should mitigate volatility in the net defined As of 31 of USD 3 In 2019, an provide security for pool as of 337 20 20 : 347 million ) and , government-related debt The access to a pool not paying a required deficit funding contribution. The benefit plan 5 regular funding reviews during the year. US pension plans There are two distinct major defined benefit plans in the a 65 . Both entrants employees have participated in a defined contribution plan. One of the in retirement credited annually the other defined the Former employees with vested benefits have the option to take a lump sum payment or a lifetime annuity. As fiduciaries governance of the plans. The portfolio s of cial responsible for the assets. The benefit plans in 2022 are estimated at USD 10 German pension plans There are two unfunded. The normal retirement age is 65 directly by UBS AG. In accrues The accumulated account an annual basis 5 %. The has been closed the amounts related to variable account balance is credited on an annual basis interest rate of 6 % for amounts accrued before 2010, of 4 % for amounts accrued 0.9 % for accrued law, whereby the responsibility to are payments is directly increased in line with price inflation. In plan investment returns with a guaranteed minimum of 0 %. The plan was implemented and for 2021. retirement savings account. The employer contributions benefit plans in 2022 are estimated at USD 12 Financial information by plan The movement sheet for defined benefit plans, as well as an analysis of amounts recognized in net profit and in Other comprehensive incom e. Defined benefit plans USD million Swiss pension plan UK pension plan US and German pension plans Total 2021 2020 2021 2020 2021 2020 2021 2020 Defined benefit obligation at the beginning of the year 15,619 13,809 4,162 3,654 1,905 1,820 21,686 19,283 Current service cost 285 262 0 0 6 6 291 268 Interest expense 33 40 58 73 30 45 122 159 Plan participant contributions 161 159 0 0 0 0 161 159 Remeasurements 490 677 71 449 (62) 105 498 1,231 of which: actuarial (gains) / losses due to changes in demographic 26 (53) 14 (14) 4 (34) 45 (101) of which: actuarial (gains) / losses due to changes in financial (385) 565 (3) 505 (78) 134 (466) 1,204 of which: experience (gains) / losses 1,2 848 165 59 (42) 12 5 919 127 Past service cost related to plan amendments 0 0 0 3 4 0 4 3 Curtailments (49) 0 0 0 0 0 (49) 0 Benefit payments (602) (641) (148) (148) (112) (108) (862) (898) Other movements 0 (4) 0 0 1 0 1 (4) Foreign currency translation (456) 1,317 (38) 132 (33) 37 (527) 1,486 Defined benefit obligation at the end of the year 15,480 15,619 4,105 4,162 1,740 1,905 21,324 21,686 of which: amounts owed to active members 8,604 8,290 150 159 222 245 8,976 8,694 of which: amounts owed to deferred members 0 0 1,593 1,879 669 743 2,262 2,622 of which: amounts owed to retirees 6,876 7,329 2,362 2,124 849 917 10,086 10,370 of which: funded plans 15,480 15,619 4,105 4,162 1,222 1,319 20,806 21,100 of which: unfunded plans 0 0 0 0 518 586 518 586 Fair value of plan assets at the beginning of the year 18,358 15,908 4,149 3,658 1,360 1,299 23,867 20,864 Return on plan assets excluding interest income 2 1,319 962 277 388 40 118 1,637 1,469 Interest income 42 48 58 73 26 38 127 159 Employer contributions 450 436 0 46 16 17 466 499 Plan participant contributions 161 159 0 0 0 0 161 159 Benefit payments (602) (641) (148) (148) (112) (108) (862) (898) Administration expenses, taxes and premiums paid (8) (8) 0 0 (4) (4) (11) (11) Other movements 0 0 0 0 1 0 1 0 Foreign currency translation (524) 1,495 (39) 132 0 0 (563) 1,626 Fair value of plan assets at the end of the year 19,196 18,358 4,297 4,149 1,329 1,360 24,821 23,867 Surplus / (deficit) 3,716 2,739 192 (13) (411) (545) 3,497 2,181 Asset ceiling effect at the beginning of the year 2,739 2,099 0 0 0 0 2,739 2,099 Interest expense on asset ceiling effect 8 7 0 0 0 0 8 7 Asset ceiling effect excluding interest expense and foreign currency asset ceiling effect 1,037 457 0 0 0 0 1,037 457 Foreign currency translation (68) 176 0 0 0 0 (68) 176 Asset ceiling effect at the end of the year 3,716 2,739 0 0 0 0 3,716 2,739 Net defined benefit asset / (liability) of major plans 0 0 192 (13) (411) (545) (219) (558) Net defined benefit asset / (liability) of remaining plans (96) (112) Total net defined benefit asset / (liability) (315) (670) of which: Net defined benefit asset 302 42 of which: Net defined benefit liability 3 (617) (711) 1 Experience (gains) / occurred. Income statement – expenses related to defined benefit plans 1 USD million Swiss pension plan UK pension plan US and German pension plans Total For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Current service cost 285 262 0 0 6 6 291 268 Interest expense related to defined benefit obligation 33 40 58 73 30 45 122 159 Interest income related to plan assets (42) (48) (58) (73) (26) (38) (127) (159) Interest expense on asset ceiling effect 8 7 0 0 0 0 8 7 Administration expenses, taxes and premiums paid 8 8 0 0 4 4 11 11 Past service cost related to plan amendments 0 0 0 3 4 0 4 3 Curtailments (49) 0 0 0 0 0 (49) 0 Net periodic expenses recognized in net profit for major plans 243 269 0 3 18 18 261 289 Net periodic expenses recognized in net profit for remaining plans 2 19 17 Total net periodic expenses recognized in net profit 280 306 1 Refer to Note 6. Other comprehensive income – gains / (losses) on defined benefit plans USD million Swiss pension plan UK pension plan US and German pension plans Total For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Remeasurement of defined benefit obligation (490) (677) (71) (449) 62 (105) (498) (1,231) of which: change in discount rate assumption 494 (447) 319 (504) 77 (141) 890 (1,092) of which: change in rate of salary increase assumption (2) (132) 0 0 0 0 (2) (132) of which: change in rate of pension increase assumption 0 0 (316) (1) (1) 1 (317) 0 of which: change in rate of interest credit on retirement savings (110) 15 0 0 (1) 24 (110) 39 of which: change in life expectancy 0 84 9 22 (3) 50 5 156 of which: change in other actuarial assumptions (24) (33) (23) (8) 2 (34) (45) (75) of which: experience gains / (losses) 1,2 (848) (165) (59) 42 (12) (5) (919) (127) Return on plan assets excluding interest income 1,319 962 277 388 40 118 1,637 1,469 Asset ceiling effect excluding interest expense and foreign currency (1,037) (457) 0 0 0 0 (1,037) (457) Total gains / (losses) recognized in other comprehensive income for major plans (207) (172) 207 (61) 103 14 102 (219) Total gains / (losses) recognized in other comprehensive income for remaining plans 31 (3) Total gains / (losses) recognized in other comprehensive income 3 133 (222) 1 Experience (gains) / occurred. The table below provides information about the duration of the DBO and the timing for expected benefit payments. Swiss pension plan UK pension plan US and German pension plans 1 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Duration of the defined benefit obligation (in years) 15.5 16.2 18.8 19.0 9.5 10.2 Maturity analysis of benefits expected to be paid USD million Benefits expected to be paid within 12 months 719 710 110 114 123 122 Benefits expected to be paid between 1 and 3 years 1,440 1,442 248 232 237 235 Benefits expected to be paid between 3 and 6 years 2,097 2,100 418 406 338 346 Benefits expected to be paid between 6 and 11 years 3,467 3,408 743 744 495 532 Benefits expected to be paid between 11 and 16 years 3,156 3,184 751 758 392 413 Benefits expected to be paid in more than 16 years 10,733 11,186 3,028 3,206 519 541 1 The duration of the defined benefit obligation represents a weighted average across US and Actuarial assumptions The actuarial assumptions based on the economic conditions prevailing in the jurisdiction in which they are offered. Changes are most rate is based on the yield of high-quality corporate bonds quoted in decrease AG regularly reviews the DBO to determine their continuing relevance. › Refer to Note 1a item 5 for a description for defined benefit plans The tables below show the significant actuarial assumptions used in calculating the DBO at the end of the year. Significant actuarial assumptions Swiss pension plan UK pension plan US and German pension plans 1 In % 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Discount rate 0.34 0.10 1.82 1.42 2.10 1.62 Rate of salary increase 2.01 2.00 0.00 0.00 2.35 2.25 Rate of pension increase 0.00 0.00 3.32 2.89 1.80 1.70 Rate of interest credit on retirement savings 1.04 0.60 0.00 0.00 1.18 1.12 1 Represents weighted average assumptions across US and German plans. Mortality tables and life expectancies for Life expectancy at age 65 for a male member currently aged 65 aged 45 Country Mortality table 31.12.21 31.12.20 31.12.21 31.12.20 Switzerland BVG 2020 G with CMI 2019 projections 21.7 21.7 23.3 23.2 UK S3PA with CMI 2020 projections 1 23.4 23.4 24.5 24.6 USA Pri-2012 with MP-2021 projection scale 2 21.9 21.8 23.3 23.2 Germany Dr. K. Heubeck 2018 G 20.5 20.8 23.2 23.6 Life expectancy at age 65 for a female member currently aged 65 aged 45 Country Mortality table 31.12.21 31.12.20 31.12.21 31.12.20 Switzerland BVG 2020 G with CMI 2019 projections 23.4 23.4 25.0 24.9 UK S3PA with CMI 2020 projections 1 24.9 24.9 26.3 26.3 USA Pri-2012 with MP-2021 projection scale 2 23.3 23.2 24.7 24.5 Germany Dr. K. Heubeck 2018 G 23.9 24.3 26.1 26.5 1 In 2020, S3PA with CMI 2019 projections was used. Sensitivity analysis of significant actuarial assumptions The table below presents a sensitivity analysis for each significant actuarial affected were reasonably circumstances may arise, which could outside Caution should be used the DBO, as the sensitivities may not be linear. Sensitivity analysis of significant actuarial 1 Increase / (decrease) in defined benefit obligation Swiss pension plan UK pension plan US and German pension plans USD million 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Discount rate Increase by 50 basis points (975) (1,030) (361) (370) (78) (91) Decrease by 50 basis points 1,116 1,181 411 423 84 99 Rate of salary increase Increase by 50 basis points 69 74 – 2 – 2 0 1 Decrease by 50 basis points (66) (71) – 2 – 2 0 (1) Rate of pension increase Increase by 50 basis points 749 793 334 358 6 8 Decrease by 50 basis points – 3 – 3 (306) (316) (6) (7) Rate of interest credit on retirement savings Increase by 50 basis points 134 142 – 4 – 4 8 9 Decrease by 50 basis points (134) 5 (113) – 4 – 4 (7) (8) Life expectancy Increase in longevity by one additional year 475 566 184 182 56 60 1 The sensitivity analyses are based on a change in one assumption while holding all other assumptions constant, so that interdependencies between the assumptions are excluded. service, a change in assumption is not 0 % as of 31 December 2021 and as 4 As the UK plan does not provide interest 17 % of retirement savings were subject to a legal minimum 1.00 %. Fair value of plan assets The tables Composition and fair value of plan assets Swiss pension plan 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 106 0 106 1 123 0 123 1 Real estate / property Domestic 0 1,994 1,994 10 0 2,018 2,018 11 Foreign 0 328 328 2 0 186 186 1 Investment funds Equity Domestic 476 0 476 2 465 0 465 3 Foreign 3,510 1,498 5,009 26 3,540 1,103 4,642 25 Bonds 1 Domestic, AAA to BBB– 2,512 0 2,512 13 2,096 0 2,096 11 Foreign, AAA to BBB– 2,877 0 2,877 15 3,462 0 3,462 19 Foreign, below BBB– 742 0 742 4 734 0 734 4 Other 2,379 2,010 4,389 23 1,894 2,097 3,991 22 Other investments 377 385 762 4 373 266 640 3 Total fair value of plan assets 12,980 6,216 19,196 100 12,688 5,670 18,358 100 31.12.21 31.12.20 Total fair value of plan assets 19,196 18,358 of which: 2 Bank accounts at UBS AG 109 130 UBS AG debt instruments 16 19 UBS Group AG shares 14 13 Securities lent to UBS AG 3 608 796 Property occupied by UBS AG 52 54 Derivative financial instruments, counterparty UBS AG 3 72 84 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s rating classification. positions disclosed 3 Securities lent to UBS AG and derivative of collateral, derivative financial instruments amounted to USD 24 9 Composition and fair value of plan assets (continued) UK pension plan 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 147 0 147 3 195 0 195 5 Bonds 1 Domestic, AAA to BBB– 2,605 0 2,605 61 2,150 0 2,150 52 Foreign, AAA to BBB– 372 0 372 9 53 0 53 1 Foreign, below BBB– 4 0 4 0 0 0 0 Investment funds Equity Domestic 44 4 47 1 34 3 37 1 Foreign 921 0 921 21 1,077 0 1,077 26 Bonds 1 Domestic, AAA to BBB– 532 147 679 16 919 131 1,050 25 Domestic, below BBB– 12 0 12 0 47 0 47 1 Foreign, AAA to BBB– 179 0 179 4 149 0 149 4 Foreign, below BBB– 115 0 115 3 110 0 110 3 Real estate Domestic 110 12 122 3 98 16 114 3 Foreign 6 34 40 1 0 37 37 1 Other (313) 0 (313) (7) (86) 0 (86) (2) Insurance contracts 0 8 8 0 0 8 8 0 Derivatives 57 (3) 54 1 (3) 0 (3) 0 Asset-backed securities 0 11 11 0 0 6 6 0 Other investments 2 (717) 10 (707) (16) (803) 9 (794) (19) Total fair value of plan assets 4,074 223 4,297 100 3,940 209 4,149 100 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s Composition and fair value of plan assets (continued) US and German pension plans 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 11 0 11 1 38 0 38 3 Equity Domestic 79 0 79 6 0 0 0 0 Foreign 31 0 31 2 0 0 0 0 Bonds 1 Domestic, AAA to BBB– 486 0 486 37 490 0 490 36 Domestic, below BBB– 17 0 17 1 7 0 7 0 Foreign, AAA to BBB– 97 0 97 7 99 0 99 7 Foreign, below BBB– 6 0 6 0 1 0 1 0 Investment funds Equity Domestic 3 0 3 0 210 0 210 15 Foreign 56 0 56 4 169 0 169 12 Bonds 1 Domestic, AAA to BBB– 269 0 269 20 195 0 195 14 Domestic, below BBB– 147 0 147 11 34 0 34 2 Foreign, AAA to BBB– 11 0 11 1 19 0 19 1 Foreign, below BBB– 2 0 2 0 3 0 3 0 Real estate Domestic 0 9 9 1 0 14 14 1 Other 99 0 99 7 79 0 79 6 Insurance contracts 0 1 1 0 0 1 1 0 Other investments Total fair value of plan assets 1,319 10 1,329 100 1,345 15 1,360 100 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s b) Defined contribution plans UBS AG the obligation is limited to its contributions made in accordance each plan, which contributions. plans are recognized as an expense. Expenses related to defined contribution For the year ended USD million 31.12.21 31.12.20 31.12.19 US plan 198 190 173 UK plan 41 36 34 Remaining plans 64 65 71 Total 1 303 291 278 1 Refer to Note 6. c) Related-party disclosure Refer to the “Composition and fair value Note 27a for more information about fair value in UBS AG and UBS Group AG instruments pension fund The following amounts have been received or paid by UBS AG from Switzerland, banking activities and arrangements. Related-party disclosure For the year ended USD million 31.12.21 31.12.20 31.12.19 Received by UBS AG Fees 22 19 19 Paid by UBS AG Rent 2 3 2 Dividends, capital repayments and interest 5 10 10 The transaction volumes in UBS Group AG shares Transaction volumes – UBS Group AG shares and UBS AG debt instruments For the year ended 31.12.21 31.12.20 Financial instruments bought by pension funds UBS Group AG shares (in thousands of shares) 847 1,677 UBS AG debt instruments (par values, USD million) 22 16 Financial instruments sold by pension funds or matured UBS Group AG shares (in thousands of shares) 1,505 2,556 UBS AG debt instruments (par values, USD million) 22 4 UBS Group AG shares held by post-employment 31.12.21 31.12.20 Number of shares (in thousands of shares) 13,456 14,112 Fair value (USD million) 241 199 |
Employee benefits_ variable com
Employee benefits: variable compensation | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Employee benefits: variable compensation [text block] | Note 28 a) Plans offered The compensation Board (GEB) members investors. Share-based awards are granted in the form of notional shares and, where in at vesting, or tax Deferred compensation awards are among other circumstances, with UBS. These regulatory regulated employees. The most significant below. › Refer to Note 1a related to share-based and other deferred compensation Mandatory deferred compensation plans The Long-Term Incentive Plan The share-based (i.e., GEB members and selected senior management). The number of notional two weighted - year performance capital and relative performance Important Banks as determined by the Financial Stability Board. The final number of shares will vest in three equal installments in each GEB performance period for selected senior management. The Equity The compensation requirements but EOP after cases, achievement of defined performance conditions. Asset Management employees receive some or all of in amount investment funds at the time of vesting. The Deferred The compensation plan for all requirements. 1 (AT1) capital settled as a cash instrument. DCCP unless the viability if the Additional performance Interest payments UBS. regulated employees, granted non-interest-bearing Financial advisor variable compensation In line businesses, the compensation for US financial advisors in Global Wealth Management and primarily based also qualify vest over performance service compensation awards errors, firm’s applicable laws and regulations. Financial advisor to into requirements. Share delivery obligations Share compensation awards were 175 2021 172 obligations are share account. As of 31 December 2021, 149 (31 December 157 share delivery obligations. b) Effect on the income statement Effect periods The table related to variable compensation, ended 31 December and will be The majority to the 2022. share - based December 2021 will recognized 2.5 years. Variable compensation including financial advisor variable Expenses recognized in 2021 Expenses deferred to 2022 and later 1 USD million Related to the 2021 performance year Related to prior performance years Total Related to the 2021 performance year Related to prior performance years Total Non-deferred cash 2,383 (10) 2,373 0 0 0 Deferred compensation awards 405 412 817 797 624 1,421 of which: Equity Ownership Plan 183 180 363 393 184 577 of which: Deferred Contingent Capital Plan 140 158 297 299 329 628 of which: Long-Term Incentive Plan 54 19 73 50 33 83 of which: Asset Management EOP 29 56 84 56 78 133 Variable compensation – performance awards 2,788 402 3,190 797 624 1,421 Variable compensation – other 2 191 38 229 215 182 397 Total variable compensation excluding financial advisor variable compensation 2,979 440 3,419 1,012 806 1,818 Financial advisor variable compensation 4,134 248 4,382 434 641 1,075 of which: non-deferred cash 3,858 (6) 3,853 0 0 0 of which: deferred share-based awards 106 51 157 123 146 269 of which: deferred cash-based awards 170 202 372 311 495 806 Compensation commitments with recruited financial advisors 3 41 438 479 662 1,682 2,344 Total FA variable compensation 4,175 685 4,860 1,097 2,323 3,419 Total variable compensation including FA variable compensation 7,155 1,125 8,280 4 2,109 3,129 5,238 1 Estimate as retention plan payments and interest that are subject to columns represent commitments entered into 651 435 59 million; financial advisor 157 85 USD 5 64 16 compensation excluding social security was USD 641 Variable compensation including financial advisor variable Expenses recognized in 2020 Expenses deferred to 2021 and later 1 USD million Related to the 2020 performance year Related to prior performance years Total Related to the 2020 performance year Related to prior performance years Total Non-deferred cash 2,167 (26) 2,141 0 0 0 Deferred compensation awards 341 727 1,068 756 288 1,044 of which: Equity Ownership Plan 137 327 463 306 69 376 of which: Deferred Contingent Capital Plan 112 351 463 280 196 476 of which: Long-Term Incentive Plan 42 11 54 50 10 61 of which: Asset Management EOP 49 39 88 120 12 132 Variable compensation – performance awards 2,508 701 3,209 756 288 1,044 Variable compensation – other 2 126 94 220 181 192 374 Total variable compensation excluding financial advisor variable compensation 2,634 795 3,429 938 480 1,418 Financial advisor variable compensation 3,356 233 3,589 350 602 952 of which: non-deferred cash 3,154 0 3,154 0 0 0 of which: deferred share-based awards 69 50 119 79 135 214 of which: deferred cash-based awards 133 183 316 271 467 738 Compensation commitments with recruited financial advisors 3 22 480 502 473 1,682 2,155 Total FA variable compensation 3,378 713 4,091 822 2,284 3,106 Total variable compensation including FA variable compensation 6,012 1,508 7,520 4 1,760 2,764 4,524 1 Estimate as of 31 plan payments and interest expense related are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. Amounts in the “Related to the 2020 performance year” columns represent commitments entered into 686 517 50 financial advisor compensation: 119 100 4 million related to 54 42 compensation excluding social security was USD 691 Variable compensation including financial advisor variable Expenses recognized in 2019 Expenses deferred to 2020 and later 1 USD million Related to the 2019 performance year Related to prior performance years Total Related to the 2019 performance year Related to prior performance years Total Non-deferred cash 1,894 (26) 1,868 0 0 0 Deferred compensation awards 299 588 887 429 608 1,036 of which: Equity Ownership Plan 122 300 422 205 219 424 of which: Deferred Contingent Capital Plan 113 262 375 173 365 538 of which: Long-Term Incentive Plan 39 0 39 25 0 25 of which: Asset Management EOP 25 26 51 26 23 49 Variable compensation – performance awards 2,193 562 2,755 429 608 1,036 Variable compensation – other 2 159 88 246 117 232 349 Total variable compensation excluding financial advisor variable compensation 2,352 650 3,001 545 840 1,385 Financial advisor variable compensation 3,233 268 3,501 197 710 907 of which: non-deferred cash 3,064 0 3,064 0 0 0 of which: deferred share-based awards 57 48 106 54 130 183 of which: deferred cash-based awards 112 219 331 144 580 724 Compensation commitments with recruited financial advisors 3 32 510 542 350 1,617 1,967 Total FA variable compensation 3,265 778 4,043 548 2,327 2,874 Total variable compensation including FA variable compensation 5,617 1,428 7,045 4 1,093 3,166 4,259 1 Estimate as of 31 December 2019. Actual amounts expensed may vary, e.g., interest expense related to the Deferred Contingent Capital Plan. requirements. Amounts reflected as deferred expenses represent entered into in 610 461 43 USD 106 61 10 allowances; social security: 25 27 security was USD 619 c) Outstanding share-based compensation awards Share and performance share awards Movements in outstanding share-based awards during 2021 and 2020 are provided in the table below. Movements in outstanding share-based compensation Number of shares 2021 Weighted average grant date fair value (USD) Number of shares 2020 Weighted average grant date fair value (USD) Outstanding, at the beginning of the year 174,900,395 12 156,064,763 14 Awarded during the year 68,721,549 15 72,250,157 11 Distributed during the year (52,137,287) 13 (46,899,362) 15 Forfeited during the year (10,906,096) 13 (6,515,164) 13 Outstanding, at the end of the year 180,578,561 13 174,900,395 12 of which: shares vested for accounting purposes 107,828,979 118,260,527 The total carrying amount of the liability related to cash-settled share-based awards as of 31 December 2021 and 31 December 2020 was USD 37 36 d) Valuation UBS share awards UBS market price SIX and conditions, where subject to on the basis of referenced to put option for the term of the transfer restriction. The grant date fair includes dividends to be paid between the grant date and distribution. |
UBS AG | |
Entity [Table] | |
Employee benefits: variable compensation [text block] | Note 28 a) Plans offered UBS plans members and other employees with the interests of investors. Share-based awards are granted in the form of notional shares and, where in at vesting, or tax Deferred compensation awards are among other circumstances, with UBS. These regulatory regulated employees. The most significant below. For under such UBS charged Note, references to shares refer to UBS Group AG shares. › Refer to Note 1a related to share-based and other deferred compensation Mandatory The Long-Term Incentive Plan The share-based (i.e., GEB members and selected senior management). The number of notional two weighted ce - year performance capital and relative performance Important Banks as determined by the Financial Stability Board. The final number of shares will vest in three each of the three years members, and cliff period for selected senior management. The Equity The compensation requirements but EOP after cases, achievement of defined performance conditions. Asset Management employees receive some or all of in amount investment funds at the time of vesting. The Deferred The compensation plan for all requirements. 1 (AT1) capital settled as a cash instrument. DCCP unless the viability if the Additional performance Interest payments UBS. regulated employees, granted non-interest-bearing Financial advisor variable compensation In line tice businesses, the compensation for US financial advisors in Global Wealth Management and primarily based also qualify vest over performance service compensation awards errors, firm’s applicable laws and regulations. Financial advisor to into requirements. b) Effect on the income statement Effect periods The table related to variable compensation, ended 31 December and will be The majority to the 2022. share - based December 2021 will recognized 2.5 years. Variable compensation including financial advisor variable Expenses recognized in 2021 Expenses deferred to 2022 and later 1 USD million Related to the 2021 performance year Related to prior performance years Total Related to the 2021 performance year Related to prior performance years Total Non-deferred cash 2,136 (8) 2,128 0 0 0 Deferred compensation awards 389 399 788 767 606 1,373 of which: Equity Ownership Plan 175 174 350 374 180 553 of which: Deferred Contingent Capital Plan 134 151 285 290 318 608 of which: Long-Term Incentive Plan 51 17 69 48 32 79 of which: Asset Management EOP 29 55 84 56 77 133 Variable compensation – performance awards 2,525 391 2,916 767 606 1,373 Variable compensation – other 2 163 33 196 210 178 388 Total variable compensation excluding financial advisor variable compensation 2,688 424 3,112 978 784 1,762 Financial advisor variable compensation 4,134 248 4,382 434 641 1,075 of which: non-deferred cash 3,858 (6) 3,853 0 0 0 of which: deferred share-based awards 106 51 157 123 146 269 of which: deferred cash-based awards 170 202 372 311 495 806 Compensation commitments with recruited financial advisors 3 41 438 479 662 1,682 2,344 Total FA variable compensation 4,175 685 4,860 1,097 2,323 3,419 Total variable compensation including FA variable compensation 6,863 1,109 7,973 4 2,074 3,107 5,181 1 Estimate as retention plan payments and interest that are subject to columns represent commitments entered into 631 419 56 million; financial advisor compensation: USD 157 77 5 59 13 Variable compensation including financial advisor variable Expenses recognized in 2020 Expenses deferred to 2021 and later 1 USD million Related to the 2020 performance year Related to prior performance years Total Related to the 2020 performance year Related to prior performance years Total Non-deferred cash 1,948 (29) 1,920 0 0 0 Deferred compensation awards 329 704 1,034 734 277 1,011 of which: Equity Ownership Plan 131 315 446 298 67 365 of which: Deferred Contingent Capital Plan 108 339 448 271 189 459 of which: Long-Term Incentive Plan 41 11 52 46 9 55 of which: Asset Management EOP 49 39 88 120 12 132 Variable compensation – performance awards 2,278 675 2,953 734 277 1,011 Variable compensation – other 2 109 92 201 176 189 364 Total variable compensation excluding financial advisor variable compensation 2,387 768 3,155 909 465 1,375 Financial advisor variable compensation 3,356 233 3,589 350 602 952 of which: non-deferred cash 3,154 0 3,154 0 0 0 of which: deferred share-based awards 69 50 119 79 135 214 of which: deferred cash-based awards 133 183 316 271 467 738 Compensation commitments with recruited financial advisors 3 22 480 502 473 1,682 2,155 Total FA variable compensation 3,378 713 4,091 822 2,284 3,106 Total variable compensation including FA variable compensation 5,765 1,481 7,246 4 1,732 2,749 4,481 1 Estimate as of 31 plan payments and interest expense related are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. represent commitments entered into 666 498 49 financial advisor compensation: USD 119 88 4 related to role-based allowances; social security: USD 51 34 Variable compensation including financial advisor variable Expenses recognized in 2019 Expenses deferred to 2020 and later 1 USD million Related to the 2019 performance year Related to prior performance years Total Related to the 2019 performance year Related to prior performance years Total Non-deferred cash 1,706 (24) 1,682 0 0 0 Deferred compensation awards 287 576 863 413 592 1,005 of which: Equity Ownership Plan 115 294 410 198 213 412 of which: Deferred Contingent Capital Plan 109 256 365 166 356 521 of which: Long-Term Incentive Plan 38 0 38 23 0 23 of which: Asset Management EOP 25 26 51 26 23 49 Variable compensation – performance awards 1,993 553 2,545 413 592 1,005 Variable compensation – other 2 140 85 225 115 228 343 Total variable compensation excluding financial advisor variable compensation 2,133 638 2,770 528 820 1,348 Financial advisor variable compensation 3,233 268 3,501 197 710 907 of which: non-deferred cash 3,064 0 3,064 0 0 0 of which: deferred share-based awards 57 48 106 54 130 183 of which: deferred cash-based awards 112 219 331 144 580 724 Compensation commitments with recruited financial advisors 3 32 510 542 350 1,617 1,967 Total FA variable compensation 3,265 778 4,043 548 2,327 2,874 Total variable compensation including FA variable compensation 5,398 1,416 6,814 4 1,076 3,146 4,222 1 Estimate as of 31 December 2019. Actual amounts expensed may vary, e.g., interest expense related to the Deferred Contingent Capital Plan. requirements. Amounts reflected as deferred expenses entered into in 595 448 42 USD 106 54 10 allowances; social security: USD 23 22 c) Outstanding share-based compensation awards Share and performance share awards Movements in outstanding share-based awards under the EOP during 2021 and 2020 are provided in the table below. The awards presented are granted by UBS AG, but are based on UBS Group AG shares. Movements in outstanding share-based compensation Number of shares 2021 Weighted average grant date fair value (USD) Number of shares 2020 Weighted average grant date fair value (USD) Outstanding, at the beginning of the year 54,557 13 90,443 14 Awarded during the year 278,756 15 19,229 11 Distributed during the year (24,176) 13 (55,114) 14 Forfeited during the year (13,215) 15 0 0 Outstanding, at the end of the year 295,921 15 54,557 13 of which: shares vested for accounting purposes 116,775 53,216 The total carrying amount of the liability related to cash-settled share-based awards as of 31 December 2021 and 31 December 2020 was USD 3 1 d) Valuation UBS share awards UBS market price SIX and conditions, where subject to on the basis of referenced to put option for the term of the transfer restriction. The grant date fair includes dividends to be paid between the grant date and distribution. |
Interests in subsidiaries
Interests in subsidiaries | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Interests In Subsidiaries Explanatory | Note 29 a) Interests in subsidiaries UBS defines its individually Group’s number contribution to the tax, regulations Commission (the SEC). Individually significant subsidiaries The subsidiaries as subsidiaries ordinary shares held entirely by the Group, and the proportion of ownership interest Group. The country where the respective registered office is located is also the global branch network and activity is conducted outside Switzerland, including in US, Singapore, Hong Kong SAR and other countries. SE has including Germany, Italy, provided in the currency of the legally registered office. Individually significant subsidiaries Company Registered office Share capital in million Equity interest accumulated in % UBS AG Zurich and Basel, Switzerland CHF 385.8 100.0 UBS Business Solutions AG 1 Zurich, Switzerland CHF 1.0 100.0 1 UBS Business Solutions AG holds subsidiaries in China, India, Israel and Poland. Individually significant subsidiaries 1 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Americas Holding LLC Wilmington, Delaware, USA Group Functions USD 4,150.0 2 100.0 UBS Americas Inc. Wilmington, Delaware, USA Group Functions USD 0.0 100.0 UBS Asset Management AG Zurich, Switzerland Asset Management CHF 43.2 100.0 UBS Bank USA Salt Lake City, Utah, USA Global Wealth Management USD 0.0 100.0 UBS Europe SE Frankfurt, Germany Global Wealth Management EUR 446.0 100.0 UBS Financial Services Inc. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS Securities LLC Wilmington, Delaware, USA Investment Bank USD 1,283.1 3 100.0 UBS Switzerland AG Zurich, Switzerland Personal & Corporate Banking CHF 10.0 100.0 1 Includes direct and indirect subsidiaries of UBS AG. 1,000 4,150,000,000 . 100,000 1,283,000,000 . Other subsidiaries The table below lists other direct and indirect subsidiaries of UBS total assets and aggregated profit before tax thresholds and are thus disclosed in accordance with requirements Other subsidiaries of UBS AG as of 31 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Asset Management (Americas) Inc. Wilmington, Delaware, USA Asset Management USD 0.0 100.0 UBS Asset Management (Hong Kong) Limited Hong Kong SAR, China Asset Management HKD 254.0 100.0 UBS Asset Management Life Ltd London, United Kingdom Asset Management GBP 15.0 100.0 UBS Asset Management Switzerland AG Zurich, Switzerland Asset Management CHF 0.5 100.0 UBS Business Solutions US LLC Wilmington, Delaware, USA Group Functions USD 0.0 100.0 UBS Credit Corp. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS (France) S.A. Paris, France Global Wealth Management EUR 133.0 100.0 UBS Fund Management (Luxembourg) S.A. Luxembourg, Luxembourg Asset Management EUR 13.0 100.0 UBS Fund Management (Switzerland) AG Basel, Switzerland Asset Management CHF 1.0 100.0 UBS (Monaco) S.A. Monte Carlo, Monaco Global Wealth Management EUR 49.2 100.0 UBS O‘Connor LLC Wilmington, Delaware, USA Asset Management USD 1.0 100.0 UBS Realty Investors LLC Boston, Massachusetts, USA Asset Management USD 9.0 100.0 UBS Securities Australia Ltd Sydney, Australia Investment Bank AUD 0.3 1 100.0 UBS Securities Hong Kong Limited Hong Kong SAR, China Investment Bank HKD 4,154.2 100.0 UBS Securities Japan Co., Ltd. Tokyo, Japan Investment Bank JPY 34,708.7 100.0 UBS SuMi TRUST Wealth Management Co., Ltd. Tokyo, Japan Global Wealth Management JPY 5,165.0 51.0 1 Includes a nominal amount relating to redeemable preference shares. Consolidated structured entities Consolidated structured funds, securitization has no individually significant subsidiaries that are SEs. In 2021 the contractual financial support not provide support, when does the p have an y intention Furthermore, otherwise, to a Group controlling the SE during the reporting period. |
UBS AG | |
Entity [Table] | |
Disclosure Of Interests In Subsidiaries Explanatory | Note 29 a) Interests in subsidiaries UBS AG either individually or in aggregate, contribute significantly to UBS AG’s number contribution to UBS AG’s in regulations Commission (the SEC). Individually significant subsidiaries The table below lists UBS AG’s individually significant subsidiaries as of listed below have share capital held entirely by UBS held is equal to the voting rights held by UBS AG. The country where the respective registered office is located is also the global branch network and activity is conducted outside Switzerland, including in US, Singapore, Hong Kong SAR and other countries. SE has including Germany, Italy, provided in the currency of the legally registered office. Individually significant subsidiaries 1 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Americas Holding LLC Wilmington, Delaware, USA Group Functions USD 4,150.0 2 100.0 UBS Americas Inc. Wilmington, Delaware, USA Group Functions USD 0.0 100.0 UBS Asset Management AG Zurich, Switzerland Asset Management CHF 43.2 100.0 UBS Bank USA Salt Lake City, Utah, USA Global Wealth Management USD 0.0 100.0 UBS Europe SE Frankfurt, Germany Global Wealth Management EUR 446.0 100.0 UBS Financial Services Inc. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS Securities LLC Wilmington, Delaware, USA Investment Bank USD 1,283.1 3 100.0 UBS Switzerland AG Zurich, Switzerland Personal & Corporate Banking CHF 10.0 100.0 1 Includes direct and indirect subsidiaries of UBS AG. 1,000 4,150,000,000 . 100,000 1,283,000,000 . Other subsidiaries The table below lists total assets and aggregated profit before tax thresholds and are thus disclosed in accordance with requirements Other subsidiaries of UBS AG as of 31 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Asset Management (Americas) Inc. Wilmington, Delaware, USA Asset Management USD 0.0 100.0 UBS Asset Management (Hong Kong) Limited Hong Kong SAR, China Asset Management HKD 254.0 100.0 UBS Asset Management Life Ltd London, United Kingdom Asset Management GBP 15.0 100.0 UBS Asset Management Switzerland AG Zurich, Switzerland Asset Management CHF 0.5 100.0 UBS Business Solutions US LLC Wilmington, Delaware, USA Group Functions USD 0.0 100.0 UBS Credit Corp. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS (France) S.A. Paris, France Global Wealth Management EUR 133.0 100.0 UBS Fund Management (Luxembourg) S.A. Luxembourg, Luxembourg Asset Management EUR 13.0 100.0 UBS Fund Management (Switzerland) AG Basel, Switzerland Asset Management CHF 1.0 100.0 UBS (Monaco) S.A. Monte Carlo, Monaco Global Wealth Management EUR 49.2 100.0 UBS O‘Connor LLC Wilmington, Delaware, USA Asset Management USD 1.0 100.0 UBS Realty Investors LLC Boston, Massachusetts, USA Asset Management USD 9.0 100.0 UBS Securities Australia Ltd Sydney, Australia Investment Bank AUD 0.3 1 100.0 UBS Securities Hong Kong Limited Hong Kong SAR, China Investment Bank HKD 4,154.2 100.0 UBS Securities Japan Co., Ltd. Tokyo, Japan Investment Bank JPY 34,708.7 100.0 UBS SuMi TRUST Wealth Management Co., Ltd. Tokyo, Japan Global Wealth Management JPY 5,165.0 51.0 1 Includes a nominal amount relating to redeemable preference shares. Consolidated structured entities Consolidated structured funds, securitization AG has no individually significant subsidiaries that are SEs. In 2021 and 2020, UBS AG obligation that could require UBS AG to provide financial support to consolidated SEs. In addition, UBS AG did financial not contractually obligated intention provide unconsolidated during the reporting period. |
Interests in associates and joi
Interests in associates and joint ventures | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of interests in associates and joint ventures [text block] | b) Interests in associates and joint ventures As of 31 December 2021 and 2020, no associate or joint venture was significant restrictions on the ability of to dividends quoted market Group. Investments in associates and joint ventures USD million 2021 2020 Carrying amount at the beginning of the year 1,557 1,051 Additions 1 388 Reclassifications 1 (386) 0 Share of comprehensive income 150 83 of which: share of net profit 2 105 84 of which: share of other comprehensive income 3 45 (1) Share of changes in retained earnings 1 (40) Dividends received (39) (33) Foreign currency translation (39) 108 Carrying amount at the end of the year 1,243 1,557 of which: associates 1,200 1,513 of which: SIX Group AG, Zurich 4 1,043 965 of which: Clearstream Fund Centre AG, Zurich 1 399 of which: other associates 157 150 of which: joint ventures 43 44 1 In the second quarter 48.8 %) in Clearstream Fund 386 sale and sold the investment in the same quarter. Refer to Note 30 for more information. 79 26 64 million from associates 19 44 1 1 associates. 17.31 %. UBS AG is represented on the Board of Directors. |
UBS AG | |
Entity [Table] | |
Disclosure of interests in associates and joint ventures [text block] | b) Interests in associates and joint ventures As of 31 December 2021 and 2020, no associate or joint venture was UBS . Also , significant restrictions on the ability of to transfer or market prices for any associates or joint ventures of UBS AG. Investments in associates and joint ventures USD million 2021 2020 Carrying amount at the beginning of the year 1,557 1,051 Additions 1 388 Reclassifications 1 (386) 0 Share of comprehensive income 150 83 of which: share of net profit 2 105 84 of which: share of other comprehensive income 3 45 (1) Share of changes in retained earnings 1 (40) Dividends received (39) (33) Foreign currency translation (39) 108 Carrying amount at the end of the year 1,243 1,557 of which: associates 1,200 1,513 of which: SIX Group AG, Zurich 4 1,043 965 of which: Clearstream Fund Centre AG, Zurich 1 399 of which: other associates 157 150 of which: joint ventures 43 44 1 In the second quarter 48.8 %) in Clearstream Fund 386 sale and sold the investment in the same quarter. Refer to Note 30 for more information. 79 26 64 million from associates 19 44 1 1 associates. 17.31 %. UBS AG is represented on the Board of Directors. |
Interests in unconsolidated str
Interests in unconsolidated structured entities | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Unconsolidated Structured Entities Explanatory | c) Unconsolidated structured entities UBS ongoing the entity, establishing counterparties 2021 , the Group interacted securitization funds, because it did not control them. Interests in unconsolidated structured entities The table below exposure assets held end, which the been disclosed. Sponsored not have an interest at year-end During 2021 and from sponsored unconsolidated SEs in interest at year-end. During 2021 and 2020, any year. UBS and and debt issuances (which vehicle), 1 2 sponsored client vehicles 0 USD 9 transfers redeemed funds, which, when combined with in a total 46 2020: USD 37 Interests in unconsolidated structured entities 31.12.21 USD million, except where indicated Securitization vehicles Client vehicles Investment funds Total Maximum exposure to loss 1 Financial assets at fair value held for trading 246 162 6,743 7,151 7,151 Derivative financial instruments 5 45 155 205 205 Loans and advances to customers 125 125 125 Financial assets at fair value not held for trading 35 222 257 257 Financial assets measured at fair value through other comprehensive 324 4,525 4,849 4,849 Other financial assets measured at amortized cost 0 2 0 1 250 Total assets 610 3 4,732 7,247 12,588 Derivative financial instruments 2 11 281 294 Total liabilities 2 11 281 294 Assets held by the unconsolidated structured entities in which UBS had (USD billion) 30 4 81 5 158 6 31.12.20 USD million, except where indicated Securitization vehicles Client vehicles Investment funds Total Maximum exposure to loss 1 Financial assets at fair value held for trading 375 131 7,595 8,101 8,101 Derivative financial instruments 6 49 158 213 211 Loans and advances to customers 179 179 179 Financial assets at fair value not held for trading 35 1 2 172 208 208 Financial assets measured at fair value through other comprehensive 6,624 6,624 6,624 Other financial assets measured at amortized cost 0 2 0 250 Total assets 416 3 6,805 8,104 15,326 Derivative financial instruments 3 11 376 390 0 Total liabilities 3 11 376 390 Assets held by the unconsolidated structured entities in which UBS had (USD billion) 39 4 136 5 124 6 1 For the purpose of this disclosure, maximum exposure to loss amounts do not consider the risk-reducing effects of collateral or other credit enhancements. The maximum exposure to loss for these instruments is equal 0.1 0.6 0.2 0.4 was held in Group Functions – Non-core and Legacy Portfolio. funds sponsored by structured investment funds and separately disclosed in the accompanying text on the following page. Prior-period The Group retains or purchases interests in in the form of credit, derivatives, Group’s carrying amount to change over time with market movements. Guarantees, of contract’s notional representing the maximum loss that the Group is exposed to. The previous activities, including effects from used to economically SE risk - reducing enhancements. In 2021 and or obligated to do so, nor so in the future. In unconsolidated movements Other instruments , which have generally been well sponsored Interests in securitization vehicles As of 31 December interests, vehicles that relate and derivative trading activities. The numbers differ 31 December 2021 Pillar 3 R eport , under 3 disclosures” ubs.com/investors , (i) exclusion that have an interest because it did not absorb any risk measurement within at default for of vehicles by third parties. › Refer to the 31 December 2021 Pillar 3 “Pillar 3 disclosures” at ubs.com/investors , for more information Interests in client vehicles Client exposure enter align investment objective, As of retained parties that trading activities, and to hedge structured product offerings. Interests in investment funds Investment funds have either passively have a and investors voting or similar rights. The primarily structured product offerings. In addition to the interests disclosed in the table on the previous page, the Group manages of whole performance of the fund. The specific fee structure is determined based on various and negotiated with clients. These in providing entity. Depending on the structure of collected ’s assets / or investors. Any are such receivable but rather by the total 370 359 billion as of 31 December 2021 and December 2020, respectively, previous page. The Group loss 31 December 2020. |
UBS AG | |
Entity [Table] | |
Disclosure Of Unconsolidated Structured Entities Explanatory | c) Unconsolidated structured entities UBS AG is considered ongoing the entity, establishing counterparties 2021 , U BS sponsored interacted securitization funds, that UBS AG did not consolidate as of 31 December 2021 because it did not control Interests in unconsolidated structured entities The exposure assets held end, which the has been disclosed. Sponsored not have an interest at year-end During from sponsored an interest at year-end. During transfer any in the year. UBS AG and deposits perspective 1 2 respectively, into sponsored client vehicles created in 2021 (2020: USD 0 9 investment invested size movements, resulted in 46 billion (31 December 2020: USD 37 Interests in unconsolidated structured entities 31.12.21 USD million, except where indicated Securitization vehicles Client vehicles Investment funds Total Maximum exposure to loss 1 Financial assets at fair value held for trading 246 162 6,743 7,151 7,151 Derivative financial instruments 5 45 155 205 205 Loans and advances to customers 125 125 125 Financial assets at fair value not held for trading 35 100 135 135 Financial assets measured at fair value through other comprehensive 324 4,525 4,849 4,849 Other financial assets measured at amortized cost 0 2 0 1 250 Total assets 610 3 4,732 7,124 12,466 Derivative financial instruments 2 11 281 294 Total liabilities 2 11 281 294 Assets held by the unconsolidated structured entities in which UBS AG had interest (USD billion) 30 4 81 5 103 6 31.12.20 USD million, except where indicated Securitization vehicles Client vehicles Investment funds Total Maximum exposure to loss 1 Financial assets at fair value held for trading 375 131 7,595 8,101 8,101 Derivative financial instruments 6 49 158 213 211 Loans and advances to customers 179 179 179 Financial assets at fair value not held for trading 35 1 2 73 109 109 Financial assets measured at fair value through other comprehensive 6,624 6,624 6,624 Other financial assets measured at amortized cost 0 2 0 250 Total assets 416 3 6,805 8,005 15,227 Derivative financial instruments 3 11 376 390 0 Total liabilities 3 11 376 390 Assets held by the unconsolidated structured entities in which UBS AG had interest (USD billion) 39 4 136 5 89 6 1 For the purpose of this disclosure, maximum exposure to loss amounts do not consider the risk-reducing effects of collateral or other credit enhancements. The maximum exposure to loss for these instruments is equal 0.1 0.6 0.2 0.4 was held in Group Functions – Non-core and Legacy Portfolio. funds sponsored by unconsolidated structured investment funds and the corresponding total asset information, where UBS AG’s information is now separately disclosed in the accompanying text on the following page. Prior-period UBS AG retains or purchases interests in unconsolidated SEs in the form credit, UBS AG’s carrying amount of UBS to change over time with market movements. Guarantees, of contract’s notional representing the maximum loss that UBS AG is exposed to. The previous UBS risk activities, including effects from used to economically SE enhancements. In 2021 and or obligated to do so, nor does UBS AG have any intention to do so in the future. In unconsolidated movements Other instruments , which have generally been well sponsored Interests in securitization vehicles As of interests, vehicles that relate and derivative trading activities. The numbers differ 31 December 2021 Pillar 3 R eport , under 3 disclosures” ubs.com/investors , (i) exclusion that are not SEs an measurement within at default for of vehicles viewed third parties. › Refer to the 31 December 2021 Pillar 3 “Pillar 3 disclosures” at ubs.com/investors , for more information Interests in client vehicles Client exposure enter align investment objective, As retained parties that trading activities, and to hedge structured product offerings. Interests in investment funds Investment funds have either passively have a and investors voting or similar rights. UBS primarily structured product offerings. In addition to the interests disclosed in the table on the previous page, UBS AG manages the assets of various pooled or / or performance of the fund. The specific fee structure is determined based on various and negotiated with clients. These in providing entity. Depending on the structure of collected ’s assets / or investors. Any are such receivable but rather by the total 425 395 billion as of 31 December 2021 and De cember 2020, respectively, previous page. UBS AG from December 2021 or 31 December 2020. |
Changes in organization and acq
Changes in organization and acquisitions and disposals of subsidiaries and businesses | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of changes in organisation and disposals [text block] | Note 30 Strategic partnership with Sumitomo Mitsui Trust Holdings In partnership (SuMi launched, with was established UBS and products and services to their respective clients. In partnership was completed, with the partnership Ltd., which is 51 %-owned and controlled by to consolidate and wealth management real Japanese transaction in the Group increased by USD 155 or loss. Disposals of subsidiaries and businesses Sale of remaining investment in Clearstream Fund Centre AG In investment in Clearstream Fund Centre for 390 majority Fondcenter recognized 631 Other income . The sale of 48.8 % investment resulted a post-tax gain of USD 37 in Other income , with no commercial provision servicing banks and insurance companies. Sale of wealth management business in Austria In domestic wealth management resulted 100 recognized Other , USD 25 Sale of wealth management business in Spain in 2022 In wealth agreement relationships, business of UBS in Spain. The closing conditions and is expected to close in the third quarter of 2022. As business disposal group held for sale within Other non-financial assets Other non-financial 647 and 823 million, transaction, UBS expects USD 0.2 Sale of UBS Swiss Financial Advisers AG in 2022 In owned Vontobel. FINMA-licensed investment transaction regulatory approvals and is of 2022. As subject were presented Management as a disposal group held for sale within Other non- financial assets Other non-financial to USD 446 475 closing of the on profit or loss or shareholders’ equity of the Group. Acquisitions of subsidiaries and businesses in 2022 Acquisition of Wealthfront in 2022 In Wealthfront, provider, 1.4 acquisition is aligned with UBS’s growth strategy will broaden new The including second Wealthfront UBS expects to assets of approximately USD 1.2 |
UBS AG | |
Entity [Table] | |
Disclosure of changes in organisation and disposals [text block] | Note 30 Strategic partnership with Sumitomo Mitsui Trust Holdings In partnership (SuMi launched, with was established UBS other’s products and services to their respective clients. In partnership was completed, with the partnership Ltd., which 51 %-owned and UBS securities and wealth management capabilities, custody, real a transaction in UBS AG increased by USD 155 loss. Disposals of subsidiaries and businesses Sale of remaining investment in Clearstream Fund Centre AG In the second investment in Clearstream Fund Centre for 390 majority Fondcenter recognized 631 Other income . The sale of 48.8 % investment resulted a post-tax gain of USD 37 in Other income , with no commercial provision servicing banks and insurance companies. Sale of wealth management business in Austria In domestic wealth management resulted 100 recognized Other , USD 25 Sale of wealth management business in Spain in 2022 In October 2021, wealth agreement relationships, business customary closing conditions and is expected to close in the third quarter of 2022. As business disposal group held for sale within Other non-financial assets Other non-financial 647 and 823 million, transaction, AG expects - tax approximately USD 0.2 Sale of UBS Swiss Financial Advisers AG in 2022 In December 2021, owned Vontobel. FINMA-licensed investment transaction regulatory approvals and is of 2022. As subject were presented Management as a disposal group held for sale within Other non- financial assets Other non-financial to USD 446 475 closing effect on profit or loss or shareholders’ equity. Acquisitions of subsidiaries and businesses in 2022 Acquisition of Wealthfront in 2022 In January Wealthfront, provider, 1.4 acquisition is aligned with UBS’s growth strategy will broaden new The including second Wealthfront and UBS intangible assets of approximately USD 1.2 |
Related parties
Related parties | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Related Party Explanatory | Note 31 UBS that are significantly influenced UBS shares control with another party), post-employment benefit plans family members are, management management Directors (BoD) and Group Executive Board (GEB). a) Remuneration of key management personnel The remuneration of the Chairman of the BoD and all GEB members is included in the table below. Remuneration of key management USD million, except where indicated 31.12.21 31.12.20 31.12.19 Base salaries and other cash payments 1 31 33 32 Incentive awards – cash 2 17 18 14 Annual incentive award under DCCP 26 27 21 Employer’s contributions to retirement benefit plans 3 3 3 Benefits in kind, fringe benefits (at market value) 1 1 1 Share-based compensation 3 45 47 37 Total 124 129 108 Total (CHF million) 4 113 121 107 1 May include role-based allowances in line is based on the composed of LTIP awards.For dollar amounts translated at the applicable performance award currency exchange rates (2021: USD / 0.92 ; 2020: USD / CHF 0.94 ; 2019: USD / CHF 0.99 ). The independent members or service contracts upon termination of their individuals for their to 7.5 6.9 7.0 (CHF 6.6 7.3 7.3 2019. b) Equity holdings of key management personnel Equity holdings of key management personnel 1 31.12.21 31.12.20 Number of shares held by members of the BoD, GEB and parties closely 2 4,597,006 5,288,317 1 No options were held in 2021 and 2020 by non-independent members provisions. Of members of and 31 December 2020. No shares were directly management 31 December 2021 and 2021, no member of the BoD or more than 1% of UBS Group AG’s shares. c) Loans, advances and mortgages to key management personnel The non-independent members granted course of business that are available to other employees, including collateral, the collectability nor firm. mortgages in conditions. Movements in the as follows Loans, advances and mortgages to key management 1 USD million, except where indicated 2021 2020 Balance at the beginning of the year 38 33 Additions 11 14 Reductions (15) (8) Balance at the end of the year 2 34 38 Balance at the end of the year (CHF million) 2, 3 31 34 1 All loans are secured loans. translated at the relevant year-end closing exchange rate. d) Other related-party transactions with entities controlled by key management personnel In entities controlled family 20 20 and December 9 , balances related 2020, entities sell any not receive any to such entities in 2021 and 2020, and fees. e) Transactions with associates and joint ventures Loans to and outstanding receivables from associates USD million 2021 2020 Carrying amount at the beginning of the year 630 982 Additions 133 527 Reductions (497) (1,001) Foreign currency translation (14) 123 Carrying amount at the end of the year 251 630 of which: unsecured loans and receivables 243 621 Other transactions with associates and As of or for the year ended USD million 31.12.21 31.12.20 Payments to associates and joint ventures for goods and services 157 139 Fees received for services provided to associates and joint ventures 104 128 Liabilities to associates and joint ventures 127 91 Commitments and contingent liabilities to associates 7 9 Refer to Note 29 for an overview of investments |
UBS AG | |
Entity [Table] | |
Disclosure Of Related Party Explanatory | Note 31 UBS significantly influenced UBS shares control with another party), post-employment benefit plans for family members are, management management Directors (BoD) and Executive Board (EB). a) Remuneration of key management personnel The remuneration of the Chairman of the BoD and all EB members is included in the table below. The independent members or benefits upon termination to these amounted to USD 7.5 6.9 7.0 million 6.6 7.3 7.3 million) in 2019. b) Equity holdings of key management personnel Equity holdings of key management personnel 1 31.12.21 31.12.20 Number of shares held by members of the BoD, EB and parties closely linked to them 2 4,175,515 4,956,640 1 No options were held in 2021 and 2020 by non-independent members provisions. Of members of and 31 December 2020. No shares were directly management 31 December 2021 and 2021, more than 1% of UBS Group AG’s shares. c) Loans, advances and mortgages to key management personnel The non-independent members granted course of business that are available to other employees, including collateral, collectability nor firm. mortgages in conditions. Movements in the as follows. Loans, advances and mortgages to key management 1 USD million, except where indicated 2021 2020 Balance at the beginning of the year 31 23 Additions 11 13 Reductions (15) (5) Balance at the end of the year 2 28 31 Balance at the end of the year (CHF million) 2, 3 25 28 1 All loans are secured loans. translated at the relevant year-end closing exchange rate. d) Other related-party transactions with entities controlled by key management personnel In 2021 entities directly controlled by UBS AG’s key management personnel or their close family and December 2021 , December 20 20 and December 9 , ere balances related 2020, entities sell any did provide services to such entities in 2021 and 2020, and therefore also received no fees. e) Transactions with associates and joint ventures Loans to and outstanding receivables from associates USD million 2021 2020 Carrying amount at the beginning of the year 630 982 Additions 133 527 Reductions (497) (1,001) Foreign currency translation (14) 123 Carrying amount at the end of the year 251 630 of which: unsecured loans and receivables 243 621 Other transactions with associates and As of or for the year ended USD million 31.12.21 31.12.20 Payments to associates and joint ventures for goods and services 157 139 Fees received for services provided to associates and joint ventures 104 128 Liabilities to associates and joint ventures 127 91 Commitments and contingent liabilities to associates 7 9 Refer to Note 29 for an overview of investments f) Receivables and payables from / to UBS Group AG and other subsidiaries of UBS Group AG USD million 31.12.21 31.12.20 Receivables Loans and advances to customers 1,049 1,470 Financial assets at fair value held for trading 187 76 Other financial assets measured at amortized cost 45 38 Payables Customer deposits 2,828 3,324 Funding from UBS Group AG 57,295 53,979 Other financial liabilities measured at amortized cost 1,887 1,820 Other financial liabilities designated at fair value 1 2,340 1,375 1 Represents funding recognized from UBS Group AG that is designated at fair value. Refer to Note |
Invested assets and net new mon
Invested assets and net new money | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of InvestedAssets And Net New Money Explanatory | Note 32 The following disclosures provide a bre assets and a money, Authority. Invested assets Invested assets with for managed fund assets, managed institutional assets, discretionary and time securities accounts. transactional corporate transactional purposes, are excluded Group only how assets (e.g., for funding or trading purposes. Discretionary decides how to invest. Other invested assets are client single another, it is counted in both investment counting divisions are independently providing a clients, and both add value and generate revenue. Net new money Net new assets withdrawn relationships Net new which / from determined at the client level, dividend income from invested money inflows. Market and currency movements, commissions new divestment between invested assets change in service level money flows. results by UBS effect is Other effects . The new Investment Bank net new UBS. Invested As of or for the year ended USD billion 31.12.21 31.12.20 Fund assets managed by UBS 419 397 Discretionary assets 1,705 1,459 Other invested assets 2,472 2,331 Total invested assets 1 4,596 4,187 of which: double counts 356 311 Net new money 1 159 127 1 Includes double counts. Development of invested assets USD billion 2021 2020 Total invested assets at the beginning of the year 1 4,187 3,607 Net new money 159 127 Market movements 2 339 359 Foreign currency translation (65) 96 Other effects (24) (1) of which: acquisitions / (divestments) (5) 0 Total invested assets at the end of the year 1 4,596 4,187 1 Includes double counts. |
UBS AG | |
Entity [Table] | |
Disclosure Of InvestedAssets And Net New Money Explanatory | Note 32 The a breakdown AG ’s invested assets net Supervisory Authority. Invested assets Invested assets with managed fund assets, managed institutional assets, discretionary and time securities transactional corporate transactional purposes, are excluded Group only how assets (e.g., for funding or trading purposes. Discretionary assets decides how to invest. Other invested assets are client single another, it is counted in both investment counting divisions are independently providing a clients, and both add value and generate revenue. Net new money Net new assets entrusted to UBS AG withdrawn relationships Net new which / from determined at the client level, dividend income from invested money inflows. Market and currency movements, commissions new divestment of between invested assets change in service level money flows. results by UBS net effect Other effects . The new Investment Bank net new UBS AG. Invested assets and net new money As of or for the year ended USD billion 31.12.21 31.12.20 Fund assets managed by UBS 419 397 Discretionary assets 1,705 1,459 Other invested assets 2,472 2,331 Total invested assets 1 4,596 4,187 of which: double counts 356 311 Net new money 1 159 127 1 Includes double counts. Development of invested assets USD billion 2021 2020 Total invested assets at the beginning of the year 1 4,187 3,607 Net new money 159 127 Market movements 2 339 359 Foreign currency translation (65) 96 Other effects (24) (1) of which: acquisitions / (divestments) (5) 0 Total invested assets at the end of the year 1 4,596 4,187 1 Includes double counts. |
Currency translation rates
Currency translation rates | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Effect Of Changes In Foreign Exchange Rates Explanatory | Note 33 The functional currency other than the US dollar into US dollars. Closing exchange rate Average rate 1 As of For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.19 1 CHF 1.10 1.13 1.09 1.07 1.01 1 EUR 1.14 1.22 1.18 1.15 1.12 1 GBP 1.35 1.37 1.37 1.29 1.28 100 JPY 0.87 0.97 0.91 0.94 0.92 1 Monthly income statement items of operations with a functional currency other than the US dollar are translated into US dollars using month-end rates. Disclosed average rates for a year represent an average of 12 month-end rates, weighted may deviate from the weighted average rates for the Group. |
UBS AG | |
Entity [Table] | |
Disclosure Of Effect Of Changes In Foreign Exchange Rates Explanatory | Note 33 The following table shows the rates of functional currency other than the US dollar into US dollars. Closing exchange rate Average rate 1 As of For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.19 1 CHF 1.10 1.13 1.09 1.07 1.01 1 EUR 1.14 1.22 1.18 1.15 1.12 1 GBP 1.35 1.37 1.37 1.29 1.28 100 JPY 0.87 0.97 0.91 0.94 0.92 1 Monthly income statement items of operations with a functional currency other than the US dollar are translated into US dollars using month-end rates. Disclosed average rates for a year represent an average of 12 month-end rates, weighted according to the income and expense volumes of all operations of UBS deviate from the weighted average rates for UBS AG. |
Events after the reporting peri
Events after the reporting period | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of events after reporting period [text block] | Note 34 Russia’s invasion of Ukraine Russia’s disruptions economy, Switzerland, the Kingdom and and sanctions businesses. UBS’s USD 0.6 2021. addition, open transactions with Russian bank- or non-bank or exchange ability which balance sheet as of USD 51 As of 3 March 2022, UBS also 0.2 of exposure arising Lombard Management. As of 3 March Wealth sanctions with total loans outstanding of under USD 10 UBS continues to closely statements, expected credit of assets, liabilities and off-balance continues counterparties possible to adverse effects on Refer to “Top and emerging risks” and “Country risk” in the “Risk management and control” section and the financial services industry is affected by and the macroeconomic climate” in the “Risk this report for more information |
UBS AG | |
Entity [Table] | |
Disclosure of events after reporting period [text block] | Note 34 Russia’s invasion of Ukraine Russia’s disruptions the markets economy, Switzerland, the Kingdom and and sanctions and other businesses. UBS USD 0.6 2021. addition, certain - or non - bank counterparties imposition of exchange limit collateral, which may result in unexpected increases in exposures. UBS AG’s net assets of USD 51 OOO approximately USD 0.2 Russian assets as financing in Global Wealth Management. As of 3 March Wealth sanctions with total loans outstanding of under USD 10 UBS financial impacts measurement exposures. implications financial however, financial statements as of 4 March 2022. Refer to “Top and emerging risks” and “Country risk” in the “Risk management and control” section and the financial services industry is affected by and the macroeconomic climate” in the “Risk this report for more information |
Main differences between IFRS a
Main differences between IFRS and Swiss GAAP | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of main differences between IFRS and Swiss GAAP [text block] | Note 35 The prepared Standards (IFRS). The (FINMA) requires financial groups presenting financial statements under differences g enerally accounting principles (GAAP) (the FINMA Accounting FINMA Ordinance differences and BO and governing pursuant to Art. 25 to Art. 42 of the BO. 1. Consolidation Under IFRS, are consolidated. Under immaterial to the consolidation, accounted financial value. 2. Classification and measurement of financial assets Under IFRS, debt instruments value through through business characteristics of instruments GAAP, trading assets and derivatives with IFRS. measured at amortized on assets in the debt instruments not for and equity with intent, are classified as Financial investments lower adjustments up to the original cost amount and losses upon disposal statement Other from ordinary Equity instruments participations in Non-consolidated investments in other Impairment Impairment other participations. cost investment are Extraordinary income Extraordinary expenses . 3. Fair value option applied to financial liabilities Under IFRS, liabilities not held for trading. option change credit is presented in Other comprehensive income Retained . issued instruments, cash under unit-linked investment contracts, and brokerage payables. Under Swiss GAAP, the fair structured debt instruments one equity. Furthermore, unrealized changes to realized own credit is recognized in . 4. Allowances and provisions for credit losses Swiss GAAP permit use of IFRS for provisions for credit losses based on an expected credit loss (ECL) model. UBS has substantial requirements, Swiss GAAP and IFRS. In scope of Swiss GAAP ECL requirements, which are not subject to ECL IFRS differences, internal ratings-based (IRB) risk, expected loss maturity of exposures detailed “ Risk management where the Pillar 1 standardized approach (SA) is used credit derives default (LGD) for the entire portfolio. 5. Hedge accounting Under IFRS, when cash flow hedge accounting is applied, the fair value a derivative designated as and reclassified to the income statement when certain conditions are value change of the is recognized in the income statement along with fair effective a derivative instrument designated deferred on the balance Other assets Other liabilities . The carrying amount of the hedged hedges is hedged risk. 6. Goodwill and intangible assets Under amortized with annually Under intangible assets with period not exceeding five years, unless a longer useful life, which may not exceed 10 are tested annually for impairment. 7. Post-employment benefit plans Swiss GAAP permit the use of IFRS or Swiss accounting for post-employment benefit plan-by-plan basis. UBS defined the UBS statements and in the UBS statements. The with the specific nature in defined under IFRS. Key the treatment and future considered under GAAP. benefit obligation in accordance with high-quality pension plan country. The Swiss GAAP (i.e., the technical interest rate) is determined by Pension Foundation Board’s investment strategy. For defined benefit plans, obligation net sheet from remeasurements recognized non-Swiss elected, income statement of UBS AG standalone under Swiss GAAP. Swiss fund statement. based accordance (FER economic benefit the conditions are liability would reserve is available reduction of a pension deficit (on an FER 26 basis). 8. Leasing Under IFRS, a single lease accounting model applies that UBS to liability arrangement. The RoU asset and the lease liability are recognized when UBS lease liability is measured based on the present value of the lease payments over the lease term, discounted using UBS’s unsecured borrowing rate. The RoU asset is recorded at an amount equal to the lease liability costs, incentives received. The RoU asset is depreciated over the shorter of the lease term or the useful life of the underlying asset. Under Swiss GAAP, and assets, classified recognized on the balance operating payments recognized as General and administrative a straight-line control treated consistent basis over the lease term. 9. Netting of derivative assets and liabilities Under IFRS, derivative assets, derivative liabilities and related cash collateral unless existence arrangements both bankruptcy UBS’s intention and Under derivative not provided the master netting are insolvency of UBS’s counterparties. 10. Negative interest Under IFRS, does not negative financial interest income, respectively. Under on negative interest on financial liabilities expense. 11. Extraordinary income and expense Certain items, participations, nd reversals impairments extraordinary available under IFRS |
UBS AG | |
Entity [Table] | |
Disclosure of main differences between IFRS and Swiss GAAP [text block] | Note 35 The consolidated financial statements of UBS AG are accordance (IFRS). The requires IFRS between IFRS and Swiss generally accepted accounting principles ( GAAP ) ( the 2020/1 BO)). Included recognition and measurement between the BO and the guidelines of FINMA governing true and fair view financial statement reporting pursuant BO. 1. Consolidation Under IFRS, are consolidated. Under immaterial to the consolidation, accounted financial value. 2. Classification and measurement of financial assets Under IFRS, debt instruments value through through business characteristics of instruments are accounted GAAP, trading assets and derivatives with IFRS. measured at amortized on assets in the debt instruments not for intent, are classified as Financial investments lower adjustments up to the original cost amount and losses upon disposal statement Other from ordinary Equity instruments participations in Non-consolidated investments in other Impairment Impairment other participations. cost investment are Extraordinary income Extraordinary expenses . 3. Fair value option applied to financial liabilities Under financial liabilities not held for trading. Instruments for which the fair amount UBS AG’s own credit Other comprehensive income directly within Retained earnings . The fair value option primarily , certain - structured agreements and cash collateral on securities lending agreements, amounts nit - linked and brokerage payables. Under Swiss GAAP, the fair structured debt instruments one equity. Furthermore, unrealized changes to changes in realized own credit is recognized in . 4. Allowances and provisions for credit losses Swiss GAAP permit use of IFRS for provisions for credit losses based on an expected credit loss (ECL) model. UBS AG the substantial majority of exposures in scope of Swiss GAAP ECL requirements, Swiss GAAP and IFRS. In scope of Swiss GAAP ECL requirements, which are not subject to ECL IFRS differences, UBS . Pillar 1 internal ratings-based (IRB) models are credit risk, ECL for expected loss maturity of exposures detailed egulatory “ Risk management where the Pillar 1 standardized approach (SA) is used credit derives default (LGD) for the entire portfolio. 5. Hedge accounting Under IFRS, when cash flow hedge accounting is applied, the fair value a derivative designated as and reclassified to the income statement when certain conditions are value change of the is recognized in the income statement along with fair effective a derivative instrument designated deferred on the balance Other assets Other liabilities . The carrying amount of the hedged hedges is hedged risk. 6. Goodwill and intangible assets Under amortized with annually Under intangible assets with period not exceeding five years, unless a longer useful life, which may not exceed 10 are tested annually for impairment. 7. Post-employment benefit plans Swiss GAAP permit the use of IFRS or Swiss for post-employment benefit plan-by-plan basis. UBS AG defined the UBS statements and in the UBS statements. The with the specific nature in defined under IFRS. Key the treatment and future considered under GAAP. benefit obligation in accordance with high-quality pension plan country. The Swiss GAAP (i.e., the technical interest rate) is determined by Pension Foundation Board’s investment strategy. For defined benefit plans, obligation net sheet from remeasurements recognized non-Swiss elected, income statement of UBS AG standalone under Swiss GAAP. Swiss fund statement. based accordance economic benefit the conditions are liability would reserve is available reduction of a pension deficit (on an FER 26 basis). 8. Leasing Under IFRS, a single lease accounting model applies UBS AG to record a right-of-use (RoU) asset and a corresponding lease liability on lease recognized when UBS the value of the lease UBS AG’s unsecured borrowing rate. an prepayments, initial direct costs, any costs to refurbish the leased asset / or depreciated over the shorter of the lease the underlying asset. Under Swiss GAAP, and assets, classified recognized on the balance operating payments recognized as General and administrative a straight-line control treated consistent basis over the lease term. 9. Netting of derivative assets and liabilities Under IFRS, derivative assets, derivative liabilities and related cash collateral unless existence arrangements both bankruptcy or (ii) UBS AG’s intention the Under GAAP, derivative , liabilities and collateral basis, agreements bankruptcy or insolvency of UBS AG’s counterparties. 10. Negative interest Under IFRS, does not negative financial interest income, respectively. Under on negative interest on financial liabilities expense. 11. Extraordinary income and expense Certain items, participations, nd reversals impairments extraordinary available under IFRS |
Supplemental guarantor informat
Supplemental guarantor information required under SEC regulations | 12 Months Ended |
Dec. 31, 2021 | |
UBS AG | |
Entity [Table] | |
Condensed Financial Information Of Parent Company Only Disclosure [Text Block] | Note 36 Joint liability of UBS Switzerland AG In Management businesses booked in Switzerland from UBS AG to UBS Switzerland AG through an asset transfer in accordance asset liability for contractual transfer date, certain registered debt securities issued by UBS AG. joint column as a subsidiary co-guarantor. The obligations 4.4 USD 5.7 billion December mainly contractual extinguishments of UBS AG liabilities. Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2021 Operating income Interest income from financial instruments measured at fair value through other comprehensive income 3,130 3,652 2,456 (703) 8,534 Interest expense from financial instruments measured at (2,847) (520) (1,024) 1,025 (3,366) Net interest income from financial instruments measured profit or loss 1,229 254 228 (274) 1,437 Net interest income 1,512 3,386 1,660 48 6,605 Other net income from financial instruments measured profit or loss 3,751 807 1,369 (83) 5,844 Credit loss (expense) / release 65 98 10 (24) 148 Fee and commission income 3,837 5,204 16,151 (770) 24,422 Fee and commission expense (810) (481) (1,450) 755 (1,985) Net fee and commission income 3,027 4,723 14,702 (14) 22,438 Other income 7,555 221 1,560 (8,396) 941 Total operating income 15,910 9,235 19,300 (8,469) 35,976 Operating expenses Personnel expenses 3,401 2,098 10,161 1 15,661 General and administrative expenses 4,255 3,442 4,474 (2,696) 9,476 Depreciation, amortization and impairment of non-financial 949 285 755 (114) 1,875 Total operating expenses 8,605 5,825 15,390 (2,809) 27,012 Operating profit / (loss) before tax 7,305 3,409 3,910 (5,660) 8,964 Tax expense / (benefit) 203 622 1,090 (11) 1,903 Net profit / (loss) 7,102 2,788 2,820 (5,649) 7,061 Net profit / (loss) attributable to non-controlling interests 0 0 29 0 29 Net profit / (loss) attributable to shareholders 7,102 2,788 2,792 (5,649) 7,032 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2021 Comprehensive income attributable to shareholders Net profit / (loss) 7,102 2,788 2,792 (5,649) 7,032 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax (1) (419) (607) 517 (510) Financial assets measured at fair value through other comprehensive income, net of tax 0 (157) 0 (157) Cash flow hedges, net of tax (1,129) (279) (250) (17) (1,675) Cost of hedging, net of tax (26) (26) Total other comprehensive income that may be reclassified to the income statement, net of tax (1,155) (699) (1,014) 500 (2,368) Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax 170 (135) 67 0 102 Own credit on financial liabilities designated at fair value, net of tax 46 46 Total other comprehensive income that will not be reclassified to the income statement, net of tax 217 (135) 67 0 148 Total other comprehensive income (939) (834) (947) 500 (2,220) Total comprehensive income attributable to shareholders 6,163 1,954 1,845 (5,149) 4,813 Total comprehensive income attributable to non-controlling interests 13 13 Total comprehensive income 6,163 1,954 1,858 (5,149) 4,826 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) As of 31 December 2021 Assets Cash and balances at central banks 53,839 91,031 47,946 192,817 Loans and advances to banks 39,681 7,066 19,858 (51,245) 15,360 Receivables from securities financing transactions 50,566 5,438 40,585 (21,577) 75,012 Cash collateral receivables on derivative instruments 29,939 779 10,314 (10,518) 30,514 Loans and advances to customers 101,458 230,170 93,252 (26,188) 398,693 Other financial assets measured at amortized cost 8,902 6,828 12,377 (1,870) 26,236 Total financial assets measured at amortized cost 284,385 341,312 224,332 (111,397) 738,632 Financial assets at fair value held for trading 116,370 79 16,740 (2,156) 131,033 of which: assets pledged as collateral that may be sold or repledged by counterparties 47,891 0 6,073 (10,568) 43,397 Derivative financial instruments 113,426 4,199 35,567 (35,047) 118,145 Brokerage receivables 14,563 7,283 (7) 21,839 Financial assets at fair value not held for trading 37,532 5,413 33,940 (17,243) 59,642 Total financial assets measured at fair value through profit or loss 281,891 9,691 93,531 (54,454) 330,659 Financial assets measured at fair value through other comprehensive income 1,007 7,837 8,844 Investments in subsidiaries and associates 54,204 37 40 (53,038) 1,243 Property, equipment and software 6,501 1,456 4,048 (293) 11,712 Goodwill and intangible assets 213 6,138 28 6,378 Deferred tax assets 936 7,903 8,839 Other non-financial assets 5,757 2,424 1,656 (1) 9,836 Total assets 634,894 354,921 345,484 (219,154) 1,116,145 Liabilities Amounts due to banks 34,691 33,453 50,405 (105,448) 13,101 Payables from securities financing transactions 16,711 526 9,910 (21,615) 5,533 Cash collateral payables on derivative instruments 30,260 153 11,845 (10,458) 31,801 Customer deposits 101,093 286,488 142,967 14,287 544,834 Funding from UBS Group AG 57,295 57,295 Debt issued measured at amortized cost 73,045 9,460 (73) 82,432 Other financial liabilities measured at amortized cost 4,477 2,477 5,057 (2,245) 9,765 Total financial liabilities measured at amortized cost 317,572 332,556 220,184 (125,551) 744,762 Financial liabilities at fair value held for trading 25,711 372 7,652 (2,046) 31,688 Derivative financial instruments 116,588 4,053 35,731 (35,063) 121,309 Brokerage payables designated at fair value 30,497 13,548 (1) 44,045 Debt issued designated at fair value 70,660 785 14 71,460 Other financial liabilities designated at fair value 11,127 24,454 (3,167) 32,414 Total financial liabilities measured at fair value through profit or loss 254,584 4,425 82,171 (40,263) 300,916 Provisions 2,023 297 1,153 (21) 3,452 Other non-financial liabilities 1,799 1,278 5,528 (33) 8,572 Total liabilities 575,978 338,556 309,036 (165,868) 1,057,702 Equity attributable to shareholders 58,916 16,365 36,108 (53,287) 58,102 Equity attributable to non-controlling interests 340 340 Total equity 58,916 16,365 36,448 (53,287) 58,442 Total liabilities and equity 634,894 354,921 345,484 (219,154) 1,116,145 1 Amounts presented for UBS AG available under “Complementary financial information” at ubs.com/investors, for information prepared UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD million UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2021 Net cash flow from / (used in) operating activities 5,714 2,131 22,718 30,563 Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets 0 (1) 0 (1) Disposal of subsidiaries, associates and intangible assets 2 16 0 577 593 Purchase of property, equipment and software (656) (276) (650) (1,581) Disposal of property, equipment and software 294 0 1 295 Purchase of financial assets measured at fair value through other (1,006) 0 (4,795) (5,802) Disposal and redemption of financial assets measured at income 189 0 4,863 5,052 Net (purchase) / redemption of debt securities measured (807) 772 (380) (415) Net cash flow from / (used in) investing activities (1,970) 495 (385) (1,860) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) (3,073) (21) 0 (3,093) Distributions paid on UBS AG shares (4,539) 0 0 (4,539) Issuance of debt designated at fair value and long-term debt measured 3 97,250 1,177 193 98,619 Repayment of debt designated at fair value and long-term debt measured 3 (78,385) (1,093) (320) (79,799) Net cash flows from other financing activities (280) 0 20 (261) Net activity related to group internal capital transactions and dividends 5,240 (537) (4,702) 0 Net cash flow from / (used in) financing activities 16,212 (475) (4,811) 10,927 Total cash flow Cash and cash equivalents at the beginning of the year 39,400 93,342 40,689 173,430 Net cash flow from / (used in) operating, investing and financing 19,957 2,151 17,523 39,630 Effects of exchange rate differences on cash and cash equivalents (1,462) (2,693) (1,151) (5,306) Cash and cash equivalents at the end of the year 4 57,895 92,799 57,061 207,755 of which: cash and balances at central banks 53,729 91,031 47,946 192,706 of which: loans and advances to banks 3,258 1,588 8,975 13,822 of which: money market paper 5 908 179 139 1,227 1 Cash flows generally represent a sale of the minority stake in Clearstream Fund Centre AG and dividends received from associates. USD 3,408 through other comprehensive income, Financial assets at fair value not held for trading and Other Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2020 Operating income Interest income from financial instruments measured at fair value through other comprehensive income 3,386 3,636 2,612 (818) 8,816 Interest expense from financial instruments measured at (3,694) (513) (1,261) 1,134 (4,333) Net interest income from financial instruments measured profit or loss 1,103 164 311 (273) 1,305 Net interest income 794 3,288 1,662 43 5,788 Other net income from financial instruments measured profit or loss 4,857 911 1,044 118 6,930 Credit loss (expense) / release (352) (286) (56) 0 (695) Fee and commission income 3,731 4,585 13,651 (984) 20,982 Fee and commission expense (644) (829) (1,263) 961 (1,775) Net fee and commission income 3,087 3,756 12,388 (23) 19,207 Other income 4,671 233 2,585 (5,941) 1,549 Total operating income 13,057 7,902 17,623 (5,803) 32,780 Operating expenses Personnel expenses 3,458 2,017 9,211 0 14,686 General and administrative expenses 3,507 3,313 4,147 (2,481) 8,486 Depreciation, amortization and impairment of non-financial 1,013 261 750 (115) 1,909 Total operating expenses 7,978 5,591 14,108 (2,596) 25,081 Operating profit / (loss) before tax 5,079 2,311 3,515 (3,207) 7,699 Tax expense / (benefit) 238 444 912 (107) 1,488 Net profit / (loss) 4,840 1,868 2,603 (3,100) 6,211 Net profit / (loss) attributable to non-controlling interests 0 0 15 0 15 Net profit / (loss) attributable to shareholders 4,840 1,868 2,588 (3,100) 6,196 1 Amounts presented for UBS AG under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2020 Comprehensive income attributable to shareholders Net profit / (loss) 4,840 1,868 2,588 (3,100) 6,196 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax 81 1,228 690 (969) 1,030 Financial assets measured at fair value through other comprehensive income, net of tax 0 0 137 0 136 Cash flow hedges, net of tax 902 26 101 (18) 1,011 Cost of hedging, net of tax (13) (13) Total other comprehensive income that may be reclassified to the income statement, net of tax 971 1,254 928 (988) 2,165 Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax (67) (107) 40 0 (134) Own credit on financial liabilities designated at fair value, net of tax (293) (293) Total other comprehensive income that will not be reclassified to the income statement, net of tax (360) (107) 40 0 (427) Total other comprehensive income 611 1,147 968 (988) 1,738 Total comprehensive income attributable to shareholders 5,451 3,015 3,556 (4,088) 7,934 Total comprehensive income attributable to non-controlling interests 36 36 Total comprehensive income 5,451 3,015 3,592 (4,088) 7,970 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) As of 31 December 2020 Assets Cash and balances at central banks 34,426 91,638 32,167 158,231 Loans and advances to banks 40,171 6,385 19,465 (50,678) 15,344 Receivables from securities financing transactions 56,568 4,026 43,350 (29,735) 74,210 Cash collateral receivables on derivative instruments 32,771 1,543 10,093 (11,671) 32,737 Loans and advances to customers 99,952 228,279 73,513 (20,767) 380,977 Other financial assets measured at amortized cost 8,411 8,084 13,368 (2,644) 27,219 Total financial assets measured at amortized cost 272,299 339,956 191,957 (115,495) 688,717 Financial assets at fair value held for trading 110,812 55 16,260 (1,634) 125,492 of which: assets pledged as collateral that may be sold or repledged by counterparties 54,468 1 6,247 (13,617) 47,098 Derivative financial instruments 154,313 6,342 44,005 (45,041) 159,618 Brokerage receivables 16,898 7,763 (2) 24,659 Financial assets at fair value not held for trading 46,198 13,068 36,444 (15,672) 80,038 Total financial assets measured at fair value through profit or loss 328,221 19,464 104,473 (62,350) 389,808 Financial assets measured at fair value through other comprehensive income 187 8,072 8,258 Investments in subsidiaries and associates 53,606 38 439 (52,526) 1,557 Property, equipment and software 6,999 1,335 3,975 (350) 11,958 Goodwill and intangible assets 217 6,234 28 6,480 Deferred tax assets 840 1 8,334 (1) 9,174 Other non-financial assets 6,641 2,063 854 (183) 9,374 Total assets 669,010 362,857 324,337 (230,878) 1,125,327 Liabilities Amounts due to banks 41,414 34,096 43,066 (107,527) 11,050 Payables from securities financing transactions 17,247 566 18,407 (29,899) 6,321 Cash collateral payables on derivative instruments 35,875 561 12,495 (11,618) 37,313 Customer deposits 98,441 293,371 112,372 23,745 527,929 Funding from UBS Group AG 53,979 53,979 Debt issued measured at amortized cost 75,658 9,687 3 3 85,351 Other financial liabilities measured at amortized cost 5,285 2,567 5,745 (3,175) 10,421 Total financial liabilities measured at amortized cost 327,898 340,848 192,088 (128,470) 732,364 Financial liabilities at fair value held for trading 28,800 335 5,989 (1,529) 33,595 Derivative financial instruments 156,192 5,593 44,359 (45,043) 161,102 Brokerage payables designated at fair value 25,045 13,704 (7) 38,742 Debt issued designated at fair value 58,986 935 (54) 59,868 Other financial liabilities designated at fair value 11,255 23,445 (2,927) 31,773 Total financial liabilities measured at fair value through profit or loss 280,279 5,927 88,433 (49,559) 325,080 Provisions 1,293 301 1,197 2,791 Other non-financial liabilities 2,173 987 3,907 (49) 7,018 Total liabilities 611,643 348,063 285,625 (178,078) 1,067,254 Equity attributable to shareholders 57,367 14,794 38,393 (52,800) 57,754 Equity attributable to non-controlling interests 319 319 Total equity 57,367 14,794 38,712 (52,800) 58,073 Total liabilities and equity 669,010 362,857 324,337 (230,878) 1,125,327 1 Amounts presented for UBS AG available under “Complementary financial information” at ubs.com/investors, for information prepared UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, Supplemental guarantor consolidated USD million UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2020 Net cash flow from / (used in) operating activities (14,883) 24,661 26,804 36,581 Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets 0 (3) (43) (46) Disposal of subsidiaries, associates and intangible assets 2 14 0 660 674 Purchase of property, equipment and software (714) (162) (697) (1,573) Disposal of property, equipment and software 361 0 3 364 Purchase of financial assets measured at fair value through other (77) 0 (6,213) (6,290) Disposal and redemption of financial assets measured at income 79 0 4,451 4,530 Net (purchase) / redemption of debt securities measured (3,021) 132 (1,277) (4,166) Net cash flow from / (used in) investing activities (3,357) (33) (3,117) (6,506) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) 23,828 17 0 23,845 Distributions paid on UBS AG shares (3,848) 0 0 (3,848) Issuance of debt designated at fair value and long-term debt measured 3 78,867 1,057 229 80,153 Repayment of debt designated at fair value and long-term debt measured 3 (86,204) (776) (118) (87,099) Net cash flows from other financing activities (290) 0 (263) (553) Net activity related to group internal capital transactions and dividends 2,984 (1,307) (1,677) 0 Net cash flow from / (used in) financing activities 15,336 (1,009) (1,829) 12,498 Total cash flow Cash and cash equivalents at the beginning of the year 39,598 62,551 17,655 119,804 Net cash flow from / (used in) operating, investing and financing (2,905) 23,619 21,859 42,573 Effects of exchange rate differences on cash and cash equivalents 2,706 7,171 1,175 11,053 Cash and cash equivalents at the end of the year 4 39,400 93,342 40,689 173,430 of which: cash and balances at central banks 34,283 91,638 32,167 158,088 of which: loans and advances to banks 4,085 1,695 8,148 13,928 of which: money market paper 5 1,032 9 374 1,415 1 Cash flows generally represent sale of the majority stake 3,828 million of cash and cash equivalents were restricted. comprehensive income, Financial assets at fair value not held for trading and Other financial assets Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2019 Operating income Interest income from financial instruments measured at fair value through other comprehensive income 4,864 4,048 3,719 (1,928) 10,703 Interest expense from financial instruments measured at (6,547) (737) (2,317) 2,298 (7,303) Net interest income from financial instruments measured profit or loss 1,177 (228) 394 (327) 1,015 Net interest income (506) 3,083 1,796 42 4,415 Other net income from financial instruments measured profit or loss 5,116 924 1,114 (322) 6,833 Credit loss (expense) / release (51) 7 (33) 0 (78) Fee and commission income 3,285 4,342 12,527 (997) 19,156 Fee and commission expense (674) (819) (1,188) 986 (1,696) Net fee and commission income 2,610 3 3,523 3 11,338 (11) 17,460 Other income 4,899 259 1,960 (6,442) 677 Total operating income 12,069 7,796 16,176 (6,733) 29,307 Operating expenses Personnel expenses 3,251 1,936 8,614 0 13,801 General and administrative expenses 3,467 3,181 4,565 (2,627) 8,586 Depreciation, amortization and impairment of non-financial 954 221 772 (196) 1,751 Total operating expenses 7,672 5,338 13,951 (2,823) 24,138 Operating profit / (loss) before tax 4,396 2,458 2,225 (3,911) 5,169 Tax expense / (benefit) 175 514 530 (21) 1,198 Net profit / (loss) 4,221 1,944 1,695 (3,890) 3,971 Net profit / (loss) attributable to non-controlling interests 0 0 6 0 6 Net profit / (loss) attributable to shareholders 4,221 1,944 1,689 (3,889) 3,965 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, ownership of a comparability” in the “UBS AG standalone financial statements” section of the UBS AG Standalone financial Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2019 Comprehensive income attributable to shareholders Net profit / (loss) 4,221 1,944 1,689 (3,889) 3,965 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax 5 150 39 (102) 92 Financial assets measured at fair value through other comprehensive income, net of tax 0 0 117 0 117 Cash flow hedges, net of tax 870 140 147 (15) 1,143 Total other comprehensive income that may be reclassified to the income statement, net of tax 875 290 303 (117) 1,351 Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax (89) (6) (75) 0 (170) Own credit on financial liabilities designated at fair value, net of tax (392) (392) Total other comprehensive income that will not be reclassified to the income statement, net of tax (481) (6) (75) 0 (562) Total other comprehensive income 394 284 228 (117) 789 Total comprehensive income attributable to shareholders 4,616 2,228 1,917 (4,007) 4,754 Total comprehensive income attributable to non-controlling interests 2 2 Total comprehensive income 4,616 2,228 1,919 (4,007) 4,756 1 Amounts presented for UBS AG under “Complementary financial information” at ubs.com/investors for information prepared in accordance with Swiss GAAP. sub-groups UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG, Supplemental guarantor consolidated USD million UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2019 Net cash flow from / (used in) operating activities 17,531 8,882 (7,608) 18,805 Purchase of subsidiaries, associates and intangible assets (6) 0 (20) (26) Disposal of subsidiaries, associates and intangible assets 2 100 0 14 114 Purchase of property, equipment and software (628) (173) (600) (1,401) Disposal of property, equipment and software 10 0 1 11 Purchase of financial assets measured at fair value through other (10) 0 (3,414) (3,424) Disposal and redemption of financial assets measured at income 10 0 3,904 3,913 Net (purchase) / redemption of debt securities measured (1,045) 437 45 (562) Net cash flow from / (used in) investing activities (1,569) 264 (70) (1,374) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) (17,150) 0 0 (17,149) Distributions paid on UBS AG shares (3,250) 0 0 (3,250) Issuance of debt designated at fair value and long-term debt measured 3 64,285 621 142 65,047 Repayment of debt designated at fair value and long-term debt measured 3 (67,113) (752) (1,017) (68,883) Net cash flows from other financing activities (262) 0 (242) (504) Net activity related to group internal capital transactions and dividends 3,569 (2,055) (1,514) 0 Net cash flow from / (used in) financing activities (19,922) (2,186) (2,630) (24,738) Total cash flow Cash and cash equivalents at the beginning of the year 42,895 54,757 28,201 125,853 Net cash flow from / (used in) operating, investing and financing (3,960) 6,961 (10,308) (7,307) Effects of exchange rate differences on cash and cash equivalents 664 833 (239) 1,258 Cash and cash equivalents at the end of the year 4 39,598 62,551 17,655 119,804 of which: cash and balances at central banks 36,275 60,926 9,756 106,957 of which: loans and advances to banks 2,697 1,127 7,493 11,317 of which: money market paper 5 626 498 406 1,530 1 Cash flows generally represent a associates. 3,192 paper is included in the balance sheet under Financial assets at and Other financial assets measured at amortized cost. |
MD&A - Risk management and cont
MD&A - Risk management and control | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Financial Risk Management Explanatory | Audited | Credit risk: contractual obligations toward UBS. This includes Settlement risk: security versus cash) where we must deliver without we will receive the countervalue. Loan underwriting risk: that are intended for further distribution. Step-in risk: that is facing stress in the absence of, or in excess of, support. Audited | Market risk market variables. Market variables include observable rates, equity prices, credit spreads and commodity (including that may be unobservable or only indirectly observable, includes issuer risk and investment risk. Issuer risk: an issuer to which we are exposed through tradable securities Investment risk: Audited | Liquidity risk: unexpected current and forecast cash flows and collateral operations or the financial condition of the Audited | Funding risk: the market on an unsecured (or even secured) basis at proposed commitments; i.e., the risk that UBS’s funding firm’s current business and desired strategy. Audited The Board management and control framework of the Group, including the Group supported the framework approved appetite methodology. Committee (the CCRC) helps the BoD and conduct, pertaining The relating to financial reporting, and the external and internal audit functions. The Group Executive Board for establishing and framework in the Group, as a whole. The Group has accountability has risk authority over allocates approved by The business division Presidents and are responsible for the divisions, and risk appetite of the business division. The regional are - divisional collaboration in their about potentially material regulatory or reputational concerns. The Group Chief for framework (including market, risks. This controls approves credit and Control is and control and authorities support the risk control process. The Group is responsible framework, identification, operational risk, identified, owned and managed according to the operational risk appetite objectives, supported by an effective control framework. The Group is transparency in assessing the financial performance of the Group and the accounting, Additional responsibilities well as treasury liquidity risk and UBS’s regulatory capital ratios. The Group Group’s legal effective or its The Head of oversight Group (GIA) effectiveness of processes to define overall effectiveness including compliance with legal and regulatory requirements and internal Chairman of the BoD. the BoD Audit Committee. Some certain significant legal entities of the Group. The legal entity risk officers financial entities of the which framework. Audited | to concentrations. Risks measures preapproval of specific transactions restrictions. dedicated independent validation. Audited Risk positions within or significant such risk concentrations critical component of our risk management and control process. For financial risks, we consider a number shared the factors. markets where the positions are traded, as well as the availability and factors. This includes an assessment of the provider of and market liquidity where the hedge might be traded. Particular attention is given risk. Wrong-way risk the size of is when a position and same event. For non-financial risks, risk concentrations may result from, example, (i.e., has number issues that may link together to create a high impact. Risk concentrations Risk Control and mitigated, possible financial stressed environment differ models. |
MD&A - Risk management and co_2
MD&A - Risk management and control - Credit Risk | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Credit Risk Explanatory | Global predominant ly conduct s securities-based (Lombard) lending and mortgage lending. A substantial portion of lending exposure arises from Personal & mainly estate, as the performance of the Swiss economy. The lending, Derivatives ding mainly investment rated and give rise to temporary concentrated exposure. Credit derivative transactions and securitized positions. Audited | management techniques Credit risk based on our estimates of probability at established for individual counterparties and groups of related counterparties covering banking and traded products, settlement amounts. Risk authorities are approved by the BoD and divisional credit rating and potential for losses. Limits apply also exposure of traded products. The framework held to maturity (take-and-hold for distribution or risk transfer (temporary exposures). We expected loss, statistical loss and stress business division levels, and to establish portfolio limits. Credit similar have comparable economic to meet contractual obligations would be changes credit controls that constrain portfolio product exposures. Audited Counterparty (CCR) arising products, which include OTC originating in ent , Non - core and Portfolio, out movements the time Bank, counterparty, size limit dependent the counterparty’s creditworthiness Limit specific classes or portfolio limits management. Trading counterparties used, we on a bilateral International Swaps master and netting law. two-way collateral required to securities collateral typically consists collateral counterparties, an the variation transactions. Regulations on margining continue to evolve. These generally expand derivatives greater amounts certain bilateral trading counterparties than had been required in the past. These changes should result in lower close-out risk over time. Audited | collateral against exposures and by utilizing credit hedging. Audited | to-back process Swiss mortgage ratio and an affordability calculation relative to gross income. Audited | lowest model - derived valuations, purchase (IPRE), owner-occupied residential properties (ORPs). Audited Global portfolio, sufficiency. types, based on associated risk factors, such as property type, loan and approval 45 % to 80 %. In other scores are also part underwriting guidelines. A applied Management are concentrations, segments, by a specialized management. Supplementing this limit framework is a real estate lending policy estate programs monitor documentation requirements. For Management regions of underwriting regulatory underwriting collateral sufficiency. Affordability is rate using, income and declared liabilities, quality and sustainability of rental a declared The applicable LTV for each mortgage is based on the quality and liquidity bank-appointed 30 % to 70 %, depending as supported by personal guarantees from the borrower. The overall portfolio is centrally assessed against a to ensure that exposures Audited securities, financial are primarily liquid transferable transferable securities, which provides a market. To used. We derive pledged ’ s H aircuts rketable securities are calculated given close-out volatile collateral will typically have larger haircuts. We assess concentration and posted counterparties. We concentration. issuers currencies may result cases, the out levels are adjusted accordingly. Audited | index CDSs, bespoke protection and other instruments to manage Legacy Portfolio. The specific profit effect arising adjustments (CVAs). We have into when not apply credit mitigants , such hedges (credit credit - index CDSs , to . credit protection protection protection providers, and also hedges counterparties. collateralized. lending portfolio, the maturity the associated loan. Such mismatches result in basis risk and may reduce the effectiveness of the credit routinely taken when necessary. Audited | credit losses that may be implicit in our current portfolio. Exposures three given credit facility, the product of these three parameters results in majority of our internal measures of credit regulatory capital calculation under based models loss, statistical loss and stress loss. Internal UBS rating scale and mapping of external ratings Internal UBS rating 1-year PD range in % Description Moody’s Investors Service mapping S&P mapping Fitch mapping 0 and 1 0.00–0.02 Investment grade Aaa AAA AAA 2 0.02–0.05 Aa1 to Aa3 AA+ to AA– AA+ to AA– 3 0.05–0.12 A1 to A3 A+ to A– A+ to A– 4 0.12–0.25 Baa1 to Baa2 BBB+ to BBB BBB+ to BBB 5 0.25–0.50 Baa3 BBB– BBB– 6 0.50–0.80 Sub-investment grade Ba1 BB+ BB+ 7 0.80–1.30 Ba2 BB BB 8 1.30–2.10 Ba3 BB– BB– 9 2.10–3.50 B1 B+ B+ 10 3.50–6.00 B2 B B 11 6.00–10.00 B3 B– B– 12 10.00–17.00 Caa1 to Caa3 13 >17 Ca to C CCC to C CCC to C Counterparty is in default Default Defaulted D D |
Disclosure Of Financial Assets That Are Either Past Due Or Impaired Explanatory | Audited | non-performing when: (i) it is more than subject conditions have been (forbearance); enforced sufficient collateral to cover evidence that recourse to collateral. Default and credit-impaired UBS uses determining the PD of definition criteria. payments of interest, principal or fees are overdue 90 days, or to loans to Banking Region presumption those portfolios, of the credit bankruptcy, commenced; terms obligations will not latter may have been made when due. If one claim against a counterparty defaulted treated as defaulted. An instrument - impaired counterparty is identified as instrument is POCI if it has been purchased at a deep discount to its originated with a defaulted counterparty. Once classified reported as past due amounts have been restructured, and three-month probation period is applied before stages 1 or 2 in stage 3 for a longer no instruments classified as POCI on our books. Audited occurred, difficulties course extending maturity, modifying the schedule of equity takes place, each case is considered individually and the exposure is remains conditions are granted that or the counterparty has recovered and the preferential conditions no longer exceed our risk tolerance. Contractual imminent conditions are within our usual risk to be forborne. |
MD&A - Risk management and co_3
MD&A - Risk management and control - Market Risk | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Market Risk Explanatory | Market activities. Trading equity underwriting market-making well as in Group in Global Wealth Non-trading interest ed with personal business, our Swiss the Investment Bank’s lending business, Group assumes managing and the Group’s liquidity and funding profile, including HQLA. Equity and debt investments can also give rise to market as benefit pension schemes. Market risk limits are set for the Group, the business divisions, Group Treasury and Non-core and Legacy Portfolio at granular levels magnitude of the market risks. Management VaR framework, trading market risks. Non-trading VaR Treasury Risk Control, as set out below. Our adjusted business divisions and Board of Directors (the BoD). These granular limits for general and specific market trading which volatility, and, for our single-name exposures, issuer credit quality. Trading portfolio transactions, transaction risk factors Thus portfolio between specific positions and associated hedges. Issuer level maximum zero recovery). Non-trading foreign exchange risk limits, with the exception of consolidated capital activity. Our Market & risk ting the - related - taking framework is by the equity from interest rates, sensitivity monitored against targets set by the Group CEO, so as the outlook and volatility expected interest rates. Limits the effect and exchange testing metrics, which flow into our risk appetite framework. Equity controls, management reporting. stress testing metrics. Audited | potential period) change in the We derived from our returns over the positions are sensitive to, and subsequently quantifies the profit / loss effect factor exchange and commodities risk historical us ing a - year - back window. Risk factor returns e.g., equity price and credit residual approach. Systematic and profit and residual systematic and implicitly modeling properties Depending on the stationarity properties of a given returns or logarithmic returns. updated fortnightly. Our VaR we source full revaluation grids systems, enabling us effects. We purposes risk R WA, consider internal measure exposures 95 % confidence 1-day associated with market risk used to under Basel III requires 99 % confidence level using a 10-day holding period use 10 - day with all observations equally weighted. Additionally, regulatory meets Management example, securitization securitization approach for regulatory purposes. We also use risk RWA. SVaR uses broadly the VaR and is (10-day) and 99 %). Unlike historical covering from 1 January seek the largest 10-day holding period VaR for the current Group portfolio across 2007 to the present. SVaR is computed weekly. Audited | implied by VaR for a variety of reasons. VaR is calibrated to indicate potential losses beyond this confidence level. The 1-day time horizon used for VaR for internal management purposes market risk within the specified period. In changes in This may happen due to the number of risk factors included in the VaR model needing to be limited. Effects errors, which the potential for actual volatility and correlation levels to differ from assumptions implicit in VaR calculations. Using a volatility will tend shorter affect VaR of increased volatility, as markets stabilize, remain the length of the historical observation period. SVaR is subject to the limitations noted for VaR above, but the use of one-year data sets avoids the smoothing effect of the five- year window gives a longer history of potential loss events. Therefore, although financial period used for management and regulatory to use of the regulatory capital requirements for market risks. We recognize associated metrics with both overlapping and complementary characteristics to completeness statistical aggregate risk measure, VaR supplements adjusted stress and comprehensive stress testing frameworks. We also risks not as risks not in VaR. with regulatory capital, calculated as a multiple of regulatory VaR and stressed VaR. Audited There material in 2021. Audited | Loans and , Loans , Financial assets at , Financial assets measured , Customer , Debt measured , subject to may statement, depending on their accounting treatment. Our customer Management interest Management Treasury, interest originating management. The residual interest interest rate swaps, to the vast majority of which we apply hedge accounting. classified as Financial assets at hedged with derivatives Long-term swaps designated in fair value hedge accounting relationships. Risk management and governance IRRBB which are the following. – Interest rate changes in are calculated as changes in the present value of irrespective of factors for statistical and stress-based measures, e.g., value-at- risk measured arising from the most adverse regulatory interest rate scenario after As the measure, we appl y an tric that includes modeled and real estate. – Net interest set ich we internally calculate by develop according assum ing constant management actions. which, includes measured and reported monthly. We actively NII, while keeping the EVE EVE and at consolidated and the sensitivity of EVE and NII under stressed market conditions by applying a suite as well as specific economic scenarios. The Group relevant, oversight over the management of IRRBB, Group Internal Audit and model governance. › Refer to “Group Internal Audit” in the “Corporate section of this report and to “Risk measurement” for more information Key modeling assumptions The cash flows in calculation other spread and are are instruments are modeled includes commercial horizon, assuming constant balance sheet structure and volumes, and options. The average loans is determined via protect determined simulating historically calibrated client rate and volume models. We prepayment agency liquidity These prepayment rates are used to forecast both mortgage loan and MBS prepayment model is used for management and regulatory fixed-term deposits generally do not carry similar to prepayment and early redemption penalties. |
Sensitivity Analysis For Each Type Of Market Risk | Management value-at-risk (1-day, 95% confidence, 5 years of historical data) of our business divisions and Group Functions by general market risk type 1 For the year ended 31.12.21 USD million Equity Interest rates Credit spreads Foreign exchange Commodities Min. 1 7 5 1 2 Max. 35 13 11 9 5 Average 7 9 7 3 3 31.12.21 8 11 7 6 3 Total management VaR, Group 4 36 11 12 Average (per business division and risk type) Global Wealth Management 1 3 1 2 0 1 2 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 3 36 11 11 7 9 7 3 3 Group Functions 4 8 5 4 0 4 4 1 0 Diversification effect 2,3 (6) (5) 0 (5) (5) (1) 0 For the year ended 31.12.20 USD million Equity Interest rates Credit spreads Foreign exchange Commodities Min. 3 6 5 2 2 Max. 29 11 11 7 6 Average 10 8 7 4 4 31.12.20 6 8 8 3 3 Total management VaR, Group 8 31 13 11 Average (per business division and risk type) Global Wealth Management 0 2 1 1 0 1 1 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 7 32 12 10 10 7 6 4 4 Group Functions 4 7 5 6 0 4 3 1 0 Diversification effect 2,3 (5) (8) 0 (4) (4) (1) 0 1 Statistics at individual levels may not be line or risk type, being driven by the extreme loss tail of the corresponding distribution of simulated profits and rendering invalid the simple summation of figures to arrive at the aggregate total. a whole. Audited regulatory EVE 15 % of tier 1 exposure value FINMA interest rate scenarios. As banking book to a +1-basis-point parallel shift in yield curves was negative 29.9 27.2 million as of sensitivity was driven quarter income should interest sensitivity Pillar 3 4.5 million per with a modeled sensitivity of USD 22.1 which 15.6 5.5 the US dollar and the Swiss franc portfolios, respectively. The would change 6.0 billion, 10.0 % capital, which would 15 % of scenario reduction of 1.8 %, or USD 1.1 banking book that is measured at fair value through profit or loss and Financial assets comprehensive . positive effect on net interest income. Interest rate risk – banking book USD million +1 bp Parallel up 1 Parallel down 1 Steepener 2 Flattener 3 Short-term up 4 Short-term down 5 CHF (5.1) (724.1) 806.3 (254.3) 117.1 (158.7) 162.5 EUR (1.1) (196.6) 231.9 (69.0) 37.4 (24.1) 27.4 GBP 0.1 33.3 (32.8) (31.1) 35.3 45.4 (43.7) USD (23.5) (5,068.3) 4,124.2 (821.4) (362.3) (2,165.9) 2,315.6 Other (0.4) (85.8) 19.9 (3.7) (34.5) (59.6) 3.8 Total effect on economic value of equity as per Pillar 3 requirement as of 31.12.21 (29.9) (6,041.4) 5,149.5 (1,179.6) (207.0) (2,362.9) 2,465.6 Additional tier 1 (AT1) capital instruments 4.5 853.4 (928.4) (9.6) 197.1 531.5 (553.3) Total including AT1 capital instruments as of 31.12.21 (25.4) (5,188.0) 4,221.1 (1,189.2) (10.0) (1,831.4) 1,912.3 1 Rates across all tenors move by ±150 bps for and long-term rates decrease. Audited | equity holdings in of purposes, including investments house may also make investments in fund interests sometimes from funds that we have sold to clients. The fair value of equity factors specific are generally and may be subject to lock-up generally measures investments are subject to a different range of controls, including preapproval Risk monitoring included in which flow into our risk appetite framework. As investment fund units totaling USD 3.0 1.8 billion was Financial assets trading 1.2 Investments in associates . Audited | Financial assets measured fair value at fair Equity , and can broadly debt securities primarily reasons. The classified as Financial assets depends which we risk sensitivity statistical appetite framework. Debt instruments classified as Financial assets measured at fair value 8.8 31 December USD 8.3 of 31 December 2020. |
MD&A - Risk management and co_4
MD&A - Risk management and control - Liquidity and funding management | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Description Of Managing Liquidity Risk | Audited | positions value across a current and of measures to conditions. behavioral results external measures, primarily the liquidity coverage ratio (the LCR) and funding strategy is proposed by Group Treasury the which is a is overseen by the BoD). Audited set business least Chief Financial Treasurer current principles are designed franchise liability on supplementary the resources. Treasury regarding used regional Control funding Audited | has liabilities survive liquidity stress instructed by firm’s liquidity reserves. Our liquid assets to and un expected volatility caused events. The liquid asset as to operate at all relevant Group and subsidiary liquidity requirements. Audited | and liability structure that enables balanced liquidity Liquidity crisis scenario support the liquidity management process immediate liquidity shortfalls can be put into effect. Audited | our types of crisis events. This assessment of contingent actions metrics, and contingency procedures. and global scope of expected cash flows, quality collateral that could be used required. Our contingent funding liquid facilities at several liquid , and business management actions. Audited including concentration risks, aiming a management team looks structure Our liquidity account the support market conditions. |
MD&A - Capital management
MD&A - Capital management | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Objectives Policies And Processes For Managing Capital Explanatory | Audited | meeting both internal assessment and regulatory requirements a prerequisite for conducting our business activities. Audited We leverage denominator (LRD) and TLAC ratio levels based on our regulatory requirements strategic focus financial Functions, as well within business resource projections, which are reflected in our capital plans. The a - planning component that is is based on to the business divisions. Limits and division levels, and the target-setting process, potential future TLAC in comparisons policy changes. |
Regulatory capital and movement [text block] | Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital USD million 31.12.21 31.12.20 Total IFRS equity 61,002 59,765 Equity attributable to non-controlling interests (340) (319) Defined benefit plans, net of tax (270) (41) Deferred tax assets recognized for tax loss carry-forwards (4,565) (5,617) Deferred tax assets on temporary differences, excess over threshold (49) (5) Goodwill, net of tax 1 (5,838) (6,319) Intangible assets, net of tax (180) (296) Compensation-related components (not recognized in net (1,700) (1,349) Expected losses on advanced internal ratings-based portfolio less provisions (482) (330) Unrealized (gains) / losses from cash flow hedges, net of tax (628) (2,321) Own credit related to gains / losses on financial liabilities 315 382 Own credit related to gains / losses on derivative financial instruments (50) (45) Unrealized gains related to debt instruments at fair value through (68) (152) Prudential valuation adjustments (167) (150) Accruals for dividends to shareholders (1,700) (1,314) Capital reserve for potential share repurchases (2,000) Other 1 0 Total common equity tier 1 capital 45,281 39,890 1 Includes goodwill 22 413 associates. Audited | premium, related issued; and reconciliation of “Reconciliation of IFRS equity to Swiss capital” table. Our 5.4 45.3 billion as profit before 9.5 0.5 eligible deferred 0.4 billion decrease of Centre AG (previously Fondcenter 0.2 billion related entity were partly offset by dividend accruals of USD 1.7 tax expenses 1.6 repurchase program of USD 0.6 effects of 0.6 capital components of USD 0.4 defined benefit plans of USD 0.2 Our USD 0.6 repurchase programs 2.6 of the 2.0 billion. fully utilized during 2021. Our loss-absorbing additional tier 1 (AT1) capital decreased by USD 1.1 15.2 USD 2.6 dollars hedge effects, 2.25 of AT1 capital instruments denominated in US dollars. Audited | by USD 1.3 44.3 included 41.1 debt. |
UBS AG | |
Entity [Table] | |
Regulatory capital and movement [text block] | Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital (UBS Group AG vs UBS AG consolidated) As of 31.12.21 USD million UBS Group AG (consolidated) UBS AG (consolidated) Difference Total IFRS equity 61,002 58,442 2,559 Equity attributable to non-controlling interests (340) (340) Defined benefit plans, net of tax (270) (270) Deferred tax assets recognized for tax loss carry-forwards (4,565) (4,565) Deferred tax assets on temporary differences, excess over threshold (49) (350) 302 Goodwill, net of tax (5,838) (5,838) Intangible assets, net of tax (180) (180) Compensation-related components (not recognized in net (1,700) (1,700) Expected losses on advanced internal ratings-based portfolio less provisions (482) (482) Unrealized (gains) / losses from cash flow hedges, net of tax (628) (628) Own credit related to gains / losses on financial liabilities 315 315 Own credit related to gains / losses on derivative financial instruments (50) (50) Unrealized gains related to debt instruments at fair value through (68) (68) Prudential valuation adjustments (167) (167) Accruals for dividends to shareholders (1,700) (4,200) 2,500 Other 1 (24) 25 Total common equity tier 1 capital 45,281 41,594 3,687 |
Material accounting policies (P
Material accounting policies (Policies) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Basis of accounting | The Financial Statements have been prepared in accordance with International Financial Reporting International presented in US dollars (USD). Disclosures and funding, integral part of the Financial to requirements Financial Instruments: , and Presentation , and repeated in this section. The applied consistently in all years presented unless otherwise stated in Note 1b. |
Critical accounting estimates and judgments | Preparation of these Financial to apply amounts contingent time they are made. Such available such estimates assumptions, which future and other pertinent factors, to determine their continuing relevance based on current conditions, estimates and Statements. Furthermore, actual results may differ significantly from UBS’s estimates, was anticipated The judgment Financial Statements: – expected credit loss measurement (refer to item 2g in this Note and to Note 20); – fair value measurement (refer to item 2f in this Note – income taxes (refer to item 6 in this Note and to Note – provisions and contingent liabilities (refer to item 9 Note 18); – post-employment benefit 27); – goodwill (refer to item 8 in this Note and to Note – consolidation of structured entities (refer to Note 29). |
Consolidation | The Financial Statements comprise the parent company as ; intercompany balances have been it when (ii) exposure to use its power to affect its own returns. Consideration determine whether the Group has the current ability decisions about those activities need to be made. Subsidiaries, when control control ceases. and circumstances indicate that there is a change to one or more elements required to establish that control is present. Business combinations are accounted for using the acquisition method. The amount of any non-controlling at acquiree’s identifiable net assets. Critical accounting estimates and judgments Each aforementioned consolidation principles. complex determining whether extent of UBS’s involvement is unique for each entity, consolidation outcome consolidated while assessment, judgment circumstances, including the the substance of voting and similar rights. |
Financial instruments | Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – cash and balances at central banks; – loans and advances to banks; – receivables from securities financing transactions; – cash collateral receivables on derivative instruments; – residential and commercial mortgages; – corporate loans; – secured loans, including Lombard loans, and unsecured loans; – loans to financial advisors; – debt securities held as high-quality liquid (HQLA). Measured at amortized cost using the effective interest method less allowances for expected credit losses (refer to items 2d and 2g in this Note for more information). The following items are recognized in the income statement: – interest income, which is accounted for in accordance with item 2d – ECL and reversals; – foreign exchange (FX) translation gains and losses. When a financial asset at amortized cost is derecognized, the gain or loss is recognized in the income statement. For amounts arising from settlement of certain derivatives, refer to the next page. Measured at FVOCI Debt instruments measured at FVOCI This classification primarily includes debt securities certain asset-backed securities held as HQLA. Measured at fair value, reported in Other comprehensive income, net of applicable income taxes, until such investments are derecognized. Upon derecognition, any accumulated balances in Other comprehensive income are reclassified to the income statement and reported within Other income. The following items, which are determined on the basis as for financial assets measured at amortized cost, recognized in the income statement: – interest income, which is accounted for in accordance with item 2d – ECL and reversals; – FX translation gains and losses. Financial assets classification Significant items included Measurement and presentation Measured at FVTPL Held for trading Financial assets held for trading include: – all derivatives with a positive replacement value, those that are designated and effective hedging instruments; and – other financial assets acquired principally for the purpose of selling or repurchasing in the near term, or that are part of a portfolio of identified financial instruments that are managed together and for there is evidence of a recent actual pattern of short-term profit taking. Included in this category are debt instruments (including those in the form of money market paper, loans) and equity instruments. Measured at fair value, income statement. Derivative assets (including derivatives that and effective hedging instruments) are generally presented as Derivative financial instruments , except those exchange-traded (ETD) and over-the-counter cleared derivatives that are legally settled on a daily or in substance net settled on a daily basis, presented within Cash collateral receivables on derivative instruments. Changes in fair value, initial transaction costs, and gains and losses arising on disposal or redemption recognized in Other net income from financial instruments measured at fair value through , except interest income on instruments other than derivatives (refer to item 2d in this Note), interest on derivatives designated as hedging instruments of interest rate risk and forward points on certain short- and long-duration FX contracts acting as economic hedges, which are reported in Net interest income. Changes in the fair value of derivatives that designated and effective hedging instruments are presented either in the income statement or Other comprehensive income , depending on the type of hedge relationship (refer to item 2j in this Note for more information). Mandatorily measured at FVTPL – Other This classification includes financial assets measured at FVTPL that are not held for trading, as follows: – certain structured loans, certain commercial loans, and receivables from securities financing transactions are managed on a fair value basis; – loans managed on a fair value basis, including those hedged with credit derivatives; – certain debt securities held as HQLA and fair value basis; – certain investment fund holdings and assets hedge delivery obligations related to cash-settled employee compensation plans; – brokerage receivables, for which contractual cash flows do not meet the SPPI criterion because the aggregate balance is accounted for as a single unit of with interest being calculated on the individual components; – auction rate securities, for which contractual cash do not meet the SPPI criterion because interest may reset at rates that contain leverage; – equity – assets held under unit-linked investment contracts. Financial liabilities classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – demand and time deposits; – retail savings / deposits; – payables – non-structured fixed-rate bonds; – subordinated debt; – certificates of deposit and covered bonds; and – cash collateral payables on derivative instruments. Measured at amortized cost using the effective interest method. When a financial liability at amortized cost is derecognized, the gain or loss is recognized in the income statement. Measured at fair value through profit or loss Held for trading Financial liabilities held for trading include: – all derivatives with a negative replacement value (including certain loan commitments), that are designated and effective hedging instruments; and – obligations to deliver financial instruments, debt and equity instruments, that UBS has third parties but does not own (short positions). Measurement and presentation of financial liabilities classified at FVTPL follow the same principles financial assets classified at FVTPL, except that of change in the fair value of a financial liability designated at FVTPL that is attributable to changes UBS’s own credit risk is presented in Other comprehensive income Retained earnings and is never reclassified to the income statement. Derivative liabilities (including derivatives that designated and effective hedging instruments) generally presented as Derivative financial instruments , except those exchange-traded and OTC-cleared derivatives that are legally settled on a daily basis substance net settled on a daily basis, which presented within Cash collateral payables on derivative instruments. Designated at FVTPL UBS designates liabilities: – issued hybrid debt instruments that primarily equity-linked, credit-linked and rates-linked bonds notes; – issued debt instruments managed on a fair basis; – certain payables from securities financing transactions; – amounts due under unit-linked investment contracts the cash flows of which are linked to financial measured at FVTPL and eliminate an accounting mismatch; – brokerage payables, which arise in conjunction with brokerage receivables and are measured at FVTPL to achieve measurement consistency. Classification, measurement and presentation UBS recognizes financial instruments when it contractual date derivative financial instruments. In transactions the financial the transferor, UBS does not recognize the transferred as its asset. UBS also acts in a fiduciary capacity, which results in it holding or benefit plans and definition they are income is excluded from the Financial Statements. Client execution through neither obtains benefits from nor controls such cash balances. All financial instruments value through through . For financial subsequently measured at amortized cost or value is adjusted for directly attributable transaction costs. Where the flows that are the the is classified business model that has collect business with the objective being achieved collecting contractual cash flows and selling financial assets. All those except for derivatives case hedge accounting requirements apply (refer Note for more information). Business model assessment and contractual cash flow characteristics UBS determines the way financial assets are managed to achieve a particular business objective. In Group asset contain a contractual cash flows arising over the life of the instrument. Debt capital instruments containing the principal amounts equity upon either breach the Swiss Supervisory Authority (FINMA) that a viability event has occurred. Such contractual provisions are not is deemed to be a non-financial variable specific to a party to contract. If a debt a future the difference between any equity issued recognized in the income statement. A gain or loss is recognized in Other income is subsequently repurchased A reissuance of debt. UBS liabilities at fair value financial instruments managed on a fair information), derivative including issuance of certain structured debt instruments. After initial recognition, UBS financial described in the table on the following pages. |
Loan commitments | Loan defined terms and classified value through profit fair measured at |
Financial guarantee contracts | Financial guarantee that holder make specified debt instrument. |
Interest income and expense | Interest statement based the effective method . calculating instruments UBS estimates future cash flows considering all contractual terms of applied to the gross carrying amount of the financial asset amortized cost asset income is determined by the adjusted for any credit loss allowance. Upfront measured at fair value where a loan is expected to be issued, and direct financial recognized over the expected EIR. Fees related to be issued, as well as loan syndication fees where UBS does not retain a portion of a comparable risk as other participants, are included in Net fee and commission and commitment or when syndication occurs. Interest included in interest income when positive and in interest expense when negative. excluding derivatives, is interest rates are income. |
Derecognition | Financial assets UBS derecognizes financial asset, risks and rewards of the asset or rewards asset. Where similar transferred if the counterparty has received the contractual rights to the cash flows of for example, In transfers where control over the financial asset is retained, UBS continues involvement, determined changes transfer. Certain futures counterparties and daily basis, basis derecognition of the associated derivatives. UBS derecognizes a financial liability when when canceled exchanged for a different substantially modified, the original new carrying amounts recognized in the income statement. |
Fair value of financial instruments | UBS accounts at fair value. Fair value is the price on the measurement date that would be liability in the principal market, absence of a principal market. Critical accounting estimates and judgments The use unobservable market requires recorded heavily on unobservable a higher that market close-out costs, which are presented in Note 21d. UBS‘s governance framework over in Note 21b, arising from instruments to reasonably possible alternative |
Allowances and provisions for expected credit losses | ECL cost, receivables, , and not measured at portion which include UBS’s credit as ability before mitigation actions. Recognition of expected credit losses ECL are recognized on the following basis: – Stage 1 instruments: Maximum 12-month from initial recognition, shortfalls that would after occurring. – Stage 2 significant an SICR) subsequent lifetime default events over the expected life of a financial instrument, weighted by no longer observed, the instrument will move back to stage 1. – Stage 3 credit-impaired occurrence of one or more loss events, by estimating cash recovery strategy. - impaired allowance has been recognized, for example because they are expected to be fully recoverable through collateral held. – Changes recognized for impaired (POCI). POCI financial instruments include those that are purchased defaulted counterparty; they derecognition. All uncollectible or forgiven. of a losses. Recoveries, in part or in full, of off are generally credited to Credit loss (expense) / release . ECL Credit (expense) / release . A corresponding ECL allowance is reported as a decrease in the carrying amount of financial assets measured at amortized cost on the balance sheet. measured at accumulated Other income . credit lines, provisions for ECL are presented in Provisions. Default and credit impairment UBS management counterparty qualitative criteria. Measurement of expected credit losses IFRS based method factors: probability exposure on an the overdrafts derives an average LGDs used in the ECL calculation are point-in-time (PIT)-based for key portfolios and consider both current conditions and expected cyclical PDs determined for treated as scenario independent. For the UBS leverages its are also used in determining expected loss (EL) and risk-weighted assets under Adjustments have been made to these models and IFRS 9-related models structure and of the fact that PDs and LGDs used in the ECL calculation are PIT- based, cycle (TTC) parameters. expected credit oversight processes. Probability of default: PD represents the over probability of lifetime remaining lifetime of PDs and scenario forecasts. client scenario dependencies and client-idiosyncratic information. Exposure EAD exposure to credit risk considering accruals, discounted at considered reflective characteristics of the respective portfolios. Loss given LGD represents time of a potential future cash expected claims and, where applicable, time to realization of collateral and the seniority of EAD. Estimation of expected credit losses Number of scenarios and estimation of scenario weights Determination of probability range especially assumptions about macroeconomic factors on the estimate. To economic . Each represented considering the exposure of key portfolios to economic risks, and for determined. The estimation scenarios based on a conditions, takes severity economic variables. The respective that macroeconomic variables will materialize. Macroeconomic and other factors The modeled historical information is key factors. information cycle-sensitive PD and LGD determination purposes, UBS projects the relevant reverting, over a specified period, to longer-term projections. Factors relevant Regional into considering UBS’s key ECL-relevant portfolios. For variables represent the most relevant factors for ECL calculation: – GDP growth rates, given performance; – unemployment clients’ ability to meet contractual obligations; – house price indices, given their collateral valuations; – interest rates, abilities to service debt; – consumer companies’ and economic stability; and – equity indices, corporate rating tools. Scenario generation, review process and governance A develop involvement from a broad range of experts. The other Scenario Sounding Sessions and ECL Management Forum, which include senior management from Group Risk and Group Finance. Important aspects particular credit addressed systematically and stage allocation and ECL allowance. The Committee , as authority under UBS’s decisions taken by the ECL Management Forum. ECL measurement period The period for which lifetime ECL are determined is based on the maximum taking prepayment financial guarantee contracts, the maximum contractual period for which to extend credit. Additionally, demand loan and contractual credit risk ability to actions. In such cases UBS is required to estimate which it is exposed to credit risk. This applies to UBS’s credit card limits, which do not have a callable components are managed as one exposure. from UBS’s credit a portfolio level, past due. for credit card as a proxy for the period that UBS is exposed to credit risk. Customary market commitments. monitoring trends combination events trigger additional informed credit are not subject a management practices and formal credit re-origination measurement types of facilities as UBS is exposed to credit risk, with 12 months also back SICR, always reporting date. Significant increase in credit risk Financial ongoing maximum assessment initial quantitative Primarily, default forward-looking instrument determined at two different dates: – at the reporting date; and – at inception of the instrument. If, based on UBS’s a instrument is transferred to stage 2 with lifetime ECL recognized . The threshold quality of the borrower, instruments based on PD changes A high-level the downgrades, The actual SICR level by interpolating between the values shown in the table. Irrespective probabilities, credit increased for an instrument if the contractual payments are more than specifically criterion instruments are transferred to stage 2 due criterion, transfer Personal & Region Switzerland but applied before a transfer back to stage 1 can be triggered. Additionally, indicators, economic list, which is used as a Exception management is further applied, and collective adjustments risk characteristics not otherwise fully reflected. In apply certain other asset-based management processes with strict margining. If margin calls are not satisfied, a position exceptional stage 2 may be made to take account of specific facts. Credit risk SICR, from mainly arises because instrument-specific, exposures stage 2 will actual holistic counterparty risk at any given date may be warranted. Critical accounting estimates and judgments The calculation of ECL requires management and make estimates and assumptions to the timing and amount of ECL recognized. Determination of a significant increase in IFRS 9 does assessment considering qualitative and quantitative criteria. An IFRS 9 ECL Management Forum results. Scenarios, scenario weights and macroeconomic ECL determines selects variables conditions. IFRS Management scenario selection and weights, post-model adjustments are required that may significantly ECL measurement period Lifetime ECL are of the transaction, Swiss callable determine the period over period is positions, and a 12-month period applied for Modeling and post-model adjustments A number ECL, significantly affect controls and GMGC) . - model are ECL Management Forum and endorsed by the A sensitivity covering , weights and SICR trigger points 20f. |
Restructured and modified financial assets | When payment default is expected, occurred, difficulties that business, such as modifying subordination, granted, each case generally classified as will preferential granted preferential conditions no longer exceed UBS’s risk tolerance. Modifications result in an alteration of future contractual cash flows and can occur within UBS’s normal risk tolerance or as part of difficulties. The could lead resulting in the new does modified contractual cash the existing recognized in the |
Offsetting | UBS net if (i) it has a legally enforceable right to set amounts realize positions include, for example, certain derivatives and repurchase and reverse exchanges and clearing houses. In assessing whether or emphasis is placed on the effectiveness of operational settlement mechanics exposure offsetting on the balance financial assets and liabilities, even enforceable netting arrangements. securities extent insignificant, receivables and payables in a single settlement process or cycle. |
Hedge accounting | The Group stated otherwise hedge meets discontinued. Voluntary permitted under Fair value hedges of interest rate risk related to debt instruments and loan assets The fair value change risk is hedged item, and recognized the change Fair value hedges of portfolio interest rate risk related to loans designated under IAS 39 Prior to discontinuation in December 2021, the fair value change of the Other or Other financial liabilities measured and recognized in the income statement the hedging instrument. Fair value hedges of FX risk related to debt instruments The hedged risk and recognized in the fair value of basis derivatives is excluded from the designation and a cost of hedging with Other comprehensive income Equity . These amounts are released statement over the term of the hedged item. Discontinuation of fair value hedges Discontinuations item amortized to the income statement over the remaining life of the hedged is derecognized, cost of statement Cash flow hedges of forecast transactions Fair value gains derivatives designated as cash risk are recognized initially in Other comprehensive income within Equity when including discontinued expected expected to reclassified to the income statement. Hedges of net investments in foreign operations Gains or losses on the hedging portion of a hedge are recognized Other comprehensive income Equity, while ineffective element statement. the cumulative Equity associated is reclassified Other income . Interest Rate Benchmark Reform UBS uncertainty before existing interest rate benchmarks are replaced with can exist, probable with little no consequential impact replacement risk-free apply the requirements of Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (Interest Rate Benchmark Reform – Phase 2). |
Fee and commission income and expenses | UBS provides to its categories: certain custody from contingent (e.g., s execution recognizes fully requires on a systematic basis over the life of the agreement. Consideration identifiable performance nature performance obligations are typically those that include time management consequence, UBS is not allocating performance obligations. Point-in-time dependent on trade performance recognized on Custodial reference to the size of the customer portfolio. However, generally customer’s portfolio and period. management beyond UBS’s control until such uncertainties are resolved. UBS’s fees are generally a result, UBS’s contracts do result in the assets. contracts, UBS has not capitalized any material costs to obtain or fulfill liabilities. UBS presents expenses primarily in line with their nature in the income directly obligations associated with the generally Total Fee commission , general and administrative expenses, Total operating . For services (where UBS fees in the not recognized the associated income collected from the given client. |
Share-based and other deferred compensation plans | UBS recognizes expenses for deferred compensation awards over the become shortened, restructuring programs or recognition date. Where no who are eligible for length-of-service criteria, the services are presumed to have been received performance year or, in the case of off-cycle awards, immediately on the grant date. Share-based compensation plans Share-based compensation the taking award, restrictions in effect and non-vesting conditions. For equity-settled the incremental increase in value. Expenses tranche basis, over the service period based number reflect the actual outcomes of service or performance conditions. For breach of to adjustment to the share-based compensation expense. For cash-settled at each reporting equals the cash distributed. Other deferred compensation plans Compensation expense for other deferred recognized on a the nature of on the the cumulative expense of respective financial instruments distributed. |
Post-employment benefit plans | Defined benefit plans Defined plans employee factors, defined present value the projected unit assets remeasurements Other income . present value of the the resulting net asset is limited to the present value of economic benefits reductions in future net specific employee and is calculated independent qualified actuaries. Critical accounting estimates and judgment s The net defined benefit liability or asset at the balance sheet date and the related personnel expense provided, assumptions. assumptions could and pension expense life expectancy, discount rate, expected salary increases, pension increases and analysis for reasonable possible movements in each significant for UBS‘s post-employment obligations is provided A separate entity are paid. UBS amounts if employees the benefits relating and prior periods. Compensation expense employees have rendered This is generally in the year of contribution. Prepaid contributions are recognized reduction in future payments is available. |
Income taxes | UBS is subject to the income tax laws the non-Swiss jurisdictions in which UBS has business operations. The Group’s provision for income and deferred paid or refunded for the current period or previous periods. Deferred between liabilities that will periods and are measured using the applicable tax rates and laws that have been reporting period and that are expected to reverse. Deferred significant being: used against profits in future years; and (ii) temporary differences that Deferred tax assets that sufficient taxable profits will be differences can be of extent there are is convincing available against which the unused tax losses can be utilized. Deferred tax liabilities between balance sheet give rise to taxable income in future periods. Deferred and current tax assets and (i) they arise in the same tax authority; (iii) are intended to be settled net or realized simultaneously. Current benefit and deferred taxes recognized in relation to: a subsidiary (for which such amounts would goodwill arising from the acquisition); (ii) gains sale of directly Equity ); instruments that are classified at of remeasurements currency translations points above are Other comprehensive income Equity . UBS reflects which acceptance by probable using either depending on which method is deemed a basis resolved. Critical accounting estimates and judgments Tax application of such UBS historical forecasts and other factors when evaluating the recoverability of its period, and its period profitability particularly sensitive to future economic, Forecasts are reviewed times, if required. If recent losses have been incurred, convincing evidence is required to prove there is sufficient future profitability given the UBS’s deferred tax through the income statement. In uncertain interpretation of tax laws, and litigation. |
Property, equipment and software | Property, is measured at accumulated reciation . Software development measured reliably and it is will begins straight line basis over an asset’s estimated useful life. Property, impairment cash - generating alongside goodwill and intangible assets as described in item 8 in this Note. the below . The recoverable amounts of such assets, other than property that has a market price, approach required by a market participant to replace the service capacity the individually for impairment. |
Goodwill | Goodwill represents the value acquired amortized, reporting period, goodwill for impairment annually, any indication An impairment charge the carrying Critical accounting estimates and judgments UBS‘s methodology for that earnings available to shareholders in years one to three; (ii) changes in the discount rates; and (iii) changes in the long-term Earnings available results, Directors. external information, and external analysts and the view of management. The each cash-generating unit are tested for sensitivity by applying reasonably possible changes to those assumptions. |
Provisions and contingent liabilities | Provisions generally recognized in 37, Provisions, Contingent Liabilities and Contingent Assets , when: (i) UBS has a present obligation as a an outflow and (iii) a reliable estimate made. The majority of UBS’s provisions and Restructuring consequence of scope including employee sabbatical measurement principles set out in item 4 UBS presents Provisions they relate to a loan commitment, a revolving revocable credit line. IAS 37 provisions are of the the balance sheet date. When conditions required a outflow disclosed for existence events not wholly within the control of UBS. Critical accounting estimates and judgments Recognition of provisions the past estimating the This which, due to their nature, outcome The amount of any provision used particular matter. Management regularly reviews such criteria for provisions have been satisfied and to determine the timing and amount of any potential outflows |
Foreign currency translation | Transactions into exchange rate date, all monetary liabilities denominated in foreign currency functional currency differences Other instruments measured at fair value through profit or loss . Non-monetary items measured at historical cost are translated at the exchange rate on the date of the transaction. Upon consolidation, assets and liabilities of are translated into US closing exchange rate expense items and other comprehensive income are translated at the translation differences are recognized in Equity the entirety, foreign operation. Share translated the historic of Share premium. Other comprehensive income in es measured at FVOCI are translated at the closing exchange rate as of the through Retained earnings . |
Equity, treasury shares and contracts on UBS Group AG shares | UBS Group AG shares held (treasury shares) UBS purchased Equity as Treasury at deducted Equity difference and their weighted average cost (net of tax, if any) Share premium . Net cash settlement contracts Contracts involving settlement, or provide the counterparty or UBS with a settlement option that includes a choice of settling net in cash, are classified as derivatives held for trading. |
UBS AG | |
Entity [Table] | |
Basis of accounting | The Financial Statements have been prepared in accordance with International Financial Reporting International presented in US dollars (USD). Disclosures and funding, integral part of the Financial to requirements Financial Instruments: , and Presentation , and repeated in this section. The applied consistently in all years presented unless otherwise stated in Note 1b. |
Critical accounting estimates and judgments | Critical accounting estimates and judgments Preparation of these Financial to apply amounts contingent time they are made. Such available AG regularly such estimates assumptions, which future and other pertinent factors, to determine their continuing relevance based on current conditions, estimates and Statements. estimates, which could result in significant was anticipated The judgment Financial Statements: – expected credit loss measurement (refer to item 2g in this Note and to Note 20); – fair value measurement (refer to item 2f in this Note – income taxes (refer to item 6 in this Note and to Note – provisions and contingent liabilities (refer to item 9 Note 18); – post-employment benefit 27); – goodwill (refer to item 8 in this Note and to Note – consolidation of structured entities (refer to Note 29). |
Consolidation | The UBS AG intercompany UBS structured entities over the relevant activities of variable returns; own returns. Consideration determine whether the current ability decisions about those activities need to be made. Subsidiaries, when control control ceases. and circumstances indicate that there is a change to one or more elements required to establish that control is present. Business combinations are accounted for using the acquisition method. The amount of any non-controlling at acquiree’s identifiable net assets. Critical accounting estimates and judgments Each aforementioned consolidation principles. complex determining whether extent uniform consolidation be consolidated while assessment, judgment circumstances, including the the substance of voting and similar rights. |
Financial instruments | Financial instruments Classification, measurement and presentation Financial assets classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – cash and balances at central banks; – loans and advances to banks; – receivables from securities financing transactions; – cash collateral receivables on derivative instruments; – residential and commercial mortgages; – corporate loans; – secured loans, including Lombard loans, and unsecured loans; – loans to financial advisors; – debt securities held as high-quality liquid (HQLA). Measured at amortized cost using the effective interest method less allowances for expected credit losses (refer to items 2d and 2g in this Note for more information). The following items are recognized in the income statement: – interest income, which is accounted for in accordance with item 2d – ECL and reversals; – foreign exchange (FX) translation gains and losses. When a financial asset at amortized cost is derecognized, the gain or loss is recognized in the income statement. For amounts arising from settlement of certain derivatives, refer to the next page. Measured at FVOCI Debt instruments measured at FVOCI This classification primarily includes debt securities certain asset-backed securities held as HQLA. Measured at fair value, reported in Other comprehensive income, net of applicable income taxes, until such investments are derecognized. Upon derecognition, any accumulated balances in Other comprehensive income are reclassified to the income statement and reported within Other income. The following items, which are determined on the basis as for financial assets measured at amortized recognized in the income statement: – interest income, which is accounted for in accordance with item 2d – ECL and reversals; – FX translation gains and losses. Financial assets classification Significant items included Measurement and presentation Measured at FVTPL Held for trading Financial assets held for trading include: – all derivatives with a positive replacement value, those that are designated and effective hedging instruments; and – other financial assets acquired principally for the purpose of selling or repurchasing in the near term, or that are part of a portfolio of identified financial instruments that are managed together and for there is evidence of a recent actual pattern of short-term profit taking. Included in this category are debt instruments (including those in the form of money market paper, loans) and equity instruments. Measured at fair value, income statement. Derivative assets (including derivatives that and effective hedging instruments) are generally presented as Derivative financial instruments , except those exchange-traded (ETD) and over-the-counter cleared derivatives that are legally settled on a daily or in substance net settled on a daily basis, presented within Cash collateral receivables on derivative instruments. Changes in fair value, initial transaction costs, and gains and losses arising on disposal or redemption recognized in Other net income from financial instruments measured at fair value through , except interest income on instruments other than derivatives (refer to item 2d in this Note), interest on derivatives designated as hedging instruments of interest rate risk and forward points on certain short- and long-duration FX contracts acting as economic hedges, which are reported in Net interest income. Changes in the fair value of derivatives that designated and effective hedging instruments are presented either in the income statement or Other comprehensive income , depending on the type of hedge relationship (refer to item 2j in this Note for more information). Mandatorily measured at FVTPL – Other This classification includes financial assets measured at FVTPL that are not held for trading, as follows: – certain structured loans, certain commercial loans, and receivables from securities financing transactions are managed on a fair value basis; – loans managed on a fair value basis, including those hedged with credit derivatives; – certain debt securities held as HQLA and fair value basis; – certain investment fund holdings and assets hedge delivery obligations related to cash-settled employee compensation plans; – brokerage receivables, for which contractual cash flows do not meet the SPPI criterion because the aggregate balance is accounted for as a single unit of with interest being calculated on the individual components; – auction rate securities, for which contractual cash do not meet the SPPI criterion because interest may reset at rates that contain leverage; – equity instruments; – assets held under unit-linked investment contracts. Classification, measurement and presentation Financial liabilities classification Significant items included Measurement and presentation Measured at amortized cost This classification includes: – demand and time deposits; – retail savings / deposits; – payables – non-structured fixed-rate bonds; – subordinated debt; – certificates of deposit and covered bonds; – obligations against funding from UBS Group AG; – cash collateral payables on derivative instruments. Measured at amortized cost using the effective interest method. When a financial liability at amortized cost is derecognized, the gain or loss is recognized in the income statement. Measured at fair value through profit or loss Held for trading Financial liabilities held for trading include: – all derivatives with a negative replacement value (including certain loan commitments), that are designated and effective hedging instruments; and – obligations to deliver financial instruments, debt and equity instruments, that UBS AG has sold third parties but does not own (short positions). Measurement and presentation of financial liabilities classified at FVTPL follow the same principles financial assets classified at FVTPL, except that of change in the fair value of a financial liability designated at FVTPL that is attributable to changes AG’s own credit risk is presented in Other comprehensive income Retained earnings and is never reclassified to the income statement. Derivative liabilities (including derivatives that designated and effective hedging instruments) generally presented as Derivative financial instruments , except those exchange-traded and OTC-cleared derivatives that are legally settled on a daily basis substance net settled on a daily basis, which presented within Cash collateral payables on derivative instruments. Designated at FVTPL UBS AG designates liabilities: – issued hybrid debt instruments that primarily include equity-linked, credit-linked and rates-linked bonds notes; – issued debt instruments managed on a fair basis; – certain payables from securities financing transactions; – amounts due under unit-linked investment contracts the cash flows of which are linked to financial measured at FVTPL and eliminate an accounting mismatch; – brokerage payables, which arise in conjunction with brokerage receivables and are measured at FVTPL to achieve measurement consistency. All financial instruments value through through . For financial subsequently measured at amortized cost or value is adjusted for directly attributable transaction costs. Where the flows that are the the is classified business model that has collect business with the objective being achieved collecting contractual cash flows and selling financial assets. All those except for derivatives case hedge accounting requirements apply (refer Note for more information). Business model assessment and contractual cash flow characteristics UBS AG determines the business objective. In assessing whether considers contain contractual cash flows arising over the life of the instrument. Financial liabilities Debt issued measured Funding , which has received from AG scope of consolidation. instruments issued cont ain ing contractual provisions down or equity tier 1 (CET1) Financial event Such derivatives, variable specific to a party to the contract. If a debt a future the difference between any equity issued recognized in the income statement. A gain or loss is recognized in Other income is subsequently repurchased A reissuance of debt. UBS liabilities at fair value financial instruments managed on a fair information), derivative including issuance of certain structured debt instruments. After initial recognition, UBS AG its described in the table on the following pages. UBS AG derecognizes a transferred financial asset, or a financial asset, if the purchaser has received substantially all the risks and rewards of the asset or rewards asset. Where similar transferred if the counterparty has received the contractual rights to the cash flows of for example, In transfers where control over the financial asset is retained, UBS AG continues to involvement, determined changes transfer. Certain futures counterparties daily basis, basis derecognition of the associated derivatives. UBS AG derecognizes i.e., when canceled exchanged for a different substantially modified, the original new carrying amounts recognized in the income statement. UBS AG recognizes financial to an instrument. AG applies settlement date accounting to all standard purchases and non-derivative financial instruments. In extent the financial derecognition by transferred instrument as its asset. UBS holding retirement benefit plans and meet satisfied, they are not recognized on UBS AG’s balance sheet and the related income is excluded from the Financial Statements. Client execution through neither obtains benefits from nor controls such cash balances. |
Loan commitments | Loan commitments and financial guarantees Loan defined terms and classified value through profit fair measured at |
Financial guarantee contracts | Financial guarantee that require UBS AG holder make specified debt instrument. |
Interest income and expense | Interest statement based the method . calculating instruments UBS terms of the instrument, EIR applied to the gross the financial interest income is cost amount adjusted for any credit loss allowance. Upfront measured at fair value where a loan is expected to be issued, and direct financial recognized over the expected EIR. Fees related to be issued, as well as loan syndication fees where UBS AG does not retain a portion retain a portion of the syndicated loan at the same effective yield for comparable risk Net fee and commission income and either recognized over the commitment or when syndication occurs. Interest included in interest income when positive and in interest expense when negative. excluding derivatives, is interest rates are income. |
Derecognition | Derecognition |
Fair value of financial instruments | UBS AG accounts liabilities at fair value. Fair date transfer participants in the principal market, or in the most advantageous market in the absence of a principal market. Critical accounting estimates and judgments The use unobservable market requires recorded heavily on unobservable a higher that market close-out costs, which are presented in Note 21d. UBS AG ‘ s described in estimated effects arising from changing significant unobservable inputs in Level 3 financial instruments in Note 21g. |
Allowances and provisions for expected credit losses | ECL cost, receivables, , and not measured at portion which AG ’s facilities, as UBS has the ability to risk mitigation actions. Recognition of expected credit losses ECL are recognized on the following basis: – Stage 1 instruments: Maximum 12-month from initial recognition, shortfalls that would after occurring. – Stage 2 significant an SICR) subsequent lifetime default events over the expected life of a financial instrument, weighted by no longer observed, the instrument will move back to stage 1. – Stage 3 credit-impaired occurrence of one or more loss events, by estimating cash recovery strategy. - impaired allowance has been recognized, for example because they are expected to be fully recoverable through collateral held. – Changes recognized for impaired (POCI). POCI financial instruments include those that are purchased defaulted counterparty; they derecognition. All uncollectible or forgiven. of a losses. Recoveries, in part or in full, of off are generally credited to Credit loss (expense) / release . ECL Credit (expense) / release . A corresponding ECL allowance is reported as a decrease in the carrying amount of financial assets measured at amortized cost on the balance sheet. measured at accumulated Other income . credit lines, provisions for ECL are presented in Provisions. Default and credit impairment UBS AG applies management counterparty qualitative criteria. Probability of default: PD represents the over probability of lifetime remaining lifetime of PDs and scenario forecasts. client scenario dependencies and client-idiosyncratic information. Exposure EAD exposure to credit risk considering accruals, discounted at considered reflective characteristics of the respective portfolios. Loss given LGD represents time of a potential future cash expected claims and, where applicable, time to realization of collateral and the seniority of EAD. Estimation of expected credit losses Number of scenarios and estimation of scenario weights Determination of probability range especially assumptions about macroeconomic factors on the estimate. To requirement, AG uses economic . Each represented considering the exposure of key portfolios to economic risks, and for determined. The estimation scenarios based on a conditions, takes severity economic variables. The respective that macroeconomic variables will materialize. Macroeconomic and other factors The modeled historical information is key factors. information cycle - sensitive nd AG projects the relevant economic factors for a period before reverting, over LGD for longer-term projections. Factors relevant Regional into considering UBS AG’s key ECL-relevant portfolios. For variables represent the most relevant factors for ECL calculation: – GDP growth rates, given performance; – unemployment clients’ ability to meet contractual obligations; – house price indices, given their collateral valuations; – interest rates, abilities to service debt; – consumer companies’ and economic stability; and – equity indices, corporate rating tools. Scenario generation, review process and governance A develop involvement from a broad range of experts. The other Scenario Sounding Sessions and ECL Management Forum, which include senior management from Group Risk and Group Finance. Important aspects particular credit addressed systematically and stage allocation and ECL allowance. The Committee , as authority under UBS the decisions taken by the ECL Management Forum. ECL measurement period The period for which lifetime ECL are determined is based on the maximum risk, taking prepayment financial guarantee contracts, the AG has obligation to extend credit. Additionally, demand loan and contractual cancellation right credit risk abi lity AG can - mitigating actions. the period UBS AG ’s contractual maturity date, are callable on demand and where the drawn and undrawn components are managed as The significant and is managed at a portfolio level, with credit actions triggered period of seven years months for AG is exposed to credit risk. Customary market commitments. monitoring trends combination events trigger additional informed credit are not subject a management practices and formal credit re-origination measurement types of facilities as UBS AG is look-back reporting date. Significant increase in credit risk Financial ongoing maximum assessment initial quantitative Primarily, UBS default forward-looking instrument determined at two different dates: – at the reporting date; and – at inception of the instrument. If, exceeds a set threshold, an SICR is deemed to have occurred and the recognized. The threshold quality of the borrower, instruments based on PD changes A high-level the downgrades, The actual SICR level by interpolating between the values shown in the table. Internal rating at origination of the instrument Rating downgrades / SICR trigger 0–3 3 4–8 2 9–13 1 Irrespective probabilities, credit increased for an instrument if the contractual payments are more than specifically criterion instruments are transferred to stage 2 due criterion, transfer Personal & Region Switzerland but applied before a transfer back to stage 1 can be triggered. Additionally, indicators, economic list, which is used as a Exception management is further applied, and collective adjustments risk characteristics not otherwise fully reflected. In apply certain other asset-based management processes with strict margining. If margin calls are not satisfied, a position exceptional stage 2 may be made to take account of specific facts. Credit risk SICR, from mainly arises because instrument-specific, exposures stage 2 will actual holistic counterparty risk at any given date may be warranted. Critical accounting estimates and judgments The calculation of ECL requires management and make estimates and assumptions to the timing and amount of ECL recognized. Determination of a significant increase in IFRS 9 does not include a definition of what constitutes an SICR, with UBS AG’s assessment considering ECL Management Forum has SICR results. Scenarios, scenario weights and macroeconomic ECL reflect an unbiased and probability-weighted amount, which UBS AG determines selects variables conditions. IFRS Management scenario selection and weights, post-model adjustments are required that may significantly ECL measurement period Lifetime ECL are of the transaction, Swiss callable master determine the period over period is positions, and a 12-month period applied for Modeling and post-model adjustments A number ECL, significantly validation Committee (the GMGC). ECL Management Forum and endorsed by the A sensitivity covering , weights and SICR trigger points 20f. IFRS based method factors: probability exposure on an the overdrafts derives an average LGDs used in the ECL calculation are point-in-time (PIT)-based for key portfolios and consider both current conditions and expected cyclical determined for treated as scenario independent. For the UBS AG that weighted assets loss models. IFRS complexity, take calculation Basel III through-the-cycle relevant for AG’s model validation and oversight processes. |
Restructured and modified financial assets | Restructured and modified financial assets When payment default is expected, occurred, UBS AG difficulties that business, such as modifying subordination, granted, each case generally classified as will preferential granted preferential conditions no longer exceed UBS AG’s risk tolerance. Modifications result in an alteration of future contractual cash flows and can occur part of a difficulties. The could lead resulting in the new does modified contractual cash the existing recognized in the |
Offsetting | UBS AG net if (i) it has a legally enforceable right to set amounts realize positions include, for example, certain derivatives and repurchase and reverse exchanges and clearing houses. In assessing whether UBS basis, or to realize the asset and settle the liability simultaneously, emphasis is placed on the effectiveness of operational settlement mechanics exposure offsetting on AG’s subject R epurchase arrangements and securities financing transactions are presented net only to the extent that the settlement mechanism or results the cycle. |
Hedge accounting | Hedge accounting UBS AG applies stated otherwise hedge meets discontinued. Voluntary permitted under Fair value hedges of interest rate risk related to debt instruments and loan assets The fair value change risk is hedged item, and recognized the change Fair value hedges of portfolio interest rate risk related to loans designated under IAS 39 Prior to discontinuation in December 2021, the fair value change of the Other or Other financial liabilities measured and recognized in the income statement the hedging instrument. Fair value hedges of FX risk related to debt instruments The hedged risk and recognized in the fair value of basis derivatives is excluded from the designation and a cost of hedging with Other comprehensive income Equity . These amounts are released statement over the term of the hedged item. Discontinuation of fair value hedges Discontinuations item amortized to the income statement over the remaining life of the hedged is derecognized, cost of statement Cash flow hedges of forecast transactions Fair value gains derivatives designated as cash risk are recognized initially in Other comprehensive income within Equity when including discontinued expected expected to reclassified to the income statement. Hedges of net investments in foreign operations Gains or losses on the hedging portion of a hedge are recognized Other comprehensive income Equity, while ineffective element statement. the cumulative Equity associated is reclassified Other income . Interest Rate Benchmark Reform UBS uncertainty before existing interest rate benchmarks are replaced with alternative can exist, probable d with little no consequential replacement risk-free interest rates expected in 2021 and beyond, UBS apply the requirements of Amendments to IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (Interest Rate Benchmark Reform – Phase 2). |
Fee and commission income and expenses | UBS provides to its categories: certain custody from contingent (e.g., securities recognizes fully requires on a systematic basis over the life of the agreement. Consideration identifiable performance nature performance obligations are typically those that include time management consequence, AG is judgment various performance obligations. Point-in-time dependent on trade performance recognized on Custodial reference to the size of the customer portfolio. However, generally customer’s portfolio and period. UBS management beyond UBS AG’s control until such uncertainties are resolved. UBS AG’s fees are generally earned from short-term contracts. As AG ’s component or or prepayment assets. Furthermore, due to the short-term nature of such contracts, to obtain or fulfill a contract assets or liabilities. UBS AG presents expenses primarily in line with their nature the income statement, differentiating between expenses that are directly obligations associated with the generally Total Fee commission , general and administrative expenses, Total operating . For services (where UBS AG specific fees in the income parties against the associated income collected from the given client. |
Share-based and other deferred compensation plans | Share-based and other deferred compensation plans UBS AG over the to shortened, restructuring programs or recognition date. Where no who are eligible for length-of-service criteria, the services are presumed to have been received performance year or, in the case of off-cycle awards, immediately on the grant date. Share-based compensation plans UBS Group settle employees of awards payment transactions. UBS granted Group AG’s account including, where effect vesting conditions. For equity-settled the incremental increase in value. Expenses tranche basis, over the service period based number reflect the actual outcomes of service or performance conditions. For breach of to adjustment to the share-based compensation expense. For cash-settled at each reporting equals the cash distributed. Other deferred compensation plans Compensation expense for other deferred recognized on a the nature of on the the cumulative expense of respective financial instruments distributed. |
Post-employment benefit plans | Post-employment benefit plans Defined benefit plans Defined plans employee factors, defined present value the projected unit assets remeasurements Other income . present value of the the resulting net asset is limited to the present value of economic benefits reductions in future net specific employee and is calculated independent qualified actuaries. Critical accounting estimates and judgments The net defined benefit liability or asset at the balance sheet date and the related personnel expense provided, assumptions. assumptions could and pension expense life expectancy, discount rate, expected salary increases, pension increases and analysis for reasonable possible movements in each significant for UBS AG‘s post-employment obligations is A separate entity are paid. further amounts if the plan does not hold sufficient assets employees the benefits relating and prior periods. Compensation expense employees have rendered This is generally in the year of contribution. Prepaid contributions are recognized reduction in future payments is available. |
Income taxes | Income taxes UBS AG is of operations. UBS and deferred paid or refunded for the current period or previous periods. Deferred between liabilities that will periods and are measured using the applicable tax rates and laws that have been reporting period and that are expected to reverse. Deferred significant being: used against profits in future years; and (ii) temporary differences that Deferred tax assets that sufficient taxable profits will be differences can be of extent there are is convincing available against which the unused tax losses can be utilized. Deferred tax liabilities between balance sheet give rise to taxable income in future periods. Deferred and current tax assets and (i) they arise in the same tax authority; (iii) are intended to be settled net or realized simultaneously. Current benefit and deferred taxes recognized in relation to: a subsidiary (for which such amounts would goodwill arising from the acquisition); (ii) gains sale of directly Equity ); instruments that are classified at of remeasurements currency translations points above are Other comprehensive income Equity . UBS AG reflects the for considered applicable, using either the most likely amount or expected value methods, depending deemed a predictor , and , the uncertainty will be resolved. Critical accounting estimates and judgments Tax application of such UBS AG historical forecasts and other factors when evaluating the recoverability of its period, and its period profitability particularly sensitive to future economic, Forecasts are reviewed times, if required. If recent losses have been incurred, convincing evidence is required to prove there is sufficient future profitability given the UBS AG ’s e , primarily recognized through the income statement. In uncertain interpretation of tax laws, and litigation. |
Property, equipment and software | Property, is measured at accumulated reciation . Software development measured reliably and it is will begins straight line basis over an asset’s estimated useful life. Property, impairment cash - generating alongside goodwill and intangible assets as described in item 8 in this Note. the below . The recoverable amounts of such assets, other than property that has a market price, approach required by a market participant to replace the service capacity the individually for impairment. |
Goodwill | Goodwill represents the value acquired amortized, reporting period, tests there is any An impairment charge the carrying Critical accounting estimates and judgments UBS model that is most sensitive to the following key assumptions: (i) forecasts of earnings available to shareholders the discount rates; and (iii) changes in the Earnings available results, Directors. external information, and external analysts and the view of management. The each cash-generating unit are tested for sensitivity by applying reasonably possible changes to those assumptions. |
Provisions and contingent liabilities | Provisions generally recognized in 37, Provisions, Contingent , has a that obligation; obligation can be made. The AG ’s ns regulatory benefits. consequence of scope including employee sabbatical measurement principles set out in item 4 UBS AG presents Provisions if they relate to a loan commitment, financial or a revolving revocable credit line. IAS 37 provisions are of the the balance sheet date. When conditions required a outflow disclosed for existence events not wholly within the control of UBS AG. Critical accounting estimates and judgments Recognition of provisions the past estimating the This which, due to their nature, outcome difficult to predict. The amount of any provision used particular matter. Management regularly reviews such criteria for provisions have been satisfied and to determine the timing and amount of any potential outflows. |
Foreign currency translation | Transactions into exchange rate date, all monetary liabilities denominated in foreign currency functional currency differences Other instruments measured at fair value through profit or loss . Non-monetary items measured at historical cost are translated at the exchange rate on the date of the transaction. Upon consolidation, assets and liabilities of are translated into US the closing exchange rate on the balance sheet date, and income and expense at the translation differences are recognized in Equity the income statement entirety, the foreign foreign operation. Share translated the historic of Share premium. Other comprehensive income in measured at FVOCI are translated at the closing exchange rate as of the through Retained earnings . |
Equity, treasury shares and contracts on UBS Group AG shares | Contracts involving settlement, AG with settlement option are classified as derivatives held for trading. |
Segment reporting (Tables)
Segment reporting (Tables) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Disclosure Of Operating Segments Explanatory | USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS For the year ended 31 December 2021 Net interest income 4,244 2,120 (15) 481 (127) 6,705 Non-interest income 15,175 2,143 2,632 8,972 (233) 28,689 Income 19,419 4,263 2,617 9,454 (359) 35,393 Credit loss (expense) / release 29 86 (1) 34 0 148 Total operating income 19,449 4,349 2,616 9,488 (360) 35,542 Total operating expenses 14,665 2,618 1,586 6,858 330 26,058 Operating profit / (loss) before tax 4,783 1,731 1,030 2,630 (689) 9,484 Tax expense / (benefit) 1,998 Net profit / (loss) 7,486 Additional information Total assets 395,235 225,370 25,639 346,431 124,507 1,117,182 Additions to non-current assets 56 16 1 30 1,989 2,091 | USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS For the year ended 31 December 2020 Net interest income 4,027 2,049 (17) 284 (481) 5,862 Non-interest income 1 13,107 1,858 2,993 9,235 30 27,222 Income 17,134 3,908 2,975 9,519 (452) 33,084 Credit loss (expense) / release (88) (257) (2) (305) (42) (694) Total operating income 17,045 3,651 2,974 9,214 (494) 32,390 Total operating expenses 13,026 2,392 1,519 6,732 567 24,235 Operating profit / (loss) before tax 4,019 1,259 1,455 2,482 (1,060) 8,155 Tax expense / (benefit) 1,583 Net profit / (loss) 6,572 Additional information Total assets 367,714 231,657 28,589 369,683 128,122 1,125,765 Additions to non-current assets 5 12 385 150 2,294 2,847 | USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS For the year ended 31 December 2019 Net interest income 3,947 1,992 (25) (669) (744) 4,501 Non-interest income 12,426 1,744 1,962 7,968 367 24,467 Income 16,373 3,736 1,938 7,299 (378) 28,967 Credit loss (expense) / release (20) (21) 0 (30) (7) (78) Total operating income 16,353 3,715 1,938 7,269 (385) 28,889 Total operating expenses 12,955 2,274 1,406 6,485 192 23,312 Operating profit / (loss) before tax 3,397 1,441 532 784 (577) 5,577 Tax expense / (benefit) 1,267 Net profit / (loss) 4,310 Additional information Total assets 309,766 209,405 34,565 315,855 102,603 972,194 Additions to non-current assets 68 10 0 1 5,217 5,297 1 Includes a USD 631 571 60 recognized in Global Wealth Management. |
UBS AG | |||
Entity [Table] | |||
Disclosure Of Operating Segments Explanatory | USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS AG For the year ended 31 December 2021 Net interest income 4,244 2,120 (15) 481 (226) 6,605 Non-interest income 15,175 2,144 2,632 8,978 294 29,222 Income 19,419 4,264 2,617 9,459 68 35,828 Credit loss (expense) / release 29 86 (1) 34 0 148 Total operating income 19,449 4,350 2,616 9,493 68 35,976 Total operating expenses 14,743 2,623 1,593 6,902 1,151 27,012 Operating profit / (loss) before tax 4,706 1,726 1,023 2,592 (1,083) 8,964 Tax expense / (benefit) 1,903 Net profit / (loss) 7,061 Additional information Total assets 395,235 225,425 25,202 346,641 123,641 1,116,145 Additions to non-current assets 56 16 1 30 1,689 1,791 | USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS AG For the year ended 31 December 2020 Net interest income 4,027 2,049 (17) 284 (555) 5,788 Non-interest income 1 13,107 1,859 2,993 9,224 504 27,686 Income 17,134 3,908 2,975 9,508 (52) 33,474 Credit loss (expense) / release (88) (257) (2) (305) (42) (695) Total operating income 17,046 3,651 2,974 9,203 (94) 32,780 Total operating expenses 13,080 2,390 1,520 6,762 1,329 25,081 Operating profit / (loss) before tax 3,965 1,261 1,454 2,441 (1,423) 7,699 Tax expense / (benefit) 1,488 Net profit / (loss) 6,211 Additional information Total assets 367,714 231,710 28,266 369,778 127,858 1,125,327 Additions to non-current assets 5 12 385 150 1,971 2,524 | USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions UBS AG For the year ended 31 December 2019 Net interest income 3,947 1,993 (25) (669) (831) 4,415 Non-interest income 12,426 1,745 1,962 7,967 869 24,970 Income 16,373 3,737 1,938 7,298 38 29,385 Credit loss (expense) / release (20) (21) 0 (30) (7) (78) Total operating income 16,353 3,717 1,938 7,268 31 29,307 Total operating expenses 13,018 2,274 1,407 6,515 925 24,138 Operating profit / (loss) before tax 3,335 1,443 531 753 (893) 5,169 Tax expense / (benefit) 1,198 Net profit / (loss) 3,971 Additional information Total assets 309,766 209,512 34,565 316,058 102,028 971,927 Additions to non-current assets 68 10 0 1 4,935 5,014 1 Includes a USD 631 571 60 recognized in Global Wealth Management. |
Segment reporting by geographic
Segment reporting by geographic location (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Geographical Areas Explanatory | For the year ended 31 December 2021 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 14.5 41 9.0 44 of which: USA 13.5 38 8.5 41 Asia Pacific 6.5 18 1.5 7 Europe, Middle East and Africa (excluding Switzerland) 7.0 20 2.9 14 Switzerland 7.9 22 7.1 35 Global (0.3) (1) 0.0 0 Total 35.5 100 20.5 100 For the year ended 31 December 2020 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 13.0 40 9.0 42 of which: USA 11.7 36 8.4 40 Asia Pacific 6.0 18 1.5 7 Europe, Middle East and Africa (excluding Switzerland) 6.5 20 3.0 14 Switzerland 6.9 21 7.6 36 Global 0.1 0 0.0 0 Total 32.4 100 21.1 100 For the year ended 31 December 2019 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 12.0 42 8.9 44 of which: USA 10.9 38 8.5 42 Asia Pacific 4.7 16 1.4 7 Europe, Middle East and Africa (excluding Switzerland) 5.8 20 3.0 15 Switzerland 6.7 23 7.1 35 Global (0.3) (1) 0.0 0 Total 28.9 100 20.3 100 |
UBS AG | |
Entity [Table] | |
Disclosure Of Geographical Areas Explanatory | For the year ended 31 December 2021 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 14.5 40 9.0 47 of which: USA 13.5 38 8.5 44 Asia Pacific 6.5 18 1.4 7 Europe, Middle East and Africa (excluding Switzerland) 7.0 19 2.6 13 Switzerland 7.9 22 6.3 33 Global 0.1 0 0.0 0 Total 36.0 100 19.3 100 For the year ended 31 December 2020 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 13.0 40 9.0 45 of which: USA 11.7 36 8.4 42 Asia Pacific 6.0 18 1.4 7 Europe, Middle East and Africa (excluding Switzerland) 6.5 20 2.7 14 Switzerland 6.9 21 6.9 34 Global 0.5 2 0.0 0 Total 32.8 100 20.0 100 For the year ended 31 December 2019 Total operating income Total non-current assets USD billion Share % USD billion Share % Americas 12.0 41 8.9 46 of which: USA 10.9 37 8.5 44 Asia Pacific 4.7 16 1.3 7 Europe, Middle East and Africa (excluding Switzerland) 5.8 20 2.6 13 Switzerland 6.7 23 6.5 34 Global 0.1 0 0.0 0 Total 29.3 100 19.3 100 |
Net interest income and other i
Net interest income and other income from fair value changes on financial instruments (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Net Interest Income And Other Net Income From Financial Instruments Measured At Fair Value Through Profit Or Loss Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Net interest income from financial instruments measured 1,431 1,299 1,011 Other net income from financial instruments measured 5,850 6,960 6,842 of which: net gains / (losses) from financial liabilities designated 1 (6,582) 1,509 (8,748) Total net income from financial instruments measured at fair value through profit or loss 7,281 8,259 7,853 Net interest income Interest income from loans and deposits 2 6,488 6,690 8,008 Interest income from securities financing transactions 3 513 862 2,005 Interest income from other financial instruments measured 284 335 364 Interest income from debt instruments measured at fair 115 101 120 Interest income from derivative instruments designated as cash 1,133 822 188 Total interest income from financial instruments measured at amortized cost and fair 8,533 8,810 10,684 Interest expense on loans and deposits 4 523 1,031 2,634 Interest expense on securities financing transactions 5 1,102 870 1,152 Interest expense on debt issued 1,533 2,237 3,285 Interest expense on lease liabilities 102 110 122 Total interest expense from financial instruments measured at amortized cost 3,259 4,247 7,194 Total net interest income from financial instruments measured at amortized cost and fair 5,274 4,563 3,490 Total net interest income from financial instruments measured at fair value through profit or loss 1,431 1,299 1,011 Total net interest income 6,705 5,862 4,501 1 Excludes fair value changes of hedges related to financial liabilities designated at fair value and foreign currency translation effects arising from translating foreign currency transactions into the respective functional currency, both of which are reported within Other net income from financial instruments measured at fair value through profit or loss. 2,068 72 USD 1,830 USD 2,068 72 1,830 through profit or loss not as well as negative interest on amounts due to banks, customer deposits, and cash collateral payables on derivative negative interest, including deposits, as well as negative securities financing transactions and negative interest, including fees, on receivables from securities |
UBS AG | |
Entity [Table] | |
Disclosure Of Net Interest Income And Other Net Income From Financial Instruments Measured At Fair Value Through Profit Or Loss Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Net interest income from financial instruments measured 1,437 1,305 1,015 Other net income from financial instruments measured 5,844 6,930 6,833 of which: net gains / (losses) from financial liabilities designated 1 (6,457) 1,625 (8,748) Total net income from financial instruments measured at fair value through profit or loss 7,281 8,235 7,848 Net interest income Interest income from loans and deposits 2 6,489 6,696 8,026 Interest income from securities financing transactions 3 513 862 2,005 Interest income from other financial instruments measured 284 335 364 Interest income from debt instruments measured at fair 115 101 120 Interest income from derivative instruments designated as cash 1,133 822 188 Total interest income from financial instruments measured at amortized cost and fair 8,534 8,816 10,703 Interest expense on loans and deposits 4 1,655 2,440 4,541 Interest expense on securities financing transactions 5 1,102 870 1,152 Interest expense on debt issued 512 918 1,491 Interest expense on lease liabilities 98 105 118 Total interest expense from financial instruments measured at amortized cost 3,366 4,333 7,303 Total net interest income from financial instruments measured at amortized cost and fair 5,168 4,483 3,400 Total net interest income from financial instruments measured at fair value through profit or loss 1,437 1,305 1,015 Total net interest income 6,605 5,788 4,415 1 Excludes fair value changes currency, both of which 2,068 72 and USD 1,830 of USD 2,068 72 1,830 through profit or instruments, as well as negative transactions and negative interest, including fees, customer deposits, and funding from UBS Group AG, Includes interest expense on payables from securities financing transactions and negative interest, including fees, |
Net fee and commission income (
Net fee and commission income (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Fee And Commission Income Expense Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Fee and commission income Underwriting fees 1,463 1,085 741 M&A and corporate finance fees 1,102 736 774 Brokerage fees 4,382 4,132 3,248 Investment fund fees 5,790 5,289 4,858 Portfolio management and related services 9,762 8,009 7,656 Other 1,874 1,710 1,832 Total fee and commission income 1 24,372 20,961 19,110 of which: recurring 15,410 13,009 12,544 of which: transaction-based 8,692 7,491 6,402 of which: performance-based 269 461 163 Fee and commission expense Brokerage fees paid 259 274 310 Distribution fees paid 611 589 590 Other 1,115 912 797 Total fee and commission expense 1,985 1,775 1,696 Net fee and commission income 22,387 19,186 17,413 of which: net brokerage fees 4,123 3,858 2,938 1 For the 14,545 1,644 3,337 million for Asset 4,814 33 12,475 USD 1,426 3,129 3,882 49 2019: USD 11,694 1,307 2,659 3,355 94 million for Group Functions). |
UBS AG | |
Entity [Table] | |
Disclosure Of Fee And Commission Income Expense Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Fee and commission income Underwriting fees 1,512 1,104 784 M&A and corporate finance fees 1,102 736 774 Brokerage fees 4,383 4,132 3,248 Investment fund fees 5,790 5,289 4,859 Portfolio management and related services 9,762 8,009 7,656 Other 1,874 1,712 1,836 Total fee and commission income 1 24,422 20,982 19,156 of which: recurring 15,410 13,010 12,545 of which: transaction-based 8,743 7,512 6,449 of which: performance-based 269 461 163 Fee and commission expense Brokerage fees paid 259 274 310 Distribution fees paid 611 589 590 Other 1,115 911 796 Total fee and commission expense 1,985 1,775 1,696 Net fee and commission income 22,438 19,207 17,460 of which: net brokerage fees 4,124 3,858 2,938 1 For the 14,545 1,645 3,337 million for Asset Management, USD 4,863 33 12,475 1,427 3,129 3,901 50 USD 11,694 1,307 2,659 3,397 98 for Group Functions). |
Other income (Tables)
Other income (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Other Operating Income Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Associates, joint ventures and subsidiaries Net gains / (losses) from acquisitions and disposals of 1 (11) 635 2 (36) Net gains / (losses) from disposals of investments in associates 41 0 4 Share of net profits of associates and joint ventures 105 84 46 Impairments related to associates 0 0 (1) Total 135 719 13 Net gains / (losses) from disposals of financial assets measured 9 40 31 Income from properties 3 23 26 27 Net gains / (losses) from properties held for sale 100 4 76 5 (19) Other 185 6 216 7 160 Total other income 452 1,076 212 1 Includes foreign exchange gains 631 stake in Fondcenter AG 140 sale-and-leaseback transactions, primarily 100 from the sale of 215 Bloomberg Commodity Index family. |
UBS AG | |
Entity [Table] | |
Disclosure Of Other Operating Income Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Associates, joint ventures and subsidiaries Net gains / (losses) from acquisitions and disposals of 1 (11) 635 2 (36) Net gains / (losses) from disposals of investments in associates 41 0 4 Share of net profits of associates and joint ventures 105 84 46 Impairments related to associates 0 0 (1) Total 134 719 13 Net gains / (losses) from disposals of financial assets measured 9 40 31 Income from properties 3 22 25 27 Net gains / (losses) from properties held for sale 100 4 76 5 (19) Income from shared services provided to UBS Group AG or its subsidiaries 451 422 464 Other 224 6 267 7 161 Total other income 941 1,549 677 1 Includes foreign exchange gains 631 stake in Fondcenter AG 140 sale-and-leaseback transactions, primarily 100 from the sale of UBS AG's domestic wealth management business in Austria. Refer to Note 30 for more 215 Bloomberg Commodity Index family. |
Personnel expenses (Tables)
Personnel expenses (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Employee Benefits Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Salaries 1 7,339 7,023 6,518 Variable compensation – performance awards 2 3,190 3,209 3 2,755 Variable compensation – other 2 229 220 246 Financial advisor compensation 2,4 4,860 4,091 4,043 Contractors 381 375 381 Social security 978 899 3 799 Post-employment benefit plans 5 833 6 845 787 of which: defined benefit plans 470 502 461 of which: defined contribution plans 363 343 326 Other personnel expenses 576 561 3 555 Total personnel expenses 18,387 17,224 16,084 1 Includes role-based allowances. employees, resulting in an 280 240 20 20 million within compensation calculated on the basis the time of 80 obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities. |
UBS AG | |
Entity [Table] | |
Disclosure Of Employee Benefits Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Salaries 1 5,723 5,535 5,183 Variable compensation – performance awards 2 2,916 2,953 3 2,545 Variable compensation – other 2 196 201 225 Financial advisor compensation 2,4 4,860 4,091 4,043 Contractors 142 138 147 Social security 762 704 3 627 Post-employment benefit plans 5 582 6 597 569 of which: defined benefit plans 280 306 of which: defined contribution plans 303 291 278 Other personnel expenses 479 466 3 461 Total personnel expenses 15,661 14,686 13,801 1 Includes role-based allowances. employees, resulting in an 270 240 20 10 million within compensation calculated on the basis the time of 49 obligation related to the Swiss pension plan resulting from a decrease in headcount following restructuring activities. |
General and administrative ex_2
General and administrative expenses (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of General And Administrative Expense Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Outsourcing costs 893 951 1,072 IT expenses 1,055 949 860 Consulting, legal and audit fees 540 646 850 Real estate and logistics costs 634 671 662 Market data services 417 413 414 Marketing and communication 242 217 270 Travel and entertainment 72 84 298 Litigation, regulatory and similar matters 2 911 197 165 Other 788 757 696 of which: UK and German bank levies 3 58 55 41 Total general and administrative expenses 5,553 4,885 5,288 1 In 2021, UBS changed expenses. of USD 1 3 11 22 38 30 USD 16 27 31 |
UBS AG | |
Entity [Table] | |
Disclosure Of General And Administrative Expense Tables Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Outsourcing costs 426 466 551 IT expenses 490 449 448 Consulting, legal and audit fees 465 566 753 Real estate and logistics costs 530 563 559 Market data services 367 361 364 Marketing and communication 171 162 191 Travel and entertainment 66 77 272 Litigation, regulatory and similar matters 2 910 197 165 Other 6,051 5,646 5,283 of which: shared services costs charged by UBS Group AG or its subsidiaries 5,321 4,939 4,621 of which: UK and German bank levies 3 58 55 41 Total general and administrative expenses 9,476 8,486 8,586 1 In administrative expenses. from third parties of USD 1 3 11 22 38 30 included a credit of USD 16 27 31 |
Income taxes (Tables)
Income taxes (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of tax expense/(benefit) recognized and its relationship with accounting profit [text block] | For the year ended USD million 31.12.21 31.12.20 31.12.19 Tax expense / (benefit) Swiss Current 680 482 365 Deferred 34 116 265 Total Swiss 714 598 630 Non-Swiss Current 884 749 426 Deferred 400 236 211 Total non-Swiss 1,284 985 637 Total income tax expense / (benefit) recognized in the income statement 1,998 1,583 1,267 |
Disclosure Of Details Of Major Components Of Tax Expense Income Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Operating profit / (loss) before tax 9,484 8,155 5,577 of which: Swiss 3,334 3,403 2,571 of which: non-Swiss 6,150 4,752 3,006 Income taxes at Swiss tax rate of 18.5 % for 2021, 19.5 % for 2020 and 20.5 % for 2019 1,755 1,590 1,143 Increase / (decrease) resulting from: Non-Swiss tax rates differing from Swiss tax rate 234 110 82 Tax effects of losses not recognized 124 144 131 Previously unrecognized tax losses now utilized (179) (212) (265) Non-taxable and lower-taxed income (278) (394) (351) Non-deductible expenses and additional taxable income 510 385 732 Adjustments related to prior years – current tax (40) (67) (5) Adjustments related to prior years – deferred tax (10) 12 (6) Change in deferred tax recognition (342) (381) (294) Adjustments to deferred tax balances arising from changes (5) 234 (9) Other items 231 161 107 Income tax expense / (benefit) 1,998 1,583 1,267 |
Disclosure Of Total Recognized And Unrecognized Deferred Tax Assets And Deferred Tax Liabilities Explanatory | USD million 31.12.21 31.12.20 Deferred tax assets 1 Gross Valuation allowance Recognized Gross Valuation allowance Recognized Tax loss carry-forwards 13,636 (9,193) 4,443 14,108 (8,715) 5,393 Temporary differences 5,133 (700) 4,433 4,384 (565) 3,819 of which: related to real estate costs capitalized for US purposes 2,272 0 2,272 2,268 0 2,268 of which: related to compensation and benefits 1,222 (209) 1,013 1,128 (173) 955 of which: other 1,639 (491) 1,148 989 (392) 564 Total deferred tax assets 18,769 (9,893) 8,876 2 18,492 (9,280) 9,212 2 of which: related to the US 8,521 8,780 of which: related to other locations 355 431 Deferred tax liabilities Cash flow hedges 118 425 Other 183 139 Total deferred tax liabilities 300 564 1 After offset of DTLs, as applicable. 77 138 or preceding year. |
Disclosure Of Expiry Of Unused Tax Losses Explanatory | Unrecognized tax loss carry-forwards USD million 31.12.21 31.12.20 Within 1 year 141 146 From 2 to 5 years 1,026 638 From 6 to 10 years 13,283 13,257 From 11 to 20 years 2,093 3,858 No expiry 18,147 17,227 Total 34,690 35,127 of which: related to the US 1 14,870 16,256 of which: related to the UK 14,909 13,848 of which: related to other locations 4,911 5,023 1 Related to UBS AG's US branch. |
UBS AG | |
Entity [Table] | |
Disclosure of tax expense/(benefit) recognized and its relationship with accounting profit [text block] | For the year ended USD million 31.12.21 31.12.20 31.12.19 Tax expense / (benefit) Swiss Current 614 417 336 Deferred 26 107 246 Total Swiss 640 524 582 Non-Swiss Current 857 715 402 Deferred 406 248 214 Total non-Swiss 1,263 963 616 Total income tax expense / (benefit) recognized in the income statement 1,903 1,488 1,198 |
Disclosure Of Details Of Major Components Of Tax Expense Income Explanatory | For the year ended USD million 31.12.21 31.12.20 31.12.19 Operating profit / (loss) before tax of which: Swiss 2,983 3,042 2,297 of which: non-Swiss 5,981 4,657 2,872 Income taxes at Swiss tax rate of 18.5 % for 2021, 19.5 % for 2020 and 20.5 % for 2019 1,658 1,501 1,060 Increase / (decrease) resulting from: Non-Swiss tax rates differing from Swiss tax rate 217 96 72 Tax effects of losses not recognized 124 144 131 Previously unrecognized tax losses now utilized (179) (212) (265) Non-taxable and lower-taxed income (252) (381) (305) Non-deductible expenses and additional taxable income 487 373 713 Adjustments related to prior years – current tax (38) (66) 1 Adjustments related to prior years – deferred tax (3) 18 (6) Change in deferred tax recognition (341) (383) (293) Adjustments to deferred tax balances arising from changes (1) 235 (9) Other items 230 163 99 Income tax expense / (benefit) 1,903 1,488 1,198 |
Disclosure Of Total Recognized And Unrecognized Deferred Tax Assets And Deferred Tax Liabilities Explanatory | USD million 31.12.21 31.12.20 Deferred tax assets 1 Gross Valuation allowance Recognized Gross Valuation allowance Recognized Tax loss carry-forwards 13,636 (9,193) 4,443 14,108 (8,715) 5,393 Temporary differences 5,092 (696) 4,396 4,343 (561) 3,782 of which: related to real estate costs capitalized for US purposes 2,272 0 2,272 2,268 0 2,268 of which: related to compensation and benefits 1,200 (209) 991 1,112 (173) 939 of which: other 1,620 (487) 1,133 963 (388) 574 Total deferred tax assets 18,728 (9,889) 8,839 2 18,450 (9,276) 9,174 2 of which: related to the US 8,521 8,780 of which: related to other locations 318 394 Deferred tax liabilities Cash flow hedges 118 425 Other 179 133 Total deferred tax liabilities 297 558 1 After offset of DTLs, as applicable. 77 138 preceding year. |
Disclosure Of Expiry Of Unused Tax Losses Explanatory | Unrecognized tax loss carry-forwards USD million 31.12.21 31.12.20 Within 1 year 141 146 From 2 to 5 years 1,026 638 From 6 to 10 years 13,283 13,257 From 11 to 20 years 2,093 3,858 No expiry 18,147 17,227 Total 34,690 35,127 of which: related to the US 1 14,870 16,256 of which: related to the UK 14,909 13,848 of which: related to other locations 4,911 5,023 1 Related to UBS AG's US branch. |
Financial assets at amortized_2
Financial assets at amortized cost and other positions in scope of expected credit loss measurement (Tables) - UBS AG | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Entity [Table] | ||
Disclosure Of Credit Risk Exposure Explanatory | USD million 31.12.21 Carrying amount 1 ECL allowances Financial instruments measured at amortized Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Cash and balances at central banks 192,817 192,817 0 0 0 0 0 0 Loans and advances to banks 15,360 15,333 26 1 (8) (7) (1) 0 Receivables from securities financing transactions 75,012 75,012 0 0 (2) (2) 0 0 Cash collateral receivables on derivative instruments 30,514 30,514 0 0 0 0 0 0 Loans and advances to customers 398,693 381,496 15,620 1,577 (850) (126) (152) (572) of which: Private clients with mortgages 152,479 143,505 8,262 711 (132) (28) (71) (33) of which: Real estate financing 43,945 40,463 3,472 9 (60) (19) (40) 0 of which: Large corporate clients 13,990 12,643 1,037 310 (170) (22) (16) (133) of which: SME clients 14,004 12,076 1,492 436 (259) (19) (15) (225) of which: Lombard 149,283 149,255 0 27 (33) (6) 0 (28) of which: Credit cards 1,716 1,345 342 29 (36) (10) (9) (17) of which: Commodity trade finance 3,813 3,799 7 7 (114) (6) 0 (108) Other financial assets measured at amortized cost 26,236 25,746 302 189 (109) (27) (7) (76) of which: Loans to financial advisors 2,453 2,184 106 163 (86) (19) (3) (63) Total financial assets measured at amortized cost 738,632 720,917 15,948 1,767 (969) (161) (160) (647) Financial assets measured at fair value through other comprehensive income 8,844 8,844 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 747,477 729,762 15,948 1,767 (969) (161) (160) (647) Total exposure ECL provisions Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Guarantees 20,972 19,695 1,127 150 (41) (18) (8) (15) of which: Large corporate clients 3,464 2,567 793 104 (6) (3) (3) 0 of which: SME clients 1,353 1,143 164 46 (8) (1) (1) (7) of which: Financial intermediaries and hedge funds 9,575 9,491 84 0 (17) (13) (4) 0 of which: Lombard 2,454 2,454 0 0 (1) 0 0 (1) of which: Commodity trade finance 3,137 3,137 0 0 (1) (1) 0 0 Irrevocable loan commitments 39,478 37,097 2,335 46 (114) (72) (42) 0 of which: Large corporate clients 23,922 21,811 2,102 9 (100) (66) (34) 0 Forward starting reverse repurchase and securities borrowing agreements 1,444 1,444 0 0 0 0 0 0 Committed unconditionally revocable credit lines 42,373 39,802 2,508 63 (38) (28) (10) 0 of which: Real estate financing 7,328 7,046 281 0 (5) (4) (1) 0 of which: Large corporate clients 5,358 4,599 736 23 (7) (4) (3) 0 of which: SME clients 5,160 4,736 389 35 (15) (11) (3) 0 of which: Lombard 8,670 8,670 0 0 0 0 0 0 of which: Credit cards 9,466 9,000 462 4 (6) (5) (2) 0 of which: Commodity trade finance 117 117 0 0 0 0 0 0 Irrevocable committed prolongation of existing loans 5,611 5,527 36 48 (3) (3) 0 0 Total off-balance sheet financial instruments and credit lines 109,878 103,565 6,006 307 (196) (121) (60) (15) Total allowances and provisions (1,165) (282) (220) (662) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the respective | USD million 31.12.20 Carrying amount 1 ECL allowances Financial instruments measured at amortized Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Cash and balances at central banks 158,231 158,231 0 0 0 0 0 0 Loans and advances to banks 15,344 15,160 184 0 (16) (9) (5) (1) Receivables from securities financing transactions 74,210 74,210 0 0 (2) (2) 0 0 Cash collateral receivables on derivative instruments 32,737 32,737 0 0 0 0 0 0 Loans and advances to customers 380,977 358,396 20,341 2,240 (1,060) (142) (215) (703) of which: Private clients with mortgages 148,175 138,769 8,448 959 (166) (35) (93) (39) of which: Real estate financing 43,429 37,568 5,838 23 (63) (15) (44) (4) of which: Large corporate clients 15,161 12,658 2,029 474 (279) (27) (40) (212) of which: SME clients 14,872 11,990 2,254 628 (310) (19) (23) (268) of which: Lombard 133,850 133,795 0 55 (36) (5) 0 (31) of which: Credit cards 1,558 1,198 330 30 (38) (11) (11) (16) of which: Commodity trade finance 3,269 3,214 43 12 (106) (5) 0 (101) Other financial assets measured at amortized cost 27,219 26,401 348 469 (133) (34) (9) (90) of which: Loans to financial advisors 2,569 1,982 137 450 (108) (27) (5) (76) Total financial assets measured at amortized cost 688,717 665,135 20,873 2,709 (1,211) (187) (229) (795) Financial assets measured at fair value through other comprehensive income 8,258 8,258 0 0 0 0 0 0 Total on-balance sheet financial assets in scope of ECL requirements 696,976 673,394 20,873 2,709 (1,211) (187) (229) (795) Total exposure ECL provisions Off-balance sheet (in scope of ECL) Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Guarantees 17,081 14,687 2,225 170 (63) (14) (15) (34) of which: Large corporate clients 3,710 2,048 1,549 113 (20) (4) (5) (12) of which: SME clients 1,310 936 326 48 (13) (1) (1) (11) of which: Financial intermediaries and hedge funds 7,637 7,413 224 0 (17) (7) (9) 0 of which: Lombard 641 633 0 8 (2) 0 0 (2) of which: Commodity trade finance 1,441 1,416 25 0 (2) (1) 0 0 Irrevocable loan commitments 41,372 36,894 4,374 104 (142) (74) (68) 0 of which: Large corporate clients 24,209 20,195 3,950 64 (121) (63) (58) 0 Forward starting reverse repurchase and securities borrowing agreements 3,247 3,247 0 0 0 0 0 0 Committed unconditionally revocable credit lines 42,077 37,176 4,792 108 (50) (29) (21) 0 of which: Real estate financing 6,328 5,811 517 0 (12) (5) (7) 0 of which: Large corporate clients 4,909 2,783 2,099 27 (9) (2) (7) 0 of which: SME clients 5,827 4,596 1,169 63 (16) (12) (4) 0 of which: Lombard 9,671 9,671 0 0 0 (1) 0 0 of which: Credit cards 8,661 8,220 430 11 (8) (6) (2) 0 of which: Commodity trade finance 242 242 0 0 0 0 0 0 Irrevocable committed prolongation of existing loans 3,282 3,277 5 0 (2) (2) 0 0 Total off-balance sheet financial instruments and credit lines 107,059 95,281 11,396 382 (257) (119) (104) (34) Total allowances and provisions (1,468) (306) (333) (829) 1 The carrying amount of financial assets measured at amortized cost represents the total gross exposure net of the |
Disclosure Of Coverage Ratios Explanatory | Coverage ratios for core loan portfolio 31.12.21 Gross carrying amount (USD million) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Private clients with mortgages 152,610 143,533 8,333 744 9 2 85 446 Real estate financing 44,004 40,483 3,512 10 14 5 114 231 Large corporate clients 14,161 12,665 1,053 443 120 18 148 2,997 SME clients 14,263 12,095 1,507 661 182 16 103 3,402 Lombard 149,316 149,261 0 55 2 0 0 5,026 Credit cards 1,752 1,355 351 46 204 72 255 3,735 Commodity trade finance 3,927 3,805 7 115 290 15 3 9,388 Other loans and advances to customers 19,510 18,425 1,010 75 23 9 15 3,730 Loans to financial advisors 2,539 2,203 109 226 338 88 303 2,791 Total 1 402,081 383,825 15,882 2,374 23 4 98 2,673 Gross exposure (USD million) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Private clients with mortgages 9,123 8,798 276 49 3 3 9 15 Real estate financing 8,766 8,481 285 0 9 7 88 0 Large corporate clients 32,748 28,981 3,630 136 34 25 110 1 SME clients 8,077 7,276 688 114 38 19 151 585 Lombard 14,438 14,438 0 0 1 0 0 0 Credit cards 9,466 9,000 462 4 7 5 34 0 Commodity trade finance 3,262 3,262 0 0 4 4 0 0 Financial intermediaries and hedge funds 13,747 13,379 369 0 13 10 120 0 8,806 8,507 296 4 15 6 30 0 Total 2 108,434 102,121 6,006 307 18 12 100 486 1 Includes Loans and 399,543 2,539 2 Excludes Forward starting reverse repurchase and securities borrowing agreements. | Coverage ratios for core loan portfolio 31.12.20 Gross carrying amount (USD million) ECL coverage (bps) On-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Private clients with mortgages 148,341 138,803 8,540 998 11 2 108 390 Real estate financing 43,492 37,583 5,883 27 15 4 75 1,414 Large corporate clients 15,440 12,684 2,069 686 181 21 192 3,089 SME clients 15,183 12,010 2,277 896 204 16 101 2,991 Lombard 133,886 133,800 0 86 3 0 0 3,592 Credit cards 1,596 1,209 342 46 240 91 333 3,488 Commodity trade finance 3,375 3,219 43 113 315 16 2 8,939 Other loans and advances to customers 20,722 19,229 1,402 91 29 13 25 3,563 Loans to financial advisors 2,677 2,009 142 526 404 135 351 1,446 Total 1 384,714 360,547 20,697 3,470 30 5 106 2,247 Gross exposure (USD million) ECL coverage (bps) Off-balance sheet Total Stage 1 Stage 2 Stage 3 Total Stage 1 Stage 2 Stage 3 Private clients with mortgages 6,285 6,083 198 3 7 6 16 197 Real estate financing 7,056 6,576 481 0 21 9 185 0 Large corporate clients 32,828 25,026 7,598 205 46 27 92 565 SME clients 9,121 7,239 1,734 148 40 19 63 779 Lombard 14,178 14,170 0 8 2 1 0 1,941 Credit cards 8,661 8,220 430 11 9 8 44 0 Commodity trade finance 1,683 1,658 25 0 10 8 15 8,279 Financial intermediaries and hedge funds 7,690 7,270 448 0 26 13 248 166 16,309 15,792 482 8 12 6 11 12,414 Total 2 103,812 92,034 11,396 382 25 13 91 894 1 Includes Loans and 382,036 2,677 2 Excludes Forward starting reverse repurchase and securities borrowing agreements. |
Derivative instruments (Tables)
Derivative instruments (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Derivative Financial Assets And Liabilities Explanatory | 31.12.21 31.12.20 USD billion Derivative financial assets Notional amounts related to derivative financial assets 2,3 Derivative financial liabilities Notional amounts related to derivative financial liabilities 2,3 Other notional amounts 2,4 Derivative financial assets Notional amounts related to derivative financial assets 2,3 Derivative financial liabilities Notional amounts related to derivative financial liabilities 2,3 Other notional amounts 2,4 Interest rate contracts 33.2 991.2 28.7 943.1 8,675.1 50.9 928.0 43.9 880.4 11,291.5 of which: forward contracts (OTC) 1 0.1 29.4 0.2 28.6 443.6 0.0 19.8 0.4 21.9 2,602.5 of which: swaps (OTC) 26.4 394.3 19.2 344.1 7,549.4 40.8 407.0 30.9 364.8 8,105.2 of which: options (OTC) 6.6 545.2 9.2 553.6 10.1 447.5 12.5 460.5 of which: futures (ETD) 525.0 480.6 of which: options (ETD) 0.0 22.4 0.0 16.8 157.1 0.0 53.6 0.0 33.1 103.3 Credit derivative contracts 1.4 44.7 1.8 46.3 2.4 57.6 2.9 64.8 of which: credit default swaps (OTC) 1.3 39.4 1.6 44.1 2.2 53.6 2.6 62.3 of which: total return swaps (OTC) 0.1 1.3 0.2 1.7 0.1 1.9 0.3 2.5 Foreign exchange contracts 53.3 3,030.8 54.1 2,938.8 1.2 68.7 2,951.1 70.5 2,820.4 1.4 of which: forward contracts (OTC) 23.8 1,008.9 23.8 1,043.2 27.3 779.1 29.0 853.3 of which: swaps (OTC) 24.3 1,606.3 24.9 1,480.3 34.3 1,727.3 34.4 1,567.3 of which: options (OTC) 5.2 412.6 5.3 408.6 7.1 440.9 7.1 394.7 Equity contracts 28.2 456.9 34.9 603.9 80.1 34.8 449.6 41.2 581.3 91.3 of which: swaps (OTC) 4.7 105.7 9.3 154.8 6.4 89.4 9.8 108.4 of which: options (OTC) 4.6 61.4 6.5 102.3 7.0 87.1 10.9 146.2 of which: futures (ETD) 71.2 67.9 of which: options (ETD) 10.2 289.6 9.8 346.3 8.8 10.7 273.1 11.3 326.8 23.5 of which: client-cleared transactions (ETD) 8.6 9.4 10.7 9.1 Commodity contracts 1.6 57.8 1.6 56.4 14.7 2.2 57.8 2.0 49.7 10.1 of which: swaps (OTC) 0.5 19.9 0.8 25.4 0.5 17.7 0.8 18.0 of which: options (OTC) 0.4 14.0 0.2 10.4 1.0 23.5 0.7 17.8 of which: futures (ETD) 13.9 9.3 of which: forward contracts (ETD) 18.1 15.2 8.0 6.3 of which: client-cleared transactions (ETD) 0.6 0.4 0.5 0.3 Loan commitments measured at FVTPL (OTC) 0.8 0.0 8.2 0.0 10.2 Unsettled purchases of non-derivative financial instruments 5 0.1 13.3 0.2 10.6 0.3 18.3 0.2 10.0 Unsettled sales of non-derivative financial instruments 5 0.2 18.2 0.1 9.4 0.2 17.2 0.3 12.9 Total derivative instruments, based on IFRS netting 6 118.1 4,613.8 121.3 4,616.6 8,771.1 159.6 4,479.5 161.1 4,429.7 11,394.4 1 Includes certain forward starting repurchase and reverse repurchase agreements that derivative financial instruments amounts of client-cleared ETD and OTC cleared through either a central counterparty or an exchange. The fair value instruments and Cash collateral trade date and settlement date right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency or to realize the asset and settle the liability simultaneously. Refer to Note 22 for more information on |
UBS AG | |
Entity [Table] | |
Disclosure Of Derivative Financial Assets And Liabilities Explanatory | 31.12.21 31.12.20 USD billion Derivative financial assets Notional amounts related to derivative financial assets 2,3 Derivative financial liabilities Notional amounts related to derivative financial liabilities 2,3 Other notional amounts 2,4 Derivative financial assets Notional amounts related to derivative financial assets 2,3 Derivative financial liabilities Notional amounts related to derivative financial liabilities 2,3 Other notional amounts 2,4 Interest rate contracts 33.2 991.2 28.7 943.1 8,675.1 50.9 928.0 43.9 880.4 11,291.5 of which: forward contracts (OTC) 1 0.1 29.4 0.2 28.6 443.6 0.0 19.8 0.4 21.9 2,602.5 of which: swaps (OTC) 26.4 394.3 19.2 344.1 7,549.4 40.8 407.0 30.9 364.8 8,105.2 of which: options (OTC) 6.6 545.2 9.2 553.6 10.1 447.5 12.5 460.5 of which: futures (ETD) 525.0 480.6 of which: options (ETD) 0.0 22.4 0.0 16.8 157.1 0.0 53.6 0.0 33.1 103.3 Credit derivative contracts 1.4 44.7 1.8 46.3 2.4 57.6 2.9 64.8 of which: credit default swaps (OTC) 1.3 39.4 1.6 44.1 2.2 53.6 2.6 62.3 of which: total return swaps (OTC) 0.1 1.3 0.2 1.7 0.1 1.9 0.3 2.5 Foreign exchange contracts 53.3 3,031.0 54.1 2,938.8 1.2 68.7 2,951.2 70.5 2,820.4 1.4 of which: forward contracts (OTC) 23.8 1,009.1 23.8 1,043.2 27.3 779.2 29.0 853.3 of which: swaps (OTC) 24.3 1,606.4 24.9 1,480.3 34.3 1,727.3 34.4 1,567.3 of which: options (OTC) 5.2 412.6 5.3 408.6 7.1 440.9 7.1 394.7 Equity contracts 28.2 456.9 34.9 603.9 80.1 34.8 449.6 41.2 581.3 91.3 of which: swaps (OTC) 4.7 105.7 9.3 154.8 6.4 89.4 9.8 108.4 of which: options (OTC) 4.6 61.4 6.5 102.3 7.0 87.1 10.9 146.2 of which: futures (ETD) 71.2 67.9 of which: options (ETD) 10.2 289.6 9.8 346.3 8.8 10.7 273.1 11.3 326.8 23.5 of which: client-cleared transactions (ETD) 8.6 9.4 10.7 9.1 Commodity contracts 1.6 57.8 1.6 56.4 14.7 2.2 57.8 2.0 49.7 10.1 of which: swaps (OTC) 0.5 19.9 0.8 25.4 0.5 17.7 0.8 18.0 of which: options (OTC) 0.4 14.0 0.2 10.4 1.0 23.5 0.7 17.8 of which: futures (ETD) 13.9 9.3 of which: forward contracts (ETD) 0.0 18.1 0.0 15.2 0.0 8.0 0.0 6.3 of which: client-cleared transactions (ETD) 0.6 0.4 0.5 0.3 Loan commitments measured at FVTPL (OTC) 0.8 0.0 8.2 0.0 10.2 Unsettled purchases of non-derivative financial instruments 5 0.1 13.3 0.2 10.6 0.3 18.3 0.2 10.0 Unsettled sales of non-derivative financial instruments 5 0.2 18.2 0.1 9.4 0.2 17.2 0.3 12.9 Total derivative instruments, based on IFRS netting 6 118.1 4,614.0 121.3 4,616.6 8,771.1 159.6 4,479.6 161.1 4,429.7 11,394.4 1 Includes certain forward starting repurchase and reverse repurchase agreements that are classified as measured derivative financial instruments amounts of client-cleared ETD and OTC cleared through either a central counterparty or an exchange. The instruments and Cash collateral trade date and enforceable right to offset the recognized amounts, both in the normal course of business and in the event of default, bankruptcy or insolvency of the entity and all of the counterparties, and intends either to settle on a net basis or to realize the asset and settle the liability simultaneously. Refer to Note 22 for more information |
Financial assets measured at _2
Financial assets measured at fair value through OCI (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Financial Assets Measured At Fair Value Through Other Comprehensive Income Tables Explanatory | USD million 31.12.21 31.12.20 Financial assets measured at fair value through other comprehensive income 1 Debt instruments Governments and government agencies 8,522 8,155 of which: USA 7,507 7,727 Banks 322 103 Total financial assets measured at fair value through other comprehensive income 8,844 8,258 Unrealized gains / (losses) recognized in Other comprehensive Unrealized gains, before tax 67 204 Unrealized (losses), before tax (80) (4) Net unrealized gains / (losses), before tax (13) 200 Net unrealized gains / (losses), after tax (7) 151 1 Refer to Note 21c for more information about product type and fair value hierarchy categorization. Refer also to Note 9 and |
UBS AG | |
Entity [Table] | |
Financial Assets Measured At Fair Value Through Other Comprehensive Income Tables Explanatory | USD million 31.12.21 31.12.20 Financial assets measured at fair value through other comprehensive income 1 Debt instruments Governments and government agencies 8,522 8,155 of which: USA 7,507 7,727 Banks 322 103 Total financial assets measured at fair value through other comprehensive income 8,844 8,258 Unrealized gains / (losses) recognized in Other comprehensive Unrealized gains, before tax 67 204 Unrealized (losses), before tax (80) (4) Net unrealized gains / (losses), before tax (13) 200 Net unrealized gains / (losses), after tax (7) 151 1 Refer to Note 21c for more information about product type and fair value hierarchy categorization. Refer |
Property, equipment and softw_2
Property, equipment and software (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Property Equipment Software Tables Explanatory | At historical cost less accumulated depreciation USD million Owned properties and equipment 1 Leased properties and equipment 2 Software Projects in progress 2021 2020 Historical cost Balance at the beginning of the year 13,185 4,249 7,768 1,036 26,238 24,431 Additions 273 213 228 1,376 2,090 2,312 Disposals / write-offs 3 (430) (223) (98) 0 (751) (990) Reclassifications 4 323 0 808 (1,149) (18) (590) Foreign currency translation (303) (66) (64) (12) (445) 1,074 Balance at the end of the year 13,048 4,174 8,642 1,250 27,113 26,238 Accumulated depreciation Balance at the beginning of the year 8,060 1,082 3,987 0 13,129 11,628 Depreciation 635 498 945 0 2,078 1,997 Impairment 5 9 1 0 0 10 72 Disposals / write-offs 3 (424) (215) (98) 0 (737) (855) Reclassifications 4 (12) 0 0 0 (12) (328) Foreign currency translation (196) (20) (28) 0 (243) 616 Balance at the end of the year 8,072 1,346 4,807 0 14,225 13,129 Net book value Net book value at the beginning of the year 5,126 3,167 3,780 1,036 13,109 12,804 Net book value at the end of the year 4,976 2,828 3,835 1,250 6 12,888 13,109 1 Includes leasehold relation to real estate, including 657 679 within Interest expense from There were no material gains 140 respective periods represents net reclassifications recoverable amount based on a value in use approach was determined to be zero. 1,087 163 |
UBS AG | |
Entity [Table] | |
Disclosure Of Property Equipment Software Tables Explanatory | At historical cost less accumulated depreciation USD million Owned properties and equipment 1 Leased properties and equipment 2 Software Projects in progress 2021 2020 Historical cost Balance at the beginning of the year 11,676 4,091 7,111 907 23,785 22,329 Additions 162 1 174 233 1,220 1,789 1,989 Disposals / write-offs 3 (345) (212) (75) 0 (632) (867) Reclassifications 4 267 0 703 (988) (18) (590) Foreign currency translation (266) (59) (48) (9) (381) 924 Balance at the end of the year 11,494 3,994 7,924 1,130 24,542 23,785 Accumulated depreciation Balance at the beginning of the year 7,188 1,019 3,621 0 11,827 10,503 Depreciation 507 474 854 0 1,835 1,779 Impairment 5 8 1 0 0 9 72 Disposals / write-offs 3 (341) (204) (75) 0 (619) (735) Reclassifications 4 (12) 0 0 0 (12) (328) Foreign currency translation (172) (18) (19) 0 (210) 535 Balance at the end of the year 7,178 1,272 4,380 0 12,830 11,827 Net book value Net book value at the beginning of the year 4,488 3,072 3,490 907 11,958 11,826 Net book value at the end of the year 4,316 2,722 3,544 1,130 6 11,712 11,958 1 Includes leasehold improvements and IT hardware. in relation to real estate, including offices, retail branches and sales offices. The 632 652 within Interest expense from There were no material gains 140 respective periods represents net reclassifications recoverable amount based on a value in use approach was determined to be zero. 1,009 121 |
Goodwill and intangible assets
Goodwill and intangible assets (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of information for cashgenerating unit with significant amount of goodwill explanatory | Discount and growth rates Discount rates Growth rates In % 31.12.21 31.12.20 31.12.21 31.12.20 Global Wealth Management Americas 9.5 9.5 4.0 5.1 Global Wealth Management Switzerland and International 8.5 8.5 3.1 3.7 Asset Management 8.5 8.5 2.9 3.5 |
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill Explanatory | USD million Goodwill Intangible assets 1 2021 2020 Historical cost Balance at the beginning of the year 6,182 1,683 7,865 7,820 Additions 1 1 147 Disposals (3) (3) (158) Write-offs (41) (41) (35) Foreign currency translation (53) (30) (83) 91 Balance at the end of the year 6,126 1,612 7,739 7,865 Accumulated amortization and impairment Balance at the beginning of the year 1,385 1,385 1,351 Amortization 31 31 55 Impairment / (reversal of impairment) 2 (1) (1) 2 Disposals 0 0 Write-offs (41) (41) (35) Foreign currency translation (13) (13) 11 Balance at the end of the year 1,360 1,360 1,385 Net book value at the end of the year 6,126 252 6,378 6,480 of which: Global Wealth Management Americas 3,720 41 3,760 3,770 of which: Global Wealth Management Switzerland and International 1,204 72 1,276 1,320 of which: Asset Management 1,202 1,202 1,226 of which: Investment Bank 139 139 161 of which: Group Functions 0 4 1 Intangible 2 Impairment charges recorded in 5 2020). |
Disclosure Of Assets With Infinite Useful Lives And Finite Useful Lives Intangible Assets Future Amortization Expense Explanatory | USD million Intangible assets Estimated aggregated amortization expenses for: 2022 29 2023 27 2024 23 2025 23 2026 23 Thereafter 126 Not amortized due to indefinite useful life 2 Total 252 |
UBS AG | |
Entity [Table] | |
Disclosure of information for cashgenerating unit with significant amount of goodwill explanatory | Discount and growth rates Discount rates Growth rates In % 31.12.21 31.12.20 31.12.21 31.12.20 Global Wealth Management Americas 9.5 9.5 4.0 5.1 Global Wealth Management Switzerland and International 8.5 8.5 3.1 3.7 Asset Management 8.5 8.5 2.9 3.5 |
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill Explanatory | USD million Goodwill Intangible assets 1 2021 2020 Historical cost Balance at the beginning of the year 6,182 1,683 7,865 7,820 Additions 1 1 147 Disposals (3) (3) (158) Write-offs (41) (41) (35) Foreign currency translation (53) (30) (83) 91 Balance at the end of the year 6,126 1,612 7,739 7,865 Accumulated amortization and impairment Balance at the beginning of the year 1,385 1,385 1,351 Amortization 31 31 55 Impairment / (reversal of impairment) 2 (1) (1) 2 Disposals 0 0 Write-offs (41) (41) (35) Foreign currency translation (13) (13) 11 Balance at the end of the year 1,360 1,360 1,385 Net book value at the end of the year 6,126 252 6,378 6,480 of which: Global Wealth Management Americas 3,720 41 3,760 3,770 of which: Global Wealth Management Switzerland and International 1,204 72 1,276 1,320 of which: Asset Management 1,202 1,202 1,226 of which: Investment Bank 139 139 161 of which: Group Functions 0 4 1 Intangible assets mainly include customer relationships, contractual rights and the fully amortized branch 2 Impairment charges recorded in 2020 relate to assets for which the recoverable amount was determined considering their value 5 2020). |
Disclosure Of Assets With Infinite Useful Lives And Finite Useful Lives Intangible Assets Future Amortization Expense Explanatory | USD million Intangible assets Estimated aggregated amortization expenses for: 2022 29 2023 27 2024 23 2025 23 2026 23 Thereafter 126 Not amortized due to indefinite useful life 2 Total 252 |
Other financial and non-finan_3
Other financial and non-financial assets (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Other financial assets measured at amortized cost | |
Entity [Table] | |
Disclosure Of Other Assets Explanatory | USD million 31.12.21 31.12.20 Debt securities 18,858 18,801 of which: government bills / bonds 9,833 9,789 Loans to financial advisors 2,453 2,569 Fee- 1,972 2,014 Finance lease receivables 1,356 1,447 Settlement and clearing accounts 455 614 Accrued interest income 520 591 Other 594 1,158 Total other financial assets measured at amortized cost 26,209 27,194 |
Other non-financial assets | |
Entity [Table] | |
Disclosure Of Other Assets Explanatory | USD million 31.12.21 31.12.20 Precious metals and other physical commodities 5,258 6,264 Deposits and collateral provided in connection with litigation, 1 1,526 1,418 Prepaid expenses 1,108 1,081 VAT and other tax receivables 638 433 Properties and other non-current assets held for sale 32 246 Assets of disposal groups held for sale 2 1,093 Other 621 326 Total other non-financial assets 10,277 9,768 1 Refer to Note 18 for more information. |
UBS AG | Other financial assets measured at amortized cost | |
Entity [Table] | |
Disclosure Of Other Assets Explanatory | USD million 31.12.21 31.12.20 Debt securities 18,858 18,801 of which: government bills / bonds 9,833 9,789 Loans to financial advisors 2,453 2,569 Fee- 1,966 2,014 Finance lease receivables 1,356 1,447 Settlement and clearing accounts 455 614 Accrued interest income 521 592 Other 627 1,182 Total other financial assets measured at amortized cost 26,236 27,219 |
UBS AG | Other non-financial assets | |
Entity [Table] | |
Disclosure Of Other Assets Explanatory | USD million 31.12.21 31.12.20 Precious metals and other physical commodities 5,258 6,264 Deposits and collateral provided in connection with litigation, 1 1,526 1,418 Prepaid expenses 717 731 VAT and other tax receivables 591 392 Properties and other non-current assets held for sale 32 246 Assets of disposal groups held for sale 2 1,093 Other 618 323 Total other non-financial assets 9,836 9,374 1 Refer to Note 18 for more information. |
Amounts due to banks and cust_2
Amounts due to banks and customer deposits (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Deposits From Banks And Customer Deposits Explanatory | USD million 31.12.21 31.12.20 Amounts due to banks Customer deposits 542,007 524,605 of which: demand deposits 246,417 236,447 of which: retail savings / deposits 247,224 220,898 of which: time deposits 1 48,365 67,260 Total amounts due to banks and customer deposits 555,108 535,655 1 Includes customer deposits in UBS AG Jersey Branch placed by UBS Switzerland AG on behalf |
UBS AG | |
Entity [Table] | |
Disclosure Of Deposits From Banks And Customer Deposits Explanatory | USD million 31.12.21 31.12.20 Amounts due to banks 13,101 11,050 Customer deposits 544,834 527,929 of which: demand deposits 247,299 237,604 of which: retail savings / deposits 247,224 220,898 of which: time deposits 1 50,312 69,427 Total amounts due to banks and customer deposits 557,935 538,979 1 Includes customer deposits in UBS AG Jersey Branch placed by UBS Switzerland AG on behalf of its clients. |
Funding From Group Explanatory | USD million 31.12.21 31.12.20 Senior unsecured debt that contributes to total loss-absorbing 38,984 36,611 Senior unsecured debt other than TLAC 4,471 2,939 High-trigger loss-absorbing additional tier 1 capital instruments 11,414 11,854 Low-trigger loss-absorbing additional tier 1 capital instruments 2,426 2,575 Total 1 57,295 53,979 1 UBS AG has also recognized funding from UBS Group AG that is designated at fair value. |
Debt issued designated at fai_2
Debt issued designated at fair value (Table) - Debt issued designated at fair value | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Designated Financial Liabilities At Fair Value Through Profit Or Loss | USD million 31.12.21 31.12.20 Issued debt instruments Equity-linked 1 47,059 41,069 Rates-linked 16,369 11,038 Credit-linked 1,723 1,933 Fixed-rate 2,868 3,604 Commodity-linked 2,911 1,497 Other 2,868 2,101 of which: debt that contributes to total loss-absorbing capacity 2,136 1,190 Total debt issued designated at fair value 73,799 61,243 of which: issued by UBS AG with original maturity greater than one 2 57,967 46,427 of which: life-to-date own credit (gain) / loss 347 418 1 Includes investment fund unit-linked instruments issued. 100 % of the balance was unsecured (31 December 2020: 100 %). |
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities Designated At Fair Value Explanatory | Contractual maturity of carrying amount USD million 2022 2023 2024 2025 2026 2027–2031 Thereafter Total 31.12.21 Total 31.12.20 UBS Group AG 1 Non-subordinated debt Fixed-rate 0 0 0 0 0 0 2,340 2,340 1,375 UBS AG 2 Non-subordinated debt Fixed-rate 4,296 1,658 716 495 226 273 1,732 9,397 9,409 Floating-rate 19,338 15,621 5,067 5,816 3,840 8,364 3,238 61,284 49,528 Subtotal 23,635 17,279 5,783 6,311 4,066 8,637 4,971 70,682 58,937 Other subsidiaries 3 Non-subordinated debt Fixed-rate 6 0 0 0 0 423 0 429 539 Floating-rate 150 47 145 0 0 0 7 349 392 Subtotal 156 47 145 0 0 423 7 778 931 Total 23,791 17,325 5,929 6,311 4,066 9,060 7,317 73,799 61,243 1 Consists of instruments issued by the legal entity UBS Group AG. |
UBS AG | |
Entity [Table] | |
Disclosure Of Designated Financial Liabilities At Fair Value Through Profit Or Loss | USD million 31.12.21 31.12.20 Issued debt instruments Equity-linked 1 47,059 41,069 Rates-linked 16,369 11,038 Credit-linked 1,723 1,933 Fixed-rate 2,868 3,604 Commodity-linked 2,911 1,497 Other 529 726 Total debt issued designated at fair value 71,460 59,868 of which: issued by UBS AG with original maturity greater than one 2 57,967 46,427 of which: life-to-date own credit (gain) / loss 144 233 1 Includes investment fund unit-linked instruments issued. 100 % of the balance was unsecured (31 December 2020: 100 %). |
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities Designated At Fair Value Explanatory | Contractual maturity of carrying amount USD million 2022 2023 2024 2025 2026 2027–2031 Thereafter Total 31.12.21 Total 31.12.20 UBS AG 1 Non-subordinated debt Fixed-rate 4,296 1,658 716 495 226 273 1,732 9,397 9,409 Floating-rate 19,338 15,621 5,067 5,816 3,840 8,364 3,238 61,284 49,528 Subtotal 23,635 17,279 5,783 6,311 4,066 8,637 4,971 70,682 58,937 Other subsidiaries 2 Non-subordinated debt Fixed-rate 6 0 0 0 0 423 0 429 539 Floating-rate 150 47 145 0 0 0 7 349 392 Subtotal 156 47 145 0 0 423 7 778 931 Total 23,791 17,325 5,929 6,311 4,066 9,060 4,977 71,460 59,868 1 Consists of instruments issued by the legal entity UBS AG. |
Debt issued measured at amortiz
Debt issued measured at amortized cost (Tables) - Notes And Debentures Issued [Member] | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Detailed Information About Borrowings Explanatory | USD million 31.12.21 31.12.20 Certificates of deposit and commercial paper 40,640 41,151 Other short-term debt 2,458 5,515 Short-term debt 1 43,098 46,666 Senior unsecured debt that contributes to total loss-absorbing 38,984 36,611 Senior unsecured debt other than TLAC 27,590 21,340 of which: issued by UBS AG with original maturity greater than one 2 23,307 18,464 Covered bonds 1,389 2,796 Subordinated debt 18,640 22,157 of which: high-trigger loss-absorbing additional tier 1 capital 11,052 11,837 of which: low-trigger loss-absorbing additional tier 1 capital 2,425 2,577 of which: low-trigger loss-absorbing tier 2 capital instruments 2,596 7,201 of which: non-Basel III-compliant tier 2 capital instruments 547 543 Debt issued through the Swiss central mortgage institutions 9,454 9,660 Other long-term debt 0 3 Long-term debt 3 96,057 92,566 Total debt issued measured at amortized cost 4 139,155 139,232 1 Debt with an original contractual maturity of 100 % of the balance was unsecured (31 December 2020: 100 %). redemption features. |
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities Measured At Amortized Cost Explanatory | Contractual maturity of carrying amount USD million 2022 2023 2024 2025 2026 2027–2031 Thereafter Total 31.12.21 Total 31.12.20 UBS Group AG 1 Non-subordinated debt Fixed-rate 3,769 4,027 5,145 5,052 6,748 12,534 3,294 40,569 33,578 Floating-rate 492 2,183 0 0 0 0 0 2,676 5,890 Subordinated debt Fixed-rate 0 0 0 0 0 0 13,477 13,477 14,413 Subtotal 4,261 6,211 5,145 5,052 6,748 12,534 16,771 56,722 53,881 UBS AG 2 Non-subordinated debt Fixed-rate 38,647 5,578 1,964 349 3,439 1,381 1,213 52,571 52,618 Floating-rate 9,807 2,093 1,922 907 508 0 0 15,238 15,299 Subordinated debt Fixed-rate 2,020 0 2,596 337 210 0 0 5,163 7,744 Subtotal 50,474 7,671 6,482 1,594 4,158 1,381 1,213 72,972 75,661 Other subsidiaries 3 Non-subordinated debt Fixed-rate 907 1,007 1,072 1,173 1,045 3,674 582 9,460 9,690 Subtotal 907 1,007 1,072 1,173 1,045 3,674 582 9,460 9,690 Total 55,642 14,889 12,698 7,818 11,951 17,590 18,566 139,155 139,232 1 Consists of debt issued by the legal entity UBS Group AG. |
UBS AG | |
Entity [Table] | |
Disclosure Of Detailed Information About Borrowings Explanatory | USD million 31.12.21 31.12.20 Certificates of deposit and commercial paper 40,640 41,151 Other short-term debt 2,458 5,515 Short-term debt 1 43,098 46,666 Senior unsecured debt 23,328 18,483 of which: issued by UBS AG with original maturity greater than one 2 23,307 18,464 Covered bonds 1,389 2,796 Subordinated debt 5,163 7,744 of which: low-trigger loss-absorbing tier 2 capital instruments 2,596 7,201 of which: non-Basel III-compliant tier 2 capital instruments 547 543 Debt issued through the Swiss central mortgage institutions 9,454 9,660 Other long-term debt 0 3 Long-term debt 3 39,334 38,685 Total debt issued measured at amortized cost 4 82,432 85,351 1 Debt with an original contractual maturity of 100 % of the balance was unsecured (31 December 2020: 100 %). redemption features. |
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities Measured At Amortized Cost Explanatory | Contractual maturity of carrying amount USD million 2022 2023 2024 2025 2026 2027–2031 Thereafter Total 31.12.21 Total 31.12.20 UBS AG 1 Non-subordinated debt Fixed-rate 38,647 5,578 1,964 349 3,439 1,381 1,213 52,571 52,618 Floating-rate 9,807 2,093 1,922 907 508 0 0 15,238 15,299 Subordinated debt Fixed-rate 2,020 0 2,596 337 210 0 0 5,163 7,744 Subtotal 50,474 7,671 6,482 1,594 4,158 1,381 1,213 72,972 75,661 Other subsidiaries 2 Non-subordinated debt Fixed-rate 907 1,007 1,072 1,173 1,045 3,674 582 9,460 9,690 Subtotal 907 1,007 1,072 1,173 1,045 3,674 582 9,460 9,690 Total 51,381 8,679 7,554 2,766 5,203 5,055 1,795 82,432 85,351 1 Consists of debt issued by the legal entity UBS AG. |
Provisions and contingent liabi
Provisions and contingent liabilities (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Total provisions recognized under both IAS 37 and IFRS 9 [textblock] | USD million 31.12.21 31.12.20 Provisions other than provisions for expected credit losses 3,322 2,571 Provisions for expected credit losses 196 257 Total provisions 3,518 2,828 |
Total provisions with additional information [textblock] | USD million Litigation, regulatory and similar matters 1 Restructuring Other 3 Total 2021 Balance at the beginning of the year 2,135 72 363 2,571 Increase in provisions recognized in the income statement 986 297 78 1,361 Release of provisions recognized in the income statement (74) (30) (32) (136) Provisions used in conformity with designated purpose (189) (165) (80) (434) Capitalized reinstatement costs 0 0 32 32 Foreign currency translation / unwind of discount (59) (3) (10) (72) Balance at the end of the year 2,798 172 2 352 3,322 1 Consists of provisions for losses 125 USD 18 47 49 operational risks. |
UBS AG | |
Entity [Table] | |
Total provisions recognized under both IAS 37 and IFRS 9 [textblock] | USD million 31.12.21 31.12.20 Provisions other than provisions for expected credit losses 3,256 2,534 Provisions for expected credit losses 196 257 Total provisions 3,452 2,791 |
Total provisions with additional information [textblock] | USD million Litigation, regulatory and similar matters 1 Restructuring Other 3 Total 2021 Balance at the beginning of the year 2,135 67 332 2,534 Increase in provisions recognized in the income statement 986 228 73 1,286 Release of provisions recognized in the income statement (74) (25) (29) (128) Provisions used in conformity with designated purpose (189) (130) (76) (396) Capitalized reinstatement costs 0 0 30 30 Foreign currency translation / unwind of discount (59) (3) (9) (70) Balance at the end of the year 2,798 137 2 321 3,256 1 Consists of provisions for losses resulting from legal, liability and compliance risks. 90 USD 13 47 49 operational risks. |
Litigation, regulatory and si_2
Litigation, regulatory and similar matters (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of provisions for litigation, regulatory and similar matters [text block] | Provisions for litigation, regulatory and similar matters 1 USD million Global Wealth Manage- ment Personal & Corporate Banking Manage- ment Investment Bank Group Functions Total 2021 Balance at the beginning of the year 861 115 0 227 932 2,135 Increase in provisions recognized in the income statement 754 84 9 107 32 986 Release of provisions recognized in the income statement (60) (11) 0 (4) 0 (74) Provisions used in conformity with designated purpose (175) (1) (1) (10) (2) (189) Foreign currency translation / unwind of discount (42) (6) 0 (11) 0 (59) Balance at the end of the year 1,338 181 8 310 962 2,798 1 Provisions, if any, Provisions, if any, for the matters described in items 1 and 6 of this Note are allocated between Global Wealth Management and 5 are allocated between the Investment Bank and Group Functions. |
UBS AG | |
Entity [Table] | |
Disclosure of provisions for litigation, regulatory and similar matters [text block] | Provisions for litigation, regulatory and similar matters 1 USD million Global Wealth Manage- ment Personal & Corporate Banking Manage- ment Investment Bank Group Functions Total 2021 Balance at the beginning of the year 861 115 0 227 932 2,135 Increase in provisions recognized in the income statement 754 84 9 107 32 986 Release of provisions recognized in the income statement (60) (11) 0 (4) 0 (74) Provisions used in conformity with designated purpose (175) (1) (1) (10) (2) (189) Foreign currency translation / unwind of discount (42) (6) 0 (11) 0 (59) Balance at the end of the year 1,338 181 8 310 962 2,798 1 Provisions, if any, Provisions, if any, for the matters described in items 1 and 6 of this Note are allocated between Global Wealth Management and Personal & Corporate Banking, and provisions, if any, for the matters described in item 5 are allocated between the Investment Bank and Group Functions. |
Other liabilities (Tables)
Other liabilities (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Other Financial Liabilities Measured At Amortized Cost Explanatory | USD million 31.12.21 31.12.20 Other accrued expenses 1,876 1,696 Accrued interest expenses 1,094 1,355 Settlement and clearing accounts 1,304 1,199 Lease liabilities 3,558 3,927 Other 1,167 1,553 Total other financial liabilities measured at amortized cost 9,001 9,729 |
Disclosure Of Other Financial Liabilities Designated At Fair Value Explanatory | USD million 31.12.21 31.12.20 Financial liabilities related to unit-linked investment contracts 21,466 20,975 Securities financing transactions 6,377 7,317 Over-the-counter debt instruments 2,128 2,060 Other 103 35 Total other financial liabilities designated at fair value 30,074 30,387 of which: life-to-date own credit (gain) / loss (32) (36) |
Disclosure Of Other Non Financial Liabilities Explanatory | USD million 31.12.21 31.12.20 Compensation-related liabilities 7,257 7,468 of which: Deferred Contingent Capital Plan 1,628 1,858 of which: financial advisor compensation plans 1,512 1,500 of which: other compensation plans 2,846 2,740 of which: net defined benefit liability 633 722 of which: other compensation-related liabilities 1 638 648 Deferred tax liabilities 300 564 Current tax liabilities 1,398 1,009 VAT and other tax payables 590 523 Deferred income 240 228 Liabilities of disposal groups held for sale 2 1,298 Other 68 61 Total other non-financial liabilities 11,151 9,854 1 Includes liabilities for payroll taxes and untaken vacation. |
UBS AG | |
Entity [Table] | |
Disclosure Of Other Financial Liabilities Measured At Amortized Cost Explanatory | USD million 31.12.21 31.12.20 Other accrued expenses 1,642 1,508 Accrued interest expenses 1,134 1,382 Settlement and clearing accounts 1,282 1,181 Lease liabilities 3,438 3,821 Other 2,269 2,530 Total other financial liabilities measured at amortized cost 9,765 10,421 |
Disclosure Of Other Financial Liabilities Designated At Fair Value Explanatory | USD million 31.12.21 31.12.20 Financial liabilities related to unit-linked investment contracts 21,466 20,975 Securities financing transactions 6,377 7,317 Over-the-counter debt instruments 2,128 2,060 Funding from UBS Group AG 2,340 1,375 Other 103 46 Total other financial liabilities designated at fair value 32,414 31,773 of which: life-to-date own credit (gain) / loss 172 148 |
Disclosure Of Other Non Financial Liabilities Explanatory | USD million 31.12.21 31.12.20 Compensation-related liabilities 4,795 4,776 of which: financial advisor compensation plans 1,512 1,497 of which: other compensation plans 2,140 2,034 of which: net defined benefit liability 617 711 of which: other compensation-related liabilities 1 526 534 Deferred tax liabilities 297 558 Current tax liabilities 1,365 943 VAT and other tax payables 524 470 Deferred income 225 212 Liabilities of disposal groups held for sale 2 1,298 Other 68 61 Total other non-financial liabilities 8,572 7,018 1 Includes liabilities for payroll taxes and untaken vacation. |
Expected credit loss measurem_2
Expected credit loss measurement (Tables) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Entity [Table] | ||
Disclosure Of Credit Loss Expense Recovery Explanatory | Credit loss (expense) / release USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions Total For the year ended 31.12.21 Stages 1 and 2 28 62 0 34 0 123 Stage 3 1 24 (1) 0 0 25 Total credit loss (expense) / release 29 86 (1) 34 0 148 For the year ended 31.12.20 Stages 1 and 2 (48) (129) 0 (88) 0 (266) Stage 3 (40) (128) (2) (217) (42) (429) Total credit loss (expense) / release (88) (257) (2) (305) (42) (694) For the year ended 31.12.19 Stages 1 and 2 3 23 0 (4) 0 22 Stage 3 (23) (44) 0 (26) (7) (100) Total credit loss (expense) / release (20) (21) 0 (30) (7) (78) | |
Disclosure Of Key Macro Economic Variables Explanatory | Scenario assumptions One year Three years cumulative 31.12.21 Upside Baseline Mild downside Severe downside Upside Baseline Mild downside Severe downside Real GDP growth (% change) United States 9.1 4.4 (0.1) (5.9) 17.8 10.1 1.8 (3.8) Eurozone 9.4 3.9 (0.1) (8.7) 17.3 7.5 0.9 (10.3) Switzerland 5.5 2.4 (0.9) (6.6) 13.1 5.8 (0.1) (5.7) Consumer price index (% change) United States 3.1 2.2 5.7 (1.2) 9.5 6.3 13.0 0.4 Eurozone 2.3 1.4 4.2 (1.3) 8.0 4.8 10.4 (1.7) Switzerland 1.8 0.3 3.5 (1.8) 6.1 1.7 9.0 (1.6) Unemployment rate (end-of-period level, %) United States 3.0 3.9 6.1 10.9 3.0 3.5 7.2 10.8 Eurozone 6.2 7.4 8.7 12.9 6.0 7.2 9.1 15.1 Switzerland 2.3 2.5 3.4 5.2 1.6 2.3 4.2 5.9 Fixed income: 10-year government bonds (change in yields, basis points) USD 50.0 16.5 259.2 (50.0) 170.0 41.2 329.2 (15.0) EUR 40.0 11.1 283.8 (35.0) 140.0 34.9 349.3 (25.0) CHF 50.0 12.1 245.5 (70.0) 150.0 34.4 307.3 (35.0) Equity indices (% change) S&P 500 12.0 14.1 (27.0) (50.2) 35.5 24.7 (21.8) (40.1) EuroStoxx 50 16.0 12.3 (23.4) (57.6) 41.6 20.7 (19.9) (50.4) SPI 14.0 12.1 (22.9) (53.6) 37.9 19.1 (19.6) (44.2) Swiss real estate (% change) Single-Family Homes 5.1 4.4 (4.3) (17.0) 15.5 7.4 (8.8) (30.0) Other real estate (% change) United States (S&P / Case-Shiller) 10.0 3.5 (2.3) (9.5) 21.7 7.1 (8.7) (26.3) Eurozone (House Price Index) 8.4 5.1 (4.0) (5.4) 17.8 9.6 (7.6) (10.8) | Scenario assumptions One year Three years cumulative 31.12.20 Baseline Severe downside Baseline Severe downside Real GDP growth (% change) United States 2.7 (5.9) 9.1 (3.8) Eurozone 2.5 (8.7) 9.9 (10.3) Switzerland 3.3 (6.6) 9.0 (5.7) Consumer price index (% change) United States 1.7 (1.2) 5.5 0.4 Eurozone 1.4 (1.3) 3.9 (1.7) Switzerland 0.3 (1.8) 0.9 (1.6) Unemployment rate (end-of-period level, %) United States 5.5 12.1 4.5 9.9 Eurozone 9.5 14.1 8.0 16.4 Switzerland 3.8 6.1 3.2 6.8 Fixed income: 10-year government bonds (change in yields, basis points) USD 22.0 (50.0) 46.0 (15.0) EUR 4.0 (35.0) 21.0 (25.0) CHF 13.0 (70.0) 31.0 (35.0) Equity indices (% change) S&P 500 (2.9) (50.2) (1.7) (40.1) EuroStoxx 50 3.8 (57.6) 13.5 (50.4) SPI (0.8) (53.6) 5.8 (44.2) Swiss real estate (% change) Single-Family Homes 3.4 (17.0) 7.1 (30.0) Other real estate (% change) United States (S&P / Case-Shiller) 2.5 (15.3) 9.2 (28.7) Eurozone (House Price Index) 1.1 (22.9) 7.2 (35.4) |
Disclosure Of Credit Risk Exposure Movement Explanatory | Development of ECL allowances and USD million Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2020 (1,468) (306) (333) (829) Net movement from new and derecognized transactions 1 (59) (72) 13 0 of which: Private clients with mortgages (7) (10) 3 0 of which: Real estate financing (7) (11) 4 0 of which: Large corporate clients (13) (21) 7 0 of which: SME clients (8) (8) 0 0 of which: Other (24) (23) (2) 0 (21) (18) (4) 0 0 (1) 1 0 Remeasurements with stage transfers 2 (40) 8 0 (49) of which: Private clients with mortgages (9) 4 (13) 0 of which: Real estate financing (3) 1 (4) 0 of which: Large corporate clients 2 (2) 12 (8) of which: SME clients (27) 5 4 (36) of which: Other (3) 0 2 (4) 2 (1) 3 0 0 1 (1) 0 Remeasurements without stage transfers 3 203 55 74 74 of which: Private clients with mortgages 33 8 26 (1) of which: Real estate financing 30 13 13 3 of which: Large corporate clients 44 5 21 17 of which: SME clients 53 (1) 1 53 of which: Other 44 29 14 2 27 15 12 0 6 8 1 (3) Model changes 4 45 29 16 0 Movements with profit or loss impact 5 148 19 104 25 Movements without profit or loss impact (write-off, FX and other) 6 154 5 9 141 Balance as of 31 December 2021 (1,165) (282) (220) (662) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. methodology changes. uncollectible or forgiven and movements in foreign exchange rates. | Development of ECL allowances and USD million Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2019 (1,029) (181) (160) (688) Net movement from new and derecognized transactions 1 (28) (90) 17 46 of which: Private clients with mortgages (2) (3) 2 0 of which: Real estate financing (3) (5) 2 0 of which: Large corporate clients (32) (29) (4) 0 of which: SME clients (16) (14) (3) 0 of which: Other 26 (39) 20 46 32 (1) 15 17 9 (1) 9 0 23 (6) 0 29 (20) (15) (5) 0 Remeasurements with stage transfers 2 (427) 45 (134) (338) of which: Private clients with mortgages (19) (2) (17) 0 of which: Real estate financing (6) 3 (9) 0 of which: Large corporate clients (224) 34 (83) (175) of which: SME clients (43) (1) (11) (31) of which: Other (134) 11 (14) (131) (36) 0 (18) (19) (12) 7 (7) (11) (36) 0 0 (36) (59) 0 0 (59) Remeasurements without stage transfers 3 (271) (88) (47) (136) of which: Private clients with mortgages (34) (19) (8) (7) of which: Real estate financing (14) (4) (11) 1 of which: Large corporate clients (149) (53) (17) (79) of which: SME clients (13) 0 (7) (6) of which: Other (60) (11) (4) (44) (18) (12) (3) (3) (3) 6 0 (9) (12) 0 0 (12) Model changes 4 32 21 11 0 Movements with profit or loss impact 5 (694) (112) (154) (429) Movements without profit or loss impact (write-off, FX and other) 6 254 (14) (19) 287 Balance as of 31 December 2020 (1,468) (306) (333) (829) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. methodology changes. uncollectible or forgiven and movements in foreign exchange rates. |
Disclosure Of Credit Risk Exposure Categories Explanatory | ECL stage 2 (“significant deterioration USD million Stage 2 of which: PD layer of which: watch list of which: ≥30 days past due On-and off-balance sheet (220) (158) (22) (39) of which: Private clients with mortgages (71) (54) 0 (17) of which: Real estate financing (43) (38) 0 (4) of which: Large corporate clients (55) (40) (15) 0 of which: SME clients (30) (19) (7) (4) of which: Financial intermediaries and hedge funds (6) (6) 0 0 of which: Loans to financial advisors (3) 0 0 (3) of which: Credit cards (11) 0 0 (11) of which: Other (1) (1) 0 0 | |
Disclosure Of Maximum Exposure To Credit Risk Explanatory | Maximum exposure to credit risk 31.12.21 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD billion Maximum exposure to credit risk Cash collateral received Collateralized by securities Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 192.8 192.8 Loans and advances to banks 4 15.5 0.1 0.1 15.3 Receivables from securities financing transactions 75.0 0.0 68.0 6.9 0.0 Cash collateral receivables on derivative instruments 5,6 30.5 18.4 12.1 Loans and advances to customers 7 397.8 37.5 128.7 191.3 20.2 4.0 16.2 Other financial assets measured at amortized cost 26.2 0.2 0.1 1.3 24.6 Total financial assets measured at amortized cost 737.8 37.7 196.9 191.3 28.4 18.4 0.0 4.0 261.0 Financial assets measured at fair value through other comprehensive income – debt 8.8 8.8 Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL 746.6 37.7 196.9 191.3 28.4 18.4 0.0 4.0 269.8 Guarantees 8 20.9 1.3 6.5 0.2 2.5 2.3 8.1 Loan commitments 8 39.4 0.5 4.0 2.4 7.3 0.3 1.7 23.1 Forward starting transactions, reverse repurchase and securities borrowing agreements 1.4 1.4 0.0 Committed unconditionally revocable credit lines 40.7 0.3 9.0 6.2 3.9 0.5 20.9 Total maximum exposure to credit risk not reflected on the balance sheet, in scope of ECL 102.5 2.2 20.9 8.7 13.7 0.0 0.3 4.5 52.1 31.12.20 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD billion Maximum exposure to credit risk Cash collateral received Collateralized by securities Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 158.2 158.2 Loans and advances to banks 4 15.4 0.1 15.3 Receivables from securities financing transactions 74.2 0.0 67.1 7.0 0.0 Cash collateral receivables on derivative instruments 5,6 32.7 21.1 11.6 Loans and advances to customers 7 379.5 25.8 118.2 194.6 21.7 4.4 14.8 Other financial assets measured at amortized cost 27.2 0.1 0.2 1.3 25.5 Total financial assets measured at amortized cost 687.3 26.0 185.7 194.6 30.1 21.1 0.0 4.4 225.5 Financial assets measured at fair value through other comprehensive income – debt 8.3 8.3 Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL 695.6 26.0 185.7 194.6 30.1 21.1 0.0 4.4 233.7 Guarantees 8 17.0 0.7 5.0 0.2 1.7 2.5 7.0 Loan commitments 8 41.2 0.0 4.2 2.1 6.8 0.4 2.4 25.3 Forward starting transactions, reverse repurchase and securities borrowing agreements 3.2 3.2 0.0 Committed unconditionally revocable credit lines 40.1 0.1 10.3 6.2 2.7 0.0 20.7 Total maximum exposure to credit risk not reflected on the balance sheet, in scope of ECL 101.6 0.8 22.7 8.5 11.2 0.0 0.4 4.9 53.0 1 Of which: USD 1,443 1,983 130 (31 December 2020: USD 154 cash, securities, real estate and other collateral. UBS applies mortgage loans, gold and other commodities. clients. clients who retain the associated credit risk. the collateral allocation was updated cash, with an offsetting reduction in loans secured by real estate and loans secured by securities. | |
Disclosure Of Internal Credit Exposures Explanatory | Financial assets subject to credit risk by rating USD million 31.12.21 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 191,015 1,802 0 0 0 0 192,817 0 192,817 of which: stage 1 191,015 1,802 0 0 0 0 192,817 0 192,817 Loans and advances to banks 407 12,623 1,171 795 490 1 15,488 (8) 15,480 of which: stage 1 407 12,623 1,146 795 488 0 15,460 (7) 15,453 of which: stage 2 0 0 24 0 2 0 27 (1) 26 of which: stage 3 0 0 0 0 0 1 1 0 1 Receivables from securities financing transactions 34,386 11,267 10,483 17,440 1,439 0 75,014 (2) 75,012 of which: stage 1 34,386 11,267 10,483 17,440 1,439 0 75,014 (2) 75,012 Cash collateral receivables on derivative instruments 7,466 13,476 5,878 3,647 47 0 30,514 0 30,514 of which: stage 1 7,466 13,476 5,878 3,647 47 0 30,514 0 30,514 Loans and advances to customers 5,295 232,233 67,620 69,892 21,423 2,148 398,611 (850) 397,761 of which: stage 1 5,295 231,153 65,084 62,796 16,362 0 380,690 (126) 380,564 of which: stage 2 0 1,080 2,536 7,096 5,061 0 15,773 (152) 15,620 of which: stage 3 0 0 0 0 0 2,148 2,148 (572) 1,577 Other financial assets measured at amortized cost 12,564 6,702 321 6,072 394 264 26,318 (109) 26,209 of which: stage 1 12,564 6,693 307 5,863 317 0 25,745 (27) 25,718 of which: stage 2 0 10 13 209 77 0 309 (7) 302 of which: stage 3 0 0 0 0 0 264 264 (76) 189 Total financial assets measured at amortized cost 251,133 278,103 85,472 97,846 23,793 2,414 738,762 (969) 737,794 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 3,996 4,771 0 77 0 0 8,844 0 8,844 Total on-balance sheet financial instruments 255,130 282,874 85,472 97,923 23,793 2,414 747,606 (969) 746,638 | Financial assets subject to credit risk by rating USD million 31.12.20 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 156,250 1,981 0 0 0 0 158,231 0 158,231 of which: stage 1 156,250 1,981 0 0 0 0 158,231 0 158,231 Loans and advances to banks 543 12,129 1,344 1,182 260 1 15,460 (16) 15,444 of which: stage 1 543 12,074 1,277 1,145 231 0 15,269 (9) 15,260 of which: stage 2 0 55 67 37 29 0 189 (5) 184 of which: stage 3 0 0 0 0 0 1 1 (1) 0 Receivables from securities financing transactions 22,998 16,009 15,367 17,995 1,842 0 74,212 (2) 74,210 of which: stage 1 22,998 16,009 15,367 17,995 1,842 0 74,212 (2) 74,210 Cash collateral receivables on derivative instruments 8,196 13,477 7,733 3,243 88 0 32,737 0 32,737 of which: stage 1 8,196 13,477 7,733 3,243 88 0 32,737 0 32,737 Loans and advances to customers 5,813 214,307 67,270 69,217 21,038 2,943 380,589 (1,060) 379,528 of which: stage 1 5,813 212,970 63,000 59,447 15,860 0 357,090 (142) 356,948 of which: stage 2 0 1,338 4,269 9,770 5,178 0 20,556 (215) 20,341 of which: stage 3 0 0 0 0 0 2,943 2,943 (703) 2,240 Other financial assets measured at amortized cost 15,404 4,018 280 6,585 481 560 27,327 (133) 27,194 of which: stage 1 15,404 4,015 269 6,334 389 0 26,410 (34) 26,377 of which: stage 2 0 3 11 251 91 0 357 (9) 348 of which: stage 3 0 0 0 0 0 560 560 (90) 469 Total financial assets measured at amortized cost 209,204 261,922 91,993 98,223 23,709 3,505 688,556 (1,211) 687,345 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 3,212 5,014 0 32 0 0 8,258 0 8,258 Total on-balance sheet financial instruments 212,417 266,936 91,993 98,255 23,709 3,505 696,815 (1,211) 695,603 |
Disclosure Of Off Balance Sheet Positions By Rating Category Explanatory | Off-balance sheet positions subject to expected USD million 31.12.21 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off - balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 4,457 7,064 4,535 3,757 1,009 150 20,972 (41) of which: stage 1 4,457 7,037 4,375 3,075 752 0 19,695 (18) of which: stage 2 0 27 160 682 258 0 1,127 (8) of which: stage 3 0 0 0 0 0 150 150 (15) Irrevocable loan commitments 2,797 14,183 7,651 8,298 6,502 46 39,478 (114) of which: stage 1 2,797 13,917 7,416 7,127 5,840 0 37,097 (72) of which: stage 2 0 266 235 1,171 663 0 2,335 (42) of which: stage 3 0 0 0 0 0 46 46 0 Forward starting reverse repurchase and securities borrowing agreements 0 0 55 1,389 0 0 1,444 0 Total off-balance sheet financial instruments 7,254 21,247 12,241 13,444 7,512 196 61,894 (155) Credit lines Committed unconditionally revocable credit lines 2,636 15,594 8,627 9,752 4,107 63 40,778 (38) of which: stage 1 2,636 15,250 8,304 8,346 3,671 0 38,207 (28) of which: stage 2 0 344 323 1,406 436 0 2,508 (10) of which: stage 3 0 0 0 0 0 63 63 0 Irrevocable committed prolongation of existing loans 17 2,438 1,422 1,084 602 48 5,611 (3) of which: stage 1 17 2,438 1,422 1,082 568 0 5,527 (3) of which: stage 2 0 0 0 1 34 0 36 0 of which: stage 3 0 0 0 0 0 48 48 0 Total credit lines 2,653 18,032 10,049 10,836 4,709 111 46,390 (41) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and | Off-balance sheet positions subject to expected USD million 31.12.20 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off - balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 3,482 4,623 3,522 4,293 991 170 17,081 (63) of which: stage 1 3,482 4,219 2,688 3,558 739 0 14,687 (14) of which: stage 2 0 404 834 736 252 0 2,225 (15) of which: stage 3 0 0 0 0 0 170 170 (34) Irrevocable loan commitments 3,018 14,516 8,583 9,302 5,850 104 41,372 (142) of which: stage 1 3,018 13,589 6,873 8,739 4,676 0 36,894 (74) of which: stage 2 0 927 1,711 563 1,174 0 4,374 (68) of which: stage 3 0 0 0 0 0 104 104 0 Forward starting reverse repurchase and securities borrowing agreements 82 150 0 3,015 0 0 3,247 0 Total off-balance sheet financial instruments 6,583 19,289 12,105 16,610 6,840 273 61,700 (205) Credit lines Committed unconditionally revocable credit lines 574 13,505 5,958 8,488 11,501 108 40,134 (50) of which: stage 1 574 12,940 4,517 6,609 10,593 0 35,233 (29) of which: stage 2 0 565 1,441 1,879 908 0 4,792 (21) of which: stage 3 0 0 0 0 0 108 108 0 Irrevocable committed prolongation of existing loans 14 1,349 931 632 357 0 3,282 (2) of which: stage 1 14 1,349 930 630 355 0 3,277 (2) of which: stage 2 0 1 1 2 1 0 5 0 of which: stage 3 0 0 0 0 0 0 0 0 Total credit lines 588 14,854 6,889 9,119 11,858 109 43,416 (52) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and |
Scenario Sensitivity Analysis Explanatory | Actual ECL allowances and provisions, including staging (as per Note 9) Pro forma ECL allowances and provisions, assuming all positions being subject to lifetime ECL Scenarios Weighted average 100% Baseline 100% Upside 100% Mild downside 100% Severe downside Weighted average USD million, except where indicated Segmentation Private clients with mortgages (95) (53) (52) (119) (207) (277) Real estate financing (62) (50) (48) (101) (97) (118) Large corporate clients (150) (116) (107) (148) (244) (257) SME clients (65) (56) (55) (71) (91) (117) Other segments (130) (112) (108) (135) (166) (291) Total (503) (387) (370) (574) (806) (1,060) | |
Scenario Sensitivity Analysis Calculation Change Explanatory | USD million Baseline Upside Mild downside Severe downside Weighted average Change in key parameters Fixed income: Government bonds (absolute change) –0.50% (1) 0 (29) (9) (4) +0.50% 1 1 39 11 5 +1.00% 4 2 88 23 14 Unemployment rate (absolute change) –1.00% (2) (2) (30) (48) (13) –0.50% (1) (1) (17) (27) (7) +0.50% 1 1 21 31 8 +1.00% 3 2 47 68 18 Real GDP growth (relative change) –2.00% 4 2 8 17 10 –1.00% 2 1 4 8 5 +1.00% (1) 0 (10) (8) (4) +2.00% (2) 0 (14) (16) (7) House Price Index (relative change) –5.00% 6 4 50 73 24 –2.50% 3 2 24 34 12 +2.50% (2) (1) (26) (31) (11) +5.00% (4) (3) (46) (31) (13) Equity (S&P500, EuroStoxx, SMI) (relative change) –10.00% 2 2 5 6 5 –5.00% 1 0 2 3 2 +5.00% (1) 0 (2) (3) (2) +10.00% (2) 0 (4) (6) (3) | |
UBS AG | ||
Entity [Table] | ||
Disclosure Of Credit Loss Expense Recovery Explanatory | Credit loss (expense) / release USD million Global Wealth Management Personal & Corporate Banking Asset Management Investment Bank Group Functions Total For the year ended 31.12.21 Stages 1 and 2 28 62 0 34 0 123 Stage 3 1 24 (1) 0 0 25 Total credit loss (expense) / release 29 86 (1) 34 0 148 For the year ended 31.12.20 Stages 1 and 2 (48) (129) 0 (88) 0 (266) Stage 3 (40) (128) (2) (217) (42) (429) Total credit loss (expense) / release (88) (257) (2) (305) (42) (695) For the year ended 31.12.19 Stages 1 and 2 3 23 0 (4) 0 22 Stage 3 (23) (44) 0 (26) (7) (100) Total credit loss (expense) / release (20) (21) 0 (30) (7) (78) | |
Disclosure Of Key Macro Economic Variables Explanatory | Scenario assumptions One year Three years cumulative 31.12.21 Upside Baseline Mild downside Severe downside Upside Baseline Mild downside Severe downside Real GDP growth (% change) United States 9.1 4.4 (0.1) (5.9) 17.8 10.1 1.8 (3.8) Eurozone 9.4 3.9 (0.1) (8.7) 17.3 7.5 0.9 (10.3) Switzerland 5.5 2.4 (0.9) (6.6) 13.1 5.8 (0.1) (5.7) Consumer price index (% change) United States 3.1 2.2 5.7 (1.2) 9.5 6.3 13.0 0.4 Eurozone 2.3 1.4 4.2 (1.3) 8.0 4.8 10.4 (1.7) Switzerland 1.8 0.3 3.5 (1.8) 6.1 1.7 9.0 (1.6) Unemployment rate (end-of-period level, %) United States 3.0 3.9 6.1 10.9 3.0 3.5 7.2 10.8 Eurozone 6.2 7.4 8.7 12.9 6.0 7.2 9.1 15.1 Switzerland 2.3 2.5 3.4 5.2 1.6 2.3 4.2 5.9 Fixed income: 10-year government bonds (change in yields, basis points) USD 50.0 16.5 259.2 (50.0) 170.0 41.2 329.2 (15.0) EUR 40.0 11.1 283.8 (35.0) 140.0 34.9 349.3 (25.0) CHF 50.0 12.1 245.5 (70.0) 150.0 34.4 307.3 (35.0) Equity indices (% change) S&P 500 12.0 14.1 (27.0) (50.2) 35.5 24.7 (21.8) (40.1) EuroStoxx 50 16.0 12.3 (23.4) (57.6) 41.6 20.7 (19.9) (50.4) SPI 14.0 12.1 (22.9) (53.6) 37.9 19.1 (19.6) (44.2) Swiss real estate (% change) Single-Family Homes 5.1 4.4 (4.3) (17.0) 15.5 7.4 (8.8) (30.0) Other real estate (% change) United States (S&P / Case-Shiller) 10.0 3.5 (2.3) (9.5) 21.7 7.1 (8.7) (26.3) Eurozone (House Price Index) 8.4 5.1 (4.0) (5.4) 17.8 9.6 (7.6) (10.8) | Scenario assumptions One year Three years cumulative 31.12.20 Baseline Severe downside Baseline Severe downside Real GDP growth (% change) United States 2.7 (5.9) 9.1 (3.8) Eurozone 2.5 (8.7) 9.9 (10.3) Switzerland 3.3 (6.6) 9.0 (5.7) Consumer price index (% change) United States 1.7 (1.2) 5.5 0.4 Eurozone 1.4 (1.3) 3.9 (1.7) Switzerland 0.3 (1.8) 0.9 (1.6) Unemployment rate (end-of-period level, %) United States 5.5 12.1 4.5 9.9 Eurozone 9.5 14.1 8.0 16.4 Switzerland 3.8 6.1 3.2 6.8 Fixed income: 10-year government bonds (change in yields, basis points) USD 22.0 (50.0) 46.0 (15.0) EUR 4.0 (35.0) 21.0 (25.0) CHF 13.0 (70.0) 31.0 (35.0) Equity indices (% change) S&P 500 (2.9) (50.2) (1.7) (40.1) EuroStoxx 50 3.8 (57.6) 13.5 (50.4) SPI (0.8) (53.6) 5.8 (44.2) Swiss real estate (% change) Single-Family Homes 3.4 (17.0) 7.1 (30.0) Other real estate (% change) United States (S&P / Case-Shiller) 2.5 (15.3) 9.2 (28.7) Eurozone (House Price Index) 1.1 (22.9) 7.2 (35.4) |
Disclosure Of Credit Risk Exposure Movement Explanatory | Development of ECL allowances and USD million Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2020 (1,468) (306) (333) (829) Net movement from new and derecognized transactions 1 (59) (72) 13 0 of which: Private clients with mortgages (7) (10) 3 0 of which: Real estate financing (7) (11) 4 0 of which: Large corporate clients (13) (21) 7 0 of which: SME clients (8) (8) 0 0 of which: Other (24) (23) (2) 0 (21) (18) (4) 0 0 (1) 1 0 Remeasurements with stage transfers 2 (40) 8 0 (49) of which: Private clients with mortgages (9) 4 (13) 0 of which: Real estate financing (3) 1 (4) 0 of which: Large corporate clients 2 (2) 12 (8) of which: SME clients (27) 5 4 (36) of which: Other (3) 0 2 (4) 2 (1) 3 0 0 1 (1) 0 Remeasurements without stage transfers 3 203 55 74 74 of which: Private clients with mortgages 33 8 26 (1) of which: Real estate financing 30 13 13 3 of which: Large corporate clients 44 5 21 17 of which: SME clients 53 (1) 1 53 of which: Other 44 29 14 2 27 15 12 0 6 8 1 (3) Model changes 4 45 29 16 0 Movements with profit or loss impact 5 148 19 104 25 Movements without profit or loss impact (write-off, FX and other) 6 154 5 9 141 Balance as of 31 December 2021 (1,165) (282) (220) (662) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. methodology changes. uncollectible or forgiven and movements in foreign exchange rates. | Development of ECL allowances and USD million Total Stage 1 Stage 2 Stage 3 Balance as of 31 December 2019 (1,029) (181) (160) (688) Net movement from new and derecognized transactions 1 (28) (90) 17 46 of which: Private clients with mortgages (2) (3) 2 0 of which: Real estate financing (3) (5) 2 0 of which: Large corporate clients (32) (29) (4) 0 of which: SME clients (16) (14) (3) 0 of which: Other 26 (39) 20 46 32 (1) 15 17 9 (1) 9 0 23 (6) 0 29 (20) (15) (5) 0 Remeasurements with stage transfers 2 (427) 45 (134) (338) of which: Private clients with mortgages (19) (2) (17) 0 of which: Real estate financing (6) 3 (9) 0 of which: Large corporate clients (224) 34 (83) (175) of which: SME clients (43) (1) (11) (31) of which: Other (134) 11 (14) (131) (36) 0 (18) (19) (12) 7 (7) (11) (36) 0 0 (36) (59) 0 0 (59) Remeasurements without stage transfers 3 (271) (88) (47) (136) of which: Private clients with mortgages (34) (19) (8) (7) of which: Real estate financing (14) (4) (11) 1 of which: Large corporate clients (149) (53) (17) (79) of which: SME clients (13) 0 (7) (6) of which: Other (60) (11) (4) (44) (18) (12) (3) (3) (3) 6 0 (9) (12) 0 0 (12) Model changes 4 32 21 11 0 Movements with profit or loss impact 5 (694) (112) (154) (429) Movements without profit or loss impact (write-off, FX and other) 6 254 (14) (19) 287 Balance as of 31 December 2020 (1,468) (306) (333) (829) 1 Represents the derecognition of loans or facilities on related to 4 Represents the change in the allowances and provisions related to changes in models and methodologies. methodology changes. uncollectible or forgiven and movements in foreign exchange rates. |
Disclosure Of Credit Risk Exposure Categories Explanatory | ECL stage 2 ("significant deterioration USD million Stage 2 of which: PD layer of which: watch list of which: ≥30 days past due On-and off-balance sheet (220) (158) (22) (39) of which: Private clients with mortgages (71) (54) 0 (17) of which: Real estate financing (43) (38) 0 (4) of which: Large corporate clients (55) (40) (15) 0 of which: SME clients (30) (19) (7) (4) of which: Financial intermediaries and hedge funds (6) (6) 0 0 of which: Loans to financial advisors (3) 0 0 (3) of which: Credit cards (11) 0 0 (11) of which: Other (1) (1) 0 0 | |
Disclosure Of Maximum Exposure To Credit Risk Explanatory | Maximum exposure to credit risk 31.12.21 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD billion Maximum exposure to credit risk Cash collateral received Collateralized by securities Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 192.8 192.8 Loans and advances to banks 4 15.4 0.1 0.1 15.1 Receivables from securities financing transactions 75.0 0.0 68.0 6.9 0.0 Cash collateral receivables on derivative instruments 5,6 30.5 18.4 12.1 Loans and advances to customers 7 398.7 38.2 128.7 191.3 20.2 4.0 16.4 Other financial assets measured at amortized cost 26.2 0.2 0.1 0.0 1.3 24.7 Total financial assets measured at amortized cost 738.6 38.4 196.9 191.3 28.4 18.4 0.0 4.0 261.1 Financial assets measured at fair value through other comprehensive income – debt 8.8 8.8 Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL 747.5 38.4 196.9 191.3 28.4 18.4 0.0 4.0 270.0 Guarantees 8 20.9 1.3 6.5 0.2 2.5 2.3 8.1 Loan commitments 8 39.4 0.5 4.0 2.4 7.3 0.3 1.7 23.1 Forward starting transactions, reverse repurchase and securities borrowing agreements 1.4 1.4 0.0 Committed unconditionally revocable credit lines 42.3 0.3 9.0 6.2 3.9 0.5 22.5 Total maximum exposure to credit risk not reflected on the balance sheet, in scope of ECL 104.1 2.2 20.9 8.7 13.7 0.0 0.3 4.5 53.7 31.12.20 Collateral 1,2 Credit enhancements 1 Exposure to credit risk after collateral and credit enhancements USD billion Maximum exposure to credit risk Cash collateral received Collateralized by securities Secured by real estate Other collateral 3 Netting Credit derivative contracts Guarantees Financial assets measured at amortized cost on the balance sheet Cash and balances at central banks 158.2 158.2 Loans and advances to banks 4 15.3 0.1 15.2 Receivables from securities financing transactions 74.2 0.0 67.1 7.0 0.0 Cash collateral receivables on derivative instruments 5,6 32.7 21.1 11.6 Loans and advances to customers 7 381.0 27.0 118.2 194.6 21.7 0.0 4.4 15.1 Other financial assets measured at amortized cost 27.2 0.1 0.2 0.0 1.3 25.5 Total financial assets measured at amortized cost 688.7 27.2 185.7 194.6 30.1 21.1 0.0 4.4 225.6 Financial assets measured at fair value through other comprehensive income – debt 8.3 8.3 Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL 697.0 27.2 185.7 194.6 30.1 21.1 0.0 4.4 233.9 Guarantees 8 17.0 0.7 5.0 0.2 1.7 2.5 7.0 Loan commitments 8 41.2 0.0 4.2 2.1 6.8 0.4 2.4 25.3 Forward starting transactions, reverse repurchase and securities borrowing agreements 3.2 3.2 0.0 Committed unconditionally revocable credit lines 42.0 0.1 10.3 6.2 2.7 0.0 22.7 Total maximum exposure to credit risk not reflected on the balance sheet, in scope of ECL 103.5 0.8 22.7 8.5 11.2 0.0 0.4 4.9 54.9 1 Of which: USD 1,443 1,983 130 (31 December 2020: USD 154 cash, securities, real inventory, mortgage loans, gold and other commodities. by those clients. behalf information. increase in loans secured by cash, with an offsetting reduction in loans secured by real estate and loans secured by securities. | |
Disclosure Of Internal Credit Exposures Explanatory | Financial assets subject to credit risk by rating USD million 31.12.21 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 191,015 1,802 0 0 0 0 192,817 0 192,817 of which: stage 1 191,015 1,802 0 0 0 0 192,817 0 192,817 Loans and advances to banks 407 12,552 1,123 795 490 1 15,368 (8) 15,360 of which: stage 1 407 12,552 1,098 795 488 0 15,340 (7) 15,333 of which: stage 2 0 0 24 0 2 0 27 (1) 26 of which: stage 3 0 0 0 0 0 1 1 0 1 Receivables from securities financing transactions 34,386 11,267 10,483 17,440 1,439 0 75,014 (2) 75,012 of which: stage 1 34,386 11,267 10,483 17,440 1,439 0 75,014 (2) 75,012 Cash collateral receivables on derivative instruments 7,466 13,476 5,878 3,647 47 0 30,514 0 30,514 of which: stage 1 7,466 13,476 5,878 3,647 47 0 30,514 0 30,514 Loans and advances to customers 5,295 232,663 67,620 70,394 21,423 2,148 399,543 (850) 398,693 of which: stage 1 5,295 231,583 65,083 63,298 16,362 0 381,622 (126) 381,496 of which: stage 2 0 1,080 2,536 7,096 5,061 0 15,773 (152) 15,620 of which: stage 3 0 0 0 0 0 2,148 2,148 (572) 1,577 Other financial assets measured at amortized cost 12,564 6,705 321 6,097 394 264 26,346 (109) 26,236 of which: stage 1 12,564 6,696 307 5,887 317 0 25,772 (27) 25,746 of which: stage 2 0 10 13 209 77 0 309 (7) 302 of which: stage 3 0 0 0 0 0 264 264 (76) 189 Total financial assets measured at amortized cost 251,133 278,465 85,424 98,372 23,793 2,414 739,601 (969) 738,632 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 3,996 4,771 0 77 0 0 8,844 0 8,844 Total on-balance sheet financial instruments 255,130 283,236 85,424 98,449 23,793 2,414 748,445 (969) 747,477 | Financial assets subject to credit risk by rating USD million 31.12.20 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total gross carrying amount ECL allowances Net carrying amount (maximum exposure to credit risk) Financial assets measured at amortized cost Cash and balances at central banks 156,250 1,981 0 0 0 0 158,231 0 158,231 of which: stage 1 156,250 1,981 0 0 0 0 158,231 0 158,231 Loans and advances to banks 543 12,029 1,344 1,182 260 1 15,360 (16) 15,344 of which: stage 1 543 11,974 1,277 1,145 231 0 15,170 (9) 15,160 of which: stage 2 0 55 67 37 29 0 189 (5) 184 of which: stage 3 0 0 0 0 0 1 1 (1) 0 Receivables from securities financing transactions 22,998 16,009 15,367 17,995 1,842 0 74,212 (2) 74,210 of which: stage 1 22,998 16,009 15,367 17,995 1,842 0 74,212 (2) 74,210 Cash collateral receivables on derivative instruments 8,196 13,477 7,733 3,243 88 0 32,737 0 32,737 of which: stage 1 8,196 13,477 7,733 3,243 88 0 32,737 0 32,737 Loans and advances to customers 5,813 215,755 67,270 69,217 21,038 2,943 382,036 (1,060) 380,977 of which: stage 1 5,813 214,418 63,000 59,447 15,860 0 358,538 (142) 358,396 of which: stage 2 0 1,338 4,269 9,770 5,178 0 20,556 (215) 20,341 of which: stage 3 0 0 0 0 0 2,943 2,943 (703) 2,240 Other financial assets measured at amortized cost 15,404 4,043 280 6,585 481 560 27,352 (133) 27,219 of which: stage 1 15,404 4,040 269 6,334 389 0 26,435 (34) 26,401 of which: stage 2 0 3 11 251 91 0 357 (9) 348 of which: stage 3 0 0 0 0 0 560 560 (90) 469 Total financial assets measured at amortized cost 209,204 263,295 91,993 98,223 23,709 3,505 689,929 (1,211) 688,717 On-balance sheet financial instruments Financial assets measured at FVOCI – debt instruments 3,212 5,014 0 32 0 0 8,258 0 8,258 Total on-balance sheet financial instruments 212,417 268,309 91,993 98,255 23,709 3,505 698,187 (1,211) 696,976 |
Disclosure Of Off Balance Sheet Positions By Rating Category Explanatory | Off-balance sheet positions subject to expected USD million 31.12.21 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off - balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 4,457 7,064 4,535 3,757 1,009 150 20,972 (41) of which: stage 1 4,457 7,037 4,375 3,075 752 0 19,695 (18) of which: stage 2 0 27 160 682 258 0 1,127 (8) of which: stage 3 0 0 0 0 0 150 150 (15) Irrevocable loan commitments 2,797 14,183 7,651 8,298 6,502 46 39,478 (114) of which: stage 1 2,797 13,917 7,416 7,127 5,840 0 37,097 (72) of which: stage 2 0 266 235 1,171 663 0 2,335 (42) of which: stage 3 0 0 0 0 0 46 46 0 Forward starting reverse repurchase and securities borrowing agreements 0 0 55 1,389 0 0 1,444 0 Total off balance sheet financial instruments 7,254 21,247 12,241 13,444 7,512 196 61,894 (155) Credit lines Committed unconditionally revocable credit lines 2,636 16,811 8,627 10,130 4,107 63 42,373 (38) of which: stage 1 2,636 16,467 8,304 8,724 3,671 0 39,802 (28) of which: stage 2 0 344 323 1,406 436 0 2,508 (10) of which: stage 3 0 0 0 0 0 63 63 0 Irrevocable committed prolongation of existing loans 17 2,438 1,422 1,084 602 48 5,611 (3) of which: stage 1 17 2,438 1,422 1,082 568 0 5,527 (3) of which: stage 2 0 0 0 1 34 0 36 0 of which: stage 3 0 0 0 0 0 48 48 0 Total credit lines 2,653 19,249 10,049 11,214 4,709 111 47,984 (41) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and | Off-balance sheet positions subject to expected USD million 31.12.20 Rating category 1 0–1 2–3 4–5 6–8 9–13 Credit- impaired (defaulted) Total off - balance sheet exposure (maximum exposure to credit risk) ECL provisions Off-balance sheet financial instruments Guarantees 3,482 4,623 3,522 4,293 991 170 17,081 (63) of which: stage 1 3,482 4,219 2,688 3,558 739 0 14,687 (14) of which: stage 2 0 404 834 736 252 0 2,225 (15) of which: stage 3 0 0 0 0 0 170 170 (34) Irrevocable loan commitments 3,018 14,516 8,583 9,302 5,850 104 41,372 (142) of which: stage 1 3,018 13,589 6,873 8,739 4,676 0 36,894 (74) of which: stage 2 0 927 1,711 563 1,174 0 4,374 (68) of which: stage 3 0 0 0 0 0 104 104 0 Forward starting reverse repurchase and securities borrowing agreements 82 150 0 3,015 0 0 3,247 0 Total off balance sheet financial instruments 6,583 19,289 12,105 16,610 6,840 273 61,700 (205) Credit lines Committed unconditionally revocable credit lines 574 15,448 5,958 8,488 11,501 108 42,077 (50) of which: stage 1 574 14,883 4,517 6,609 10,593 0 37,176 (29) of which: stage 2 0 565 1,441 1,879 908 0 4,792 (21) of which: stage 3 0 0 0 0 0 108 108 0 Irrevocable committed prolongation of existing loans 14 1,349 931 632 357 0 3,282 (2) of which: stage 1 14 1,349 930 630 355 0 3,277 (2) of which: stage 2 0 1 1 2 1 0 5 0 of which: stage 3 0 0 0 0 0 0 0 0 Total credit lines 588 16,797 6,889 9,119 11,858 109 45,359 (52) 1 Refer to the “Internal UBS rating scale and mapping of external ratings” table in the “Risk management and |
Scenario Sensitivity Analysis Explanatory | Actual ECL allowances and provisions, including staging (as per Note 9) Pro forma ECL allowances and provisions, assuming all positions being subject to lifetime ECL Scenarios Weighted average 100% Baseline 100% Upside 100% Mild downside 100% Severe downside Weighted average USD million, except where indicated Segmentation Private clients with mortgages (95) (53) (52) (119) (207) (277) Real estate financing (62) (50) (48) (101) (97) (118) Large corporate clients (150) (116) (107) (148) (244) (257) SME clients (65) (56) (55) (71) (91) (117) Other segments (130) (112) (108) (135) (166) (291) Total (503) (387) (370) (574) (806) (1,060) | |
Scenario Sensitivity Analysis Calculation Change Explanatory | USD million Baseline Upside Mild downside Severe downside Weighted average Change in key parameters Fixed income: Government bonds (absolute change) –0.50% (1) 0 (29) (9) (4) +0.50% 1 1 39 11 5 +1.00% 4 2 88 23 14 Unemployment rate (absolute change) –1.00% (2) (2) (30) (48) (13) –0.50% (1) (1) (17) (27) (7) +0.50% 1 1 21 31 8 +1.00% 3 2 47 68 18 Real GDP growth (relative change) –2.00% 4 2 8 17 10 –1.00% 2 1 4 8 5 +1.00% (1) 0 (10) (8) (4) +2.00% (2) 0 (14) (16) (7) House Price Index (relative change) –5.00% 6 4 50 73 24 –2.50% 3 2 24 34 12 +2.50% (2) (1) (26) (31) (11) +5.00% (4) (3) (46) (31) (13) Equity (S&P500, EuroStoxx, SMI) (relative change) –10.00% 2 2 5 6 5 –5.00% 1 0 2 3 2 +5.00% (1) 0 (2) (3) (2) +10.00% (2) 0 (4) (6) (3) |
Fair value measurement (Tables)
Fair value measurement (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Fair Value Measurement Of Assets Explanatory | Determination of fair values from quoted market 1 31.12.21 31.12.20 USD million Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial assets measured at fair value on a recurring basis Financial assets at fair value held for trading 113,697 14,825 2,299 130,821 107,507 15,553 2,337 125,397 of which: Equity instruments 97,958 1,090 149 99,197 90,307 1,101 171 91,579 Government bills / bonds 7,135 1,351 10 8,496 9,028 2,207 10 11,245 Investment fund units 7,843 1,364 21 9,229 7,374 1,794 23 9,192 Corporate and municipal bonds 708 7,604 556 8,868 789 8,356 817 9,961 Loans 0 3,099 1,443 4,542 0 1,860 1,134 2,995 Asset-backed securities 53 317 120 489 8 236 181 425 Derivative financial instruments 522 116,479 1,140 118,142 795 157,068 1,754 159,617 of which: Foreign exchange contracts 255 53,043 7 53,305 319 68,424 5 68,749 Interest rate contracts 0 32,747 494 33,241 0 50,353 537 50,890 Equity / index contracts 0 27,861 384 28,245 0 33,990 853 34,842 Credit derivative contracts 0 1,179 236 1,414 0 2,008 350 2,358 Commodity contracts 0 1,590 16 1,606 0 2,211 6 2,217 Brokerage receivables 0 21,839 0 21,839 0 24,659 0 24,659 Financial assets at fair value not held for trading 2 27,278 28,622 4,180 60,080 40,986 35,435 3,942 80,364 of which: Financial assets for unit-linked investment contracts 21,110 187 6 21,303 20,628 101 2 20,731 Corporate and municipal bonds 123 13,937 306 14,366 290 16,957 372 17,619 Government bills / bonds 5,624 3,236 0 8,860 19,704 3,593 0 23,297 Loans 0 4,982 892 5,874 0 7,699 862 8,561 Securities financing transactions 0 5,704 100 5,804 0 6,629 122 6,751 Auction rate securities 0 0 1,585 1,585 0 0 1,527 1,527 Investment fund units 338 574 117 1,028 278 447 105 831 Equity instruments 83 2 681 765 86 0 544 631 Other 0 0 495 495 0 10 408 418 Financial assets measured at fair value through other comprehensive income on Financial assets measured at fair value through other comprehensive 2 2,704 6,140 0 8,844 1,144 7,114 0 8,258 of which: Asset-backed securities 0 4,849 0 4,849 0 6,624 0 6,624 Government bills / bonds 2,658 27 0 2,686 1,103 47 0 1,150 Corporate and municipal bonds 45 1,265 0 1,310 40 444 0 485 Non-financial assets measured at fair value on a recurring basis Precious metals and other physical commodities 5,258 0 0 5,258 6,264 0 0 6,264 Non-financial assets measured at fair value on a non-recurring basis Other non-financial assets 3 0 0 26 26 0 1 245 246 Total assets measured at fair value 149,459 187,905 7,645 345,010 156,696 239,831 8,278 404,805 |
Disclosure Of Fair Value Measurement Of Liabilities Explanatory | Determination of fair values from quoted market 1 31.12.21 31.12.20 USD million Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial liabilities measured at fair value on a recurring basis Financial liabilities at fair value held for trading 25,413 6,170 105 31,688 26,888 6,652 55 33,595 of which: Equity instruments 18,328 513 83 18,924 22,519 425 40 22,985 Corporate and municipal bonds 30 4,219 17 4,266 31 4,048 9 4,089 Government bills / bonds 5,883 826 0 6,709 3,642 1,036 0 4,678 Investment fund units 1,172 555 6 1,733 696 1,127 5 1,828 Derivative financial instruments 509 118,558 2,242 121,309 746 156,884 3,471 161,102 of which: Foreign exchange contracts 258 53,800 21 54,078 316 70,149 61 70,527 Interest rate contracts 0 28,398 278 28,675 0 43,389 527 43,916 Equity / index contracts 0 33,438 1,511 34,949 0 38,870 2,306 41,176 Credit derivative contracts 0 1,412 341 1,753 0 2,403 528 2,931 Commodity contracts 0 1,503 63 1,566 0 2,003 24 2,027 Financial liabilities designated at fair value on a recurring basis Brokerage payables designated at fair value 0 44,045 0 44,045 0 38,742 0 38,742 Debt issued designated at fair value 2 0 59,606 14,194 73,799 0 50,273 10,970 61,243 Other financial liabilities designated at fair value 2 0 29,258 816 30,074 0 29,671 716 30,387 of which: Financial liabilities related to unit-linked investment contracts 0 21,466 0 21,466 0 20,975 0 20,975 Securities financing transactions 0 6,375 2 6,377 0 7,317 0 7,317 Over-the-counter debt instruments 0 1,334 794 2,128 0 1,363 697 2,060 Total liabilities measured at fair value 25,922 257,637 17,357 300,916 27,635 282,222 15,212 325,069 1 Bifurcated embedded derivatives are presented on the same balance sheet lines 2 As of 31 December 2021, USD 17 21 8 8 fair value through other 36 16 1 1 liabilities designated at fair value are expected to be recovered or settled after 12 months. at the lower of their net carrying amount or fair value less costs to sell. |
Disclosure Of Valuation Adjustment Reserves On The Balance Sheet Explanatory | Valuation adjustment reserves on the balance sheet As of Life-to-date gain / (loss), USD million 31.12.21 31.12.20 31.12.19 Deferred day-1 profit or loss reserves 418 269 146 Own credit adjustments on financial liabilities designated at fair value (315) (381) (88) CVAs, FVAs, (1,004) (959) (706) |
Disclosure Of Deferred Day-One Profit Or Loss Explanatory | Deferred day-1 profit or loss reserves USD million 2021 2020 2019 Reserve balance at the beginning of the year 269 146 255 Profit / (loss) deferred on new transactions 459 362 171 (Profit) / loss recognized in the income statement (308) (238) (278) Foreign currency translation (2) 0 (2) Reserve balance at the end of the year 418 269 146 |
Own credit adjustments on financial liabilities designated at fair value | Own credit adjustments on financial liabilities Included in Other comprehensive income For the year ended USD million 31.12.21 31.12.20 31.12.19 Recognized during the period: Realized gain / (loss) (14) 2 8 Unrealized gain / (loss) 60 (295) (408) Total gain / (loss), before tax 46 (293) (400) As of USD million 31.12.21 31.12.20 31.12.19 Recognized on the balance sheet as of the end of the period: Unrealized life-to-date gain / (loss) (315) (381) (88) |
Valuation adjustments on financial instruments | Valuation adjustments on financial instruments As of Life-to-date gain / (loss), USD million 31.12.21 31.12.20 Credit valuation adjustments 1 (44) (66) Funding valuation adjustments (49) (73) Debit valuation adjustments 2 0 Other valuation adjustments (913) (820) of which: liquidity (341) (340) of which: model uncertainty (571) (479) 1 Amounts do not include reserves against defaulted counterparties. |
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Of Assets And Liabilities Explanatory | Valuation techniques and inputs used in the fair value measurement Fair value Significant unobservable input(s) 1 Range of inputs Assets Liabilities Valuation technique(s) 31.12.21 31.12.20 USD billion 31.12.21 31.12.20 31.12.21 31.12.20 low high weighted average 2 low high weighted average 2 unit 1 Financial assets and liabilities at fair value held for trading and Financial assets at fair Corporate and municipal bonds 0.9 1.2 0.0 0.0 Relative value to market comparable Bond price equivalent 16 143 98 1 143 100 points Discounted expected cash flows Discount margin 434 434 268 268 basis points Traded loans, loans measured at fair value, loan commitments and guarantees 2.8 2.4 0.0 0.0 Relative value to market comparable Loan price equivalent 0 101 99 0 101 99 points Discounted expected cash flows Credit spread 175 800 436 190 800 398 basis points Market comparable and securitization model Credit spread 28 1,544 241 40 1,858 333 basis points Auction rate securities 1.6 1.5 Discounted expected cash flows Credit spread 115 197 153 100 188 140 basis points Investment fund units 3 0.1 0.1 0.0 0.0 Relative value to market comparable Net asset value Equity instruments 3 0.8 0.7 0.1 0.0 Relative value to market comparable Price Debt issued designated at fair value 4 14.2 11.0 Other financial liabilities designated at fair value 0.8 0.7 Discounted expected cash flows Funding spread 24 175 42 175 basis points Derivative financial instruments Interest rate contracts 0.5 0.5 0.3 0.5 Option model Volatility of interest rates 65 81 29 69 basis points Credit derivative contracts 0.2 0.3 0.3 0.5 Discounted expected cash flows Credit spreads 1 583 1 489 basis points Bond price equivalent 2 136 0 100 points Equity / index contracts 0.4 0.9 1.5 2.3 Option model Equity dividend yields 0 11 0 13 % Volatility of equity stocks, equity and other indices 4 98 4 100 % Equity-to-FX correlation (29) 76 (34) 65 % Equity-to-equity correlation (25) 100 (16) 100 % 1 The ranges of significant for most non-derivative financial liabilities designated at investments. linked notes, all of which have embedded derivative parameters that are considered to be unobservable. lines in this table. |
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities Explanatory | Sensitivity of fair value measurements to changes 1 31.12.21 31.12.20 USD million Favorable changes Unfavorable changes Favorable changes Unfavorable changes Traded loans, loans designated at fair value, loan commitments and guarantees 19 (13) 29 (28) Securities financing transactions 41 (53) 40 (52) Auction rate securities 66 2 (66) 2 105 (105) Asset-backed securities 20 (20) 41 (41) Equity instruments 173 (146) 129 (96) Interest rate derivative contracts, net 29 (19) 11 (16) Credit derivative contracts, net 5 (8) 10 (14) Foreign exchange derivative contracts, net 19 (11) 20 (15) Equity / index derivative contracts, net 368 (335) 318 (294) Other 50 (73) 91 (107) Total 790 (744) 794 (768) 1 Sensitivity of issued and various parameters and a change in assumptions regarding the underlying statistical distribution. |
Disclosure Of Level 3 Of Fair Value Of Financial Instruments Explanatory | Movements of Level 3 instruments Total gains / losses included in comprehensive income USD billion Balance as of 31 December 2019 Net gains / losses included in income 1 of which: related to Level 3 instruments held at the end of the reporting period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance as of 31 December 2020 Financial assets at fair value held for trading 1.8 (0.1) (0.1) 0.8 (1.4) 1.0 0.0 0.3 0.0 0.0 2.3 of which: Investment fund units 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Corporate and municipal bonds 0.5 0.0 0.0 0.7 (0.5) 0.0 0.0 0.1 0.0 0.0 0.8 Loans 0.8 0.0 (0.1) 0.0 (0.7) 1.0 0.0 0.1 0.0 0.0 1.1 Other 0.4 0.0 0.0 0.1 (0.3) 0.0 0.0 0.2 0.0 0.0 0.4 Derivative financial instruments – assets 1.3 0.3 0.4 0.0 0.0 0.7 (0.5) 0.1 (0.2) 0.1 1.8 of which: Interest rate contracts 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 Equity / index contracts 0.6 0.1 0.1 0.0 0.0 0.6 (0.3) 0.0 (0.1) 0.0 0.9 Credit derivative contracts 0.4 0.0 0.0 0.0 0.0 0.1 (0.2) 0.1 0.0 0.0 0.3 Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Financial assets at fair value not held for trading 4.0 0.0 0.1 0.8 (0.9) 0.0 0.0 0.1 0.0 0.0 3.9 of which: Loans 1.2 0.0 0.0 0.3 (0.7) 0.0 0.0 0.0 0.0 0.0 0.9 Auction rate securities 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 Equity instruments 0.5 0.0 0.0 0.1 (0.1) 0.0 0.0 0.0 0.0 0.0 0.5 Other 0.7 0.0 0.0 0.4 (0.2) 0.0 0.0 0.0 0.0 0.0 1.0 Derivative financial instruments – liabilities 2.0 1.3 1.2 0.0 0.0 1.2 (0.9) 0.4 (0.6) 0.1 3.5 of which: Interest rate contracts 0.1 0.3 0.3 0.0 0.0 0.3 (0.2) 0.2 (0.2) 0.0 0.5 Equity / index contracts 1.3 1.0 0.8 0.0 0.0 0.8 (0.6) 0.1 (0.2) 0.0 2.3 Credit derivative contracts 0.5 0.0 0.0 0.0 0.0 0.1 (0.1) 0.1 (0.2) 0.0 0.5 Other 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 Debt issued designated at fair value 9.9 0.2 0.0 0.0 0.0 7.6 (5.7) 0.5 (1.7) 0.2 11.0 Other financial liabilities designated at fair value 0.8 0.1 0.1 0.0 0.0 0.3 (0.5) 0.0 0.0 0.0 0.7 1 Net gains / losses Level 3 assets as of 31 December 2021 were USD 7.6 8.3 17.4 15.2 Total gains / losses included in comprehensive income Balance as of 31 December 2020 2 Net gains / losses included in income 1 of which: related to Level 3 instruments held at the end of the reporting period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance as of 31 December 2021 2 2.3 0.0 (0.1) 0.3 (1.6) 1.2 0.0 0.3 (0.3) 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 (0.4) 0.0 0.0 0.0 (0.1) 0.0 0.6 1.1 0.0 0.0 0.0 (0.8) 1.2 0.0 0.0 (0.2) 0.0 1.4 0.4 0.0 0.0 0.1 (0.4) 0.0 0.0 0.3 0.0 0.0 0.3 1.8 (0.2) (0.1) 0.0 0.0 0.5 (0.7) 0.1 (0.3) 0.0 1.1 0.5 0.1 0.1 0.0 0.0 0.1 (0.2) 0.0 (0.1) 0.0 0.5 0.9 (0.1) (0.1) 0.0 0.0 0.3 (0.4) 0.0 (0.2) 0.0 0.4 0.3 (0.1) (0.1) 0.0 0.0 0.0 (0.1) 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.1 0.1 1.0 (0.6) 0.0 0.0 0.1 (0.3) 0.0 4.2 0.9 0.0 0.0 0.6 (0.3) 0.0 0.0 0.0 (0.3) 0.0 0.9 1.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.5 0.1 0.1 0.1 (0.1) 0.0 0.0 0.0 0.0 0.0 0.7 1.0 0.0 (0.1) 0.3 (0.2) 0.0 0.0 0.0 0.0 0.0 1.0 3.5 0.2 0.0 0.0 0.0 0.9 (1.8) 0.0 (0.5) 0.0 2.2 0.5 (0.1) (0.1) 0.0 0.0 0.0 (0.1) 0.0 0.0 0.0 0.3 2.3 0.3 0.1 0.0 0.0 0.8 (1.5) 0.0 (0.4) 0.0 1.5 0.5 (0.1) (0.1) 0.0 0.0 0.0 0.0 0.0 (0.1) 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.0 (0.1) 0.0 0.0 0.0 0.1 11.0 0.7 0.6 0.0 0.0 8.0 (4.2) 0.2 (1.2) (0.2) 14.2 0.7 0.0 0.0 0.0 0.0 0.4 (0.2) 0.0 0.0 0.0 0.8 |
Disclosure Of Maximum Credit Risk Exposure Explanatory | Maximum exposure to credit risk 31.12.21 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD billion Cash collateral received Collateral- ized by securities Secured by real estate Other collateral Netting Credit derivative contracts Guarantees Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 22.4 22.4 Derivative financial instruments 4,5 118.1 4.2 103.2 10.7 Brokerage receivables 21.8 21.6 0.2 Financial assets at fair value not held for trading – debt instruments 6 37.0 11.2 25.7 Total financial assets measured at fair value 199.4 0.0 37.1 0.0 0.0 103.2 0.0 0.0 59.1 Guarantees 7 0.2 0.2 0.0 31.12.20 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD billion Cash collateral received Collateral- ized by securities Secured by real estate Other collateral Netting Credit derivative contracts Guarantees Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 24.6 24.6 Derivative financial instruments 4,5 159.6 6.0 138.4 15.2 Brokerage receivables 24.7 24.4 0.3 Financial assets at fair value not held for trading – debt instruments 6 58.2 13.2 45.0 Total financial assets measured at fair value 267.1 0.0 43.6 0.0 0.0 138.4 0.0 0.0 85.1 Guarantees 7 0.5 0.1 0.3 0.0 1 The maximum exposure to loss is generally equal to the carrying amount and subject the purpose of this disclosure, collateral 0 0 commitments and forward starting reverse repurchase agreements classified as derivatives. USD 27.8 21.9 8.2 0.8 9.4 billion, of which USD 0.8 balance sheet. Refer to agreements. |
Disclosure Of Fair Value Of Financial Instruments Not Measured At Fair Value Explanatory | Financial instruments not measured at fair value 31.12.21 31.12.20 Carrying amount Fair value Carrying amount Fair value USD billion Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Assets 2 Cash and balances at central banks 192.8 192.7 0.1 0.0 0.0 192.8 158.2 158.1 0.1 0.0 0.0 158.2 Loans and advances to banks 15.5 14.8 0.0 0.7 0.0 15.5 15.4 14.7 0.0 0.6 0.1 15.4 Receivables from securities financing transactions 75.0 71.6 0.0 1.3 2.1 75.0 74.2 64.9 0.0 7.6 1.7 74.2 Cash collateral receivables on derivative instruments 30.5 30.5 0.0 0.0 0.0 30.5 32.7 32.7 0.0 0.0 0.0 32.7 Loans and advances to customers 397.8 163.1 0.0 43.8 190.1 396.9 379.5 172.0 0.0 34.2 174.6 380.8 Other financial assets measured at amortized cost 26.2 4.1 9.3 10.7 2.4 26.5 27.2 5.3 9.4 10.9 2.3 28.0 Liabilities 2 Amounts due to banks 13.1 9.1 0.0 4.0 0.0 13.1 11.0 8.5 0.0 2.6 0.0 11.0 Payables from securities financing transactions 5.5 4.1 0.0 1.5 0.0 5.5 6.3 6.0 0.0 0.3 0.0 6.3 Cash collateral payables on derivative instruments 31.8 31.8 0.0 0.0 0.0 31.8 37.3 37.3 0.0 0.0 0.0 37.3 Customer deposits 542.0 535.4 0.0 6.6 0.0 542.0 524.6 519.4 0.0 5.3 0.0 524.7 Debt issued measured at amortized cost 139.2 15.8 0.0 125.3 0.0 141.1 139.2 16.4 0.0 125.5 0.0 141.9 Other financial liabilities measured at amortized cost 3 5.4 5.4 0.0 0.0 0.0 5.4 5.8 5.7 0.0 0.0 0.1 5.8 1 Includes certain financial instruments where the carrying amount is a reasonable with a remaining maturity (excluding 0 0 USD 0 0 1 1 175 2020: USD 163 19 20 1 0 of Amounts due to 3 2 84 82 3 (31 December 2020: USD 3 |
UBS AG | |
Entity [Table] | |
Disclosure Of Fair Value Measurement Of Assets Explanatory | Determination of fair values from quoted market 1 31.12.21 31.12.20 USD million Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial assets measured at fair value on a recurring basis Financial assets at fair value held for trading 113,722 15,012 2,299 131,033 107,526 15,630 2,337 125,492 of which: Equity instruments 97,983 1,090 149 99,222 90,327 1,101 171 91,599 Government bills / bonds 7,135 1,351 10 8,496 9,028 2,207 10 11,245 Investment fund units 7,843 1,364 21 9,229 7,374 1,794 23 9,192 Corporate and municipal bonds 708 7,791 556 9,055 789 8,432 817 10,038 Loans 0 3,099 1,443 4,542 0 1,860 1,134 2,995 Asset-backed securities 53 317 120 489 8 236 181 425 Derivative financial instruments 522 116,482 1,140 118,145 795 157,069 1,754 159,618 of which: Foreign exchange contracts 255 53,046 7 53,307 319 68,425 5 68,750 Interest rate contracts 0 32,747 494 33,241 0 50,353 537 50,890 Equity / index contracts 0 27,861 384 28,245 0 33,990 853 34,842 Credit derivative contracts 0 1,179 236 1,414 0 2,008 350 2,358 Commodity contracts 0 1,590 16 1,606 0 2,211 6 2,217 Brokerage receivables 0 21,839 0 21,839 0 24,659 0 24,659 Financial assets at fair value not held for trading 2 27,278 28,185 4,180 59,642 40,986 35,110 3,942 80,038 of which: Financial assets for unit-linked investment contracts 21,110 187 6 21,303 20,628 101 2 20,731 Corporate and municipal bonds 123 13,937 306 14,366 290 16,957 372 17,619 Government bills / bonds 5,624 3,236 0 8,860 19,704 3,593 0 23,297 Loans 0 4,982 892 5,874 0 7,699 862 8,561 Securities financing transactions 0 5,704 100 5,804 0 6,629 122 6,751 Auction rate securities 0 0 1,585 1,585 0 0 1,527 1,527 Investment fund units 338 137 117 591 278 121 105 505 Equity instruments 83 2 681 765 86 0 544 631 Other 0 0 495 495 0 10 408 418 Financial assets measured at fair value through other comprehensive income on Financial assets measured at fair value through other comprehensive 2 2,704 6,140 0 8,844 1,144 7,114 0 8,258 of which: Asset-backed securities 0 4,849 0 4,849 0 6,624 0 6,624 Government bills / bonds 2,658 27 0 2,686 1,103 47 0 1,150 Corporate and municipal bonds 45 1,265 0 1,310 40 444 0 485 Non-financial assets measured at fair value on a recurring basis Precious metals and other physical commodities 5,258 0 0 5,258 6,264 0 0 6,264 Non-financial assets measured at fair value on a non-recurring basis Other non-financial assets 3 0 0 26 26 0 1 245 246 Total assets measured at fair value 149,484 187,658 7,645 344,787 156,716 239,583 8,278 404,576 |
Disclosure Of Fair Value Measurement Of Liabilities Explanatory | Determination of fair values from quoted market 1 31.12.21 31.12.20 USD million Level 1 Level 2 Level 3 Total Level 1 Level 2 Level 3 Total Financial liabilities measured at fair value on a recurring basis Financial liabilities at fair value held for trading 25,413 6,170 105 31,688 26,889 6,652 55 33,595 of which: Equity instruments 18,328 513 83 18,924 22,519 425 40 22,985 Corporate and municipal bonds 30 4,219 17 4,266 31 4,048 9 4,089 Government bills / bonds 5,883 826 0 6,709 3,642 1,036 0 4,678 Investment fund units 1,172 555 6 1,733 696 1,127 5 1,828 Derivative financial instruments 509 118,558 2,242 121,309 746 156,884 3,471 161,102 of which: Foreign exchange contracts 258 53,800 21 54,078 316 70,149 61 70,527 Interest rate contracts 0 28,398 278 28,675 0 43,389 527 43,916 Equity / index contracts 0 33,438 1,511 34,949 0 38,870 2,306 41,176 Credit derivative contracts 0 1,412 341 1,753 0 2,403 528 2,931 Commodity contracts 0 1,503 63 1,566 0 2,003 24 2,027 Financial liabilities designated at fair value on a recurring basis Brokerage payables designated at fair value 0 44,045 0 44,045 0 38,742 0 38,742 Debt issued designated at fair value 2 0 59,606 11,854 71,460 0 50,273 9,595 59,868 Other financial liabilities designated at fair value 2 0 29,258 3,156 32,414 0 29,682 2,091 31,773 of which: Financial liabilities related to unit-linked investment contracts 0 21,466 0 21,466 0 20,975 0 20,975 Securities financing transactions 0 6,375 2 6,377 0 7,317 0 7,317 Over-the-counter debt instruments 0 1,334 794 2,128 0 1,363 697 2,060 Total liabilities measured at fair value 25,922 257,637 17,357 300,916 27,635 282,233 15,212 325,080 1 Bifurcated embedded derivatives are presented on the same balance sheet lines 2 As of 31 December 2021, USD 16 20 8 8 fair value through other 33 15 3 3 liabilities designated at fair value are expected to be recovered or settled after 12 months. at the lower of their net carrying amount or fair value less costs to sell. |
Disclosure Of Valuation Adjustment Reserves On The Balance Sheet Explanatory | Valuation adjustment reserves on the balance sheet As of Life-to-date gain / (loss), USD million 31.12.21 31.12.20 31.12.19 Deferred day-1 profit or loss reserves 418 269 146 Own credit adjustments on financial liabilities designated at fair value (315) (381) (88) CVAs, FVAs, (1,004) (959) (706) |
Disclosure Of Deferred Day-One Profit Or Loss Explanatory | Deferred day-1 profit or loss reserves USD million 2021 2020 2019 Reserve balance at the beginning of the year 269 146 255 Profit / (loss) deferred on new transactions 459 362 171 (Profit) / loss recognized in the income statement (308) (238) (278) Foreign currency translation (2) 0 (2) Reserve balance at the end of the year 418 269 146 |
Own credit adjustments on financial liabilities designated at fair value | Own credit adjustments on financial liabilities Included in Other comprehensive income For the year ended USD million 31.12.21 31.12.20 31.12.19 Recognized during the period: Realized gain / (loss) (14) 2 8 Unrealized gain / (loss) 60 (295) (408) Total gain / (loss), before tax 46 (293) (400) As of USD million 31.12.21 31.12.20 31.12.19 Recognized on the balance sheet as of the end of the period: Unrealized life-to-date gain / (loss) (315) (381) (88) |
Valuation adjustments on financial instruments | Valuation adjustments on financial instruments As of Life-to-date gain / (loss), USD million 31.12.21 31.12.20 Credit valuation adjustments 1 (44) (66) Funding valuation adjustments (49) (73) Debit valuation adjustments 2 0 Other valuation adjustments (913) (820) of which: liquidity (341) (340) of which: model uncertainty (571) (479) 1 Amounts do not include reserves against defaulted counterparties. |
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Of Assets And Liabilities Explanatory | Valuation techniques and inputs used in the fair value measurement Fair value Significant unobservable input(s) 1 Range of inputs Assets Liabilities Valuation technique(s) 31.12.21 31.12.20 USD billion 31.12.21 31.12.20 31.12.21 31.12.20 low high weighted average 2 low high weighted average 2 unit 1 Financial assets and liabilities at fair value held for trading and Financial assets at fair Corporate and municipal bonds 0.9 1.2 0.0 0.0 Relative value to market comparable Bond price equivalent 16 143 98 1 143 100 points Discounted expected cash flows Discount margin 434 434 268 268 basis points Traded loans, loans measured at fair value, loan commitments and guarantees 2.8 2.4 0.0 0.0 Relative value to market comparable Loan price equivalent 0 101 99 0 101 99 points Discounted expected cash flows Credit spread 175 800 436 190 800 398 basis points Market comparable and securitization model Credit spread 28 1,544 241 40 1,858 333 basis points Auction rate securities 1.6 1.5 Discounted expected cash flows Credit spread 115 197 153 100 188 140 basis points Investment fund units 3 0.1 0.1 0.0 0.0 Relative value to market comparable Net asset value Equity instruments 3 0.8 0.7 0.1 0.0 Relative value to market comparable Price Debt issued designated at fair value 4 11.9 9.6 Other financial liabilities designated at fair value 3.2 2.1 Discounted expected cash flows Funding spread 24 175 42 175 basis points Derivative financial instruments Interest rate contracts 0.5 0.5 0.3 0.5 Option model Volatility of interest rates 65 81 29 69 basis points Credit derivative contracts 0.2 0.3 0.3 0.5 Discounted expected cash flows Credit spreads 1 583 1 489 basis points Bond price equivalent 2 136 0 100 points Equity / index contracts 0.4 0.9 1.5 2.3 Option model Equity dividend yields 0 11 0 13 % Volatility of equity stocks, equity and other indices 4 98 4 100 % Equity-to-FX correlation (29) 76 (34) 65 % Equity-to-equity correlation (25) 100 (16) 100 % 1 The ranges of significant for most non-derivative financial liabilities designated at investments. linked notes, all of which have embedded derivative parameters that are considered to be unobservable. lines in this table. |
Disclosure Of Sensitivity Analysis Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities Explanatory | Sensitivity of fair value measurements to changes 1 31.12.21 31.12.20 USD million Favorable changes Unfavorable changes Favorable changes Unfavorable changes Traded loans, loans designated at fair value, loan commitments and guarantees 19 (13) 29 (28) Securities financing transactions 41 (53) 40 (52) Auction rate securities 66 2 (66) 2 105 (105) Asset-backed securities 20 (20) 41 (41) Equity instruments 173 (146) 129 (96) Interest rate derivative contracts, net 29 (19) 11 (16) Credit derivative contracts, net 5 (8) 10 (14) Foreign exchange derivative contracts, net 19 (11) 20 (15) Equity / index derivative contracts, net 368 (335) 318 (294) Other 50 (73) 91 (107) Total 790 (744) 794 (768) 1 Sensitivity of issued and various parameters and a change in assumptions regarding the underlying statistical distribution. |
Disclosure Of Level 3 Of Fair Value Of Financial Instruments Explanatory | Movements of Level 3 instruments Total gains / losses included in comprehensive income USD billion Balance as of 31 December 2019 Net gains / losses included in income 1 of which: related to Level 3 instruments held at the end of the reporting period Purchases Sales Issuances Settlements Transfers into Level 3 Transfers out of Level 3 Foreign currency translation Balance as of 31 December 2020 Financial assets at fair value held for trading 1.8 (0.1) (0.1) 0.8 (1.4) 1.0 0.0 0.3 0.0 0.0 2.3 of which: Investment fund units 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Corporate and municipal bonds 0.5 0.0 0.0 0.7 (0.5) 0.0 0.0 0.1 0.0 0.0 0.8 Loans 0.8 0.0 (0.1) 0.0 (0.7) 1.0 0.0 0.1 0.0 0.0 1.1 Other 0.4 0.0 0.0 0.1 (0.3) 0.0 0.0 0.2 0.0 0.0 0.4 Derivative financial instruments – assets 1.3 0.3 0.4 0.0 0.0 0.7 (0.5) 0.1 (0.2) 0.1 1.8 of which: Interest rate contracts 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 Equity / index contracts 0.6 0.1 0.1 0.0 0.0 0.6 (0.3) 0.0 (0.1) 0.0 0.9 Credit derivative contracts 0.4 0.0 0.0 0.0 0.0 0.1 (0.2) 0.1 0.0 0.0 0.3 Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 Financial assets at fair value not held for trading 4.0 0.0 0.1 0.8 (0.9) 0.0 0.0 0.1 0.0 0.0 3.9 of which: Loans 1.2 0.0 0.0 0.3 (0.7) 0.0 0.0 0.0 0.0 0.0 0.9 Auction rate securities 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 Equity instruments 0.5 0.0 0.0 0.1 (0.1) 0.0 0.0 0.0 0.0 0.0 0.5 Other 0.7 0.0 0.0 0.4 (0.2) 0.0 0.0 0.0 0.0 0.0 1.0 Derivative financial instruments – liabilities 2.0 1.3 1.2 0.0 0.0 1.2 (0.9) 0.4 (0.6) 0.1 3.5 of which: Interest rate contracts 0.1 0.3 0.3 0.0 0.0 0.3 (0.2) 0.2 (0.2) 0.0 0.5 Equity / index contracts 1.3 1.0 0.8 0.0 0.0 0.8 (0.6) 0.1 (0.2) 0.0 2.3 Credit derivative contracts 0.5 0.0 0.0 0.0 0.0 0.1 (0.1) 0.1 (0.2) 0.0 0.5 Other 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 Debt issued designated at fair value 9.6 0.0 (0.2) 0.0 0.0 6.6 (5.6) 0.5 (1.7) 0.2 9.6 Other financial liabilities designated at fair value 1.0 0.2 0.2 0.0 0.0 1.4 (0.6) 0.0 0.0 0.0 2.1 1 Net gains / losses Level 3 assets as of 31 December 2021 were USD 7.6 8.3 17.4 15.2 |
Disclosure Of Maximum Credit Risk Exposure Explanatory | Maximum exposure to credit risk 31.12.21 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD billion Cash collateral received Collateral- ized by securities Secured by real estate Other collateral Netting Credit derivative contracts Guarantees Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 22.6 22.6 Derivative financial instruments 4,5 118.1 4.2 103.2 10.7 Brokerage receivables 21.8 0.0 21.6 0.2 Financial assets at fair value not held for trading – debt instruments 6 37.0 0.0 11.2 25.7 Total financial assets measured at fair value 199.5 0.0 37.1 0.0 0.0 103.2 0.0 0.0 59.2 Guarantees 7 0.2 0.0 0.2 0.0 31.12.20 Maximum exposure to credit risk Collateral Credit enhancements Exposure to credit risk after collateral and credit enhancements USD billion Cash collateral received Collateral- ized by securities Secured by real estate Other collateral Netting Credit derivative contracts Guarantees Financial assets measured at fair value on the balance sheet 1 Financial assets at fair value held for trading – debt instruments 2,3 24.7 24.7 Derivative financial instruments 4,5 159.6 6.0 138.4 15.2 Brokerage receivables 24.7 24.4 0.3 Financial assets at fair value not held for trading – debt instruments 6 58.2 0.0 13.2 45.0 Total financial assets measured at fair value 267.2 0.0 43.6 0.0 0.0 138.4 0.0 0.0 85.2 Guarantees 7 0.5 0.1 0.3 0.0 1 The maximum exposure to loss is generally equal to the carrying amount and subject to change over time with market movements. the purpose of this disclosure, collateral and credit enhancements were 0 0 commitments and forward starting reverse repurchase of USD 27.8 21.9 8.2 0.8 9.4 billion, of which USD 0.8 balance sheet. Refer to Note 22 agreements. |
Disclosure Of Fair Value Of Financial Instruments Not Measured At Fair Value Explanatory | Financial instruments not measured at fair value 31.12.21 31.12.20 Carrying amount Fair value Carrying amount Fair value USD billion Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Total Carrying amount approximates fair value 1 Level 1 Level 2 Level 3 Total Assets 2 Cash and balances at central banks 192.8 192.7 0.1 0.0 0.0 192.8 158.2 158.1 0.1 0.0 0.0 158.2 Loans and advances to banks 15.4 14.6 0.0 0.7 0.0 15.3 15.3 14.6 0.0 0.6 0.1 15.3 Receivables from securities financing transactions 75.0 71.6 0.0 1.3 2.1 75.0 74.2 64.9 0.0 7.6 1.7 74.2 Cash collateral receivables on derivative instruments 30.5 30.5 0.0 0.0 0.0 30.5 32.7 32.7 0.0 0.0 0.0 32.7 Loans and advances to customers 398.7 163.7 0.0 43.8 190.4 397.9 381.0 173.1 0.0 34.2 174.9 382.3 Other financial assets measured at amortized cost 26.2 4.1 9.3 10.7 2.4 26.5 27.2 5.4 9.4 10.9 2.3 28.0 Liabilities 2 Amounts due to banks 13.1 9.1 0.0 4.0 0.0 13.1 11.0 8.5 0.0 2.6 0.0 11.1 Payables from securities financing transactions 5.5 4.1 0.0 1.5 0.0 5.5 6.3 6.0 0.0 0.2 0.0 6.3 Cash collateral payables on derivative instruments 31.8 31.8 0.0 0.0 0.0 31.8 37.3 37.3 0.0 0.0 0.0 37.3 Customer deposits 544.8 537.6 0.0 7.3 0.0 544.8 527.9 521.8 0.0 6.2 0.0 528.0 Funding from UBS Group AG 57.3 2.8 0.0 56.0 0.0 58.8 54.0 0.0 0.0 55.6 0.0 55.6 Debt issued measured at amortized cost 82.4 13.0 0.0 69.8 0.0 82.8 85.4 16.4 0.0 70.0 0.0 86.3 Other financial liabilities measured at amortized cost 3 6.3 6.3 0.0 0.0 0.0 6.3 6.6 6.6 0.0 0.0 0.1 6.7 1 Includes certain financial instruments where the carrying amount is a reasonable with a remaining maturity (excluding 0 0 USD 0 0 1 1 175 2020: USD 163 19 20 1 0 of Amounts due to banks, 4 3 53 49 31 2020: USD 31 3 3 after 12 months. |
Offsetting financial assets a_2
Offsetting financial assets and financial liabilities (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Offsetting Of Financial Assets Explanatory | Financial assets subject to offsetting, enforceable Assets subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Assets not subject to netting arrangements 4 Total assets As of 31.12.21, USD billion Gross assets before netting Netting with gross liabilities 2 Net assets recognized on the balance sheet Financial liabilities Collateral received Assets after consideration of netting potential Assets recognized on the balance sheet Total assets after consideration of netting potential Total assets recognized on the balance sheet Receivables from securities financing transactions 67.7 (13.8) 53.9 (2.9) (51.0) 0.0 21.1 21.1 75.0 Derivative financial instruments 116.0 (3.6) 112.4 (88.9) (18.5) 5.0 5.7 10.7 118.1 Cash collateral receivables on derivative instruments 1 29.4 0.0 29.4 (15.2) (3.3) 11.0 1.1 12.1 30.5 Financial assets at fair value not held for trading 93.1 (87.6) 5.5 (1.1) (4.4) 0.0 54.6 54.6 60.1 of which: reverse repurchase agreements 93.1 (87.6) 5.5 (1.1) (4.4) 0.0 0.3 0.3 5.8 Total assets 306.2 (105.0) 201.2 (108.1) (77.2) 15.9 82.6 98.5 283.7 As of 31.12.20, USD billion Receivables from securities financing transactions 70.3 (13.4) 57.0 (1.7) (55.3) 0.0 17.3 17.3 74.2 Derivative financial instruments 156.9 (5.0) 151.9 (117.2) (27.2) 7.5 7.7 15.2 159.6 Cash collateral receivables on derivative instruments 1 31.9 0.0 31.9 (19.6) (1.5) 10.8 0.8 11.6 32.7 Financial assets at fair value not held for trading 85.6 (79.1) 6.5 (0.8) (5.8) 0.0 73.9 73.9 80.4 of which: reverse repurchase agreements 85.6 (79.1) 6.5 (0.8) (5.8) 0.0 0.2 0.2 6.7 Total assets 344.8 (97.5) 247.3 (139.3) (89.8) 18.3 99.7 117.9 346.9 1 The net IAS 32 principles and exchange-traded directly to the amounts presented in the “Netting with gross assets” column in “Receivables from securities financing securities financing transactions” and “Other financial instruments and cash collateral table. |
Disclosure Of Offsetting Of Financial Liabilities Explanatory | Financial liabilities subject to offsetting, enforceable Liabilities subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Liabilities not subject to netting arrangements 4 Total liabilities As of 31.12.21, USD billion Gross liabilities before netting Netting with gross assets 2 Net liabilities recognized on the balance sheet Financial assets Collateral pledged Liabilities after consideration of netting potential Liabilities recognized on the balance sheet Total liabilities after consideration of netting potential Total liabilities recognized on the balance sheet Payables from securities financing transactions 16.9 (12.8) 4.1 (1.8) (2.3) 0.0 1.4 1.4 5.5 Derivative financial instruments 118.4 (3.6) 114.9 (88.9) (18.1) 7.9 6.4 14.3 121.3 Cash collateral payables on derivative instruments 1 30.4 0.0 30.4 (13.1) (3.3) 14.0 1.4 15.4 31.8 Other financial liabilities designated at fair value 94.8 (88.6) 6.2 (2.2) (3.8) 0.2 23.9 24.1 30.1 of which: repurchase agreements 94.6 (88.6) 6.0 (2.2) (3.8) 0.0 0.4 0.4 6.4 Total liabilities 260.6 (105.0) 155.6 (106.0) (27.5) 22.1 33.1 55.2 188.7 As of 31.12.20, USD billion Payables from securities financing transactions 18.2 (13.3) 4.9 (1.6) (3.3) 0.0 1.4 1.4 6.3 Derivative financial instruments 157.1 (5.0) 152.1 (117.2) (23.9) 10.9 9.0 19.9 161.1 Cash collateral payables on derivative instruments 1 35.6 0.0 35.6 (19.6) (2.1) 13.9 1.7 15.7 37.3 Other financial liabilities designated at fair value 87.0 (79.2) 7.8 (0.8) (6.3) 0.7 22.6 23.3 30.4 of which: repurchase agreements 86.2 (79.2) 7.0 (0.8) (6.3) 0.0 0.3 0.3 7.3 Total liabilities 297.8 (97.5) 200.3 (139.2) (35.5) 25.6 34.8 60.4 235.1 1 The net amount of Cash collateral payables on derivative instruments recognized on the balance sheet includes certain OTC derivatives that are net settled on a daily basis either legally or in substance under IAS 32 principles and exchange-traded derivatives that are economically settled on presented in the financing transactions” and “Other financial liabilities designated at fair value” transactions” and “Financial assets collateral presented have been liabilities not subject to enforceable netting arrangements and other out-of-scope items. |
UBS AG | |
Entity [Table] | |
Disclosure Of Offsetting Of Financial Assets Explanatory | Financial assets subject to offsetting, enforceable Assets subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Assets not subject to netting arrangements 4 Total assets As of 31.12.21, USD billion Gross assets before netting Netting with gross liabilities 2 Net assets recognized on the balance sheet Financial liabilities Collateral received Assets after consideration of netting potential Assets recognized on the balance sheet Total assets after consideration of netting potential Total assets recognized on the balance sheet Receivables from securities financing transactions 67.7 (13.8) 53.9 (2.9) (51.0) 0.0 21.1 21.1 75.0 Derivative financial instruments 116.0 (3.6) 112.4 (88.9) (18.5) 5.0 5.8 10.7 118.1 Cash collateral receivables on derivative instruments 1 29.4 0.0 29.4 (15.2) (3.3) 11.0 1.1 12.1 30.5 Financial assets at fair value not held for trading 93.1 (87.6) 5.5 (1.1) (4.4) 0.0 54.1 54.1 59.6 of which: reverse repurchase agreements 93.1 (87.6) 5.5 (1.1) (4.4) 0.0 0.3 0.3 5.8 Total assets 306.2 (105.0) 201.2 (108.1) (77.2) 15.9 82.1 98.1 283.3 As of 31.12.20, USD billion Receivables from securities financing transactions 70.3 (13.4) 57.0 (1.7) (55.3) 0.0 17.3 17.3 74.2 Derivative financial instruments 156.9 (5.0) 151.9 (117.2) (27.2) 7.5 7.7 15.2 159.6 Cash collateral receivables on derivative instruments 1 31.9 0.0 31.9 (19.6) (1.5) 10.8 0.8 11.6 32.7 Financial assets at fair value not held for trading 85.6 (79.1) 6.5 (0.8) (5.8) 0.0 73.5 73.5 80.0 of which: reverse repurchase agreements 85.6 (79.1) 6.5 (0.8) (5.8) 0.0 0.2 0.2 6.7 Total assets 344.8 (97.5) 247.3 (139.3) (89.8) 18.3 99.3 117.6 346.6 1 The net IAS 32 principles and exchange-traded directly to the amounts presented in the “Netting with gross assets” column in “Receivables from securities financing securities financing transactions” and “Other financial instruments and cash collateral table. |
Disclosure Of Offsetting Of Financial Liabilities Explanatory | Financial liabilities subject to offsetting, enforceable Liabilities subject to netting arrangements Netting recognized on the balance sheet Netting potential not recognized on the balance sheet 3 Liabilities not subject to netting arrangements 4 Total liabilities As of 31.12.21, USD billion Gross liabilities before netting Netting with gross assets 2 Net liabilities recognized on the balance sheet Financial assets Collateral pledged Liabilities after consideration of netting potential Liabilities recognized on the balance sheet Total liabilities after consideration of netting potential Total liabilities recognized on the balance sheet Payables from securities financing transactions 16.9 (12.8) 4.1 (1.8) (2.3) 0.0 1.4 1.4 5.5 Derivative financial instruments 118.4 (3.6) 114.9 (88.9) (18.1) 7.9 6.4 14.3 121.3 Cash collateral payables on derivative instruments 1 30.4 0.0 30.4 (13.1) (3.3) 14.0 1.4 15.4 31.8 Other financial liabilities designated at fair value 94.8 (88.6) 6.2 (2.2) (3.8) 0.2 26.3 26.5 32.4 of which: repurchase agreements 94.6 (88.6) 6.0 (2.2) (3.8) 0.0 0.4 0.4 6.4 Total liabilities 260.6 (105.0) 155.6 (106.0) (27.5) 22.1 35.5 57.6 191.1 As of 31.12.20, USD billion Payables from securities financing transactions 18.2 (13.3) 4.9 (1.6) (3.3) 0.0 1.4 1.4 6.3 Derivative financial instruments 157.1 (5.0) 152.1 (117.2) (23.9) 10.9 9.0 19.9 161.1 Cash collateral payables on derivative instruments 1 35.6 0.0 35.6 (19.6) (2.1) 13.9 1.7 15.7 37.3 Other financial liabilities designated at fair value 87.0 (79.2) 7.8 (0.8) (6.3) 0.7 24.0 24.7 31.8 of which: repurchase agreements 86.2 (79.2) 7.0 (0.8) (6.3) 0.0 0.3 0.3 7.3 Total liabilities 297.8 (97.5) 200.3 (139.2) (35.5) 25.6 36.2 61.7 236.5 1 The net amount of Cash collateral payables on derivative instruments recognized on the balance sheet includes certain OTC derivatives that are net settled on a daily basis either legally or in substance under IAS 32 principles and exchange-traded derivatives that are economically settled on presented in the financing transactions” and “Other financial liabilities designated at fair value” transactions” and “Financial assets collateral presented have been liabilities not subject to enforceable netting arrangements and other out-of-scope items. |
Restricted financial assets (Ta
Restricted financial assets (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of restricted financial assets [text block] | Restricted financial assets USD million 31.12.21 31.12.20 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties of which: mortgage loans 1 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties of which: mortgage loans 1 Financial assets pledged as collateral Financial assets at fair value held for trading 63,725 43,397 64,367 47,098 Loans and advances to customers 18,160 16,330 20,361 18,191 Financial assets at fair value not held for trading 961 961 2,140 2,140 Debt securities classified as Other financial assets measured cost 2,234 1,870 2,506 2,506 Financial assets measured at fair value through other comprehensive income 0 0 149 149 Total financial assets pledged as collateral 2 85,079 89,523 Other restricted financial assets Loans and advances to banks 3,408 3,730 Financial assets at fair value held for trading 392 741 Cash collateral receivables on derivative instruments 4,747 3,765 Loans and advances to customers 1,237 756 Financial assets at fair value not held for trading 22,765 23,243 Financial assets measured at fair value through other comprehensive income 894 0 Other 97 110 Total other restricted financial assets 33,540 32,345 Total financial assets pledged and other restricted financial assets 118,619 121,868 1 All related USD 2.7 2.7 requirements. 4.4 USD 1.3 |
UBS AG | |
Entity [Table] | |
Disclosure of restricted financial assets [text block] | Restricted financial assets USD million 31.12.21 31.12.20 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties of which: mortgage loans 1 Restricted financial assets of which: assets pledged as collateral that may be sold or repledged by counterparties of which: mortgage loans 1 Financial assets pledged as collateral Financial assets at fair value held for trading 63,834 43,397 64,418 47,098 Loans and advances to customers 18,160 16,330 20,361 18,191 Financial assets at fair value not held for trading 961 961 2,140 2,140 Debt securities classified as Other financial assets measured cost 2,234 1,870 2,506 2,506 Financial assets measured at fair value through other comprehensive income 0 0 149 149 Total financial assets pledged as collateral 2 85,188 89,574 Other restricted financial assets Loans and advances to banks 3,408 3,730 Financial assets at fair value held for trading 392 741 Cash collateral receivables on derivative instruments 4,747 3,765 Loans and advances to customers 1,237 756 Financial assets at fair value not held for trading 22,328 22,917 Financial assets measured at fair value through other comprehensive income 894 0 Other 97 110 Total other restricted financial assets 33,104 32,019 Total financial assets pledged and other restricted financial assets 118,292 121,593 1 All related USD 2.7 2.7 requirements. 4.4 USD 1.3 |
Transferred financial assets _3
Transferred financial assets that are not derecognized in their entirety (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition Explanatory | Transferred financial assets subject to continued recognition in full USD million 31.12.21 31.12.20 Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Financial assets at fair value held for trading that may be sold or repledged 43,397 17,687 47,098 18,874 relating to securities lending and repurchase agreements in 17,970 17,687 19,177 18,874 relating to securities lending agreements in exchange for securities 24,146 27,595 relating to other financial asset transfers 1,281 326 Financial assets at fair value not held for trading that may be sold or repledged counterparties 961 898 2,140 1,378 Debt securities classified as Other financial assets measured sold or repledged by counterparties 1,870 1,725 2,506 1,963 Financial assets measured at fair value through other comprehensive or repledged by counterparties 0 0 149 148 Total financial assets transferred 46,227 20,311 51,893 22,363 |
UBS AG | |
Entity [Table] | |
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition Explanatory | Transferred financial assets subject to continued recognition in full USD million 31.12.21 31.12.20 Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Carrying amount of transferred assets Carrying amount of associated liabilities recognized on balance sheet Financial assets at fair value held for trading that may be sold or repledged 43,397 17,687 47,098 18,874 relating to securities lending and repurchase agreements in 17,970 17,687 19,177 18,874 relating to securities lending agreements in exchange for securities 24,146 27,595 relating to other financial asset transfers 1,281 326 Financial assets at fair value not held for trading that may be sold or repledged counterparties 961 898 2,140 1,378 Debt securities classified as Other financial assets measured sold or repledged by counterparties 1,870 1,725 2,506 1,963 Financial assets measured at fair value through other comprehensive or repledged by counterparties 0 0 149 148 Total financial assets transferred 46,227 20,311 51,893 22,363 |
Off-balance sheet assets rece_2
Off-balance sheet assets received (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Tabular disclosure of off-balance sheet assets received [text block] | Off-balance sheet assets received USD million 31.12.21 31.12.20 Fair value of assets received that can be sold or repledged 497,828 500,689 received as collateral under reverse repurchase, securities borrowing and lending arrangements, derivative and other transactions 1 483,426 487,904 received in unsecured borrowings 14,402 12,785 Thereof sold or repledged 2 367,440 367,258 in connection with financing activities 319,176 315,603 to satisfy commitments under short sale transactions 31,688 33,595 in connection with derivative and other transactions 1 16,575 18,059 1 Includes securities received as initial margin from its clients that UBS is required to remit to central counterparties, 2 Does not include off-balance 12.7 18.9 settlement purposes for which there are no associated liabilities or contingent liabilities. |
UBS AG | |
Entity [Table] | |
Tabular disclosure of off-balance sheet assets received [text block] | Off-balance sheet assets received USD million 31.12.21 31.12.20 Fair value of assets received that can be sold or repledged 497,828 500,689 received as collateral under reverse repurchase, securities borrowing and lending arrangements, derivative and other transactions 1 483,426 487,904 received in unsecured borrowings 14,402 12,785 Thereof sold or repledged 2 367,440 367,258 in connection with financing activities 319,176 315,603 to satisfy commitments under short sale transactions 31,688 33,595 in connection with derivative and other transactions 1 16,575 18,059 1 Includes securities services. 12.7 18.9 clearing and settlement purposes for which there are no associated liabilities or contingent liabilities. |
Maturity analysis of financia_2
Maturity analysis of financial liabilities (Tables) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Entity [Table] | ||
Disclosure of maturity analysis for financial liabilities [text block] | Maturity analysis of financial liabilities 31.12.21 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.7 2.4 3.5 0.6 13.1 Payables from securities financing transactions 3.8 0.3 1.6 0.0 5.7 Cash collateral payables on derivative instruments 31.8 31.8 Customer deposits 530.1 5.2 3.3 3.2 0.4 542.3 Debt issued measured at amortized cost 2 4.0 12.7 41.1 53.5 37.6 148.9 Other financial liabilities measured at amortized cost 4.5 0.1 0.5 1.8 1.6 8.4 0.1 0.1 0.5 1.8 1.6 4.0 Total financial liabilities measured at amortized cost 580.9 20.8 49.9 59.2 39.5 750.2 Financial liabilities at fair value held for trading 3,4 31.7 31.7 Derivative financial instruments 3,5 121.3 121.3 Brokerage payables designated at fair value 44.0 44.0 Debt issued designated at fair value 6 13.8 11.5 13.5 24.5 18.5 81.9 Other financial liabilities designated at fair value 28.1 0.4 0.5 0.4 1.1 30.5 Total financial liabilities measured at fair value through profit or loss 239.0 11.9 14.0 24.9 19.6 309.4 Total 819.8 32.7 63.9 84.1 59.1 1,059.6 Guarantees, commitments and forward starting transactions Loan commitments 7 38.3 0.5 0.7 0.0 39.5 Guarantees 21.2 0.0 21.2 Forward starting transactions, reverse repurchase and securities borrowing agreements 7 1.4 1.4 Total 60.9 0.5 0.7 0.0 0.0 62.1 | 31.12.20 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.1 2.4 2.1 0.5 0.0 11.1 Payables from securities financing transactions 5.6 0.4 0.3 0.0 0.0 6.3 Cash collateral payables on derivative instruments 37.3 37.3 Customer deposits 512.8 6.6 3.5 1.8 0.2 524.9 Debt issued measured at amortized cost 2 9.0 8.3 41.9 53.7 35.6 148.5 Other financial liabilities measured at amortized cost 4.5 0.1 0.5 2.0 1.8 8.9 0.1 0.1 0.5 2.0 1.8 4.5 Total financial liabilities measured at amortized cost 575.3 17.9 48.2 58.0 37.7 737.1 Financial liabilities at fair value held for trading 3,4 33.6 33.6 Derivative financial instruments 3,5 161.1 161.1 Brokerage payables designated at fair value 38.7 38.7 Debt issued designated at fair value 6 21.9 16.8 7.1 9.2 9.5 64.5 Other financial liabilities designated at fair value 27.9 0.6 0.6 0.7 1.1 30.9 Total financial liabilities measured at fair value through profit or loss 283.2 17.4 7.7 9.9 10.6 328.8 Total 858.5 35.3 56.0 67.9 48.3 1,065.9 Guarantees, commitments and forward starting transactions Loan commitments 7 40.5 0.5 0.4 0.0 41.4 Guarantees 17.5 17.5 Forward starting transactions, reverse repurchase and securities borrowing agreements 7 3.2 3.2 Total 61.3 0.5 0.4 0.0 0.0 62.2 1 Except for financial liabilities payments. that would have to be paid if these positions had to be settled or 30.8 USD 32.6 0.9 1.0 0 0 34 (31 December 2020: USD 32 full contractual committed amount of USD 36.0 31.3 by reference to the Excludes derivative loan commitments and forward starting reverse repurchase agreements measured at fair value |
UBS AG | ||
Entity [Table] | ||
Disclosure of maturity analysis for financial liabilities [text block] | Maturity analysis of financial liabilities 31.12.21 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.7 2.4 3.5 0.6 0.0 13.1 Payables from securities financing transactions 3.8 0.3 1.6 0.0 5.7 Cash collateral payables on derivative instruments 31.8 31.8 Customer deposits 531.0 6.6 3.3 3.9 0.4 545.1 Funding from UBS Group AG 2 0.2 3.3 2.3 28.8 30.6 65.3 Debt issued measured at amortized cost 2 3.8 9.4 38.8 25.1 7.6 84.7 Other financial liabilities measured at amortized cost 5.3 0.1 0.4 1.8 1.5 9.1 of which: lease liabilities 0.1 0.1 0.4 1.8 1.5 3.9 Total financial liabilities measured at amortized cost 582.6 22.1 49.9 60.2 40.1 754.8 Financial liabilities at fair value held for trading 3,4 31.7 31.7 Derivative financial instruments 3,5 121.3 121.3 Brokerage payables designated at fair value 44.0 44.0 Debt issued designated at fair value 6 13.8 11.5 13.5 24.5 12.5 75.9 Other financial liabilities designated at fair value 28.1 0.4 0.5 0.4 7.1 36.5 Total financial liabilities measured at fair value through profit or loss 239.0 11.9 14.0 24.9 19.6 309.4 Total 821.6 34.0 63.9 85.0 59.6 1,064.2 Guarantees, commitments and forward starting transactions Loan commitments 7 38.3 0.5 0.7 0.0 39.5 Guarantees 21.2 0.0 21.2 Forward starting transactions, reverse repurchase and securities borrowing agreements 7 1.4 1.4 Total 60.9 0.5 0.7 0.0 0.0 62.1 | 31.12.20 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Financial liabilities recognized on balance sheet 1 Amounts due to banks 6.1 2.4 2.1 0.5 0.0 11.1 Payables from securities financing transactions 5.6 0.4 0.3 0.0 0.0 6.3 Cash collateral payables on derivative instruments 37.3 37.3 Customer deposits 514.0 7.8 3.5 2.8 0.2 528.2 Funding from UBS Group AG 2 0.1 0.3 6.2 29.1 24.8 60.5 Debt issued measured at amortized cost 2 8.8 7.8 38.2 24.5 8.9 88.2 Other financial liabilities measured at amortized cost 5.3 0.1 0.5 2.0 1.8 9.6 of which: lease liabilities 0.1 0.1 0.5 2.0 1.8 4.4 Total financial liabilities measured at amortized cost 577.2 18.9 50.7 58.8 35.8 741.3 Financial liabilities at fair value held for trading 3,4 33.6 33.6 Derivative financial instruments 3,5 161.1 161.1 Brokerage payables designated at fair value 38.7 38.7 Debt issued designated at fair value 6 21.9 16.8 7.1 9.2 6.0 61.0 Other financial liabilities designated at fair value 27.9 0.6 0.6 0.7 4.6 34.3 Total financial liabilities measured at fair value through profit or loss 283.2 17.4 7.7 9.8 10.6 328.8 Total 860.3 36.3 58.4 68.6 46.4 1,070.0 Guarantees, commitments and forward starting transactions Loan commitments 7 40.5 0.5 0.4 0.0 41.4 Guarantees 17.5 17.5 Forward starting transactions, reverse repurchase and securities borrowing agreements 7 3.2 3.2 Total 61.3 0.5 0.4 0.0 0.0 62.2 1 Except for financial liabilities at payments. that would have to be paid if these positions had to be settled 30.8 USD 32.6 0.9 1.0 0 0 34 (31 December 2020: USD 32 full contractual committed amount of USD 36.0 31.3 by reference 7 Excludes derivative loan commitments and forward starting reverse repurchase agreements measured at fair value |
Interest rate benchmark reform
Interest rate benchmark reform (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Schedule Of Interest Rate Benchmark Reform Maximum Exposure [Table] | |
Disclosure Of Quantitative Information About Financial Instruments That Have Yet To Transition To Alternative Benchmark Rate Explanatory | 31.12.21 LIBOR benchmark rates Measure CHF USD GBP EUR 1 JPY Carrying value of non-derivative financial instruments Total non-derivative financial assets USD million 21,616 2 65,234 3 45 4 1 0 Total non-derivative financial liabilities USD million 27 4 1,985 4 3 4 5 0 Trade count of derivative financial instruments Total derivative financial instruments Trade count 829 6 40,500 7 183 6 3,744 6 184 6 Off-balance sheet exposures Total irrevocable loan commitments USD million 0 11,863 8 0 0 0 1 Relates primarily to EUR LIBOR positions. and brokerage accounts, amounting to USD 37 5 1 credit lines, where IBOR transition efforts are complete, except for USD LIBOR. The remainder primarily relates to US mortgages and corporate lending. can reset to rates linked to transitioned in January 2022, and an insignificant amount of cleared derivatives, where the respective clearing houses’ organized transition happened in January 2022. 5,000 derivatives, of which approximately 500 swaps with an ARR leg 3 remaining and approximately USD 2 that can be drawn in US dollars only and will transition in 2022–2023. |
UBS AG | |
Schedule Of Interest Rate Benchmark Reform Maximum Exposure [Table] | |
Disclosure Of Quantitative Information About Financial Instruments That Have Yet To Transition To Alternative Benchmark Rate Explanatory | 31.12.21 LIBOR benchmark rates Measure CHF USD GBP EUR 1 JPY Carrying value of non-derivative financial instruments Total non-derivative financial assets USD million 21,616 2 65,234 3 45 4 1 0 Total non-derivative financial liabilities USD million 27 4 1,985 4 3 4 5 0 Trade count of derivative financial instruments Total derivative financial instruments Trade count 829 6 40,500 7 183 6 3,744 6 184 6 Off-balance sheet exposures Total irrevocable loan commitments USD million 0 11,863 8 0 0 0 1 Relates primarily to EUR LIBOR positions. and brokerage accounts, amounting to USD 37 5 1 credit lines, where IBOR transition efforts are complete, except for USD LIBOR. The remainder primarily relates to US mortgages and corporate lending. can reset to rates linked to transitioned in January 2022, and an insignificant amount of cleared derivatives, where the respective clearing houses’ organized transition happened in January 2022. 5,000 derivatives, of which approximately 500 swaps with an ARR leg 3 remaining and approximately USD 2 that can be drawn in US dollars only and will transition in 2022–2023. |
Hedge accounting (Tables)
Hedge accounting (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Disclosure Of Fair Value Hedge Accounting [Table] | |
Disclosure Of Detailed Information About Hedging Instruments Explanatory | All hedges: designated hedging instruments As of or for the year ended 31.12.21 Carrying amount USD million Notional amount Derivative financial assets Derivative financial liabilities Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Interest rate risk Fair value hedges 89,525 0 7 (1,604) 1,602 (2) Cash flow hedges 79,573 12 1 (1,185) 990 (196) Foreign exchange risk Fair value hedges 2 27,875 87 261 (2,139) 2,181 42 Hedges of net investments in foreign operations 13,939 23 105 497 (497) 0 As of or for the year ended 31.12.20 Carrying amount USD million Notional amount Derivative financial assets Derivative financial liabilities Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Interest rate risk Fair value hedges 80,759 12 1,231 (1,247) (16) Cash flow hedges 72,732 18 2,213 (2,012) 201 Foreign exchange risk Fair value hedges 2 21,555 449 7 (1,735) 1,715 (20) Hedges of net investments in foreign operations 13,775 3 194 (937) 936 (2) 1 Amounts used accounting designation and accounted for as a cost of hedging with amounts deferred in Other comprehensive income within Equity. |
Disclosure of fair value hedge accounting [text block] | Fair value hedges: designated hedged items USD million 31.12.21 31.12.20 Interest rate risk FX risk Interest rate risk FX risk Debt issued measured at amortized cost Carrying amount of designated debt issued 74,700 27,875 70,429 21,555 478 2,401 Other financial assets measured at amortized cost – debt securities Carrying amount of designated debt securities 2,677 3,242 (7) (38) Loans and advances to customers 1 Carrying amount of designated loans 13,835 10,374 of which: accumulated amount of fair value hedge adjustment 2 (109) 100 of which: accumulated amount of fair value hedge adjustment subject portfolio that ceased to be part of hedge accounting 2 3 111 1 Prior to 31 December 2021, these amounts were designated in fair value hedges of portfolio interest rate risk under IAS 39. customers, whereas prior to 1 January 2021 amounts were presented within either Other financial assets |
Disclosure of fair value hedge accounting related to debt issued and debt securities [text block] | Fair value hedges: profile of the timing of the 31.12.21 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 0 8 10 49 22 90 Cross-currency swaps 1 1 6 13 6 28 31.12.20 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 1 0 4 9 46 12 70 Cross-currency swaps 0 0 4 16 2 22 1 In accordance with IFRS 7 requirements, the fair value hedges of portfolio interest rate risk |
Disclosure of cash flow hedge accounting [text block] | Cash flow hedge reserve on a pre-tax basis USD million 31.12.21 31.12.20 Amounts related to hedge relationships for which hedge 26 2,560 Amounts related to hedge relationships for which hedge 743 296 Total other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis 769 2,856 |
Disclosure of foreign currecny translation hedge accounting [text block] | Foreign currency translation reserve on a pre-tax basis USD million 31.12.21 31.12.20 Amounts related to hedge relationships for which hedge (45) (559) Amounts related to hedge relationships for which hedge 262 268 Total other comprehensive income recognized directly in equity related to hedging instruments basis 217 (291) |
Disclosure Hedge Accounting Referencing LIBOR Explanatory | Hedging instruments referencing LIBOR 31.12.21 31.12.20 Carrying amount Carrying amount USD million Notional amount Derivative financial assets Derivative financial liabilities Notional amount Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 23,367 0 0 37,146 1 (12) Cash flow hedges 10,803 0 0 11,179 0 0 |
UBS AG | |
Disclosure Of Fair Value Hedge Accounting [Table] | |
Disclosure Of Detailed Information About Hedging Instruments Explanatory | All hedges: designated hedging instruments As of or for the year ended 31.12.21 USD million Notional amount Carrying amount Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 89,525 0 7 (1,604) 1,602 (2) Cash flow hedges 79,573 12 1 (1,185) 990 (196) Foreign exchange risk Fair value hedges 2 27,875 87 261 (2,139) 2,181 42 Hedges of net investments in foreign operations 13,761 23 103 492 (491) 0 As of or for the year ended 31.12.20 USD million Notional amount Carrying amount Changes in fair value of hedging instruments 1 Changes in fair value of hedged items 1 Hedge ineffectiveness recognized in the income statement Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 80,759 12 1,231 (1,247) (16) Cash flow hedges 72,732 18 2,213 (2,012) 201 Foreign exchange risk Fair value hedges 2 21,555 449 7 (1,735) 1,715 (20) Hedges of net investments in foreign operations 13,634 3 193 (939) 938 (2) 1 Amounts used accounting designation and accounted for as a cost of hedging with amounts deferred in Other comprehensive income within Equity. |
Disclosure of fair value hedge accounting [text block] | Fair value hedges: designated hedged items USD million 31.12.21 31.12.20 Interest rate risk FX risk Interest rate risk FX risk Debt issued measured at amortized cost Carrying amount of designated debt issued 21,653 11,392 24,247 10,889 261 761 Funding from UBS Group AG Carrying amount of designated debt instruments 53,047 16,483 46,182 10,666 218 1,640 Other financial assets measured at amortized cost – debt securities Carrying amount of designated debt securities 2,677 3,242 (7) (38) Loans and advances to customers 1 Carrying amount of designated loans 13,835 10,374 of which: accumulated amount of fair value hedge adjustment 2 (109) 100 of which: accumulated amount of fair value hedge adjustment subject portion of the portfolio that ceased to be part of hedge 2 3 111 1 Prior to 31 December 2021, these amounts were designated in fair value customers, whereas prior to 1 January 2021 amounts were presented within either Other financial assets |
Disclosure of fair value hedge accounting related to debt issued and debt securities [text block] | Fair value hedges: profile of the timing of the 31.12.21 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 0 8 10 49 22 90 Cross-currency swaps 1 1 6 13 6 28 31.12.20 USD billion Due within 1 month Due between 1 and 3 months Due between 3 and 12 months Due between 1 and 5 years Due after 5 years Total Interest rate swaps 1 0 4 9 46 12 70 Cross-currency swaps 0 0 4 16 2 22 1 In accordance with IFRS 7 requirements, the fair value hedges of portfolio interest rate risk |
Disclosure of cash flow hedge accounting [text block] | Cash flow hedge reserve on a pre-tax basis USD million 31.12.21 31.12.20 Amounts related to hedge relationships for which hedge 26 2,560 Amounts related to hedge relationships for which hedge 743 296 Total other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis 769 2,856 |
Disclosure of foreign currecny translation hedge accounting [text block] | Foreign currency translation reserve on a pre-tax basis USD million 31.12.21 31.12.20 Amounts related to hedge relationships for which hedge (569) Amounts related to hedge relationships for which hedge 268 Total other comprehensive income recognized directly in equity related to hedging instruments basis 201 (302) |
Disclosure Hedge Accounting Referencing LIBOR Explanatory | Hedging instruments referencing LIBOR 31.12.21 31.12.20 Carrying amount Carrying amount USD million Notional amount Derivative financial assets Derivative financial liabilities Notional amount Derivative financial assets Derivative financial liabilities Interest rate risk Fair value hedges 23,367 0 0 37,146 1 (12) Cash flow hedges 10,803 0 0 11,179 0 0 |
Post-employment benefit plans (
Post-employment benefit plans (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Defined Benefit Plans Explanatory | Defined benefit plans USD million Swiss pension plan UK pension plan US and German pension plans Total 2021 2020 2021 2020 2021 2020 2021 2020 Defined benefit obligation at the beginning of the year 27,728 24,496 4,162 3,654 1,905 1,820 33,795 29,970 Current service cost 494 447 0 0 6 6 500 453 Interest expense 58 72 58 73 30 45 147 190 Plan participant contributions 266 259 0 0 0 0 266 259 Remeasurements 837 1,279 71 449 (62) 105 846 1,832 of which: actuarial (gains) / losses due to changes in demographic 51 (164) 14 (14) 4 (34) 69 (212) of which: actuarial (gains) / losses due to changes in financial (678) 983 (3) 505 (78) 134 (759) 1,621 of which: experience (gains) / losses 1 1,464 460 59 (42) 12 5 1,535 423 Past service cost related to plan amendments 0 0 0 3 4 0 4 3 Curtailments (80) 0 0 0 0 0 (80) 0 Benefit payments (1,097) (1,153) (148) (148) (112) (108) (1,357) (1,409) Other movements 0 (4) 0 0 1 0 1 (4) Foreign currency translation (809) 2,333 (38) 132 (33) 37 (880) 2,501 Defined benefit obligation at the end of the year 27,398 27,728 4,105 4,162 1,740 1,905 33,242 33,795 of which: amounts owed to active members 14,333 13,765 150 159 222 245 14,705 14,169 of which: amounts owed to deferred members 0 0 1,593 1,879 669 743 2,262 2,622 of which: amounts owed to retirees 13,065 13,963 2,362 2,124 849 917 16,276 17,004 of which: funded plans 27,398 27,728 4,105 4,162 1,222 1,319 32,724 33,209 of which: unfunded plans 0 0 0 0 518 586 518 586 Fair value of plan assets at the beginning of the year 32,590 28,219 4,149 3,658 1,360 1,299 38,100 33,176 Return on plan assets excluding interest income 2,322 1,818 277 388 40 118 2,639 2,324 Interest income 74 84 58 73 26 38 159 196 Employer contributions 763 729 0 46 16 17 779 792 Plan participant contributions 266 259 0 0 0 0 266 259 Benefit payments (1,097) (1,153) (148) (148) (112) (108) (1,357) (1,409) Administration expenses, taxes and premiums paid (13) (13) 0 0 (4) (4) (17) (17) Other movements 0 0 0 0 1 0 1 0 Foreign currency translation (930) 2,647 (39) 132 0 0 (969) 2,779 Fair value of plan assets at the end of the year 33,975 32,590 4,297 4,149 1,329 1,360 39,601 38,100 Surplus / (deficit) 6,577 4,862 192 (13) (411) (545) 6,358 4,304 Asset ceiling effect at the beginning of the year 4,862 3,724 0 0 0 0 4,862 3,724 Interest expense on asset ceiling effect 15 12 0 0 0 0 15 12 Asset ceiling effect excluding interest expense and foreign currency asset ceiling effect 1,821 814 0 0 0 0 1,821 814 Foreign currency translation (121) 313 0 0 0 0 (121) 313 Asset ceiling effect at the end of the year 6,577 4,862 0 0 0 0 6,577 4,862 Net defined benefit asset / (liability) of major plans 0 0 192 (13) (411) (545) (219) (558) Net defined benefit asset / (liability) of remaining plans (112) (123) Total net defined benefit asset / (liability) (331) (680) of which: Net defined benefit asset 302 42 of which: Net defined benefit liability 2 (633) (722) 1 Experience (gains) / occurred. Income statement – expenses related to defined benefit plans 1 USD million Swiss pension plan UK pension plan US and German pension plans Total For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Current service cost 494 447 0 0 6 6 500 453 Interest expense related to defined benefit obligation 58 72 58 73 30 45 147 190 Interest income related to plan assets (74) (84) (58) (73) (26) (38) (159) (196) Interest expense on asset ceiling effect 15 12 0 0 0 0 15 12 Administration expenses, taxes and premiums paid 13 13 0 0 4 4 17 17 Past service cost related to plan amendments 0 0 0 3 4 0 4 3 Curtailments (80) 0 0 0 0 0 (80) 0 Net periodic expenses recognized in net profit for major plans 426 459 0 3 18 18 444 479 Net periodic expenses recognized in net profit for remaining plans 2 25 23 Total net periodic expenses recognized in net profit 470 502 1 Refer to Note 6. Other comprehensive income – gains / (losses) on defined benefit plans USD million Swiss pension plan UK pension plan US and German pension plans Total For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Remeasurement of defined benefit obligation (837) (1,279) (71) (449) 62 (105) (846) (1,832) of which: change in discount rate assumption 870 (777) 319 (504) 77 (141) 1,267 (1,421) of which: change in rate of salary increase assumption (3) (230) 0 0 0 0 (3) (230) of which: change in rate of pension increase assumption 0 0 (316) (1) (1) 1 (318) 0 of which: change in rate of interest credit on retirement savings (193) 26 0 0 (1) 24 (194) 50 of which: change in life expectancy 0 261 9 22 (3) 50 5 333 of which: change in other actuarial assumptions (47) (99) (23) (8) 2 (34) (68) (142) of which: experience gains / (losses) 1 (1,464) (460) (59) 42 (12) (5) (1,535) (423) Return on plan assets excluding interest income 2,322 1,818 277 388 40 118 2,639 2,324 Asset ceiling effect excluding interest expense and foreign currency (1,821) (814) 0 0 0 0 (1,821) (814) Total gains / (losses) recognized in other comprehensive income for major plans (336) (276) 207 (61) 103 14 (27) (323) Total gains / (losses) recognized in other comprehensive income for remaining plans 30 (4) Total gains / (losses) recognized in other comprehensive income 2 2 (327) 1 Experience (gains) / occurred. |
Disclosure of maturity analysis of expected benefit payments [text block] | Swiss pension plan UK pension plan US and German pension plans 1 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Duration of the defined benefit obligation (in years) 15.1 15.7 18.8 19.0 9.5 10.2 Maturity analysis of benefits expected to be paid USD million Benefits expected to be paid within 12 months 1,312 1,293 110 114 123 122 Benefits expected to be paid between 1 and 3 years 2,636 2,630 248 232 237 235 Benefits expected to be paid between 3 and 6 years 3,824 3,839 418 406 338 346 Benefits expected to be paid between 6 and 11 years 6,220 6,166 743 744 495 532 Benefits expected to be paid between 11 and 16 years 5,572 5,646 751 758 392 413 Benefits expected to be paid in more than 16 years 18,092 18,884 3,028 3,206 519 541 1 The duration of the defined benefit obligation represents a weighted average across US and |
Disclosure of actuarial assumptions [text block] | Significant actuarial assumptions Swiss pension plan UK pension plan US and German pension plans 1 In % 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Discount rate 0.34 0.10 1.82 1.42 2.10 1.62 Rate of salary increase 2.01 2.00 0.00 0.00 2.35 2.25 Rate of pension increase 0.00 0.00 3.32 2.89 1.80 1.70 Rate of interest credit on retirement savings 1.04 0.60 0.00 0.00 1.18 1.12 1 Represents weighted average assumptions across US and German plans. |
Disclosure Of Sensitivity Analysis For Actuarial Assumptions Explanatory | Sensitivity analysis of significant actuarial 1 Increase / (decrease) in defined benefit obligation Swiss pension plan UK pension plan US and German pension plans USD million 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Discount rate Increase by 50 basis points (1,695) (1,793) (361) (370) (78) (91) Decrease by 50 basis points 1,933 2,048 411 423 84 99 Rate of salary increase Increase by 50 basis points 109 117 – 2 – 2 0 1 Decrease by 50 basis points (104) (111) – 2 – 2 0 (1) Rate of pension increase Increase by 50 basis points 1,333 1,413 334 358 6 8 Decrease by 50 basis points – 3 – 3 (306) (316) (6) (7) Rate of interest credit on retirement savings Increase by 50 basis points 224 236 – 4 – 4 8 9 Decrease by 50 basis points (224) 5 (188) – 4 – 4 (7) (8) Life expectancy Increase in longevity by one additional year 915 1,061 184 182 56 60 1 The sensitivity analyses are based on a change in one assumption while holding all other assumptions constant, so that interdependencies between the assumptions are excluded. service, a change in assumption is not 0 % as of 31 December 2021 and as 4 As the UK plan does not provide interest 19 % of retirement savings were subject to a legal minimum 1.00 %. |
Disclosure of composition and fair value of plan assets [text block] | Composition and fair value of plan assets Swiss pension plan 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 187 0 187 1 219 0 219 1 Real estate / property Domestic 0 3,530 3,530 10 0 3,582 3,582 11 Foreign 0 580 580 2 0 331 331 1 Investment funds Equity Domestic 843 0 843 2 826 0 826 3 Foreign 6,213 2,652 8,865 26 6,284 1,958 8,242 25 Bonds 1 Domestic, AAA to BBB– 4,446 0 4,446 13 3,721 0 3,721 11 Foreign, AAA to BBB– 5,093 0 5,093 15 6,146 0 6,146 19 Foreign, below BBB– 1,314 0 1,314 4 1,303 0 1,303 4 Other 4,211 3,558 7,769 23 3,363 3,722 7,085 22 Other investments 668 682 1,349 4 663 473 1,136 3 Total fair value of plan assets 22,973 11,002 33,975 100 22,525 10,065 32,590 100 31.12.21 31.12.20 Total fair value of plan assets 33,975 32,590 of which: 2 Bank accounts at UBS 194 231 UBS debt instruments 28 34 UBS shares 25 24 Securities lent to UBS 3 1,079 1,416 Property occupied by UBS 93 96 Derivative financial instruments, counterparty UBS 3 128 149 1 The bond credit ratings from other rating positions disclosed in the table encompass both direct investments in UBS instruments and indirect investments, i.e., those made through funds that the pension fund invests in. financial instruments are amounted to USD 43 17 Composition and fair value of plan assets UK pension plan 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 147 0 147 3 195 0 195 5 Bonds 1 Domestic, AAA to BBB– 2,605 0 2,605 61 2,150 0 2,150 52 Foreign, AAA to BBB– 372 0 372 9 53 0 53 1 Foreign, below BBB– 4 0 4 0 0 0 0 0 Investment funds Equity Domestic 44 4 47 1 34 3 37 1 Foreign 921 0 921 21 1,077 0 1,077 26 Bonds 1 Domestic, AAA to BBB– 532 147 679 16 919 131 1,050 25 Domestic, below BBB– 12 0 12 0 47 0 47 1 Foreign, AAA to BBB– 179 0 179 4 149 0 149 4 Foreign, below BBB– 115 0 115 3 110 0 110 3 Real estate Domestic 110 12 122 3 98 16 114 3 Foreign 6 34 40 1 0 37 37 1 Other (313) 0 (313) (7) (86) 0 (86) (2) Insurance contracts 0 8 8 0 0 8 8 0 Derivatives 57 (3) 54 1 (3) 0 (3) 0 Asset-backed securities 0 11 11 0 0 6 6 0 Other investments 2 (717) 10 (707) (16) (803) 9 (794) (19) Total fair value of plan assets 4,074 223 4,297 100 3,940 209 4,149 100 1 The bond credit ratings from other rating agencies were used, these were converted to the equivalent rating in S&P’s US and German pension plans 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 11 0 11 1 38 0 38 3 Equity Domestic 79 0 79 6 0 0 0 0 Foreign 31 0 31 2 0 0 0 0 Bonds 1 Domestic, AAA to BBB– 486 0 486 37 490 0 490 36 Domestic, below BBB– 17 0 17 1 7 0 7 0 Foreign, AAA to BBB– 97 0 97 7 99 0 99 7 Foreign, below BBB– 6 0 6 0 1 0 1 0 Investment funds Equity Domestic 3 0 3 0 210 0 210 15 Foreign 56 0 56 4 169 0 169 12 Bonds 1 Domestic, AAA to BBB– 269 0 269 20 195 0 195 14 Domestic, below BBB– 147 0 147 11 34 0 34 2 Foreign, AAA to BBB– 11 0 11 1 19 0 19 1 Foreign, below BBB– 2 0 2 0 3 0 3 0 Real estate Domestic 0 9 9 1 0 14 14 1 Other 99 0 99 7 79 0 79 6 Insurance contracts 0 1 1 0 0 1 1 0 Other investments 5 0 5 0 0 0 0 0 Total fair value of plan assets 1,319 10 1,329 100 1,345 15 1,360 100 1 The bond credit ratings from other rating agencies were used, these were converted to the equivalent rating in S&P’s |
Disclosure Of Expenses On Defined Contribution Plans Explanatory | Expenses related to defined contribution For the year ended USD million 31.12.21 31.12.20 31.12.19 US plan 198 190 173 UK plan 101 88 82 Remaining plans 64 65 71 Total 1 363 343 326 1 Refer to Note 6. |
Disclosure Of Transactions Between Related Parties Explanatory | Related-party disclosure For the year ended USD million 31.12.21 31.12.20 31.12.19 Received by UBS Fees 39 34 34 Paid by UBS Rent 4 5 4 Dividends, capital repayments and interest 5 10 11 |
Disclosure of transaction volumes of UBS shares and UBS debt instruments [text block] | Transaction volumes – UBS shares and UBS debt instruments For the year ended 31.12.21 31.12.20 Financial instruments bought by pension funds UBS shares (in thousands of shares) 907 1,758 UBS debt instruments (par values, USD million) 37 28 Financial instruments sold by pension funds or matured UBS shares (in thousands of shares) 1,688 2,605 UBS debt instruments (par values, USD million) 40 6 UBS shares held by post-employment benefit 31.12.21 31.12.20 Number of shares (in thousands of shares) 14,073 14,854 Fair value (USD million) 252 210 |
Actuarial Assumption Of Mortality Rates [Member] | |
Entity [Table] | |
Disclosure of actuarial assumptions [text block] | Mortality tables and life expectancies for Life expectancy at age 65 for a male member currently aged 65 aged 45 Country Mortality table 31.12.21 31.12.20 31.12.21 31.12.20 Switzerland BVG 2020 G with CMI 2019 projections 21.7 21.7 23.3 23.2 UK S3PA with CMI 2020 projections 1 23.4 23.4 24.5 24.6 USA Pri-2012 with MP-2021 projection scale 2 21.9 21.8 23.3 23.2 Germany Dr. K. Heubeck 2018 G 20.5 20.8 23.2 23.6 Life expectancy at age 65 for a female member currently aged 65 aged 45 Country Mortality table 31.12.21 31.12.20 31.12.21 31.12.20 Switzerland BVG 2020 G with CMI 2019 projections 23.4 23.4 25.0 24.9 UK S3PA with CMI 2020 projections 1 24.9 24.9 26.3 26.3 USA Pri-2012 with MP-2021 projection scale 2 23.3 23.2 24.7 24.5 Germany Dr. K. Heubeck 2018 G 23.9 24.3 26.1 26.5 1 In 2020, S3PA with CMI 2019 projections was used. |
UBS AG | |
Entity [Table] | |
Disclosure Of Defined Benefit Plans Explanatory | Defined benefit plans USD million Swiss pension plan UK pension plan US and German pension plans Total 2021 2020 2021 2020 2021 2020 2021 2020 Defined benefit obligation at the beginning of the year 15,619 13,809 4,162 3,654 1,905 1,820 21,686 19,283 Current service cost 285 262 0 0 6 6 291 268 Interest expense 33 40 58 73 30 45 122 159 Plan participant contributions 161 159 0 0 0 0 161 159 Remeasurements 490 677 71 449 (62) 105 498 1,231 of which: actuarial (gains) / losses due to changes in demographic 26 (53) 14 (14) 4 (34) 45 (101) of which: actuarial (gains) / losses due to changes in financial (385) 565 (3) 505 (78) 134 (466) 1,204 of which: experience (gains) / losses 1,2 848 165 59 (42) 12 5 919 127 Past service cost related to plan amendments 0 0 0 3 4 0 4 3 Curtailments (49) 0 0 0 0 0 (49) 0 Benefit payments (602) (641) (148) (148) (112) (108) (862) (898) Other movements 0 (4) 0 0 1 0 1 (4) Foreign currency translation (456) 1,317 (38) 132 (33) 37 (527) 1,486 Defined benefit obligation at the end of the year 15,480 15,619 4,105 4,162 1,740 1,905 21,324 21,686 of which: amounts owed to active members 8,604 8,290 150 159 222 245 8,976 8,694 of which: amounts owed to deferred members 0 0 1,593 1,879 669 743 2,262 2,622 of which: amounts owed to retirees 6,876 7,329 2,362 2,124 849 917 10,086 10,370 of which: funded plans 15,480 15,619 4,105 4,162 1,222 1,319 20,806 21,100 of which: unfunded plans 0 0 0 0 518 586 518 586 Fair value of plan assets at the beginning of the year 18,358 15,908 4,149 3,658 1,360 1,299 23,867 20,864 Return on plan assets excluding interest income 2 1,319 962 277 388 40 118 1,637 1,469 Interest income 42 48 58 73 26 38 127 159 Employer contributions 450 436 0 46 16 17 466 499 Plan participant contributions 161 159 0 0 0 0 161 159 Benefit payments (602) (641) (148) (148) (112) (108) (862) (898) Administration expenses, taxes and premiums paid (8) (8) 0 0 (4) (4) (11) (11) Other movements 0 0 0 0 1 0 1 0 Foreign currency translation (524) 1,495 (39) 132 0 0 (563) 1,626 Fair value of plan assets at the end of the year 19,196 18,358 4,297 4,149 1,329 1,360 24,821 23,867 Surplus / (deficit) 3,716 2,739 192 (13) (411) (545) 3,497 2,181 Asset ceiling effect at the beginning of the year 2,739 2,099 0 0 0 0 2,739 2,099 Interest expense on asset ceiling effect 8 7 0 0 0 0 8 7 Asset ceiling effect excluding interest expense and foreign currency asset ceiling effect 1,037 457 0 0 0 0 1,037 457 Foreign currency translation (68) 176 0 0 0 0 (68) 176 Asset ceiling effect at the end of the year 3,716 2,739 0 0 0 0 3,716 2,739 Net defined benefit asset / (liability) of major plans 0 0 192 (13) (411) (545) (219) (558) Net defined benefit asset / (liability) of remaining plans (96) (112) Total net defined benefit asset / (liability) (315) (670) of which: Net defined benefit asset 302 42 of which: Net defined benefit liability 3 (617) (711) 1 Experience (gains) / occurred. Income statement – expenses related to defined benefit plans 1 USD million Swiss pension plan UK pension plan US and German pension plans Total For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Current service cost 285 262 0 0 6 6 291 268 Interest expense related to defined benefit obligation 33 40 58 73 30 45 122 159 Interest income related to plan assets (42) (48) (58) (73) (26) (38) (127) (159) Interest expense on asset ceiling effect 8 7 0 0 0 0 8 7 Administration expenses, taxes and premiums paid 8 8 0 0 4 4 11 11 Past service cost related to plan amendments 0 0 0 3 4 0 4 3 Curtailments (49) 0 0 0 0 0 (49) 0 Net periodic expenses recognized in net profit for major plans 243 269 0 3 18 18 261 289 Net periodic expenses recognized in net profit for remaining plans 2 19 17 Total net periodic expenses recognized in net profit 280 306 1 Refer to Note 6. Other comprehensive income – gains / (losses) on defined benefit plans USD million Swiss pension plan UK pension plan US and German pension plans Total For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Remeasurement of defined benefit obligation (490) (677) (71) (449) 62 (105) (498) (1,231) of which: change in discount rate assumption 494 (447) 319 (504) 77 (141) 890 (1,092) of which: change in rate of salary increase assumption (2) (132) 0 0 0 0 (2) (132) of which: change in rate of pension increase assumption 0 0 (316) (1) (1) 1 (317) 0 of which: change in rate of interest credit on retirement savings (110) 15 0 0 (1) 24 (110) 39 of which: change in life expectancy 0 84 9 22 (3) 50 5 156 of which: change in other actuarial assumptions (24) (33) (23) (8) 2 (34) (45) (75) of which: experience gains / (losses) 1,2 (848) (165) (59) 42 (12) (5) (919) (127) Return on plan assets excluding interest income 1,319 962 277 388 40 118 1,637 1,469 Asset ceiling effect excluding interest expense and foreign currency (1,037) (457) 0 0 0 0 (1,037) (457) Total gains / (losses) recognized in other comprehensive income for major plans (207) (172) 207 (61) 103 14 102 (219) Total gains / (losses) recognized in other comprehensive income for remaining plans 31 (3) Total gains / (losses) recognized in other comprehensive income 3 133 (222) 1 Experience (gains) / occurred. |
Disclosure of maturity analysis of expected benefit payments [text block] | Swiss pension plan UK pension plan US and German pension plans 1 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Duration of the defined benefit obligation (in years) 15.5 16.2 18.8 19.0 9.5 10.2 Maturity analysis of benefits expected to be paid USD million Benefits expected to be paid within 12 months 719 710 110 114 123 122 Benefits expected to be paid between 1 and 3 years 1,440 1,442 248 232 237 235 Benefits expected to be paid between 3 and 6 years 2,097 2,100 418 406 338 346 Benefits expected to be paid between 6 and 11 years 3,467 3,408 743 744 495 532 Benefits expected to be paid between 11 and 16 years 3,156 3,184 751 758 392 413 Benefits expected to be paid in more than 16 years 10,733 11,186 3,028 3,206 519 541 1 The duration of the defined benefit obligation represents a weighted average across US and |
Disclosure of actuarial assumptions [text block] | Significant actuarial assumptions Swiss pension plan UK pension plan US and German pension plans 1 In % 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Discount rate 0.34 0.10 1.82 1.42 2.10 1.62 Rate of salary increase 2.01 2.00 0.00 0.00 2.35 2.25 Rate of pension increase 0.00 0.00 3.32 2.89 1.80 1.70 Rate of interest credit on retirement savings 1.04 0.60 0.00 0.00 1.18 1.12 1 Represents weighted average assumptions across US and German plans. |
Disclosure Of Sensitivity Analysis For Actuarial Assumptions Explanatory | Sensitivity analysis of significant actuarial 1 Increase / (decrease) in defined benefit obligation Swiss pension plan UK pension plan US and German pension plans USD million 31.12.21 31.12.20 31.12.21 31.12.20 31.12.21 31.12.20 Discount rate Increase by 50 basis points (975) (1,030) (361) (370) (78) (91) Decrease by 50 basis points 1,116 1,181 411 423 84 99 Rate of salary increase Increase by 50 basis points 69 74 – 2 – 2 0 1 Decrease by 50 basis points (66) (71) – 2 – 2 0 (1) Rate of pension increase Increase by 50 basis points 749 793 334 358 6 8 Decrease by 50 basis points – 3 – 3 (306) (316) (6) (7) Rate of interest credit on retirement savings Increase by 50 basis points 134 142 – 4 – 4 8 9 Decrease by 50 basis points (134) 5 (113) – 4 – 4 (7) (8) Life expectancy Increase in longevity by one additional year 475 566 184 182 56 60 1 The sensitivity analyses are based on a change in one assumption while holding all other assumptions constant, so that interdependencies between the assumptions are excluded. service, a change in assumption is not 0 % as of 31 December 2021 and as 4 As the UK plan does not provide interest 17 % of retirement savings were subject to a legal minimum 1.00 %. |
Disclosure of composition and fair value of plan assets [text block] | Composition and fair value of plan assets Swiss pension plan 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 106 0 106 1 123 0 123 1 Real estate / property Domestic 0 1,994 1,994 10 0 2,018 2,018 11 Foreign 0 328 328 2 0 186 186 1 Investment funds Equity Domestic 476 0 476 2 465 0 465 3 Foreign 3,510 1,498 5,009 26 3,540 1,103 4,642 25 Bonds 1 Domestic, AAA to BBB– 2,512 0 2,512 13 2,096 0 2,096 11 Foreign, AAA to BBB– 2,877 0 2,877 15 3,462 0 3,462 19 Foreign, below BBB– 742 0 742 4 734 0 734 4 Other 2,379 2,010 4,389 23 1,894 2,097 3,991 22 Other investments 377 385 762 4 373 266 640 3 Total fair value of plan assets 12,980 6,216 19,196 100 12,688 5,670 18,358 100 31.12.21 31.12.20 Total fair value of plan assets 19,196 18,358 of which: 2 Bank accounts at UBS AG 109 130 UBS AG debt instruments 16 19 UBS Group AG shares 14 13 Securities lent to UBS AG 3 608 796 Property occupied by UBS AG 52 54 Derivative financial instruments, counterparty UBS AG 3 72 84 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s rating classification. positions disclosed 3 Securities lent to UBS AG and derivative of collateral, derivative financial instruments amounted to USD 24 9 Composition and fair value of plan assets (continued) UK pension plan 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 147 0 147 3 195 0 195 5 Bonds 1 Domestic, AAA to BBB– 2,605 0 2,605 61 2,150 0 2,150 52 Foreign, AAA to BBB– 372 0 372 9 53 0 53 1 Foreign, below BBB– 4 0 4 0 0 0 0 Investment funds Equity Domestic 44 4 47 1 34 3 37 1 Foreign 921 0 921 21 1,077 0 1,077 26 Bonds 1 Domestic, AAA to BBB– 532 147 679 16 919 131 1,050 25 Domestic, below BBB– 12 0 12 0 47 0 47 1 Foreign, AAA to BBB– 179 0 179 4 149 0 149 4 Foreign, below BBB– 115 0 115 3 110 0 110 3 Real estate Domestic 110 12 122 3 98 16 114 3 Foreign 6 34 40 1 0 37 37 1 Other (313) 0 (313) (7) (86) 0 (86) (2) Insurance contracts 0 8 8 0 0 8 8 0 Derivatives 57 (3) 54 1 (3) 0 (3) 0 Asset-backed securities 0 11 11 0 0 6 6 0 Other investments 2 (717) 10 (707) (16) (803) 9 (794) (19) Total fair value of plan assets 4,074 223 4,297 100 3,940 209 4,149 100 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s Composition and fair value of plan assets (continued) US and German pension plans 31.12.21 31.12.20 Fair value Plan asset allocation % Fair value Plan asset allocation % USD million Quoted in an active market Other Total Quoted in an active market Other Total Cash and cash equivalents 11 0 11 1 38 0 38 3 Equity Domestic 79 0 79 6 0 0 0 0 Foreign 31 0 31 2 0 0 0 0 Bonds 1 Domestic, AAA to BBB– 486 0 486 37 490 0 490 36 Domestic, below BBB– 17 0 17 1 7 0 7 0 Foreign, AAA to BBB– 97 0 97 7 99 0 99 7 Foreign, below BBB– 6 0 6 0 1 0 1 0 Investment funds Equity Domestic 3 0 3 0 210 0 210 15 Foreign 56 0 56 4 169 0 169 12 Bonds 1 Domestic, AAA to BBB– 269 0 269 20 195 0 195 14 Domestic, below BBB– 147 0 147 11 34 0 34 2 Foreign, AAA to BBB– 11 0 11 1 19 0 19 1 Foreign, below BBB– 2 0 2 0 3 0 3 0 Real estate Domestic 0 9 9 1 0 14 14 1 Other 99 0 99 7 79 0 79 6 Insurance contracts 0 1 1 0 0 1 1 0 Other investments Total fair value of plan assets 1,319 10 1,329 100 1,345 15 1,360 100 1 The bond credit ratings are from other rating agencies were used, these were converted to the equivalent rating in S&P’s |
Disclosure Of Expenses On Defined Contribution Plans Explanatory | Expenses related to defined contribution For the year ended USD million 31.12.21 31.12.20 31.12.19 US plan 198 190 173 UK plan 41 36 34 Remaining plans 64 65 71 Total 1 303 291 278 1 Refer to Note 6. |
Disclosure Of Transactions Between Related Parties Explanatory | Related-party disclosure For the year ended USD million 31.12.21 31.12.20 31.12.19 Received by UBS AG Fees 22 19 19 Paid by UBS AG Rent 2 3 2 Dividends, capital repayments and interest 5 10 10 |
Disclosure of transaction volumes of UBS shares and UBS debt instruments [text block] | Transaction volumes – UBS Group AG shares and UBS AG debt instruments For the year ended 31.12.21 31.12.20 Financial instruments bought by pension funds UBS Group AG shares (in thousands of shares) 847 1,677 UBS AG debt instruments (par values, USD million) 22 16 Financial instruments sold by pension funds or matured UBS Group AG shares (in thousands of shares) 1,505 2,556 UBS AG debt instruments (par values, USD million) 22 4 UBS Group AG shares held by post-employment 31.12.21 31.12.20 Number of shares (in thousands of shares) 13,456 14,112 Fair value (USD million) 241 199 |
UBS AG | Actuarial Assumption Of Mortality Rates [Member] | |
Entity [Table] | |
Disclosure of actuarial assumptions [text block] | Mortality tables and life expectancies for Life expectancy at age 65 for a male member currently aged 65 aged 45 Country Mortality table 31.12.21 31.12.20 31.12.21 31.12.20 Switzerland BVG 2020 G with CMI 2019 projections 21.7 21.7 23.3 23.2 UK S3PA with CMI 2020 projections 1 23.4 23.4 24.5 24.6 USA Pri-2012 with MP-2021 projection scale 2 21.9 21.8 23.3 23.2 Germany Dr. K. Heubeck 2018 G 20.5 20.8 23.2 23.6 Life expectancy at age 65 for a female member currently aged 65 aged 45 Country Mortality table 31.12.21 31.12.20 31.12.21 31.12.20 Switzerland BVG 2020 G with CMI 2019 projections 23.4 23.4 25.0 24.9 UK S3PA with CMI 2020 projections 1 24.9 24.9 26.3 26.3 USA Pri-2012 with MP-2021 projection scale 2 23.3 23.2 24.7 24.5 Germany Dr. K. Heubeck 2018 G 23.9 24.3 26.1 26.5 1 In 2020, S3PA with CMI 2019 projections was used. |
Employee benefits_ variable c_2
Employee benefits: variable compensation (Tables) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Disclosure of compensation-related personnel expenses [text block] | Variable compensation including financial advisor variable Expenses recognized in 2020 Expenses deferred to 2021 and later 1 USD million Related to the 2020 performance year Related to prior performance years Total Related to the 2020 performance year Related to prior performance years Total Non-deferred cash 2,167 (26) 2,141 0 0 0 Deferred compensation awards 341 727 1,068 756 288 1,044 of which: Equity Ownership Plan 137 327 463 306 69 376 of which: Deferred Contingent Capital Plan 112 351 463 280 196 476 of which: Long-Term Incentive Plan 42 11 54 50 10 61 of which: Asset Management EOP 49 39 88 120 12 132 Variable compensation – performance awards 2,508 701 3,209 756 288 1,044 Variable compensation – other 2 126 94 220 181 192 374 Total variable compensation excluding financial advisor variable compensation 2,634 795 3,429 938 480 1,418 Financial advisor variable compensation 3,356 233 3,589 350 602 952 of which: non-deferred cash 3,154 0 3,154 0 0 0 of which: deferred share-based awards 69 50 119 79 135 214 of which: deferred cash-based awards 133 183 316 271 467 738 Compensation commitments with recruited financial advisors 3 22 480 502 473 1,682 2,155 Total FA variable compensation 3,378 713 4,091 822 2,284 3,106 Total variable compensation including FA variable compensation 6,012 1,508 7,520 4 1,760 2,764 4,524 1 Estimate as of 31 plan payments and interest expense related are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. Amounts in the “Related to the 2020 performance year” columns represent commitments entered into 686 517 50 financial advisor compensation: 119 100 4 million related to 54 42 compensation excluding social security was USD 691 | Variable compensation including financial advisor variable Expenses recognized in 2019 Expenses deferred to 2020 and later 1 USD million Related to the 2019 performance year Related to prior performance years Total Related to the 2019 performance year Related to prior performance years Total Non-deferred cash 1,894 (26) 1,868 0 0 0 Deferred compensation awards 299 588 887 429 608 1,036 of which: Equity Ownership Plan 122 300 422 205 219 424 of which: Deferred Contingent Capital Plan 113 262 375 173 365 538 of which: Long-Term Incentive Plan 39 0 39 25 0 25 of which: Asset Management EOP 25 26 51 26 23 49 Variable compensation – performance awards 2,193 562 2,755 429 608 1,036 Variable compensation – other 2 159 88 246 117 232 349 Total variable compensation excluding financial advisor variable compensation 2,352 650 3,001 545 840 1,385 Financial advisor variable compensation 3,233 268 3,501 197 710 907 of which: non-deferred cash 3,064 0 3,064 0 0 0 of which: deferred share-based awards 57 48 106 54 130 183 of which: deferred cash-based awards 112 219 331 144 580 724 Compensation commitments with recruited financial advisors 3 32 510 542 350 1,617 1,967 Total FA variable compensation 3,265 778 4,043 548 2,327 2,874 Total variable compensation including FA variable compensation 5,617 1,428 7,045 4 1,093 3,166 4,259 1 Estimate as of 31 December 2019. Actual amounts expensed may vary, e.g., interest expense related to the Deferred Contingent Capital Plan. requirements. Amounts reflected as deferred expenses represent entered into in 610 461 43 USD 106 61 10 allowances; social security: 25 27 security was USD 619 | |
Disclosure of number and weighted average exercise prices of UBS share and performance share awards [text block] | Movements in outstanding share-based compensation Number of shares 2021 Weighted average grant date fair value (USD) Number of shares 2020 Weighted average grant date fair value (USD) Outstanding, at the beginning of the year 174,900,395 12 156,064,763 14 Awarded during the year 68,721,549 15 72,250,157 11 Distributed during the year (52,137,287) 13 (46,899,362) 15 Forfeited during the year (10,906,096) 13 (6,515,164) 13 Outstanding, at the end of the year 180,578,561 13 174,900,395 12 of which: shares vested for accounting purposes 107,828,979 118,260,527 | ||
UBS AG | |||
Entity [Table] | |||
Disclosure of compensation-related personnel expenses [text block] | Variable compensation including financial advisor variable Expenses recognized in 2020 Expenses deferred to 2021 and later 1 USD million Related to the 2020 performance year Related to prior performance years Total Related to the 2020 performance year Related to prior performance years Total Non-deferred cash 1,948 (29) 1,920 0 0 0 Deferred compensation awards 329 704 1,034 734 277 1,011 of which: Equity Ownership Plan 131 315 446 298 67 365 of which: Deferred Contingent Capital Plan 108 339 448 271 189 459 of which: Long-Term Incentive Plan 41 11 52 46 9 55 of which: Asset Management EOP 49 39 88 120 12 132 Variable compensation – performance awards 2,278 675 2,953 734 277 1,011 Variable compensation – other 2 109 92 201 176 189 364 Total variable compensation excluding financial advisor variable compensation 2,387 768 3,155 909 465 1,375 Financial advisor variable compensation 3,356 233 3,589 350 602 952 of which: non-deferred cash 3,154 0 3,154 0 0 0 of which: deferred share-based awards 69 50 119 79 135 214 of which: deferred cash-based awards 133 183 316 271 467 738 Compensation commitments with recruited financial advisors 3 22 480 502 473 1,682 2,155 Total FA variable compensation 3,378 713 4,091 822 2,284 3,106 Total variable compensation including FA variable compensation 5,765 1,481 7,246 4 1,732 2,749 4,481 1 Estimate as of 31 plan payments and interest expense related are subject to vesting requirements. Amounts reflected as deferred expenses represent the maximum deferred exposure as of the balance sheet date. represent commitments entered into 666 498 49 financial advisor compensation: USD 119 88 4 related to role-based allowances; social security: USD 51 34 | Variable compensation including financial advisor variable Expenses recognized in 2019 Expenses deferred to 2020 and later 1 USD million Related to the 2019 performance year Related to prior performance years Total Related to the 2019 performance year Related to prior performance years Total Non-deferred cash 1,706 (24) 1,682 0 0 0 Deferred compensation awards 287 576 863 413 592 1,005 of which: Equity Ownership Plan 115 294 410 198 213 412 of which: Deferred Contingent Capital Plan 109 256 365 166 356 521 of which: Long-Term Incentive Plan 38 0 38 23 0 23 of which: Asset Management EOP 25 26 51 26 23 49 Variable compensation – performance awards 1,993 553 2,545 413 592 1,005 Variable compensation – other 2 140 85 225 115 228 343 Total variable compensation excluding financial advisor variable compensation 2,133 638 2,770 528 820 1,348 Financial advisor variable compensation 3,233 268 3,501 197 710 907 of which: non-deferred cash 3,064 0 3,064 0 0 0 of which: deferred share-based awards 57 48 106 54 130 183 of which: deferred cash-based awards 112 219 331 144 580 724 Compensation commitments with recruited financial advisors 3 32 510 542 350 1,617 1,967 Total FA variable compensation 3,265 778 4,043 548 2,327 2,874 Total variable compensation including FA variable compensation 5,398 1,416 6,814 4 1,076 3,146 4,222 1 Estimate as of 31 December 2019. Actual amounts expensed may vary, e.g., interest expense related to the Deferred Contingent Capital Plan. requirements. Amounts reflected as deferred expenses entered into in 595 448 42 USD 106 54 10 allowances; social security: USD 23 22 | |
Disclosure of number and weighted average exercise prices of UBS share and performance share awards [text block] | Movements in outstanding share-based compensation Number of shares 2021 Weighted average grant date fair value (USD) Number of shares 2020 Weighted average grant date fair value (USD) Outstanding, at the beginning of the year 54,557 13 90,443 14 Awarded during the year 278,756 15 19,229 11 Distributed during the year (24,176) 13 (55,114) 14 Forfeited during the year (13,215) 15 0 0 Outstanding, at the end of the year 295,921 15 54,557 13 of which: shares vested for accounting purposes 116,775 53,216 |
Interests in subsidiaries (Tabl
Interests in subsidiaries (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Significant Investments In Subsidiaries Explanatory | Individually significant subsidiaries Company Registered office Share capital in million Equity interest accumulated in % UBS AG Zurich and Basel, Switzerland CHF 385.8 100.0 UBS Business Solutions AG 1 Zurich, Switzerland CHF 1.0 100.0 1 UBS Business Solutions AG holds subsidiaries in China, India, Israel and Poland. Individually significant subsidiaries 1 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Americas Holding LLC Wilmington, Delaware, USA Group Functions USD 4,150.0 2 100.0 UBS Americas Inc. Wilmington, Delaware, USA Group Functions USD 0.0 100.0 UBS Asset Management AG Zurich, Switzerland Asset Management CHF 43.2 100.0 UBS Bank USA Salt Lake City, Utah, USA Global Wealth Management USD 0.0 100.0 UBS Europe SE Frankfurt, Germany Global Wealth Management EUR 446.0 100.0 UBS Financial Services Inc. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS Securities LLC Wilmington, Delaware, USA Investment Bank USD 1,283.1 3 100.0 UBS Switzerland AG Zurich, Switzerland Personal & Corporate Banking CHF 10.0 100.0 1 Includes direct and indirect subsidiaries of UBS AG. 1,000 4,150,000,000 . 100,000 1,283,000,000 . |
UBS AG Subsidiaries | |
Entity [Table] | |
Disclosure Of Significant Investments In Subsidiaries Explanatory | Other subsidiaries of UBS AG as of 31 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Asset Management (Americas) Inc. Wilmington, Delaware, USA Asset Management USD 0.0 100.0 UBS Asset Management (Hong Kong) Limited Hong Kong SAR, China Asset Management HKD 254.0 100.0 UBS Asset Management Life Ltd London, United Kingdom Asset Management GBP 15.0 100.0 UBS Asset Management Switzerland AG Zurich, Switzerland Asset Management CHF 0.5 100.0 UBS Business Solutions US LLC Wilmington, Delaware, USA Group Functions USD 0.0 100.0 UBS Credit Corp. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS (France) S.A. Paris, France Global Wealth Management EUR 133.0 100.0 UBS Fund Management (Luxembourg) S.A. Luxembourg, Luxembourg Asset Management EUR 13.0 100.0 UBS Fund Management (Switzerland) AG Basel, Switzerland Asset Management CHF 1.0 100.0 UBS (Monaco) S.A. Monte Carlo, Monaco Global Wealth Management EUR 49.2 100.0 UBS O‘Connor LLC Wilmington, Delaware, USA Asset Management USD 1.0 100.0 UBS Realty Investors LLC Boston, Massachusetts, USA Asset Management USD 9.0 100.0 UBS Securities Australia Ltd Sydney, Australia Investment Bank AUD 0.3 1 100.0 UBS Securities Hong Kong Limited Hong Kong SAR, China Investment Bank HKD 4,154.2 100.0 UBS Securities Japan Co., Ltd. Tokyo, Japan Investment Bank JPY 34,708.7 100.0 UBS SuMi TRUST Wealth Management Co., Ltd. Tokyo, Japan Global Wealth Management JPY 5,165.0 51.0 1 Includes a nominal amount relating to redeemable preference shares. |
UBS AG | |
Entity [Table] | |
Disclosure Of Significant Investments In Subsidiaries Explanatory | Individually significant subsidiaries 1 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Americas Holding LLC Wilmington, Delaware, USA Group Functions USD 4,150.0 2 100.0 UBS Americas Inc. Wilmington, Delaware, USA Group Functions USD 0.0 100.0 UBS Asset Management AG Zurich, Switzerland Asset Management CHF 43.2 100.0 UBS Bank USA Salt Lake City, Utah, USA Global Wealth Management USD 0.0 100.0 UBS Europe SE Frankfurt, Germany Global Wealth Management EUR 446.0 100.0 UBS Financial Services Inc. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS Securities LLC Wilmington, Delaware, USA Investment Bank USD 1,283.1 3 100.0 UBS Switzerland AG Zurich, Switzerland Personal & Corporate Banking CHF 10.0 100.0 1 Includes direct and indirect subsidiaries of UBS AG. 1,000 4,150,000,000 . 100,000 1,283,000,000 . |
UBS AG | UBS AG Subsidiaries | |
Entity [Table] | |
Disclosure Of Significant Investments In Subsidiaries Explanatory | Other subsidiaries of UBS AG as of 31 Company Registered office Primary business Share capital in million Equity interest accumulated in % UBS Asset Management (Americas) Inc. Wilmington, Delaware, USA Asset Management USD 0.0 100.0 UBS Asset Management (Hong Kong) Limited Hong Kong SAR, China Asset Management HKD 254.0 100.0 UBS Asset Management Life Ltd London, United Kingdom Asset Management GBP 15.0 100.0 UBS Asset Management Switzerland AG Zurich, Switzerland Asset Management CHF 0.5 100.0 UBS Business Solutions US LLC Wilmington, Delaware, USA Group Functions USD 0.0 100.0 UBS Credit Corp. Wilmington, Delaware, USA Global Wealth Management USD 0.0 100.0 UBS (France) S.A. Paris, France Global Wealth Management EUR 133.0 100.0 UBS Fund Management (Luxembourg) S.A. Luxembourg, Luxembourg Asset Management EUR 13.0 100.0 UBS Fund Management (Switzerland) AG Basel, Switzerland Asset Management CHF 1.0 100.0 UBS (Monaco) S.A. Monte Carlo, Monaco Global Wealth Management EUR 49.2 100.0 UBS O‘Connor LLC Wilmington, Delaware, USA Asset Management USD 1.0 100.0 UBS Realty Investors LLC Boston, Massachusetts, USA Asset Management USD 9.0 100.0 UBS Securities Australia Ltd Sydney, Australia Investment Bank AUD 0.3 1 100.0 UBS Securities Hong Kong Limited Hong Kong SAR, China Investment Bank HKD 4,154.2 100.0 UBS Securities Japan Co., Ltd. Tokyo, Japan Investment Bank JPY 34,708.7 100.0 UBS SuMi TRUST Wealth Management Co., Ltd. Tokyo, Japan Global Wealth Management JPY 5,165.0 51.0 1 Includes a nominal amount relating to redeemable preference shares. |
Interests in associates and j_2
Interests in associates and joint ventures (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of investments in associates and joint ventures [text block] | Investments in associates and joint ventures USD million 2021 2020 Carrying amount at the beginning of the year 1,557 1,051 Additions 1 388 Reclassifications 1 (386) 0 Share of comprehensive income 150 83 of which: share of net profit 2 105 84 of which: share of other comprehensive income 3 45 (1) Share of changes in retained earnings 1 (40) Dividends received (39) (33) Foreign currency translation (39) 108 Carrying amount at the end of the year 1,243 1,557 of which: associates 1,200 1,513 of which: SIX Group AG, Zurich 4 1,043 965 of which: Clearstream Fund Centre AG, Zurich 1 399 of which: other associates 157 150 of which: joint ventures 43 44 1 In the second quarter 48.8 %) in Clearstream Fund 386 sale and sold the investment in the same quarter. Refer to Note 30 for more information. 79 26 64 million from associates 19 44 1 1 associates. 17.31 %. UBS AG is represented on the Board of Directors. |
UBS AG | |
Entity [Table] | |
Disclosure of investments in associates and joint ventures [text block] | Investments in associates and joint ventures USD million 2021 2020 Carrying amount at the beginning of the year 1,557 1,051 Additions 1 388 Reclassifications 1 (386) 0 Share of comprehensive income 150 83 of which: share of net profit 2 105 84 of which: share of other comprehensive income 3 45 (1) Share of changes in retained earnings 1 (40) Dividends received (39) (33) Foreign currency translation (39) 108 Carrying amount at the end of the year 1,243 1,557 of which: associates 1,200 1,513 of which: SIX Group AG, Zurich 4 1,043 965 of which: Clearstream Fund Centre AG, Zurich 1 399 of which: other associates 157 150 of which: joint ventures 43 44 1 In the second quarter 48.8 %) in Clearstream Fund 386 sale and sold the investment in the same quarter. Refer to Note 30 for more information. 79 26 64 million from associates 19 44 1 1 associates. 17.31 %. UBS AG is represented on the Board of Directors. |
Interests in unconsolidated s_2
Interests in unconsolidated structured entities (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Interests In Unconsolidated Structured Entities Explanatory | Interests in unconsolidated structured entities 31.12.21 USD million, except where indicated Securitization vehicles Client vehicles Investment funds Total Maximum exposure to loss 1 Financial assets at fair value held for trading 246 162 6,743 7,151 7,151 Derivative financial instruments 5 45 155 205 205 Loans and advances to customers 125 125 125 Financial assets at fair value not held for trading 35 222 257 257 Financial assets measured at fair value through other comprehensive 324 4,525 4,849 4,849 Other financial assets measured at amortized cost 0 2 0 1 250 Total assets 610 3 4,732 7,247 12,588 Derivative financial instruments 2 11 281 294 Total liabilities 2 11 281 294 Assets held by the unconsolidated structured entities in which UBS had (USD billion) 30 4 81 5 158 6 31.12.20 USD million, except where indicated Securitization vehicles Client vehicles Investment funds Total Maximum exposure to loss 1 Financial assets at fair value held for trading 375 131 7,595 8,101 8,101 Derivative financial instruments 6 49 158 213 211 Loans and advances to customers 179 179 179 Financial assets at fair value not held for trading 35 1 2 172 208 208 Financial assets measured at fair value through other comprehensive 6,624 6,624 6,624 Other financial assets measured at amortized cost 0 2 0 250 Total assets 416 3 6,805 8,104 15,326 Derivative financial instruments 3 11 376 390 0 Total liabilities 3 11 376 390 Assets held by the unconsolidated structured entities in which UBS had (USD billion) 39 4 136 5 124 6 1 For the purpose of this disclosure, maximum exposure to loss amounts do not consider the risk-reducing effects of collateral or other credit enhancements. The maximum exposure to loss for these instruments is equal 0.1 0.6 0.2 0.4 was held in Group Functions – Non-core and Legacy Portfolio. funds sponsored by structured investment funds and separately disclosed in the accompanying text on the following page. Prior-period |
UBS AG | |
Entity [Table] | |
Disclosure Of Interests In Unconsolidated Structured Entities Explanatory | Interests in unconsolidated structured entities 31.12.21 USD million, except where indicated Securitization vehicles Client vehicles Investment funds Total Maximum exposure to loss 1 Financial assets at fair value held for trading 246 162 6,743 7,151 7,151 Derivative financial instruments 5 45 155 205 205 Loans and advances to customers 125 125 125 Financial assets at fair value not held for trading 35 100 135 135 Financial assets measured at fair value through other comprehensive 324 4,525 4,849 4,849 Other financial assets measured at amortized cost 0 2 0 1 250 Total assets 610 3 4,732 7,124 12,466 Derivative financial instruments 2 11 281 294 Total liabilities 2 11 281 294 Assets held by the unconsolidated structured entities in which UBS AG had interest (USD billion) 30 4 81 5 103 6 31.12.20 USD million, except where indicated Securitization vehicles Client vehicles Investment funds Total Maximum exposure to loss 1 Financial assets at fair value held for trading 375 131 7,595 8,101 8,101 Derivative financial instruments 6 49 158 213 211 Loans and advances to customers 179 179 179 Financial assets at fair value not held for trading 35 1 2 73 109 109 Financial assets measured at fair value through other comprehensive 6,624 6,624 6,624 Other financial assets measured at amortized cost 0 2 0 250 Total assets 416 3 6,805 8,005 15,227 Derivative financial instruments 3 11 376 390 0 Total liabilities 3 11 376 390 Assets held by the unconsolidated structured entities in which UBS AG had interest (USD billion) 39 4 136 5 89 6 1 For the purpose of this disclosure, maximum exposure to loss amounts do not consider the risk-reducing effects of collateral or other credit enhancements. The maximum exposure to loss for these instruments is equal 0.1 0.6 0.2 0.4 was held in Group Functions – Non-core and Legacy Portfolio. funds sponsored by unconsolidated structured investment funds and the corresponding total asset information, where UBS AG’s information is now separately disclosed in the accompanying text on the following page. Prior-period |
Related parties (Tables)
Related parties (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Related-party disclosure For the year ended USD million 31.12.21 31.12.20 31.12.19 Received by UBS Fees 39 34 34 Paid by UBS Rent 4 5 4 Dividends, capital repayments and interest 5 10 11 |
Remuneration | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Remuneration of key management USD million, except where indicated 31.12.21 31.12.20 31.12.19 Base salaries and other cash payments 1 31 33 32 Incentive awards – cash 2 17 18 14 Annual incentive award under DCCP 26 27 21 Employer’s contributions to retirement benefit plans 3 3 3 Benefits in kind, fringe benefits (at market value) 1 1 1 Share-based compensation 3 45 47 37 Total 124 129 108 Total (CHF million) 4 113 121 107 1 May include role-based allowances in line is based on the composed of LTIP awards.For dollar amounts translated at the applicable performance award currency exchange rates (2021: USD / 0.92 ; 2020: USD / CHF 0.94 ; 2019: USD / CHF 0.99 ). |
Equity holdings | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Equity holdings of key management personnel 1 31.12.21 31.12.20 Number of shares held by members of the BoD, GEB and parties closely 2 4,597,006 5,288,317 1 No options were held in 2021 and 2020 by non-independent members provisions. |
Key management personnel | Loans, advances and mortgages | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Loans, advances and mortgages to key management 1 USD million, except where indicated 2021 2020 Balance at the beginning of the year 38 33 Additions 11 14 Reductions (15) (8) Balance at the end of the year 2 34 38 Balance at the end of the year (CHF million) 2, 3 31 34 1 All loans are secured loans. translated at the relevant year-end closing exchange rate. |
Associates and joint ventures | Loans, advances and mortgages | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Loans to and outstanding receivables from associates USD million 2021 2020 Carrying amount at the beginning of the year 630 982 Additions 133 527 Reductions (497) (1,001) Foreign currency translation (14) 123 Carrying amount at the end of the year 251 630 of which: unsecured loans and receivables 243 621 Other transactions with associates and As of or for the year ended USD million 31.12.21 31.12.20 Payments to associates and joint ventures for goods and services 157 139 Fees received for services provided to associates and joint ventures 104 128 Liabilities to associates and joint ventures 127 91 Commitments and contingent liabilities to associates 7 9 |
UBS AG | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Related-party disclosure For the year ended USD million 31.12.21 31.12.20 31.12.19 Received by UBS AG Fees 22 19 19 Paid by UBS AG Rent 2 3 2 Dividends, capital repayments and interest 5 10 10 |
UBS AG | Equity holdings | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Equity holdings of key management personnel 1 31.12.21 31.12.20 Number of shares held by members of the BoD, EB and parties closely linked to them 2 4,175,515 4,956,640 1 No options were held in 2021 and 2020 by non-independent members provisions. |
UBS AG | Key management personnel | Loans, advances and mortgages | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Loans, advances and mortgages to key management 1 USD million, except where indicated 2021 2020 Balance at the beginning of the year 31 23 Additions 11 13 Reductions (15) (5) Balance at the end of the year 2 28 31 Balance at the end of the year (CHF million) 2, 3 25 28 1 All loans are secured loans. translated at the relevant year-end closing exchange rate. |
UBS AG | Associates and joint ventures | Loans, advances and mortgages | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | Loans to and outstanding receivables from associates USD million 2021 2020 Carrying amount at the beginning of the year 630 982 Additions 133 527 Reductions (497) (1,001) Foreign currency translation (14) 123 Carrying amount at the end of the year 251 630 of which: unsecured loans and receivables 243 621 Other transactions with associates and As of or for the year ended USD million 31.12.21 31.12.20 Payments to associates and joint ventures for goods and services 157 139 Fees received for services provided to associates and joint ventures 104 128 Liabilities to associates and joint ventures 127 91 Commitments and contingent liabilities to associates 7 9 |
UBS AG | UBS Group AG and other subsidiaries of UBS Group AG | Loans, advances and mortgages | |
Entity [Table] | |
Disclosure Of Transactions Between Related Parties Explanatory | USD million 31.12.21 31.12.20 Receivables Loans and advances to customers 1,049 1,470 Financial assets at fair value held for trading 187 76 Other financial assets measured at amortized cost 45 38 Payables Customer deposits 2,828 3,324 Funding from UBS Group AG 57,295 53,979 Other financial liabilities measured at amortized cost 1,887 1,820 Other financial liabilities designated at fair value 1 2,340 1,375 1 Represents funding recognized from UBS Group AG that is designated at fair value. Refer to Note |
Invested assets and net new m_2
Invested assets and net new money (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of invested assets and net new money [text block] | Invested As of or for the year ended USD billion 31.12.21 31.12.20 Fund assets managed by UBS 419 397 Discretionary assets 1,705 1,459 Other invested assets 2,472 2,331 Total invested assets 1 4,596 4,187 of which: double counts 356 311 Net new money 1 159 127 1 Includes double counts. |
Development of invested assets | Development of invested assets USD billion 2021 2020 Total invested assets at the beginning of the year 1 4,187 3,607 Net new money 159 127 Market movements 2 339 359 Foreign currency translation (65) 96 Other effects (24) (1) of which: acquisitions / (divestments) (5) 0 Total invested assets at the end of the year 1 4,596 4,187 1 Includes double counts. |
UBS AG | |
Entity [Table] | |
Disclosure of invested assets and net new money [text block] | Invested assets and net new money As of or for the year ended USD billion 31.12.21 31.12.20 Fund assets managed by UBS 419 397 Discretionary assets 1,705 1,459 Other invested assets 2,472 2,331 Total invested assets 1 4,596 4,187 of which: double counts 356 311 Net new money 1 159 127 1 Includes double counts. |
Development of invested assets | Development of invested assets USD billion 2021 2020 Total invested assets at the beginning of the year 1 4,187 3,607 Net new money 159 127 Market movements 2 339 359 Foreign currency translation (65) 96 Other effects (24) (1) of which: acquisitions / (divestments) (5) 0 Total invested assets at the end of the year 1 4,596 4,187 1 Includes double counts. |
Currency translation rates (Tab
Currency translation rates (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of foreign exchange rates [text block] | Closing exchange rate Average rate 1 As of For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.19 1 CHF 1.10 1.13 1.09 1.07 1.01 1 EUR 1.14 1.22 1.18 1.15 1.12 1 GBP 1.35 1.37 1.37 1.29 1.28 100 JPY 0.87 0.97 0.91 0.94 0.92 1 Monthly income statement items of operations with a functional currency other than the US dollar are translated into US dollars using month-end rates. Disclosed average rates for a year represent an average of 12 month-end rates, weighted may deviate from the weighted average rates for the Group. |
UBS AG | |
Entity [Table] | |
Disclosure of foreign exchange rates [text block] | Closing exchange rate Average rate 1 As of For the year ended 31.12.21 31.12.20 31.12.21 31.12.20 31.12.19 1 CHF 1.10 1.13 1.09 1.07 1.01 1 EUR 1.14 1.22 1.18 1.15 1.12 1 GBP 1.35 1.37 1.37 1.29 1.28 100 JPY 0.87 0.97 0.91 0.94 0.92 1 Monthly income statement items of operations with a functional currency other than the US dollar are translated into US dollars using month-end rates. Disclosed average rates for a year represent an average of 12 month-end rates, weighted according to the income and expense volumes of all operations of UBS deviate from the weighted average rates for UBS AG. |
Supplemental guarantor inform_2
Supplemental guarantor information required under SEC regulations (Tables) - UBS AG | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Schedule Of Condensed Income Statement [Table Text Block] | Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2021 Operating income Interest income from financial instruments measured at fair value through other comprehensive income 3,130 3,652 2,456 (703) 8,534 Interest expense from financial instruments measured at (2,847) (520) (1,024) 1,025 (3,366) Net interest income from financial instruments measured profit or loss 1,229 254 228 (274) 1,437 Net interest income 1,512 3,386 1,660 48 6,605 Other net income from financial instruments measured profit or loss 3,751 807 1,369 (83) 5,844 Credit loss (expense) / release 65 98 10 (24) 148 Fee and commission income 3,837 5,204 16,151 (770) 24,422 Fee and commission expense (810) (481) (1,450) 755 (1,985) Net fee and commission income 3,027 4,723 14,702 (14) 22,438 Other income 7,555 221 1,560 (8,396) 941 Total operating income 15,910 9,235 19,300 (8,469) 35,976 Operating expenses Personnel expenses 3,401 2,098 10,161 1 15,661 General and administrative expenses 4,255 3,442 4,474 (2,696) 9,476 Depreciation, amortization and impairment of non-financial 949 285 755 (114) 1,875 Total operating expenses 8,605 5,825 15,390 (2,809) 27,012 Operating profit / (loss) before tax 7,305 3,409 3,910 (5,660) 8,964 Tax expense / (benefit) 203 622 1,090 (11) 1,903 Net profit / (loss) 7,102 2,788 2,820 (5,649) 7,061 Net profit / (loss) attributable to non-controlling interests 0 0 29 0 29 Net profit / (loss) attributable to shareholders 7,102 2,788 2,792 (5,649) 7,032 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, | Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2020 Operating income Interest income from financial instruments measured at fair value through other comprehensive income 3,386 3,636 2,612 (818) 8,816 Interest expense from financial instruments measured at (3,694) (513) (1,261) 1,134 (4,333) Net interest income from financial instruments measured profit or loss 1,103 164 311 (273) 1,305 Net interest income 794 3,288 1,662 43 5,788 Other net income from financial instruments measured profit or loss 4,857 911 1,044 118 6,930 Credit loss (expense) / release (352) (286) (56) 0 (695) Fee and commission income 3,731 4,585 13,651 (984) 20,982 Fee and commission expense (644) (829) (1,263) 961 (1,775) Net fee and commission income 3,087 3,756 12,388 (23) 19,207 Other income 4,671 233 2,585 (5,941) 1,549 Total operating income 13,057 7,902 17,623 (5,803) 32,780 Operating expenses Personnel expenses 3,458 2,017 9,211 0 14,686 General and administrative expenses 3,507 3,313 4,147 (2,481) 8,486 Depreciation, amortization and impairment of non-financial 1,013 261 750 (115) 1,909 Total operating expenses 7,978 5,591 14,108 (2,596) 25,081 Operating profit / (loss) before tax 5,079 2,311 3,515 (3,207) 7,699 Tax expense / (benefit) 238 444 912 (107) 1,488 Net profit / (loss) 4,840 1,868 2,603 (3,100) 6,211 Net profit / (loss) attributable to non-controlling interests 0 0 15 0 15 Net profit / (loss) attributable to shareholders 4,840 1,868 2,588 (3,100) 6,196 1 Amounts presented for UBS AG under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, | Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2019 Operating income Interest income from financial instruments measured at fair value through other comprehensive income 4,864 4,048 3,719 (1,928) 10,703 Interest expense from financial instruments measured at (6,547) (737) (2,317) 2,298 (7,303) Net interest income from financial instruments measured profit or loss 1,177 (228) 394 (327) 1,015 Net interest income (506) 3,083 1,796 42 4,415 Other net income from financial instruments measured profit or loss 5,116 924 1,114 (322) 6,833 Credit loss (expense) / release (51) 7 (33) 0 (78) Fee and commission income 3,285 4,342 12,527 (997) 19,156 Fee and commission expense (674) (819) (1,188) 986 (1,696) Net fee and commission income 2,610 3 3,523 3 11,338 (11) 17,460 Other income 4,899 259 1,960 (6,442) 677 Total operating income 12,069 7,796 16,176 (6,733) 29,307 Operating expenses Personnel expenses 3,251 1,936 8,614 0 13,801 General and administrative expenses 3,467 3,181 4,565 (2,627) 8,586 Depreciation, amortization and impairment of non-financial 954 221 772 (196) 1,751 Total operating expenses 7,672 5,338 13,951 (2,823) 24,138 Operating profit / (loss) before tax 4,396 2,458 2,225 (3,911) 5,169 Tax expense / (benefit) 175 514 530 (21) 1,198 Net profit / (loss) 4,221 1,944 1,695 (3,890) 3,971 Net profit / (loss) attributable to non-controlling interests 0 0 6 0 6 Net profit / (loss) attributable to shareholders 4,221 1,944 1,689 (3,889) 3,965 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, ownership of a comparability” in the “UBS AG standalone financial statements” section of the UBS AG Standalone financial |
Condensed Statement Of Comprehensive Income [Table Text Block] | Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2021 Comprehensive income attributable to shareholders Net profit / (loss) 7,102 2,788 2,792 (5,649) 7,032 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax (1) (419) (607) 517 (510) Financial assets measured at fair value through other comprehensive income, net of tax 0 (157) 0 (157) Cash flow hedges, net of tax (1,129) (279) (250) (17) (1,675) Cost of hedging, net of tax (26) (26) Total other comprehensive income that may be reclassified to the income statement, net of tax (1,155) (699) (1,014) 500 (2,368) Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax 170 (135) 67 0 102 Own credit on financial liabilities designated at fair value, net of tax 46 46 Total other comprehensive income that will not be reclassified to the income statement, net of tax 217 (135) 67 0 148 Total other comprehensive income (939) (834) (947) 500 (2,220) Total comprehensive income attributable to shareholders 6,163 1,954 1,845 (5,149) 4,813 Total comprehensive income attributable to non-controlling interests 13 13 Total comprehensive income 6,163 1,954 1,858 (5,149) 4,826 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, | Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2020 Comprehensive income attributable to shareholders Net profit / (loss) 4,840 1,868 2,588 (3,100) 6,196 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax 81 1,228 690 (969) 1,030 Financial assets measured at fair value through other comprehensive income, net of tax 0 0 137 0 136 Cash flow hedges, net of tax 902 26 101 (18) 1,011 Cost of hedging, net of tax (13) (13) Total other comprehensive income that may be reclassified to the income statement, net of tax 971 1,254 928 (988) 2,165 Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax (67) (107) 40 0 (134) Own credit on financial liabilities designated at fair value, net of tax (293) (293) Total other comprehensive income that will not be reclassified to the income statement, net of tax (360) (107) 40 0 (427) Total other comprehensive income 611 1,147 968 (988) 1,738 Total comprehensive income attributable to shareholders 5,451 3,015 3,556 (4,088) 7,934 Total comprehensive income attributable to non-controlling interests 36 36 Total comprehensive income 5,451 3,015 3,592 (4,088) 7,970 1 Amounts presented for UBS under “Complementary financial Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, | Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) For the year ended 31 December 2019 Comprehensive income attributable to shareholders Net profit / (loss) 4,221 1,944 1,689 (3,889) 3,965 Other comprehensive income Other comprehensive income that may be reclassified to the income statement Foreign currency translation, net of tax 5 150 39 (102) 92 Financial assets measured at fair value through other comprehensive income, net of tax 0 0 117 0 117 Cash flow hedges, net of tax 870 140 147 (15) 1,143 Total other comprehensive income that may be reclassified to the income statement, net of tax 875 290 303 (117) 1,351 Other comprehensive income that will not be reclassified to the income statement Defined benefit plans, net of tax (89) (6) (75) 0 (170) Own credit on financial liabilities designated at fair value, net of tax (392) (392) Total other comprehensive income that will not be reclassified to the income statement, net of tax (481) (6) (75) 0 (562) Total other comprehensive income 394 284 228 (117) 789 Total comprehensive income attributable to shareholders 4,616 2,228 1,917 (4,007) 4,754 Total comprehensive income attributable to non-controlling interests 2 2 Total comprehensive income 4,616 2,228 1,919 (4,007) 4,756 1 Amounts presented for UBS AG under “Complementary financial information” at ubs.com/investors for information prepared in accordance with Swiss GAAP. sub-groups UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG, |
Schedule Of Condensed Balance Sheet [Table Text Block] | Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) As of 31 December 2021 Assets Cash and balances at central banks 53,839 91,031 47,946 192,817 Loans and advances to banks 39,681 7,066 19,858 (51,245) 15,360 Receivables from securities financing transactions 50,566 5,438 40,585 (21,577) 75,012 Cash collateral receivables on derivative instruments 29,939 779 10,314 (10,518) 30,514 Loans and advances to customers 101,458 230,170 93,252 (26,188) 398,693 Other financial assets measured at amortized cost 8,902 6,828 12,377 (1,870) 26,236 Total financial assets measured at amortized cost 284,385 341,312 224,332 (111,397) 738,632 Financial assets at fair value held for trading 116,370 79 16,740 (2,156) 131,033 of which: assets pledged as collateral that may be sold or repledged by counterparties 47,891 0 6,073 (10,568) 43,397 Derivative financial instruments 113,426 4,199 35,567 (35,047) 118,145 Brokerage receivables 14,563 7,283 (7) 21,839 Financial assets at fair value not held for trading 37,532 5,413 33,940 (17,243) 59,642 Total financial assets measured at fair value through profit or loss 281,891 9,691 93,531 (54,454) 330,659 Financial assets measured at fair value through other comprehensive income 1,007 7,837 8,844 Investments in subsidiaries and associates 54,204 37 40 (53,038) 1,243 Property, equipment and software 6,501 1,456 4,048 (293) 11,712 Goodwill and intangible assets 213 6,138 28 6,378 Deferred tax assets 936 7,903 8,839 Other non-financial assets 5,757 2,424 1,656 (1) 9,836 Total assets 634,894 354,921 345,484 (219,154) 1,116,145 Liabilities Amounts due to banks 34,691 33,453 50,405 (105,448) 13,101 Payables from securities financing transactions 16,711 526 9,910 (21,615) 5,533 Cash collateral payables on derivative instruments 30,260 153 11,845 (10,458) 31,801 Customer deposits 101,093 286,488 142,967 14,287 544,834 Funding from UBS Group AG 57,295 57,295 Debt issued measured at amortized cost 73,045 9,460 (73) 82,432 Other financial liabilities measured at amortized cost 4,477 2,477 5,057 (2,245) 9,765 Total financial liabilities measured at amortized cost 317,572 332,556 220,184 (125,551) 744,762 Financial liabilities at fair value held for trading 25,711 372 7,652 (2,046) 31,688 Derivative financial instruments 116,588 4,053 35,731 (35,063) 121,309 Brokerage payables designated at fair value 30,497 13,548 (1) 44,045 Debt issued designated at fair value 70,660 785 14 71,460 Other financial liabilities designated at fair value 11,127 24,454 (3,167) 32,414 Total financial liabilities measured at fair value through profit or loss 254,584 4,425 82,171 (40,263) 300,916 Provisions 2,023 297 1,153 (21) 3,452 Other non-financial liabilities 1,799 1,278 5,528 (33) 8,572 Total liabilities 575,978 338,556 309,036 (165,868) 1,057,702 Equity attributable to shareholders 58,916 16,365 36,108 (53,287) 58,102 Equity attributable to non-controlling interests 340 340 Total equity 58,916 16,365 36,448 (53,287) 58,442 Total liabilities and equity 634,894 354,921 345,484 (219,154) 1,116,145 1 Amounts presented for UBS AG available under “Complementary financial information” at ubs.com/investors, for information prepared UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, | Supplemental guarantor consolidated USD million UBS AG (standalone) 1 UBS Switzerland AG (standalone) 1 Other subsidiaries 2 Elimination entries UBS AG (consolidated) As of 31 December 2020 Assets Cash and balances at central banks 34,426 91,638 32,167 158,231 Loans and advances to banks 40,171 6,385 19,465 (50,678) 15,344 Receivables from securities financing transactions 56,568 4,026 43,350 (29,735) 74,210 Cash collateral receivables on derivative instruments 32,771 1,543 10,093 (11,671) 32,737 Loans and advances to customers 99,952 228,279 73,513 (20,767) 380,977 Other financial assets measured at amortized cost 8,411 8,084 13,368 (2,644) 27,219 Total financial assets measured at amortized cost 272,299 339,956 191,957 (115,495) 688,717 Financial assets at fair value held for trading 110,812 55 16,260 (1,634) 125,492 of which: assets pledged as collateral that may be sold or repledged by counterparties 54,468 1 6,247 (13,617) 47,098 Derivative financial instruments 154,313 6,342 44,005 (45,041) 159,618 Brokerage receivables 16,898 7,763 (2) 24,659 Financial assets at fair value not held for trading 46,198 13,068 36,444 (15,672) 80,038 Total financial assets measured at fair value through profit or loss 328,221 19,464 104,473 (62,350) 389,808 Financial assets measured at fair value through other comprehensive income 187 8,072 8,258 Investments in subsidiaries and associates 53,606 38 439 (52,526) 1,557 Property, equipment and software 6,999 1,335 3,975 (350) 11,958 Goodwill and intangible assets 217 6,234 28 6,480 Deferred tax assets 840 1 8,334 (1) 9,174 Other non-financial assets 6,641 2,063 854 (183) 9,374 Total assets 669,010 362,857 324,337 (230,878) 1,125,327 Liabilities Amounts due to banks 41,414 34,096 43,066 (107,527) 11,050 Payables from securities financing transactions 17,247 566 18,407 (29,899) 6,321 Cash collateral payables on derivative instruments 35,875 561 12,495 (11,618) 37,313 Customer deposits 98,441 293,371 112,372 23,745 527,929 Funding from UBS Group AG 53,979 53,979 Debt issued measured at amortized cost 75,658 9,687 3 3 85,351 Other financial liabilities measured at amortized cost 5,285 2,567 5,745 (3,175) 10,421 Total financial liabilities measured at amortized cost 327,898 340,848 192,088 (128,470) 732,364 Financial liabilities at fair value held for trading 28,800 335 5,989 (1,529) 33,595 Derivative financial instruments 156,192 5,593 44,359 (45,043) 161,102 Brokerage payables designated at fair value 25,045 13,704 (7) 38,742 Debt issued designated at fair value 58,986 935 (54) 59,868 Other financial liabilities designated at fair value 11,255 23,445 (2,927) 31,773 Total financial liabilities measured at fair value through profit or loss 280,279 5,927 88,433 (49,559) 325,080 Provisions 1,293 301 1,197 2,791 Other non-financial liabilities 2,173 987 3,907 (49) 7,018 Total liabilities 611,643 348,063 285,625 (178,078) 1,067,254 Equity attributable to shareholders 57,367 14,794 38,393 (52,800) 57,754 Equity attributable to non-controlling interests 319 319 Total equity 57,367 14,794 38,712 (52,800) 58,073 Total liabilities and equity 669,010 362,857 324,337 (230,878) 1,125,327 1 Amounts presented for UBS AG available under “Complementary financial information” at ubs.com/investors, for information prepared UBS Americas Holding LLC, UBS Europe SE and UBS Asset Management AG significant sub-groups, | |
Schedule Of Condensed Cash Flow Statement [Table Text Block] | Supplemental guarantor consolidated USD million UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2021 Net cash flow from / (used in) operating activities 5,714 2,131 22,718 30,563 Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets 0 (1) 0 (1) Disposal of subsidiaries, associates and intangible assets 2 16 0 577 593 Purchase of property, equipment and software (656) (276) (650) (1,581) Disposal of property, equipment and software 294 0 1 295 Purchase of financial assets measured at fair value through other (1,006) 0 (4,795) (5,802) Disposal and redemption of financial assets measured at income 189 0 4,863 5,052 Net (purchase) / redemption of debt securities measured (807) 772 (380) (415) Net cash flow from / (used in) investing activities (1,970) 495 (385) (1,860) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) (3,073) (21) 0 (3,093) Distributions paid on UBS AG shares (4,539) 0 0 (4,539) Issuance of debt designated at fair value and long-term debt measured 3 97,250 1,177 193 98,619 Repayment of debt designated at fair value and long-term debt measured 3 (78,385) (1,093) (320) (79,799) Net cash flows from other financing activities (280) 0 20 (261) Net activity related to group internal capital transactions and dividends 5,240 (537) (4,702) 0 Net cash flow from / (used in) financing activities 16,212 (475) (4,811) 10,927 Total cash flow Cash and cash equivalents at the beginning of the year 39,400 93,342 40,689 173,430 Net cash flow from / (used in) operating, investing and financing 19,957 2,151 17,523 39,630 Effects of exchange rate differences on cash and cash equivalents (1,462) (2,693) (1,151) (5,306) Cash and cash equivalents at the end of the year 4 57,895 92,799 57,061 207,755 of which: cash and balances at central banks 53,729 91,031 47,946 192,706 of which: loans and advances to banks 3,258 1,588 8,975 13,822 of which: money market paper 5 908 179 139 1,227 1 Cash flows generally represent a sale of the minority stake in Clearstream Fund Centre AG and dividends received from associates. USD 3,408 through other comprehensive income, Financial assets at fair value not held for trading and Other | Supplemental guarantor consolidated USD million UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2020 Net cash flow from / (used in) operating activities (14,883) 24,661 26,804 36,581 Cash flow from / (used in) investing activities Purchase of subsidiaries, associates and intangible assets 0 (3) (43) (46) Disposal of subsidiaries, associates and intangible assets 2 14 0 660 674 Purchase of property, equipment and software (714) (162) (697) (1,573) Disposal of property, equipment and software 361 0 3 364 Purchase of financial assets measured at fair value through other (77) 0 (6,213) (6,290) Disposal and redemption of financial assets measured at income 79 0 4,451 4,530 Net (purchase) / redemption of debt securities measured (3,021) 132 (1,277) (4,166) Net cash flow from / (used in) investing activities (3,357) (33) (3,117) (6,506) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) 23,828 17 0 23,845 Distributions paid on UBS AG shares (3,848) 0 0 (3,848) Issuance of debt designated at fair value and long-term debt measured 3 78,867 1,057 229 80,153 Repayment of debt designated at fair value and long-term debt measured 3 (86,204) (776) (118) (87,099) Net cash flows from other financing activities (290) 0 (263) (553) Net activity related to group internal capital transactions and dividends 2,984 (1,307) (1,677) 0 Net cash flow from / (used in) financing activities 15,336 (1,009) (1,829) 12,498 Total cash flow Cash and cash equivalents at the beginning of the year 39,598 62,551 17,655 119,804 Net cash flow from / (used in) operating, investing and financing (2,905) 23,619 21,859 42,573 Effects of exchange rate differences on cash and cash equivalents 2,706 7,171 1,175 11,053 Cash and cash equivalents at the end of the year 4 39,400 93,342 40,689 173,430 of which: cash and balances at central banks 34,283 91,638 32,167 158,088 of which: loans and advances to banks 4,085 1,695 8,148 13,928 of which: money market paper 5 1,032 9 374 1,415 1 Cash flows generally represent sale of the majority stake 3,828 million of cash and cash equivalents were restricted. comprehensive income, Financial assets at fair value not held for trading and Other financial assets | Supplemental guarantor consolidated USD million UBS AG 1 UBS Switzerland AG 1 Other 1 UBS AG (consolidated) For the year ended 31 December 2019 Net cash flow from / (used in) operating activities 17,531 8,882 (7,608) 18,805 Purchase of subsidiaries, associates and intangible assets (6) 0 (20) (26) Disposal of subsidiaries, associates and intangible assets 2 100 0 14 114 Purchase of property, equipment and software (628) (173) (600) (1,401) Disposal of property, equipment and software 10 0 1 11 Purchase of financial assets measured at fair value through other (10) 0 (3,414) (3,424) Disposal and redemption of financial assets measured at income 10 0 3,904 3,913 Net (purchase) / redemption of debt securities measured (1,045) 437 45 (562) Net cash flow from / (used in) investing activities (1,569) 264 (70) (1,374) Cash flow from / (used in) financing activities Net short-term debt issued / (repaid) (17,150) 0 0 (17,149) Distributions paid on UBS AG shares (3,250) 0 0 (3,250) Issuance of debt designated at fair value and long-term debt measured 3 64,285 621 142 65,047 Repayment of debt designated at fair value and long-term debt measured 3 (67,113) (752) (1,017) (68,883) Net cash flows from other financing activities (262) 0 (242) (504) Net activity related to group internal capital transactions and dividends 3,569 (2,055) (1,514) 0 Net cash flow from / (used in) financing activities (19,922) (2,186) (2,630) (24,738) Total cash flow Cash and cash equivalents at the beginning of the year 42,895 54,757 28,201 125,853 Net cash flow from / (used in) operating, investing and financing (3,960) 6,961 (10,308) (7,307) Effects of exchange rate differences on cash and cash equivalents 664 833 (239) 1,258 Cash and cash equivalents at the end of the year 4 39,598 62,551 17,655 119,804 of which: cash and balances at central banks 36,275 60,926 9,756 106,957 of which: loans and advances to banks 2,697 1,127 7,493 11,317 of which: money market paper 5 626 498 406 1,530 1 Cash flows generally represent a associates. 3,192 paper is included in the balance sheet under Financial assets at and Other financial assets measured at amortized cost. |
MD&A - Risk management and co_5
MD&A - Risk management and control - Credit Risk (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Internal UBS rating scale and mapping of external ratings [text block] | Internal UBS rating scale and mapping of external ratings Internal UBS rating 1-year PD range in % Description Moody’s Investors Service mapping S&P mapping Fitch mapping 0 and 1 0.00–0.02 Investment grade Aaa AAA AAA 2 0.02–0.05 Aa1 to Aa3 AA+ to AA– AA+ to AA– 3 0.05–0.12 A1 to A3 A+ to A– A+ to A– 4 0.12–0.25 Baa1 to Baa2 BBB+ to BBB BBB+ to BBB 5 0.25–0.50 Baa3 BBB– BBB– 6 0.50–0.80 Sub-investment grade Ba1 BB+ BB+ 7 0.80–1.30 Ba2 BB BB 8 1.30–2.10 Ba3 BB– BB– 9 2.10–3.50 B1 B+ B+ 10 3.50–6.00 B2 B B 11 6.00–10.00 B3 B– B– 12 10.00–17.00 Caa1 to Caa3 13 >17 Ca to C CCC to C CCC to C Counterparty is in default Default Defaulted D D |
UBS AG | |
Entity [Table] | |
Internal UBS rating scale and mapping of external ratings [text block] | Internal UBS rating scale and mapping of external ratings Internal UBS rating 1-year PD range in % Description Moody’s Investors Service mapping S&P mapping Fitch mapping 0 and 1 0.00–0.02 Investment grade Aaa AAA AAA 2 0.02–0.05 Aa1 to Aa3 AA+ to AA– AA+ to AA– 3 0.05–0.12 A1 to A3 A+ to A– A+ to A– 4 0.12–0.25 Baa1 to Baa2 BBB+ to BBB BBB+ to BBB 5 0.25–0.50 Baa3 BBB– BBB– 6 0.50–0.80 Sub-investment grade Ba1 BB+ BB+ 7 0.80–1.30 Ba2 BB BB 8 1.30–2.10 Ba3 BB– BB– 9 2.10–3.50 B1 B+ B+ 10 3.50–6.00 B2 B B 11 6.00–10.00 B3 B– B– 12 10.00–17.00 Caa1 to Caa3 13 >17 Ca to C CCC to C CCC to C Counterparty is in default Default Defaulted D D |
MD&A - Risk management and co_6
MD&A - Risk management and control - Market Risk (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of detailed information about management value-at-risk [text block] | Management value-at-risk (1-day, 95% confidence, 5 years of historical data) of our business divisions and Group Functions by general market risk type 1 For the year ended 31.12.21 USD million Equity Interest rates Credit spreads Foreign exchange Commodities Min. 1 7 5 1 2 Max. 35 13 11 9 5 Average 7 9 7 3 3 31.12.21 8 11 7 6 3 Total management VaR, Group 4 36 11 12 Average (per business division and risk type) Global Wealth Management 1 3 1 2 0 1 2 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 3 36 11 11 7 9 7 3 3 Group Functions 4 8 5 4 0 4 4 1 0 Diversification effect 2,3 (6) (5) 0 (5) (5) (1) 0 For the year ended 31.12.20 USD million Equity Interest rates Credit spreads Foreign exchange Commodities Min. 3 6 5 2 2 Max. 29 11 11 7 6 Average 10 8 7 4 4 31.12.20 6 8 8 3 3 Total management VaR, Group 8 31 13 11 Average (per business division and risk type) Global Wealth Management 0 2 1 1 0 1 1 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 7 32 12 10 10 7 6 4 4 Group Functions 4 7 5 6 0 4 3 1 0 Diversification effect 2,3 (5) (8) 0 (4) (4) (1) 0 1 Statistics at individual levels may not be line or risk type, being driven by the extreme loss tail of the corresponding distribution of simulated profits and rendering invalid the simple summation of figures to arrive at the aggregate total. a whole. |
Disclosure of interest rate sensitivity - banking book [text block] | Interest rate risk – banking book USD million +1 bp Parallel up 1 Parallel down 1 Steepener 2 Flattener 3 Short-term up 4 Short-term down 5 CHF (5.1) (724.1) 806.3 (254.3) 117.1 (158.7) 162.5 EUR (1.1) (196.6) 231.9 (69.0) 37.4 (24.1) 27.4 GBP 0.1 33.3 (32.8) (31.1) 35.3 45.4 (43.7) USD (23.5) (5,068.3) 4,124.2 (821.4) (362.3) (2,165.9) 2,315.6 Other (0.4) (85.8) 19.9 (3.7) (34.5) (59.6) 3.8 Total effect on economic value of equity as per Pillar 3 requirement as of 31.12.21 (29.9) (6,041.4) 5,149.5 (1,179.6) (207.0) (2,362.9) 2,465.6 Additional tier 1 (AT1) capital instruments 4.5 853.4 (928.4) (9.6) 197.1 531.5 (553.3) Total including AT1 capital instruments as of 31.12.21 (25.4) (5,188.0) 4,221.1 (1,189.2) (10.0) (1,831.4) 1,912.3 1 Rates across all tenors move by ±150 bps for and long-term rates decrease. |
UBS AG | |
Entity [Table] | |
Disclosure of detailed information about management value-at-risk [text block] | Management value-at-risk (1-day, 95% confidence, 5 years of historical data) of our business divisions and Group Functions by general market risk type 1 For the year ended 31.12.21 USD million Equity Interest rates Credit spreads Foreign exchange Commodities Min. 1 7 5 1 2 Max. 35 13 11 9 5 Average 7 9 7 3 3 31.12.21 8 11 7 6 3 Total management VaR, Group 4 36 11 12 Average (per business division and risk type) Global Wealth Management 1 3 1 2 0 1 2 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 3 36 11 11 7 9 7 3 3 Group Functions 4 8 5 4 0 4 4 1 0 Diversification effect 2,3 (6) (5) 0 (5) (5) (1) 0 For the year ended 31.12.20 USD million Equity Interest rates Credit spreads Foreign exchange Commodities Min. 3 6 5 2 2 Max. 29 11 11 7 6 Average 10 8 7 4 4 31.12.20 6 8 8 3 3 Total management VaR, Group 8 31 13 11 Average (per business division and risk type) Global Wealth Management 0 2 1 1 0 1 1 0 0 Personal & Corporate Banking 0 0 0 0 0 0 0 0 0 Asset Management 0 0 0 0 0 0 0 0 0 Investment Bank 7 32 12 10 10 7 6 4 4 Group Functions 4 7 5 6 0 4 3 1 0 Diversification effect 2,3 (5) (8) 0 (4) (4) (1) 0 1 Statistics at individual levels may not be line or risk type, being driven by the extreme loss tail of the corresponding distribution of simulated profits and rendering invalid the simple summation of figures to arrive at the aggregate total. a whole. |
Disclosure of interest rate sensitivity - banking book [text block] | Interest rate risk – banking book USD million +1 bp Parallel up 1 Parallel down 1 Steepener 2 Flattener 3 Short-term up 4 Short-term down 5 CHF (5.1) (724.1) 806.3 (254.3) 117.1 (158.7) 162.5 EUR (1.1) (196.6) 231.9 (69.0) 37.4 (24.1) 27.4 GBP 0.1 33.3 (32.8) (31.1) 35.3 45.4 (43.7) USD (23.5) (5,068.3) 4,124.2 (821.4) (362.3) (2,165.9) 2,315.6 Other (0.4) (85.8) 19.9 (3.7) (34.5) (59.6) 3.8 Total effect on economic value of equity as per Pillar 3 requirement as of 31.12.21 (29.9) (6,041.4) 5,149.5 (1,179.6) (207.0) (2,362.9) 2,465.6 Additional tier 1 (AT1) capital instruments 4.5 853.4 (928.4) (9.6) 197.1 531.5 (553.3) Total including AT1 capital instruments as of 31.12.21 (25.4) (5,188.0) 4,221.1 (1,189.2) (10.0) (1,831.4) 1,912.3 1 Rates across all tenors move by ±150 bps for and long-term rates decrease. |
MD&A - Capital management (Tabl
MD&A - Capital management (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Disclosure of reconciliation IFRS equity to Swiss SRB CET1 capital [text block] | Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital USD million 31.12.21 31.12.20 Total IFRS equity 61,002 59,765 Equity attributable to non-controlling interests (340) (319) Defined benefit plans, net of tax (270) (41) Deferred tax assets recognized for tax loss carry-forwards (4,565) (5,617) Deferred tax assets on temporary differences, excess over threshold (49) (5) Goodwill, net of tax 1 (5,838) (6,319) Intangible assets, net of tax (180) (296) Compensation-related components (not recognized in net (1,700) (1,349) Expected losses on advanced internal ratings-based portfolio less provisions (482) (330) Unrealized (gains) / losses from cash flow hedges, net of tax (628) (2,321) Own credit related to gains / losses on financial liabilities 315 382 Own credit related to gains / losses on derivative financial instruments (50) (45) Unrealized gains related to debt instruments at fair value through (68) (152) Prudential valuation adjustments (167) (150) Accruals for dividends to shareholders (1,700) (1,314) Capital reserve for potential share repurchases (2,000) Other 1 0 Total common equity tier 1 capital 45,281 39,890 1 Includes goodwill 22 413 associates. |
UBS AG | |
Entity [Table] | |
Disclosure of reconciliation IFRS equity to Swiss SRB CET1 capital [text block] | Reconciliation of IFRS equity to Swiss SRB common equity tier 1 capital (UBS Group AG vs UBS AG consolidated) As of 31.12.21 USD million UBS Group AG (consolidated) UBS AG (consolidated) Difference Total IFRS equity 61,002 58,442 2,559 Equity attributable to non-controlling interests (340) (340) Defined benefit plans, net of tax (270) (270) Deferred tax assets recognized for tax loss carry-forwards (4,565) (4,565) Deferred tax assets on temporary differences, excess over threshold (49) (350) 302 Goodwill, net of tax (5,838) (5,838) Intangible assets, net of tax (180) (180) Compensation-related components (not recognized in net (1,700) (1,700) Expected losses on advanced internal ratings-based portfolio less provisions (482) (482) Unrealized (gains) / losses from cash flow hedges, net of tax (628) (628) Own credit related to gains / losses on financial liabilities 315 315 Own credit related to gains / losses on derivative financial instruments (50) (50) Unrealized gains related to debt instruments at fair value through (68) (68) Prudential valuation adjustments (167) (167) Accruals for dividends to shareholders (1,700) (4,200) 2,500 Other 1 (24) 25 Total common equity tier 1 capital 45,281 41,594 3,687 |
Share capital (Narrative) (Deta
Share capital (Narrative) (Detail) SFr / shares in Units, $ in Millions | 12 Months Ended | ||||
Dec. 31, 2021CHF (SFr)SFr / sharesshares | Dec. 31, 2021USD ($)shares | Dec. 31, 2019shares | Dec. 31, 2020shares | Dec. 31, 2018shares | |
Ordinary share capital | |||||
Shares issued | 3,702,422,995 | 3,859,055,395 | 3,859,055,395 | 3,855,634,749 | |
Par value of shares | SFr / shares | SFr 0.10 | ||||
Share capital | SFr | SFr 370,242,299.50 | ||||
Issuance / (canceled) of shares | (156,632,400) | (156,632,400) | 3,420,646 | ||
Cancelation of treasury shares related to the 2018-2021 share repurchase program | $ | $ 0 | ||||
Cancellation of second trading line treasury shares | 156,632,400 | 156,632,400 | |||
Conditional share capital | |||||
Additional shares that could have been issued to fund UBS's employee share option programs | 121,705,830 | ||||
Value of available shares to fund UBS employee share option programs | SFr | SFr 12,170,583 | ||||
Additional conditional capital available for conversion rights and warrants granted in connection with the issuance of bonds or similar financial instruments | 380,000,000 | ||||
Value of additional conditional capital available for conversion rights and warrants granted in connection with the issuance of bonds or similar financial instruments | SFr | SFr 38,000,000 | ||||
Share capital | |||||
Ordinary share capital | |||||
Cancelation of treasury shares related to the 2018-2021 share repurchase program | $ | $ (16) | ||||
UBS AG | |||||
Ordinary share capital | |||||
Shares issued | 3,858,408,466 | 3,858,408,466 | |||
Par value of shares | SFr / shares | SFr 0.10 | ||||
Share capital | SFr | SFr 385,840,846.60 | ||||
Conditional share capital | |||||
Additional conditional capital available for conversion rights and warrants granted in connection with the issuance of bonds or similar financial instruments | 380,000,000 | ||||
Value of additional conditional capital available for conversion rights and warrants granted in connection with the issuance of bonds or similar financial instruments | SFr | SFr 38,000,000 |
Share repurchase program (Narra
Share repurchase program (Narrative) (Detail) shares in Millions, SFr in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021CHF (SFr)shares | Dec. 31, 2021USD ($)shares | Dec. 31, 2020USD ($)shares | |
Share Repurchase Program [Table] | |||
Amount invested to aquire own registered shares as part of the share repurchase program | $ | $ 2,600 | ||
2018-2021 | |||
Share Repurchase Program [Table] | |||
Maximum amount intended for the purchase of own registered shares as part of the share repurchase program | SFr | SFr 2,000 | ||
Shares aquired as part of the share repurchase program | shares | 8 | 8 | 31 |
Amount invested to aquire own registered shares as part of the share repurchase program | $ | $ 112 | $ 364 | |
From 2021 | |||
Share Repurchase Program [Table] | |||
Maximum amount intended for the purchase of own registered shares as part of the share repurchase program | SFr | SFr 4,000 | ||
Shares aquired as part of the share repurchase program | shares | 153 | 153 | |
Amount invested to aquire own registered shares as part of the share repurchase program | SFr 2,294 | $ 2,500 |
Material accounting policies (N
Material accounting policies (Narrative) (Detail) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Date of authorisation for issue of financial statements | Feb. 24, 2022 |
UBS AG [Member] | |
Entity [Table] | |
Date of authorisation for issue of financial statements | Feb. 24, 2022 |
Segment reporting (Detail)
Segment reporting (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Operating Segments [Table] | |||
Net interest income | $ 6,705 | $ 5,862 | $ 4,501 |
Non-interest income | 28,689 | 27,222 | 24,467 |
Income | 35,393 | 33,084 | 28,967 |
Credit loss (expense) / release | 148 | (694) | (78) |
Total operating income | 35,542 | 32,390 | 28,889 |
Total operating expenses | 26,058 | 24,235 | 23,312 |
Operating profit / (loss) before tax | 9,484 | 8,155 | 5,577 |
Tax expense / (benefit) | 1,998 | 1,583 | 1,267 |
Net profit / (loss) | 7,486 | 6,572 | 4,310 |
Additional information | |||
Total assets | 1,117,182 | 1,125,765 | 972,194 |
Additions to non-current assets | 2,091 | 2,847 | 5,297 |
Clearstream Fund Centre AG | |||
Additional information | |||
Gains (losses) on the sale of subsidiaries | 631 | ||
Global Wealth Management | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | 4,244 | 4,027 | 3,947 |
Non-interest income | 15,175 | 13,107 | 12,426 |
Income | 19,419 | 17,134 | 16,373 |
Credit loss (expense) / release | 29 | (88) | (20) |
Total operating income | 19,449 | 17,045 | 16,353 |
Total operating expenses | 14,665 | 13,026 | 12,955 |
Operating profit / (loss) before tax | 4,783 | 4,019 | 3,397 |
Additional information | |||
Total assets | 395,235 | 367,714 | 309,766 |
Additions to non-current assets | 56 | 5 | 68 |
Global Wealth Management | Clearstream Fund Centre AG | |||
Additional information | |||
Gains (losses) on the sale of subsidiaries | 60 | ||
Personal & Corporate Banking | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | 2,120 | 2,049 | 1,992 |
Non-interest income | 2,143 | 1,858 | 1,744 |
Income | 4,263 | 3,908 | 3,736 |
Credit loss (expense) / release | 86 | (257) | (21) |
Total operating income | 4,349 | 3,651 | 3,715 |
Total operating expenses | 2,618 | 2,392 | 2,274 |
Operating profit / (loss) before tax | 1,731 | 1,259 | 1,441 |
Additional information | |||
Total assets | 225,370 | 231,657 | 209,405 |
Additions to non-current assets | 16 | 12 | 10 |
Asset Management | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | (15) | (17) | (25) |
Non-interest income | 2,632 | 2,993 | 1,962 |
Income | 2,617 | 2,975 | 1,938 |
Credit loss (expense) / release | (1) | (2) | 0 |
Total operating income | 2,616 | 2,974 | 1,938 |
Total operating expenses | 1,586 | 1,519 | 1,406 |
Operating profit / (loss) before tax | 1,030 | 1,455 | 532 |
Additional information | |||
Total assets | 25,639 | 28,589 | 34,565 |
Additions to non-current assets | 1 | 385 | 0 |
Asset Management | Clearstream Fund Centre AG | |||
Additional information | |||
Gains (losses) on the sale of subsidiaries | 571 | ||
Investment Bank | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | 481 | 284 | (669) |
Non-interest income | 8,972 | 9,235 | 7,968 |
Income | 9,454 | 9,519 | 7,299 |
Credit loss (expense) / release | 34 | (305) | (30) |
Total operating income | 9,488 | 9,214 | 7,269 |
Total operating expenses | 6,858 | 6,732 | 6,485 |
Operating profit / (loss) before tax | 2,630 | 2,482 | 784 |
Additional information | |||
Total assets | 346,431 | 369,683 | 315,855 |
Additions to non-current assets | 30 | 150 | 1 |
Group Functions | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | (127) | (481) | (744) |
Non-interest income | (233) | 30 | 367 |
Income | (359) | (452) | (378) |
Credit loss (expense) / release | 0 | (42) | (7) |
Total operating income | (360) | (494) | (385) |
Total operating expenses | 330 | 567 | 192 |
Operating profit / (loss) before tax | (689) | (1,060) | (577) |
Additional information | |||
Total assets | 124,507 | 128,122 | 102,603 |
Additions to non-current assets | 1,989 | 2,294 | 5,217 |
UBS AG | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | 6,605 | 5,788 | 4,415 |
Non-interest income | 29,222 | 27,686 | 24,970 |
Income | 35,828 | 33,474 | 29,385 |
Credit loss (expense) / release | 148 | (695) | (78) |
Total operating income | 35,976 | 32,780 | 29,307 |
Total operating expenses | 27,012 | 25,081 | 24,138 |
Operating profit / (loss) before tax | 8,964 | 7,699 | 5,169 |
Tax expense / (benefit) | 1,903 | 1,488 | 1,198 |
Net profit / (loss) | 7,061 | 6,211 | 3,971 |
Additional information | |||
Total assets | 1,116,145 | 1,125,327 | 971,927 |
Additions to non-current assets | 1,791 | 2,524 | 5,014 |
UBS AG | Clearstream Fund Centre AG | |||
Additional information | |||
Gains (losses) on the sale of subsidiaries | 631 | ||
UBS AG | Global Wealth Management | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | 4,244 | 4,027 | 3,947 |
Non-interest income | 15,175 | 13,107 | 12,426 |
Income | 19,419 | 17,134 | 16,373 |
Credit loss (expense) / release | 29 | (88) | (20) |
Total operating income | 19,449 | 17,046 | 16,353 |
Total operating expenses | 14,743 | 13,080 | 13,018 |
Operating profit / (loss) before tax | 4,706 | 3,965 | 3,335 |
Additional information | |||
Total assets | 395,235 | 367,714 | 309,766 |
Additions to non-current assets | 56 | 5 | 68 |
UBS AG | Global Wealth Management | Clearstream Fund Centre AG | |||
Additional information | |||
Gains (losses) on the sale of subsidiaries | 60 | ||
UBS AG | Personal & Corporate Banking | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | 2,120 | 2,049 | 1,993 |
Non-interest income | 2,144 | 1,859 | 1,745 |
Income | 4,264 | 3,908 | 3,737 |
Credit loss (expense) / release | 86 | (257) | (21) |
Total operating income | 4,350 | 3,651 | 3,717 |
Total operating expenses | 2,623 | 2,390 | 2,274 |
Operating profit / (loss) before tax | 1,726 | 1,261 | 1,443 |
Additional information | |||
Total assets | 225,425 | 231,710 | 209,512 |
Additions to non-current assets | 16 | 12 | 10 |
UBS AG | Asset Management | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | (15) | (17) | (25) |
Non-interest income | 2,632 | 2,993 | 1,962 |
Income | 2,617 | 2,975 | 1,938 |
Credit loss (expense) / release | (1) | (2) | 0 |
Total operating income | 2,616 | 2,974 | 1,938 |
Total operating expenses | 1,593 | 1,520 | 1,407 |
Operating profit / (loss) before tax | 1,023 | 1,454 | 531 |
Additional information | |||
Total assets | 25,202 | 28,266 | 34,565 |
Additions to non-current assets | 1 | 385 | 0 |
UBS AG | Asset Management | Clearstream Fund Centre AG | |||
Additional information | |||
Gains (losses) on the sale of subsidiaries | 571 | ||
UBS AG | Investment Bank | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | 481 | 284 | (669) |
Non-interest income | 8,978 | 9,224 | 7,967 |
Income | 9,459 | 9,508 | 7,298 |
Credit loss (expense) / release | 34 | (305) | (30) |
Total operating income | 9,493 | 9,203 | 7,268 |
Total operating expenses | 6,902 | 6,762 | 6,515 |
Operating profit / (loss) before tax | 2,592 | 2,441 | 753 |
Additional information | |||
Total assets | 346,641 | 369,778 | 316,058 |
Additions to non-current assets | 30 | 150 | 1 |
UBS AG | Group Functions | |||
Disclosure Of Operating Segments [Table] | |||
Net interest income | (226) | (555) | (831) |
Non-interest income | 294 | 504 | 869 |
Income | 68 | (52) | 38 |
Credit loss (expense) / release | 0 | (42) | (7) |
Total operating income | 68 | (94) | 31 |
Total operating expenses | 1,151 | 1,329 | 925 |
Operating profit / (loss) before tax | (1,083) | (1,423) | (893) |
Additional information | |||
Total assets | 123,641 | 127,858 | 102,028 |
Additions to non-current assets | $ 1,689 | $ 1,971 | $ 4,935 |
Segment reporting by geograph_2
Segment reporting by geographic location (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 35,542 | $ 32,390 | $ 28,889 |
Total operating income (Share %) | 100.00% | 100.00% | 100.00% |
Total non-current assets | $ 20,500 | $ 21,100 | $ 20,300 |
Total non-current assets (Share %) | 100.00% | 100.00% | 100.00% |
Americas | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 14,500 | $ 13,000 | $ 12,000 |
Total operating income (Share %) | 41.00% | 40.00% | 42.00% |
Total non-current assets | $ 9,000 | $ 9,000 | $ 8,900 |
Total non-current assets (Share %) | 44.00% | 42.00% | 44.00% |
of which: USA | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 13,500 | $ 11,700 | $ 10,900 |
Total operating income (Share %) | 38.00% | 36.00% | 38.00% |
Total non-current assets | $ 8,500 | $ 8,400 | $ 8,500 |
Total non-current assets (Share %) | 41.00% | 40.00% | 42.00% |
Asia Pacific | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 6,500 | $ 6,000 | $ 4,700 |
Total operating income (Share %) | 18.00% | 18.00% | 16.00% |
Total non-current assets | $ 1,500 | $ 1,500 | $ 1,400 |
Total non-current assets (Share %) | 7.00% | 7.00% | 7.00% |
Europe, Middle East and Africa (excluding Switzerland) | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 7,000 | $ 6,500 | $ 5,800 |
Total operating income (Share %) | 20.00% | 20.00% | 20.00% |
Total non-current assets | $ 2,900 | $ 3,000 | $ 3,000 |
Total non-current assets (Share %) | 14.00% | 14.00% | 15.00% |
Switzerland | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 7,900 | $ 6,900 | $ 6,700 |
Total operating income (Share %) | 22.00% | 21.00% | 23.00% |
Total non-current assets | $ 7,100 | $ 7,600 | $ 7,100 |
Total non-current assets (Share %) | 35.00% | 36.00% | 35.00% |
Global | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ (300) | $ 100 | $ (300) |
Total operating income (Share %) | (1.00%) | 0.00% | (1.00%) |
Total non-current assets | $ 0 | $ 0 | $ 0 |
Total non-current assets (Share %) | 0.00% | 0.00% | 0.00% |
UBS AG | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 35,976 | $ 32,780 | $ 29,307 |
Total operating income (Share %) | 100.00% | 100.00% | 100.00% |
Total non-current assets | $ 19,300 | $ 20,000 | $ 19,300 |
Total non-current assets (Share %) | 100.00% | 100.00% | 100.00% |
UBS AG | Americas | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 14,500 | $ 13,000 | $ 12,000 |
Total operating income (Share %) | 40.00% | 40.00% | 41.00% |
Total non-current assets | $ 9,000 | $ 9,000 | $ 8,900 |
Total non-current assets (Share %) | 47.00% | 45.00% | 46.00% |
UBS AG | of which: USA | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 13,500 | $ 11,700 | $ 10,900 |
Total operating income (Share %) | 38.00% | 36.00% | 37.00% |
Total non-current assets | $ 8,500 | $ 8,400 | $ 8,500 |
Total non-current assets (Share %) | 44.00% | 42.00% | 44.00% |
UBS AG | Asia Pacific | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 6,500 | $ 6,000 | $ 4,700 |
Total operating income (Share %) | 18.00% | 18.00% | 16.00% |
Total non-current assets | $ 1,400 | $ 1,400 | $ 1,300 |
Total non-current assets (Share %) | 7.00% | 7.00% | 7.00% |
UBS AG | Europe, Middle East and Africa (excluding Switzerland) | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 7,000 | $ 6,500 | $ 5,800 |
Total operating income (Share %) | 19.00% | 20.00% | 20.00% |
Total non-current assets | $ 2,600 | $ 2,700 | $ 2,600 |
Total non-current assets (Share %) | 13.00% | 14.00% | 13.00% |
UBS AG | Switzerland | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 7,900 | $ 6,900 | $ 6,700 |
Total operating income (Share %) | 22.00% | 21.00% | 23.00% |
Total non-current assets | $ 6,300 | $ 6,900 | $ 6,500 |
Total non-current assets (Share %) | 33.00% | 34.00% | 34.00% |
UBS AG | Global | |||
Disclosure Of Geographical Areas [Table] | |||
Total operating income | $ 100 | $ 500 | $ 100 |
Total operating income (Share %) | 0.00% | 2.00% | 0.00% |
Total non-current assets | $ 0 | $ 0 | $ 0 |
Total non-current assets (Share %) | 0.00% | 0.00% | 0.00% |
Net interest income and other_2
Net interest income and other net income from fair value changes on financial instruments (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Net Interest And Other Income From Fair Value Changes By Segments [Table] | |||
Other net income from financial instruments measured at fair value through profit or loss | $ 5,850 | $ 6,960 | $ 6,842 |
of which: net gains / (losses) from financial liabilities designated at fair value | (6,582) | 1,509 | (8,748) |
Net income from financial instruments measured at fair value through profit or loss | 7,281 | 8,259 | 7,853 |
Net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | |||
Interest income from loans and deposits | 6,488 | 6,690 | 8,008 |
Interest income from securities financing transactions | 513 | 862 | 2,005 |
Interest income from other financial instruments measured at amortized cost | 284 | 335 | 364 |
Interest income from debt instruments measured at fair value through other comprehensive income | 115 | 101 | 120 |
Interest income from derivative instruments designated as cash flow hedges | 1,133 | 822 | 188 |
Total interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 8,533 | 8,810 | 10,684 |
Interest expense on loans and deposits | 523 | 1,031 | 2,634 |
Interest expense on securities financing transactions | 1,102 | 870 | 1,152 |
Interest expense on debt issued | 1,533 | 2,237 | 3,285 |
Interest expense on lease liabilities | 102 | 110 | 122 |
Total interest expense from financial instruments measured at amortized cost | 3,259 | 4,247 | 7,194 |
Total net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 5,274 | 4,563 | 3,490 |
Net Interest Income From Financial Instruments Measured At Fair Value Through Profit Or Loss [Abstract] | |||
Net interest income from financial instruments measured at fair value through profit or loss | 1,431 | 1,299 | 1,011 |
Net interest income | 6,705 | 5,862 | 4,501 |
Net gains / (losses) on financial liabilities related to unit-linked investment contracts, which are designated at fair value through profit of loss | (2,068) | (72) | (1,830) |
Net gains / (losses) on financial assets for unit-linked investment contracts that are mandatorily measured at fair value through profit or loss not held for trading | 2,068 | 72 | 1,830 |
UBS AG [Member] | |||
Net Interest And Other Income From Fair Value Changes By Segments [Table] | |||
Other net income from financial instruments measured at fair value through profit or loss | 5,844 | 6,930 | 6,833 |
of which: net gains / (losses) from financial liabilities designated at fair value | (6,457) | 1,625 | (8,748) |
Net income from financial instruments measured at fair value through profit or loss | 7,281 | 8,235 | 7,848 |
Net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | |||
Interest income from loans and deposits | 6,489 | 6,696 | 8,026 |
Interest income from securities financing transactions | 513 | 862 | 2,005 |
Interest income from other financial instruments measured at amortized cost | 284 | 335 | 364 |
Interest income from debt instruments measured at fair value through other comprehensive income | 115 | 101 | 120 |
Interest income from derivative instruments designated as cash flow hedges | 1,133 | 822 | 188 |
Total interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 8,534 | 8,816 | 10,703 |
Interest expense on loans and deposits | 1,655 | 2,440 | 4,541 |
Interest expense on securities financing transactions | 1,102 | 870 | 1,152 |
Interest expense on debt issued | 512 | 918 | 1,491 |
Interest expense on lease liabilities | 98 | 105 | 118 |
Total interest expense from financial instruments measured at amortized cost | 3,366 | 4,333 | 7,303 |
Total net interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 5,168 | 4,483 | 3,400 |
Net Interest Income From Financial Instruments Measured At Fair Value Through Profit Or Loss [Abstract] | |||
Net interest income from financial instruments measured at fair value through profit or loss | 1,437 | 1,305 | 1,015 |
Net interest income | 6,605 | 5,788 | 4,415 |
Net gains / (losses) on financial liabilities related to unit-linked investment contracts, which are designated at fair value through profit of loss | (2,068) | (72) | (1,830) |
Net gains / (losses) on financial assets for unit-linked investment contracts that are mandatorily measured at fair value through profit or loss not held for trading | $ 2,068 | $ 72 | $ 1,830 |
Net fee and commission income_2
Net fee and commission income (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Underwriting fees | $ 1,463 | $ 1,085 | $ 741 |
M&A and corporate finance fees | 1,102 | 736 | 774 |
Brokerage fees | 4,382 | 4,132 | 3,248 |
Investment fund fees | 5,790 | 5,289 | 4,858 |
Portfolio management and related services | 9,762 | 8,009 | 7,656 |
Other | 1,874 | 1,710 | 1,832 |
Total fee and commission income | 24,372 | 20,961 | 19,110 |
Brokerage fees paid | 259 | 274 | 310 |
Distribution fees paid | 611 | 589 | 590 |
Other | 1,115 | 912 | 797 |
Total fee and commission expense | 1,985 | 1,775 | 1,696 |
Net fee and commission income | 22,387 | 19,186 | 17,413 |
of which: net brokerage fees | 4,123 | 3,858 | 2,938 |
Global Wealth Management | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 14,545 | 12,475 | 11,694 |
Personal & Corporate Banking | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 1,644 | 1,426 | 1,307 |
Asset Management | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 3,337 | 3,129 | 2,659 |
Investment Bank | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 4,814 | 3,882 | 3,355 |
Group Functions | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 33 | 49 | 94 |
of which: recurring | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 15,410 | 13,009 | 12,544 |
of which: transaction-based | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 8,692 | 7,491 | 6,402 |
of which: performance-based | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 269 | 461 | 163 |
UBS AG | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Underwriting fees | 1,512 | 1,104 | 784 |
M&A and corporate finance fees | 1,102 | 736 | 774 |
Brokerage fees | 4,383 | 4,132 | 3,248 |
Investment fund fees | 5,790 | 5,289 | 4,859 |
Portfolio management and related services | 9,762 | 8,009 | 7,656 |
Other | 1,874 | 1,712 | 1,836 |
Total fee and commission income | 24,422 | 20,982 | 19,156 |
Brokerage fees paid | 259 | 274 | 310 |
Distribution fees paid | 611 | 589 | 590 |
Other | 1,115 | 911 | 796 |
Total fee and commission expense | 1,985 | 1,775 | 1,696 |
Net fee and commission income | 22,438 | 19,207 | 17,460 |
of which: net brokerage fees | 4,124 | 3,858 | 2,938 |
UBS AG | Global Wealth Management | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 14,545 | 12,475 | 11,694 |
UBS AG | Personal & Corporate Banking | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 1,645 | 1,427 | 1,307 |
UBS AG | Asset Management | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 3,337 | 3,129 | 2,659 |
UBS AG | Investment Bank | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 4,863 | 3,901 | 3,397 |
UBS AG | Group Functions | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 33 | 50 | 98 |
UBS AG | of which: recurring | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 15,410 | 13,010 | 12,545 |
UBS AG | of which: transaction-based | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | 8,743 | 7,512 | 6,449 |
UBS AG | of which: performance-based | |||
Disclosure Of Disaggregation Of Revenue From Contracts With Customers [Table] | |||
Total fee and commission income | $ 269 | $ 461 | $ 163 |
Other income (Detail)
Other income (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Associates, joint ventures and subsidiaries | |||
Net gains / (losses) from acquisitions and disposals of subsidiaries | $ (11) | $ 635 | $ (36) |
Net gains / (losses) from disposals of investments in associates | 41 | 0 | 4 |
Share of net profits of associates and joint ventures | 105 | 84 | 46 |
Impairments related to associates | 0 | 0 | 1 |
Total | 135 | 719 | 13 |
Net gains / (losses) from disposals of financial assets measured at fair value through other comprehensive income | 9 | 40 | 31 |
Income from properties | 23 | 26 | 27 |
Net gains / (losses) from properties held for sale | 100 | 76 | (19) |
Other | 185 | 216 | 160 |
Total other income | 452 | 1,076 | 212 |
Net gains / (losses) arising from sale-and-leaseback transactions | 140 | ||
Gains / (losses) on the sales of intellectual property rights | 215 | ||
Clearstream Fund Centre AG | |||
Associates, joint ventures and subsidiaries | |||
Net gains / (losses) from disposals of investments in associates | 37 | ||
Gains (losses) on the sale of subsidiaries | 631 | ||
Wealth management business in Austria | |||
Associates, joint ventures and subsidiaries | |||
Other | 100 | ||
UBS AG | |||
Associates, joint ventures and subsidiaries | |||
Net gains / (losses) from acquisitions and disposals of subsidiaries | (11) | 635 | (36) |
Net gains / (losses) from disposals of investments in associates | 41 | 0 | 4 |
Share of net profits of associates and joint ventures | 105 | 84 | 46 |
Impairments related to associates | 0 | 0 | 1 |
Total | 134 | 719 | 13 |
Net gains / (losses) from disposals of financial assets measured at fair value through other comprehensive income | 9 | 40 | 31 |
Income from properties | 22 | 25 | 27 |
Net gains / (losses) from properties held for sale | 100 | 76 | (19) |
Income from shared services provided to UBS Group AG or its subsidiaries | 451 | 422 | 464 |
Other | 224 | 267 | 161 |
Total other income | 941 | 1,549 | $ 677 |
Net gains / (losses) arising from sale-and-leaseback transactions | 140 | ||
Gains / (losses) on the sales of intellectual property rights | 215 | ||
UBS AG | Clearstream Fund Centre AG | |||
Associates, joint ventures and subsidiaries | |||
Net gains / (losses) from disposals of investments in associates | 37 | ||
Gains (losses) on the sale of subsidiaries | $ 631 | ||
UBS AG | Wealth management business in Austria | |||
Associates, joint ventures and subsidiaries | |||
Other | $ 100 |
Personnel expenses (Detail)
Personnel expenses (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Salaries | $ 7,339 | $ 7,023 | $ 6,518 |
Variable compensation - performance awards | 3,190 | 3,209 | 2,755 |
Variable compensation - other | 229 | 220 | 246 |
Financial advisor compensation | 4,860 | 4,091 | 4,043 |
Contractors | 381 | 375 | 381 |
Social security | 978 | 899 | 799 |
Post-employment benefit plans | 833 | 845 | 787 |
of which: defined benefit plans | 470 | 502 | 461 |
of which: defined contribution plans | 363 | 343 | 326 |
Other personnel expenses | 576 | 561 | 555 |
Total personnel expenses | 18,387 | 17,224 | 16,084 |
Curtailments | 80 | ||
Increase (decrease) due to modification of deferred compensation awards | |||
Entity [Table] | |||
Variable compensation - performance awards | 240 | ||
Social security | 20 | ||
Other personnel expenses | 20 | ||
Total personnel expenses | 280 | ||
UBS AG | |||
Entity [Table] | |||
Salaries | 5,723 | 5,535 | 5,183 |
Variable compensation - performance awards | 2,916 | 2,953 | 2,545 |
Variable compensation - other | 196 | 201 | 225 |
Financial advisor compensation | 4,860 | 4,091 | 4,043 |
Contractors | 142 | 138 | 147 |
Social security | 762 | 704 | 627 |
Post-employment benefit plans | 582 | 597 | 569 |
of which: defined benefit plans | 280 | 306 | |
of which: defined contribution plans | 303 | 291 | 278 |
Other personnel expenses | 479 | 466 | 461 |
Total personnel expenses | 15,661 | 14,686 | $ 13,801 |
Curtailments | $ 49 | ||
UBS AG | Increase (decrease) due to modification of deferred compensation awards | |||
Entity [Table] | |||
Variable compensation - performance awards | 240 | ||
Social security | 20 | ||
Other personnel expenses | 10 | ||
Total personnel expenses | $ 270 |
General and administrative ex_3
General and administrative expenses (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Outsourcing costs | $ 893 | $ 951 | $ 1,072 |
IT expenses | 1,055 | 949 | 860 |
Consulting, legal and audit fees | 540 | 646 | 850 |
Real estate and logistics costs | 634 | 671 | 662 |
Market data services | 417 | 413 | 414 |
Marketing and communication | 242 | 217 | 270 |
Travel and entertainment | 72 | 84 | 298 |
Litigation, regulatory and similar matters | 911 | 197 | 165 |
Other | 788 | 757 | 696 |
of which: UK and German bank levies | 58 | 55 | 41 |
Total general and administrative expenses | 5,553 | 4,885 | 5,288 |
UK bank levy net expenses | 22 | 38 | 30 |
UK bank levy credit from prior years | 16 | 27 | 31 |
Recoveries from third parties | 1 | 3 | 11 |
UBS AG | |||
Entity [Table] | |||
Outsourcing costs | 426 | 466 | 551 |
IT expenses | 490 | 449 | 448 |
Consulting, legal and audit fees | 465 | 566 | 753 |
Real estate and logistics costs | 530 | 563 | 559 |
Market data services | 367 | 361 | 364 |
Marketing and communication | 171 | 162 | 191 |
Travel and entertainment | 66 | 77 | 272 |
Litigation, regulatory and similar matters | 910 | 197 | 165 |
Other | 6,051 | 5,646 | 5,283 |
of which: shared service costs charged by UBS Group AG or its subsidiaries | 5,321 | 4,939 | 4,621 |
of which: UK and German bank levies | 58 | 55 | 41 |
Total general and administrative expenses | 9,476 | 8,486 | 8,586 |
UK bank levy net expenses | 22 | 38 | 30 |
UK bank levy credit from prior years | 16 | 27 | 31 |
Recoveries from third parties | $ 1 | $ 3 | $ 11 |
Income taxes (Narrative) (Detai
Income taxes (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Net tax expense | $ 1,998 | $ 1,583 | $ 1,267 |
Effective tax rate | 21.10% | ||
Current tax expense / (benefit) | $ 1,600 | ||
Deferred tax assets | 8,876 | 9,212 | |
Net tax expense / (benefit) recognized in other comprehensive income | (479) | 237 | |
Deferred tax expense income in respect of movements in the expected value of future tax deductions for deferred compensation awards | 77 | (138) | |
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 34,690 | 35,127 | |
UK | |||
Entity [Table] | |||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,909 | 13,848 | |
United States | |||
Entity [Table] | |||
Deferred tax assets | 8,521 | 8,780 | |
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,870 | 16,256 | |
Other locations | |||
Entity [Table] | |||
Deferred tax assets | 355 | 431 | |
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 4,911 | 5,023 | |
Swiss | |||
Entity [Table] | |||
Net tax expense | 714 | 598 | 630 |
Current tax expense / (benefit) | 680 | 482 | 365 |
Deferred tax expense / (benefit) | 34 | 116 | 265 |
Non-Swiss | |||
Entity [Table] | |||
Net tax expense | 1,284 | 985 | 637 |
Current tax expense / (benefit) | 884 | 749 | 426 |
Deferred tax expense / (benefit) | 400 | 236 | 211 |
Deferred tax expense / (benefit) resulting from the remeasurement of DTAs | (334) | ||
Deferred tax expense / (benefit) resulting from the net upward remeasurement of DTAs for certain entities | (152) | ||
Deferred tax expense / (benefit) resulting from the contribution of certain real estate assets from UBS AG to UBS Americas Inc. | (113) | ||
Amortisation of deferred tax assets | 734 | ||
Deferred tax expense income in respect of movements in the expected value of future tax deductions for deferred compensation awards | 69 | ||
UBS AG | |||
Entity [Table] | |||
Net tax expense | $ 1,903 | 1,488 | 1,198 |
Effective tax rate | 21.20% | ||
Deferred tax assets | $ 8,839 | 9,174 | |
Net tax expense / (benefit) recognized in other comprehensive income | (455) | 258 | |
Deferred tax expense income in respect of movements in the expected value of future tax deductions for deferred compensation awards | 77 | (138) | |
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 34,690 | 35,127 | |
UBS AG | UK | |||
Entity [Table] | |||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,909 | 13,848 | |
UBS AG | United States | |||
Entity [Table] | |||
Deferred tax assets | 8,521 | 8,780 | |
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,870 | 16,256 | |
UBS AG | Other locations | |||
Entity [Table] | |||
Deferred tax assets | 318 | 394 | |
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 4,911 | 5,023 | |
UBS AG | Swiss | |||
Entity [Table] | |||
Net tax expense | 640 | 524 | 582 |
Current tax expense / (benefit) | 614 | 417 | 336 |
Deferred tax expense / (benefit) | 26 | 107 | 246 |
UBS AG | Non-Swiss | |||
Entity [Table] | |||
Net tax expense | 1,263 | 963 | 616 |
Current tax expense / (benefit) | 857 | 715 | 402 |
Deferred tax expense / (benefit) | 406 | $ 248 | $ 214 |
Deferred tax expense / (benefit) resulting from the remeasurement of DTAs | (334) | ||
Deferred tax expense / (benefit) resulting from the net upward remeasurement of DTAs for certain entities | (152) | ||
Deferred tax expense / (benefit) resulting from the contribution of certain real estate assets from UBS AG to UBS Americas Inc. | (113) | ||
Amortisation of deferred tax assets | 740 | ||
Deferred tax expense income in respect of movements in the expected value of future tax deductions for deferred compensation awards | $ 69 |
Income taxes (Detail 1)
Income taxes (Detail 1) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Major Components Of Tax Expense Income [Table] | |||
Current tax expense / (benefit) | $ 1,600 | ||
Income tax expense / (benefit) | 1,998 | $ 1,583 | $ 1,267 |
Swiss | |||
Major Components Of Tax Expense Income [Table] | |||
Current tax expense / (benefit) | 680 | 482 | 365 |
Deferred tax expense / (benefit) | 34 | 116 | 265 |
Income tax expense / (benefit) | 714 | 598 | 630 |
Non-Swiss | |||
Major Components Of Tax Expense Income [Table] | |||
Current tax expense / (benefit) | 884 | 749 | 426 |
Deferred tax expense / (benefit) | 400 | 236 | 211 |
Income tax expense / (benefit) | 1,284 | 985 | 637 |
UBS AG | |||
Major Components Of Tax Expense Income [Table] | |||
Income tax expense / (benefit) | 1,903 | 1,488 | 1,198 |
UBS AG | Swiss | |||
Major Components Of Tax Expense Income [Table] | |||
Current tax expense / (benefit) | 614 | 417 | 336 |
Deferred tax expense / (benefit) | 26 | 107 | 246 |
Income tax expense / (benefit) | 640 | 524 | 582 |
UBS AG | Non-Swiss | |||
Major Components Of Tax Expense Income [Table] | |||
Current tax expense / (benefit) | 857 | 715 | 402 |
Deferred tax expense / (benefit) | 406 | 248 | 214 |
Income tax expense / (benefit) | $ 1,263 | $ 963 | $ 616 |
Income taxes (Detail 2)
Income taxes (Detail 2) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Major Components Of Tax Expense Income [Table] | |||
Operating profit / (loss) before tax | $ 9,484 | $ 8,155 | $ 5,577 |
Income taxes at Swiss tax rate of 19.5% for 2020, 20.5% for 2019 and 21% for 2018 | 1,755 | 1,590 | 1,143 |
Increase / (decrease) resulting from: | |||
Non-Swiss tax rates differing from Swiss tax rate | 234 | 110 | 82 |
Tax effects of losses not recognized | 124 | 144 | 131 |
Previously unrecognized tax losses now utilized | (179) | (212) | (265) |
Non-taxable and lower taxed income | (278) | (394) | (351) |
Non-deductible expenses and additional taxable income | 510 | 385 | 732 |
Adjustments related to prior years - current tax | (40) | (67) | (5) |
Adjustments related to prior years - deferred tax | (10) | 12 | (6) |
Change in deferred tax recognition | (342) | (381) | (294) |
Adjustments to deferred tax balances arising from changes in tax rates | (5) | 234 | (9) |
Other items | 231 | 161 | 107 |
Income tax expense / (benefit) | $ 1,998 | $ 1,583 | $ 1,267 |
Applicable tax rate | 18.50% | 19.50% | 20.50% |
Swiss | |||
Major Components Of Tax Expense Income [Table] | |||
Operating profit / (loss) before tax | $ 3,334 | $ 3,403 | $ 2,571 |
Increase / (decrease) resulting from: | |||
Income tax expense / (benefit) | 714 | 598 | 630 |
Non-Swiss | |||
Major Components Of Tax Expense Income [Table] | |||
Operating profit / (loss) before tax | 6,150 | 4,752 | 3,006 |
Increase / (decrease) resulting from: | |||
Income tax expense / (benefit) | 1,284 | 985 | 637 |
UBS AG | |||
Major Components Of Tax Expense Income [Table] | |||
Operating profit / (loss) before tax | 8,964 | 7,699 | 5,169 |
Income taxes at Swiss tax rate of 19.5% for 2020, 20.5% for 2019 and 21% for 2018 | 1,658 | 1,501 | 1,060 |
Increase / (decrease) resulting from: | |||
Non-Swiss tax rates differing from Swiss tax rate | 217 | 96 | 72 |
Tax effects of losses not recognized | 124 | 144 | 131 |
Previously unrecognized tax losses now utilized | (179) | (212) | (265) |
Non-taxable and lower taxed income | (252) | (381) | (305) |
Non-deductible expenses and additional taxable income | 487 | 373 | 713 |
Adjustments related to prior years - current tax | (38) | (66) | 1 |
Adjustments related to prior years - deferred tax | (3) | 18 | (6) |
Change in deferred tax recognition | (341) | (383) | (293) |
Adjustments to deferred tax balances arising from changes in tax rates | (1) | 235 | (9) |
Other items | 230 | 163 | 99 |
Income tax expense / (benefit) | $ 1,903 | $ 1,488 | $ 1,198 |
Applicable tax rate | 18.50% | 19.50% | 20.50% |
UBS AG | Swiss | |||
Major Components Of Tax Expense Income [Table] | |||
Operating profit / (loss) before tax | $ 2,983 | $ 3,042 | $ 2,297 |
Increase / (decrease) resulting from: | |||
Income tax expense / (benefit) | 640 | 524 | 582 |
UBS AG | Non-Swiss | |||
Major Components Of Tax Expense Income [Table] | |||
Operating profit / (loss) before tax | 5,981 | 4,657 | 2,872 |
Increase / (decrease) resulting from: | |||
Income tax expense / (benefit) | $ 1,263 | $ 963 | $ 616 |
Income taxes - DTA (Detail 3.1)
Income taxes - DTA (Detail 3.1) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | $ 18,769 | $ 18,492 |
Valuation allowance | (9,893) | (9,280) |
Recognized | 8,876 | 9,212 |
US | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Recognized | 8,521 | 8,780 |
Other locations | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Recognized | 355 | 431 |
Tax loss carry-forwards | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 13,636 | 14,108 |
Valuation allowance | (9,193) | (8,715) |
Recognized | 4,443 | 5,393 |
Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 5,133 | 4,384 |
Valuation allowance | (700) | (565) |
Recognized | 4,433 | 3,819 |
of which: related to real estate costs capitalized for US tax purposes | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 2,272 | 2,268 |
Valuation allowance | 0 | 0 |
Recognized | 2,272 | 2,268 |
of which: related to compensation and benefits | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 1,222 | 1,128 |
Valuation allowance | (209) | (173) |
Recognized | 1,013 | 955 |
of which: other | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 1,639 | 989 |
Valuation allowance | (491) | (392) |
Recognized | 1,148 | 564 |
UBS AG | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 18,728 | 18,450 |
Valuation allowance | (9,889) | (9,276) |
Recognized | 8,839 | 9,174 |
UBS AG | US | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Recognized | 8,521 | 8,780 |
UBS AG | Other locations | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Recognized | 318 | 394 |
UBS AG | Tax loss carry-forwards | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 13,636 | 14,108 |
Valuation allowance | (9,193) | (8,715) |
Recognized | 4,443 | 5,393 |
UBS AG | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 5,092 | 4,343 |
Valuation allowance | (696) | (561) |
Recognized | 4,396 | 3,782 |
UBS AG | of which: related to real estate costs capitalized for US tax purposes | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 2,272 | 2,268 |
Valuation allowance | 0 | 0 |
Recognized | 2,272 | 2,268 |
UBS AG | of which: related to compensation and benefits | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 1,200 | 1,112 |
Valuation allowance | (209) | (173) |
Recognized | 991 | 939 |
UBS AG | of which: other | Temporary differences | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Gross | 1,620 | 963 |
Valuation allowance | (487) | (388) |
Recognized | $ 1,133 | $ 574 |
Income taxes - DTL (Detail 3.2)
Income taxes - DTL (Detail 3.2) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Cash flow hedges | $ 118 | $ 425 |
Other | 183 | 139 |
Total deferred tax liabilities | 300 | 564 |
UBS AG | ||
Disclosure Of Temporary Difference Unused Tax Losses And Unused Tax Credits [Table] | ||
Cash flow hedges | 118 | 425 |
Other | 179 | 133 |
Total deferred tax liabilities | $ 297 | $ 558 |
Income taxes (Detail 4)
Income taxes (Detail 4) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | $ 34,690 | $ 35,127 |
United States | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,870 | 16,256 |
UK | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,909 | 13,848 |
Other locations | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 4,911 | 5,023 |
Within 1 year | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 141 | 146 |
From 2 to 5 years | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 1,026 | 638 |
From 6 to 10 years | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 13,283 | 13,257 |
From 11 to 20 years | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 2,093 | 3,858 |
No expiry | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 18,147 | 17,227 |
UBS AG | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 34,690 | 35,127 |
UBS AG | United States | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,870 | 16,256 |
UBS AG | UK | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 14,909 | 13,848 |
UBS AG | Other locations | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 4,911 | 5,023 |
UBS AG | Within 1 year | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 141 | 146 |
UBS AG | From 2 to 5 years | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 1,026 | 638 |
UBS AG | From 6 to 10 years | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 13,283 | 13,257 |
UBS AG | From 11 to 20 years | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | 2,093 | 3,858 |
UBS AG | No expiry | ||
Unrecognized Tax Loss Carry Forwards [Table] | ||
Unrecognized tax losses carried forward for which no deferred tax asset recognised | $ 18,147 | $ 17,227 |
Expected credit loss measurem_3
Expected credit loss measurement - On-balance sheet financial assets subject to ECL (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | $ (1,165) | $ (1,468) | $ (1,029) |
Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 746,638 | 695,603 | |
Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 737,794 | 687,345 | |
Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 192,817 | 158,231 | |
Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,480 | 15,444 | |
Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 75,012 | 74,210 | |
Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 30,514 | 32,737 | |
Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 397,761 | 379,528 | |
Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 152,479 | 148,175 | |
Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 43,945 | 43,429 | |
Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 13,990 | 15,161 | |
Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 14,004 | 14,872 | |
Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 149,283 | 133,850 | |
Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,716 | 1,558 | |
Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,813 | 3,269 | |
Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 26,209 | 27,194 | |
Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,453 | 2,569 | |
Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 8,844 | 8,258 | |
Twelve-month expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (282) | (306) | (181) |
Twelve-month expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 728,923 | 672,021 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 720,079 | 663,763 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 192,817 | 158,231 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,453 | 15,260 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 75,012 | 74,210 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 30,514 | 32,737 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 380,564 | 356,948 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 143,505 | 138,769 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 40,463 | 37,568 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 12,643 | 12,658 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 12,076 | 11,990 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 149,255 | 133,795 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,345 | 1,198 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,799 | 3,214 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 25,718 | 26,377 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,184 | 1,982 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 8,844 | 8,258 | |
Lifetime expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (220) | (333) | (160) |
Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (71) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (43) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (55) | ||
Lifetime expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (30) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (11) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,948 | 20,873 | |
Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,948 | 20,873 | |
Lifetime expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 26 | 184 | |
Lifetime expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,620 | 20,341 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 8,262 | 8,448 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,472 | 5,838 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,037 | 2,029 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,492 | 2,254 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 342 | 330 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 7 | 43 | |
Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 302 | 348 | |
Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 106 | 137 | |
Lifetime expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (662) | (829) | (688) |
Lifetime expected credit losses | Credit-impaired positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,767 | 2,709 | |
Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,767 | 2,709 | |
Lifetime expected credit losses | Credit-impaired positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,577 | 2,240 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 711 | 959 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 9 | 23 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 310 | 474 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 436 | 628 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 27 | 55 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 29 | 30 | |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 7 | 12 | |
Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 189 | 469 | |
Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 163 | 450 | |
Lifetime expected credit losses | Credit-impaired positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Gross carrying amount | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 747,606 | 696,815 | |
Gross carrying amount | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 738,762 | 688,556 | |
Gross carrying amount | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 192,817 | 158,231 | |
Gross carrying amount | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,488 | 15,460 | |
Gross carrying amount | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 75,014 | 74,212 | |
Gross carrying amount | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 30,514 | 32,737 | |
Gross carrying amount | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 398,611 | 380,589 | |
Gross carrying amount | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 152,610 | 148,341 | |
Gross carrying amount | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 44,004 | 43,492 | |
Gross carrying amount | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 14,161 | 15,440 | |
Gross carrying amount | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 14,263 | 15,183 | |
Gross carrying amount | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 149,316 | 133,886 | |
Gross carrying amount | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,752 | 1,596 | |
Gross carrying amount | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,927 | 3,375 | |
Gross carrying amount | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 26,318 | 27,327 | |
Gross carrying amount | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,539 | 2,677 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 192,817 | 158,231 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,460 | 15,269 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 75,014 | 74,212 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 30,514 | 32,737 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 380,690 | 357,090 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 143,533 | 138,803 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 40,483 | 37,583 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 12,665 | 12,684 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 12,095 | 12,010 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 149,261 | 133,800 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,355 | 1,209 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,805 | 3,219 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 25,745 | 26,410 | |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,203 | 2,009 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 27 | 189 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,773 | 20,556 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 8,333 | 8,540 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,512 | 5,883 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,053 | 2,069 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,507 | 2,277 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 351 | 342 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 7 | 43 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 309 | 357 | |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 109 | 142 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1 | 1 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,148 | 2,943 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 744 | 998 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 10 | 27 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 443 | 686 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 661 | 896 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 55 | 86 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 46 | 46 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 115 | 113 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 264 | 560 | |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 226 | 526 | |
Allowance for expected credit loss | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (969) | (1,211) | |
Allowance for expected credit loss | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (969) | (1,211) | |
Allowance for expected credit loss | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (8) | (16) | |
Allowance for expected credit loss | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (2) | (2) | |
Allowance for expected credit loss | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (850) | (1,060) | |
Allowance for expected credit loss | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (132) | (166) | |
Allowance for expected credit loss | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (60) | (63) | |
Allowance for expected credit loss | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (170) | (279) | |
Allowance for expected credit loss | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (259) | (310) | |
Allowance for expected credit loss | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (33) | (36) | |
Allowance for expected credit loss | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (36) | (38) | |
Allowance for expected credit loss | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (114) | (106) | |
Allowance for expected credit loss | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (109) | (133) | |
Allowance for expected credit loss | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (86) | (108) | |
Allowance for expected credit loss | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (161) | (187) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (161) | (187) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (7) | (9) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (2) | (2) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (126) | (142) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (28) | (35) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (19) | (15) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (22) | (27) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (19) | (19) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (6) | (5) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (10) | (11) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (6) | (5) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (27) | (34) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (19) | (27) | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (160) | (229) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (160) | (229) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (1) | (5) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (152) | (215) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (71) | (93) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (40) | (44) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (16) | (40) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (15) | (23) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (9) | (11) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (7) | (9) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (3) | (5) | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (647) | (795) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (647) | (795) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | (1) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (572) | (703) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (33) | (39) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | (4) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (133) | (212) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (225) | (268) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (28) | (31) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (17) | (16) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (108) | (101) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (76) | (90) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (63) | (76) | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (1,165) | (1,468) | (1,029) |
UBS AG | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 747,477 | 696,976 | |
UBS AG | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 738,632 | 688,717 | |
UBS AG | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 192,817 | 158,231 | |
UBS AG | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,360 | 15,344 | |
UBS AG | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 75,012 | 74,210 | |
UBS AG | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 30,514 | 32,737 | |
UBS AG | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 398,693 | 380,977 | |
UBS AG | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 152,479 | 148,175 | |
UBS AG | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 43,945 | 43,429 | |
UBS AG | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 13,990 | 15,161 | |
UBS AG | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 14,004 | 14,872 | |
UBS AG | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 149,283 | 133,850 | |
UBS AG | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,716 | 1,558 | |
UBS AG | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,813 | 3,269 | |
UBS AG | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 26,236 | 27,219 | |
UBS AG | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,453 | 2,569 | |
UBS AG | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 8,844 | 8,258 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (282) | (306) | (181) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 729,762 | 673,394 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 720,917 | 665,135 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 192,817 | 158,231 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,333 | 15,160 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 75,012 | 74,210 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 30,514 | 32,737 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 381,496 | 358,396 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 143,505 | 138,769 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 40,463 | 37,568 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 12,643 | 12,658 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 12,076 | 11,990 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 149,255 | 133,795 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,345 | 1,198 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,799 | 3,214 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 25,746 | 26,401 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,184 | 1,982 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 8,844 | 8,258 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (220) | (333) | (160) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (71) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (43) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (55) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (30) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (11) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,948 | 20,873 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,948 | 20,873 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 26 | 184 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,620 | 20,341 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 8,262 | 8,448 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,472 | 5,838 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,037 | 2,029 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,492 | 2,254 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 342 | 330 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 7 | 43 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 302 | 348 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 106 | 137 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (662) | (829) | $ (688) |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,767 | 2,709 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,767 | 2,709 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,577 | 2,240 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 711 | 959 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 9 | 23 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 310 | 474 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 436 | 628 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 27 | 55 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 29 | 30 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 7 | 12 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 189 | 469 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 163 | 450 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Gross carrying amount | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 748,445 | 698,187 | |
UBS AG | Gross carrying amount | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 739,601 | 689,929 | |
UBS AG | Gross carrying amount | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 192,817 | 158,231 | |
UBS AG | Gross carrying amount | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,368 | 15,360 | |
UBS AG | Gross carrying amount | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 75,014 | 74,212 | |
UBS AG | Gross carrying amount | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 30,514 | 32,737 | |
UBS AG | Gross carrying amount | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 399,543 | 382,036 | |
UBS AG | Gross carrying amount | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 152,610 | 148,341 | |
UBS AG | Gross carrying amount | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 44,004 | 43,492 | |
UBS AG | Gross carrying amount | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 14,161 | 15,440 | |
UBS AG | Gross carrying amount | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 14,263 | 15,183 | |
UBS AG | Gross carrying amount | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 149,316 | 133,886 | |
UBS AG | Gross carrying amount | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,752 | 1,596 | |
UBS AG | Gross carrying amount | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,927 | 3,375 | |
UBS AG | Gross carrying amount | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 26,346 | 27,352 | |
UBS AG | Gross carrying amount | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,539 | 2,677 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 192,817 | 158,231 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,340 | 15,170 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 75,014 | 74,212 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 30,514 | 32,737 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 381,622 | 358,538 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 143,533 | 138,803 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 40,483 | 37,583 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 12,665 | 12,684 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 12,095 | 12,010 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 149,261 | 133,800 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,355 | 1,209 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,805 | 3,219 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 25,772 | 26,435 | |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,203 | 2,009 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 27 | 189 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 15,773 | 20,556 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 8,333 | 8,540 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 3,512 | 5,883 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,053 | 2,069 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1,507 | 2,277 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 351 | 342 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 7 | 43 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 309 | 357 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 109 | 142 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 1 | 1 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 2,148 | 2,943 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 744 | 998 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 10 | 27 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 443 | 686 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 661 | 896 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 55 | 86 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 46 | 46 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 115 | 113 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 264 | 560 | |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 226 | 526 | |
UBS AG | Allowance for expected credit loss | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (969) | (1,211) | |
UBS AG | Allowance for expected credit loss | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (969) | (1,211) | |
UBS AG | Allowance for expected credit loss | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (8) | (16) | |
UBS AG | Allowance for expected credit loss | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (2) | (2) | |
UBS AG | Allowance for expected credit loss | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (850) | (1,060) | |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (132) | (166) | |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (60) | (63) | |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (170) | (279) | |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (259) | (310) | |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (33) | (36) | |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (36) | (38) | |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (114) | (106) | |
UBS AG | Allowance for expected credit loss | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (109) | (133) | |
UBS AG | Allowance for expected credit loss | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (86) | (108) | |
UBS AG | Allowance for expected credit loss | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (161) | (187) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (161) | (187) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (7) | (9) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (2) | (2) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (126) | (142) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (28) | (35) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (19) | (15) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (22) | (27) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (19) | (19) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (6) | (5) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (10) | (11) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (6) | (5) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (27) | (34) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (19) | (27) | |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (160) | (229) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (160) | (229) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (1) | (5) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (152) | (215) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (71) | (93) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (40) | (44) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (16) | (40) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (15) | (23) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (9) | (11) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (7) | (9) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (3) | (5) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total on-balance sheet financial assets in scope of ECL requirements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (647) | (795) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (647) | (795) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Cash and balances at central banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | (1) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Receivables from securities financing transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Cash collateral receivables on derivative instruments | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | 0 | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (572) | (703) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (33) | (39) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | 0 | (4) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (133) | (212) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (225) | (268) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (28) | (31) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (17) | (16) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (108) | (101) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (76) | (90) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | (63) | (76) | |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Financial assets measured at fair value through other comprehensive income | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Financial assets | $ 0 | $ 0 |
Expected credit loss measurem_4
Expected credit loss measurement - Off-balance sheet financial assets subject to ECL (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Disclosure Of Provision Matrix [Table] | |||
Total exposure | $ 108,284 | $ 105,116 | |
ECL provision | (196) | (257) | |
Total ECL allowances and provisions | (1,165) | (1,468) | $ (1,029) |
Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,766 | 7,056 | |
Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 32,748 | 32,828 | |
SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,077 | 9,121 | |
Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 12,153 | 7,690 | |
Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 14,438 | 14,178 | |
Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,466 | 8,661 | |
Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,262 | 1,683 | |
Guarantees | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 20,972 | 17,081 | |
ECL provision | (41) | (63) | |
Guarantees | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,464 | 3,710 | |
ECL provision | (6) | (20) | |
Guarantees | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,353 | 1,310 | |
ECL provision | (8) | (13) | |
Guarantees | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,575 | 7,637 | |
ECL provision | (17) | (17) | |
Guarantees | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,454 | 641 | |
ECL provision | (1) | (2) | |
Guarantees | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,137 | 1,441 | |
ECL provision | (1) | (2) | |
Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 39,478 | 41,372 | |
ECL provision | (114) | (142) | |
Irrevocable loan commitments | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 23,922 | 24,209 | |
ECL provision | (100) | (121) | |
Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,444 | 3,247 | |
ECL provision | 0 | 0 | |
Committed unconditionally revocable credit lines | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 40,778 | 40,134 | |
ECL provision | (38) | (50) | |
Committed unconditionally revocable credit lines | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 7,328 | 6,328 | |
ECL provision | (5) | (12) | |
Committed unconditionally revocable credit lines | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 5,358 | 4,909 | |
ECL provision | (7) | (9) | |
Committed unconditionally revocable credit lines | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 5,160 | 5,827 | |
ECL provision | (15) | (16) | |
Committed unconditionally revocable credit lines | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,670 | 9,671 | |
ECL provision | 0 | 0 | |
Committed unconditionally revocable credit lines | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,466 | 8,661 | |
ECL provision | (6) | (8) | |
Committed unconditionally revocable credit lines | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 117 | 242 | |
ECL provision | 0 | 0 | |
Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 5,611 | 3,282 | |
ECL provision | (3) | (2) | |
Twelve-month expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 101,971 | 93,337 | |
ECL provision | (121) | (119) | |
Total ECL allowances and provisions | (282) | (306) | (181) |
Twelve-month expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,481 | 6,576 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 28,981 | 25,026 | |
Twelve-month expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 7,276 | 7,239 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 11,784 | 7,242 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 14,438 | 14,170 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,000 | 8,220 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,262 | 1,658 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 19,695 | 14,687 | |
ECL provision | (18) | (14) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,567 | 2,048 | |
ECL provision | (3) | (4) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,143 | 936 | |
ECL provision | (1) | (1) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,491 | 7,413 | |
ECL provision | (13) | (7) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,454 | 633 | |
ECL provision | 0 | 0 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,137 | 1,416 | |
ECL provision | (1) | (1) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 37,097 | 36,894 | |
ECL provision | (72) | (74) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 21,811 | 20,195 | |
ECL provision | (66) | (63) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,444 | 3,247 | |
ECL provision | 0 | 0 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 38,207 | 35,233 | |
ECL provision | (28) | (29) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 7,046 | 5,811 | |
ECL provision | (4) | (5) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 4,599 | 2,783 | |
ECL provision | (4) | (2) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 4,736 | 4,596 | |
ECL provision | (11) | (12) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,670 | 9,671 | |
ECL provision | 0 | (1) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,000 | 8,220 | |
ECL provision | (5) | (6) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 117 | 242 | |
ECL provision | 0 | 0 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 5,527 | 3,277 | |
ECL provision | (3) | (2) | |
Lifetime expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 6,006 | 11,396 | |
ECL provision | (60) | (104) | |
Total ECL allowances and provisions | (220) | (333) | (160) |
Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 285 | 481 | |
Total ECL allowances and provisions | (43) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,630 | 7,598 | |
Total ECL allowances and provisions | (55) | ||
Lifetime expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 688 | 1,734 | |
Total ECL allowances and provisions | (30) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 369 | 448 | |
Total ECL allowances and provisions | (6) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 462 | 430 | |
Total ECL allowances and provisions | (11) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 25 | |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,127 | 2,225 | |
ECL provision | (8) | (15) | |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 793 | 1,549 | |
ECL provision | (3) | (5) | |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 164 | 326 | |
ECL provision | (1) | (1) | |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 84 | 224 | |
ECL provision | (4) | (9) | |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 25 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,335 | 4,374 | |
ECL provision | (42) | (68) | |
Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,102 | 3,950 | |
ECL provision | (34) | (58) | |
Lifetime expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,508 | 4,792 | |
ECL provision | (10) | (21) | |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 281 | 517 | |
ECL provision | (1) | (7) | |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 736 | 2,099 | |
ECL provision | (3) | (7) | |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 389 | 1,169 | |
ECL provision | (3) | (4) | |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 462 | 430 | |
ECL provision | (2) | (2) | |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 36 | 5 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 307 | 382 | |
ECL provision | (15) | (34) | |
Total ECL allowances and provisions | (662) | (829) | (688) |
Lifetime expected credit losses | Credit-impaired positions | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 136 | 205 | |
Lifetime expected credit losses | Credit-impaired positions | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 114 | 148 | |
Lifetime expected credit losses | Credit-impaired positions | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 8 | |
Lifetime expected credit losses | Credit-impaired positions | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 4 | 11 | |
Lifetime expected credit losses | Credit-impaired positions | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 150 | 170 | |
ECL provision | (15) | (34) | |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 104 | 113 | |
ECL provision | 0 | (12) | |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 46 | 48 | |
ECL provision | (7) | (11) | |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 8 | |
ECL provision | (1) | (2) | |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 46 | 104 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9 | 64 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 63 | 108 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 23 | 27 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 35 | 63 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 4 | 11 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 48 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 109,878 | 107,059 | |
ECL provision | (196) | (257) | |
Total ECL allowances and provisions | (1,165) | (1,468) | (1,029) |
UBS AG | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,766 | 7,056 | |
UBS AG | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 32,748 | 32,828 | |
UBS AG | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,077 | 9,121 | |
UBS AG | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 13,747 | 7,690 | |
UBS AG | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 14,438 | 14,178 | |
UBS AG | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,466 | 8,661 | |
UBS AG | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,262 | 1,683 | |
UBS AG | Guarantees | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 20,972 | 17,081 | |
ECL provision | (41) | (63) | |
UBS AG | Guarantees | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,464 | 3,710 | |
ECL provision | (6) | (20) | |
UBS AG | Guarantees | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,353 | 1,310 | |
ECL provision | (8) | (13) | |
UBS AG | Guarantees | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,575 | 7,637 | |
ECL provision | (17) | (17) | |
UBS AG | Guarantees | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,454 | 641 | |
ECL provision | (1) | (2) | |
UBS AG | Guarantees | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,137 | 1,441 | |
ECL provision | (1) | (2) | |
UBS AG | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 39,478 | 41,372 | |
ECL provision | (114) | (142) | |
UBS AG | Irrevocable loan commitments | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 23,922 | 24,209 | |
ECL provision | (100) | (121) | |
UBS AG | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,444 | 3,247 | |
ECL provision | 0 | 0 | |
UBS AG | Committed unconditionally revocable credit lines | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 42,373 | 42,077 | |
ECL provision | (38) | (50) | |
UBS AG | Committed unconditionally revocable credit lines | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 7,328 | 6,328 | |
ECL provision | (5) | (12) | |
UBS AG | Committed unconditionally revocable credit lines | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 5,358 | 4,909 | |
ECL provision | (7) | (9) | |
UBS AG | Committed unconditionally revocable credit lines | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 5,160 | 5,827 | |
ECL provision | (15) | (16) | |
UBS AG | Committed unconditionally revocable credit lines | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,670 | 9,671 | |
ECL provision | 0 | 0 | |
UBS AG | Committed unconditionally revocable credit lines | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,466 | 8,661 | |
ECL provision | (6) | (8) | |
UBS AG | Committed unconditionally revocable credit lines | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 117 | 242 | |
ECL provision | 0 | 0 | |
UBS AG | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 5,611 | 3,282 | |
ECL provision | (3) | (2) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 103,565 | 95,281 | |
ECL provision | (121) | (119) | |
Total ECL allowances and provisions | (282) | (306) | (181) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,481 | 6,576 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 28,981 | 25,026 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 7,276 | 7,239 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 13,379 | 7,270 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 14,438 | 14,170 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,000 | 8,220 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,262 | 1,658 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 19,695 | 14,687 | |
ECL provision | (18) | (14) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,567 | 2,048 | |
ECL provision | (3) | (4) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,143 | 936 | |
ECL provision | (1) | (1) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,491 | 7,413 | |
ECL provision | (13) | (7) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,454 | 633 | |
ECL provision | 0 | 0 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,137 | 1,416 | |
ECL provision | (1) | (1) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 37,097 | 36,894 | |
ECL provision | (72) | (74) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 21,811 | 20,195 | |
ECL provision | (66) | (63) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,444 | 3,247 | |
ECL provision | 0 | 0 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 39,802 | 37,176 | |
ECL provision | (28) | (29) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 7,046 | 5,811 | |
ECL provision | (4) | (5) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 4,599 | 2,783 | |
ECL provision | (4) | (2) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 4,736 | 4,596 | |
ECL provision | (11) | (12) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 8,670 | 9,671 | |
ECL provision | 0 | (1) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9,000 | 8,220 | |
ECL provision | (5) | (6) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 117 | 242 | |
ECL provision | 0 | 0 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 5,527 | 3,277 | |
ECL provision | (3) | (2) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 6,006 | 11,396 | |
ECL provision | (60) | (104) | |
Total ECL allowances and provisions | (220) | (333) | (160) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 285 | 481 | |
Total ECL allowances and provisions | (43) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 3,630 | 7,598 | |
Total ECL allowances and provisions | (55) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 688 | 1,734 | |
Total ECL allowances and provisions | (30) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 369 | 448 | |
Total ECL allowances and provisions | (6) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 462 | 430 | |
Total ECL allowances and provisions | (11) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 25 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 1,127 | 2,225 | |
ECL provision | (8) | (15) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 793 | 1,549 | |
ECL provision | (3) | (5) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 164 | 326 | |
ECL provision | (1) | (1) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 84 | 224 | |
ECL provision | (4) | (9) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 25 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,335 | 4,374 | |
ECL provision | (42) | (68) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,102 | 3,950 | |
ECL provision | (34) | (58) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 2,508 | 4,792 | |
ECL provision | (10) | (21) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 281 | 517 | |
ECL provision | (1) | (7) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 736 | 2,099 | |
ECL provision | (3) | (7) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 389 | 1,169 | |
ECL provision | (3) | (4) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 462 | 430 | |
ECL provision | (2) | (2) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 36 | 5 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 307 | 382 | |
ECL provision | (15) | (34) | |
Total ECL allowances and provisions | (662) | (829) | $ (688) |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 136 | 205 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 114 | 148 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 8 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 4 | 11 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 150 | 170 | |
ECL provision | (15) | (34) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 104 | 113 | |
ECL provision | 0 | (12) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 46 | 48 | |
ECL provision | (7) | (11) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 8 | |
ECL provision | (1) | (2) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 46 | 104 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 9 | 64 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Forward starting reverse repurchase and securities borrowing agreements | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 63 | 108 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 23 | 27 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 35 | 63 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Lombard | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 4 | 11 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Commodity trade finance | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 0 | 0 | |
ECL provision | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Irrevocable committed prolongation of existing loans | |||
Disclosure Of Provision Matrix [Table] | |||
Total exposure | 48 | 0 | |
ECL provision | $ 0 | $ 0 |
Expected credit loss measurem_5
Expected credit loss measurement - Coverage ratios (Detail 1) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.03% | 0.07% |
Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.09% | 0.21% |
Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.34% | 0.46% |
SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.38% | 0.40% |
Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.01% | 0.02% |
Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.07% | 0.09% |
Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.04% | 0.10% |
Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 746,638 | $ 695,603 |
Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 737,794 | 687,345 |
Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 397,761 | 379,528 |
Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 152,479 | 148,175 |
Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 43,945 | 43,429 |
Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 13,990 | 15,161 |
Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 14,004 | 14,872 |
Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 149,283 | 133,850 |
Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,716 | 1,558 |
Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 3,813 | 3,269 |
Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 26,209 | 27,194 |
Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 2,453 | 2,569 |
Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 8,844 | $ 8,258 |
Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.30% | |
Twelve-month expected credit losses | Positions that are not credit impaired | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.03% | 0.06% |
Twelve-month expected credit losses | Positions that are not credit impaired | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.07% | 0.09% |
Twelve-month expected credit losses | Positions that are not credit impaired | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.25% | 0.27% |
Twelve-month expected credit losses | Positions that are not credit impaired | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.19% | 0.19% |
Twelve-month expected credit losses | Positions that are not credit impaired | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.01% |
Twelve-month expected credit losses | Positions that are not credit impaired | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.05% | 0.08% |
Twelve-month expected credit losses | Positions that are not credit impaired | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.04% | 0.08% |
Twelve-month expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 728,923 | $ 672,021 |
Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 720,079 | 663,763 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 380,564 | 356,948 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 143,505 | 138,769 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 40,463 | 37,568 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 12,643 | 12,658 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 12,076 | 11,990 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 149,255 | 133,795 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,345 | 1,198 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 3,799 | 3,214 |
Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 25,718 | 26,377 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 2,184 | 1,982 |
Twelve-month expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 8,844 | $ 8,258 |
Twelve-month expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.05% | |
Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.09% | 0.16% |
Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.88% | 1.85% |
Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 1.10% | 0.92% |
Lifetime expected credit losses | Positions that are not credit impaired | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 1.51% | 0.63% |
Lifetime expected credit losses | Positions that are not credit impaired | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.00% |
Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.34% | 0.44% |
Lifetime expected credit losses | Positions that are not credit impaired | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.15% |
Lifetime expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 15,948 | $ 20,873 |
Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 15,948 | 20,873 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 15,620 | 20,341 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 8,262 | 8,448 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 3,472 | 5,838 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,037 | 2,029 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,492 | 2,254 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 342 | 330 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 7 | 43 |
Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 302 | 348 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 106 | 137 |
Lifetime expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | $ 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 1.06% | |
Lifetime expected credit losses | Credit-impaired positions | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.15% | 1.97% |
Lifetime expected credit losses | Credit-impaired positions | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.00% |
Lifetime expected credit losses | Credit-impaired positions | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.01% | 5.65% |
Lifetime expected credit losses | Credit-impaired positions | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 5.85% | 7.79% |
Lifetime expected credit losses | Credit-impaired positions | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 19.41% |
Lifetime expected credit losses | Credit-impaired positions | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.00% |
Lifetime expected credit losses | Credit-impaired positions | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 82.79% |
Lifetime expected credit losses | Credit-impaired positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,767 | $ 2,709 |
Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,767 | 2,709 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,577 | 2,240 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 711 | 959 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 9 | 23 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 310 | 474 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 436 | 628 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 27 | 55 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 29 | 30 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 7 | 12 |
Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 189 | 469 |
Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 163 | 450 |
Lifetime expected credit losses | Credit-impaired positions | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | $ 0 |
Lifetime expected credit losses | Credit-impaired positions | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 22.47% | |
Gross carrying amount | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 747,606 | $ 696,815 |
Gross carrying amount | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 738,762 | 688,556 |
Gross carrying amount | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 398,611 | 380,589 |
Gross carrying amount | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 152,610 | $ 148,341 |
ECL coverage | 0.09% | 0.11% |
Gross carrying amount | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 44,004 | $ 43,492 |
ECL coverage | 0.14% | 0.15% |
Gross carrying amount | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 14,161 | $ 15,440 |
ECL coverage | 1.20% | 1.81% |
Gross carrying amount | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 14,263 | $ 15,183 |
ECL coverage | 1.82% | 2.04% |
Gross carrying amount | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 149,316 | $ 133,886 |
ECL coverage | 0.02% | 0.03% |
Gross carrying amount | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,752 | $ 1,596 |
ECL coverage | 2.04% | 2.40% |
Gross carrying amount | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 3,927 | $ 3,375 |
ECL coverage | 2.90% | 3.15% |
Gross carrying amount | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 18,578 | $ 19,274 |
ECL coverage | 0.25% | 0.31% |
Gross carrying amount | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 26,318 | $ 27,327 |
Gross carrying amount | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 2,539 | $ 2,677 |
ECL coverage | 3.38% | 4.04% |
Gross carrying amount | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 401,150 | $ 383,266 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 380,690 | 357,090 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 143,533 | $ 138,803 |
ECL coverage | 0.02% | 0.02% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 40,483 | $ 37,583 |
ECL coverage | 0.05% | 0.04% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 12,665 | $ 12,684 |
ECL coverage | 0.18% | 0.21% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 12,095 | $ 12,010 |
ECL coverage | 0.16% | 0.16% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 149,261 | $ 133,800 |
ECL coverage | 0.00% | 0.00% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,355 | $ 1,209 |
ECL coverage | 0.72% | 0.91% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 3,805 | $ 3,219 |
ECL coverage | 0.15% | 0.16% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 17,493 | $ 17,781 |
ECL coverage | 0.09% | 0.14% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 25,745 | $ 26,410 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 2,203 | $ 2,009 |
ECL coverage | 0.88% | 1.35% |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 382,893 | $ 359,099 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 15,773 | 20,556 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 8,333 | $ 8,540 |
ECL coverage | 0.85% | 1.08% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 3,512 | $ 5,883 |
ECL coverage | 1.14% | 0.75% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,053 | $ 2,069 |
ECL coverage | 1.48% | 1.92% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,507 | $ 2,277 |
ECL coverage | 1.03% | 1.01% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | $ 0 |
ECL coverage | 0.00% | 0.00% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 351 | $ 342 |
ECL coverage | 2.55% | 3.33% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 7 | $ 43 |
ECL coverage | 0.03% | 0.02% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,010 | $ 1,402 |
ECL coverage | 0.15% | 0.25% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 309 | $ 357 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 109 | $ 142 |
ECL coverage | 3.03% | 3.51% |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 15,882 | $ 20,697 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 2,148 | 2,943 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 744 | $ 998 |
ECL coverage | 4.46% | 3.90% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 10 | $ 27 |
ECL coverage | 2.31% | 14.14% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 443 | $ 686 |
ECL coverage | 29.97% | 30.89% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 661 | $ 896 |
ECL coverage | 34.02% | 29.91% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 55 | $ 86 |
ECL coverage | 50.26% | 35.92% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 46 | $ 46 |
ECL coverage | 37.35% | 34.88% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 115 | $ 113 |
ECL coverage | 93.88% | 89.39% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 75 | $ 91 |
ECL coverage | 37.30% | 35.63% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 264 | $ 560 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 226 | $ 526 |
ECL coverage | 27.91% | 14.46% |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 2,374 | $ 3,470 |
Allowance for expected credit loss | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (969) | (1,211) |
Allowance for expected credit loss | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (969) | (1,211) |
Allowance for expected credit loss | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (850) | (1,060) |
Allowance for expected credit loss | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (132) | (166) |
Allowance for expected credit loss | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (60) | (63) |
Allowance for expected credit loss | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (170) | (279) |
Allowance for expected credit loss | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (259) | (310) |
Allowance for expected credit loss | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (33) | (36) |
Allowance for expected credit loss | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (36) | (38) |
Allowance for expected credit loss | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (114) | (106) |
Allowance for expected credit loss | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (109) | (133) |
Allowance for expected credit loss | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (86) | (108) |
Allowance for expected credit loss | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | 0 |
Allowance for expected credit loss | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.23% | |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ (161) | (187) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (161) | (187) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (126) | (142) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (28) | (35) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (19) | (15) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (22) | (27) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (19) | (19) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (6) | (5) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (10) | (11) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (6) | (5) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (27) | (34) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (19) | (27) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | 0 |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.04% | |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ (160) | (229) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (160) | (229) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (152) | (215) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (71) | (93) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (40) | (44) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (16) | (40) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (15) | (23) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (9) | (11) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (7) | (9) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (3) | (5) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.98% | |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ (647) | (795) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (647) | (795) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (572) | (703) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (33) | (39) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | (4) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (133) | (212) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (225) | (268) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (28) | (31) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (17) | (16) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (108) | (101) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (76) | (90) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (63) | (76) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | $ 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 26.73% | |
UBS AG | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.03% | 0.07% |
UBS AG | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.09% | 0.21% |
UBS AG | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.34% | 0.46% |
UBS AG | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.38% | 0.40% |
UBS AG | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.01% | 0.02% |
UBS AG | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.07% | 0.09% |
UBS AG | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.04% | 0.10% |
UBS AG | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 747,477 | $ 696,976 |
UBS AG | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 738,632 | 688,717 |
UBS AG | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 398,693 | 380,977 |
UBS AG | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 152,479 | 148,175 |
UBS AG | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 43,945 | 43,429 |
UBS AG | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 13,990 | 15,161 |
UBS AG | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 14,004 | 14,872 |
UBS AG | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 149,283 | 133,850 |
UBS AG | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,716 | 1,558 |
UBS AG | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 3,813 | 3,269 |
UBS AG | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 26,236 | 27,219 |
UBS AG | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 2,453 | 2,569 |
UBS AG | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 8,844 | $ 8,258 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.03% | 0.06% |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.07% | 0.09% |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.25% | 0.27% |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.19% | 0.19% |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.01% |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.05% | 0.08% |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.04% | 0.08% |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 729,762 | $ 673,394 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 720,917 | 665,135 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 381,496 | 358,396 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 143,505 | 138,769 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 40,463 | 37,568 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 12,643 | 12,658 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 12,076 | 11,990 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 149,255 | 133,795 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,345 | 1,198 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 3,799 | 3,214 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 25,746 | 26,401 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 2,184 | 1,982 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 8,844 | $ 8,258 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.09% | 0.16% |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.88% | 1.85% |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 1.10% | 0.92% |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 1.51% | 0.63% |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.00% |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.34% | 0.44% |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.15% |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 15,948 | $ 20,873 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 15,948 | 20,873 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 15,620 | 20,341 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 8,262 | 8,448 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 3,472 | 5,838 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,037 | 2,029 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,492 | 2,254 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 342 | 330 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 7 | 43 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 302 | 348 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 106 | 137 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | $ 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.15% | 1.97% |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.00% |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.01% | 5.65% |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 5.85% | 7.79% |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 19.41% |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 0.00% |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
ECL coverage | 0.00% | 82.79% |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,767 | $ 2,709 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,767 | 2,709 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 1,577 | 2,240 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 711 | 959 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 9 | 23 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 310 | 474 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 436 | 628 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 27 | 55 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 29 | 30 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 7 | 12 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 189 | 469 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 163 | 450 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 748,445 | 698,187 |
UBS AG | Gross carrying amount | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 739,601 | 689,929 |
UBS AG | Gross carrying amount | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 399,543 | 382,036 |
UBS AG | Gross carrying amount | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 152,610 | $ 148,341 |
ECL coverage | 0.09% | 0.11% |
UBS AG | Gross carrying amount | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 44,004 | $ 43,492 |
ECL coverage | 0.14% | 0.15% |
UBS AG | Gross carrying amount | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 14,161 | $ 15,440 |
ECL coverage | 1.20% | 1.81% |
UBS AG | Gross carrying amount | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 14,263 | $ 15,183 |
ECL coverage | 1.82% | 2.04% |
UBS AG | Gross carrying amount | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 149,316 | $ 133,886 |
ECL coverage | 0.02% | 0.03% |
UBS AG | Gross carrying amount | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,752 | $ 1,596 |
ECL coverage | 2.04% | 2.40% |
UBS AG | Gross carrying amount | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 3,927 | $ 3,375 |
ECL coverage | 2.90% | 3.15% |
UBS AG | Gross carrying amount | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 19,510 | $ 20,722 |
ECL coverage | 0.23% | 0.29% |
UBS AG | Gross carrying amount | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 26,346 | $ 27,352 |
UBS AG | Gross carrying amount | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 2,539 | $ 2,677 |
ECL coverage | 3.38% | 4.04% |
UBS AG | Gross carrying amount | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 402,081 | $ 384,714 |
ECL coverage | 0.23% | 0.30% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 381,622 | $ 358,538 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 143,533 | $ 138,803 |
ECL coverage | 0.02% | 0.02% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 40,483 | $ 37,583 |
ECL coverage | 0.05% | 0.04% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 12,665 | $ 12,684 |
ECL coverage | 0.18% | 0.21% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 12,095 | $ 12,010 |
ECL coverage | 0.16% | 0.16% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 149,261 | $ 133,800 |
ECL coverage | 0.00% | 0.00% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,355 | $ 1,209 |
ECL coverage | 0.72% | 0.91% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 3,805 | $ 3,219 |
ECL coverage | 0.15% | 0.16% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 18,425 | $ 19,229 |
ECL coverage | 0.09% | 0.13% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 25,772 | $ 26,435 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 2,203 | $ 2,009 |
ECL coverage | 0.88% | 1.35% |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 383,825 | $ 360,547 |
ECL coverage | 0.04% | 0.05% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 15,773 | $ 20,556 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 8,333 | $ 8,540 |
ECL coverage | 0.85% | 1.08% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 3,512 | $ 5,883 |
ECL coverage | 1.14% | 0.75% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,053 | $ 2,069 |
ECL coverage | 1.48% | 1.92% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,507 | $ 2,277 |
ECL coverage | 1.03% | 1.01% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | $ 0 |
ECL coverage | 0.00% | 0.00% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 351 | $ 342 |
ECL coverage | 2.55% | 3.33% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 7 | $ 43 |
ECL coverage | 0.03% | 0.02% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 1,010 | $ 1,402 |
ECL coverage | 0.15% | 0.25% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 309 | $ 357 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 109 | $ 142 |
ECL coverage | 3.03% | 3.51% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 15,882 | $ 20,697 |
ECL coverage | 0.98% | 1.06% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 2,148 | $ 2,943 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 744 | $ 998 |
ECL coverage | 4.46% | 3.90% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 10 | $ 27 |
ECL coverage | 2.31% | 14.14% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 443 | $ 686 |
ECL coverage | 29.97% | 30.89% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 661 | $ 896 |
ECL coverage | 34.02% | 29.91% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 55 | $ 86 |
ECL coverage | 50.26% | 35.92% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 46 | $ 46 |
ECL coverage | 37.35% | 34.88% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 115 | $ 113 |
ECL coverage | 93.88% | 89.39% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Other loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 75 | $ 91 |
ECL coverage | 37.30% | 35.63% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 264 | $ 560 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 226 | $ 526 |
ECL coverage | 27.91% | 14.46% |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Total | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 2,374 | $ 3,470 |
ECL coverage | 26.73% | 22.47% |
UBS AG | Allowance for expected credit loss | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ (969) | $ (1,211) |
UBS AG | Allowance for expected credit loss | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (969) | (1,211) |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (850) | (1,060) |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (132) | (166) |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (60) | (63) |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (170) | (279) |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (259) | (310) |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (33) | (36) |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (36) | (38) |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (114) | (106) |
UBS AG | Allowance for expected credit loss | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (109) | (133) |
UBS AG | Allowance for expected credit loss | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (86) | (108) |
UBS AG | Allowance for expected credit loss | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (161) | (187) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (161) | (187) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (126) | (142) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (28) | (35) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (19) | (15) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (22) | (27) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (19) | (19) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (6) | (5) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (10) | (11) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (6) | (5) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (27) | (34) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (19) | (27) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (160) | (229) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (160) | (229) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (152) | (215) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (71) | (93) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (40) | (44) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (16) | (40) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (15) | (23) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (9) | (11) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (7) | (9) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (3) | (5) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total on-balance sheet financial assets in scope of ECL requirements | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (647) | (795) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (647) | (795) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (572) | (703) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Private clients with mortgages | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (33) | (39) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Real estate financing | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | 0 | (4) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Large corporate clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (133) | (212) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | SME clients | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (225) | (268) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Lombard | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (28) | (31) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Credit cards | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (17) | (16) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | Commodity trade finance | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (108) | (101) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (76) | (90) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans to financial advisors | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | (63) | (76) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Credit Risk Exposure [Table] | ||
Financial assets | $ 0 | $ 0 |
Expected credit loss measurem_6
Expected credit loss measurement - Coverage ratios (Detail 2) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 108,284 | $ 105,116 |
Private clients with mortgages | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.03% | 0.07% |
Total exposure | $ 9,123 | $ 6,285 |
Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.09% | 0.21% |
Total exposure | $ 8,766 | $ 7,056 |
Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.34% | 0.46% |
Total exposure | $ 32,748 | $ 32,828 |
SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.38% | 0.40% |
Total exposure | $ 8,077 | $ 9,121 |
Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.01% | 0.02% |
Total exposure | $ 14,438 | $ 14,178 |
Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.07% | 0.09% |
Total exposure | $ 9,466 | $ 8,661 |
Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.04% | 0.10% |
Total exposure | $ 3,262 | $ 1,683 |
Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.15% | 0.26% |
Total exposure | $ 12,153 | $ 7,690 |
Guarantees | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 20,972 | 17,081 |
Guarantees | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 3,464 | 3,710 |
Guarantees | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,353 | 1,310 |
Guarantees | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,454 | 641 |
Guarantees | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 3,137 | 1,441 |
Guarantees | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9,575 | 7,637 |
Irrevocable loan commitments | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 39,478 | 41,372 |
Irrevocable loan commitments | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 23,922 | 24,209 |
Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,444 | 3,247 |
Committed unconditionally revocable credit lines | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 40,778 | 40,134 |
Committed unconditionally revocable credit lines | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 7,328 | 6,328 |
Committed unconditionally revocable credit lines | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 5,358 | 4,909 |
Committed unconditionally revocable credit lines | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 5,160 | 5,827 |
Committed unconditionally revocable credit lines | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 8,670 | 9,671 |
Committed unconditionally revocable credit lines | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9,466 | 8,661 |
Committed unconditionally revocable credit lines | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 117 | 242 |
Irrevocable committed prolongation of existing loans | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 5,611 | $ 3,282 |
Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.15% | 0.13% |
Total exposure | $ 8,806 | $ 14,366 |
Total | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.18% | 0.25% |
Total exposure | $ 106,840 | $ 101,869 |
Twelve-month expected credit losses | Positions that are not credit impaired | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 101,971 | $ 93,337 |
Twelve-month expected credit losses | Positions that are not credit impaired | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.03% | 0.06% |
Total exposure | $ 8,798 | $ 6,083 |
Twelve-month expected credit losses | Positions that are not credit impaired | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.07% | 0.09% |
Total exposure | $ 8,481 | $ 6,576 |
Twelve-month expected credit losses | Positions that are not credit impaired | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.25% | 0.27% |
Total exposure | $ 28,981 | $ 25,026 |
Twelve-month expected credit losses | Positions that are not credit impaired | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.19% | 0.19% |
Total exposure | $ 7,276 | $ 7,239 |
Twelve-month expected credit losses | Positions that are not credit impaired | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.01% |
Total exposure | $ 14,438 | $ 14,170 |
Twelve-month expected credit losses | Positions that are not credit impaired | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.05% | 0.08% |
Total exposure | $ 9,000 | $ 8,220 |
Twelve-month expected credit losses | Positions that are not credit impaired | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.04% | 0.08% |
Total exposure | $ 3,262 | $ 1,658 |
Twelve-month expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.12% | 0.13% |
Total exposure | $ 11,784 | $ 7,242 |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 19,695 | 14,687 |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,567 | 2,048 |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,143 | 936 |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,454 | 633 |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 3,137 | 1,416 |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9,491 | 7,413 |
Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 37,097 | 36,894 |
Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 21,811 | 20,195 |
Twelve-month expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,444 | 3,247 |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 38,207 | 35,233 |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 7,046 | 5,811 |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 4,599 | 2,783 |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 4,736 | 4,596 |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 8,670 | 9,671 |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9,000 | 8,220 |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 117 | 242 |
Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 5,527 | $ 3,277 |
Twelve-month expected credit losses | Positions that are not credit impaired | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.06% | 0.07% |
Total exposure | $ 8,507 | $ 13,876 |
Twelve-month expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.12% | 0.13% |
Total exposure | $ 100,527 | $ 90,090 |
Lifetime expected credit losses | Positions that are not credit impaired | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 6,006 | $ 11,396 |
Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.09% | 0.16% |
Total exposure | $ 276 | $ 198 |
Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.88% | 1.85% |
Total exposure | $ 285 | $ 481 |
Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 1.10% | 0.92% |
Total exposure | $ 3,630 | $ 7,598 |
Lifetime expected credit losses | Positions that are not credit impaired | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 1.51% | 0.63% |
Total exposure | $ 688 | $ 1,734 |
Lifetime expected credit losses | Positions that are not credit impaired | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.00% |
Total exposure | $ 0 | $ 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.34% | 0.44% |
Total exposure | $ 462 | $ 430 |
Lifetime expected credit losses | Positions that are not credit impaired | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.15% |
Total exposure | $ 0 | $ 25 |
Lifetime expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 1.20% | 2.48% |
Total exposure | $ 369 | $ 448 |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,127 | 2,225 |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 793 | 1,549 |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 164 | 326 |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 25 |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 84 | 224 |
Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,335 | 4,374 |
Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,102 | 3,950 |
Lifetime expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,508 | 4,792 |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 281 | 517 |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 736 | 2,099 |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 389 | 1,169 |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 462 | 430 |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 36 | $ 5 |
Lifetime expected credit losses | Positions that are not credit impaired | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.30% | 0.11% |
Total exposure | $ 296 | $ 482 |
Lifetime expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 1.00% | 0.91% |
Total exposure | $ 6,006 | $ 11,396 |
Lifetime expected credit losses | Credit-impaired positions | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 307 | $ 382 |
Lifetime expected credit losses | Credit-impaired positions | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.15% | 1.97% |
Total exposure | $ 49 | $ 3 |
Lifetime expected credit losses | Credit-impaired positions | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.00% |
Total exposure | $ 0 | $ 0 |
Lifetime expected credit losses | Credit-impaired positions | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.01% | 5.65% |
Total exposure | $ 136 | $ 205 |
Lifetime expected credit losses | Credit-impaired positions | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 5.85% | 7.79% |
Total exposure | $ 114 | $ 148 |
Lifetime expected credit losses | Credit-impaired positions | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 19.41% |
Total exposure | $ 0 | $ 8 |
Lifetime expected credit losses | Credit-impaired positions | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.00% |
Total exposure | $ 4 | $ 11 |
Lifetime expected credit losses | Credit-impaired positions | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 82.79% |
Total exposure | $ 0 | $ 0 |
Lifetime expected credit losses | Credit-impaired positions | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 1.66% |
Total exposure | $ 0 | $ 0 |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 150 | 170 |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 104 | 113 |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 46 | 48 |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 8 |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 46 | 104 |
Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9 | 64 |
Lifetime expected credit losses | Credit-impaired positions | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 63 | 108 |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 23 | 27 |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 35 | 63 |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 4 | 11 |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 48 | $ 0 |
Lifetime expected credit losses | Credit-impaired positions | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 124.14% |
Total exposure | $ 4 | $ 8 |
Lifetime expected credit losses | Credit-impaired positions | Total | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 4.86% | 8.94% |
Total exposure | $ 307 | $ 382 |
UBS AG | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 109,878 | $ 107,059 |
UBS AG | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.03% | 0.07% |
Total exposure | $ 9,123 | $ 6,285 |
UBS AG | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.09% | 0.21% |
Total exposure | $ 8,766 | $ 7,056 |
UBS AG | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.34% | 0.46% |
Total exposure | $ 32,748 | $ 32,828 |
UBS AG | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.38% | 0.40% |
Total exposure | $ 8,077 | $ 9,121 |
UBS AG | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.01% | 0.02% |
Total exposure | $ 14,438 | $ 14,178 |
UBS AG | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.07% | 0.09% |
Total exposure | $ 9,466 | $ 8,661 |
UBS AG | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.04% | 0.10% |
Total exposure | $ 3,262 | $ 1,683 |
UBS AG | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.13% | 0.26% |
Total exposure | $ 13,747 | $ 7,690 |
UBS AG | Guarantees | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 20,972 | 17,081 |
UBS AG | Guarantees | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 3,464 | 3,710 |
UBS AG | Guarantees | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,353 | 1,310 |
UBS AG | Guarantees | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,454 | 641 |
UBS AG | Guarantees | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 3,137 | 1,441 |
UBS AG | Guarantees | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9,575 | 7,637 |
UBS AG | Irrevocable loan commitments | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 39,478 | 41,372 |
UBS AG | Irrevocable loan commitments | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 23,922 | 24,209 |
UBS AG | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,444 | 3,247 |
UBS AG | Committed unconditionally revocable credit lines | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 42,373 | 42,077 |
UBS AG | Committed unconditionally revocable credit lines | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 7,328 | 6,328 |
UBS AG | Committed unconditionally revocable credit lines | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 5,358 | 4,909 |
UBS AG | Committed unconditionally revocable credit lines | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 5,160 | 5,827 |
UBS AG | Committed unconditionally revocable credit lines | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 8,670 | 9,671 |
UBS AG | Committed unconditionally revocable credit lines | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9,466 | 8,661 |
UBS AG | Committed unconditionally revocable credit lines | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 117 | 242 |
UBS AG | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 5,611 | $ 3,282 |
UBS AG | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.15% | 0.12% |
Total exposure | $ 8,806 | $ 16,309 |
UBS AG | Total | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.18% | 0.25% |
Total exposure | $ 108,434 | $ 103,812 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 103,565 | $ 95,281 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.03% | 0.06% |
Total exposure | $ 8,798 | $ 6,083 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.07% | 0.09% |
Total exposure | $ 8,481 | $ 6,576 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.25% | 0.27% |
Total exposure | $ 28,981 | $ 25,026 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.19% | 0.19% |
Total exposure | $ 7,276 | $ 7,239 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.01% |
Total exposure | $ 14,438 | $ 14,170 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.05% | 0.08% |
Total exposure | $ 9,000 | $ 8,220 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.04% | 0.08% |
Total exposure | $ 3,262 | $ 1,658 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.10% | 0.13% |
Total exposure | $ 13,379 | $ 7,270 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 19,695 | 14,687 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,567 | 2,048 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,143 | 936 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,454 | 633 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 3,137 | 1,416 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9,491 | 7,413 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 37,097 | 36,894 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 21,811 | 20,195 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,444 | 3,247 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 39,802 | 37,176 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 7,046 | 5,811 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 4,599 | 2,783 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 4,736 | 4,596 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 8,670 | 9,671 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9,000 | 8,220 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 117 | 242 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 5,527 | $ 3,277 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.06% | 0.06% |
Total exposure | $ 8,507 | $ 15,792 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.12% | 0.13% |
Total exposure | $ 102,121 | $ 92,034 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 6,006 | $ 11,396 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.09% | 0.16% |
Total exposure | $ 276 | $ 198 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.88% | 1.85% |
Total exposure | $ 285 | $ 481 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 1.10% | 0.92% |
Total exposure | $ 3,630 | $ 7,598 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 1.51% | 0.63% |
Total exposure | $ 688 | $ 1,734 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.00% |
Total exposure | $ 0 | $ 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.34% | 0.44% |
Total exposure | $ 462 | $ 430 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.15% |
Total exposure | $ 0 | $ 25 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 1.20% | 2.48% |
Total exposure | $ 369 | $ 448 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 1,127 | 2,225 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 793 | 1,549 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 164 | 326 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 25 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 84 | 224 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,335 | 4,374 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,102 | 3,950 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 2,508 | 4,792 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 281 | 517 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 736 | 2,099 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 389 | 1,169 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 462 | 430 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 36 | $ 5 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.30% | 0.11% |
Total exposure | $ 296 | $ 482 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Total | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 1.00% | 0.91% |
Total exposure | $ 6,006 | $ 11,396 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 307 | $ 382 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Private clients with mortgages | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.15% | 1.97% |
Total exposure | $ 49 | $ 3 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.00% |
Total exposure | $ 0 | $ 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.01% | 5.65% |
Total exposure | $ 136 | $ 205 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 5.85% | 7.79% |
Total exposure | $ 114 | $ 148 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 19.41% |
Total exposure | $ 0 | $ 8 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 0.00% |
Total exposure | $ 4 | $ 11 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 82.79% |
Total exposure | $ 0 | $ 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 1.66% |
Total exposure | $ 0 | $ 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 150 | 170 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 104 | 113 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 46 | 48 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 8 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | Financial intermediaries and hedge funds | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 46 | 104 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 9 | 64 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 63 | 108 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Real estate financing | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Large corporate clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 23 | 27 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | SME clients | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 35 | 63 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Lombard | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Credit cards | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 4 | 11 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | Commodity trade finance | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Provision Matrix [Table] | ||
Total exposure | $ 48 | $ 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Other off-balance sheet commitments | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 0.00% | 124.14% |
Total exposure | $ 4 | $ 8 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Total | ||
Disclosure Of Provision Matrix [Table] | ||
ECL coverage | 4.86% | 8.94% |
Total exposure | $ 307 | $ 382 |
Derivative instruments (Narrati
Derivative instruments (Narrative) (Detail) - Interest rate swap contract - Over-the-counter | Dec. 31, 2021 | Dec. 31, 2020 |
Within 1 year | ||
Maturity Profile Of Derivatives Notionals [Table] | ||
Maturity profile of derivatives based on notional amount | 40.00% | 50.00% |
Due between 1 and 5 years | ||
Maturity Profile Of Derivatives Notionals [Table] | ||
Maturity profile of derivatives based on notional amount | 36.00% | 30.00% |
Due after 5 years | ||
Maturity Profile Of Derivatives Notionals [Table] | ||
Maturity profile of derivatives based on notional amount | 25.00% | 20.00% |
UBS AG | Within 1 year | ||
Maturity Profile Of Derivatives Notionals [Table] | ||
Maturity profile of derivatives based on notional amount | 40.00% | 50.00% |
UBS AG | Due between 1 and 5 years | ||
Maturity Profile Of Derivatives Notionals [Table] | ||
Maturity profile of derivatives based on notional amount | 36.00% | 30.00% |
UBS AG | Due after 5 years | ||
Maturity Profile Of Derivatives Notionals [Table] | ||
Maturity profile of derivatives based on notional amount | 25.00% | 20.00% |
Derivative instruments (Detail)
Derivative instruments (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Derivative [Table] | ||
Derivative financial assets | $ 118,142 | $ 159,617 |
Notional amounts related to derivative financial assets | 4,613,800 | 4,479,500 |
Derivative financial liabilities | 121,309 | 161,102 |
Notional amounts related to derivative financial liabilities | 4,616,600 | 4,429,700 |
Other amounts values | 8,771,100 | 11,394,400 |
Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 33,200 | 50,900 |
Notional amounts related to derivative financial assets | 991,200 | 928,000 |
Derivative financial liabilities | 28,700 | 43,900 |
Notional amounts related to derivative financial liabilities | 943,100 | 880,400 |
Other amounts values | 8,675,100 | 11,291,500 |
Credit derivative contracts | ||
Derivative [Table] | ||
Derivative financial assets | 1,400 | 2,400 |
Notional amounts related to derivative financial assets | 44,700 | 57,600 |
Derivative financial liabilities | 1,800 | 2,900 |
Notional amounts related to derivative financial liabilities | 46,300 | 64,800 |
Foreign exchange contracts | ||
Derivative [Table] | ||
Derivative financial assets | 53,300 | 68,700 |
Notional amounts related to derivative financial assets | 3,030,800 | 2,951,100 |
Derivative financial liabilities | 54,100 | 70,500 |
Notional amounts related to derivative financial liabilities | 2,938,800 | 2,820,400 |
Other amounts values | 1,200 | 1,400 |
Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 28,200 | 34,800 |
Notional amounts related to derivative financial assets | 456,900 | 449,600 |
Derivative financial liabilities | 34,900 | 41,200 |
Notional amounts related to derivative financial liabilities | 603,900 | 581,300 |
Other amounts values | 80,100 | 91,300 |
Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 1,600 | 2,200 |
Notional amounts related to derivative financial assets | 57,800 | 57,800 |
Derivative financial liabilities | 1,600 | 2,000 |
Notional amounts related to derivative financial liabilities | 56,400 | 49,700 |
Other amounts values | 14,700 | 10,100 |
Loan commitments measured at FVTPL | ||
Derivative [Table] | ||
Notional amounts related to derivative financial assets | 800 | |
Unsettled purchases of non-derivative financial instruments | ||
Derivative [Table] | ||
Derivative financial assets | 100 | 300 |
Notional amounts related to derivative financial assets | 13,300 | 18,300 |
Derivative financial liabilities | 200 | 200 |
Notional amounts related to derivative financial liabilities | 10,600 | 10,000 |
Unsettled sales of non-derivative financial instruments | ||
Derivative [Table] | ||
Derivative financial assets | 200 | 200 |
Notional amounts related to derivative financial assets | 18,200 | 17,200 |
Derivative financial liabilities | 100 | 300 |
Notional amounts related to derivative financial liabilities | 9,400 | 12,900 |
Over-the-counter (OTC) contracts | Loan commitments measured at FVTPL | ||
Derivative [Table] | ||
Derivative financial liabilities | 0 | 0 |
Notional amounts related to derivative financial liabilities | 8,200 | 10,200 |
Forward contracts | Over-the-counter (OTC) contracts | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 100 | 0 |
Notional amounts related to derivative financial assets | 29,400 | 19,800 |
Derivative financial liabilities | 200 | 400 |
Notional amounts related to derivative financial liabilities | 28,600 | 21,900 |
Other amounts values | 443,600 | 2,602,500 |
Forward contracts | Over-the-counter (OTC) contracts | Foreign exchange contracts | ||
Derivative [Table] | ||
Derivative financial assets | 23,800 | 27,300 |
Notional amounts related to derivative financial assets | 1,008,900 | 779,100 |
Derivative financial liabilities | 23,800 | 29,000 |
Notional amounts related to derivative financial liabilities | 1,043,200 | 853,300 |
Forward contracts | Exchange-traded derivatives (ETD) | Commodity contracts | ||
Derivative [Table] | ||
Notional amounts related to derivative financial assets | 18,100 | 8,000 |
Notional amounts related to derivative financial liabilities | 15,200 | 6,300 |
Swaps | Over-the-counter (OTC) contracts | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 26,400 | 40,800 |
Notional amounts related to derivative financial assets | 394,300 | 407,000 |
Derivative financial liabilities | 19,200 | 30,900 |
Notional amounts related to derivative financial liabilities | 344,100 | 364,800 |
Other amounts values | 7,549,400 | 8,105,200 |
Swaps | Over-the-counter (OTC) contracts | Foreign exchange contracts | ||
Derivative [Table] | ||
Derivative financial assets | 24,300 | 34,300 |
Notional amounts related to derivative financial assets | 1,606,300 | 1,727,300 |
Derivative financial liabilities | 24,900 | 34,400 |
Notional amounts related to derivative financial liabilities | 1,480,300 | 1,567,300 |
Swaps | Over-the-counter (OTC) contracts | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 4,700 | 6,400 |
Notional amounts related to derivative financial assets | 105,700 | 89,400 |
Derivative financial liabilities | 9,300 | 9,800 |
Notional amounts related to derivative financial liabilities | 154,800 | 108,400 |
Swaps | Over-the-counter (OTC) contracts | Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 500 | 500 |
Notional amounts related to derivative financial assets | 19,900 | 17,700 |
Derivative financial liabilities | 800 | 800 |
Notional amounts related to derivative financial liabilities | 25,400 | 18,000 |
Options | Over-the-counter (OTC) contracts | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 6,600 | 10,100 |
Notional amounts related to derivative financial assets | 545,200 | 447,500 |
Derivative financial liabilities | 9,200 | 12,500 |
Notional amounts related to derivative financial liabilities | 553,600 | 460,500 |
Options | Over-the-counter (OTC) contracts | Foreign exchange contracts | ||
Derivative [Table] | ||
Derivative financial assets | 5,200 | 7,100 |
Notional amounts related to derivative financial assets | 412,600 | 440,900 |
Derivative financial liabilities | 5,300 | 7,100 |
Notional amounts related to derivative financial liabilities | 408,600 | 394,700 |
Options | Over-the-counter (OTC) contracts | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 4,600 | 7,000 |
Notional amounts related to derivative financial assets | 61,400 | 87,100 |
Derivative financial liabilities | 6,500 | 10,900 |
Notional amounts related to derivative financial liabilities | 102,300 | 146,200 |
Options | Over-the-counter (OTC) contracts | Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 400 | 1,000 |
Notional amounts related to derivative financial assets | 14,000 | 23,500 |
Derivative financial liabilities | 200 | 700 |
Notional amounts related to derivative financial liabilities | 10,400 | 17,800 |
Options | Exchange-traded derivatives (ETD) | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 0 | 0 |
Notional amounts related to derivative financial assets | 22,400 | 53,600 |
Derivative financial liabilities | 0 | 0 |
Notional amounts related to derivative financial liabilities | 16,800 | 33,100 |
Other amounts values | 157,100 | 103,300 |
Options | Exchange-traded derivatives (ETD) | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 10,200 | 10,700 |
Notional amounts related to derivative financial assets | 289,600 | 273,100 |
Derivative financial liabilities | 9,800 | 11,300 |
Notional amounts related to derivative financial liabilities | 346,300 | 326,800 |
Other amounts values | 8,800 | 23,500 |
Futures | Exchange-traded derivatives (ETD) | Interest rate contracts | ||
Derivative [Table] | ||
Other amounts values | 525,000 | 480,600 |
Futures | Exchange-traded derivatives (ETD) | Equity contracts | ||
Derivative [Table] | ||
Other amounts values | 71,200 | 67,900 |
Futures | Exchange-traded derivatives (ETD) | Commodity contracts | ||
Derivative [Table] | ||
Other amounts values | 13,900 | 9,300 |
Client-cleared transactions | Exchange-traded derivatives (ETD) | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 8,600 | 10,700 |
Derivative financial liabilities | 9,400 | 9,100 |
Client-cleared transactions | Exchange-traded derivatives (ETD) | Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 600 | 500 |
Derivative financial liabilities | 400 | 300 |
Credit default swaps | Over-the-counter (OTC) contracts | Credit derivative contracts | ||
Derivative [Table] | ||
Derivative financial assets | 1,300 | 2,200 |
Notional amounts related to derivative financial assets | 39,400 | 53,600 |
Derivative financial liabilities | 1,600 | 2,600 |
Notional amounts related to derivative financial liabilities | 44,100 | 62,300 |
Total return swaps | Over-the-counter (OTC) contracts | Credit derivative contracts | ||
Derivative [Table] | ||
Derivative financial assets | 100 | 100 |
Notional amounts related to derivative financial assets | 1,300 | 1,900 |
Derivative financial liabilities | 200 | 300 |
Notional amounts related to derivative financial liabilities | 1,700 | 2,500 |
UBS AG | ||
Derivative [Table] | ||
Derivative financial assets | 118,145 | 159,618 |
Notional amounts related to derivative financial assets | 4,614,000 | 4,479,600 |
Derivative financial liabilities | 121,309 | 161,102 |
Notional amounts related to derivative financial liabilities | 4,616,600 | 4,429,700 |
Other amounts values | 8,771,100 | 11,394,400 |
UBS AG | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 33,200 | 50,900 |
Notional amounts related to derivative financial assets | 991,200 | 928,000 |
Derivative financial liabilities | 28,700 | 43,900 |
Notional amounts related to derivative financial liabilities | 943,100 | 880,400 |
Other amounts values | 8,675,100 | 11,291,500 |
UBS AG | Credit derivative contracts | ||
Derivative [Table] | ||
Derivative financial assets | 1,400 | 2,400 |
Notional amounts related to derivative financial assets | 44,700 | 57,600 |
Derivative financial liabilities | 1,800 | 2,900 |
Notional amounts related to derivative financial liabilities | 46,300 | 64,800 |
UBS AG | Foreign exchange contracts | ||
Derivative [Table] | ||
Derivative financial assets | 53,300 | 68,700 |
Notional amounts related to derivative financial assets | 3,031,000 | 2,951,200 |
Derivative financial liabilities | 54,100 | 70,500 |
Notional amounts related to derivative financial liabilities | 2,938,800 | 2,820,400 |
Other amounts values | 1,200 | 1,400 |
UBS AG | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 28,200 | 34,800 |
Notional amounts related to derivative financial assets | 456,900 | 449,600 |
Derivative financial liabilities | 34,900 | 41,200 |
Notional amounts related to derivative financial liabilities | 603,900 | 581,300 |
Other amounts values | 80,100 | 91,300 |
UBS AG | Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 1,600 | 2,200 |
Notional amounts related to derivative financial assets | 57,800 | 57,800 |
Derivative financial liabilities | 1,600 | 2,000 |
Notional amounts related to derivative financial liabilities | 56,400 | 49,700 |
Other amounts values | 14,700 | 10,100 |
UBS AG | Loan commitments measured at FVTPL | ||
Derivative [Table] | ||
Notional amounts related to derivative financial assets | 800 | |
UBS AG | Unsettled purchases of non-derivative financial instruments | ||
Derivative [Table] | ||
Derivative financial assets | 100 | 300 |
Notional amounts related to derivative financial assets | 13,300 | 18,300 |
Derivative financial liabilities | 200 | 200 |
Notional amounts related to derivative financial liabilities | 10,600 | 10,000 |
UBS AG | Unsettled sales of non-derivative financial instruments | ||
Derivative [Table] | ||
Derivative financial assets | 200 | 200 |
Notional amounts related to derivative financial assets | 18,200 | 17,200 |
Derivative financial liabilities | 100 | 300 |
Notional amounts related to derivative financial liabilities | 9,400 | 12,900 |
UBS AG | Over-the-counter (OTC) contracts | Loan commitments measured at FVTPL | ||
Derivative [Table] | ||
Derivative financial liabilities | 0 | 0 |
Notional amounts related to derivative financial liabilities | 8,200 | 10,200 |
UBS AG | Forward contracts | Over-the-counter (OTC) contracts | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 100 | 0 |
Notional amounts related to derivative financial assets | 29,400 | 19,800 |
Derivative financial liabilities | 200 | 400 |
Notional amounts related to derivative financial liabilities | 28,600 | 21,900 |
Other amounts values | 443,600 | 2,602,500 |
UBS AG | Forward contracts | Over-the-counter (OTC) contracts | Foreign exchange contracts | ||
Derivative [Table] | ||
Derivative financial assets | 23,800 | 27,300 |
Notional amounts related to derivative financial assets | 1,009,100 | 779,200 |
Derivative financial liabilities | 23,800 | 29,000 |
Notional amounts related to derivative financial liabilities | 1,043,200 | 853,300 |
UBS AG | Forward contracts | Exchange-traded derivatives (ETD) | Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 0 | 0 |
Notional amounts related to derivative financial assets | 18,100 | 8,000 |
Derivative financial liabilities | 0 | 0 |
Notional amounts related to derivative financial liabilities | 15,200 | 6,300 |
UBS AG | Swaps | Over-the-counter (OTC) contracts | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 26,400 | 40,800 |
Notional amounts related to derivative financial assets | 394,300 | 407,000 |
Derivative financial liabilities | 19,200 | 30,900 |
Notional amounts related to derivative financial liabilities | 344,100 | 364,800 |
Other amounts values | 7,549,400 | 8,105,200 |
UBS AG | Swaps | Over-the-counter (OTC) contracts | Foreign exchange contracts | ||
Derivative [Table] | ||
Derivative financial assets | 24,300 | 34,300 |
Notional amounts related to derivative financial assets | 1,606,400 | 1,727,300 |
Derivative financial liabilities | 24,900 | 34,400 |
Notional amounts related to derivative financial liabilities | 1,480,300 | 1,567,300 |
UBS AG | Swaps | Over-the-counter (OTC) contracts | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 4,700 | 6,400 |
Notional amounts related to derivative financial assets | 105,700 | 89,400 |
Derivative financial liabilities | 9,300 | 9,800 |
Notional amounts related to derivative financial liabilities | 154,800 | 108,400 |
UBS AG | Swaps | Over-the-counter (OTC) contracts | Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 500 | 500 |
Notional amounts related to derivative financial assets | 19,900 | 17,700 |
Derivative financial liabilities | 800 | 800 |
Notional amounts related to derivative financial liabilities | 25,400 | 18,000 |
UBS AG | Options | Over-the-counter (OTC) contracts | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 6,600 | 10,100 |
Notional amounts related to derivative financial assets | 545,200 | 447,500 |
Derivative financial liabilities | 9,200 | 12,500 |
Notional amounts related to derivative financial liabilities | 553,600 | 460,500 |
UBS AG | Options | Over-the-counter (OTC) contracts | Foreign exchange contracts | ||
Derivative [Table] | ||
Derivative financial assets | 5,200 | 7,100 |
Notional amounts related to derivative financial assets | 412,600 | 440,900 |
Derivative financial liabilities | 5,300 | 7,100 |
Notional amounts related to derivative financial liabilities | 408,600 | 394,700 |
UBS AG | Options | Over-the-counter (OTC) contracts | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 4,600 | 7,000 |
Notional amounts related to derivative financial assets | 61,400 | 87,100 |
Derivative financial liabilities | 6,500 | 10,900 |
Notional amounts related to derivative financial liabilities | 102,300 | 146,200 |
UBS AG | Options | Over-the-counter (OTC) contracts | Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 400 | 1,000 |
Notional amounts related to derivative financial assets | 14,000 | 23,500 |
Derivative financial liabilities | 200 | 700 |
Notional amounts related to derivative financial liabilities | 10,400 | 17,800 |
UBS AG | Options | Exchange-traded derivatives (ETD) | Interest rate contracts | ||
Derivative [Table] | ||
Derivative financial assets | 0 | 0 |
Notional amounts related to derivative financial assets | 22,400 | 53,600 |
Derivative financial liabilities | 0 | 0 |
Notional amounts related to derivative financial liabilities | 16,800 | 33,100 |
Other amounts values | 157,100 | 103,300 |
UBS AG | Options | Exchange-traded derivatives (ETD) | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 10,200 | 10,700 |
Notional amounts related to derivative financial assets | 289,600 | 273,100 |
Derivative financial liabilities | 9,800 | 11,300 |
Notional amounts related to derivative financial liabilities | 346,300 | 326,800 |
Other amounts values | 8,800 | 23,500 |
UBS AG | Futures | Exchange-traded derivatives (ETD) | Interest rate contracts | ||
Derivative [Table] | ||
Other amounts values | 525,000 | 480,600 |
UBS AG | Futures | Exchange-traded derivatives (ETD) | Equity contracts | ||
Derivative [Table] | ||
Other amounts values | 71,200 | 67,900 |
UBS AG | Futures | Exchange-traded derivatives (ETD) | Commodity contracts | ||
Derivative [Table] | ||
Other amounts values | 13,900 | 9,300 |
UBS AG | Client-cleared transactions | Exchange-traded derivatives (ETD) | Equity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 8,600 | 10,700 |
Derivative financial liabilities | 9,400 | 9,100 |
UBS AG | Client-cleared transactions | Exchange-traded derivatives (ETD) | Commodity contracts | ||
Derivative [Table] | ||
Derivative financial assets | 600 | 500 |
Derivative financial liabilities | 400 | 300 |
UBS AG | Credit default swaps | Over-the-counter (OTC) contracts | Credit derivative contracts | ||
Derivative [Table] | ||
Derivative financial assets | 1,300 | 2,200 |
Notional amounts related to derivative financial assets | 39,400 | 53,600 |
Derivative financial liabilities | 1,600 | 2,600 |
Notional amounts related to derivative financial liabilities | 44,100 | 62,300 |
UBS AG | Total return swaps | Over-the-counter (OTC) contracts | Credit derivative contracts | ||
Derivative [Table] | ||
Derivative financial assets | 100 | 100 |
Notional amounts related to derivative financial assets | 1,300 | 1,900 |
Derivative financial liabilities | 200 | 300 |
Notional amounts related to derivative financial liabilities | $ 1,700 | $ 2,500 |
Financial assets measured at _3
Financial assets measured at fair value through OCI (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Debt instruments | ||
Government and government agencies | $ 8,522 | $ 8,155 |
of which: USA | 7,507 | 7,727 |
Banks | 322 | 103 |
Total financial assets measured at fair value through other comprehensive income | 8,844 | 8,258 |
Unrealized gains - before tax | 67 | 204 |
Unrealized (losses) - before tax | (80) | (4) |
Net unrealized gains / (losses) - before tax | (13) | 200 |
Net unrealized gains / (losses) - after tax | (7) | 151 |
UBS AG | ||
Debt instruments | ||
Government and government agencies | 8,522 | 8,155 |
of which: USA | 7,507 | 7,727 |
Banks | 322 | 103 |
Total financial assets measured at fair value through other comprehensive income | 8,844 | 8,258 |
Unrealized gains - before tax | 67 | 204 |
Unrealized (losses) - before tax | (80) | (4) |
Net unrealized gains / (losses) - before tax | (13) | 200 |
Net unrealized gains / (losses) - after tax | $ (7) | $ 151 |
Property, equipment and softw_3
Property, equipment and software (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | $ 13,109 | $ 12,804 |
Balance at the end of the year | 12,888 | 13,109 |
Cash outflows on lease | 657 | 679 |
Net gains / (losses) arising from sale-and-leaseback transactions | 140 | |
Internally generated software in progress | 1,087 | |
Own use properties in progress | 163 | |
Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 26,238 | 24,431 |
Additions | 2,090 | 2,312 |
Disposals / write-offs | (751) | (990) |
Reclassifications | (18) | (590) |
Foreign currency translation | (445) | 1,074 |
Balance at the end of the year | 27,113 | 26,238 |
Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 13,129 | 11,628 |
Depreciation | 2,078 | 1,997 |
Impairment | 10 | 72 |
Disposals / write-offs | (737) | (855) |
Reclassifications | (12) | (328) |
Foreign currency translation | (243) | 616 |
Balance at the end of the year | 14,225 | 13,129 |
Owned properties and equipment | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 5,126 | |
Balance at the end of the year | 4,976 | 5,126 |
Owned properties and equipment | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 13,185 | |
Additions | 273 | |
Disposals / write-offs | (430) | |
Reclassifications | 323 | |
Foreign currency translation | (303) | |
Balance at the end of the year | 13,048 | 13,185 |
Owned properties and equipment | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 8,060 | |
Depreciation | 635 | |
Impairment | 9 | |
Disposals / write-offs | (424) | |
Reclassifications | (12) | |
Foreign currency translation | (196) | |
Balance at the end of the year | 8,072 | 8,060 |
Leased properties and equipment | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 3,167 | |
Balance at the end of the year | 2,828 | 3,167 |
Leased properties and equipment | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 4,249 | |
Additions | 213 | |
Disposals / write-offs | (223) | |
Reclassifications | 0 | |
Foreign currency translation | (66) | |
Balance at the end of the year | 4,174 | 4,249 |
Leased properties and equipment | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 1,082 | |
Depreciation | 498 | |
Impairment | 1 | |
Disposals / write-offs | (215) | |
Reclassifications | 0 | |
Foreign currency translation | (20) | |
Balance at the end of the year | 1,346 | 1,082 |
Software | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 3,780 | |
Balance at the end of the year | 3,835 | 3,780 |
Software | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 7,768 | |
Additions | 228 | |
Disposals / write-offs | (98) | |
Reclassifications | 808 | |
Foreign currency translation | (64) | |
Balance at the end of the year | 8,642 | 7,768 |
Software | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 3,987 | |
Depreciation | 945 | |
Impairment | 0 | |
Disposals / write-offs | (98) | |
Reclassifications | 0 | |
Foreign currency translation | (28) | |
Balance at the end of the year | 4,807 | 3,987 |
Projects in progress | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 1,036 | |
Balance at the end of the year | 1,250 | 1,036 |
Projects in progress | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 1,036 | |
Additions | 1,376 | |
Disposals / write-offs | 0 | |
Reclassifications | (1,149) | |
Foreign currency translation | (12) | |
Balance at the end of the year | 1,250 | 1,036 |
Projects in progress | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 0 | |
Depreciation | 0 | |
Impairment | 0 | |
Disposals / write-offs | 0 | |
Reclassifications | 0 | |
Foreign currency translation | 0 | |
Balance at the end of the year | 0 | 0 |
UBS AG | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 11,958 | 11,826 |
Balance at the end of the year | 11,712 | 11,958 |
Net gains / (losses) arising from sale-and-leaseback transactions | 140 | |
UBS AG | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 23,785 | 22,329 |
Additions | 1,789 | 1,989 |
Disposals / write-offs | (632) | (867) |
Reclassifications | (18) | (590) |
Foreign currency translation | (381) | 924 |
Balance at the end of the year | 24,542 | 23,785 |
UBS AG | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 11,827 | 10,503 |
Depreciation | 1,835 | 1,779 |
Impairment | 9 | 72 |
Disposals / write-offs | (619) | (735) |
Reclassifications | (12) | (328) |
Foreign currency translation | (210) | 535 |
Balance at the end of the year | 12,830 | 11,827 |
UBS AG | Owned properties and equipment | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 4,488 | |
Balance at the end of the year | 4,316 | 4,488 |
UBS AG | Owned properties and equipment | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 11,676 | |
Additions | 162 | |
Disposals / write-offs | (345) | |
Reclassifications | 267 | |
Foreign currency translation | (266) | |
Balance at the end of the year | 11,494 | 11,676 |
UBS AG | Owned properties and equipment | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 7,188 | |
Depreciation | 507 | |
Impairment | 8 | |
Disposals / write-offs | (341) | |
Reclassifications | (12) | |
Foreign currency translation | (172) | |
Balance at the end of the year | 7,178 | 7,188 |
UBS AG | Leased properties and equipment | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 3,072 | |
Balance at the end of the year | 2,722 | 3,072 |
Cash outflows on lease | 632 | 652 |
UBS AG | Leased properties and equipment | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 4,091 | |
Additions | 174 | |
Disposals / write-offs | (212) | |
Reclassifications | 0 | |
Foreign currency translation | (59) | |
Balance at the end of the year | 3,994 | 4,091 |
UBS AG | Leased properties and equipment | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 1,019 | |
Depreciation | 474 | |
Impairment | 1 | |
Disposals / write-offs | (204) | |
Reclassifications | 0 | |
Foreign currency translation | (18) | |
Balance at the end of the year | 1,272 | 1,019 |
UBS AG | Software | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 3,490 | |
Balance at the end of the year | 3,544 | 3,490 |
UBS AG | Software | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 7,111 | |
Additions | 233 | |
Disposals / write-offs | (75) | |
Reclassifications | 703 | |
Foreign currency translation | (48) | |
Balance at the end of the year | 7,924 | 7,111 |
UBS AG | Software | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 3,621 | |
Depreciation | 854 | |
Impairment | 0 | |
Disposals / write-offs | (75) | |
Reclassifications | 0 | |
Foreign currency translation | (19) | |
Balance at the end of the year | 4,380 | 3,621 |
UBS AG | Projects in progress | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 907 | |
Balance at the end of the year | 1,130 | 907 |
Internally generated software in progress | 1,009 | |
Own use properties in progress | 121 | |
UBS AG | Projects in progress | Historical cost | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 907 | |
Additions | 1,220 | |
Disposals / write-offs | 0 | |
Reclassifications | (988) | |
Foreign currency translation | (9) | |
Balance at the end of the year | 1,130 | 907 |
UBS AG | Projects in progress | Accumulated depreciation | ||
Disclosure Of Property Equipment Software [Table] | ||
Balance at the beginning of the year | 0 | |
Depreciation | 0 | |
Impairment | 0 | |
Disposals / write-offs | 0 | |
Reclassifications | 0 | |
Foreign currency translation | 0 | |
Balance at the end of the year | $ 0 | $ 0 |
Goodwill and intangible asset_2
Goodwill and intangible assets (Narrative) (Detail) $ in Billions | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | |
Goodwill | $ 6.1 |
Change in forecast earnings available to shareholders used for goodwill impairment sensitivity analysis | 20.00% |
Change in discount rates used for goodwill impairment sensitivity analysis | 1.50% |
Change in long-term growth rates used for goodwill impairment sensitivity analysis | 0.75% |
Increase / (decrease) in other notional amounts | $ (2,600) |
Global Wealth Management Americas | |
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | |
Goodwill | 3.7 |
Global Wealth Management Switzerland and International | |
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | |
Goodwill | 1.2 |
Segment AM Member [Member] | |
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | |
Goodwill | 1.2 |
UBS AG | |
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | |
Goodwill | $ 6.1 |
Change in forecast earnings available to shareholders used for goodwill impairment sensitivity analysis | 20.00% |
Change in discount rates used for goodwill impairment sensitivity analysis | 1.50% |
Change in long-term growth rates used for goodwill impairment sensitivity analysis | 0.75% |
Increase / (decrease) in other notional amounts | $ (2,600) |
UBS AG | Global Wealth Management Americas | |
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | |
Goodwill | 3.7 |
UBS AG | Global Wealth Management Switzerland and International | |
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | |
Goodwill | 1.2 |
UBS AG | Segment AM Member [Member] | |
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | |
Goodwill | $ 1.2 |
Goodwill and intangible asset_3
Goodwill and intangible assets (Detail 1) | Dec. 31, 2021 | Dec. 31, 2020 |
Global Wealth Management Americas | ||
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | ||
Growth rates | 4.00% | 5.10% |
Discount rates current year | 9.50% | |
Discount rates previous year | 9.50% | |
Global Wealth Management Switzerland and International | ||
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | ||
Growth rates | 3.10% | 3.70% |
Discount rates current year | 8.50% | |
Discount rates previous year | 8.50% | |
Asset Management | ||
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | ||
Growth rates | 2.90% | 3.50% |
Discount rates current year | 8.50% | |
Discount rates previous year | 8.50% | |
UBS AG | Global Wealth Management Americas | ||
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | ||
Growth rates | 4.00% | 5.10% |
Discount rates current year | 9.50% | |
Discount rates previous year | 9.50% | |
UBS AG | Global Wealth Management Switzerland and International | ||
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | ||
Growth rates | 3.10% | 3.70% |
Discount rates current year | 8.50% | |
Discount rates previous year | 8.50% | |
UBS AG | Asset Management | ||
Disclosure Of Information For Individual Asset Or Cashgenerating Unit With Significant Amount Of Goodwill Or Intangible Assets With Indefinite Useful Lives [Table] | ||
Growth rates | 2.90% | 3.50% |
Discount rates current year | 8.50% | |
Discount rates previous year | 8.50% |
Goodwill and intangible asset_4
Goodwill and intangible assets (Detail 2) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | $ 6,480 | |
Balance at the end of the year | 6,378 | $ 6,480 |
of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 3,770 | |
Balance at the end of the year | 3,760 | 3,770 |
of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,320 | |
Balance at the end of the year | 1,276 | 1,320 |
of which: Asset Management | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,226 | |
Balance at the end of the year | 1,202 | 1,226 |
of which: Investment Bank | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 161 | |
Balance at the end of the year | 139 | 161 |
of which: Group Functions | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 4 | |
Balance at the end of the year | 0 | 4 |
Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 7,865 | 7,820 |
Additions | 1 | 147 |
Disposals | (3) | (158) |
Write-offs | (41) | (35) |
Foreign currency translation | (83) | 91 |
Balance at the end of the year | 7,739 | 7,865 |
Accumulated amortization and impairment | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,385 | 1,351 |
Amortization | 31 | 55 |
Impairment | (1) | 2 |
Disposals | 0 | 0 |
Write-offs | (41) | (35) |
Foreign currency translation | (13) | 11 |
Balance at the end of the year | 1,360 | 1,385 |
Goodwill | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 6,126 | |
Goodwill | of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 3,720 | |
Goodwill | of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 1,204 | |
Goodwill | of which: Asset Management | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 1,202 | |
Goodwill | Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 6,182 | |
Disposals | (3) | |
Foreign currency translation | (53) | |
Balance at the end of the year | 6,126 | 6,182 |
Intangible assets | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 252 | |
Intangible assets | of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 41 | |
Intangible assets | of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 72 | |
Intangible assets | of which: Investment Bank | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 139 | |
Intangible assets | Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,683 | |
Additions | 1 | |
Write-offs | (41) | |
Foreign currency translation | (30) | |
Balance at the end of the year | 1,612 | 1,683 |
Intangible assets | Accumulated amortization and impairment | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,385 | |
Amortization | 31 | |
Impairment | (1) | |
Write-offs | (41) | |
Foreign currency translation | (13) | |
Balance at the end of the year | 1,360 | 1,385 |
Recoverable amount of the impaired assets | 5 | |
UBS AG | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 6,480 | |
Balance at the end of the year | 6,378 | 6,480 |
UBS AG | of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 3,770 | |
Balance at the end of the year | 3,760 | 3,770 |
UBS AG | of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,320 | |
Balance at the end of the year | 1,276 | 1,320 |
UBS AG | of which: Asset Management | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,226 | |
Balance at the end of the year | 1,202 | 1,226 |
UBS AG | of which: Investment Bank | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 161 | |
Balance at the end of the year | 139 | 161 |
UBS AG | of which: Group Functions | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 4 | |
Balance at the end of the year | 0 | 4 |
UBS AG | Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 7,865 | 7,820 |
Additions | 1 | 147 |
Disposals | (3) | (158) |
Write-offs | (41) | (35) |
Foreign currency translation | (83) | 91 |
Balance at the end of the year | 7,739 | 7,865 |
UBS AG | Accumulated amortization and impairment | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,385 | 1,351 |
Amortization | 31 | 55 |
Impairment | (1) | 2 |
Disposals | 0 | 0 |
Write-offs | (41) | (35) |
Foreign currency translation | (13) | 11 |
Balance at the end of the year | 1,360 | 1,385 |
UBS AG | Goodwill | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 6,126 | |
UBS AG | Goodwill | of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 3,720 | |
UBS AG | Goodwill | of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 1,204 | |
UBS AG | Goodwill | of which: Asset Management | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 1,202 | |
UBS AG | Goodwill | Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 6,182 | |
Disposals | (3) | |
Foreign currency translation | (53) | |
Balance at the end of the year | 6,126 | 6,182 |
UBS AG | Intangible assets | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 252 | |
UBS AG | Intangible assets | of which: Global Wealth Management Americas | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 41 | |
UBS AG | Intangible assets | of which: Global Wealth Management Switzerland and International | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 72 | |
UBS AG | Intangible assets | of which: Investment Bank | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the end of the year | 139 | |
UBS AG | Intangible assets | Historical cost | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,683 | |
Additions | 1 | |
Write-offs | (41) | |
Foreign currency translation | (30) | |
Balance at the end of the year | 1,612 | 1,683 |
UBS AG | Intangible assets | Accumulated amortization and impairment | ||
Disclosure Of Reconciliation Of Changes In Intangible Assets And Goodwill [Table] | ||
Balance at the beginning of the year | 1,385 | |
Amortization | 31 | |
Impairment | (1) | |
Write-offs | (41) | |
Foreign currency translation | (13) | |
Balance at the end of the year | $ 1,360 | 1,385 |
Recoverable amount of the impaired assets | $ 5 |
Goodwill and intangible asset_5
Goodwill and intangible assets (Detail 3) $ in Millions | Dec. 31, 2021USD ($) |
Entity [Table] | |
2022 | $ 29 |
2023 | 27 |
2024 | 23 |
2025 | 23 |
2026 | 23 |
Thereafter | 126 |
Not amortized due to indefinite useful life | 2 |
Total | 252 |
UBS AG | |
Entity [Table] | |
2022 | 29 |
2023 | 27 |
2024 | 23 |
2025 | 23 |
2026 | 23 |
Thereafter | 126 |
Not amortized due to indefinite useful life | 2 |
Total | $ 252 |
Other financial assets measured
Other financial assets measured at amortized cost (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Debt securities | $ 18,858 | $ 18,801 |
of which: government bills / bonds | 9,833 | 9,789 |
Loans to financial advisors | 2,453 | 2,569 |
Fee- and commission-related receivables | 1,972 | 2,014 |
Finance lease receivables | 1,356 | 1,447 |
Settlement and clearing accounts | 455 | 614 |
Accrued interest income | 520 | 591 |
Other | 594 | 1,158 |
Total other financial assets measured at amortized cost | 26,209 | 27,194 |
UBS AG | ||
Entity [Table] | ||
Debt securities | 18,858 | 18,801 |
of which: government bills / bonds | 9,833 | 9,789 |
Loans to financial advisors | 2,453 | 2,569 |
Fee- and commission-related receivables | 1,966 | 2,014 |
Finance lease receivables | 1,356 | 1,447 |
Settlement and clearing accounts | 455 | 614 |
Accrued interest income | 521 | 592 |
Other | 627 | 1,182 |
Total other financial assets measured at amortized cost | $ 26,236 | $ 27,219 |
Other non-financial assets (Det
Other non-financial assets (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Precious metals and other physical commodities | $ 5,258 | $ 6,264 |
Bail deposit | 1,526 | 1,418 |
Prepaid expenses | 1,108 | 1,081 |
VAT and other tax receivables | 638 | 433 |
Properties and other non-current assets held for sale | 32 | 246 |
Assets of disposal groups held for sale | 1,093 | |
Other | 621 | 326 |
Total other non-financial assets | 10,277 | 9,768 |
UBS AG | ||
Entity [Table] | ||
Precious metals and other physical commodities | 5,258 | 6,264 |
Bail deposit | 1,526 | 1,418 |
Prepaid expenses | 717 | 731 |
VAT and other tax receivables | 591 | 392 |
Properties and other non-current assets held for sale | 32 | 246 |
Assets of disposal groups held for sale | 1,093 | |
Other | 618 | 323 |
Total other non-financial assets | $ 9,836 | $ 9,374 |
Amounts due to banks and cust_3
Amounts due to banks and customer deposits (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Deposits From Customers [Table] | ||
Amounts due to banks | $ 13,101 | $ 11,050 |
Customer deposits | 542,007 | 524,605 |
of which: demand deposits | 246,417 | 236,447 |
of which: retail savings / deposits | 247,224 | 220,898 |
of which: time deposits | 48,365 | 67,260 |
Total amounts due to banks and customer deposits | 555,108 | 535,655 |
UBS AG | ||
Deposits From Customers [Table] | ||
Amounts due to banks | 13,101 | 11,050 |
Customer deposits | 544,834 | 527,929 |
of which: demand deposits | 247,299 | 237,604 |
of which: retail savings / deposits | 247,224 | 220,898 |
of which: time deposits | 50,312 | 69,427 |
Total amounts due to banks and customer deposits | $ 557,935 | $ 538,979 |
Funding from Group and other su
Funding from Group and other subsidiaries (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Senior unsecured debt that contributes to total loss-absorbing capacity (TLAC) | $ 2,136 | $ 1,190 |
High-trigger loss-absorbing additional tier 1 capital instruments | 11,052 | 11,837 |
Low-trigger loss-absorbing additional tier 1 capital instruments | 2,425 | 2,577 |
UBS AG | ||
Entity [Table] | ||
Senior unsecured debt that contributes to total loss-absorbing capacity (TLAC) | 38,984 | 36,611 |
Senior unsecured debt other than TLAC | 4,471 | 2,939 |
High-trigger loss-absorbing additional tier 1 capital instruments | 11,414 | 11,854 |
Low-trigger loss-absorbing additional tier 1 capital instruments | 2,426 | 2,575 |
Total | $ 57,295 | $ 53,979 |
Debt issued designated at fai_3
Debt issued designated at fair value (Detail 1) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Issued debt instruments | ||
Equity-linked | $ 47,059 | $ 41,069 |
Rates-linked | 16,369 | 11,038 |
Credit-linked | 1,723 | 1,933 |
Fixed-rate | 2,868 | 3,604 |
Commodity-linked | 2,911 | 1,497 |
Other | 2,868 | 2,101 |
of which: debt that contributes to total loss-absorbing capacity | 2,136 | 1,190 |
Total debt issued designated at fair value | 73,799 | 61,243 |
of which: issued by UBS AG with original maturity greater than one year | 57,967 | 46,427 |
of which: life-to-date own credit (gain) / loss | $ 347 | $ 418 |
Unsecured portion of issued debt instruments with original maturity greater than one year | 100.00% | 100.00% |
UBS AG | ||
Issued debt instruments | ||
Equity-linked | $ 47,059 | $ 41,069 |
Rates-linked | 16,369 | 11,038 |
Credit-linked | 1,723 | 1,933 |
Fixed-rate | 2,868 | 3,604 |
Commodity-linked | 2,911 | 1,497 |
Other | 529 | 726 |
of which: debt that contributes to total loss-absorbing capacity | 38,984 | 36,611 |
Total debt issued designated at fair value | 71,460 | 59,868 |
of which: issued by UBS AG with original maturity greater than one year | 57,967 | 46,427 |
of which: life-to-date own credit (gain) / loss | $ 144 | $ 233 |
Unsecured portion of issued debt instruments with original maturity greater than one year | 100.00% | 100.00% |
Debt issued designated at fai_4
Debt issued designated at fair value (Detail 2) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | $ 73,799 | $ 61,243 |
UBS Group AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,340 | 1,375 |
UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 70,682 | 58,937 |
UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,397 | 9,409 |
UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 61,284 | 49,528 |
Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 778 | 931 |
Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 429 | 539 |
Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 349 | 392 |
2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 23,791 | |
2022 | UBS Group AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2022 | UBS Group AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2022 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 23,635 | |
2022 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,296 | |
2022 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 19,338 | |
2022 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 156 | |
2022 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6 | |
2022 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 150 | |
2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 17,325 | |
2023 | UBS Group AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2023 | UBS Group AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2023 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 17,279 | |
2023 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,658 | |
2023 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 15,621 | |
2023 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 47 | |
2023 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2023 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 47 | |
2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,929 | |
2024 | UBS Group AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2024 | UBS Group AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2024 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,783 | |
2024 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 716 | |
2024 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,067 | |
2024 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 145 | |
2024 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2024 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 145 | |
2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,311 | |
2025 | UBS Group AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2025 | UBS Group AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2025 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,311 | |
2025 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 495 | |
2025 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,816 | |
2025 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2025 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2025 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,066 | |
2026 | UBS Group AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2026 | UBS Group AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2026 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,066 | |
2026 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 226 | |
2026 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,840 | |
2026 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2026 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2026 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,060 | |
2027-2031 | UBS Group AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2027-2031 | UBS Group AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
2027-2031 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 8,637 | |
2027-2031 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 273 | |
2027-2031 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 8,364 | |
2027-2031 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 423 | |
2027-2031 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 423 | |
2027-2031 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 7,317 | |
Thereafter | UBS Group AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,340 | |
Thereafter | UBS Group AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,340 | |
Thereafter | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,971 | |
Thereafter | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,732 | |
Thereafter | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,238 | |
Thereafter | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 7 | |
Thereafter | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
Thereafter | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 7 | |
UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 71,460 | 59,868 |
UBS AG | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 70,682 | 58,937 |
UBS AG | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,397 | 9,409 |
UBS AG | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 61,284 | 49,528 |
UBS AG | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 778 | 931 |
UBS AG | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 429 | 539 |
UBS AG | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 349 | $ 392 |
UBS AG | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 23,791 | |
UBS AG | 2022 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 23,635 | |
UBS AG | 2022 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,296 | |
UBS AG | 2022 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 19,338 | |
UBS AG | 2022 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 156 | |
UBS AG | 2022 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6 | |
UBS AG | 2022 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 150 | |
UBS AG | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 17,325 | |
UBS AG | 2023 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 17,279 | |
UBS AG | 2023 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,658 | |
UBS AG | 2023 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 15,621 | |
UBS AG | 2023 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 47 | |
UBS AG | 2023 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | 2023 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 47 | |
UBS AG | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,929 | |
UBS AG | 2024 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,783 | |
UBS AG | 2024 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 716 | |
UBS AG | 2024 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,067 | |
UBS AG | 2024 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 145 | |
UBS AG | 2024 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | 2024 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 145 | |
UBS AG | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,311 | |
UBS AG | 2025 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,311 | |
UBS AG | 2025 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 495 | |
UBS AG | 2025 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,816 | |
UBS AG | 2025 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | 2025 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | 2025 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,066 | |
UBS AG | 2026 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,066 | |
UBS AG | 2026 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 226 | |
UBS AG | 2026 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,840 | |
UBS AG | 2026 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | 2026 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | 2026 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,060 | |
UBS AG | 2027-2031 | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 8,637 | |
UBS AG | 2027-2031 | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 273 | |
UBS AG | 2027-2031 | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 8,364 | |
UBS AG | 2027-2031 | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 423 | |
UBS AG | 2027-2031 | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 423 | |
UBS AG | 2027-2031 | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,977 | |
UBS AG | Thereafter | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,971 | |
UBS AG | Thereafter | UBS AG | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,732 | |
UBS AG | Thereafter | UBS AG | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,238 | |
UBS AG | Thereafter | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 7 | |
UBS AG | Thereafter | Other subsidiaries | Fixed-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | Thereafter | Other subsidiaries | Floating-rate | Non-subordinated debt | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | $ 7 |
Debt issued measured at amort_2
Debt issued measured at amortized cost (Detail 1) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Certificates of deposit and commercial paper | $ 40,640 | $ 41,151 |
Other short-term debt | 2,458 | 5,515 |
Short-term debt | 43,098 | 46,666 |
Senior unsecured debt that contributes to total loss-absorbing capacity (TLAC) | 38,984 | 36,611 |
Senior unsecured debt other than TLAC | 27,590 | 21,340 |
of which: issued by UBS AG with original maturity greater than one year | 23,307 | 18,464 |
Covered bonds | 1,389 | 2,796 |
Subordinated debt | 18,640 | 22,157 |
of which: high-trigger loss-absorbing additional tier 1 capital instruments | 11,052 | 11,837 |
of which: low-trigger loss-absorbing additional tier 1 capital instruments | 2,425 | 2,577 |
of which: low-trigger loss-absorbing tier 2 capital instruments | 2,596 | 7,201 |
of which: non-Basel III-compliant tier 2 capital instruments | 547 | 543 |
Debt issued through the Swiss central mortgage institutions | 9,454 | 9,660 |
Other long-term debt | 0 | 3 |
Long-term debt | 96,057 | 92,566 |
Total debt issued measured at amortized cost | $ 139,155 | $ 139,232 |
Unsecured portion of senior fixed-rate bonds issued with maturity greater than one year | 100.00% | 100.00% |
UBS AG | ||
Entity [Table] | ||
Certificates of deposit and commercial paper | $ 41,151 | $ 40,640 |
Other short-term debt | 2,458 | 5,515 |
Short-term debt | 43,098 | 46,666 |
Senior unsecured debt other than TLAC | 23,328 | 18,483 |
of which: issued by UBS AG with original maturity greater than one year | 23,307 | 18,464 |
Covered bonds | 1,389 | 2,796 |
Subordinated debt | 5,163 | 7,744 |
of which: high-trigger loss-absorbing additional tier 1 capital instruments | 11,414 | 11,854 |
of which: low-trigger loss-absorbing additional tier 1 capital instruments | 2,426 | 2,575 |
of which: low-trigger loss-absorbing tier 2 capital instruments | 2,596 | 7,201 |
of which: non-Basel III-compliant tier 2 capital instruments | 547 | 543 |
Debt issued through the Swiss central mortgage institutions | 9,454 | 9,660 |
Other long-term debt | 0 | 3 |
Long-term debt | 39,334 | 38,685 |
Total debt issued measured at amortized cost | $ 82,432 | $ 85,351 |
Unsecured portion of senior fixed-rate bonds issued with maturity greater than one year | 100.00% | 100.00% |
Debt issued measured at amort_3
Debt issued measured at amortized cost (Detail 2) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | $ 139,155 | $ 139,232 |
2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 55,642 | |
2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 14,889 | |
2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 12,698 | |
2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 7,818 | |
2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 11,951 | |
2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 17,590 | |
Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 18,566 | |
UBS Group AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 56,722 | 53,881 |
UBS Group AG | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,261 | |
UBS Group AG | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,211 | |
UBS Group AG | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,145 | |
UBS Group AG | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,052 | |
UBS Group AG | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,748 | |
UBS Group AG | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 12,534 | |
UBS Group AG | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 16,771 | |
UBS Group AG | Non-subordinated debt | Fixed-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 40,569 | 33,578 |
UBS Group AG | Non-subordinated debt | Fixed-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,769 | |
UBS Group AG | Non-subordinated debt | Fixed-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,027 | |
UBS Group AG | Non-subordinated debt | Fixed-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,145 | |
UBS Group AG | Non-subordinated debt | Fixed-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,052 | |
UBS Group AG | Non-subordinated debt | Fixed-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,748 | |
UBS Group AG | Non-subordinated debt | Fixed-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 12,534 | |
UBS Group AG | Non-subordinated debt | Fixed-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,294 | |
UBS Group AG | Non-subordinated debt | Floating-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,676 | 5,890 |
UBS Group AG | Non-subordinated debt | Floating-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 492 | |
UBS Group AG | Non-subordinated debt | Floating-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,183 | |
UBS Group AG | Non-subordinated debt | Floating-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Non-subordinated debt | Floating-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Non-subordinated debt | Floating-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Non-subordinated debt | Floating-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Non-subordinated debt | Floating-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Subordinated debt | Fixed-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 13,477 | 14,413 |
UBS Group AG | Subordinated debt | Fixed-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Subordinated debt | Fixed-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Subordinated debt | Fixed-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Subordinated debt | Fixed-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Subordinated debt | Fixed-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Subordinated debt | Fixed-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS Group AG | Subordinated debt | Fixed-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 13,477 | |
UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 72,972 | 75,661 |
UBS AG | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 50,474 | |
UBS AG | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 7,671 | |
UBS AG | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,482 | |
UBS AG | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,594 | |
UBS AG | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,158 | |
UBS AG | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,381 | |
UBS AG | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,213 | |
UBS AG | Non-subordinated debt | Fixed-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 52,571 | 52,618 |
UBS AG | Non-subordinated debt | Fixed-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 38,647 | |
UBS AG | Non-subordinated debt | Fixed-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,578 | |
UBS AG | Non-subordinated debt | Fixed-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,964 | |
UBS AG | Non-subordinated debt | Fixed-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 349 | |
UBS AG | Non-subordinated debt | Fixed-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,439 | |
UBS AG | Non-subordinated debt | Fixed-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,381 | |
UBS AG | Non-subordinated debt | Fixed-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,213 | |
UBS AG | Non-subordinated debt | Floating-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 15,238 | 15,299 |
UBS AG | Non-subordinated debt | Floating-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,807 | |
UBS AG | Non-subordinated debt | Floating-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,093 | |
UBS AG | Non-subordinated debt | Floating-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,922 | |
UBS AG | Non-subordinated debt | Floating-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 907 | |
UBS AG | Non-subordinated debt | Floating-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 508 | |
UBS AG | Non-subordinated debt | Floating-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | Non-subordinated debt | Floating-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | Subordinated debt | Fixed-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,163 | 7,744 |
UBS AG | Subordinated debt | Fixed-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,020 | |
UBS AG | Subordinated debt | Fixed-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | Subordinated debt | Fixed-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,596 | |
UBS AG | Subordinated debt | Fixed-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 337 | |
UBS AG | Subordinated debt | Fixed-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 210 | |
UBS AG | Subordinated debt | Fixed-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | Subordinated debt | Fixed-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,460 | 9,690 |
Other subsidiaries | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 907 | |
Other subsidiaries | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,007 | |
Other subsidiaries | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,072 | |
Other subsidiaries | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,173 | |
Other subsidiaries | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,045 | |
Other subsidiaries | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,674 | |
Other subsidiaries | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 582 | |
Other subsidiaries | Non-subordinated debt | Fixed-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,460 | 9,690 |
Other subsidiaries | Non-subordinated debt | Fixed-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 907 | |
Other subsidiaries | Non-subordinated debt | Fixed-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,007 | |
Other subsidiaries | Non-subordinated debt | Fixed-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,072 | |
Other subsidiaries | Non-subordinated debt | Fixed-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,173 | |
Other subsidiaries | Non-subordinated debt | Fixed-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,045 | |
Other subsidiaries | Non-subordinated debt | Fixed-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,674 | |
Other subsidiaries | Non-subordinated debt | Fixed-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 582 | |
UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 82,432 | 85,351 |
UBS AG | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 51,381 | |
UBS AG | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 8,679 | |
UBS AG | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 7,554 | |
UBS AG | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,766 | |
UBS AG | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,203 | |
UBS AG | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,055 | |
UBS AG | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,795 | |
UBS AG | UBS AG | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 72,972 | 75,661 |
UBS AG | UBS AG | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 50,474 | |
UBS AG | UBS AG | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 7,671 | |
UBS AG | UBS AG | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 6,482 | |
UBS AG | UBS AG | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,594 | |
UBS AG | UBS AG | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 4,158 | |
UBS AG | UBS AG | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,381 | |
UBS AG | UBS AG | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,213 | |
UBS AG | UBS AG | Non-subordinated debt | Fixed-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 52,571 | 52,618 |
UBS AG | UBS AG | Non-subordinated debt | Fixed-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 38,647 | |
UBS AG | UBS AG | Non-subordinated debt | Fixed-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,578 | |
UBS AG | UBS AG | Non-subordinated debt | Fixed-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,964 | |
UBS AG | UBS AG | Non-subordinated debt | Fixed-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 349 | |
UBS AG | UBS AG | Non-subordinated debt | Fixed-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,439 | |
UBS AG | UBS AG | Non-subordinated debt | Fixed-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,381 | |
UBS AG | UBS AG | Non-subordinated debt | Fixed-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,213 | |
UBS AG | UBS AG | Non-subordinated debt | Floating-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 15,238 | 15,299 |
UBS AG | UBS AG | Non-subordinated debt | Floating-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,807 | |
UBS AG | UBS AG | Non-subordinated debt | Floating-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,093 | |
UBS AG | UBS AG | Non-subordinated debt | Floating-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,922 | |
UBS AG | UBS AG | Non-subordinated debt | Floating-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 907 | |
UBS AG | UBS AG | Non-subordinated debt | Floating-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 508 | |
UBS AG | UBS AG | Non-subordinated debt | Floating-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | UBS AG | Non-subordinated debt | Floating-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | UBS AG | Subordinated debt | Fixed-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 5,163 | 7,744 |
UBS AG | UBS AG | Subordinated debt | Fixed-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,020 | |
UBS AG | UBS AG | Subordinated debt | Fixed-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | UBS AG | Subordinated debt | Fixed-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 2,596 | |
UBS AG | UBS AG | Subordinated debt | Fixed-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 337 | |
UBS AG | UBS AG | Subordinated debt | Fixed-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 210 | |
UBS AG | UBS AG | Subordinated debt | Fixed-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | UBS AG | Subordinated debt | Fixed-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 0 | |
UBS AG | Other subsidiaries | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,460 | 9,690 |
UBS AG | Other subsidiaries | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 907 | |
UBS AG | Other subsidiaries | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,007 | |
UBS AG | Other subsidiaries | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,072 | |
UBS AG | Other subsidiaries | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,173 | |
UBS AG | Other subsidiaries | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,045 | |
UBS AG | Other subsidiaries | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,674 | |
UBS AG | Other subsidiaries | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 582 | |
UBS AG | Other subsidiaries | Non-subordinated debt | Fixed-rate | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 9,460 | $ 9,690 |
UBS AG | Other subsidiaries | Non-subordinated debt | Fixed-rate | 2022 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 907 | |
UBS AG | Other subsidiaries | Non-subordinated debt | Fixed-rate | 2023 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,007 | |
UBS AG | Other subsidiaries | Non-subordinated debt | Fixed-rate | 2024 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,072 | |
UBS AG | Other subsidiaries | Non-subordinated debt | Fixed-rate | 2025 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,173 | |
UBS AG | Other subsidiaries | Non-subordinated debt | Fixed-rate | 2026 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 1,045 | |
UBS AG | Other subsidiaries | Non-subordinated debt | Fixed-rate | 2027-2031 | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | 3,674 | |
UBS AG | Other subsidiaries | Non-subordinated debt | Fixed-rate | Thereafter | ||
Disclosure Of Maturity Analysis For Nonderivative Financial Liabilities [Table] | ||
Total | $ 582 |
Debt issued measured at amort_4
Debt issued measured at amortized cost (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Entity [Table] | ||
Hedge accounting impact on carrying amount | $ 478 | $ 2,401 |
UBS AG | ||
Entity [Table] | ||
Hedge accounting impact on carrying amount | $ 261 | $ 761 |
Provisions (Detail)
Provisions (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Provisions other than provisions for expected credit losses | $ 3,322 | $ 2,571 |
Provisions for expected credit losses | 196 | 257 |
Total provisions | 3,518 | 2,828 |
UBS AG | ||
Entity [Table] | ||
Provisions other than provisions for expected credit losses | 3,256 | 2,534 |
Provisions for expected credit losses | 196 | 257 |
Total provisions | $ 3,452 | $ 2,791 |
Provisions - additional informa
Provisions - additional information (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Provisions [Table] | ||
Balance at the beginning of period | $ 2,571 | |
Increase in provisions recognized in the income statement | 1,361 | |
Release of provisions recognized in the income statement | (136) | |
Provisions used in conformity with designated purpose | (434) | |
Capitalized reinstatement costs | 32 | |
Foreign currency translation / unwind of discount | (72) | |
Balance at the end of period | 3,322 | |
Litigation, regulatory and similar matters | ||
Provisions [Table] | ||
Balance at the beginning of period | 2,135 | |
Increase in provisions recognized in the income statement | 986 | |
Release of provisions recognized in the income statement | (74) | |
Provisions used in conformity with designated purpose | (189) | |
Capitalized reinstatement costs | 0 | |
Foreign currency translation / unwind of discount | (59) | |
Balance at the end of period | 2,798 | |
Restructuring | ||
Provisions [Table] | ||
Balance at the beginning of period | 72 | |
Increase in provisions recognized in the income statement | 297 | |
Release of provisions recognized in the income statement | (30) | |
Provisions used in conformity with designated purpose | (165) | |
Capitalized reinstatement costs | 0 | |
Foreign currency translation / unwind of discount | (3) | |
Balance at the end of period | 172 | |
Personnel-related restructuring provisions | 47 | $ 49 |
Real estate related provisions for onerous lease contracts | 125 | 18 |
Other | ||
Provisions [Table] | ||
Balance at the beginning of period | 363 | |
Increase in provisions recognized in the income statement | 78 | |
Release of provisions recognized in the income statement | (32) | |
Provisions used in conformity with designated purpose | (80) | |
Capitalized reinstatement costs | 32 | |
Foreign currency translation / unwind of discount | (10) | |
Balance at the end of period | 352 | |
UBS AG | ||
Provisions [Table] | ||
Balance at the beginning of period | 2,534 | |
Increase in provisions recognized in the income statement | 1,286 | |
Release of provisions recognized in the income statement | (128) | |
Provisions used in conformity with designated purpose | (396) | |
Capitalized reinstatement costs | 30 | |
Foreign currency translation / unwind of discount | (70) | |
Balance at the end of period | 3,256 | |
UBS AG | Litigation, regulatory and similar matters | ||
Provisions [Table] | ||
Balance at the beginning of period | 2,135 | |
Increase in provisions recognized in the income statement | 986 | |
Release of provisions recognized in the income statement | (74) | |
Provisions used in conformity with designated purpose | (189) | |
Capitalized reinstatement costs | 0 | |
Foreign currency translation / unwind of discount | (59) | |
Balance at the end of period | 2,798 | |
UBS AG | Restructuring | ||
Provisions [Table] | ||
Balance at the beginning of period | 67 | |
Increase in provisions recognized in the income statement | 228 | |
Release of provisions recognized in the income statement | (25) | |
Provisions used in conformity with designated purpose | (130) | |
Capitalized reinstatement costs | 0 | |
Foreign currency translation / unwind of discount | (3) | |
Balance at the end of period | 137 | |
Personnel-related restructuring provisions | 47 | 49 |
Real estate related provisions for onerous lease contracts | 90 | $ 13 |
UBS AG | Other | ||
Provisions [Table] | ||
Balance at the beginning of period | 332 | |
Increase in provisions recognized in the income statement | 73 | |
Release of provisions recognized in the income statement | (29) | |
Provisions used in conformity with designated purpose | (76) | |
Capitalized reinstatement costs | 30 | |
Foreign currency translation / unwind of discount | (9) | |
Balance at the end of period | $ 321 |
Litigation, regulatory and si_3
Litigation, regulatory and similar matters (Detail) $ in Millions | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | $ 2,571 |
Increase in provisions recognized in the income statement | 1,361 |
Release of provisions recognized in the income statement | (136) |
Provisions used in conformity with designated purpose | (434) |
Foreign currency translation / unwind of discount | (72) |
Balance at the end of period | 3,322 |
Litigation, regulatory and similar matters | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 2,135 |
Increase in provisions recognized in the income statement | 986 |
Release of provisions recognized in the income statement | (74) |
Provisions used in conformity with designated purpose | (189) |
Foreign currency translation / unwind of discount | (59) |
Balance at the end of period | 2,798 |
Litigation, regulatory and similar matters | Global Wealth Management | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 861 |
Increase in provisions recognized in the income statement | 754 |
Release of provisions recognized in the income statement | (60) |
Provisions used in conformity with designated purpose | (175) |
Foreign currency translation / unwind of discount | (42) |
Balance at the end of period | 1,338 |
Litigation, regulatory and similar matters | Personal & Corporate Banking | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 115 |
Increase in provisions recognized in the income statement | 84 |
Release of provisions recognized in the income statement | (11) |
Provisions used in conformity with designated purpose | (1) |
Foreign currency translation / unwind of discount | (6) |
Balance at the end of period | 181 |
Litigation, regulatory and similar matters | Asset Management | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 0 |
Increase in provisions recognized in the income statement | 9 |
Release of provisions recognized in the income statement | 0 |
Provisions used in conformity with designated purpose | 1 |
Foreign currency translation / unwind of discount | 0 |
Balance at the end of period | 8 |
Litigation, regulatory and similar matters | Investment Bank | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 227 |
Increase in provisions recognized in the income statement | 107 |
Release of provisions recognized in the income statement | (4) |
Provisions used in conformity with designated purpose | (10) |
Foreign currency translation / unwind of discount | (11) |
Balance at the end of period | 310 |
Litigation, regulatory and similar matters | Group Functions | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 932 |
Increase in provisions recognized in the income statement | 32 |
Release of provisions recognized in the income statement | 0 |
Provisions used in conformity with designated purpose | (2) |
Foreign currency translation / unwind of discount | 0 |
Balance at the end of period | 962 |
UBS AG | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 2,534 |
Increase in provisions recognized in the income statement | 1,286 |
Release of provisions recognized in the income statement | (128) |
Provisions used in conformity with designated purpose | (396) |
Foreign currency translation / unwind of discount | (70) |
Balance at the end of period | 3,256 |
UBS AG | Litigation, regulatory and similar matters | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 2,135 |
Increase in provisions recognized in the income statement | 986 |
Release of provisions recognized in the income statement | (74) |
Provisions used in conformity with designated purpose | (189) |
Foreign currency translation / unwind of discount | (59) |
Balance at the end of period | 2,798 |
UBS AG | Litigation, regulatory and similar matters | Global Wealth Management | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 861 |
Increase in provisions recognized in the income statement | 754 |
Release of provisions recognized in the income statement | (60) |
Provisions used in conformity with designated purpose | (175) |
Foreign currency translation / unwind of discount | (42) |
Balance at the end of period | 1,338 |
UBS AG | Litigation, regulatory and similar matters | Personal & Corporate Banking | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 115 |
Increase in provisions recognized in the income statement | 84 |
Release of provisions recognized in the income statement | (11) |
Provisions used in conformity with designated purpose | (1) |
Foreign currency translation / unwind of discount | (6) |
Balance at the end of period | 181 |
UBS AG | Litigation, regulatory and similar matters | Asset Management | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 0 |
Increase in provisions recognized in the income statement | 9 |
Release of provisions recognized in the income statement | 0 |
Provisions used in conformity with designated purpose | (1) |
Foreign currency translation / unwind of discount | 0 |
Balance at the end of period | 8 |
UBS AG | Litigation, regulatory and similar matters | Investment Bank | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 227 |
Increase in provisions recognized in the income statement | 107 |
Release of provisions recognized in the income statement | (4) |
Provisions used in conformity with designated purpose | (10) |
Foreign currency translation / unwind of discount | (11) |
Balance at the end of period | 310 |
UBS AG | Litigation, regulatory and similar matters | Group Functions | |
Disclosure Of Operating Segments [Table] | |
Balance at the beginning of period | 932 |
Increase in provisions recognized in the income statement | 32 |
Release of provisions recognized in the income statement | 0 |
Provisions used in conformity with designated purpose | (2) |
Foreign currency translation / unwind of discount | 0 |
Balance at the end of period | $ 962 |
Litigation, regulatory and si_4
Litigation, regulatory and similar matters (Narrative) (Detail) - 12 months ended Dec. 31, 2021 € in Thousands, $ in Millions | EUR (€) | USD ($) | USD ($) |
Inquiries regarding cross-border wealth management businesses | Investigations in France | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Fine decision French Court | € 3,700,000 | ||
Civil damages award announcement of the French Court | 800,000 | ||
Provision recorded to cover pending legal case | 1,100,000 | $ 1,252 | |
Inquiries regarding cross-border wealth management businesses | Investigations in France involving UBS AG | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Bail (caution) ordered to be paid | 1,100,000 | ||
Fine decision French Court of Appeal | 3,750 | ||
Bail (caution) ordered to be confiscated, verdict of the French Court of Appeal | 1,000,000 | ||
Civil damages award announcement of the French Court of Appeal | 800,000 | ||
Civil damages award deducted from the bail, announcement of the French Court of Appeal | 99,000 | ||
Inquiries regarding cross-border wealth management businesses | Investigations in France involving UBS (France) S.A. | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Bail (caution) ordered to be paid | 40,000 | ||
Reduced bail (caution) ordered to be paid | 10,000 | ||
Fine decision French Court of Appeal | 1,875 | ||
Inquiries regarding cross-border wealth management businesses | Investigation in Belgium | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Settlement made | 49,000 | ||
Madoff | claims filed in Luxembourg by liquidators of two Luxembourg funds against UBS entities, non-UBS entities and certain individuals | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Minimum total claims against all defendants | 2,100,000 | ||
Madoff | claims filed in the US by BMIS Trustee against UBS entities and various other parties | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Amounts claimed | $ | $ 125 | ||
Minimum total claims against all defendants | $ | 2,000 | ||
Puerto Rico | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Amount in dispute | $ | 125 | ||
Puerto Rico | Customer arbitration claims | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Settlement made | $ | 3,100 | ||
Agreed settlement pending approval | $ | 15 | ||
Amounts claimed | $ | 3,400 | ||
Puerto Rico | Action filed on behalf of Employee Retirement System of the Commonwealth of Puerto Rico (System) against over 40 defendants | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Minimum total claims against all defendants | $ | 800 | ||
Amount of bonds issued and underwritten by the System | $ | 3,000 | ||
Puerto Rico | Claims filed by four US insurance companies that insured issues of Puerto Rico municipal bonds | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Minimum total claims against all defendants | $ | 955 | ||
Foreign exchange, LIBOR and benchmark rates, and other trading practices | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Fine provided in announcement of the European Commission | 172,000 | ||
Foreign exchange, LIBOR and benchmark rates, and other trading practices - Foreign exchange-related civil litigation | Claims under the Commodity Exchange Act | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Settlement made | $ | 141 | ||
UBS AG | Inquiries regarding cross-border wealth management businesses | Investigations in France | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Fine decision French Court | 3,700,000 | ||
Civil damages award announcement of the French Court | 800,000 | ||
Provision recorded to cover pending legal case | 1,100,000 | $ 1,252 | |
UBS AG | Inquiries regarding cross-border wealth management businesses | Investigations in France involving UBS AG | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Bail (caution) ordered to be paid | 1,100,000 | ||
Fine decision French Court of Appeal | 3,750 | ||
Bail (caution) ordered to be confiscated, verdict of the French Court of Appeal | 1,000 | ||
Civil damages award announcement of the French Court of Appeal | 800,000 | ||
Civil damages award deducted from the bail, announcement of the French Court of Appeal | 99,000 | ||
UBS AG | Inquiries regarding cross-border wealth management businesses | Investigations in France involving UBS (France) S.A. | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Bail (caution) ordered to be paid | 40,000 | ||
Reduced bail (caution) ordered to be paid | 10,000 | ||
Fine decision French Court of Appeal | 1,875 | ||
UBS AG | Inquiries regarding cross-border wealth management businesses | Investigation in Belgium | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Settlement made | 49,000 | ||
UBS AG | Madoff | claims filed in Luxembourg by liquidators of two Luxembourg funds against UBS entities, non-UBS entities and certain individuals | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Minimum total claims against all defendants | 2,100,000 | ||
UBS AG | Madoff | claims filed in the US by BMIS Trustee against UBS entities and various other parties | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Amounts claimed | $ | 125 | ||
Minimum total claims against all defendants | $ | 2,000 | ||
UBS AG | Puerto Rico | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Amount in dispute | $ | 125 | ||
UBS AG | Puerto Rico | Customer arbitration claims | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Settlement made | $ | 3,100 | ||
Agreed settlement pending approval | $ | 15 | ||
Amounts claimed | $ | 3,400 | ||
UBS AG | Puerto Rico | Action filed on behalf of Employee Retirement System of the Commonwealth of Puerto Rico (System) against over 40 defendants | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Minimum total claims against all defendants | $ | 800 | ||
Amount of bonds issued and underwritten by the System | $ | 3,000 | ||
UBS AG | Puerto Rico | Claims filed by four US insurance companies that insured issues of Puerto Rico municipal bonds | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Minimum total claims against all defendants | $ | 955 | ||
UBS AG | Foreign exchange, LIBOR and benchmark rates, and other trading practices | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Fine provided in announcement of the European Commission | € 172,000 | ||
UBS AG | Foreign exchange, LIBOR and benchmark rates, and other trading practices - Foreign exchange-related civil litigation | Claims under the Commodity Exchange Act | |||
Disclosure Of Litigation Regulatory And Similar Matters [Table] | |||
Settlement made | $ | $ 141 |
Other financial liabilities mea
Other financial liabilities measured at amortized cost (Detail) - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Other accrued expenses | $ 1,876,000,000 | $ 1,696,000,000 |
Accrued interest expenses | 1,094,000,000 | 1,355,000,000 |
Settlement and clearing accounts | 1,304,000,000 | 1,199,000,000 |
Lease liabilities | 3,558,000,000 | 3,927,000,000 |
Other | 1,167,000,000 | 1,553,000,000 |
Total other financial liabilities measured at amortized cost | 9,001,000,000 | 9,729,000,000 |
UBS AG | ||
Entity [Table] | ||
Other accrued expenses | 1,642,000,000 | 1,508,000,000 |
Accrued interest expenses | 1,134,000,000 | 1,382,000,000 |
Settlement and clearing accounts | 1,282,000,000 | 1,181,000,000 |
Lease liabilities | 3,438,000,000 | 3,821,000,000 |
Other | 2,269,000,000 | 2,530,000,000 |
Total other financial liabilities measured at amortized cost | $ 9,765,000,000 | $ 10,421,000,000 |
Other financial liabilities des
Other financial liabilities designated at fair value (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Financial liabilities related to unit-linked investment contracts | $ 21,466 | $ 20,975 |
Securities financing transactions | 6,377 | 7,317 |
Over-the-counter debt instruments | 2,128 | 2,060 |
Other | 103 | 35 |
Total other financial liabilities designated at fair value | 30,074 | 30,387 |
of which: life-to-date own credit (gain) / loss | 32 | 36 |
UBS AG | ||
Entity [Table] | ||
Financial liabilities related to unit-linked investment contracts | 21,466 | 20,975 |
Securities financing transactions | 6,377 | 7,317 |
Over-the-counter debt instruments | 2,128 | 2,060 |
Funding from UBS Group AG and its subsidiaries | 2,340 | 1,375 |
Other | 103 | 46 |
Total other financial liabilities designated at fair value | 32,414 | 31,773 |
of which: life-to-date own credit (gain) / loss | $ 172 | $ 148 |
Other non-financial liabilities
Other non-financial liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Compensation-related liabilities | $ 7,257 | $ 7,468 |
of which: Deferred Contingent Capital Plan | 1,628 | 1,858 |
of which: financial advisor compensation plans | 1,512 | 1,500 |
of which: other compensation plans | 2,846 | 2,740 |
of which: net defined benefit liability | 633 | 722 |
of which: other compensation-related liabilities | 638 | 648 |
Deferred tax liabilities | 300 | 564 |
Current tax liabilities | 1,398 | 1,009 |
VAT and other tax payables | 590 | 523 |
Deferred income | 240 | 228 |
Liabilities of disposal group held for sale | 1,298 | |
Other | 68 | 61 |
Total other non-financial liabilities | 11,151 | 9,854 |
UBS AG | ||
Entity [Table] | ||
Compensation-related liabilities | 4,795 | 4,776 |
of which: financial advisor compensation plans | 1,512 | 1,497 |
of which: other compensation plans | 2,140 | 2,034 |
of which: net defined benefit liability | 617 | 711 |
of which: other compensation-related liabilities | 526 | 534 |
Deferred tax liabilities | 297 | 558 |
Current tax liabilities | 1,365 | 943 |
VAT and other tax payables | 524 | 470 |
Deferred income | 225 | 212 |
Liabilities of disposal group held for sale | 1,298 | |
Other | 68 | 61 |
Total other non-financial liabilities | $ 8,572 | $ 7,018 |
Expected credit loss measurem_7
Expected credit loss measurement - ECL for the period (Narrative) (Detail 1) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | $ (148) | $ 694 | $ 78 |
Update of the forward-looking scenarios | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (91) | ||
Model updates | |||
Disclosure Of Provision Matrix [Table] | |||
Development of ECL allowances and provisions | 45 | ||
Post-model adjustment updates | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (224) | ||
Post-model adjustment updates relating to COVID-19 | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (117) | ||
Post-model adjustment updates relating to other overlays | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (16) | ||
Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (86) | 257 | 21 |
Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (34) | 305 | 30 |
Investment Bank | Model updates | |||
Disclosure Of Provision Matrix [Table] | |||
Development of ECL allowances and provisions | 25 | ||
Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (29) | 88 | 20 |
Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | 0 | 42 | 7 |
Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (123) | 266 | (22) |
Positions that are not credit impaired | New transactions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (10) | ||
Positions that are not credit impaired | Model updates | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (45) | ||
Positions that are not credit impaired | Post-model adjustment updates | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (68) | ||
Positions that are not credit impaired | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (62) | 129 | (23) |
Positions that are not credit impaired | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (34) | 88 | 4 |
Positions that are not credit impaired | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (28) | 48 | (3) |
Positions that are not credit impaired | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | 0 | 0 | 0 |
Credit-impaired positions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (25) | 429 | 100 |
Credit-impaired positions | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (24) | 128 | 44 |
Credit-impaired positions | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | 0 | 217 | 26 |
Credit-impaired positions | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (1) | 40 | 23 |
Credit-impaired positions | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | 0 | 42 | 7 |
UBS AG | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (148) | 695 | 78 |
UBS AG | Update of the forward-looking scenarios | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (91) | ||
UBS AG | Model updates | |||
Disclosure Of Provision Matrix [Table] | |||
Development of ECL allowances and provisions | 45 | ||
UBS AG | Post-model adjustment updates | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (224) | ||
UBS AG | Post-model adjustment updates relating to COVID-19 | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (117) | ||
UBS AG | Post-model adjustment updates relating to other overlays | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (16) | ||
UBS AG | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (86) | 257 | 21 |
UBS AG | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (34) | 305 | 30 |
UBS AG | Investment Bank | Model updates | |||
Disclosure Of Provision Matrix [Table] | |||
Development of ECL allowances and provisions | 25 | ||
UBS AG | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (29) | 88 | 20 |
UBS AG | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | 0 | 42 | 7 |
UBS AG | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (123) | 266 | (22) |
UBS AG | Positions that are not credit impaired | New transactions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (10) | ||
UBS AG | Positions that are not credit impaired | Model updates | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (45) | ||
UBS AG | Positions that are not credit impaired | Post-model adjustment updates | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (68) | ||
UBS AG | Positions that are not credit impaired | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (62) | 129 | (23) |
UBS AG | Positions that are not credit impaired | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (34) | 88 | 4 |
UBS AG | Positions that are not credit impaired | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (28) | 48 | (3) |
UBS AG | Positions that are not credit impaired | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | 0 | 0 | 0 |
UBS AG | Credit-impaired positions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (25) | 429 | 100 |
UBS AG | Credit-impaired positions | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (24) | 128 | 44 |
UBS AG | Credit-impaired positions | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | 0 | 217 | 26 |
UBS AG | Credit-impaired positions | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | (1) | 40 | 23 |
UBS AG | Credit-impaired positions | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss expense / (release) | $ 0 | $ 42 | $ 7 |
Expected credit loss measurem_8
Expected credit loss measurement - Credit loss (expense) / release (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | $ 148 | $ (694) | $ (78) |
Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 29 | (88) | (20) |
Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 86 | (257) | (21) |
Asset Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | (1) | (2) | 0 |
Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 34 | (305) | (30) |
Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | (42) | (7) |
Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 123 | (266) | 22 |
Positions that are not credit impaired | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 28 | (48) | 3 |
Positions that are not credit impaired | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 62 | (129) | 23 |
Positions that are not credit impaired | Asset Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | 0 | 0 |
Positions that are not credit impaired | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 34 | (88) | (4) |
Positions that are not credit impaired | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | 0 | 0 |
Credit-impaired positions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 25 | (429) | (100) |
Credit-impaired positions | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 1 | (40) | (23) |
Credit-impaired positions | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 24 | (128) | (44) |
Credit-impaired positions | Asset Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | (1) | (2) | 0 |
Credit-impaired positions | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | (217) | (26) |
Credit-impaired positions | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | (42) | (7) |
UBS AG | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 148 | (695) | (78) |
UBS AG | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 29 | (88) | (20) |
UBS AG | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 86 | (257) | (21) |
UBS AG | Asset Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | (1) | (2) | 0 |
UBS AG | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 34 | (305) | (30) |
UBS AG | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | (42) | (7) |
UBS AG | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 123 | (266) | 22 |
UBS AG | Positions that are not credit impaired | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 28 | (48) | 3 |
UBS AG | Positions that are not credit impaired | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 62 | (129) | 23 |
UBS AG | Positions that are not credit impaired | Asset Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | 0 | 0 |
UBS AG | Positions that are not credit impaired | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 34 | (88) | (4) |
UBS AG | Positions that are not credit impaired | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | 0 | 0 |
UBS AG | Credit-impaired positions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 25 | (429) | (100) |
UBS AG | Credit-impaired positions | Global Wealth Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 1 | (40) | (23) |
UBS AG | Credit-impaired positions | Personal & Corporate Banking | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 24 | (128) | (44) |
UBS AG | Credit-impaired positions | Asset Management | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | (1) | (2) | 0 |
UBS AG | Credit-impaired positions | Investment Bank | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | 0 | (217) | (26) |
UBS AG | Credit-impaired positions | Group Functions | |||
Disclosure Of Provision Matrix [Table] | |||
Credit loss (expense) / release | $ 0 | $ (42) | $ (7) |
Expected credit loss measurem_9
Expected credit loss measurement - ECL scenario weights (Narrative) (Detail 2) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Upside ECL scenario | ||
Disclosure Of Provision Matrix [Table] | ||
Assigned weights | 5.00% | 0.00% |
Baseline ECL scenario | ||
Disclosure Of Provision Matrix [Table] | ||
Assigned weights | 55.00% | 60.00% |
Mild downside ECL scenario | ||
Disclosure Of Provision Matrix [Table] | ||
Assigned weights | 10.00% | 0.00% |
Severe downside ECL scenario | ||
Disclosure Of Provision Matrix [Table] | ||
Assigned weights | 30.00% | 40.00% |
UBS AG | Upside ECL scenario | ||
Disclosure Of Provision Matrix [Table] | ||
Assigned weights | 5.00% | 0.00% |
UBS AG | Baseline ECL scenario | ||
Disclosure Of Provision Matrix [Table] | ||
Assigned weights | 55.00% | 60.00% |
UBS AG | Mild downside ECL scenario | ||
Disclosure Of Provision Matrix [Table] | ||
Assigned weights | 10.00% | 0.00% |
UBS AG | Severe downside ECL scenario | ||
Disclosure Of Provision Matrix [Table] | ||
Assigned weights | 30.00% | 40.00% |
Expected credit loss measure_10
Expected credit loss measurement - Scenario assumptions (Detail) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Upside ECL scenario | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.10% | |
Upside ECL scenario | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.40% | |
Upside ECL scenario | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.50% | |
Upside ECL scenario | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.10% | |
Upside ECL scenario | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.30% | |
Upside ECL scenario | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.80% | |
Upside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.00% | |
Upside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.20% | |
Upside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.30% | |
Upside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 50.00% | |
Upside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 40.00% | |
Upside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 50.00% | |
Upside ECL scenario | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.00% | |
Upside ECL scenario | Within 1 year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 16.00% | |
Upside ECL scenario | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 14.00% | |
Upside ECL scenario | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.10% | |
Upside ECL scenario | Within 1 year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.00% | |
Upside ECL scenario | Within 1 year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 8.40% | |
Upside ECL scenario | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 17.80% | |
Upside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 17.30% | |
Upside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 13.10% | |
Upside ECL scenario | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.50% | |
Upside ECL scenario | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 8.00% | |
Upside ECL scenario | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.10% | |
Upside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.00% | |
Upside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.00% | |
Upside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.60% | |
Upside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 170.00% | |
Upside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 140.00% | |
Upside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 150.00% | |
Upside ECL scenario | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 35.50% | |
Upside ECL scenario | cumulative 3-year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 41.60% | |
Upside ECL scenario | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 37.90% | |
Upside ECL scenario | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 15.50% | |
Upside ECL scenario | cumulative 3-year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 21.70% | |
Upside ECL scenario | cumulative 3-year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 17.80% | |
Baseline ECL scenario | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.40% | 2.70% |
Baseline ECL scenario | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.90% | 2.50% |
Baseline ECL scenario | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.40% | 3.30% |
Baseline ECL scenario | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.20% | 1.70% |
Baseline ECL scenario | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.40% | 1.40% |
Baseline ECL scenario | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.30% | 0.30% |
Baseline ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.90% | 5.50% |
Baseline ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.40% | 9.50% |
Baseline ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.50% | 3.80% |
Baseline ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.165% | 0.22% |
Baseline ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.111% | 0.04% |
Baseline ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.121% | 0.13% |
Baseline ECL scenario | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 14.10% | (2.90%) |
Baseline ECL scenario | Within 1 year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.30% | 3.80% |
Baseline ECL scenario | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.10% | (0.80%) |
Baseline ECL scenario | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.40% | 3.40% |
Baseline ECL scenario | Within 1 year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.50% | 2.50% |
Baseline ECL scenario | Within 1 year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.10% | 1.10% |
Baseline ECL scenario | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.10% | 9.10% |
Baseline ECL scenario | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.50% | 9.90% |
Baseline ECL scenario | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.80% | 9.00% |
Baseline ECL scenario | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.30% | 5.50% |
Baseline ECL scenario | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.80% | 3.90% |
Baseline ECL scenario | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.70% | 0.90% |
Baseline ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.50% | 4.50% |
Baseline ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.20% | 8.00% |
Baseline ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.30% | 3.20% |
Baseline ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.412% | 0.46% |
Baseline ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.349% | 0.21% |
Baseline ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.344% | 0.31% |
Baseline ECL scenario | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 24.70% | (1.70%) |
Baseline ECL scenario | cumulative 3-year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 20.70% | 13.50% |
Baseline ECL scenario | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 19.10% | 5.80% |
Baseline ECL scenario | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.40% | 7.10% |
Baseline ECL scenario | cumulative 3-year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.10% | 9.20% |
Baseline ECL scenario | cumulative 3-year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.60% | 7.20% |
Mild downside ECL scenario | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.10%) | |
Mild downside ECL scenario | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.10%) | |
Mild downside ECL scenario | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.90%) | |
Mild downside ECL scenario | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.70% | |
Mild downside ECL scenario | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.20% | |
Mild downside ECL scenario | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.50% | |
Mild downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.10% | |
Mild downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 8.70% | |
Mild downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.40% | |
Mild downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 259.20% | |
Mild downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 283.80% | |
Mild downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 245.50% | |
Mild downside ECL scenario | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (27.00%) | |
Mild downside ECL scenario | Within 1 year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (23.40%) | |
Mild downside ECL scenario | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (22.90%) | |
Mild downside ECL scenario | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (4.30%) | |
Mild downside ECL scenario | Within 1 year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (2.30%) | |
Mild downside ECL scenario | Within 1 year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (4.00%) | |
Mild downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.80% | |
Mild downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.90% | |
Mild downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.10%) | |
Mild downside ECL scenario | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 13.00% | |
Mild downside ECL scenario | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.40% | |
Mild downside ECL scenario | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.00% | |
Mild downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.20% | |
Mild downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.10% | |
Mild downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.20% | |
Mild downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 329.20% | |
Mild downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 349.30% | |
Mild downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 307.30% | |
Mild downside ECL scenario | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (21.80%) | |
Mild downside ECL scenario | cumulative 3-year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (19.90%) | |
Mild downside ECL scenario | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (19.60%) | |
Mild downside ECL scenario | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (8.80%) | |
Mild downside ECL scenario | cumulative 3-year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (8.70%) | |
Mild downside ECL scenario | cumulative 3-year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (7.60%) | |
Severe downside ECL scenario | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (5.90%) | (5.90%) |
Severe downside ECL scenario | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (8.70%) | (8.70%) |
Severe downside ECL scenario | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (6.60%) | (6.60%) |
Severe downside ECL scenario | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.20%) | (1.20%) |
Severe downside ECL scenario | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.30%) | (1.30%) |
Severe downside ECL scenario | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.80%) | (1.80%) |
Severe downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.90% | 12.10% |
Severe downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.90% | 14.10% |
Severe downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.20% | 6.10% |
Severe downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.50%) | (0.50%) |
Severe downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.35%) | (0.35%) |
Severe downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.70%) | (0.70%) |
Severe downside ECL scenario | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (50.20%) | (50.20%) |
Severe downside ECL scenario | Within 1 year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (57.60%) | (57.60%) |
Severe downside ECL scenario | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (53.60%) | (53.60%) |
Severe downside ECL scenario | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (17.00%) | (17.00%) |
Severe downside ECL scenario | Within 1 year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (9.50%) | (15.30%) |
Severe downside ECL scenario | Within 1 year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (5.40%) | (22.90%) |
Severe downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (3.80%) | (3.80%) |
Severe downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (10.30%) | (10.30%) |
Severe downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (5.70%) | (5.70%) |
Severe downside ECL scenario | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.40% | 0.40% |
Severe downside ECL scenario | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.70%) | (1.70%) |
Severe downside ECL scenario | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.60%) | (1.60%) |
Severe downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.80% | 9.90% |
Severe downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 15.10% | 16.40% |
Severe downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.90% | 6.80% |
Severe downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.15%) | (0.15%) |
Severe downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.25%) | (0.25%) |
Severe downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.35%) | (0.35%) |
Severe downside ECL scenario | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (40.10%) | (40.10%) |
Severe downside ECL scenario | cumulative 3-year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (50.40%) | (50.40%) |
Severe downside ECL scenario | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (44.20%) | (44.20%) |
Severe downside ECL scenario | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (30.00%) | (30.00%) |
Severe downside ECL scenario | cumulative 3-year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (26.30%) | (28.70%) |
Severe downside ECL scenario | cumulative 3-year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (10.80%) | (35.40%) |
UBS AG | Upside ECL scenario | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.10% | |
UBS AG | Upside ECL scenario | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.40% | |
UBS AG | Upside ECL scenario | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.50% | |
UBS AG | Upside ECL scenario | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.10% | |
UBS AG | Upside ECL scenario | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.30% | |
UBS AG | Upside ECL scenario | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.80% | |
UBS AG | Upside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.00% | |
UBS AG | Upside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.20% | |
UBS AG | Upside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.30% | |
UBS AG | Upside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 50.00% | |
UBS AG | Upside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 40.00% | |
UBS AG | Upside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 50.00% | |
UBS AG | Upside ECL scenario | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.00% | |
UBS AG | Upside ECL scenario | Within 1 year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 16.00% | |
UBS AG | Upside ECL scenario | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 14.00% | |
UBS AG | Upside ECL scenario | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.10% | |
UBS AG | Upside ECL scenario | Within 1 year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.00% | |
UBS AG | Upside ECL scenario | Within 1 year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 8.40% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 17.80% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 17.30% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 13.10% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.50% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 8.00% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.10% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.00% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.00% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.60% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 170.00% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 140.00% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 150.00% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 35.50% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 41.60% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 37.90% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 15.50% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 21.70% | |
UBS AG | Upside ECL scenario | cumulative 3-year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 17.80% | |
UBS AG | Baseline ECL scenario | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.40% | 2.70% |
UBS AG | Baseline ECL scenario | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.90% | 2.50% |
UBS AG | Baseline ECL scenario | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.40% | 3.30% |
UBS AG | Baseline ECL scenario | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.20% | 1.70% |
UBS AG | Baseline ECL scenario | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.40% | 1.40% |
UBS AG | Baseline ECL scenario | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.30% | 0.30% |
UBS AG | Baseline ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.90% | 5.50% |
UBS AG | Baseline ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.40% | 9.50% |
UBS AG | Baseline ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.50% | 3.80% |
UBS AG | Baseline ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 16.50% | 22.00% |
UBS AG | Baseline ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 11.10% | 4.00% |
UBS AG | Baseline ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.10% | 13.00% |
UBS AG | Baseline ECL scenario | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 14.10% | (2.90%) |
UBS AG | Baseline ECL scenario | Within 1 year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.30% | 3.80% |
UBS AG | Baseline ECL scenario | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.10% | (0.80%) |
UBS AG | Baseline ECL scenario | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.40% | 3.40% |
UBS AG | Baseline ECL scenario | Within 1 year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.50% | 2.50% |
UBS AG | Baseline ECL scenario | Within 1 year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.10% | 1.10% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.10% | 9.10% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.50% | 9.90% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.80% | 9.00% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.30% | 5.50% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.80% | 3.90% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.70% | 0.90% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.50% | 4.50% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.20% | 8.00% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 2.30% | 3.20% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 41.20% | 46.00% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 34.90% | 21.00% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 34.40% | 31.00% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 24.70% | (1.70%) |
UBS AG | Baseline ECL scenario | cumulative 3-year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 20.70% | 13.50% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 19.10% | 5.80% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.40% | 7.10% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.10% | 9.20% |
UBS AG | Baseline ECL scenario | cumulative 3-year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.60% | 7.20% |
UBS AG | Mild downside ECL scenario | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.10%) | |
UBS AG | Mild downside ECL scenario | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.10%) | |
UBS AG | Mild downside ECL scenario | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.90%) | |
UBS AG | Mild downside ECL scenario | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.70% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.20% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.50% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 6.10% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 8.70% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 3.40% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 259.20% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 283.80% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 245.50% | |
UBS AG | Mild downside ECL scenario | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (27.00%) | |
UBS AG | Mild downside ECL scenario | Within 1 year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (23.40%) | |
UBS AG | Mild downside ECL scenario | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (22.90%) | |
UBS AG | Mild downside ECL scenario | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (4.30%) | |
UBS AG | Mild downside ECL scenario | Within 1 year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (2.30%) | |
UBS AG | Mild downside ECL scenario | Within 1 year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (4.00%) | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 1.80% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.90% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (0.10%) | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 13.00% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.40% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.00% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 7.20% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 9.10% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 4.20% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 329.20% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 349.30% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 307.30% | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (21.80%) | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (19.90%) | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (19.60%) | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (8.80%) | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (8.70%) | |
UBS AG | Mild downside ECL scenario | cumulative 3-year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (7.60%) | |
UBS AG | Severe downside ECL scenario | Within 1 year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (5.90%) | (5.90%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (8.70%) | (8.70%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (6.60%) | (6.60%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.20%) | (1.20%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.30%) | (1.30%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.80%) | (1.80%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.90% | 12.10% |
UBS AG | Severe downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 12.90% | 14.10% |
UBS AG | Severe downside ECL scenario | Within 1 year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.20% | 6.10% |
UBS AG | Severe downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (50.00%) | (50.00%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (35.00%) | (35.00%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (70.00%) | (70.00%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (50.20%) | (50.20%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (57.60%) | (57.60%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (53.60%) | (53.60%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (17.00%) | (17.00%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (9.50%) | (15.30%) |
UBS AG | Severe downside ECL scenario | Within 1 year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (5.40%) | (22.90%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (3.80%) | (3.80%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (10.30%) | (10.30%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Real GDP growth (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (5.70%) | (5.70%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Consumer price index (% change) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 0.40% | 0.40% |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Consumer price index (% change) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.70%) | (1.70%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Consumer price index (% change) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (1.60%) | (1.60%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | United States | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 10.80% | 9.90% |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Eurozone | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 15.10% | 16.40% |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Unemployment rate (end-of-period level, %) | Switzerland | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | 5.90% | 6.80% |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | USD | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (15.00%) | (15.00%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | EUR | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (25.00%) | (25.00%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Fixed income: 10-year government bonds (change in yields, basis points) | CHF | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (35.00%) | (35.00%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Equity indices (% change) | S&P500 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (40.10%) | (40.10%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Equity indices (% change) | EuroStoxx50 | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (50.40%) | (50.40%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Equity indices (% change) | SPI | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (44.20%) | (44.20%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Swiss real estate (% change) | Single Family Homes | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (30.00%) | (30.00%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Other real estate (% change) | United States S&P / Case Shiller | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (26.30%) | (28.70%) |
UBS AG | Severe downside ECL scenario | cumulative 3-year | Other real estate (% change) | Eurozone House Price Index | ||
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | ||
Economic forecast | (10.80%) | (35.40%) |
Expected credit loss measure_11
Expected credit loss measurement - Development of ECL allowances and provisions (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | $ (1,165) | $ (1,468) | $ (1,029) |
ECL movement with profit or loss impact | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 148 | (694) | |
Net movement from new and derecognized transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (59) | (28) | |
Net movement from new and derecognized transactions | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (7) | (2) | |
Net movement from new and derecognized transactions | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (7) | (3) | |
Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (13) | (32) | |
Net movement from new and derecognized transactions | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (8) | (16) | |
Net movement from new and derecognized transactions | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (24) | 26 | |
Net movement from new and derecognized transactions | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 32 | ||
Net movement from new and derecognized transactions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 9 | |
Net movement from new and derecognized transactions | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 23 | ||
Net movement from new and derecognized transactions | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (21) | (20) | |
Book quality movements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 163 | ||
Remeasurements with stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (40) | (427) | |
Remeasurements with stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (9) | (19) | |
Remeasurements with stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (3) | (6) | |
Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 2 | (224) | |
Remeasurements with stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (27) | (43) | |
Remeasurements with stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (3) | (134) | |
Remeasurements with stage transfers | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (36) | ||
Remeasurements with stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | (12) | |
Remeasurements with stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (36) | ||
Remeasurements with stage transfers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (59) | ||
Remeasurements with stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 2 | ||
Remeasurements without stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 203 | (271) | |
Remeasurements without stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 33 | (34) | |
Remeasurements without stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 30 | (14) | |
Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 44 | (149) | |
Remeasurements without stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 53 | (13) | |
Remeasurements without stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 44 | (60) | |
Remeasurements without stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 6 | (18) | |
Remeasurements without stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (3) | ||
Remeasurements without stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 27 | ||
Remeasurements without stage transfers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (12) | ||
Model changes | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 45 | 32 | |
Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 154 | 254 | |
Write offs / recoveries | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 137 | ||
Foreign exchange movements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 18 | ||
Twelve-month expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (282) | (306) | (181) |
Twelve-month expected credit losses | Positions that are not credit impaired | ECL movement with profit or loss impact | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 19 | (112) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (72) | (90) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (10) | (3) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (11) | (5) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (21) | (29) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (8) | (14) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (23) | (39) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | (1) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (6) | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (18) | (15) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 8 | 45 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 4 | (2) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | 3 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (2) | 34 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 5 | (1) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 11 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | 7 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 55 | (88) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 8 | (19) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 13 | (4) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 5 | (53) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | 0 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 29 | (11) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 8 | (12) | |
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 6 | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 15 | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Twelve-month expected credit losses | Positions that are not credit impaired | Model changes | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 29 | 21 | |
Twelve-month expected credit losses | Positions that are not credit impaired | Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 5 | (14) | |
Lifetime expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (220) | (333) | (160) |
Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (71) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (43) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (55) | ||
Lifetime expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (30) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (1) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (3) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (11) | ||
Lifetime expected credit losses | Positions that are not credit impaired | ECL movement with profit or loss impact | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 104 | (154) | |
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 13 | 17 | |
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 3 | 2 | |
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 4 | 2 | |
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 7 | (4) | |
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | (3) | |
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (2) | 20 | |
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 15 | ||
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | 9 | |
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (4) | (5) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | (134) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (13) | (17) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (4) | (9) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 12 | (83) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 4 | (11) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 2 | (14) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (18) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | (7) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 3 | ||
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 74 | (47) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 26 | (8) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 13 | (11) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 21 | (17) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | (7) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 14 | (4) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | (3) | |
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 12 | ||
Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | Positions that are not credit impaired | Model changes | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 16 | 11 | |
Lifetime expected credit losses | Positions that are not credit impaired | Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 9 | (19) | |
Lifetime expected credit losses | Credit-impaired positions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (662) | (829) | (688) |
Lifetime expected credit losses | Credit-impaired positions | ECL movement with profit or loss impact | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 25 | (429) | |
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 46 | |
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 46 | |
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 17 | ||
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 29 | ||
Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (49) | (338) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (8) | (175) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (36) | (31) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (4) | (131) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (19) | ||
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | (11) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (36) | ||
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (59) | ||
Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 74 | (136) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | (7) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 3 | 1 | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 17 | (79) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 53 | (6) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 2 | (44) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (3) | (3) | |
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (9) | ||
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (12) | ||
Lifetime expected credit losses | Credit-impaired positions | Model changes | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
Lifetime expected credit losses | Credit-impaired positions | Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 141 | 287 | |
UBS AG | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (1,165) | (1,468) | (1,029) |
UBS AG | ECL movement with profit or loss impact | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 148 | (694) | |
UBS AG | Net movement from new and derecognized transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (59) | (28) | |
UBS AG | Net movement from new and derecognized transactions | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (7) | (2) | |
UBS AG | Net movement from new and derecognized transactions | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (7) | (3) | |
UBS AG | Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (13) | (32) | |
UBS AG | Net movement from new and derecognized transactions | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (8) | (16) | |
UBS AG | Net movement from new and derecognized transactions | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (24) | 26 | |
UBS AG | Net movement from new and derecognized transactions | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 32 | ||
UBS AG | Net movement from new and derecognized transactions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 9 | |
UBS AG | Net movement from new and derecognized transactions | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 23 | ||
UBS AG | Net movement from new and derecognized transactions | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (21) | (20) | |
UBS AG | Book quality movements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 163 | ||
UBS AG | Remeasurements with stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (40) | (427) | |
UBS AG | Remeasurements with stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (9) | (19) | |
UBS AG | Remeasurements with stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (3) | (6) | |
UBS AG | Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 2 | (224) | |
UBS AG | Remeasurements with stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (27) | (43) | |
UBS AG | Remeasurements with stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (3) | (134) | |
UBS AG | Remeasurements with stage transfers | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (36) | ||
UBS AG | Remeasurements with stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | (12) | |
UBS AG | Remeasurements with stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (36) | ||
UBS AG | Remeasurements with stage transfers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (59) | ||
UBS AG | Remeasurements with stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 2 | ||
UBS AG | Remeasurements without stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 203 | (271) | |
UBS AG | Remeasurements without stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 33 | (34) | |
UBS AG | Remeasurements without stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 30 | (14) | |
UBS AG | Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 44 | (149) | |
UBS AG | Remeasurements without stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 53 | (13) | |
UBS AG | Remeasurements without stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 44 | (60) | |
UBS AG | Remeasurements without stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 6 | (18) | |
UBS AG | Remeasurements without stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (3) | ||
UBS AG | Remeasurements without stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 27 | ||
UBS AG | Remeasurements without stage transfers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (12) | ||
UBS AG | Model changes | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 45 | 32 | |
UBS AG | Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 154 | 254 | |
UBS AG | Write offs / recoveries | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 137 | ||
UBS AG | Foreign exchange movements | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 18 | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (282) | (306) | (181) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | ECL movement with profit or loss impact | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 19 | (112) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (72) | (90) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (10) | (3) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (11) | (5) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (21) | (29) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (8) | (14) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (23) | (39) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | (1) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (6) | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (18) | (15) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 8 | 45 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 4 | (2) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | 3 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (2) | 34 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 5 | (1) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 11 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | 7 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 55 | (88) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 8 | (19) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 13 | (4) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 5 | (53) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | 0 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 29 | (11) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 8 | (12) | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 6 | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 15 | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Model changes | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 29 | 21 | |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 5 | (14) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (220) | (333) | (160) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (71) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (43) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (55) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (30) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (1) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (3) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (11) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | ECL movement with profit or loss impact | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 104 | (154) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 13 | 17 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 3 | 2 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 4 | 2 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 7 | (4) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | (3) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (2) | 20 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 15 | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | 9 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Net movement from new and derecognized transactions | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (4) | (5) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | (134) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (13) | (17) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (4) | (9) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 12 | (83) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 4 | (11) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 2 | (14) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (18) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | (7) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements with stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 3 | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 74 | (47) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 26 | (8) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 13 | (11) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 21 | (17) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | (7) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 14 | (4) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 1 | (3) | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 12 | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Remeasurements without stage transfers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Model changes | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 16 | 11 | |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 9 | (19) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Total ECL allowances and provisions | (662) | (829) | $ (688) |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | ECL movement with profit or loss impact | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 25 | (429) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 46 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 46 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 17 | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 29 | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Net movement from new and derecognized transactions | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (49) | (338) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (8) | (175) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (36) | (31) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (4) | (131) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Securities financing transactions REIT | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (19) | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | (11) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (36) | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Commodity trade finance | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (59) | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements with stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 74 | (136) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Private clients with mortgages | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (1) | (7) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Real estate financing | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 3 | 1 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Large corporate clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 17 | (79) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | SME clients | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 53 | (6) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Other | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 2 | (44) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Loans to financial advisors | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (3) | (3) | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Lombard | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (9) | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Financial intermediaries and hedge funds | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Remeasurements without stage transfers | Credit cards | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | (12) | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Model changes | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | 0 | 0 | |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Movements without profit or loss impact (write-off, FX and other) | |||
Disclosure Of Credit Risk Exposure [Table] | |||
Development of ECL allowances and provisions | $ 141 | $ 287 |
Expected credit loss measure_12
Expected credit loss measurement - Stage 2 classification by trigger (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 |
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | $ (1,165) | $ (1,468) | $ (1,029) |
Twelve-month expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (282) | (306) | (181) |
Lifetime expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (220) | (333) | (160) |
Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (71) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (43) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (55) | ||
Lifetime expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (30) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (6) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (3) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (11) | ||
Lifetime expected credit losses | Positions that are not credit impaired | Other | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (1) | ||
Lifetime expected credit losses | of which: PD layer | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (158) | ||
Lifetime expected credit losses | of which: PD layer | Private clients with mortgages | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (54) | ||
Lifetime expected credit losses | of which: PD layer | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (38) | ||
Lifetime expected credit losses | of which: PD layer | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (40) | ||
Lifetime expected credit losses | of which: PD layer | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (19) | ||
Lifetime expected credit losses | of which: PD layer | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (6) | ||
Lifetime expected credit losses | of which: PD layer | Loans to financial advisors | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: PD layer | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: PD layer | Other | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (1) | ||
Lifetime expected credit losses | of which: watch list | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (22) | ||
Lifetime expected credit losses | of which: watch list | Private clients with mortgages | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (15) | ||
Lifetime expected credit losses | of which: watch list | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (7) | ||
Lifetime expected credit losses | of which: watch list | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | Loans to financial advisors | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: watch list | Other | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: 30 days past due | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (39) | ||
Lifetime expected credit losses | of which: 30 days past due | Private clients with mortgages | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (17) | ||
Lifetime expected credit losses | of which: 30 days past due | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (4) | ||
Lifetime expected credit losses | of which: 30 days past due | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: 30 days past due | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (4) | ||
Lifetime expected credit losses | of which: 30 days past due | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | of which: 30 days past due | Loans to financial advisors | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (3) | ||
Lifetime expected credit losses | of which: 30 days past due | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (11) | ||
Lifetime expected credit losses | of which: 30 days past due | Other | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
Lifetime expected credit losses | Credit-impaired positions | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (662) | (829) | (688) |
UBS AG | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (1,165) | (1,468) | (1,029) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (282) | (306) | (181) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (220) | (333) | (160) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Private clients with mortgages | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (71) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (43) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (55) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (30) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (6) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans to financial advisors | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (3) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (11) | ||
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Other | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (1) | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (158) | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | Private clients with mortgages | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (54) | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (38) | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (40) | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (19) | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (6) | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | Loans to financial advisors | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: PD layer | Other | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (1) | ||
UBS AG | Lifetime expected credit losses | of which: watch list | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (22) | ||
UBS AG | Lifetime expected credit losses | of which: watch list | Private clients with mortgages | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: watch list | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: watch list | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (15) | ||
UBS AG | Lifetime expected credit losses | of which: watch list | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (7) | ||
UBS AG | Lifetime expected credit losses | of which: watch list | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: watch list | Loans to financial advisors | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: watch list | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: watch list | Other | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (39) | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | Private clients with mortgages | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (17) | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | Real estate financing | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (4) | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | Large corporate clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | SME clients | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (4) | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | Financial intermediaries and hedge funds | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | Loans to financial advisors | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (3) | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | Credit cards | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | (11) | ||
UBS AG | Lifetime expected credit losses | of which: 30 days past due | Other | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | 0 | ||
UBS AG | Lifetime expected credit losses | Credit-impaired positions | |||
Disclosure Of Provision Matrix [Table] | |||
Total ECL allowances and provisions | $ (662) | $ (829) | $ (688) |
Expected credit loss measure_13
Expected credit loss measurement - Maximum exposure to credit risk (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL | ||
Credit enhancements | ||
Collateral and credit enhancements related to credit-impaired financial assets measured at amortized cost | $ 1,443 | $ 1,983 |
Collateral and credit enhancements related to off-balance sheet financial instruments and other credit lines for credit-impaired positions | 130 | 154 |
Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 746,600 | 695,600 |
Collateral | ||
Cash collateral received | 37,700 | 26,000 |
Collateralized by securities | 196,900 | 185,700 |
Secured by real estate | 191,300 | 194,600 |
Other collateral | 28,400 | 30,100 |
Credit enhancements | ||
Netting | 18,400 | 21,100 |
Credit derivative contracts | 0 | 0 |
Guarantees | 4,000 | 4,400 |
Exposure to credit risk after collateral and credit enhancements | 269,800 | 233,700 |
Total financial assets measured at amortized cost | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 737,800 | 687,300 |
Collateral | ||
Cash collateral received | 37,700 | 26,000 |
Collateralized by securities | 196,900 | 185,700 |
Secured by real estate | 191,300 | 194,600 |
Other collateral | 28,400 | 30,100 |
Credit enhancements | ||
Netting | 18,400 | 21,100 |
Credit derivative contracts | 0 | 0 |
Guarantees | 4,000 | 4,400 |
Exposure to credit risk after collateral and credit enhancements | 261,000 | 225,500 |
Cash and balances at central banks | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 192,800 | 158,200 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 192,800 | 158,200 |
Loans and advances to banks | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 15,500 | 15,400 |
Collateral | ||
Collateralized by securities | 100 | 100 |
Credit enhancements | ||
Guarantees | 100 | |
Exposure to credit risk after collateral and credit enhancements | 15,300 | 15,300 |
Receivables from securities financing transactions | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 75,000 | 74,200 |
Collateral | ||
Cash collateral received | 0 | 0 |
Collateralized by securities | 68,000 | 67,100 |
Other collateral | 6,900 | 7,000 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 0 | 0 |
Cash collateral receivables on derivative instruments | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 30,500 | 32,700 |
Credit enhancements | ||
Netting | 18,400 | 21,100 |
Exposure to credit risk after collateral and credit enhancements | 12,100 | 11,600 |
Loans and advances to customers | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 397,800 | 379,500 |
Collateral | ||
Cash collateral received | 37,500 | 25,800 |
Collateralized by securities | 128,700 | 118,200 |
Secured by real estate | 191,300 | 194,600 |
Other collateral | 20,200 | 21,700 |
Credit enhancements | ||
Guarantees | 4,000 | 4,400 |
Exposure to credit risk after collateral and credit enhancements | 16,200 | 14,800 |
Other financial assets measured at amortized cost | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 26,200 | 27,200 |
Collateral | ||
Cash collateral received | 200 | 100 |
Collateralized by securities | 100 | 200 |
Other collateral | 1,300 | 1,300 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 24,600 | 25,500 |
Financial assets measured at fair value through other comprehensive income - debt | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 8,800 | 8,300 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 8,800 | 8,300 |
Total maximum exposure to credit risk not reflected on the balance sheet | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 102,500 | 101,600 |
Collateral | ||
Cash collateral received | 2,200 | 800 |
Collateralized by securities | 20,900 | 22,700 |
Secured by real estate | 8,700 | 8,500 |
Other collateral | 13,700 | 11,200 |
Credit enhancements | ||
Netting | 0 | 0 |
Credit derivative contracts | 300 | 400 |
Guarantees | 4,500 | 4,900 |
Exposure to credit risk after collateral and credit enhancements | 52,100 | 53,000 |
Guarantees | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 20,900 | 17,000 |
Collateral | ||
Cash collateral received | 1,300 | 700 |
Collateralized by securities | 6,500 | 5,000 |
Secured by real estate | 200 | 200 |
Other collateral | 2,500 | 1,700 |
Credit enhancements | ||
Guarantees | 2,300 | 2,500 |
Exposure to credit risk after collateral and credit enhancements | 8,100 | 7,000 |
Loan commitments | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 39,400 | 41,200 |
Collateral | ||
Cash collateral received | 500 | 0 |
Collateralized by securities | 4,000 | 4,200 |
Secured by real estate | 2,400 | 2,100 |
Other collateral | 7,300 | 6,800 |
Credit enhancements | ||
Credit derivative contracts | 300 | 400 |
Guarantees | 1,700 | 2,400 |
Exposure to credit risk after collateral and credit enhancements | 23,100 | 25,300 |
Forward starting reverse repurchase and securities borrowing agreements | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 1,400 | 3,200 |
Collateral | ||
Collateralized by securities | 1,400 | 3,200 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 0 | 0 |
Committed unconditionally revocable credit lines | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 40,700 | 40,100 |
Collateral | ||
Cash collateral received | 300 | 100 |
Collateralized by securities | 9,000 | 10,300 |
Secured by real estate | 6,200 | 6,200 |
Other collateral | 3,900 | 2,700 |
Credit enhancements | ||
Guarantees | 500 | 0 |
Exposure to credit risk after collateral and credit enhancements | 20,900 | 20,700 |
UBS AG | Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL | ||
Credit enhancements | ||
Collateral and credit enhancements related to credit-impaired financial assets measured at amortized cost | 1,443 | 1,983 |
Collateral and credit enhancements related to off-balance sheet financial instruments and other credit lines for credit-impaired positions | 130 | 154 |
UBS AG | Total maximum exposure to credit risk reflected on the balance sheet in scope of ECL | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 747,500 | 697,000 |
Collateral | ||
Cash collateral received | 38,400 | 27,200 |
Collateralized by securities | 196,900 | 185,700 |
Secured by real estate | 191,300 | 194,600 |
Other collateral | 28,400 | 30,100 |
Credit enhancements | ||
Netting | 18,400 | 21,100 |
Credit derivative contracts | 0 | 0 |
Guarantees | 4,000 | 4,400 |
Exposure to credit risk after collateral and credit enhancements | 270,000 | 233,900 |
UBS AG | Total financial assets measured at amortized cost | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 738,600 | 688,700 |
Collateral | ||
Cash collateral received | 38,400 | 27,200 |
Collateralized by securities | 196,900 | 185,700 |
Secured by real estate | 191,300 | 194,600 |
Other collateral | 28,400 | 30,100 |
Credit enhancements | ||
Netting | 18,400 | 21,100 |
Credit derivative contracts | 0 | 0 |
Guarantees | 4,000 | 4,400 |
Exposure to credit risk after collateral and credit enhancements | 261,100 | 225,600 |
UBS AG | Cash and balances at central banks | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 192,800 | 158,200 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 192,800 | 158,200 |
UBS AG | Loans and advances to banks | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 15,400 | 15,300 |
Collateral | ||
Collateralized by securities | 100 | 100 |
Credit enhancements | ||
Guarantees | 100 | |
Exposure to credit risk after collateral and credit enhancements | 15,100 | 15,200 |
UBS AG | Receivables from securities financing transactions | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 75,000 | 74,200 |
Collateral | ||
Cash collateral received | 0 | 0 |
Collateralized by securities | 68,000 | 67,100 |
Other collateral | 6,900 | 7,000 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 0 | 0 |
UBS AG | Cash collateral receivables on derivative instruments | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 30,500 | 32,700 |
Credit enhancements | ||
Netting | 18,400 | 21,100 |
Exposure to credit risk after collateral and credit enhancements | 12,100 | 11,600 |
UBS AG | Loans and advances to customers | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 398,700 | 381,000 |
Collateral | ||
Cash collateral received | 38,200 | 27,000 |
Collateralized by securities | 128,700 | 118,200 |
Secured by real estate | 191,300 | 194,600 |
Other collateral | 20,200 | 21,700 |
Credit enhancements | ||
Credit derivative contracts | 0 | |
Guarantees | 4,000 | 4,400 |
Exposure to credit risk after collateral and credit enhancements | 16,400 | 15,100 |
UBS AG | Other financial assets measured at amortized cost | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 26,200 | 27,200 |
Collateral | ||
Cash collateral received | 200 | 100 |
Collateralized by securities | 100 | 200 |
Secured by real estate | 0 | 0 |
Other collateral | 1,300 | 1,300 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 24,700 | 25,500 |
UBS AG | Financial assets measured at fair value through other comprehensive income - debt | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 8,800 | 8,300 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 8,800 | 8,300 |
UBS AG | Total maximum exposure to credit risk not reflected on the balance sheet | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 104,100 | 103,500 |
Collateral | ||
Cash collateral received | 2,200 | 800 |
Collateralized by securities | 20,900 | 22,700 |
Secured by real estate | 8,700 | 8,500 |
Other collateral | 13,700 | 11,200 |
Credit enhancements | ||
Netting | 0 | 0 |
Credit derivative contracts | 300 | 400 |
Guarantees | 4,500 | 4,900 |
Exposure to credit risk after collateral and credit enhancements | 53,700 | 54,900 |
UBS AG | Guarantees | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 20,900 | 17,000 |
Collateral | ||
Cash collateral received | 1,300 | 700 |
Collateralized by securities | 6,500 | 5,000 |
Secured by real estate | 200 | 200 |
Other collateral | 2,500 | 1,700 |
Credit enhancements | ||
Guarantees | 2,300 | 2,500 |
Exposure to credit risk after collateral and credit enhancements | 8,100 | 7,000 |
UBS AG | Loan commitments | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 39,400 | 41,200 |
Collateral | ||
Cash collateral received | 500 | 0 |
Collateralized by securities | 4,000 | 4,200 |
Secured by real estate | 2,400 | 2,100 |
Other collateral | 7,300 | 6,800 |
Credit enhancements | ||
Credit derivative contracts | 300 | 400 |
Guarantees | 1,700 | 2,400 |
Exposure to credit risk after collateral and credit enhancements | 23,100 | 25,300 |
UBS AG | Forward starting reverse repurchase and securities borrowing agreements | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 1,400 | 3,200 |
Collateral | ||
Collateralized by securities | 1,400 | 3,200 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 0 | 0 |
UBS AG | Committed unconditionally revocable credit lines | Financial Assets At Amortised Cost [Member] | ||
Maximum Exposure To Credit Risk Expected Credit Loss [Table] | ||
Maximum exposure to credit risk | 42,300 | 42,000 |
Collateral | ||
Cash collateral received | 300 | 100 |
Collateralized by securities | 9,000 | 10,300 |
Secured by real estate | 6,200 | 6,200 |
Other collateral | 3,900 | 2,700 |
Credit enhancements | ||
Guarantees | 500 | 0 |
Exposure to credit risk after collateral and credit enhancements | $ 22,500 | $ 22,700 |
Expected credit loss measure_14
Expected credit loss measurement - Financial assets subject to credit risk by rating category (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | $ 746,638 | $ 695,603 |
Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 737,794 | 687,345 |
Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 192,817 | 158,231 |
Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,480 | 15,444 |
Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 75,012 | 74,210 |
Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 30,514 | 32,737 |
Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 397,761 | 379,528 |
Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 26,209 | 27,194 |
Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 8,844 | 8,258 |
Twelve-month expected credit losses | Positions that are not credit impaired | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 728,923 | 672,021 |
Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 720,079 | 663,763 |
Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 192,817 | 158,231 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,453 | 15,260 |
Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 75,012 | 74,210 |
Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 30,514 | 32,737 |
Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 380,564 | 356,948 |
Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 25,718 | 26,377 |
Lifetime expected credit losses | Positions that are not credit impaired | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,948 | 20,873 |
Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,948 | 20,873 |
Lifetime expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 26 | 184 |
Lifetime expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,620 | 20,341 |
Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 302 | 348 |
Lifetime expected credit losses | Credit-impaired positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,767 | 2,709 |
Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,767 | 2,709 |
Lifetime expected credit losses | Credit-impaired positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,577 | 2,240 |
Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 189 | 469 |
Gross carrying amount | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 747,606 | 696,815 |
Gross carrying amount | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 738,762 | 688,556 |
Gross carrying amount | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 192,817 | 158,231 |
Gross carrying amount | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,488 | 15,460 |
Gross carrying amount | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 75,014 | 74,212 |
Gross carrying amount | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 30,514 | 32,737 |
Gross carrying amount | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 398,611 | 380,589 |
Gross carrying amount | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 26,318 | 27,327 |
Gross carrying amount | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 8,844 | 8,258 |
Gross carrying amount | Rating category 0-1 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 255,130 | 212,417 |
Gross carrying amount | Rating category 0-1 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 251,133 | 209,204 |
Gross carrying amount | Rating category 0-1 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 191,015 | 156,250 |
Gross carrying amount | Rating category 0-1 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 407 | 543 |
Gross carrying amount | Rating category 0-1 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 34,386 | 22,998 |
Gross carrying amount | Rating category 0-1 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 7,466 | 8,196 |
Gross carrying amount | Rating category 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,295 | 5,813 |
Gross carrying amount | Rating category 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 12,564 | 15,404 |
Gross carrying amount | Rating category 0-1 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 3,996 | 3,212 |
Gross carrying amount | Rating category 2-3 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 282,874 | 266,936 |
Gross carrying amount | Rating category 2-3 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 278,103 | 261,922 |
Gross carrying amount | Rating category 2-3 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,802 | 1,981 |
Gross carrying amount | Rating category 2-3 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 12,623 | 12,129 |
Gross carrying amount | Rating category 2-3 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 11,267 | 16,009 |
Gross carrying amount | Rating category 2-3 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 13,476 | 13,477 |
Gross carrying amount | Rating category 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 232,233 | 214,307 |
Gross carrying amount | Rating category 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 6,702 | 4,018 |
Gross carrying amount | Rating category 2-3 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 4,771 | 5,014 |
Gross carrying amount | Rating category 4-5 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 85,472 | 91,993 |
Gross carrying amount | Rating category 4-5 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 85,472 | 91,993 |
Gross carrying amount | Rating category 4-5 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Rating category 4-5 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,171 | 1,344 |
Gross carrying amount | Rating category 4-5 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 10,483 | 15,367 |
Gross carrying amount | Rating category 4-5 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,878 | 7,733 |
Gross carrying amount | Rating category 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 67,620 | 67,270 |
Gross carrying amount | Rating category 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 321 | 280 |
Gross carrying amount | Rating category 4-5 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Rating category 6-8 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 97,923 | 98,255 |
Gross carrying amount | Rating category 6-8 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 97,846 | 98,223 |
Gross carrying amount | Rating category 6-8 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Rating category 6-8 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 795 | 1,182 |
Gross carrying amount | Rating category 6-8 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 17,440 | 17,995 |
Gross carrying amount | Rating category 6-8 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 3,647 | 3,243 |
Gross carrying amount | Rating category 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 69,892 | 69,217 |
Gross carrying amount | Rating category 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 6,072 | 6,585 |
Gross carrying amount | Rating category 6-8 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 77 | 32 |
Gross carrying amount | Rating category 9-13 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 23,793 | 23,709 |
Gross carrying amount | Rating category 9-13 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 23,793 | 23,709 |
Gross carrying amount | Rating category 9-13 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Rating category 9-13 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 490 | 260 |
Gross carrying amount | Rating category 9-13 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,439 | 1,842 |
Gross carrying amount | Rating category 9-13 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 47 | 88 |
Gross carrying amount | Rating category 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 21,423 | 21,038 |
Gross carrying amount | Rating category 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 394 | 481 |
Gross carrying amount | Rating category 9-13 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Rating category Defaulted | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,414 | 3,505 |
Gross carrying amount | Rating category Defaulted | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,414 | 3,505 |
Gross carrying amount | Rating category Defaulted | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Rating category Defaulted | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1 | 1 |
Gross carrying amount | Rating category Defaulted | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Rating category Defaulted | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Rating category Defaulted | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,148 | 2,943 |
Gross carrying amount | Rating category Defaulted | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 264 | 560 |
Gross carrying amount | Rating category Defaulted | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 192,817 | 158,231 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,460 | 15,269 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 75,014 | 74,212 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 30,514 | 32,737 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 380,690 | 357,090 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 25,745 | 26,410 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 191,015 | 156,250 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 407 | 543 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 34,386 | 22,998 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 7,466 | 8,196 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,295 | 5,813 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 12,564 | 15,404 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,802 | 1,981 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 12,623 | 12,074 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 11,267 | 16,009 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 13,476 | 13,477 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 231,153 | 212,970 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 6,693 | 4,015 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,146 | 1,277 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 10,483 | 15,367 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,878 | 7,733 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 65,084 | 63,000 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 307 | 269 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 795 | 1,145 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 17,440 | 17,995 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 3,647 | 3,243 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 62,796 | 59,447 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,863 | 6,334 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 488 | 231 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,439 | 1,842 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 47 | 88 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 16,362 | 15,860 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 317 | 389 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 27 | 189 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,773 | 20,556 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 309 | 357 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 55 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,080 | 1,338 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 10 | 3 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 24 | 67 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,536 | 4,269 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 13 | 11 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 37 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 7,096 | 9,770 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 209 | 251 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2 | 29 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,061 | 5,178 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 77 | 91 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1 | 1 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,148 | 2,943 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 264 | 560 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1 | 1 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,148 | 2,943 |
Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 264 | 560 |
Allowance for expected credit loss | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (969) | (1,211) |
Allowance for expected credit loss | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (969) | (1,211) |
Allowance for expected credit loss | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (8) | (16) |
Allowance for expected credit loss | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (2) | (2) |
Allowance for expected credit loss | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (850) | (1,060) |
Allowance for expected credit loss | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (109) | (133) |
Allowance for expected credit loss | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (161) | (187) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (161) | (187) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (7) | (9) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (2) | (2) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (126) | (142) |
Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (27) | (34) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (160) | (229) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (160) | (229) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (1) | (5) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (152) | (215) |
Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (7) | (9) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (647) | (795) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (647) | (795) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | (1) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (572) | (703) |
Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (76) | (90) |
UBS AG | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 747,477 | 696,976 |
UBS AG | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 738,632 | 688,717 |
UBS AG | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 192,817 | 158,231 |
UBS AG | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,360 | 15,344 |
UBS AG | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 75,012 | 74,210 |
UBS AG | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 30,514 | 32,737 |
UBS AG | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 398,693 | 380,977 |
UBS AG | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 26,236 | 27,219 |
UBS AG | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 8,844 | 8,258 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 729,762 | 673,394 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 720,917 | 665,135 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 192,817 | 158,231 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,333 | 15,160 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 75,012 | 74,210 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 30,514 | 32,737 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 381,496 | 358,396 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 25,746 | 26,401 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,948 | 20,873 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,948 | 20,873 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 26 | 184 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,620 | 20,341 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 302 | 348 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,767 | 2,709 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,767 | 2,709 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,577 | 2,240 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 189 | 469 |
UBS AG | Gross carrying amount | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 748,445 | 698,187 |
UBS AG | Gross carrying amount | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 739,601 | 689,929 |
UBS AG | Gross carrying amount | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 192,817 | 158,231 |
UBS AG | Gross carrying amount | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,368 | 15,360 |
UBS AG | Gross carrying amount | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 75,014 | 74,212 |
UBS AG | Gross carrying amount | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 30,514 | 32,737 |
UBS AG | Gross carrying amount | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 399,543 | 382,036 |
UBS AG | Gross carrying amount | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 26,346 | 27,352 |
UBS AG | Gross carrying amount | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 8,844 | 8,258 |
UBS AG | Gross carrying amount | Rating category 0-1 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 255,130 | 212,417 |
UBS AG | Gross carrying amount | Rating category 0-1 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 251,133 | 209,204 |
UBS AG | Gross carrying amount | Rating category 0-1 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 191,015 | 156,250 |
UBS AG | Gross carrying amount | Rating category 0-1 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 407 | 543 |
UBS AG | Gross carrying amount | Rating category 0-1 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 34,386 | 22,998 |
UBS AG | Gross carrying amount | Rating category 0-1 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 7,466 | 8,196 |
UBS AG | Gross carrying amount | Rating category 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,295 | 5,813 |
UBS AG | Gross carrying amount | Rating category 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 12,564 | 15,404 |
UBS AG | Gross carrying amount | Rating category 0-1 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 3,996 | 3,212 |
UBS AG | Gross carrying amount | Rating category 2-3 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 283,236 | 268,309 |
UBS AG | Gross carrying amount | Rating category 2-3 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 278,465 | 263,295 |
UBS AG | Gross carrying amount | Rating category 2-3 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,802 | 1,981 |
UBS AG | Gross carrying amount | Rating category 2-3 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 12,552 | 12,029 |
UBS AG | Gross carrying amount | Rating category 2-3 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 11,267 | 16,009 |
UBS AG | Gross carrying amount | Rating category 2-3 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 13,476 | 13,477 |
UBS AG | Gross carrying amount | Rating category 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 232,663 | 215,755 |
UBS AG | Gross carrying amount | Rating category 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 6,705 | 4,043 |
UBS AG | Gross carrying amount | Rating category 2-3 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 4,771 | 5,014 |
UBS AG | Gross carrying amount | Rating category 4-5 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 85,424 | 91,993 |
UBS AG | Gross carrying amount | Rating category 4-5 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 85,424 | 91,993 |
UBS AG | Gross carrying amount | Rating category 4-5 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Rating category 4-5 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,123 | 1,344 |
UBS AG | Gross carrying amount | Rating category 4-5 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 10,483 | 15,367 |
UBS AG | Gross carrying amount | Rating category 4-5 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,878 | 7,733 |
UBS AG | Gross carrying amount | Rating category 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 67,620 | 67,270 |
UBS AG | Gross carrying amount | Rating category 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 321 | 280 |
UBS AG | Gross carrying amount | Rating category 4-5 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Rating category 6-8 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 98,449 | 98,255 |
UBS AG | Gross carrying amount | Rating category 6-8 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 98,372 | 98,223 |
UBS AG | Gross carrying amount | Rating category 6-8 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Rating category 6-8 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 795 | 1,182 |
UBS AG | Gross carrying amount | Rating category 6-8 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 17,440 | 17,995 |
UBS AG | Gross carrying amount | Rating category 6-8 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 3,647 | 3,243 |
UBS AG | Gross carrying amount | Rating category 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 70,394 | 69,217 |
UBS AG | Gross carrying amount | Rating category 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 6,097 | 6,585 |
UBS AG | Gross carrying amount | Rating category 6-8 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 77 | 32 |
UBS AG | Gross carrying amount | Rating category 9-13 | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 23,793 | 23,709 |
UBS AG | Gross carrying amount | Rating category 9-13 | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 23,793 | 23,709 |
UBS AG | Gross carrying amount | Rating category 9-13 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Rating category 9-13 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 490 | 260 |
UBS AG | Gross carrying amount | Rating category 9-13 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,439 | 1,842 |
UBS AG | Gross carrying amount | Rating category 9-13 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 47 | 88 |
UBS AG | Gross carrying amount | Rating category 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 21,423 | 21,038 |
UBS AG | Gross carrying amount | Rating category 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 394 | 481 |
UBS AG | Gross carrying amount | Rating category 9-13 | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Rating category Defaulted | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,414 | 3,505 |
UBS AG | Gross carrying amount | Rating category Defaulted | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,414 | 3,505 |
UBS AG | Gross carrying amount | Rating category Defaulted | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Rating category Defaulted | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1 | 1 |
UBS AG | Gross carrying amount | Rating category Defaulted | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Rating category Defaulted | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Rating category Defaulted | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,148 | 2,943 |
UBS AG | Gross carrying amount | Rating category Defaulted | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 264 | 560 |
UBS AG | Gross carrying amount | Rating category Defaulted | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 192,817 | 158,231 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,340 | 15,170 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 75,014 | 74,212 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 30,514 | 32,737 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 381,622 | 358,538 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 25,772 | 26,435 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 191,015 | 156,250 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 407 | 543 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 34,386 | 22,998 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 7,466 | 8,196 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,295 | 5,813 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 12,564 | 15,404 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,802 | 1,981 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 12,552 | 11,974 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 11,267 | 16,009 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 13,476 | 13,477 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 231,583 | 214,418 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 6,696 | 4,040 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,098 | 1,277 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 10,483 | 15,367 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,878 | 7,733 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 65,083 | 63,000 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 307 | 269 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 795 | 1,145 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 17,440 | 17,995 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 3,647 | 3,243 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 63,298 | 59,447 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,887 | 6,334 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 488 | 231 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,439 | 1,842 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 47 | 88 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 16,362 | 15,860 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 317 | 389 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 27 | 189 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 15,773 | 20,556 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 309 | 357 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 55 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1,080 | 1,338 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 10 | 3 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 24 | 67 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,536 | 4,269 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 13 | 11 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 37 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 7,096 | 9,770 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 209 | 251 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2 | 29 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 5,061 | 5,178 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 77 | 91 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1 | 1 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,148 | 2,943 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 264 | 560 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 1 | 1 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 2,148 | 2,943 |
UBS AG | Gross carrying amount | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 264 | 560 |
UBS AG | Allowance for expected credit loss | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (969) | (1,211) |
UBS AG | Allowance for expected credit loss | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (969) | (1,211) |
UBS AG | Allowance for expected credit loss | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (8) | (16) |
UBS AG | Allowance for expected credit loss | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (2) | (2) |
UBS AG | Allowance for expected credit loss | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (850) | (1,060) |
UBS AG | Allowance for expected credit loss | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (109) | (133) |
UBS AG | Allowance for expected credit loss | Financial assets measured at FVOCI - debt instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (161) | (187) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (161) | (187) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (7) | (9) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (2) | (2) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (126) | (142) |
UBS AG | Allowance for expected credit loss | Twelve-month expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (27) | (34) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (160) | (229) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (160) | (229) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (1) | (5) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (152) | (215) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Positions that are not credit impaired | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (7) | (9) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total on balance sheet financial instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (647) | (795) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Total financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (647) | (795) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Cash and balances at central banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to banks | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | (1) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Receivables from securities financing transactions | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Cash collateral receivables on derivative instruments | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | 0 | 0 |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Loans and advances to customers | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | (572) | (703) |
UBS AG | Allowance for expected credit loss | Lifetime expected credit losses | Credit-impaired positions | Other financial assets measured at amortized cost | ||
Disclosure Of Internal Credit Exposures [Table] | ||
Financial assets | $ (76) | $ (90) |
Expected credit loss measure_15
Expected credit loss measurement - Off balance sheet positions subject to expected credit loss by rating category (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | $ 108,284 | $ 105,116 |
ECL provision | (196) | (257) |
Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 61,894 | 61,700 |
ECL provision | (155) | (205) |
Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 20,972 | 17,081 |
ECL provision | (41) | (63) |
Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 39,478 | 41,372 |
ECL provision | (114) | (142) |
Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,444 | 3,247 |
ECL provision | 0 | 0 |
Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 46,390 | 43,416 |
ECL provision | (41) | (52) |
Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 40,778 | 40,134 |
ECL provision | (38) | (50) |
Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 5,611 | 3,282 |
ECL provision | (3) | (2) |
Rating category 0-1 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,254 | 6,583 |
Rating category 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,457 | 3,482 |
Rating category 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,797 | 3,018 |
Rating category 0-1 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 82 |
Rating category 0-1 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,653 | 588 |
Rating category 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,636 | 574 |
Rating category 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 17 | 14 |
Rating category 2-3 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 21,247 | 19,289 |
Rating category 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,064 | 4,623 |
Rating category 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 14,183 | 14,516 |
Rating category 2-3 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 150 |
Rating category 2-3 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 18,032 | 14,854 |
Rating category 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 15,594 | 13,505 |
Rating category 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,438 | 1,349 |
Rating category 4-5 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 12,241 | 12,105 |
Rating category 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,535 | 3,522 |
Rating category 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,651 | 8,583 |
Rating category 4-5 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 55 | 0 |
Rating category 4-5 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,049 | 6,889 |
Rating category 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,627 | 5,958 |
Rating category 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,422 | 931 |
Rating category 6-8 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 13,444 | 16,610 |
Rating category 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 3,757 | 4,293 |
Rating category 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,298 | 9,302 |
Rating category 6-8 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,389 | 3,015 |
Rating category 6-8 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,836 | 9,119 |
Rating category 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 9,752 | 8,488 |
Rating category 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,084 | 632 |
Rating category 9-13 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,512 | 6,840 |
Rating category 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,009 | 991 |
Rating category 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 6,502 | 5,850 |
Rating category 9-13 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Rating category 9-13 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,709 | 11,858 |
Rating category 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,107 | 11,501 |
Rating category 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 602 | 357 |
Rating category Defaulted | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 196 | 273 |
Rating category Defaulted | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 150 | 170 |
Rating category Defaulted | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 46 | 104 |
Rating category Defaulted | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Rating category Defaulted | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 111 | 109 |
Rating category Defaulted | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 63 | 108 |
Rating category Defaulted | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 48 | 0 |
Twelve-month expected credit losses | Positions that are not credit impaired | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 101,971 | 93,337 |
ECL provision | (121) | (119) |
Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 19,695 | 14,687 |
ECL provision | (18) | (14) |
Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 37,097 | 36,894 |
ECL provision | (72) | (74) |
Twelve-month expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,444 | 3,247 |
ECL provision | 0 | 0 |
Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 38,207 | 35,233 |
ECL provision | (28) | (29) |
Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 5,527 | 3,277 |
ECL provision | (3) | (2) |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,457 | 3,482 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,797 | 3,018 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,636 | 574 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 17 | 14 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,037 | 4,219 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 13,917 | 13,589 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 15,250 | 12,940 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,438 | 1,349 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,375 | 2,688 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,416 | 6,873 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,304 | 4,517 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,422 | 930 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 3,075 | 3,558 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,127 | 8,739 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,346 | 6,609 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,082 | 630 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 752 | 739 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 5,840 | 4,676 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 3,671 | 10,593 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 568 | 355 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 6,006 | 11,396 |
ECL provision | (60) | (104) |
Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,127 | 2,225 |
ECL provision | (8) | (15) |
Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,335 | 4,374 |
ECL provision | (42) | (68) |
Lifetime expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
ECL provision | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,508 | 4,792 |
ECL provision | (10) | (21) |
Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 36 | 5 |
ECL provision | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 27 | 404 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 266 | 927 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 344 | 565 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 1 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 160 | 834 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 235 | 1,711 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 323 | 1,441 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 1 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 682 | 736 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,171 | 563 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,406 | 1,879 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1 | 2 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 258 | 252 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 663 | 1,174 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 436 | 908 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 34 | 1 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 307 | 382 |
ECL provision | (15) | (34) |
Lifetime expected credit losses | Credit-impaired positions | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 150 | 170 |
ECL provision | (15) | (34) |
Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 46 | 104 |
ECL provision | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
ECL provision | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 63 | 108 |
ECL provision | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 48 | 0 |
ECL provision | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 150 | 170 |
Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 46 | 104 |
Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 63 | 108 |
Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 48 | 0 |
UBS AG | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 109,878 | 107,059 |
ECL provision | (196) | (257) |
UBS AG | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 61,894 | 61,700 |
ECL provision | (155) | (205) |
UBS AG | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 20,972 | 17,081 |
ECL provision | (41) | (63) |
UBS AG | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 39,478 | 41,372 |
ECL provision | (114) | (142) |
UBS AG | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,444 | 3,247 |
ECL provision | 0 | 0 |
UBS AG | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 47,984 | 45,359 |
ECL provision | (41) | (52) |
UBS AG | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 42,373 | 42,077 |
ECL provision | (38) | (50) |
UBS AG | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 5,611 | 3,282 |
ECL provision | (3) | (2) |
UBS AG | Rating category 0-1 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,254 | 6,583 |
UBS AG | Rating category 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,457 | 3,482 |
UBS AG | Rating category 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,797 | 3,018 |
UBS AG | Rating category 0-1 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 82 |
UBS AG | Rating category 0-1 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,653 | 588 |
UBS AG | Rating category 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,636 | 574 |
UBS AG | Rating category 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 17 | 14 |
UBS AG | Rating category 2-3 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 21,247 | 19,289 |
UBS AG | Rating category 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,064 | 4,623 |
UBS AG | Rating category 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 14,183 | 14,516 |
UBS AG | Rating category 2-3 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 150 |
UBS AG | Rating category 2-3 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 19,249 | 16,797 |
UBS AG | Rating category 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 16,811 | 15,448 |
UBS AG | Rating category 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,438 | 1,349 |
UBS AG | Rating category 4-5 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 12,241 | 12,105 |
UBS AG | Rating category 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,535 | 3,522 |
UBS AG | Rating category 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,651 | 8,583 |
UBS AG | Rating category 4-5 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 55 | 0 |
UBS AG | Rating category 4-5 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,049 | 6,889 |
UBS AG | Rating category 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,627 | 5,958 |
UBS AG | Rating category 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,422 | 931 |
UBS AG | Rating category 6-8 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 13,444 | 16,610 |
UBS AG | Rating category 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 3,757 | 4,293 |
UBS AG | Rating category 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,298 | 9,302 |
UBS AG | Rating category 6-8 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,389 | 3,015 |
UBS AG | Rating category 6-8 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 11,214 | 9,119 |
UBS AG | Rating category 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 10,130 | 8,488 |
UBS AG | Rating category 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,084 | 632 |
UBS AG | Rating category 9-13 | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,512 | 6,840 |
UBS AG | Rating category 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,009 | 991 |
UBS AG | Rating category 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 6,502 | 5,850 |
UBS AG | Rating category 9-13 | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Rating category 9-13 | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,709 | 11,858 |
UBS AG | Rating category 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,107 | 11,501 |
UBS AG | Rating category 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 602 | 357 |
UBS AG | Rating category Defaulted | Off Balance Sheet Financial Instruments Without Other Credit Lines [Member] | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 196 | 273 |
UBS AG | Rating category Defaulted | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 150 | 170 |
UBS AG | Rating category Defaulted | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 46 | 104 |
UBS AG | Rating category Defaulted | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Rating category Defaulted | Total other credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 111 | 109 |
UBS AG | Rating category Defaulted | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 63 | 108 |
UBS AG | Rating category Defaulted | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 48 | 0 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 103,565 | 95,281 |
ECL provision | (121) | (119) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 19,695 | 14,687 |
ECL provision | (18) | (14) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 37,097 | 36,894 |
ECL provision | (72) | (74) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,444 | 3,247 |
ECL provision | 0 | 0 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 39,802 | 37,176 |
ECL provision | (28) | (29) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 5,527 | 3,277 |
ECL provision | (3) | (2) |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,457 | 3,482 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,797 | 3,018 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,636 | 574 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 17 | 14 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,037 | 4,219 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 13,917 | 13,589 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 16,467 | 14,883 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,438 | 1,349 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 4,375 | 2,688 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,416 | 6,873 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,304 | 4,517 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,422 | 930 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 3,075 | 3,558 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 7,127 | 8,739 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 8,724 | 6,609 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,082 | 630 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 752 | 739 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 5,840 | 4,676 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 3,671 | 10,593 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 568 | 355 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Twelve-month expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 6,006 | 11,396 |
ECL provision | (60) | (104) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,127 | 2,225 |
ECL provision | (8) | (15) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,335 | 4,374 |
ECL provision | (42) | (68) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
ECL provision | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 2,508 | 4,792 |
ECL provision | (10) | (21) |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 36 | 5 |
ECL provision | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 27 | 404 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 266 | 927 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 344 | 565 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 1 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 160 | 834 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 235 | 1,711 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 323 | 1,441 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 1 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 682 | 736 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,171 | 563 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1,406 | 1,879 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 1 | 2 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 258 | 252 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 663 | 1,174 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 436 | 908 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 34 | 1 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Positions that are not credit impaired | Rating category Defaulted | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 307 | 382 |
ECL provision | (15) | (34) |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 150 | 170 |
ECL provision | (15) | (34) |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 46 | 104 |
ECL provision | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Forward starting reverse repurchase and securities borrowing agreements | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
ECL provision | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 63 | 108 |
ECL provision | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 48 | 0 |
ECL provision | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 0-1 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 2-3 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 4-5 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 6-8 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category 9-13 | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 0 | 0 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Guarantees | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 150 | 170 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Irrevocable loan commitments | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 46 | 104 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Committed unconditionally revocable credit lines | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | 63 | 108 |
UBS AG | Lifetime expected credit losses | Credit-impaired positions | Rating category Defaulted | Irrevocable committed prolongation of existing loans | ||
Disclosure Of Off Balance Sheet Positions Subject To Expected Credit Loss By Rating Category [Table] | ||
Exposure To Credit Risk On Loan Commitments And Financial Guarantee Contracts | $ 48 | $ 0 |
Expected credit loss measure_16
Expected credit loss measurement - Potential effect on stage 1 and stage 2 positions from changing key parameters (Detail) $ in Thousands | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Baseline ECL scenario | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | $ (1,000) |
Baseline ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
Baseline ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 4,000 |
Baseline ECL scenario | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
Baseline ECL scenario | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
Baseline ECL scenario | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
Baseline ECL scenario | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 3,000 |
Baseline ECL scenario | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 4,000 |
Baseline ECL scenario | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Baseline ECL scenario | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
Baseline ECL scenario | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
Baseline ECL scenario | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 6,000 |
Baseline ECL scenario | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 3,000 |
Baseline ECL scenario | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
Baseline ECL scenario | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (4,000) |
Baseline ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Baseline ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
Baseline ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
Baseline ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
Upside ECL scenario | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
Upside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
Upside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Upside ECL scenario | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
Upside ECL scenario | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
Upside ECL scenario | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
Upside ECL scenario | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Upside ECL scenario | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Upside ECL scenario | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
Upside ECL scenario | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
Upside ECL scenario | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
Upside ECL scenario | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 4,000 |
Upside ECL scenario | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Upside ECL scenario | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
Upside ECL scenario | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (3,000) |
Upside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Upside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
Upside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
Upside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
Mild downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (29,000) |
Mild downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 39,000 |
Mild downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 88,000 |
Mild downside ECL scenario | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (30,000) |
Mild downside ECL scenario | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (17,000) |
Mild downside ECL scenario | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 21,000 |
Mild downside ECL scenario | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 47,000 |
Mild downside ECL scenario | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 8,000 |
Mild downside ECL scenario | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 4,000 |
Mild downside ECL scenario | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (10,000) |
Mild downside ECL scenario | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (14,000) |
Mild downside ECL scenario | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 50,000 |
Mild downside ECL scenario | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 24,000 |
Mild downside ECL scenario | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (26,000) |
Mild downside ECL scenario | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (46,000) |
Mild downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 5,000 |
Mild downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Mild downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
Mild downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (4,000) |
Severe downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (9,000) |
Severe downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 11,000 |
Severe downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 23,000 |
Severe downside ECL scenario | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (48,000) |
Severe downside ECL scenario | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (27,000) |
Severe downside ECL scenario | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 31,000 |
Severe downside ECL scenario | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 68,000 |
Severe downside ECL scenario | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 17,000 |
Severe downside ECL scenario | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 8,000 |
Severe downside ECL scenario | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (8,000) |
Severe downside ECL scenario | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (16,000) |
Severe downside ECL scenario | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 73,000 |
Severe downside ECL scenario | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 34,000 |
Severe downside ECL scenario | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (31,000) |
Severe downside ECL scenario | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (31,000) |
Severe downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 6,000 |
Severe downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 3,000 |
Severe downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (3,000) |
Severe downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (6,000) |
Weighted average | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (4,000) |
Weighted average | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 5,000 |
Weighted average | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 14,000 |
Weighted average | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (13,000) |
Weighted average | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (7,000) |
Weighted average | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 8,000 |
Weighted average | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 18,000 |
Weighted average | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 10,000 |
Weighted average | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 5,000 |
Weighted average | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (4,000) |
Weighted average | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (7,000) |
Weighted average | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 24,000 |
Weighted average | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 12,000 |
Weighted average | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (11,000) |
Weighted average | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (13,000) |
Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 5,000 |
Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (3,000) |
UBS AG | Baseline ECL scenario | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
UBS AG | Baseline ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
UBS AG | Baseline ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 4,000 |
UBS AG | Baseline ECL scenario | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
UBS AG | Baseline ECL scenario | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
UBS AG | Baseline ECL scenario | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
UBS AG | Baseline ECL scenario | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 3,000 |
UBS AG | Baseline ECL scenario | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 4,000 |
UBS AG | Baseline ECL scenario | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Baseline ECL scenario | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
UBS AG | Baseline ECL scenario | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
UBS AG | Baseline ECL scenario | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 6,000 |
UBS AG | Baseline ECL scenario | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 3,000 |
UBS AG | Baseline ECL scenario | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
UBS AG | Baseline ECL scenario | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (4,000) |
UBS AG | Baseline ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Baseline ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
UBS AG | Baseline ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
UBS AG | Baseline ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
UBS AG | Upside ECL scenario | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
UBS AG | Upside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
UBS AG | Upside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Upside ECL scenario | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
UBS AG | Upside ECL scenario | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
UBS AG | Upside ECL scenario | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
UBS AG | Upside ECL scenario | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Upside ECL scenario | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Upside ECL scenario | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 1,000 |
UBS AG | Upside ECL scenario | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
UBS AG | Upside ECL scenario | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
UBS AG | Upside ECL scenario | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 4,000 |
UBS AG | Upside ECL scenario | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Upside ECL scenario | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (1,000) |
UBS AG | Upside ECL scenario | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (3,000) |
UBS AG | Upside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Upside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
UBS AG | Upside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
UBS AG | Upside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 0 |
UBS AG | Mild downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (29,000) |
UBS AG | Mild downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 39,000 |
UBS AG | Mild downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 88,000 |
UBS AG | Mild downside ECL scenario | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (30,000) |
UBS AG | Mild downside ECL scenario | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (17,000) |
UBS AG | Mild downside ECL scenario | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 21,000 |
UBS AG | Mild downside ECL scenario | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 47,000 |
UBS AG | Mild downside ECL scenario | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 8,000 |
UBS AG | Mild downside ECL scenario | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 4,000 |
UBS AG | Mild downside ECL scenario | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (10,000) |
UBS AG | Mild downside ECL scenario | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (14,000) |
UBS AG | Mild downside ECL scenario | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 50,000 |
UBS AG | Mild downside ECL scenario | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 24,000 |
UBS AG | Mild downside ECL scenario | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (26,000) |
UBS AG | Mild downside ECL scenario | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (46,000) |
UBS AG | Mild downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 5,000 |
UBS AG | Mild downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Mild downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
UBS AG | Mild downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (4,000) |
UBS AG | Severe downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (9,000) |
UBS AG | Severe downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 11,000 |
UBS AG | Severe downside ECL scenario | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 23,000 |
UBS AG | Severe downside ECL scenario | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (48,000) |
UBS AG | Severe downside ECL scenario | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (27,000) |
UBS AG | Severe downside ECL scenario | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 31,000 |
UBS AG | Severe downside ECL scenario | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 68,000 |
UBS AG | Severe downside ECL scenario | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 17,000 |
UBS AG | Severe downside ECL scenario | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 8,000 |
UBS AG | Severe downside ECL scenario | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (8,000) |
UBS AG | Severe downside ECL scenario | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (16,000) |
UBS AG | Severe downside ECL scenario | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 73,000 |
UBS AG | Severe downside ECL scenario | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 34,000 |
UBS AG | Severe downside ECL scenario | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (31,000) |
UBS AG | Severe downside ECL scenario | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (31,000) |
UBS AG | Severe downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 6,000 |
UBS AG | Severe downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 3,000 |
UBS AG | Severe downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (3,000) |
UBS AG | Severe downside ECL scenario | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (6,000) |
UBS AG | Weighted average | Fixed income: 10-year government bonds (relative change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (4,000) |
UBS AG | Weighted average | Fixed income: 10-year government bonds (relative change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 5,000 |
UBS AG | Weighted average | Fixed income: 10-year government bonds (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 14,000 |
UBS AG | Weighted average | Unemployment rate (absolute change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (13,000) |
UBS AG | Weighted average | Unemployment rate (absolute change) | Minus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (7,000) |
UBS AG | Weighted average | Unemployment rate (absolute change) | Plus 0.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 8,000 |
UBS AG | Weighted average | Unemployment rate (absolute change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 18,000 |
UBS AG | Weighted average | Real GDP growth (relative change) | Minus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 10,000 |
UBS AG | Weighted average | Real GDP growth (relative change) | Minus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 5,000 |
UBS AG | Weighted average | Real GDP growth (relative change) | Plus 1.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (4,000) |
UBS AG | Weighted average | Real GDP growth (relative change) | Plus 2.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (7,000) |
UBS AG | Weighted average | House Price Index (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 24,000 |
UBS AG | Weighted average | House Price Index (relative change) | Minus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 12,000 |
UBS AG | Weighted average | House Price Index (relative change) | Plus 2.50 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (11,000) |
UBS AG | Weighted average | House Price Index (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (13,000) |
UBS AG | Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 5,000 |
UBS AG | Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Minus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | 2,000 |
UBS AG | Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 5.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | (2,000) |
UBS AG | Weighted average | Equity (S&P500, EuroStoxx, SMI) (relative change) | Plus 10.00 percent | |
Disclosure Of Key Macro Economic Variables Used For Expected Credit Loss Model [Table] | |
Economic forecast financial effect | $ (3,000) |
Expected credit loss measure_17
Expected credit loss measurement - Potential effect on stage 1 and stage 2 positions from changing scenario weights or moving to an ECL lifetime calculation (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | $ (1,165) | $ (1,468) | $ (1,029) |
Weighted average | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | $ (503) | $ (639) | |
ECL with adjusted probabilities of scenario weights in percent of baseline | 130.00% | 145.00% | |
Weighted average | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | $ (95) | ||
Weighted average | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (62) | ||
Weighted average | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (150) | ||
Weighted average | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (65) | ||
Weighted average | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (130) | ||
Baseline ECL scenario | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (387) | $ (442) | |
Baseline ECL scenario | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (53) | ||
Baseline ECL scenario | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (50) | ||
Baseline ECL scenario | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (116) | ||
Baseline ECL scenario | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (56) | ||
Baseline ECL scenario | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (112) | ||
Upside ECL scenario | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (370) | ||
Upside ECL scenario | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (52) | ||
Upside ECL scenario | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (48) | ||
Upside ECL scenario | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (107) | ||
Upside ECL scenario | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (55) | ||
Upside ECL scenario | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (108) | ||
Mild downside ECL scenario | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (574) | ||
Mild downside ECL scenario | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (119) | ||
Mild downside ECL scenario | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (101) | ||
Mild downside ECL scenario | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (148) | ||
Mild downside ECL scenario | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (71) | ||
Mild downside ECL scenario | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (135) | ||
Severe downside ECL scenario | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (806) | ||
Severe downside ECL scenario | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (207) | ||
Severe downside ECL scenario | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (97) | ||
Severe downside ECL scenario | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (244) | ||
Severe downside ECL scenario | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (91) | ||
Severe downside ECL scenario | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (166) | ||
Lifetime weighted average | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (1,060) | ||
Lifetime weighted average | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (277) | ||
Lifetime weighted average | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (118) | ||
Lifetime weighted average | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (257) | ||
Lifetime weighted average | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (117) | ||
Lifetime weighted average | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (291) | ||
UBS AG | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (1,165) | (1,468) | $ (1,029) |
UBS AG | Weighted average | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | $ (503) | $ (639) | |
ECL with adjusted probabilities of scenario weights in percent of baseline | 130.00% | 145.00% | |
UBS AG | Weighted average | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | $ (95) | ||
UBS AG | Weighted average | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (62) | ||
UBS AG | Weighted average | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (150) | ||
UBS AG | Weighted average | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (65) | ||
UBS AG | Weighted average | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (130) | ||
UBS AG | Baseline ECL scenario | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (387) | $ (442) | |
UBS AG | Baseline ECL scenario | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (53) | ||
UBS AG | Baseline ECL scenario | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (50) | ||
UBS AG | Baseline ECL scenario | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (116) | ||
UBS AG | Baseline ECL scenario | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (56) | ||
UBS AG | Baseline ECL scenario | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (112) | ||
UBS AG | Upside ECL scenario | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (370) | ||
UBS AG | Upside ECL scenario | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (52) | ||
UBS AG | Upside ECL scenario | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (48) | ||
UBS AG | Upside ECL scenario | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (107) | ||
UBS AG | Upside ECL scenario | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (55) | ||
UBS AG | Upside ECL scenario | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (108) | ||
UBS AG | Mild downside ECL scenario | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (574) | ||
UBS AG | Mild downside ECL scenario | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (119) | ||
UBS AG | Mild downside ECL scenario | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (101) | ||
UBS AG | Mild downside ECL scenario | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (148) | ||
UBS AG | Mild downside ECL scenario | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (71) | ||
UBS AG | Mild downside ECL scenario | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (135) | ||
UBS AG | Severe downside ECL scenario | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (806) | ||
UBS AG | Severe downside ECL scenario | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (207) | ||
UBS AG | Severe downside ECL scenario | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (97) | ||
UBS AG | Severe downside ECL scenario | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (244) | ||
UBS AG | Severe downside ECL scenario | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (91) | ||
UBS AG | Severe downside ECL scenario | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (166) | ||
UBS AG | Lifetime weighted average | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (1,060) | ||
UBS AG | Lifetime weighted average | Private clients with mortgages | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (277) | ||
UBS AG | Lifetime weighted average | Real estate financing | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (118) | ||
UBS AG | Lifetime weighted average | Large corporate clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (257) | ||
UBS AG | Lifetime weighted average | SME clients | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | (117) | ||
UBS AG | Lifetime weighted average | Other segments | |||
ECL Measurement Sensitivity Analysis [Table] | |||
Total ECL allowances and provisions | $ (291) |
Fair value measurement (Narrati
Fair value measurement (Narrative) (Detail) $ in Millions | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Entity [Table] | |
Other net income from financial instruments measured at fair value through profit or loss, swaps portfolio close | $ (861) |
UBS AG | |
Entity [Table] | |
Other net income from financial instruments measured at fair value through profit or loss, swaps portfolio close | $ (861) |
FVM - Fair value hierarchy - As
FVM - Fair value hierarchy - Assets (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | $ 345,010 | $ 404,805 |
Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value expected to be recovered or settled after 12 months | 17,000 | 21,000 |
Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value expected to be recovered or settled after 12 months | 8,000 | 8,000 |
Measured at fair value on a recurring basis | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 130,821 | 125,397 |
Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 99,197 | 91,579 |
Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 8,496 | 11,245 |
Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 9,229 | 9,192 |
Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 8,868 | 9,961 |
Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,542 | 2,995 |
Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 489 | 425 |
Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 118,142 | 159,617 |
Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 53,305 | 68,749 |
Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 33,241 | 50,890 |
Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 28,245 | 34,842 |
Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,414 | 2,358 |
Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,606 | 2,217 |
Measured at fair value on a recurring basis | Brokerage receivables | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21,839 | 24,659 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 60,080 | 80,364 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 765 | 631 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 8,860 | 23,297 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 5,804 | 6,751 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,585 | 1,527 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,028 | 831 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21,303 | 20,731 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 14,366 | 17,619 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 5,874 | 8,561 |
Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 495 | 418 |
Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 8,844 | 8,258 |
Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2,686 | 1,150 |
Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,310 | 485 |
Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,849 | 6,624 |
Measured at fair value on a recurring basis | Non-financial assets - Precious metals and other physical commodities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 5,258 | 6,264 |
Measured at fair value on a non-recurring basis | Other non-financial assets | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 26 | 246 |
Level 1 | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 149,459 | 156,696 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 113,697 | 107,507 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 97,958 | 90,307 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7,135 | 9,028 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7,843 | 7,374 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 708 | 789 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 53 | 8 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 522 | 795 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 255 | 319 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Brokerage receivables | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 27,278 | 40,986 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 83 | 86 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 5,624 | 19,704 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 338 | 278 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21,110 | 20,628 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 123 | 290 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2,704 | 1,144 |
Level 1 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2,658 | 1,103 |
Level 1 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 45 | 40 |
Level 1 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Non-financial assets - Precious metals and other physical commodities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 5,258 | 6,264 |
Level 1 | Measured at fair value on a non-recurring basis | Other non-financial assets | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 0 | 0 |
Level 2 | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 187,905 | 239,831 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 14,825 | 15,553 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,090 | 1,101 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,351 | 2,207 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,364 | 1,794 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7,604 | 8,356 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 3,099 | 1,860 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 317 | 236 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 116,479 | 157,068 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 53,043 | 68,424 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 32,747 | 50,353 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 27,861 | 33,990 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,179 | 2,008 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,590 | 2,211 |
Level 2 | Measured at fair value on a recurring basis | Brokerage receivables | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21,839 | 24,659 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 28,622 | 35,435 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2 | 0 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 3,236 | 3,593 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 5,704 | 6,629 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 574 | 447 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 187 | 101 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 13,937 | 16,957 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,982 | 7,699 |
Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 10 |
Level 2 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 6,140 | 7,114 |
Level 2 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 27 | 47 |
Level 2 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,265 | 444 |
Level 2 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,849 | 6,624 |
Level 2 | Measured at fair value on a recurring basis | Non-financial assets - Precious metals and other physical commodities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 0 | 0 |
Level 2 | Measured at fair value on a non-recurring basis | Other non-financial assets | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 0 | 1 |
Level 3 | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7,645 | 8,278 |
Level 3 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 800 | 700 |
Level 3 | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,600 | 1,500 |
Level 3 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 100 | 100 |
Level 3 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 900 | 1,200 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2,299 | 2,337 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 149 | 171 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 10 | 10 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21 | 23 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 556 | 817 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,443 | 1,134 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 120 | 181 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,140 | 1,754 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7 | 5 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 494 | 537 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 384 | 853 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 236 | 350 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 16 | 6 |
Level 3 | Measured at fair value on a recurring basis | Brokerage receivables | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,180 | 3,942 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 681 | 544 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 100 | 122 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,585 | 1,527 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 117 | 105 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 6 | 2 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 306 | 372 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 892 | 862 |
Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 495 | 408 |
Level 3 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Non-financial assets - Precious metals and other physical commodities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 0 | 0 |
Level 3 | Measured at fair value on a non-recurring basis | Other non-financial assets | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 26 | 245 |
UBS AG | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 344,787 | 404,576 |
UBS AG | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value expected to be recovered or settled after 12 months | 16,000 | 20,000 |
UBS AG | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value expected to be recovered or settled after 12 months | 8,000 | 8,000 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 131,033 | 125,492 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 99,222 | 91,599 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 8,496 | 11,245 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 9,229 | 7,374 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 9,055 | 789 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,542 | 0 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 489 | 8 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 118,145 | 159,618 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 53,307 | 68,750 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 33,241 | 50,890 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 28,245 | 34,842 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,414 | 2,358 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,606 | 2,217 |
UBS AG | Measured at fair value on a recurring basis | Brokerage receivables | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21,839 | 24,659 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 59,642 | 80,038 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 765 | 631 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 8,860 | 23,297 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 5,804 | 6,751 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,585 | 1,527 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 591 | 505 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21,303 | 20,731 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 14,366 | 17,619 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 5,874 | 8,561 |
UBS AG | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 495 | 418 |
UBS AG | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 8,844 | 8,258 |
UBS AG | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2,686 | 1,150 |
UBS AG | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,310 | 485 |
UBS AG | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,849 | 6,624 |
UBS AG | Measured at fair value on a recurring basis | Non-financial assets - Precious metals and other physical commodities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 5,258 | 6,264 |
UBS AG | Measured at fair value on a non-recurring basis | Other non-financial assets | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 26 | 246 |
UBS AG | Level 1 | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 149,484 | 156,716 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 113,722 | 107,526 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 97,983 | 90,327 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7,135 | 9,028 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7,843 | 1,794 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 708 | 8,432 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 1,860 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 53 | 236 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 522 | 795 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 255 | 319 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Brokerage receivables | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 27,278 | 40,986 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 83 | 86 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 5,624 | 19,704 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 338 | 278 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21,110 | 20,628 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 123 | 290 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2,704 | 1,144 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2,658 | 1,103 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 45 | 40 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Non-financial assets - Precious metals and other physical commodities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 5,258 | 6,264 |
UBS AG | Level 1 | Measured at fair value on a non-recurring basis | Other non-financial assets | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 0 | 0 |
UBS AG | Level 2 | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 187,658 | 239,583 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 15,012 | 15,630 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,090 | 1,101 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,351 | 2,207 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,364 | 23 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7,791 | 817 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 3,099 | 1,134 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 317 | 181 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 116,482 | 157,069 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 53,046 | 68,425 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 32,747 | 50,353 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 27,861 | 33,990 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,179 | 2,008 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,590 | 2,211 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Brokerage receivables | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21,839 | 24,659 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 28,185 | 35,110 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2 | 0 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 3,236 | 3,593 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 5,704 | 6,629 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 137 | 121 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 187 | 101 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 13,937 | 16,957 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,982 | 7,699 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 10 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 6,140 | 7,114 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 27 | 47 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,265 | 444 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,849 | 6,624 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Non-financial assets - Precious metals and other physical commodities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 0 | 0 |
UBS AG | Level 2 | Measured at fair value on a non-recurring basis | Other non-financial assets | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 0 | 1 |
UBS AG | Level 3 | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7,645 | 8,278 |
UBS AG | Level 3 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 800 | 700 |
UBS AG | Level 3 | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,600 | 1,500 |
UBS AG | Level 3 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 100 | 100 |
UBS AG | Level 3 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 900 | 1,200 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 2,299 | 2,337 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 149 | 171 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 10 | 10 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 21 | 9,192 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 556 | 10,038 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,443 | 2,995 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value held for trading | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 120 | 425 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,140 | 1,754 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 7 | 5 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 494 | 537 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 384 | 853 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 236 | 350 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 16 | 6 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Brokerage receivables | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 4,180 | 3,942 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 681 | 544 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 100 | 122 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 1,585 | 1,527 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 117 | 105 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Financial assets for unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 6 | 2 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 306 | 372 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 892 | 862 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 495 | 408 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial assets measured at fair value through other comprehensive income | Asset-backed securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Non-financial assets - Precious metals and other physical commodities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a non-recurring basis | Other non-financial assets | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Other non-financial assets measured at fair value | $ 26 | $ 245 |
FVM - Fair value hierarchy - Li
FVM - Fair value hierarchy - Liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | $ 300,916 | $ 325,069 |
Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial liabilities measured at fair value expected to be recovered or settled after 12 months | 16,000 | 36,000 |
Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial liabilities measured at fair value expected to be recovered or settled after 12 months | 1,000 | 1,000 |
Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 31,688 | 33,595 |
Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6,709 | 4,678 |
Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 4,266 | 4,089 |
Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,733 | 1,828 |
Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 18,924 | 22,985 |
Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 121,309 | 161,102 |
Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 28,675 | 43,916 |
Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,753 | 2,931 |
Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 54,078 | 70,527 |
Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 34,949 | 41,176 |
Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,566 | 2,027 |
Measured at fair value on a recurring basis | Brokerage payables designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 44,045 | 38,742 |
Measured at fair value on a recurring basis | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 73,799 | 61,243 |
Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 30,074 | 30,387 |
Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 21,466 | 20,975 |
Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6,377 | 7,317 |
Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 2,128 | 2,060 |
Level 1 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 25,922 | 27,635 |
Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 25,413 | 26,888 |
Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 5,883 | 3,642 |
Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 30 | 31 |
Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,172 | 696 |
Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 18,328 | 22,519 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 509 | 746 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 258 | 316 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Brokerage payables designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 1 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 2 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 257,637 | 282,222 |
Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6,170 | 6,652 |
Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 826 | 1,036 |
Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 4,219 | 4,048 |
Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 555 | 1,127 |
Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 513 | 425 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 118,558 | 156,884 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 28,398 | 43,389 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,412 | 2,403 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 53,800 | 70,149 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 33,438 | 38,870 |
Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,503 | 2,003 |
Level 2 | Measured at fair value on a recurring basis | Brokerage payables designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 44,045 | 38,742 |
Level 2 | Measured at fair value on a recurring basis | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 59,606 | 50,273 |
Level 2 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 29,258 | 29,671 |
Level 2 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 21,466 | 20,975 |
Level 2 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6,375 | 7,317 |
Level 2 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,334 | 1,363 |
Level 3 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 17,357 | 15,212 |
Level 3 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 3 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 3 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 100 | 0 |
Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 105 | 55 |
Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 17 | 9 |
Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6 | 5 |
Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 83 | 40 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 2,242 | 3,471 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 278 | 527 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 341 | 528 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 21 | 61 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,511 | 2,306 |
Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 63 | 24 |
Level 3 | Measured at fair value on a recurring basis | Brokerage payables designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 14,194 | 10,970 |
Level 3 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 816 | 716 |
Level 3 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
Level 3 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 2 | 0 |
Level 3 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 794 | 697 |
UBS AG | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 300,916 | 325,080 |
UBS AG | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial liabilities measured at fair value expected to be recovered or settled after 12 months | 15,000 | 33,000 |
UBS AG | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial liabilities measured at fair value expected to be recovered or settled after 12 months | 3,000 | 3,000 |
UBS AG | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 31,688 | 33,595 |
UBS AG | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6,709 | 4,678 |
UBS AG | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 4,266 | 4,089 |
UBS AG | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,733 | 1,828 |
UBS AG | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 18,924 | 22,985 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 121,309 | 161,102 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 28,675 | 43,916 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,753 | 2,931 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 54,078 | 70,527 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 34,949 | 41,176 |
UBS AG | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,566 | 2,027 |
UBS AG | Measured at fair value on a recurring basis | Brokerage payables designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 44,045 | 38,742 |
UBS AG | Measured at fair value on a recurring basis | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 71,460 | 59,868 |
UBS AG | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 32,414 | 31,773 |
UBS AG | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 21,466 | 20,975 |
UBS AG | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6,377 | 7,317 |
UBS AG | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 2,128 | 2,060 |
UBS AG | Level 1 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 25,922 | 27,635 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 25,413 | 26,889 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 5,883 | 3,642 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 30 | 31 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,172 | 696 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 18,328 | 22,519 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 509 | 746 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 258 | 316 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Brokerage payables designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 1 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 2 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 257,637 | 282,233 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6,170 | 6,652 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 826 | 1,036 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 4,219 | 4,048 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 555 | 1,127 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 513 | 425 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 118,558 | 156,884 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 28,398 | 43,389 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,412 | 2,403 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 53,800 | 70,149 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 33,438 | 38,870 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,503 | 2,003 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Brokerage payables designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 44,045 | 38,742 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 59,606 | 50,273 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 29,258 | 29,682 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 21,466 | 20,975 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6,375 | 7,317 |
UBS AG | Level 2 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,334 | 1,363 |
UBS AG | Level 3 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 17,357 | 15,212 |
UBS AG | Level 3 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 3 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 3 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 100 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 105 | 55 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Government bills / bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 17 | 9 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 6 | 5 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Financial liabilities at fair value held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 83 | 40 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 2,242 | 3,471 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 278 | 527 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 341 | 528 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Foreign exchange contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 21 | 61 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 1,511 | 2,306 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Derivative financial instruments | Commodity contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 63 | 24 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Brokerage payables designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 11,854 | 9,595 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 3,156 | 2,091 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Financial liabilities related to unit-linked investment contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 0 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Securities financing transactions | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | 2 | 0 |
UBS AG | Level 3 | Measured at fair value on a recurring basis | Other financial liabilities designated at fair value | Over-the-counter debt instruments | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Financial Liabilities At Fair Value | $ 794 | $ 697 |
FVM - Valuation adjustment rese
FVM - Valuation adjustment reserves on the balance sheet (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Jan. 01, 2021 | Dec. 31, 2020 | Jan. 01, 2020 | Dec. 31, 2019 | Jan. 01, 2019 | Dec. 31, 2018 |
Entity [Table] | |||||||
Deferred day-1 profit or loss reserves | $ 418 | $ 269 | $ 269 | $ 146 | $ 146 | $ 255 | $ 255 |
Own credit adjustments on financial liabilities designated at fair value | (315) | (381) | (88) | ||||
CVAs, FVAs, DVAs and other valuation adjustments | (1,004) | (959) | (706) | ||||
UBS AG | |||||||
Entity [Table] | |||||||
Deferred day-1 profit or loss reserves | 418 | 269 | 146 | $ 255 | |||
Own credit adjustments on financial liabilities designated at fair value | (315) | (381) | (88) | ||||
CVAs, FVAs, DVAs and other valuation adjustments | $ (1,004) | $ (959) | $ (706) |
FVM - Valuation adjustments_ De
FVM - Valuation adjustments: Deferred day-1 P&L (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Reserve balance at the beginning of the year | $ 269 | $ 146 | $ 255 |
Profit / (loss) deferred on new transactions | 459 | 362 | 171 |
(Profit) / loss recognized in the income statement | (308) | (238) | (278) |
Foreign currency translation | (2) | 0 | (2) |
Reserve balance at the end of the year | 418 | 269 | 146 |
UBS AG | |||
Entity [Table] | |||
Reserve balance at the beginning of the year | 269 | 146 | 255 |
Profit / (loss) deferred on new transactions | 459 | 362 | 171 |
(Profit) / loss recognized in the income statement | (308) | (238) | (278) |
Foreign currency translation | (2) | 0 | (2) |
Reserve balance at the end of the year | $ 418 | $ 269 | $ 146 |
FVM - Valuation adjustments_ Ow
FVM - Valuation adjustments: Own credit adjustments on financial liabilities designated at fair value (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Recognized on the balance sheet as of the end of the year: | |||
Unrealized life-to-date gain / (loss) | $ (315) | $ (381) | $ (88) |
Included in Other comprehensive income | |||
Recognized during the year: | |||
Realized gain / (loss) | (14) | 2 | 8 |
Unrealized gain / (loss) | 60 | (295) | (408) |
Total gain / (loss), before tax | 46 | (293) | (400) |
Recognized on the balance sheet as of the end of the year: | |||
Unrealized life-to-date gain / (loss) | (315) | (381) | (88) |
UBS AG | |||
Recognized on the balance sheet as of the end of the year: | |||
Unrealized life-to-date gain / (loss) | (315) | (381) | (88) |
UBS AG | Included in Other comprehensive income | |||
Recognized during the year: | |||
Realized gain / (loss) | (14) | 2 | 8 |
Unrealized gain / (loss) | 60 | (295) | (408) |
Total gain / (loss), before tax | 46 | (293) | (400) |
Recognized on the balance sheet as of the end of the year: | |||
Unrealized life-to-date gain / (loss) | $ (315) | $ (381) | $ (88) |
FVM - Valuation adjustments_ Va
FVM - Valuation adjustments: Valuation adjustments on financial instruments (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Entity [Table] | ||
Credit valuation adjustments | $ (44) | $ (66) |
Funding valuation adjustments | (49) | (73) |
Debit valuation adjustments | 2 | 0 |
Other valuation adjustments | (913) | (820) |
of which: liquidity | (341) | (340) |
of which: model uncertainty | (571) | (479) |
UBS AG | ||
Entity [Table] | ||
Credit valuation adjustments | (44) | (66) |
Funding valuation adjustments | (49) | (73) |
Debit valuation adjustments | 2 | 0 |
Other valuation adjustments | (913) | (820) |
of which: liquidity | (341) | (340) |
of which: model uncertainty | $ (571) | $ (479) |
FVM - Level 3 instruments_ Valu
FVM - Level 3 instruments: Valuation techniques and inputs (Detail) $ in Millions | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) |
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 345,010 | $ 404,805 |
Financial liabilities measured at fair value | 300,916 | 325,069 |
Debt issued designated at fair value | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial liabilities measured at fair value | 14,200 | 11,000 |
Other financial liabilities designated at fair value | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial liabilities measured at fair value | 800 | 700 |
Level 3 | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | 7,645 | 8,278 |
Financial liabilities measured at fair value | 17,357 | 15,212 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | 900 | 1,200 |
Financial liabilities measured at fair value | 0 | 0 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | 900 | 1,200 |
Financial liabilities measured at fair value | $ 0 | $ 0 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.16 | 0.01 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 1.43 | 1.43 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.98 | 1 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0434 | 0.0268 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0434 | 0.0268 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 2,800 | $ 2,400 |
Financial liabilities measured at fair value | $ 0 | $ 0 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0 | 0 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 1.01 | 1.01 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.99 | 0.99 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0175 | 0.0190 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0800 | 0.0800 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0436 | 0.0398 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0028 | 0.0040 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.1544 | 0.1858 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0241 | 0.0333 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 1,600 | $ 1,500 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0115 | 0.0100 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0197 | 0.0188 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0153 | 0.0140 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Investment fund units | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 100 | $ 100 |
Financial liabilities measured at fair value | 0 | 0 |
Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Equity instruments | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | 800 | 700 |
Financial liabilities measured at fair value | 100 | 0 |
Level 3 | Debt issued designated at fair value | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial liabilities measured at fair value | 14,200 | 11,000 |
Level 3 | Other financial liabilities designated at fair value | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial liabilities measured at fair value | $ 800 | $ 700 |
Level 3 | Other financial liabilities designated at fair value | Discounted expected cash flows | Funding spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0024 | 0.0042 |
Level 3 | Other financial liabilities designated at fair value | Discounted expected cash flows | Funding spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0175 | 0.0175 |
Level 3 | Derivative financial instruments: Interest rate contracts | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 500 | $ 500 |
Financial liabilities measured at fair value | $ 300 | $ 500 |
Level 3 | Derivative financial instruments: Interest rate contracts | Option model | Volatility of interest rates | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0065 | 0.0029 |
Level 3 | Derivative financial instruments: Interest rate contracts | Option model | Volatility of interest rates | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0081 | 0.0069 |
Level 3 | Derivative financial instruments: Credit derivative contracts | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 200 | $ 300 |
Financial liabilities measured at fair value | $ 300 | $ 500 |
Level 3 | Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Bond price equivalent (% of par) | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.02 | 0 |
Level 3 | Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Bond price equivalent (% of par) | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 1.36 | 1 |
Level 3 | Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0001 | 0.0001 |
Level 3 | Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0583 | 0.0489 |
Level 3 | Derivative financial instruments: Equity / index contracts | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 400 | $ 900 |
Financial liabilities measured at fair value | $ 1,500 | $ 2,300 |
Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity dividend yields | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0 | 0 |
Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity dividend yields | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.11 | 0.13 |
Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Volatility of equity stocks, equity and other indices | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.04 | 0.04 |
Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Volatility of equity stocks, equity and other indices | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.98 | 1 |
Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity-to-FX correlation | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | (0.29) | (0.34) |
Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity-to-FX correlation | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.76 | 0.65 |
Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity-to-equity correlation | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | (0.25) | (0.16) |
Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity-to-equity correlation | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 1 | 1 |
UBS AG | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 344,787 | $ 404,576 |
Financial liabilities measured at fair value | 300,916 | 325,080 |
UBS AG | Debt issued designated at fair value | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial liabilities measured at fair value | 11,000 | |
UBS AG | Other financial liabilities designated at fair value | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial liabilities measured at fair value | 700 | |
UBS AG | Level 3 | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | 7,645 | 8,278 |
Financial liabilities measured at fair value | 17,357 | 15,212 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | 900 | 1,200 |
Financial liabilities measured at fair value | $ 0 | $ 0 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.16 | 0.01 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 1.43 | 1.43 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Relative value to market comparable | Bond price equivalent (% of par) | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.98 | 1 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0434 | 0.0268 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Corporate and municipal bonds | Discounted expected cash flows | Discount margin | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0434 | 0.0268 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 2,800 | $ 2,400 |
Financial liabilities measured at fair value | $ 0 | $ 0 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0 | 0 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 1.01 | 1.01 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Relative value to market comparable | Loan price equivalent (% of par) | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.99 | 0.99 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0175 | 0.0190 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0800 | 0.0800 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Discounted expected cash flows | Credit spread | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0436 | 0.0398 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0028 | 0.0040 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.1544 | 0.1858 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Traded loans, loans mandatorily at fair value, loan commitments and guarantees | Market comparable and securitization model | Credit spread | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0241 | 0.0333 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 1,600 | $ 1,500 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0115 | 0.0100 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0197 | 0.0188 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Auction rate securities | Discounted expected cash flows | Credit spread | Weighted average | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0153 | 0.0140 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Investment fund units | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 100 | $ 100 |
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Level 3 | Financial assets and liabilities at fair value held for trading, Financial assets at fair value not held for trading: Equity instruments | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | 800 | 700 |
Financial liabilities measured at fair value | 100 | 0 |
UBS AG | Level 3 | Debt issued designated at fair value | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial liabilities measured at fair value | 11,900 | 9,600 |
UBS AG | Level 3 | Other financial liabilities designated at fair value | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial liabilities measured at fair value | $ 3,200 | $ 2,100 |
UBS AG | Level 3 | Other financial liabilities designated at fair value | Discounted expected cash flows | Funding spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0024 | 0.0042 |
UBS AG | Level 3 | Other financial liabilities designated at fair value | Discounted expected cash flows | Funding spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0175 | 0.0175 |
UBS AG | Level 3 | Derivative financial instruments: Interest rate contracts | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 500 | $ 500 |
Financial liabilities measured at fair value | $ 300 | $ 500 |
UBS AG | Level 3 | Derivative financial instruments: Interest rate contracts | Option model | Volatility of interest rates | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0065 | 0.0029 |
UBS AG | Level 3 | Derivative financial instruments: Interest rate contracts | Option model | Volatility of interest rates | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0081 | 0.0069 |
UBS AG | Level 3 | Derivative financial instruments: Credit derivative contracts | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 200 | $ 300 |
Financial liabilities measured at fair value | $ 300 | $ 500 |
UBS AG | Level 3 | Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Bond price equivalent (% of par) | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.02 | 0 |
UBS AG | Level 3 | Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Bond price equivalent (% of par) | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 1.36 | 1 |
UBS AG | Level 3 | Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit spread | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0001 | 0.0001 |
UBS AG | Level 3 | Derivative financial instruments: Credit derivative contracts | Discounted expected cash flows | Credit spread | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.0583 | 0.0489 |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Financial assets measured at fair value | $ 400 | $ 900 |
Financial liabilities measured at fair value | $ 1,500 | $ 2,300 |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity dividend yields | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0 | 0 |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity dividend yields | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.11 | 0.13 |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Volatility of equity stocks, equity and other indices | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.04 | 0.04 |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Volatility of equity stocks, equity and other indices | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.98 | 1 |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity-to-FX correlation | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | (0.29) | (0.34) |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity-to-FX correlation | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 0.76 | 0.65 |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity-to-equity correlation | Low | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | (0.25) | (0.16) |
UBS AG | Level 3 | Derivative financial instruments: Equity / index contracts | Option model | Equity-to-equity correlation | High | ||
Disclosure Of Significant Unobservable Inputs Used In Fair Value Measurement Table [Table] | ||
Significant unobservable input(s) | 1 | 1 |
FVM - Level 3 instruments_ Sens
FVM - Level 3 instruments: Sensitivity to changes in unobservable input assumptions (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | $ 790 | $ 794 |
Unfavorable changes | (744) | (768) |
Traded loans, loans designated at fair value, loan commitments and guarantees | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 19 | 29 |
Unfavorable changes | (13) | (28) |
Securities financing transactions | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 41 | 40 |
Unfavorable changes | (53) | (52) |
Auction rate securities | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 66 | 105 |
Unfavorable changes | (66) | (105) |
Asset-backed securities | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 20 | 41 |
Unfavorable changes | (20) | (41) |
Equity instruments | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 173 | 129 |
Unfavorable changes | (146) | (96) |
Interest rate derivative contracts, net | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 29 | 11 |
Unfavorable changes | (19) | (16) |
Credit derivative contracts, net | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 5 | 10 |
Unfavorable changes | (8) | (14) |
Foreign exchange derivative contracts, net | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 19 | 20 |
Unfavorable changes | (11) | (15) |
Equity / index derivative contracts, net | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 368 | 318 |
Unfavorable changes | (335) | (294) |
Other | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 50 | 91 |
Unfavorable changes | (73) | (107) |
UBS AG | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 790 | 794 |
Unfavorable changes | (744) | (768) |
UBS AG | Traded loans, loans designated at fair value, loan commitments and guarantees | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 19 | 29 |
Unfavorable changes | (13) | (28) |
UBS AG | Securities financing transactions | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 41 | 40 |
Unfavorable changes | (53) | (52) |
UBS AG | Auction rate securities | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 66 | 105 |
Unfavorable changes | (66) | (105) |
UBS AG | Asset-backed securities | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 20 | 41 |
Unfavorable changes | (20) | (41) |
UBS AG | Equity instruments | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 173 | 129 |
Unfavorable changes | (146) | (96) |
UBS AG | Interest rate derivative contracts, net | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 29 | 11 |
Unfavorable changes | (19) | (16) |
UBS AG | Credit derivative contracts, net | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 5 | 10 |
Unfavorable changes | (8) | (14) |
UBS AG | Foreign exchange derivative contracts, net | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 19 | 20 |
Unfavorable changes | (11) | (15) |
UBS AG | Equity / index derivative contracts, net | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 368 | 318 |
Unfavorable changes | (335) | (294) |
UBS AG | Other | ||
Sensitivity Of Fair Value Measurement To Changes In Unobservable Inputs Assets And Liabilities [Table] | ||
Favorable changes | 50 | 91 |
Unfavorable changes | $ (73) | $ (107) |
FVM - Movements of level 3 inst
FVM - Movements of level 3 instruments - Assets (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | $ 404,805 | |
Balance at the end of period | 345,010 | $ 404,805 |
Level 3 | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 8,278 | |
Balance at the end of period | 7,645 | 8,278 |
Level 3 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 100 | |
Balance at the end of period | 100 | 100 |
Level 3 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,200 | |
Balance at the end of period | 900 | 1,200 |
Level 3 | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,500 | |
Balance at the end of period | 1,600 | 1,500 |
Level 3 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 700 | |
Balance at the end of period | 800 | 700 |
Level 3 | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 2,300 | 1,800 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | (100) |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | (100) |
Purchases | 300 | 800 |
Sales | (1,600) | (1,400) |
Issuances | 1,200 | 1,000 |
Settlements | 0 | 0 |
Transfers into Level 3 | 300 | 300 |
Transfers out of Level 3 | (300) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 2,300 | 2,300 |
Level 3 | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 0 | 0 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 0 | 0 |
Level 3 | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 800 | 500 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 200 | 700 |
Sales | (400) | (500) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (100) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 600 | 800 |
Level 3 | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,100 | 800 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | (100) |
Purchases | 0 | 0 |
Sales | (800) | (700) |
Issuances | 1,200 | 1,000 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (200) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,400 | 1,100 |
Level 3 | Financial assets at fair value held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 400 | 400 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 100 | 100 |
Sales | (400) | (300) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 300 | 200 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 300 | 400 |
Level 3 | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 3,900 | 4,000 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 100 |
Purchases | 1,000 | 800 |
Sales | (600) | (900) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 100 | 100 |
Transfers out of Level 3 | (300) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 4,200 | 3,900 |
Level 3 | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 900 | 1,200 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 600 | 300 |
Sales | (300) | (700) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | (300) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 900 | 900 |
Level 3 | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,500 | 1,500 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,600 | 1,500 |
Level 3 | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 500 | 500 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 0 |
Purchases | 100 | 100 |
Sales | (100) | (100) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 700 | 500 |
Level 3 | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,000 | 700 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 0 |
Purchases | 300 | 400 |
Sales | (200) | (200) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,000 | 1,000 |
Level 3 | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,800 | 1,300 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (200) | 300 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 400 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 500 | 700 |
Settlements | (700) | (500) |
Transfers into Level 3 | 100 | 100 |
Transfers out of Level 3 | (300) | (200) |
Foreign currency translation | 0 | 100 |
Balance at the end of period | 1,100 | 1,800 |
Level 3 | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 500 | 300 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 200 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 200 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 100 | 0 |
Settlements | (200) | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | (100) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 500 | 500 |
Level 3 | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 900 | 600 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (100) | 100 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 100 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 300 | 600 |
Settlements | (400) | (300) |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | (200) | (100) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 400 | 900 |
Level 3 | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 300 | 400 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (100) | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 100 |
Settlements | (100) | (200) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 200 | 300 |
Level 3 | Derivative financial instruments | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 0 | 0 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 0 | 0 |
UBS AG | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 404,576 | |
Balance at the end of period | 344,787 | 404,576 |
UBS AG | Level 3 | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 8,278 | |
Balance at the end of period | 7,645 | 8,278 |
UBS AG | Level 3 | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 100 | |
Balance at the end of period | 100 | 100 |
UBS AG | Level 3 | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,200 | |
Balance at the end of period | 900 | 1,200 |
UBS AG | Level 3 | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,500 | |
Balance at the end of period | 1,600 | 1,500 |
UBS AG | Level 3 | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 700 | |
Balance at the end of period | 800 | 700 |
UBS AG | Level 3 | Financial assets at fair value held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 2,300 | 1,800 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | (100) |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | (100) |
Purchases | 300 | 800 |
Sales | (1,600) | (1,400) |
Issuances | 1,200 | 1,000 |
Settlements | 0 | 0 |
Transfers into Level 3 | 300 | 300 |
Transfers out of Level 3 | (300) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 2,300 | 2,300 |
UBS AG | Level 3 | Financial assets at fair value held for trading | Investment fund units | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 0 | 0 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 0 | 0 |
UBS AG | Level 3 | Financial assets at fair value held for trading | Corporate and municipal bonds | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 800 | 500 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 200 | 700 |
Sales | (400) | (500) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (100) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 600 | 800 |
UBS AG | Level 3 | Financial assets at fair value held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,100 | 800 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | (100) |
Purchases | 0 | 0 |
Sales | (800) | (700) |
Issuances | 1,200 | 1,000 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (200) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,400 | 1,100 |
UBS AG | Level 3 | Financial assets at fair value held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 400 | 400 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 100 | 100 |
Sales | (400) | (300) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 300 | 200 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 300 | 400 |
UBS AG | Level 3 | Financial assets at fair value not held for trading | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 3,900 | 4,000 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 100 |
Purchases | 1,000 | 800 |
Sales | (600) | (900) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 100 | 100 |
Transfers out of Level 3 | (300) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 4,200 | 3,900 |
UBS AG | Level 3 | Financial assets at fair value not held for trading | Loans | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 900 | 1,200 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 600 | 300 |
Sales | (300) | (700) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | (300) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 900 | 900 |
UBS AG | Level 3 | Financial assets at fair value not held for trading | Auction rate securities | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,500 | 1,500 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,600 | 1,500 |
UBS AG | Level 3 | Financial assets at fair value not held for trading | Equity instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 500 | 500 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 0 |
Purchases | 100 | 100 |
Sales | (100) | (100) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 700 | 500 |
UBS AG | Level 3 | Financial assets at fair value not held for trading | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,000 | 700 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 0 |
Purchases | 300 | 400 |
Sales | (200) | (200) |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,000 | 1,000 |
UBS AG | Level 3 | Derivative financial instruments | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 1,800 | 1,300 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (200) | 300 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 400 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 500 | 700 |
Settlements | (700) | (500) |
Transfers into Level 3 | 100 | 100 |
Transfers out of Level 3 | (300) | (200) |
Foreign currency translation | 0 | 100 |
Balance at the end of period | 1,100 | 1,800 |
UBS AG | Level 3 | Derivative financial instruments | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 500 | 300 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 100 | 200 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 200 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 100 | 0 |
Settlements | (200) | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | (100) | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 500 | 500 |
UBS AG | Level 3 | Derivative financial instruments | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 900 | 600 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (100) | 100 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 100 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 300 | 600 |
Settlements | (400) | (300) |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | (200) | (100) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 400 | 900 |
UBS AG | Level 3 | Derivative financial instruments | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 300 | 400 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | (100) | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 100 |
Settlements | (100) | (200) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 200 | 300 |
UBS AG | Level 3 | Derivative financial instruments | Other | ||
Disclosure Of Fair Value Measurement Of Assets [Table] | ||
Balance at the beginning of the period | 0 | 0 |
Total gains / (losses) included in comprehensive income - Net gains / (losses) included in income | 0 | 0 |
Total gains / (losses) included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 0 |
Settlements | 0 | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | $ 0 | $ 0 |
FVM - Movements of level 3 in_2
FVM - Movements of level 3 instruments - Liabilities (Detail) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | $ 325,069 | |
Balance at the end of period | 300,916 | $ 325,069 |
Level 3 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 15,212 | |
Balance at the end of period | 17,357 | 15,212 |
Level 3 | Derivative financial liabilities | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 3,500 | 2,000 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 200 | 1,300 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 1,200 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 900 | 1,200 |
Settlements | (1,800) | (900) |
Transfers into Level 3 | 0 | 400 |
Transfers out of Level 3 | (500) | (600) |
Foreign currency translation | 0 | 100 |
Balance at the end of period | 2,200 | 3,500 |
Level 3 | Derivative financial liabilities | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 500 | 100 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | (100) | 300 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 300 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 300 |
Settlements | (100) | (200) |
Transfers into Level 3 | 0 | 200 |
Transfers out of Level 3 | 0 | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 300 | 500 |
Level 3 | Derivative financial liabilities | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 2,300 | 1,300 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 300 | 1,000 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 800 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 800 | 800 |
Settlements | (1,500) | (600) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (400) | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,500 | 2,300 |
Level 3 | Derivative financial liabilities | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 500 | 500 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | (100) | 0 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 100 |
Settlements | 0 | (100) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (100) | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 300 | 500 |
Level 3 | Derivative financial liabilities | Other | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 100 | 100 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 100 | 0 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 0 |
Settlements | (100) | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 100 | 100 |
Level 3 | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 11,000 | 9,900 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 700 | 200 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 600 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 8,000 | 7,600 |
Settlements | (4,200) | (5,700) |
Transfers into Level 3 | 200 | 500 |
Transfers out of Level 3 | (1,200) | (1,700) |
Foreign currency translation | (200) | 200 |
Balance at the end of period | 14,200 | 11,000 |
Level 3 | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 700 | 800 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 0 | 100 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 100 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 400 | 300 |
Settlements | (200) | (500) |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 800 | 700 |
UBS AG | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 325,080 | |
Balance at the end of period | 300,916 | 325,080 |
UBS AG | Level 3 | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 15,212 | |
Balance at the end of period | 17,357 | 15,212 |
UBS AG | Level 3 | Derivative financial liabilities | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 3,500 | 2,000 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 200 | 1,300 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 1,200 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 900 | 1,200 |
Settlements | (1,800) | (900) |
Transfers into Level 3 | 0 | 400 |
Transfers out of Level 3 | (500) | (600) |
Foreign currency translation | 0 | 100 |
Balance at the end of period | 2,200 | 3,500 |
UBS AG | Level 3 | Derivative financial liabilities | Interest rate contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 500 | 100 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | (100) | 300 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 300 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 300 |
Settlements | (100) | (200) |
Transfers into Level 3 | 0 | 200 |
Transfers out of Level 3 | 0 | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 300 | 500 |
UBS AG | Level 3 | Derivative financial liabilities | Equity / index contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 2,300 | 1,300 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 300 | 1,000 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 100 | 800 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 800 | 800 |
Settlements | (1,500) | (600) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (400) | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 1,500 | 2,300 |
UBS AG | Level 3 | Derivative financial liabilities | Credit derivative contracts | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 500 | 500 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | (100) | 0 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | (100) | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 100 |
Settlements | 0 | (100) |
Transfers into Level 3 | 0 | 100 |
Transfers out of Level 3 | (100) | (200) |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 300 | 500 |
UBS AG | Level 3 | Derivative financial liabilities | Other | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 100 | 100 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 100 | 0 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 0 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 0 | 0 |
Settlements | (100) | 0 |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | 100 | 100 |
UBS AG | Level 3 | Debt issued designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 9,600 | 9,600 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 700 | 0 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 600 | (200) |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 7,100 | 6,600 |
Settlements | (4,200) | (5,600) |
Transfers into Level 3 | 100 | 500 |
Transfers out of Level 3 | (1,200) | (1,700) |
Foreign currency translation | (200) | 200 |
Balance at the end of period | 11,900 | 9,600 |
UBS AG | Level 3 | Other financial liabilities designated at fair value | ||
Disclosure Of Fair Value Measurement Of Liabilities [Table] | ||
Balance at the beginning of the period | 2,100 | 1,000 |
Total gains / losses included in comprehensive income - Net gains / losses included in income | 0 | 200 |
Total gains / losses included in comprehensive income - of which: related to Level 3 instruments held at the end of the reporting period | 0 | 200 |
Purchases | 0 | 0 |
Sales | 0 | 0 |
Issuances | 1,300 | 1,400 |
Settlements | (200) | (600) |
Transfers into Level 3 | 0 | 0 |
Transfers out of Level 3 | 0 | 0 |
Foreign currency translation | 0 | 0 |
Balance at the end of period | $ 3,200 | $ 2,100 |
Maximum exposure to credit risk
Maximum exposure to credit risk - assets at fair value (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Credit enhancements | ||
Notional amounts of derivatives | $ 36,000 | $ 31,300 |
Total financial assets measured at fair value | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 199,400 | 267,100 |
Collateral | ||
Cash collateral received | 0 | 0 |
Collateralized by securities | 37,100 | 43,600 |
Secured by real estate | 0 | 0 |
Other collateral | 0 | 0 |
Credit enhancements | ||
Netting | 103,200 | 138,400 |
Credit derivative contracts | 0 | 0 |
Guarantees | 0 | 0 |
Exposure to credit risk after collateral and credit enhancements | 59,100 | 85,100 |
Financial assets at fair value held for trading - debt instruments | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 22,400 | 24,600 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 22,400 | 24,600 |
Derivative financial instruments | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 118,100 | 159,600 |
Collateral | ||
Collateralized by securities | 4,200 | 6,000 |
Credit enhancements | ||
Netting | 103,200 | 138,400 |
Exposure to credit risk after collateral and credit enhancements | 10,700 | 15,200 |
Loan commitments and forward starting reverse repurchase agreements classified as derivatives | 0 | 0 |
Brokerage receivables | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 21,800 | 24,700 |
Collateral | ||
Collateralized by securities | 21,600 | 24,400 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 200 | 300 |
Financial assets at fair value not held for trading - debt instruments | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 37,000 | 58,200 |
Collateral | ||
Collateralized by securities | 11,200 | 13,200 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 25,700 | 45,000 |
Guarantees | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 200 | 500 |
Collateral | ||
Other collateral | 100 | |
Credit enhancements | ||
Guarantees | 200 | 300 |
Exposure to credit risk after collateral and credit enhancements | 0 | 0 |
Forward starting reverse repurchase agreements | Financial Assets At Fair Value [Member] | ||
Credit enhancements | ||
Notional amounts of derivatives | 27,800 | 21,900 |
Loan commitments | Financial Assets At Fair Value [Member] | ||
Credit enhancements | ||
Notional amounts of derivatives | 8,200 | 9,400 |
Sub- participated loan commitments | Financial Assets At Fair Value [Member] | ||
Credit enhancements | ||
Notional amounts of derivatives | 800 | 800 |
UBS AG | ||
Credit enhancements | ||
Notional amounts of derivatives | 36,000 | 31,300 |
UBS AG | Total financial assets measured at fair value | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 199,500 | 267,200 |
Collateral | ||
Cash collateral received | 0 | 0 |
Collateralized by securities | 37,100 | 43,600 |
Secured by real estate | 0 | 0 |
Other collateral | 0 | 0 |
Credit enhancements | ||
Netting | 103,200 | 138,400 |
Credit derivative contracts | 0 | 0 |
Guarantees | 0 | 0 |
Exposure to credit risk after collateral and credit enhancements | 59,200 | 85,200 |
UBS AG | Financial assets at fair value held for trading - debt instruments | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 22,600 | 24,700 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 22,600 | 24,700 |
UBS AG | Derivative financial instruments | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 118,100 | 159,600 |
Collateral | ||
Collateralized by securities | 4,200 | 6,000 |
Credit enhancements | ||
Netting | 103,200 | 138,400 |
Exposure to credit risk after collateral and credit enhancements | 10,700 | 15,200 |
Loan commitments and forward starting reverse repurchase agreements classified as derivatives | 0 | 0 |
UBS AG | Brokerage receivables | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 21,800 | 24,700 |
Collateral | ||
Cash collateral received | 0 | |
Collateralized by securities | 21,600 | 24,400 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 200 | 300 |
UBS AG | Financial assets at fair value not held for trading - debt instruments | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 37,000 | 58,200 |
Collateral | ||
Cash collateral received | 0 | 0 |
Collateralized by securities | 11,200 | 13,200 |
Credit enhancements | ||
Exposure to credit risk after collateral and credit enhancements | 25,700 | 45,000 |
UBS AG | Guarantees | Financial Assets At Fair Value [Member] | ||
Maximum Exposure To Credit Risk [Table] | ||
Maximum Exposure To Credit Risk | 200 | 500 |
Collateral | ||
Other collateral | 0 | 100 |
Credit enhancements | ||
Guarantees | 200 | 300 |
Exposure to credit risk after collateral and credit enhancements | 0 | 0 |
UBS AG | Forward starting reverse repurchase agreements | Financial Assets At Fair Value [Member] | ||
Credit enhancements | ||
Notional amounts of derivatives | 27,800 | 21,900 |
UBS AG | Loan commitments | Financial Assets At Fair Value [Member] | ||
Credit enhancements | ||
Notional amounts of derivatives | 8,200 | 9,400 |
UBS AG | Sub- participated loan commitments | Financial Assets At Fair Value [Member] | ||
Credit enhancements | ||
Notional amounts of derivatives | $ 800 | $ 800 |
FVM - Financial instruments not
FVM - Financial instruments not measured at fair value - Assets (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Carrying amount | ||
Cash and balances at central banks | $ 192,817 | $ 158,231 |
Loans and advances to banks | 15,480 | 15,444 |
Receivables from securities financing transactions | 75,012 | 74,210 |
Cash collateral receivables on derivative instruments | 30,514 | 32,737 |
Loans and advances to customers | 397,761 | 379,528 |
Other financial assets measured at amortized cost | 26,209 | 27,194 |
Fair Value | ||
Financial assets measured at fair value | 345,010 | 404,805 |
Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 149,459 | 156,696 |
Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 187,905 | 239,831 |
Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 7,645 | 8,278 |
Not measured at fair value | ||
Carrying amount | ||
Cash and balances at central banks | 192,800 | 158,200 |
Loans and advances to banks | 15,500 | 15,400 |
Receivables from securities financing transactions | 75,000 | 74,200 |
Cash collateral receivables on derivative instruments | 30,500 | 32,700 |
Loans and advances to customers | 397,800 | 379,500 |
Other financial assets measured at amortized cost | 26,200 | 27,200 |
Not measured at fair value | Cash and balances at central banks | ||
Fair Value | ||
Financial assets measured at fair value | 192,800 | 158,200 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 0 | 0 |
Not measured at fair value | Cash and balances at central banks | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 192,700 | 158,100 |
Not measured at fair value | Cash and balances at central banks | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 100 | 100 |
Not measured at fair value | Cash and balances at central banks | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
Not measured at fair value | Cash and balances at central banks | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
Not measured at fair value | Loans and advances to banks | ||
Fair Value | ||
Financial assets measured at fair value | 15,500 | 15,400 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 0 | 0 |
Not measured at fair value | Loans and advances to banks | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 14,800 | 14,700 |
Not measured at fair value | Loans and advances to banks | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
Not measured at fair value | Loans and advances to banks | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 700 | 600 |
Not measured at fair value | Loans and advances to banks | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 100 |
Not measured at fair value | Receivables from securities financing transactions | ||
Fair Value | ||
Financial assets measured at fair value | 75,000 | 74,200 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 1,000 | 1,000 |
Not measured at fair value | Receivables from securities financing transactions | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 71,600 | 64,900 |
Not measured at fair value | Receivables from securities financing transactions | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
Not measured at fair value | Receivables from securities financing transactions | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 1,300 | 7,600 |
Not measured at fair value | Receivables from securities financing transactions | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 2,100 | 1,700 |
Not measured at fair value | Cash collateral receivables on derivative instruments | ||
Fair Value | ||
Financial assets measured at fair value | 30,500 | 32,700 |
Not measured at fair value | Cash collateral receivables on derivative instruments | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 30,500 | 32,700 |
Not measured at fair value | Cash collateral receivables on derivative instruments | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
Not measured at fair value | Cash collateral receivables on derivative instruments | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
Not measured at fair value | Cash collateral receivables on derivative instruments | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
Not measured at fair value | Loans and advances to customers | ||
Fair Value | ||
Financial assets measured at fair value | 396,900 | 380,800 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 175,000 | 163,000 |
Not measured at fair value | Loans and advances to customers | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 163,100 | 172,000 |
Not measured at fair value | Loans and advances to customers | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
Not measured at fair value | Loans and advances to customers | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 43,800 | 34,200 |
Not measured at fair value | Loans and advances to customers | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 190,100 | 174,600 |
Not measured at fair value | Other financial assets measured at amortized cost | ||
Fair Value | ||
Financial assets measured at fair value | 26,500 | 28,000 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 19,000 | 20,000 |
Not measured at fair value | Other financial assets measured at amortized cost | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 4,100 | 5,300 |
Not measured at fair value | Other financial assets measured at amortized cost | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 9,300 | 9,400 |
Not measured at fair value | Other financial assets measured at amortized cost | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 10,700 | 10,900 |
Not measured at fair value | Other financial assets measured at amortized cost | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 2,400 | 2,300 |
UBS AG | ||
Carrying amount | ||
Cash and balances at central banks | 192,817 | 158,231 |
Loans and advances to banks | 15,360 | 15,344 |
Receivables from securities financing transactions | 75,012 | 74,210 |
Cash collateral receivables on derivative instruments | 30,514 | 32,737 |
Loans and advances to customers | 398,693 | 380,977 |
Other financial assets measured at amortized cost | 26,236 | 27,219 |
Fair Value | ||
Financial assets measured at fair value | 344,787 | 404,576 |
UBS AG | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 149,484 | 156,716 |
UBS AG | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 187,658 | 239,583 |
UBS AG | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 7,645 | 8,278 |
UBS AG | Not measured at fair value | ||
Carrying amount | ||
Cash and balances at central banks | 192,800 | 158,200 |
Loans and advances to banks | 15,400 | 15,300 |
Receivables from securities financing transactions | 75,000 | 74,200 |
Cash collateral receivables on derivative instruments | 30,500 | 32,700 |
Loans and advances to customers | 398,700 | 381,000 |
Other financial assets measured at amortized cost | 26,200 | 27,200 |
UBS AG | Not measured at fair value | Cash and balances at central banks | ||
Fair Value | ||
Financial assets measured at fair value | 192,800 | 158,200 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 0 | 0 |
UBS AG | Not measured at fair value | Cash and balances at central banks | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 192,700 | 158,100 |
UBS AG | Not measured at fair value | Cash and balances at central banks | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 100 | 100 |
UBS AG | Not measured at fair value | Cash and balances at central banks | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Cash and balances at central banks | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Loans and advances to banks | ||
Fair Value | ||
Financial assets measured at fair value | 15,300 | 15,300 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 0 | 0 |
UBS AG | Not measured at fair value | Loans and advances to banks | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 14,600 | 14,600 |
UBS AG | Not measured at fair value | Loans and advances to banks | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Loans and advances to banks | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 700 | 600 |
UBS AG | Not measured at fair value | Loans and advances to banks | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 100 |
UBS AG | Not measured at fair value | Receivables from securities financing transactions | ||
Fair Value | ||
Financial assets measured at fair value | 75,000 | 74,200 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 1,000 | 1,000 |
UBS AG | Not measured at fair value | Receivables from securities financing transactions | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 71,600 | 64,900 |
UBS AG | Not measured at fair value | Receivables from securities financing transactions | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Receivables from securities financing transactions | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 1,300 | 7,600 |
UBS AG | Not measured at fair value | Receivables from securities financing transactions | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 2,100 | 1,700 |
UBS AG | Not measured at fair value | Cash collateral receivables on derivative instruments | ||
Fair Value | ||
Financial assets measured at fair value | 30,500 | 32,700 |
UBS AG | Not measured at fair value | Cash collateral receivables on derivative instruments | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 30,500 | 32,700 |
UBS AG | Not measured at fair value | Cash collateral receivables on derivative instruments | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Cash collateral receivables on derivative instruments | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Cash collateral receivables on derivative instruments | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Loans and advances to customers | ||
Fair Value | ||
Financial assets measured at fair value | 397,900 | 382,300 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 163,000 | 175,000 |
UBS AG | Not measured at fair value | Loans and advances to customers | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 163,700 | 173,100 |
UBS AG | Not measured at fair value | Loans and advances to customers | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Loans and advances to customers | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 43,800 | 34,200 |
UBS AG | Not measured at fair value | Loans and advances to customers | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | 190,400 | 174,900 |
UBS AG | Not measured at fair value | Other financial assets measured at amortized cost | ||
Fair Value | ||
Financial assets measured at fair value | 26,500 | 28,000 |
Financial assets not measured at fair value expected to be recovered or settled after 12 months | 20,000 | 19,000 |
UBS AG | Not measured at fair value | Other financial assets measured at amortized cost | Carrying amount approximates fair value | ||
Fair Value | ||
Financial assets measured at fair value | 4,100 | 5,400 |
UBS AG | Not measured at fair value | Other financial assets measured at amortized cost | Level 1 | ||
Fair Value | ||
Financial assets measured at fair value | 9,300 | 9,400 |
UBS AG | Not measured at fair value | Other financial assets measured at amortized cost | Level 2 | ||
Fair Value | ||
Financial assets measured at fair value | 10,700 | 10,900 |
UBS AG | Not measured at fair value | Other financial assets measured at amortized cost | Level 3 | ||
Fair Value | ||
Financial assets measured at fair value | $ 2,400 | $ 2,300 |
FVM - Financial instruments n_2
FVM - Financial instruments not measured at fair value - Liabilities (Detail) - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 |
Carrying amount | ||
Amounts due to banks | $ 13,101,000,000 | $ 11,050,000,000 |
Payables from securities financing transactions | 5,533,000,000 | 6,321,000,000 |
Cash collateral payables on derivative instruments | 31,798,000,000 | 37,312,000,000 |
Customer deposits | 542,007,000,000 | 524,605,000,000 |
Debt issued measured at amortized cost | 139,155,000,000 | 139,232,000,000 |
Other financial liabilities measured at amortized cost | 9,001,000,000 | 9,729,000,000 |
Fair Value | ||
Financial liabilities measured at fair value | 300,916,000,000 | 325,069,000,000 |
Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 25,922,000,000 | 27,635,000,000 |
Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 257,637,000,000 | 282,222,000,000 |
Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 17,357,000,000 | 15,212,000,000 |
Not measured at fair value | ||
Carrying amount | ||
Amounts due to banks | 13,100,000,000 | 11,000,000,000 |
Payables from securities financing transactions | 5,500,000,000 | 6,300,000,000 |
Cash collateral payables on derivative instruments | 31,800,000,000 | 37,300,000,000 |
Customer deposits | 542,000,000,000 | 524,600,000,000 |
Debt issued measured at amortized cost | 139,200,000,000 | 139,200,000,000 |
Other financial liabilities measured at amortized cost | 5,400,000,000 | 5,800,000,000 |
Not measured at fair value | Amount due to banks | ||
Fair Value | ||
Financial liabilities measured at fair value | 13,100,000,000 | 11,000,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 1,000,000,000 | 0 |
Not measured at fair value | Amount due to banks | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 9,100,000,000 | 8,500,000,000 |
Not measured at fair value | Amount due to banks | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Amount due to banks | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 4,000,000,000 | 2,600,000,000 |
Not measured at fair value | Amount due to banks | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Payables from securities financing transactions | ||
Fair Value | ||
Financial liabilities measured at fair value | 5,500,000,000 | 6,300,000,000 |
Not measured at fair value | Payables from securities financing transactions | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 4,100,000,000 | 6,000,000,000 |
Not measured at fair value | Payables from securities financing transactions | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Payables from securities financing transactions | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 1,500,000,000 | 300,000,000 |
Not measured at fair value | Payables from securities financing transactions | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Cash collateral payables on derivative instruments | ||
Fair Value | ||
Financial liabilities measured at fair value | 31,800,000,000 | 37,300,000,000 |
Not measured at fair value | Cash collateral payables on derivative instruments | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 31,800,000,000 | 37,300,000,000 |
Not measured at fair value | Cash collateral payables on derivative instruments | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Cash collateral payables on derivative instruments | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Cash collateral payables on derivative instruments | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Customer deposits | ||
Fair Value | ||
Financial liabilities measured at fair value | 542,000,000,000 | 524,700,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 3,000,000,000 | 2,000,000,000 |
Not measured at fair value | Customer deposits | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 535,400,000,000 | 519,400,000,000 |
Not measured at fair value | Customer deposits | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Customer deposits | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 6,600,000,000 | 5,300,000,000 |
Not measured at fair value | Customer deposits | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Debt issued measured at amortized cost | ||
Fair Value | ||
Financial liabilities measured at fair value | 141,100,000,000 | 141,900,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 84,000,000,000 | 82,000,000,000 |
Not measured at fair value | Debt issued measured at amortized cost | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 15,800,000,000 | 16,400,000,000 |
Not measured at fair value | Debt issued measured at amortized cost | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Debt issued measured at amortized cost | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 125,300,000,000 | 125,500,000,000 |
Not measured at fair value | Debt issued measured at amortized cost | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Other financial liabilities measured at amortized cost | ||
Fair Value | ||
Financial liabilities measured at fair value | 5,400,000,000 | 5,800,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 3,000,000,000 | 3,000,000,000 |
Not measured at fair value | Other financial liabilities measured at amortized cost | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 5,400,000,000 | 5,700,000,000 |
Not measured at fair value | Other financial liabilities measured at amortized cost | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Other financial liabilities measured at amortized cost | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
Not measured at fair value | Other financial liabilities measured at amortized cost | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 100,000,000 |
UBS AG | ||
Carrying amount | ||
Amounts due to banks | 13,101,000,000 | 11,050,000,000 |
Payables from securities financing transactions | 5,533,000,000 | 6,321,000,000 |
Cash collateral payables on derivative instruments | 31,801,000,000 | 37,313,000,000 |
Customer deposits | 544,834,000,000 | 527,929,000,000 |
Funding from UBS Group AG | 57,295,000,000 | 53,979,000,000 |
Debt issued measured at amortized cost | 82,432,000,000 | 85,351,000,000 |
Other financial liabilities measured at amortized cost | 9,765,000,000 | 10,421,000,000 |
Fair Value | ||
Financial liabilities measured at fair value | 300,916,000,000 | 325,080,000,000 |
UBS AG | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 25,922,000,000 | 27,635,000,000 |
UBS AG | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 257,637,000,000 | 282,233,000,000 |
UBS AG | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 17,357,000,000 | 15,212,000,000 |
UBS AG | Not measured at fair value | ||
Carrying amount | ||
Amounts due to banks | 13,100,000,000 | 11,000,000,000 |
Payables from securities financing transactions | 5,500,000,000 | 6,300,000,000 |
Cash collateral payables on derivative instruments | 31,800,000,000 | 37,300,000,000 |
Customer deposits | 544,800,000,000 | 527,900,000,000 |
Funding from UBS Group AG | 57,300,000,000 | 54,000,000,000 |
Debt issued measured at amortized cost | 82,400,000,000 | 85,400,000,000 |
Other financial liabilities measured at amortized cost | 6,300,000,000 | 6,600,000,000 |
UBS AG | Not measured at fair value | Amount due to banks | ||
Fair Value | ||
Financial liabilities measured at fair value | 13,100,000,000 | 11,100,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 1,000,000,000 | 0 |
UBS AG | Not measured at fair value | Amount due to banks | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 9,100,000,000 | 8,500,000,000 |
UBS AG | Not measured at fair value | Amount due to banks | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Amount due to banks | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 4,000,000,000 | 2,600,000,000 |
UBS AG | Not measured at fair value | Amount due to banks | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Payables from securities financing transactions | ||
Fair Value | ||
Financial liabilities measured at fair value | 5,500,000,000 | 6,300,000,000 |
UBS AG | Not measured at fair value | Payables from securities financing transactions | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 4,100,000,000 | 6,000,000,000 |
UBS AG | Not measured at fair value | Payables from securities financing transactions | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Payables from securities financing transactions | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 1,500,000,000 | 200,000,000 |
UBS AG | Not measured at fair value | Payables from securities financing transactions | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Cash collateral payables on derivative instruments | ||
Fair Value | ||
Financial liabilities measured at fair value | 31,800,000,000 | 37,300,000,000 |
UBS AG | Not measured at fair value | Cash collateral payables on derivative instruments | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 31,800,000,000 | 37,300,000,000 |
UBS AG | Not measured at fair value | Cash collateral payables on derivative instruments | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Cash collateral payables on derivative instruments | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Cash collateral payables on derivative instruments | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Customer deposits | ||
Fair Value | ||
Financial liabilities measured at fair value | 544,800,000,000 | 528,000,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 4,000,000,000 | 3,000,000,000 |
UBS AG | Not measured at fair value | Customer deposits | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 537,600,000,000 | 521,800,000,000 |
UBS AG | Not measured at fair value | Customer deposits | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Customer deposits | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 7,300,000,000 | 6,200,000,000 |
UBS AG | Not measured at fair value | Customer deposits | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Funding from UBS Group AG and its subsidiaries | ||
Fair Value | ||
Financial liabilities measured at fair value | 58,800,000,000 | 55,600,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 53,000,000,000 | 49,000,000,000 |
UBS AG | Not measured at fair value | Funding from UBS Group AG and its subsidiaries | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 2,800,000,000 | 0 |
UBS AG | Not measured at fair value | Funding from UBS Group AG and its subsidiaries | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Funding from UBS Group AG and its subsidiaries | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 56,000,000,000 | 55,600,000,000 |
UBS AG | Not measured at fair value | Funding from UBS Group AG and its subsidiaries | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Debt issued measured at amortized cost | ||
Fair Value | ||
Financial liabilities measured at fair value | 82,800,000,000 | 86,300,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 31,000,000,000 | 31,000,000,000 |
UBS AG | Not measured at fair value | Debt issued measured at amortized cost | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 13,000,000,000 | 16,400,000,000 |
UBS AG | Not measured at fair value | Debt issued measured at amortized cost | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Debt issued measured at amortized cost | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 69,800,000,000 | 70,000,000,000 |
UBS AG | Not measured at fair value | Debt issued measured at amortized cost | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Other financial liabilities measured at amortized cost | ||
Fair Value | ||
Financial liabilities measured at fair value | 6,300,000,000 | 6,700,000,000 |
Financial liabilities not measured at fair value expected to be recovered or settled after 12 months | 3,000,000,000 | 3,000,000,000 |
UBS AG | Not measured at fair value | Other financial liabilities measured at amortized cost | Carrying amount approximates fair value | ||
Fair Value | ||
Financial liabilities measured at fair value | 6,300,000,000 | 6,600,000,000 |
UBS AG | Not measured at fair value | Other financial liabilities measured at amortized cost | Level 1 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Other financial liabilities measured at amortized cost | Level 2 | ||
Fair Value | ||
Financial liabilities measured at fair value | 0 | 0 |
UBS AG | Not measured at fair value | Other financial liabilities measured at amortized cost | Level 3 | ||
Fair Value | ||
Financial liabilities measured at fair value | $ 0 | $ 100,000,000 |
Offsetting financial assets (De
Offsetting financial assets (Detail) - USD ($) $ in Billions | Dec. 31, 2021 | Dec. 31, 2020 |
Netting recognized on the balance sheet | ||
Gross assets before netting | $ 306.2 | $ 344.8 |
Netting with gross liabilities | (105) | (97.5) |
Net assets recognized on the balance sheet | 201.2 | 247.3 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (108.1) | (139.3) |
Collateral received | (77.2) | (89.8) |
Assets after consideration of netting potential | 15.9 | 18.3 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 82.6 | 99.7 |
Total assets | ||
Total assets, after consideration of further netting potential | 98.5 | 117.9 |
Total assets recognized on the balance sheet | 283.7 | 346.9 |
Receivables from securities financing transactions | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 67.7 | 70.3 |
Netting with gross liabilities | (13.8) | (13.4) |
Net assets recognized on the balance sheet | 53.9 | 57 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (2.9) | (1.7) |
Collateral received | (51) | (55.3) |
Assets after consideration of netting potential | 0 | 0 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 21.1 | 17.3 |
Total assets | ||
Total assets, after consideration of further netting potential | 21.1 | 17.3 |
Total assets recognized on the balance sheet | 75 | 74.2 |
Derivative financial instruments | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 116 | 156.9 |
Netting with gross liabilities | (3.6) | (5) |
Net assets recognized on the balance sheet | 112.4 | 151.9 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (88.9) | (117.2) |
Collateral received | (18.5) | (27.2) |
Assets after consideration of netting potential | 5 | 7.5 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 5.7 | 7.7 |
Total assets | ||
Total assets, after consideration of further netting potential | 10.7 | 15.2 |
Total assets recognized on the balance sheet | 118.1 | 159.6 |
Cash collateral receivables on derivative instruments | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 29.4 | 31.9 |
Netting with gross liabilities | 0 | 0 |
Net assets recognized on the balance sheet | 29.4 | 31.9 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (15.2) | (19.6) |
Collateral received | (3.3) | (1.5) |
Assets after consideration of netting potential | 11 | 10.8 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 1.1 | 0.8 |
Total assets | ||
Total assets, after consideration of further netting potential | 12.1 | 11.6 |
Total assets recognized on the balance sheet | 30.5 | 32.7 |
Financial assets at fair value not held for trading | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 93.1 | 85.6 |
Netting with gross liabilities | (87.6) | (79.1) |
Net assets recognized on the balance sheet | 5.5 | 6.5 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (1.1) | (0.8) |
Collateral received | (4.4) | (5.8) |
Assets after consideration of netting potential | 0 | 0 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 54.6 | 73.9 |
Total assets | ||
Total assets, after consideration of further netting potential | 54.6 | 73.9 |
Total assets recognized on the balance sheet | 60.1 | 80.4 |
of which: reverse repurchase agreements | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 93.1 | 85.6 |
Netting with gross liabilities | (87.6) | (79.1) |
Net assets recognized on the balance sheet | 5.5 | 6.5 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (1.1) | (0.8) |
Collateral received | (4.4) | (5.8) |
Assets after consideration of netting potential | 0 | 0 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 0.3 | 0.2 |
Total assets | ||
Total assets, after consideration of further netting potential | 0.3 | 0.2 |
Total assets recognized on the balance sheet | 5.8 | 6.7 |
UBS AG | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 306.2 | 344.8 |
Netting with gross liabilities | (105) | (97.5) |
Net assets recognized on the balance sheet | 201.2 | 247.3 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (108.1) | (139.3) |
Collateral received | (77.2) | (89.8) |
Assets after consideration of netting potential | 15.9 | 18.3 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 82.1 | 99.3 |
Total assets | ||
Total assets, after consideration of further netting potential | 98.1 | 117.6 |
Total assets recognized on the balance sheet | 283.3 | 346.6 |
UBS AG | Receivables from securities financing transactions | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 67.7 | 70.3 |
Netting with gross liabilities | (13.8) | (13.4) |
Net assets recognized on the balance sheet | 53.9 | 57 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (2.9) | (1.7) |
Collateral received | (51) | (55.3) |
Assets after consideration of netting potential | 0 | 0 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 21.1 | 17.3 |
Total assets | ||
Total assets, after consideration of further netting potential | 21.1 | 17.3 |
Total assets recognized on the balance sheet | 75 | 74.2 |
UBS AG | Derivative financial instruments | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 116 | 156.9 |
Netting with gross liabilities | (3.6) | (5) |
Net assets recognized on the balance sheet | 112.4 | 151.9 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (88.9) | (117.2) |
Collateral received | (18.5) | (27.2) |
Assets after consideration of netting potential | 5 | 7.5 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 5.8 | 7.7 |
Total assets | ||
Total assets, after consideration of further netting potential | 10.7 | 15.2 |
Total assets recognized on the balance sheet | 118.1 | 159.6 |
UBS AG | Cash collateral receivables on derivative instruments | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 29.4 | 31.9 |
Netting with gross liabilities | 0 | 0 |
Net assets recognized on the balance sheet | 29.4 | 31.9 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (15.2) | (19.6) |
Collateral received | (3.3) | (1.5) |
Assets after consideration of netting potential | 11 | 10.8 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 1.1 | 0.8 |
Total assets | ||
Total assets, after consideration of further netting potential | 12.1 | 11.6 |
Total assets recognized on the balance sheet | 30.5 | 32.7 |
UBS AG | Financial assets at fair value not held for trading | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 93.1 | 85.6 |
Netting with gross liabilities | (87.6) | (79.1) |
Net assets recognized on the balance sheet | 5.5 | 6.5 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (1.1) | (0.8) |
Collateral received | (4.4) | (5.8) |
Assets after consideration of netting potential | 0 | 0 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 54.1 | 73.5 |
Total assets | ||
Total assets, after consideration of further netting potential | 54.1 | 73.5 |
Total assets recognized on the balance sheet | 59.6 | 80 |
UBS AG | of which: reverse repurchase agreements | ||
Netting recognized on the balance sheet | ||
Gross assets before netting | 93.1 | 85.6 |
Netting with gross liabilities | (87.6) | (79.1) |
Net assets recognized on the balance sheet | 5.5 | 6.5 |
Netting potential not recognized on the balance sheet | ||
Financial liabilities | (1.1) | (0.8) |
Collateral received | (4.4) | (5.8) |
Assets after consideration of netting potential | 0 | 0 |
Assets not subject to netting arrangements | ||
Assets recognized on the balance sheet | 0.3 | 0.2 |
Total assets | ||
Total assets, after consideration of further netting potential | 0.3 | 0.2 |
Total assets recognized on the balance sheet | $ 5.8 | $ 6.7 |
Offsetting financial liabilitie
Offsetting financial liabilities (Detail) - USD ($) $ in Billions | Dec. 31, 2021 | Dec. 31, 2020 |
Netting recognized on the balance sheet | ||
Gross liabilities before netting | $ 260.6 | $ 297.8 |
Netting with gross assets | (105) | (97.5) |
Net liabilities recognized on the balance sheet | 155.6 | 200.3 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (106) | (139.2) |
Collateral pledged | (27.5) | (35.5) |
Liabilities after consideration of netting potential | 22.1 | 25.6 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 33.1 | 34.8 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 55.2 | 60.4 |
Total liabilities recognized on the balance sheet | 188.7 | 235.1 |
Payables from securities financing transactions | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 16.9 | 18.2 |
Netting with gross assets | (12.8) | (13.3) |
Net liabilities recognized on the balance sheet | 4.1 | 4.9 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (1.8) | (1.6) |
Collateral pledged | (2.3) | (3.3) |
Liabilities after consideration of netting potential | 0 | 0 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 1.4 | 1.4 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 1.4 | 1.4 |
Total liabilities recognized on the balance sheet | 5.5 | 6.3 |
Derivative financial instruments - liabilities | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 118.4 | 157.1 |
Netting with gross assets | (3.6) | (5) |
Net liabilities recognized on the balance sheet | 114.9 | 152.1 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (88.9) | (117.2) |
Collateral pledged | (18.1) | (23.9) |
Liabilities after consideration of netting potential | 7.9 | 10.9 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 6.4 | 9 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 14.3 | 19.9 |
Total liabilities recognized on the balance sheet | 121.3 | 161.1 |
Cash collateral payables on derivative instruments | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 30.4 | 35.6 |
Netting with gross assets | 0 | 0 |
Net liabilities recognized on the balance sheet | 30.4 | 35.6 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (13.1) | (19.6) |
Collateral pledged | (3.3) | (2.1) |
Liabilities after consideration of netting potential | 14 | 13.9 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 1.4 | 1.7 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 15.4 | 15.7 |
Total liabilities recognized on the balance sheet | 31.8 | 37.3 |
Other financial liabilities designated at fair value | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 94.8 | 87 |
Netting with gross assets | (88.6) | (79.2) |
Net liabilities recognized on the balance sheet | 6.2 | 7.8 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (2.2) | (0.8) |
Collateral pledged | (3.8) | (6.3) |
Liabilities after consideration of netting potential | 0.2 | 0.7 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 23.9 | 22.6 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 24.1 | 23.3 |
Total liabilities recognized on the balance sheet | 30.1 | 30.4 |
of which: repurchase agreements | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 94.6 | 86.2 |
Netting with gross assets | (88.6) | (79.2) |
Net liabilities recognized on the balance sheet | 6 | 7 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (2.2) | (0.8) |
Collateral pledged | (3.8) | (6.3) |
Liabilities after consideration of netting potential | 0 | 0 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 0.4 | 0.3 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 0.4 | 0.3 |
Total liabilities recognized on the balance sheet | 6.4 | 7.3 |
UBS AG | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 260.6 | 297.8 |
Netting with gross assets | (105) | (97.5) |
Net liabilities recognized on the balance sheet | 155.6 | 200.3 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (106) | (139.2) |
Collateral pledged | (27.5) | (35.5) |
Liabilities after consideration of netting potential | 22.1 | 25.6 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 35.5 | 36.2 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 57.6 | 61.7 |
Total liabilities recognized on the balance sheet | 191.1 | 236.5 |
UBS AG | Payables from securities financing transactions | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 16.9 | 18.2 |
Netting with gross assets | (12.8) | (13.3) |
Net liabilities recognized on the balance sheet | 4.1 | 4.9 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (1.8) | (1.6) |
Collateral pledged | (2.3) | (3.3) |
Liabilities after consideration of netting potential | 0 | 0 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 1.4 | 1.4 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 1.4 | 1.4 |
Total liabilities recognized on the balance sheet | 5.5 | 6.3 |
UBS AG | Derivative financial instruments - liabilities | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 118.4 | 157.1 |
Netting with gross assets | (3.6) | (5) |
Net liabilities recognized on the balance sheet | 114.9 | 152.1 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (88.9) | (117.2) |
Collateral pledged | (18.1) | (23.9) |
Liabilities after consideration of netting potential | 7.9 | 10.9 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 6.4 | 9 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 14.3 | 19.9 |
Total liabilities recognized on the balance sheet | 121.3 | 161.1 |
UBS AG | Cash collateral payables on derivative instruments | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 30.4 | 35.6 |
Netting with gross assets | 0 | 0 |
Net liabilities recognized on the balance sheet | 30.4 | 35.6 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (13.1) | (19.6) |
Collateral pledged | (3.3) | (2.1) |
Liabilities after consideration of netting potential | 14 | 13.9 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 1.4 | 1.7 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 15.4 | 15.7 |
Total liabilities recognized on the balance sheet | 31.8 | 37.3 |
UBS AG | Other financial liabilities designated at fair value | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 94.8 | 87 |
Netting with gross assets | (88.6) | (79.2) |
Net liabilities recognized on the balance sheet | 6.2 | 7.8 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (2.2) | (0.8) |
Collateral pledged | (3.8) | (6.3) |
Liabilities after consideration of netting potential | 0.2 | 0.7 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 26.3 | 24 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 26.5 | 24.7 |
Total liabilities recognized on the balance sheet | 32.4 | 31.8 |
UBS AG | of which: repurchase agreements | ||
Netting recognized on the balance sheet | ||
Gross liabilities before netting | 94.6 | 86.2 |
Netting with gross assets | (88.6) | (79.2) |
Net liabilities recognized on the balance sheet | 6 | 7 |
Netting potential not recognized on the balance sheet | ||
Financial assets | (2.2) | (0.8) |
Collateral pledged | (3.8) | (6.3) |
Liabilities after consideration of netting potential | 0 | 0 |
Liabilities not subject to netting arrangements | ||
Liabilities recognized on the balance sheet | 0.4 | 0.3 |
Total liabilities | ||
Total liabilities after consideration of netting potential | 0.4 | 0.3 |
Total liabilities recognized on the balance sheet | $ 6.4 | $ 7.3 |
Restricted financial assets (De
Restricted financial assets (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Financial assets pledged as collateral | ||
Financial assets at fair value held for trading | $ 63,725 | $ 64,367 |
of which: assets pledged as collateral which may be sold or repledged by counterparties | 43,397 | 47,098 |
Loans and advances to customers | 18,160 | 20,361 |
of which: mortgage loans | 16,330 | 18,191 |
Financial assets at fair value not held for trading | 961 | 2,140 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 961 | 2,140 |
Debt securities classified as Other financial assets measured at amortized cost | 2,234 | 2,506 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 1,870 | 2,506 |
Financial assets measured at fair value through other comprehensive income | 0 | 149 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 0 | 149 |
Total financial assets pledged as collateral | 85,079 | 89,523 |
Other restricted financial assets | ||
Loans and advances to banks | 3,408 | 3,730 |
Financial assets at fair value held for trading | 392 | 741 |
Cash collateral receivables on derivative instruments | 4,747 | 3,765 |
Loans and advances to customers | 1,237 | 756 |
Financial assets at fair value not held for trading | 22,765 | 23,243 |
Financial assets measured at fair value through other comprehensive income | 894 | 0 |
Other | 97 | 110 |
Total other restricted financial assets | 33,540 | 32,345 |
Total financial assets pledged and other restricted financial assets | 118,619 | 121,868 |
Pledged mortgage loans that could be withdrawn or used | 2,700 | 2,700 |
Assets placed with central banks related to undrawn credit lines and for payment, clearing and settlement purposes | 4,400 | 1,300 |
UBS AG | ||
Financial assets pledged as collateral | ||
Financial assets at fair value held for trading | 63,834 | 64,418 |
of which: assets pledged as collateral which may be sold or repledged by counterparties | 43,397 | 47,098 |
Loans and advances to customers | 18,160 | 20,361 |
of which: mortgage loans | 16,330 | 18,191 |
Financial assets at fair value not held for trading | 961 | 2,140 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 961 | 2,140 |
Debt securities classified as Other financial assets measured at amortized cost | 2,234 | 2,506 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 1,870 | 2,506 |
Financial assets measured at fair value through other comprehensive income | 0 | 149 |
of which: assets pledged as collateral that may be sold or repledged by counterparties | 0 | 149 |
Total financial assets pledged as collateral | 85,188 | 89,574 |
Other restricted financial assets | ||
Loans and advances to banks | 3,408 | 3,730 |
Financial assets at fair value held for trading | 392 | 741 |
Cash collateral receivables on derivative instruments | 4,747 | 3,765 |
Loans and advances to customers | 1,237 | 756 |
Financial assets at fair value not held for trading | 22,328 | 22,917 |
Financial assets measured at fair value through other comprehensive income | 894 | 0 |
Other | 97 | 110 |
Total other restricted financial assets | 33,104 | 32,019 |
Total financial assets pledged and other restricted financial assets | 118,292 | 121,593 |
Pledged mortgage loans that could be withdrawn or used | 2,700 | 2,700 |
Assets placed with central banks related to undrawn credit lines and for payment, clearing and settlement purposes | $ 4,400 | $ 1,300 |
Restricted financial assets (Na
Restricted financial assets (Narrative) (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Pledged mortgage loans serve as collateral for existing liabilities against Swiss central mortgage institutions and for existing covered bond issuances | $ 10,843 | $ 12,456 |
UBS AG | ||
Entity [Table] | ||
Pledged mortgage loans serve as collateral for existing liabilities against Swiss central mortgage institutions and for existing covered bond issuances | $ 10,843 | $ 12,456 |
Transferred financial assets _4
Transferred financial assets that are not derecognized in their entirety (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | $ 46,227 | $ 51,893 |
Carrying amount of associated liabilities recognized on balance sheet | 20,311 | 22,363 |
Financial assets at fair value held for trading that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 43,397 | 47,098 |
Carrying amount of associated liabilities recognized on balance sheet | 17,687 | 18,874 |
relating to securities lending and repurchase agreements in exchange for cash received | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 17,970 | 19,177 |
Carrying amount of associated liabilities recognized on balance sheet | 17,687 | 18,874 |
relating to securities lending agreements in exchange for securities received | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 24,146 | 27,595 |
relating to other financial asset transfers | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 1,281 | 326 |
Financial assets at fair value not held for trading that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 961 | 2,140 |
Carrying amount of associated liabilities recognized on balance sheet | 898 | 1,378 |
Debt securities classified as Other financial assets measured at amortized cost that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 1,870 | 2,506 |
Carrying amount of associated liabilities recognized on balance sheet | 1,725 | 1,963 |
Financial assets measured at fair value through other comprehensive income that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 0 | 149 |
Carrying amount of associated liabilities recognized on balance sheet | 0 | 148 |
UBS AG | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 46,227 | 51,893 |
Carrying amount of associated liabilities recognized on balance sheet | 20,311 | 22,363 |
UBS AG | Financial assets at fair value held for trading that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 43,397 | 47,098 |
Carrying amount of associated liabilities recognized on balance sheet | 17,687 | 18,874 |
UBS AG | relating to securities lending and repurchase agreements in exchange for cash received | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 17,970 | 19,177 |
Carrying amount of associated liabilities recognized on balance sheet | 17,687 | 18,874 |
UBS AG | relating to securities lending agreements in exchange for securities received | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 24,146 | 27,595 |
UBS AG | relating to other financial asset transfers | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 1,281 | 326 |
UBS AG | Financial assets at fair value not held for trading that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 961 | 2,140 |
Carrying amount of associated liabilities recognized on balance sheet | 898 | 1,378 |
UBS AG | Debt securities classified as Other financial assets measured at amortized cost that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 1,870 | 2,506 |
Carrying amount of associated liabilities recognized on balance sheet | 1,725 | 1,963 |
UBS AG | Financial assets measured at fair value through other comprehensive income that may be sold or repledged by counterparties | ||
Disclosure Of Financial Assets Transferred During Period Which Do Not Qualify For Derecognition [Table] | ||
Carrying amount of transferred assets | 0 | 149 |
Carrying amount of associated liabilities recognized on balance sheet | $ 0 | $ 148 |
Transferred financial assets _5
Transferred financial assets that are not derecognized in their entirety (Narrative) (Detail) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Proportion of transferred financial assets that were trading portfolio assets in exchange for cash | 41.00% |
Minimum haircut applied to transferred assets in securities lending and repurchase agreements | 0.00% |
Maximum haircut applied to transferred assets in securities lending and repurchase agreements | 15.00% |
UBS AG | |
Entity [Table] | |
Proportion of transferred financial assets that were trading portfolio assets in exchange for cash | 41.00% |
Minimum haircut applied to transferred assets in securities lending and repurchase agreements | 0.00% |
Maximum haircut applied to transferred assets in securities lending and repurchase agreements | 15.00% |
Off-balance sheet assets rece_3
Off-balance sheet assets received (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Fair value of assets received that can be sold or repledged | $ 497,828 | $ 500,689 |
received as collateral under reverse repurchase, securities borrowing and lending arrangements, derivative and other transactions | 483,426 | 487,904 |
received in unsecured borrowings | 14,402 | 12,785 |
Thereof sold or repledged | 367,440 | 367,258 |
in connection with financing activities | 319,176 | 315,603 |
to satisfy commitments under short sale transactions | 31,688 | 33,595 |
in connection with derivative and other transactions | 16,575 | 18,059 |
Off balance sheet securities placed with central banks related to undrawn credit lines and for payment clearing and settlement purposes | 12,700 | 18,900 |
UBS AG | ||
Entity [Table] | ||
Fair value of assets received that can be sold or repledged | 497,828 | 500,689 |
received as collateral under reverse repurchase, securities borrowing and lending arrangements, derivative and other transactions | 483,426 | 487,904 |
received in unsecured borrowings | 14,402 | 12,785 |
Thereof sold or repledged | 367,440 | 367,258 |
in connection with financing activities | 319,176 | 315,603 |
to satisfy commitments under short sale transactions | 31,688 | 33,595 |
in connection with derivative and other transactions | 16,575 | 18,059 |
Off balance sheet securities placed with central banks related to undrawn credit lines and for payment clearing and settlement purposes | $ 12,700 | $ 18,900 |
Maturity analysis of financia_3
Maturity analysis of financial liabilities (Detail) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | $ 13,100 | $ 11,100 |
Payables from securities financing transactions, undiscounted cash flows | 5,700 | 6,300 |
Cash collateral payables on derivative instruments, undiscounted cash flows | 31,800 | 37,300 |
Customer deposits, undiscounted cash flows | 542,300 | 524,900 |
Debt issued measured at amortized cost, undiscounted cash flows | 148,900 | 148,500 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 8,400 | 8,900 |
of which: lease liabilities, undiscounted cash flow | 4,000 | 4,500 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 750,200 | 737,100 |
Financial liabilities at fair value held for trading | 31,688 | 33,595 |
Derivative financial instruments | 121,309 | 161,102 |
Brokerage payables designated at fair value, undiscounted cash flows | 44,000 | 38,700 |
Debt issued designated at fair value, undiscounted cash flows | 81,900 | 64,500 |
Other financial liabilities designated at fair value, undiscounted cash flows | 30,500 | 30,900 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 309,400 | 328,800 |
Total financial liabilities, undiscounted cash flows | 1,059,600 | 1,065,900 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 39,500 | 41,400 |
Guarantees | 21,200 | 17,500 |
Forward starting transactions, reverse repurchase agreements and securities borrowing agreements | 1,400 | 3,200 |
Total | 62,100 | 62,200 |
Trading portfolio liabilities contractually due within one month | 30,800 | 32,600 |
Trading portfolio liabilities contractually due between one month and one year | 900 | 1,000 |
Trading portfolio liabilities contractually due between 1 and 5 years | 0 | 0 |
Loan commitments and forward starting reverse repurchase agreements classified as derivatives | 34 | 32 |
Notional amounts of derivatives | 36,000 | 31,300 |
Due within 1 month | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 6,700 | 6,100 |
Payables from securities financing transactions, undiscounted cash flows | 3,800 | 5,600 |
Cash collateral payables on derivative instruments, undiscounted cash flows | 31,800 | 37,300 |
Customer deposits, undiscounted cash flows | 530,100 | 512,800 |
Debt issued measured at amortized cost, undiscounted cash flows | 4,000 | 9,000 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 4,500 | 4,500 |
of which: lease liabilities, undiscounted cash flow | 100 | 100 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 580,900 | 575,300 |
Financial liabilities at fair value held for trading | 31,700 | 33,600 |
Derivative financial instruments | 121,300 | 161,100 |
Brokerage payables designated at fair value, undiscounted cash flows | 44,000 | 38,700 |
Debt issued designated at fair value, undiscounted cash flows | 13,800 | 21,900 |
Other financial liabilities designated at fair value, undiscounted cash flows | 28,100 | 27,900 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 239,000 | 283,200 |
Total financial liabilities, undiscounted cash flows | 819,800 | 858,500 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 38,300 | 40,500 |
Guarantees | 21,200 | 17,500 |
Forward starting transactions, reverse repurchase agreements and securities borrowing agreements | 1,400 | 3,200 |
Total | 60,900 | 61,300 |
Due between 1 and 3 months | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 2,400 | 2,400 |
Payables from securities financing transactions, undiscounted cash flows | 300 | 400 |
Customer deposits, undiscounted cash flows | 5,200 | 6,600 |
Debt issued measured at amortized cost, undiscounted cash flows | 12,700 | 8,300 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 100 | 100 |
of which: lease liabilities, undiscounted cash flow | 100 | 100 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 20,800 | 17,900 |
Debt issued designated at fair value, undiscounted cash flows | 11,500 | 16,800 |
Other financial liabilities designated at fair value, undiscounted cash flows | 400 | 600 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 11,900 | 17,400 |
Total financial liabilities, undiscounted cash flows | 32,700 | 35,300 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 500 | 500 |
Total | 500 | 500 |
Due between 3 and 12 months | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 3,500 | 2,100 |
Payables from securities financing transactions, undiscounted cash flows | 1,600 | 300 |
Customer deposits, undiscounted cash flows | 3,300 | 3,500 |
Debt issued measured at amortized cost, undiscounted cash flows | 41,100 | 41,900 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 500 | 500 |
of which: lease liabilities, undiscounted cash flow | 500 | 500 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 49,900 | 48,200 |
Debt issued designated at fair value, undiscounted cash flows | 13,500 | 7,100 |
Other financial liabilities designated at fair value, undiscounted cash flows | 500 | 600 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 14,000 | 7,700 |
Total financial liabilities, undiscounted cash flows | 63,900 | 56,000 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 700 | 400 |
Guarantees | 0 | |
Total | 700 | 400 |
Due between 1 and 5 years | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 600 | 500 |
Payables from securities financing transactions, undiscounted cash flows | 0 | 0 |
Customer deposits, undiscounted cash flows | 3,200 | 1,800 |
Debt issued measured at amortized cost, undiscounted cash flows | 53,500 | 53,700 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 1,800 | 2,000 |
of which: lease liabilities, undiscounted cash flow | 1,800 | 2,000 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 59,200 | 58,000 |
Debt issued designated at fair value, undiscounted cash flows | 24,500 | 9,200 |
Other financial liabilities designated at fair value, undiscounted cash flows | 400 | 700 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 24,900 | 9,900 |
Total financial liabilities, undiscounted cash flows | 84,100 | 67,900 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 0 | 0 |
Total | 0 | 0 |
Due after 5 years | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 0 | |
Payables from securities financing transactions, undiscounted cash flows | 0 | |
Customer deposits, undiscounted cash flows | 400 | 200 |
Debt issued measured at amortized cost, undiscounted cash flows | 37,600 | 35,600 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 1,600 | 1,800 |
of which: lease liabilities, undiscounted cash flow | 1,600 | 1,800 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 39,500 | 37,700 |
Debt issued designated at fair value, undiscounted cash flows | 18,500 | 9,500 |
Other financial liabilities designated at fair value, undiscounted cash flows | 1,100 | 1,100 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 19,600 | 10,600 |
Total financial liabilities, undiscounted cash flows | 59,100 | 48,300 |
Guarantees, commitments and forward starting transactions | ||
Total | 0 | 0 |
UBS AG | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 13,100 | 11,100 |
Payables from securities financing transactions, undiscounted cash flows | 5,700 | 6,300 |
Cash collateral payables on derivative instruments, undiscounted cash flows | 31,800 | 37,300 |
Customer deposits, undiscounted cash flows | 545,100 | 528,200 |
Funding from UBS Group AG and its subsidiaries, undiscounted cash flows | 65,300 | 60,500 |
Debt issued measured at amortized cost, undiscounted cash flows | 84,700 | 88,200 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 9,100 | 9,600 |
of which: lease liabilities, undiscounted cash flow | 3,900 | 4,400 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 754,800 | 741,300 |
Financial liabilities at fair value held for trading | 31,688 | 33,595 |
Derivative financial instruments | 121,309 | 161,102 |
Brokerage payables designated at fair value, undiscounted cash flows | 44,000 | 38,700 |
Debt issued designated at fair value, undiscounted cash flows | 75,900 | 61,000 |
Other financial liabilities designated at fair value, undiscounted cash flows | 36,500 | 34,300 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 309,400 | 328,800 |
Total financial liabilities, undiscounted cash flows | 1,064,200 | 1,070,000 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 39,500 | 41,400 |
Guarantees | 21,200 | 17,500 |
Forward starting transactions, reverse repurchase agreements and securities borrowing agreements | 1,400 | 3,200 |
Total | 62,100 | 62,200 |
Trading portfolio liabilities contractually due within one month | 30,800 | 32,600 |
Trading portfolio liabilities contractually due between one month and one year | 900 | 1,000 |
Trading portfolio liabilities contractually due between 1 and 5 years | 0 | 0 |
Loan commitments and forward starting reverse repurchase agreements classified as derivatives | 34 | 32 |
Notional amounts of derivatives | 36,000 | 31,300 |
UBS AG | Due within 1 month | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 6,700 | 6,100 |
Payables from securities financing transactions, undiscounted cash flows | 3,800 | 5,600 |
Cash collateral payables on derivative instruments, undiscounted cash flows | 31,800 | 37,300 |
Customer deposits, undiscounted cash flows | 531,000 | 514,000 |
Funding from UBS Group AG and its subsidiaries, undiscounted cash flows | 200 | 100 |
Debt issued measured at amortized cost, undiscounted cash flows | 3,800 | 8,800 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 5,300 | 5,300 |
of which: lease liabilities, undiscounted cash flow | 100 | 100 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 582,600 | 577,200 |
Financial liabilities at fair value held for trading | 31,700 | 33,600 |
Derivative financial instruments | 121,300 | 161,100 |
Brokerage payables designated at fair value, undiscounted cash flows | 44,000 | 38,700 |
Debt issued designated at fair value, undiscounted cash flows | 13,800 | 21,900 |
Other financial liabilities designated at fair value, undiscounted cash flows | 28,100 | 27,900 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 239,000 | 283,200 |
Total financial liabilities, undiscounted cash flows | 821,600 | 860,300 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 38,300 | 40,500 |
Guarantees | 21,200 | 17,500 |
Forward starting transactions, reverse repurchase agreements and securities borrowing agreements | 1,400 | 3,200 |
Total | 60,900 | 61,300 |
UBS AG | Due between 1 and 3 months | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 2,400 | 2,400 |
Payables from securities financing transactions, undiscounted cash flows | 300 | 400 |
Customer deposits, undiscounted cash flows | 6,600 | 7,800 |
Funding from UBS Group AG and its subsidiaries, undiscounted cash flows | 3,300 | 300 |
Debt issued measured at amortized cost, undiscounted cash flows | 9,400 | 7,800 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 100 | 100 |
of which: lease liabilities, undiscounted cash flow | 100 | 100 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 22,100 | 18,900 |
Debt issued designated at fair value, undiscounted cash flows | 11,500 | 16,800 |
Other financial liabilities designated at fair value, undiscounted cash flows | 400 | 600 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 11,900 | 17,400 |
Total financial liabilities, undiscounted cash flows | 34,000 | 36,300 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 500 | 500 |
Total | 500 | 500 |
UBS AG | Due between 3 and 12 months | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 3,500 | 2,100 |
Payables from securities financing transactions, undiscounted cash flows | 1,600 | 300 |
Customer deposits, undiscounted cash flows | 3,300 | 3,500 |
Funding from UBS Group AG and its subsidiaries, undiscounted cash flows | 2,300 | 6,200 |
Debt issued measured at amortized cost, undiscounted cash flows | 38,800 | 38,200 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 400 | 500 |
of which: lease liabilities, undiscounted cash flow | 400 | 500 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 49,900 | 50,700 |
Debt issued designated at fair value, undiscounted cash flows | 13,500 | 7,100 |
Other financial liabilities designated at fair value, undiscounted cash flows | 500 | 600 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 14,000 | 7,700 |
Total financial liabilities, undiscounted cash flows | 63,900 | 58,400 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 700 | 400 |
Total | 700 | 400 |
Trading portfolio liabilities contractually due within one month | 0 | |
UBS AG | Due between 1 and 5 years | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 600 | 500 |
Payables from securities financing transactions, undiscounted cash flows | 0 | 0 |
Customer deposits, undiscounted cash flows | 3,900 | 2,800 |
Funding from UBS Group AG and its subsidiaries, undiscounted cash flows | 28,800 | 29,100 |
Debt issued measured at amortized cost, undiscounted cash flows | 25,100 | 24,500 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 1,800 | 2,000 |
of which: lease liabilities, undiscounted cash flow | 1,800 | 2,000 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 60,200 | 58,800 |
Debt issued designated at fair value, undiscounted cash flows | 24,500 | 9,200 |
Other financial liabilities designated at fair value, undiscounted cash flows | 400 | 700 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 24,900 | 9,800 |
Total financial liabilities, undiscounted cash flows | 85,000 | 68,600 |
Guarantees, commitments and forward starting transactions | ||
Loan commitments | 0 | 0 |
Total | 0 | 0 |
UBS AG | Due after 5 years | ||
Financial liabilities recognized on balance sheet | ||
Amounts due to banks, undiscounted cash flows | 0 | 0 |
Payables from securities financing transactions, undiscounted cash flows | 0 | |
Customer deposits, undiscounted cash flows | 400 | 200 |
Funding from UBS Group AG and its subsidiaries, undiscounted cash flows | 30,600 | 24,800 |
Debt issued measured at amortized cost, undiscounted cash flows | 7,600 | 8,900 |
Other financial liabilities measured at amortized cost, undiscounted cash flows | 1,500 | 1,800 |
of which: lease liabilities, undiscounted cash flow | 1,500 | 1,800 |
Total financial liabilities measured at amortized cost, undiscounted cash flows | 40,100 | 35,800 |
Debt issued designated at fair value, undiscounted cash flows | 12,500 | 6,000 |
Other financial liabilities designated at fair value, undiscounted cash flows | 7,100 | 4,600 |
Total financial liabilities measured at fair value through profit or loss, undiscounted cash flows | 19,600 | 10,600 |
Total financial liabilities, undiscounted cash flows | 59,600 | 46,400 |
Guarantees, commitments and forward starting transactions | ||
Total | $ 0 | $ 0 |
Interest rate benchmark refor_2
Interest rate benchmark reform (Narrative) (Detail) $ in Billions | Dec. 31, 2021USD ($) |
Entity [Table] | |
Mortgages linked to CHF LIBOR | $ 21 |
JPY and USD benchmark bonds resettable to LIBOR | 3 |
Multicurrency Loan Commitments | 5 |
UBS AG [Member] | |
Entity [Table] | |
Mortgages linked to CHF LIBOR | 21 |
JPY and USD benchmark bonds resettable to LIBOR | 3 |
Multicurrency Loan Commitments | $ 5 |
Interest rate benchmark refor_3
Interest rate benchmark reform (Detail) $ in Millions | 12 Months Ended | |
Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | |
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total off-balance sheet irrevocable loan commitments | $ 39,500 | $ 41,400 |
Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
USD LIBOR securities-based lending | 37,000 | |
USD LIBOR brokerage accounts | 5,000 | |
Carrying value of loans related to revolving multi-currency credit lines where IBOR transition efforts are complete, except for USD LIBOR | $ 1,000 | |
Trade count of derivative financial instruments, cross currency derivatives | 5,000 | |
Trade count of derivative financial instruments, cross currency derivatives which have a non-USD LIBOR leg, in addition to a USD LIBOR leg | 500 | |
Multicurrency loan commitments that have only USD LIBOR exposure remaining | $ 3,000 | |
Multicurrency loan commitments with non-USD LIBOR optionality | 2,000 | |
LIBOR benchmark rate CHF | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 21,616 | |
Total carrying value of non-derivative financial liabilities | $ 27 | |
Trade count of derivative financial instruments | 829 | |
Total off-balance sheet irrevocable loan commitments | $ 0 | |
LIBOR benchmark rate USD | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 65,234 | |
Total carrying value of non-derivative financial liabilities | $ 1,985 | |
Trade count of derivative financial instruments | 40,500 | |
Total off-balance sheet irrevocable loan commitments | $ 11,863 | |
LIBOR benchmark rate GBP | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 45 | |
Total carrying value of non-derivative financial liabilities | $ 3 | |
Trade count of derivative financial instruments | 183 | |
Total off-balance sheet irrevocable loan commitments | $ 0 | |
LIBOR benchmark rate EUR | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 1 | |
Total carrying value of non-derivative financial liabilities | $ 5 | |
Trade count of derivative financial instruments | 3,744 | |
Total off-balance sheet irrevocable loan commitments | $ 0 | |
LIBOR benchmark rate JPY | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 0 | |
Total carrying value of non-derivative financial liabilities | $ 0 | |
Trade count of derivative financial instruments | 184 | |
Total off-balance sheet irrevocable loan commitments | $ 0 | |
UBS AG | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total off-balance sheet irrevocable loan commitments | 39,500 | $ 41,400 |
UBS AG | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
USD LIBOR securities-based lending | 37,000 | |
USD LIBOR brokerage accounts | 5,000 | |
Carrying value of loans related to revolving multi-currency credit lines where IBOR transition efforts are complete, except for USD LIBOR | $ 1,000 | |
Trade count of derivative financial instruments, cross currency derivatives | 5,000 | |
Trade count of derivative financial instruments, cross currency derivatives which have a non-USD LIBOR leg, in addition to a USD LIBOR leg | 500 | |
Multicurrency loan commitments that have only USD LIBOR exposure remaining | $ 3,000 | |
Multicurrency loan commitments with non-USD LIBOR optionality | 2,000 | |
UBS AG | LIBOR benchmark rate CHF | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 21,616 | |
Total carrying value of non-derivative financial liabilities | $ 27 | |
Trade count of derivative financial instruments | 829 | |
Total off-balance sheet irrevocable loan commitments | $ 0 | |
UBS AG | LIBOR benchmark rate USD | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 65,234 | |
Total carrying value of non-derivative financial liabilities | $ 1,985 | |
Trade count of derivative financial instruments | 40,500 | |
Total off-balance sheet irrevocable loan commitments | $ 11,863 | |
UBS AG | LIBOR benchmark rate GBP | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 45 | |
Total carrying value of non-derivative financial liabilities | $ 3 | |
Trade count of derivative financial instruments | 183 | |
Total off-balance sheet irrevocable loan commitments | $ 0 | |
UBS AG | LIBOR benchmark rate EUR | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 1 | |
Total carrying value of non-derivative financial liabilities | $ 5 | |
Trade count of derivative financial instruments | 3,744 | |
Total off-balance sheet irrevocable loan commitments | $ 0 | |
UBS AG | LIBOR benchmark rate JPY | Interest rate benchmark reform | ||
Maximum Exposure Of Financial Instruments To Interest Rate Benchmark Reform [Table] | ||
Total carrying value of non-derivative financial assets | 0 | |
Total carrying value of non-derivative financial liabilities | $ 0 | |
Trade count of derivative financial instruments | 184 | |
Total off-balance sheet irrevocable loan commitments | $ 0 |
Hedge accounting (Detail 1)
Hedge accounting (Detail 1) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Fair value hedges | Interest rate risk | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Notional amount | $ 89,525 | $ 80,759 |
Derivative financial assets | 0 | |
Derivative financial liabilities | 7 | 12 |
Changes in fair value of hedging instruments | (1,604) | 1,231 |
Changes in fair value of hedged items | 1,602 | (1,247) |
Hedge ineffectiveness recognized the income statement | (2) | (16) |
Fair value hedges | Foreign exchange risk | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Notional amount | 27,875 | 21,555 |
Derivative financial assets | 87 | 449 |
Derivative financial liabilities | 261 | 7 |
Changes in fair value of hedging instruments | (2,139) | (1,735) |
Changes in fair value of hedged items | 2,181 | 1,715 |
Hedge ineffectiveness recognized the income statement | 42 | (20) |
Cash flow hedges | Interest rate risk | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Notional amount | 79,573 | 72,732 |
Derivative financial assets | 12 | 18 |
Derivative financial liabilities | 1,000 | |
Changes in fair value of hedging instruments | (1,185) | 2,213 |
Changes in fair value of hedged items | 990 | (2,012) |
Hedge ineffectiveness recognized the income statement | (196) | 201 |
Hedges of net investments in foreign operations | Foreign exchange risk | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Notional amount | 13,939 | 13,775 |
Derivative financial assets | 23 | 3 |
Derivative financial liabilities | 105 | 194 |
Changes in fair value of hedging instruments | 497 | (937) |
Changes in fair value of hedged items | (497) | 936 |
Hedge ineffectiveness recognized the income statement | 0 | (2) |
UBS AG | Fair value hedges | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Derivative financial assets | 0 | 1 |
Derivative financial liabilities | 0 | (12) |
UBS AG | Fair value hedges | Interest rate risk | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Notional amount | 89,525 | 80,759 |
Derivative financial assets | 0 | |
Derivative financial liabilities | 7 | 12 |
Changes in fair value of hedging instruments | (1,604) | 1,231 |
Changes in fair value of hedged items | 1,602 | (1,247) |
Hedge ineffectiveness recognized the income statement | (2) | (16) |
UBS AG | Fair value hedges | Foreign exchange risk | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Notional amount | 27,875 | 21,555 |
Derivative financial assets | 87 | 449 |
Derivative financial liabilities | 261 | 7 |
Changes in fair value of hedging instruments | (2,139) | (1,735) |
Changes in fair value of hedged items | 2,181 | 1,715 |
Hedge ineffectiveness recognized the income statement | 42 | (20) |
UBS AG | Cash flow hedges | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Derivative financial assets | 0 | 0 |
Derivative financial liabilities | 0 | 0 |
UBS AG | Cash flow hedges | Interest rate risk | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Notional amount | 79,573 | 72,732 |
Derivative financial assets | 12 | 18 |
Derivative financial liabilities | 1 | |
Changes in fair value of hedging instruments | (1,185) | 2,213 |
Changes in fair value of hedged items | 990 | (2,012) |
Hedge ineffectiveness recognized the income statement | (196) | 201 |
UBS AG | Hedges of net investments in foreign operations | Foreign exchange risk | ||
Disclosure Of Fair Value Hedge Accounting [Table] | ||
Notional amount | 13,761 | 13,634 |
Derivative financial assets | 23 | 3 |
Derivative financial liabilities | 103 | 193 |
Changes in fair value of hedging instruments | 492 | (939) |
Changes in fair value of hedged items | (491) | 938 |
Hedge ineffectiveness recognized the income statement | $ 0 | $ (2) |
Hedge accounting (Detail 2)
Hedge accounting (Detail 2) ฿ in Millions, $ in Millions | Dec. 31, 2021USD ($) | Dec. 31, 2020THB (฿) | Dec. 31, 2020USD ($) |
Interest rate risk | |||
Hedged items: Debt issued measured at amortized cost | |||
Carrying amount of designated debt | $ 74,700 | $ 70,429 | |
of which: accumulated amount of fair value hedge adjustment | 478 | 2,401 | |
Hedged items: Other financial assets measured at amortized cost - debt securities | |||
Carrying amount of designated debt securities | 2,677 | 3,242 | |
of which: accumulated amount of fair value hedge adjustment | (7) | (38) | |
Hedged Items: Loans and advances to customers | |||
Carrying amount of designated loans | 13,835 | 10,374 | |
of which: accumulated amount of fair value hedge adjustment | (109) | 100 | |
of which: accumulated amount of fair value hedge adjustment, subject to amortization attributable to the portion of the portfolio that ceased to be part of hedge accounting | 3 | 111 | |
Foreign exchange risk | |||
Hedged items: Debt issued measured at amortized cost | |||
Carrying amount of designated debt | 27,875 | 21,555 | |
UBS AG | Interest rate risk | |||
Hedged items: Debt issued measured at amortized cost | |||
Carrying amount of designated debt | 21,653 | 24,247 | |
of which: accumulated amount of fair value hedge adjustment | 261 | 761 | |
Hedged items: Other financial assets measured at amortized cost - debt securities | |||
Carrying amount of designated debt securities | 2,677 | ฿ 3,242 | |
of which: accumulated amount of fair value hedge adjustment | (7) | ฿ (38) | |
Hedged Items: Loans and advances to customers | |||
Carrying amount of designated loans | 13,835 | 10,374 | |
of which: accumulated amount of fair value hedge adjustment | (109) | 100 | |
of which: accumulated amount of fair value hedge adjustment, subject to amortization attributable to the portion of the portfolio that ceased to be part of hedge accounting | 3 | 111 | |
Hedged items: funding from UBS Group AG and its subsidiaries | |||
Carrying amount | 53,047 | 46,182 | |
of which: accumulated amount of fair value hedge adjustment | 218 | 1,640 | |
UBS AG | Foreign exchange risk | |||
Hedged items: Debt issued measured at amortized cost | |||
Carrying amount of designated debt | 11,392 | 10,889 | |
Hedged items: funding from UBS Group AG and its subsidiaries | |||
Carrying amount | $ 16,483 | $ 10,666 |
Hedge accounting (Detail 3)
Hedge accounting (Detail 3) - USD ($) $ in Billions | Dec. 31, 2021 | Dec. 31, 2020 |
Interest rate swaps | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | $ 90 | $ 70 |
Interest rate swaps | Due within 1 month | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 0 | 0 |
Interest rate swaps | Due between 1 and 3 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 8 | 4 |
Interest rate swaps | Due between 3 and 12 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 10 | 9 |
Interest rate swaps | Due between 1 and 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 49 | 46 |
Interest rate swaps | Due after 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 22 | 12 |
Cross-currency swaps | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 28 | 22 |
Cross-currency swaps | Due within 1 month | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 1 | 0 |
Cross-currency swaps | Due between 1 and 3 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 1 | 0 |
Cross-currency swaps | Due between 3 and 12 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 6 | 4 |
Cross-currency swaps | Due between 1 and 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 13 | 16 |
Cross-currency swaps | Due after 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 6 | 2 |
UBS AG | Interest rate swaps | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 90 | 70 |
UBS AG | Interest rate swaps | Due within 1 month | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 0 | 0 |
UBS AG | Interest rate swaps | Due between 1 and 3 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 8 | 4 |
UBS AG | Interest rate swaps | Due between 3 and 12 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 10 | 9 |
UBS AG | Interest rate swaps | Due between 1 and 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 49 | 46 |
UBS AG | Interest rate swaps | Due after 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 22 | 12 |
UBS AG | Cross-currency swaps | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 28 | 22 |
UBS AG | Cross-currency swaps | Due within 1 month | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 1 | 0 |
UBS AG | Cross-currency swaps | Due between 1 and 3 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 1 | 0 |
UBS AG | Cross-currency swaps | Due between 3 and 12 months | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 6 | 4 |
UBS AG | Cross-currency swaps | Due between 1 and 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | 13 | 16 |
UBS AG | Cross-currency swaps | Due after 5 years | ||
Profile Of The Timing Of The Nominal Amount Of The Hedging Instrument [Table] | ||
Hedging instruments | $ 6 | $ 2 |
Hedge accounting (Detail 4)
Hedge accounting (Detail 4) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Cash flow hedge reserve amounts related to hedge relationships for which hedge accounting continues to be applied | $ 26 | $ 2,560 |
Cash flow hedge reserve amounts related to hedge relationships for which hedge accounting is no longer applied | 743 | 296 |
Total Other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis | 769 | 2,856 |
UBS AG | ||
Entity [Table] | ||
Cash flow hedge reserve amounts related to hedge relationships for which hedge accounting continues to be applied | 26 | 2,560 |
Cash flow hedge reserve amounts related to hedge relationships for which hedge accounting is no longer applied | 743 | 296 |
Total Other comprehensive income recognized directly in equity related to cash flow hedges, on a pre-tax basis | $ 769 | $ 2,856 |
Hedge accounting (Detail 5)
Hedge accounting (Detail 5) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Entity [Table] | ||
Foreign currency translation reserve amounts related to hedge relationships for which hedge accounting continues to be applied | $ (45) | $ (559) |
Foreign currency translation reserve amounts related to hedge relationships for which hedge accounting is no longer applied | 262 | 268 |
Total other comprehensive income recognized directly in equity related to hedging instruments in net investment hedges, on a pre-tax basis | 217 | (291) |
UBS AG | ||
Entity [Table] | ||
Foreign currency translation reserve amounts related to hedge relationships for which hedge accounting continues to be applied | (569) | |
Foreign currency translation reserve amounts related to hedge relationships for which hedge accounting is no longer applied | 268 | |
Total other comprehensive income recognized directly in equity related to hedging instruments in net investment hedges, on a pre-tax basis | $ 201 | $ (302) |
Hedge accounting (Detail 6)
Hedge accounting (Detail 6) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Fair value hedges | Interest rate risk | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Table] | ||
Derivative financial assets | $ 0 | |
Derivative financial liabilities | 7 | $ 12 |
Fair value hedges | Interest rate risk | Interest rate benchmark reform exceptions effect on cash flow hedges | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Table] | ||
Nominal amount | 23,367 | 37,146 |
Derivative financial assets | 0 | 1 |
Derivative financial liabilities | 0 | (12) |
Cash flow hedges | Interest rate risk | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Table] | ||
Derivative financial assets | 12 | 18 |
Derivative financial liabilities | 1,000 | |
Cash flow hedges | Interest rate risk | Interest rate benchmark reform exceptions effect on cash flow hedges | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Table] | ||
Nominal amount | 10,803 | 11,179 |
Derivative financial assets | 0 | 0 |
Derivative financial liabilities | 0 | 0 |
UBS AG | Fair value hedges | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Table] | ||
Nominal amount | 23,367 | 37,146 |
Derivative financial assets | 0 | 1 |
Derivative financial liabilities | 0 | (12) |
UBS AG | Fair value hedges | Interest rate risk | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Table] | ||
Derivative financial assets | 0 | |
Derivative financial liabilities | 7 | 12 |
UBS AG | Cash flow hedges | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Table] | ||
Nominal amount | 10,803 | 11,179 |
Derivative financial assets | 0 | 0 |
Derivative financial liabilities | 0 | 0 |
UBS AG | Cash flow hedges | Interest rate risk | ||
Nominal And Carrying Amount Of Cash Flow Hedges Of Forecast Transactions [Table] | ||
Derivative financial assets | 12 | $ 18 |
Derivative financial liabilities | $ 1 |
Post-employment benefit plans_2
Post-employment benefit plans (Narrative) (Detail) SFr in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021CHF (SFr)yr | Dec. 31, 2021USD ($)yr | Dec. 31, 2020USD ($) | |
Major plans | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Surplus / (deficit) | $ 6,358 | $ 4,304 | |
Swiss pension plan | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Normal retirement age | yr | 65 | 65 | |
Minimum age required to draw early retirement benefits | yr | 58 | 58 | |
Maximum retirement age starting 2019 | yr | 70 | 70 | |
Maximum period to restore full funding in case an underfunded situation occurs | 10 years | 10 years | |
Maximum obligation from the employer on the additional contributions required if a Swiss pension plan were to become significantly underfunded | 50.00% | 50.00% | |
Technical funding ratio | 134.80% | 134.80% | 132.60% |
Surplus / (deficit) | $ 6,577 | $ 4,862 | |
Additional employer contributions expected to be paid to employees retirement assets | SFr 720 | 790 | |
Additional employer contributions paid to employees retirement assets | 254 | 235 | |
Minimum commitment toward the pension fund under the related leases | 9 | 11 | |
Swiss pension plan | 2022 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Additional employer contributions paid to employees retirement assets | SFr 193 | 212 | |
Regular employer contributions expected for the next year | $ 491 | ||
Swiss pension plan | Maximum | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions on contributory base salary (as a percent) | 6.50% | 6.50% | |
Employer contributions on contributory variable compensation (as a percent) | 2.80% | 2.80% | |
Employee contributions on contributory base salary (as a percent) | 2.50% | 2.50% | |
Employee contributions on contributory variable compensation (as a percent) | 0.00% | 0.00% | |
Swiss pension plan | Minimum | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions on contributory base salary (as a percent) | 27.50% | 27.50% | |
Employer contributions on contributory variable compensation (as a percent) | 9.00% | 9.00% | |
Employee contributions on contributory base salary (as a percent) | 13.50% | 13.50% | |
Employee contributions on contributory variable compensation (as a percent) | 9.00% | 9.00% | |
UK pension plan | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Normal retirement age | yr | 60 | 60 | |
Surplus / (deficit) | $ 192 | (13) | |
Employer contributions | 46 | ||
Longevity swap value | (3) | ||
Collateral pool established for pension fund | 337 | 347 | |
UK pension plan | 2022 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions | 5 | ||
US and German pension plans | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Surplus / (deficit) | $ (411) | (545) | |
US Pension Plans [Member] | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Normal retirement age | yr | 65 | 65 | |
US Pension Plans [Member] | 2022 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions | $ 10 | ||
German pension plans | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Normal retirement age | yr | 65 | 65 | |
German pension plans | 2022 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions | $ 12 | ||
German pension plans - Larger | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 5.00% | 5.00% | |
German pension plans - Smaller | before 2010 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 6.00% | 6.00% | |
German pension plans - Smaller | 2010-2017 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 4.00% | 4.00% | |
German pension plans - Smaller | time after 2017 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 0.90% | 0.90% | |
German pension plans - New funded plan | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 0.00% | 0.00% | |
UBS AG | Major plans | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Surplus / (deficit) | $ 3,497 | $ 2,181 | |
UBS AG | Swiss pension plan | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Normal retirement age | yr | 65 | 65 | |
Minimum age required to draw early retirement benefits | yr | 58 | 58 | |
Maximum retirement age starting 2019 | yr | 70 | 70 | |
Maximum period to restore full funding in case an underfunded situation occurs | 10 years | 10 years | |
Maximum obligation from the employer on the additional contributions required if a Swiss pension plan were to become significantly underfunded | 50.00% | 50.00% | |
Technical funding ratio | 134.80% | 134.80% | 132.60% |
Surplus / (deficit) | $ 3,716 | $ 2,739 | |
Additional employer contributions expected to be paid to employees retirement assets | SFr 450 | 494 | |
Additional employer contributions paid to employees retirement assets | 152 | 143 | |
Minimum commitment toward the pension fund under the related leases | 5 | 6 | |
UBS AG | Swiss pension plan | 2022 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Additional employer contributions paid to employees retirement assets | SFr 116 | 127 | |
Regular employer contributions expected for the next year | $ 277 | ||
UBS AG | Swiss pension plan | Maximum | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions on contributory base salary (as a percent) | 6.50% | 6.50% | |
Employer contributions on contributory variable compensation (as a percent) | 2.80% | 2.80% | |
Employee contributions on contributory base salary (as a percent) | 2.50% | 2.50% | |
Employee contributions on contributory variable compensation (as a percent) | 0.00% | 0.00% | |
UBS AG | Swiss pension plan | Minimum | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions on contributory base salary (as a percent) | 27.50% | 27.50% | |
Employer contributions on contributory variable compensation (as a percent) | 9.00% | 9.00% | |
Employee contributions on contributory base salary (as a percent) | 13.50% | 13.50% | |
Employee contributions on contributory variable compensation (as a percent) | 9.00% | 9.00% | |
UBS AG | UK pension plan | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Normal retirement age | yr | 60 | 60 | |
Surplus / (deficit) | $ 192 | (13) | |
Employer contributions | 46 | ||
Longevity swap value | (3) | ||
Collateral pool established for pension fund | 337 | 347 | |
UBS AG | UK pension plan | 2022 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions | 5 | ||
UBS AG | US and German pension plans | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Surplus / (deficit) | $ (411) | $ (545) | |
UBS AG | US Pension Plans [Member] | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Normal retirement age | yr | 65 | 65 | |
UBS AG | US Pension Plans [Member] | 2022 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions | $ 10 | ||
UBS AG | German pension plans | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Normal retirement age | yr | 65 | 65 | |
UBS AG | German pension plans | 2022 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Employer contributions | $ 12 | ||
UBS AG | German pension plans - Larger | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 5.00% | 5.00% | |
UBS AG | German pension plans - Smaller | before 2010 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 6.00% | 6.00% | |
UBS AG | German pension plans - Smaller | 2010-2017 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 4.00% | 4.00% | |
UBS AG | German pension plans - Smaller | time after 2017 | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 0.90% | 0.90% | |
UBS AG | German pension plans - New funded plan | |||
Disclosure Of Defined Benefit Plans [Table] | |||
Interest rate | 0.00% | 0.00% |
Defined benefit plans (Detail 4
Defined benefit plans (Detail 4.1) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | $ (680) | |
At the end of the year | (331) | $ (680) |
Major plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (558) | |
Remeasurement of defined benefit obligation | (846) | (1,832) |
Past service cost related to plan amendments | (4) | (3) |
Return on plan assets excluding interest income | 2,639 | 2,324 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,821) | (814) |
At the end of the year | (219) | (558) |
Major plans | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 33,795 | 29,970 |
Current service cost | 500 | 453 |
Interest expense | 147 | 190 |
Plan participant contributions | 266 | 259 |
Remeasurement of defined benefit obligation | 846 | 1,832 |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 69 | (212) |
of which: actuarial (gains) / losses due to changes in financial assumptions | (759) | 1,621 |
of which: experience (gains) / losses | 1,535 | 423 |
Past service cost related to plan amendments | 4 | 3 |
Curtailments | (80) | 0 |
Benefit payments | (1,357) | (1,409) |
Other movements | 1 | (4) |
Foreign currency translation | (880) | 2,501 |
At the end of the year | 33,242 | 33,795 |
Major plans | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 38,100 | 33,176 |
Plan participant contributions | 266 | 259 |
Benefit payments | (1,357) | (1,409) |
Other movements | 1 | 0 |
Return on plan assets excluding interest income | 2,639 | 2,324 |
Interest income | 159 | 196 |
Employer contributions | 779 | 792 |
Administration expenses, taxes and premiums paid | (17) | (17) |
Foreign currency translation | (969) | 2,779 |
At the end of the year | 39,601 | 38,100 |
Major plans | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 4,862 | 3,724 |
Interest expense on asset ceiling effect | 15 | 12 |
Asset ceiling effect excluding interest expense and foreign currency translation | 1,821 | 814 |
Foreign currency translation | (121) | 313 |
At the end of the year | 6,577 | 4,862 |
Swiss pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 0 | |
Remeasurement of defined benefit obligation | (837) | (1,279) |
Past service cost related to plan amendments | 0 | 0 |
Return on plan assets excluding interest income | 2,322 | 1,818 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,821) | (814) |
At the end of the year | 0 | 0 |
Swiss pension plan | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 27,728 | 24,496 |
Current service cost | 494 | 447 |
Interest expense | 58 | 72 |
Plan participant contributions | 266 | 259 |
Remeasurement of defined benefit obligation | 837 | 1,279 |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 51 | (164) |
of which: actuarial (gains) / losses due to changes in financial assumptions | (678) | 983 |
of which: experience (gains) / losses | 1,464 | 460 |
Past service cost related to plan amendments | 0 | 0 |
Curtailments | (80) | 0 |
Benefit payments | (1,097) | (1,153) |
Other movements | 0 | (4) |
Foreign currency translation | (809) | 2,333 |
At the end of the year | 27,398 | 27,728 |
Swiss pension plan | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 32,590 | 28,219 |
Plan participant contributions | 266 | 259 |
Benefit payments | (1,097) | (1,153) |
Other movements | 0 | 0 |
Return on plan assets excluding interest income | 2,322 | 1,818 |
Interest income | 74 | 84 |
Employer contributions | 763 | 729 |
Administration expenses, taxes and premiums paid | (13) | (13) |
Foreign currency translation | (930) | 2,647 |
At the end of the year | 33,975 | 32,590 |
Swiss pension plan | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 4,862 | 3,724 |
Interest expense on asset ceiling effect | 15 | 12 |
Asset ceiling effect excluding interest expense and foreign currency translation | 1,821 | 814 |
Foreign currency translation | (121) | 313 |
At the end of the year | 6,577 | 4,862 |
UK pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (13) | |
Remeasurement of defined benefit obligation | (71) | (449) |
Past service cost related to plan amendments | 0 | (3) |
Return on plan assets excluding interest income | 277 | 388 |
Employer contributions | 46 | |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
At the end of the year | 192 | (13) |
UK pension plan | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 4,162 | 3,654 |
Current service cost | 0 | 0 |
Interest expense | 58 | 73 |
Plan participant contributions | 0 | 0 |
Remeasurement of defined benefit obligation | 71 | 449 |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 14 | (14) |
of which: actuarial (gains) / losses due to changes in financial assumptions | (3) | 505 |
of which: experience (gains) / losses | 59 | (42) |
Past service cost related to plan amendments | 0 | 3 |
Curtailments | 0 | 0 |
Benefit payments | (148) | (148) |
Other movements | 0 | 0 |
Foreign currency translation | (38) | 132 |
At the end of the year | 4,105 | 4,162 |
UK pension plan | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 4,149 | 3,658 |
Plan participant contributions | 0 | 0 |
Benefit payments | (148) | (148) |
Other movements | 0 | 0 |
Return on plan assets excluding interest income | 277 | 388 |
Interest income | 58 | 73 |
Employer contributions | 0 | 46 |
Administration expenses, taxes and premiums paid | 0 | 0 |
Foreign currency translation | (39) | 132 |
At the end of the year | 4,297 | 4,149 |
UK pension plan | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 0 | 0 |
Interest expense on asset ceiling effect | 0 | 0 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Foreign currency translation | 0 | 0 |
At the end of the year | 0 | 0 |
US and German pension plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (545) | |
Remeasurement of defined benefit obligation | 62 | (105) |
Past service cost related to plan amendments | (4) | 0 |
Return on plan assets excluding interest income | 40 | 118 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
At the end of the year | (411) | (545) |
US and German pension plans | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 1,905 | 1,820 |
Current service cost | 6 | 6 |
Interest expense | 30 | 45 |
Plan participant contributions | 0 | 0 |
Remeasurement of defined benefit obligation | (62) | 105 |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 4 | (34) |
of which: actuarial (gains) / losses due to changes in financial assumptions | (78) | 134 |
of which: experience (gains) / losses | 12 | 5 |
Past service cost related to plan amendments | 4 | 0 |
Curtailments | 0 | 0 |
Benefit payments | (112) | (108) |
Other movements | 1 | 0 |
Foreign currency translation | (33) | 37 |
At the end of the year | 1,740 | 1,905 |
US and German pension plans | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 1,360 | 1,299 |
Plan participant contributions | 0 | 0 |
Benefit payments | (112) | (108) |
Other movements | 1 | 0 |
Return on plan assets excluding interest income | 40 | 118 |
Interest income | 26 | 38 |
Employer contributions | 16 | 17 |
Administration expenses, taxes and premiums paid | (4) | (4) |
Foreign currency translation | 0 | 0 |
At the end of the year | 1,329 | 1,360 |
US and German pension plans | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 0 | 0 |
Interest expense on asset ceiling effect | 0 | 0 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Foreign currency translation | 0 | 0 |
At the end of the year | 0 | 0 |
Remaining plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (123) | |
At the end of the year | (112) | (123) |
UBS AG | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (670) | |
At the end of the year | (315) | (670) |
UBS AG | Major plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (558) | |
Remeasurement of defined benefit obligation | (498) | (1,231) |
Past service cost related to plan amendments | (4) | (3) |
Return on plan assets excluding interest income | 1,637 | 1,469 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,037) | (457) |
At the end of the year | (219) | (558) |
UBS AG | Major plans | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 21,686 | 19,283 |
Current service cost | 291 | 268 |
Interest expense | 122 | 159 |
Plan participant contributions | 161 | 159 |
Remeasurement of defined benefit obligation | 498 | 1,231 |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 45 | (101) |
of which: actuarial (gains) / losses due to changes in financial assumptions | (466) | 1,204 |
of which: experience (gains) / losses | 919 | 127 |
Past service cost related to plan amendments | 4 | 3 |
Curtailments | (49) | 0 |
Benefit payments | (862) | (898) |
Other movements | 1 | (4) |
Foreign currency translation | (527) | 1,486 |
At the end of the year | 21,324 | 21,686 |
UBS AG | Major plans | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 23,867 | 20,864 |
Plan participant contributions | 161 | 159 |
Benefit payments | (862) | (898) |
Other movements | 1 | 0 |
Return on plan assets excluding interest income | 1,637 | 1,469 |
Interest income | 127 | 159 |
Employer contributions | 466 | 499 |
Administration expenses, taxes and premiums paid | (11) | (11) |
Foreign currency translation | (563) | 1,626 |
At the end of the year | 24,821 | 23,867 |
UBS AG | Major plans | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 2,739 | 2,099 |
Interest expense on asset ceiling effect | 8 | 7 |
Asset ceiling effect excluding interest expense and foreign currency translation | 1,037 | 457 |
Foreign currency translation | (68) | 176 |
At the end of the year | 3,716 | 2,739 |
UBS AG | Swiss pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 0 | |
Remeasurement of defined benefit obligation | (490) | (677) |
Past service cost related to plan amendments | 0 | 0 |
Return on plan assets excluding interest income | 1,319 | 962 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,037) | (457) |
At the end of the year | 0 | 0 |
UBS AG | Swiss pension plan | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 15,619 | 13,809 |
Current service cost | 285 | 262 |
Interest expense | 33 | 40 |
Plan participant contributions | 161 | 159 |
Remeasurement of defined benefit obligation | 490 | 677 |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 26 | (53) |
of which: actuarial (gains) / losses due to changes in financial assumptions | (385) | 565 |
of which: experience (gains) / losses | 848 | 165 |
Past service cost related to plan amendments | 0 | 0 |
Curtailments | (49) | 0 |
Benefit payments | (602) | (641) |
Other movements | 0 | (4) |
Foreign currency translation | (456) | 1,317 |
At the end of the year | 15,480 | 15,619 |
UBS AG | Swiss pension plan | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 18,358 | 15,908 |
Plan participant contributions | 161 | 159 |
Benefit payments | (602) | (641) |
Other movements | 0 | 0 |
Return on plan assets excluding interest income | 1,319 | 962 |
Interest income | 42 | 48 |
Employer contributions | 450 | 436 |
Administration expenses, taxes and premiums paid | (8) | (8) |
Foreign currency translation | (524) | 1,495 |
At the end of the year | 19,196 | 18,358 |
UBS AG | Swiss pension plan | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 2,739 | 2,099 |
Interest expense on asset ceiling effect | 8 | 7 |
Asset ceiling effect excluding interest expense and foreign currency translation | 1,037 | 457 |
Foreign currency translation | (68) | 176 |
At the end of the year | 3,716 | 2,739 |
UBS AG | UK pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (13) | |
Remeasurement of defined benefit obligation | (71) | (449) |
Past service cost related to plan amendments | 0 | (3) |
Return on plan assets excluding interest income | 277 | 388 |
Employer contributions | 46 | |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
At the end of the year | 192 | (13) |
UBS AG | UK pension plan | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 4,162 | 3,654 |
Current service cost | 0 | 0 |
Interest expense | 58 | 73 |
Plan participant contributions | 0 | 0 |
Remeasurement of defined benefit obligation | 71 | 449 |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 14 | (14) |
of which: actuarial (gains) / losses due to changes in financial assumptions | (3) | 505 |
of which: experience (gains) / losses | 59 | (42) |
Past service cost related to plan amendments | 0 | 3 |
Curtailments | 0 | 0 |
Benefit payments | (148) | (148) |
Other movements | 0 | 0 |
Foreign currency translation | (38) | 132 |
At the end of the year | 4,105 | 4,162 |
UBS AG | UK pension plan | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 4,149 | 3,658 |
Plan participant contributions | 0 | 0 |
Benefit payments | (148) | (148) |
Other movements | 0 | 0 |
Return on plan assets excluding interest income | 277 | 388 |
Interest income | 58 | 73 |
Employer contributions | 0 | 46 |
Administration expenses, taxes and premiums paid | 0 | 0 |
Foreign currency translation | (39) | 132 |
At the end of the year | 4,297 | 4,149 |
UBS AG | UK pension plan | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 0 | 0 |
Interest expense on asset ceiling effect | 0 | 0 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Foreign currency translation | 0 | 0 |
At the end of the year | 0 | 0 |
UBS AG | US and German pension plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (545) | |
Remeasurement of defined benefit obligation | 62 | (105) |
Past service cost related to plan amendments | (4) | 0 |
Return on plan assets excluding interest income | 40 | 118 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
At the end of the year | (411) | (545) |
UBS AG | US and German pension plans | Defined benefit obligation | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 1,905 | 1,820 |
Current service cost | 6 | 6 |
Interest expense | 30 | 45 |
Plan participant contributions | 0 | 0 |
Remeasurement of defined benefit obligation | (62) | 105 |
of which: actuarial (gains) / losses due to changes in demographic assumptions | 4 | (34) |
of which: actuarial (gains) / losses due to changes in financial assumptions | (78) | 134 |
of which: experience (gains) / losses | 12 | 5 |
Past service cost related to plan amendments | 4 | 0 |
Curtailments | 0 | 0 |
Benefit payments | (112) | (108) |
Other movements | 1 | 0 |
Foreign currency translation | (33) | 37 |
At the end of the year | 1,740 | 1,905 |
UBS AG | US and German pension plans | Fair value of plan assets | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 1,360 | 1,299 |
Plan participant contributions | 0 | 0 |
Benefit payments | (112) | (108) |
Other movements | 1 | 0 |
Return on plan assets excluding interest income | 40 | 118 |
Interest income | 26 | 38 |
Employer contributions | 16 | 17 |
Administration expenses, taxes and premiums paid | (4) | (4) |
Foreign currency translation | 0 | 0 |
At the end of the year | 1,329 | 1,360 |
UBS AG | US and German pension plans | Asset ceiling effect | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | 0 | 0 |
Interest expense on asset ceiling effect | 0 | 0 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Foreign currency translation | 0 | 0 |
At the end of the year | 0 | 0 |
UBS AG | Remaining plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
At the beginning of the year | (112) | |
At the end of the year | $ (96) | $ (112) |
Defined benefit plans (Detail_2
Defined benefit plans (Detail 4.2) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: net defined benefit asset | $ 302 | $ 42 |
of which: net defined benefit liability | (633) | (722) |
Major plans | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: amounts owed to active members | 14,705 | 14,169 |
of which: amounts owed to deferred members | 2,262 | 2,622 |
of which: amounts owed to retirees | 16,276 | 17,004 |
Swiss pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: amounts owed to active members | 14,333 | 13,765 |
of which: amounts owed to deferred members | 0 | 0 |
of which: amounts owed to retirees | 13,065 | 13,963 |
UK pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: amounts owed to active members | 150 | 159 |
of which: amounts owed to deferred members | 1,593 | 1,879 |
of which: amounts owed to retirees | 2,362 | 2,124 |
US and German pension plans | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: amounts owed to active members | 222 | 245 |
of which: amounts owed to deferred members | 669 | 743 |
of which: amounts owed to retirees | 849 | 917 |
UBS AG | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: net defined benefit asset | 302 | 42 |
of which: net defined benefit liability | (617) | (711) |
UBS AG | Major plans | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: amounts owed to active members | 8,976 | 8,694 |
of which: amounts owed to deferred members | 2,262 | 2,622 |
of which: amounts owed to retirees | 10,086 | 10,370 |
UBS AG | Swiss pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: amounts owed to active members | 8,604 | 8,290 |
of which: amounts owed to deferred members | 0 | 0 |
of which: amounts owed to retirees | 6,876 | 7,329 |
UBS AG | UK pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: amounts owed to active members | 150 | 159 |
of which: amounts owed to deferred members | 1,593 | 1,879 |
of which: amounts owed to retirees | 2,362 | 2,124 |
UBS AG | US and German pension plans | ||
Disclosure Of Net Defined Benefit Liability Asset On Balance Sheet [Table] | ||
of which: amounts owed to active members | 222 | 245 |
of which: amounts owed to deferred members | 669 | 743 |
of which: amounts owed to retirees | $ 849 | $ 917 |
Defined benefit plans (Detail_3
Defined benefit plans (Detail 4.3) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Net defined benefit asset / (liability) | $ (331) | $ (680) |
Total | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Defined benefit obligation from funded plans | 32,724 | 33,209 |
Defined benefit obligation from unfunded plans | 518 | 586 |
Surplus / (deficit) | 6,358 | 4,304 |
Net defined benefit asset / (liability) | (219) | (558) |
Swiss pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Defined benefit obligation from funded plans | 27,398 | 27,728 |
Defined benefit obligation from unfunded plans | 0 | 0 |
Plan assets | 33,975 | 32,590 |
Surplus / (deficit) | 6,577 | 4,862 |
Net defined benefit asset / (liability) | 0 | 0 |
UK pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Defined benefit obligation from funded plans | 4,105 | 4,162 |
Defined benefit obligation from unfunded plans | 0 | 0 |
Plan assets | 4,297 | 4,149 |
Surplus / (deficit) | 192 | (13) |
Net defined benefit asset / (liability) | 192 | (13) |
US and German pension plans | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Defined benefit obligation from funded plans | 1,222 | 1,319 |
Defined benefit obligation from unfunded plans | 518 | 586 |
Plan assets | 1,329 | 1,360 |
Surplus / (deficit) | (411) | (545) |
Net defined benefit asset / (liability) | (411) | (545) |
UBS AG | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Net defined benefit asset / (liability) | (315) | (670) |
UBS AG | Total | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Defined benefit obligation from funded plans | 20,806 | 21,100 |
Defined benefit obligation from unfunded plans | 518 | 586 |
Surplus / (deficit) | 3,497 | 2,181 |
Net defined benefit asset / (liability) | (219) | (558) |
UBS AG | Swiss pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Defined benefit obligation from funded plans | 15,480 | 15,619 |
Defined benefit obligation from unfunded plans | 0 | 0 |
Plan assets | 19,196 | 18,358 |
Surplus / (deficit) | 3,716 | 2,739 |
Net defined benefit asset / (liability) | 0 | 0 |
UBS AG | UK pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Defined benefit obligation from funded plans | 4,105 | 4,162 |
Defined benefit obligation from unfunded plans | 0 | 0 |
Plan assets | 4,297 | 4,149 |
Surplus / (deficit) | 192 | (13) |
Net defined benefit asset / (liability) | 192 | (13) |
UBS AG | US and German pension plans | ||
Disclosure Of Net Defined Benefit Liability Asset By Funded And Unfunded [Table] | ||
Defined benefit obligation from funded plans | 1,222 | 1,319 |
Defined benefit obligation from unfunded plans | 518 | 586 |
Plan assets | 1,329 | 1,360 |
Surplus / (deficit) | (411) | (545) |
Net defined benefit asset / (liability) | $ (411) | $ (545) |
Defined benefit plans (Detail 5
Defined benefit plans (Detail 5.1) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Curtailments | $ (80) | ||
Net periodic expenses recognized in net profit | 470 | $ 502 | $ 461 |
Major plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Current service cost | 500 | 453 | |
Interest expense related to defined benefit obligation | 147 | 190 | |
Interest income related to plan assets | (159) | (196) | |
Interest expense on asset ceiling effect | 15 | 12 | |
Administration expenses, taxes and premiums paid | 17 | 17 | |
Past service cost related to plan amendments | 4 | 3 | |
Curtailments | (80) | 0 | |
Net periodic expenses recognized in net profit | 444 | 479 | |
Swiss pension plan | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Current service cost | 494 | 447 | |
Interest expense related to defined benefit obligation | 58 | 72 | |
Interest income related to plan assets | (74) | (84) | |
Interest expense on asset ceiling effect | 15 | 12 | |
Administration expenses, taxes and premiums paid | 13 | 13 | |
Past service cost related to plan amendments | 0 | 0 | |
Curtailments | (80) | 0 | |
Net periodic expenses recognized in net profit | 426 | 459 | |
UK pension plan | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Current service cost | 0 | 0 | |
Interest expense related to defined benefit obligation | 58 | 73 | |
Interest income related to plan assets | (58) | (73) | |
Interest expense on asset ceiling effect | 0 | 0 | |
Administration expenses, taxes and premiums paid | 0 | 0 | |
Past service cost related to plan amendments | 0 | 3 | |
Curtailments | 0 | 0 | |
Net periodic expenses recognized in net profit | 0 | 3 | |
US and German pension plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Current service cost | 6 | 6 | |
Interest expense related to defined benefit obligation | 30 | 45 | |
Interest income related to plan assets | (26) | (38) | |
Interest expense on asset ceiling effect | 0 | 0 | |
Administration expenses, taxes and premiums paid | 4 | 4 | |
Past service cost related to plan amendments | 4 | 0 | |
Curtailments | 0 | 0 | |
Net periodic expenses recognized in net profit | 18 | 18 | |
Remaining plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Net periodic expenses recognized in net profit | 25 | 23 | |
UBS AG | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Curtailments | (49) | ||
Net periodic expenses recognized in net profit | 280 | 306 | |
UBS AG | Major plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Current service cost | 291 | 268 | |
Interest expense related to defined benefit obligation | 122 | 159 | |
Interest income related to plan assets | (127) | (159) | |
Interest expense on asset ceiling effect | 8 | 7 | |
Administration expenses, taxes and premiums paid | 11 | 11 | |
Past service cost related to plan amendments | 4 | 3 | |
Curtailments | (49) | 0 | |
Net periodic expenses recognized in net profit | 261 | 289 | |
UBS AG | Swiss pension plan | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Current service cost | 285 | 262 | |
Interest expense related to defined benefit obligation | 33 | 40 | |
Interest income related to plan assets | (42) | (48) | |
Interest expense on asset ceiling effect | 8 | 7 | |
Administration expenses, taxes and premiums paid | 8 | 8 | |
Past service cost related to plan amendments | 0 | 0 | |
Curtailments | (49) | 0 | |
Net periodic expenses recognized in net profit | 243 | 269 | |
UBS AG | UK pension plan | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Current service cost | 0 | 0 | |
Interest expense related to defined benefit obligation | 58 | 73 | |
Interest income related to plan assets | (58) | (73) | |
Interest expense on asset ceiling effect | 0 | 0 | |
Administration expenses, taxes and premiums paid | 0 | 0 | |
Past service cost related to plan amendments | 0 | 3 | |
Curtailments | 0 | 0 | |
Net periodic expenses recognized in net profit | 0 | 3 | |
UBS AG | US and German pension plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Current service cost | 6 | 6 | |
Interest expense related to defined benefit obligation | 30 | 45 | |
Interest income related to plan assets | (26) | (38) | |
Interest expense on asset ceiling effect | 0 | 0 | |
Administration expenses, taxes and premiums paid | 4 | 4 | |
Past service cost related to plan amendments | 4 | 0 | |
Curtailments | 0 | 0 | |
Net periodic expenses recognized in net profit | 18 | 18 | |
UBS AG | Remaining plans | |||
Post-employment Benefit Expense Defined Benefit Pension Plans [Table] | |||
Net periodic expenses recognized in net profit | $ 19 | $ 17 |
Defined benefit plans (Detail_4
Defined benefit plans (Detail 5.2) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Total gains / (losses) recognized in other comprehensive income, before tax | $ 2 | $ (327) |
Major plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (846) | (1,832) |
Return on plan assets excluding interest income | 2,639 | 2,324 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,821) | (814) |
Total gains / (losses) recognized in other comprehensive income, before tax | (27) | (323) |
Major plans | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 1,267 | (1,421) |
Major plans | of which: change in rate of salary increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (3) | (230) |
Major plans | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (318) | 0 |
Major plans | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (194) | 50 |
Major plans | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 5 | 333 |
Major plans | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (68) | (142) |
Major plans | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (1,535) | (423) |
Swiss pension plan | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (837) | (1,279) |
Return on plan assets excluding interest income | 2,322 | 1,818 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,821) | (814) |
Total gains / (losses) recognized in other comprehensive income, before tax | (336) | (276) |
Swiss pension plan | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 870 | (777) |
Swiss pension plan | of which: change in rate of salary increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (3) | (230) |
Swiss pension plan | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
Swiss pension plan | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (193) | 26 |
Swiss pension plan | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 261 |
Swiss pension plan | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (47) | (99) |
Swiss pension plan | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (1,464) | (460) |
UK pension plan | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (71) | (449) |
Return on plan assets excluding interest income | 277 | 388 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Total gains / (losses) recognized in other comprehensive income, before tax | 207 | (61) |
UK pension plan | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 319 | (504) |
UK pension plan | of which: change in rate of salary increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
UK pension plan | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (316) | (1) |
UK pension plan | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
UK pension plan | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 9 | 22 |
UK pension plan | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (23) | (8) |
UK pension plan | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (59) | 42 |
US and German pension plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 62 | (105) |
Return on plan assets excluding interest income | 40 | 118 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Total gains / (losses) recognized in other comprehensive income, before tax | 103 | 14 |
US and German pension plans | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 77 | (141) |
US and German pension plans | of which: change in rate of salary increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
US and German pension plans | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (1) | 1 |
US and German pension plans | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (1) | 24 |
US and German pension plans | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (3) | 50 |
US and German pension plans | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 2 | (34) |
US and German pension plans | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (12) | (5) |
Remaining plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Total gains / (losses) recognized in other comprehensive income, before tax | 30 | (4) |
UBS AG | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Total gains / (losses) recognized in other comprehensive income, before tax | 133 | (222) |
UBS AG | Major plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (498) | (1,231) |
Return on plan assets excluding interest income | 1,637 | 1,469 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,037) | (457) |
Total gains / (losses) recognized in other comprehensive income, before tax | 102 | (219) |
UBS AG | Major plans | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 890 | (1,092) |
UBS AG | Major plans | of which: change in rate of salary increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (2) | (132) |
UBS AG | Major plans | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (317) | 0 |
UBS AG | Major plans | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (110) | 39 |
UBS AG | Major plans | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 5 | 156 |
UBS AG | Major plans | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (45) | (75) |
UBS AG | Major plans | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (919) | (127) |
UBS AG | Swiss pension plan | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (490) | (677) |
Return on plan assets excluding interest income | 1,319 | 962 |
Asset ceiling effect excluding interest expense and foreign currency translation | (1,037) | (457) |
Total gains / (losses) recognized in other comprehensive income, before tax | (207) | (172) |
UBS AG | Swiss pension plan | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 494 | (447) |
UBS AG | Swiss pension plan | of which: change in rate of salary increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (2) | (132) |
UBS AG | Swiss pension plan | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
UBS AG | Swiss pension plan | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (110) | 15 |
UBS AG | Swiss pension plan | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 84 |
UBS AG | Swiss pension plan | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (24) | (33) |
UBS AG | Swiss pension plan | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (848) | (165) |
UBS AG | UK pension plan | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (71) | (449) |
Return on plan assets excluding interest income | 277 | 388 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Total gains / (losses) recognized in other comprehensive income, before tax | 207 | (61) |
UBS AG | UK pension plan | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 319 | (504) |
UBS AG | UK pension plan | of which: change in rate of salary increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
UBS AG | UK pension plan | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (316) | (1) |
UBS AG | UK pension plan | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
UBS AG | UK pension plan | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 9 | 22 |
UBS AG | UK pension plan | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (23) | (8) |
UBS AG | UK pension plan | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (59) | 42 |
UBS AG | US and German pension plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 62 | (105) |
Return on plan assets excluding interest income | 40 | 118 |
Asset ceiling effect excluding interest expense and foreign currency translation | 0 | 0 |
Total gains / (losses) recognized in other comprehensive income, before tax | 103 | 14 |
UBS AG | US and German pension plans | of which: change in discount rate assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 77 | (141) |
UBS AG | US and German pension plans | of which: change in rate of salary increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 0 | 0 |
UBS AG | US and German pension plans | of which: change in rate of pension increase assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (1) | 1 |
UBS AG | US and German pension plans | of which: change in rate of interest credit on retirement savings assumption | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (1) | 24 |
UBS AG | US and German pension plans | of which: change in life expectancy | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (3) | 50 |
UBS AG | US and German pension plans | of which: change in other actuarial assumptions | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | 2 | (34) |
UBS AG | US and German pension plans | of which: experience gains / (losses) | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Remeasurement of defined benefit obligation | (12) | (5) |
UBS AG | Remaining plans | ||
Other Comprehensive Income Before Tax Gains Losses On Remeasurements Of Defined Benefit Pension Plans [Table] | ||
Total gains / (losses) recognized in other comprehensive income, before tax | $ 31 | $ (3) |
Defined benefit plans (Detail 6
Defined benefit plans (Detail 6) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Swiss pension plan | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Duration of the defined benefit obligation | 15 years 1 month 6 days | 15 years 8 months 12 days |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 1,312 | $ 1,293 |
Benefits expected to be paid between 1 and 3 years | 2,636 | 2,630 |
Benefits expected to be paid between 3 and 6 years | 3,824 | 3,839 |
Benefits expected to be paid between 6 and 11 years | 6,220 | 6,166 |
Benefits expected to be paid between 11 and 16 years | 5,572 | 5,646 |
Benefits expected to be paid in more than 16 years | $ 18,092 | $ 18,884 |
UK pension plan | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Duration of the defined benefit obligation | 18 years 9 months 18 days | 19 years |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 110 | $ 114 |
Benefits expected to be paid between 1 and 3 years | 248 | 232 |
Benefits expected to be paid between 3 and 6 years | 418 | 406 |
Benefits expected to be paid between 6 and 11 years | 743 | 744 |
Benefits expected to be paid between 11 and 16 years | 751 | 758 |
Benefits expected to be paid in more than 16 years | $ 3,028 | $ 3,206 |
US and German pension plans | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Duration of the defined benefit obligation | 9 years 6 months | 10 years 2 months 12 days |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 123 | $ 122 |
Benefits expected to be paid between 1 and 3 years | 237 | 235 |
Benefits expected to be paid between 3 and 6 years | 338 | 346 |
Benefits expected to be paid between 6 and 11 years | 495 | 532 |
Benefits expected to be paid between 11 and 16 years | 392 | 413 |
Benefits expected to be paid in more than 16 years | $ 519 | $ 541 |
UBS AG | Swiss pension plan | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Duration of the defined benefit obligation | 15 years 6 months | 16 years 2 months 12 days |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 719 | $ 710 |
Benefits expected to be paid between 1 and 3 years | 1,440 | 1,442 |
Benefits expected to be paid between 3 and 6 years | 2,097 | 2,100 |
Benefits expected to be paid between 6 and 11 years | 3,467 | 3,408 |
Benefits expected to be paid between 11 and 16 years | 3,156 | 3,184 |
Benefits expected to be paid in more than 16 years | $ 10,733 | $ 11,186 |
UBS AG | UK pension plan | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Duration of the defined benefit obligation | 18 years 9 months 18 days | 19 years |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 110 | $ 114 |
Benefits expected to be paid between 1 and 3 years | 248 | 232 |
Benefits expected to be paid between 3 and 6 years | 418 | 406 |
Benefits expected to be paid between 6 and 11 years | 743 | 744 |
Benefits expected to be paid between 11 and 16 years | 751 | 758 |
Benefits expected to be paid in more than 16 years | $ 3,028 | $ 3,206 |
UBS AG | US and German pension plans | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Duration of the defined benefit obligation | 9 years 6 months | 10 years 2 months 12 days |
Maturity analysis of benefits expected to be paid | ||
Benefits expected to be paid within 12 months | $ 123 | $ 122 |
Benefits expected to be paid between 1 and 3 years | 237 | 235 |
Benefits expected to be paid between 3 and 6 years | 338 | 346 |
Benefits expected to be paid between 6 and 11 years | 495 | 532 |
Benefits expected to be paid between 11 and 16 years | 392 | 413 |
Benefits expected to be paid in more than 16 years | $ 519 | $ 541 |
Defined benefit plans (Detail 7
Defined benefit plans (Detail 7) | Dec. 31, 2021 | Dec. 31, 2020 |
Swiss pension plan | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Discount rate | 0.34% | 0.10% |
Rate of salary increase | 2.01% | 2.00% |
Rate of pension increase | 0.00% | 0.00% |
Rate of interest credit on retirement savings | 1.04% | 0.60% |
UK pension plan | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Discount rate | 1.82% | 1.42% |
Rate of salary increase | 0.00% | 0.00% |
Rate of pension increase | 3.32% | 2.89% |
Rate of interest credit on retirement savings | 0.00% | 0.00% |
US and German pension plans | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Discount rate | 2.10% | 1.62% |
Rate of salary increase | 2.35% | 2.25% |
Rate of pension increase | 1.80% | 1.70% |
Rate of interest credit on retirement savings | 1.18% | 1.12% |
UBS AG | Swiss pension plan | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Discount rate | 0.34% | 0.10% |
Rate of salary increase | 2.01% | 2.00% |
Rate of pension increase | 0.00% | 0.00% |
Rate of interest credit on retirement savings | 1.04% | 0.60% |
UBS AG | UK pension plan | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Discount rate | 1.82% | 1.42% |
Rate of salary increase | 0.00% | 0.00% |
Rate of pension increase | 3.32% | 2.89% |
Rate of interest credit on retirement savings | 0.00% | 0.00% |
UBS AG | US and German pension plans | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Discount rate | 2.10% | 1.62% |
Rate of salary increase | 2.35% | 2.25% |
Rate of pension increase | 1.80% | 1.70% |
Rate of interest credit on retirement savings | 1.18% | 1.12% |
Defined benefit plans (Detail 8
Defined benefit plans (Detail 8) - yr | Dec. 31, 2021 | Dec. 31, 2020 |
Switzerland | aged 65 | Mortality table Switzerland | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 21.7 | 21.7 |
Life expectancy at age 65 for a female member currently | 23.4 | 23.4 |
Switzerland | aged 45 | Mortality table Switzerland | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 23.3 | 23.2 |
Life expectancy at age 65 for a female member currently | 25 | 24.9 |
UK | aged 65 | Mortality table UK | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 23.4 | 23.4 |
Life expectancy at age 65 for a female member currently | 24.9 | 24.9 |
UK | aged 45 | Mortality table UK | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 24.5 | 24.6 |
Life expectancy at age 65 for a female member currently | 26.3 | 26.3 |
United States | aged 65 | Mortality table USA | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 21.9 | 21.8 |
Life expectancy at age 65 for a female member currently | 23.3 | 23.2 |
United States | aged 45 | Mortality table USA | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 23.3 | 23.2 |
Life expectancy at age 65 for a female member currently | 24.7 | 24.5 |
Germany | aged 65 | Mortality table Germany | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 20.5 | 20.8 |
Life expectancy at age 65 for a female member currently | 23.9 | 24.3 |
Germany | aged 45 | Mortality table Germany | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 23.2 | 23.6 |
Life expectancy at age 65 for a female member currently | 26.1 | 26.5 |
UBS AG | Switzerland | aged 65 | Mortality table Switzerland | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 21.7 | 21.7 |
Life expectancy at age 65 for a female member currently | 23.4 | 23.4 |
UBS AG | Switzerland | aged 45 | Mortality table Switzerland | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 23.3 | 23.2 |
Life expectancy at age 65 for a female member currently | 25 | 24.9 |
UBS AG | UK | aged 65 | Mortality table UK | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 23.4 | 23.4 |
Life expectancy at age 65 for a female member currently | 24.9 | 24.9 |
UBS AG | UK | aged 45 | Mortality table UK | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 24.5 | 24.6 |
Life expectancy at age 65 for a female member currently | 26.3 | 26.3 |
UBS AG | United States | aged 65 | Mortality table USA | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 21.9 | 21.8 |
Life expectancy at age 65 for a female member currently | 23.3 | 23.2 |
UBS AG | United States | aged 45 | Mortality table USA | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 23.3 | 23.2 |
Life expectancy at age 65 for a female member currently | 24.7 | 24.5 |
UBS AG | Germany | aged 65 | Mortality table Germany | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 20.5 | 20.8 |
Life expectancy at age 65 for a female member currently | 23.9 | 24.3 |
UBS AG | Germany | aged 45 | Mortality table Germany | ||
Disclosure Of Defined Benefit Plans [Table] | ||
Life expectancy at age 65 for a male member currently | 23.2 | 23.6 |
Life expectancy at age 65 for a female member currently | 26.1 | 26.5 |
Defined benefit plans (Detail 9
Defined benefit plans (Detail 9) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Swiss pension plan | ||
Increase / (decrease) in defined benefit obligation | ||
Portion of retirement savings subject to legal minimum interest rate | 19.00% | |
Legal minimum interest rate on retirement savings | 1.00% | |
Rate of pension increase | 0.00% | 0.00% |
Swiss pension plan | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | $ (1,695) | $ (1,793) |
Decrease by 50 basis points | 1,933 | 2,048 |
Swiss pension plan | Rate of salary increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 109 | 117 |
Decrease by 50 basis points | (104) | (111) |
Swiss pension plan | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 1,333 | 1,413 |
Swiss pension plan | Rate of interest credit on retirement savings | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 224 | 236 |
Decrease by 50 basis points | $ (224) | (188) |
Portion of retirement savings subject to legal minimum interest rate | 19.00% | |
Legal minimum interest rate on retirement savings | 1.00% | |
Swiss pension plan | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | $ 915 | $ 1,061 |
UK pension plan | ||
Increase / (decrease) in defined benefit obligation | ||
Rate of pension increase | 3.32% | 2.89% |
UK pension plan | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | $ (361) | $ (370) |
Decrease by 50 basis points | 411 | 423 |
UK pension plan | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 334 | 358 |
Decrease by 50 basis points | (306) | (316) |
UK pension plan | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | $ 184 | $ 182 |
US and German pension plans | ||
Increase / (decrease) in defined benefit obligation | ||
Rate of pension increase | 1.80% | 1.70% |
US and German pension plans | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | $ (78) | $ (91) |
Decrease by 50 basis points | 84 | 99 |
US and German pension plans | Rate of salary increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 0 | 1 |
Decrease by 50 basis points | 0 | (1) |
US and German pension plans | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 6 | 8 |
Decrease by 50 basis points | (6) | (7) |
US and German pension plans | Rate of interest credit on retirement savings | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 8 | 9 |
Decrease by 50 basis points | (7) | (8) |
US and German pension plans | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | $ 56 | $ 60 |
UBS AG | Swiss pension plan | ||
Increase / (decrease) in defined benefit obligation | ||
Portion of retirement savings subject to legal minimum interest rate | 17.00% | |
Legal minimum interest rate on retirement savings | 1.00% | |
Rate of pension increase | 0.00% | 0.00% |
UBS AG | Swiss pension plan | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | $ (975) | $ (1,030) |
Decrease by 50 basis points | 1,116 | 1,181 |
UBS AG | Swiss pension plan | Rate of salary increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 69 | 74 |
Decrease by 50 basis points | (66) | (71) |
UBS AG | Swiss pension plan | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 749 | 793 |
UBS AG | Swiss pension plan | Rate of interest credit on retirement savings | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 134 | 142 |
Decrease by 50 basis points | (134) | (113) |
UBS AG | Swiss pension plan | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | $ 475 | $ 566 |
UBS AG | UK pension plan | ||
Increase / (decrease) in defined benefit obligation | ||
Rate of pension increase | 3.32% | 2.89% |
UBS AG | UK pension plan | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | $ (361) | $ (370) |
Decrease by 50 basis points | 411 | 423 |
UBS AG | UK pension plan | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 334 | 358 |
Decrease by 50 basis points | (306) | (316) |
UBS AG | UK pension plan | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | $ 184 | $ 182 |
UBS AG | US and German pension plans | ||
Increase / (decrease) in defined benefit obligation | ||
Rate of pension increase | 1.80% | 1.70% |
UBS AG | US and German pension plans | Discount rate | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | $ (78) | $ (91) |
Decrease by 50 basis points | 84 | 99 |
UBS AG | US and German pension plans | Rate of salary increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 0 | 1 |
Decrease by 50 basis points | 0 | (1) |
UBS AG | US and German pension plans | Rate of pension increase | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 6 | 8 |
Decrease by 50 basis points | (6) | (7) |
UBS AG | US and German pension plans | Rate of interest credit on retirement savings | ||
Increase / (decrease) in defined benefit obligation | ||
Increase by 50 basis points | 8 | 9 |
Decrease by 50 basis points | (7) | (8) |
UBS AG | US and German pension plans | Life expectancy | ||
Increase / (decrease) in defined benefit obligation | ||
Increase in longevity by one additional year | $ 56 | $ 60 |
Defined benefit plans (Detail 1
Defined benefit plans (Detail 10) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Swiss pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 33,975 | $ 32,590 |
Plan asset allocation % | 100.00% | 100.00% |
Swiss pension plan | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 187 | $ 219 |
Plan asset allocation % | 1.00% | 1.00% |
Swiss pension plan | Real estate / property - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 3,530 | $ 3,582 |
Plan asset allocation % | 10.00% | 11.00% |
Swiss pension plan | Real estate / property - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 580 | $ 331 |
Plan asset allocation % | 2.00% | 1.00% |
Swiss pension plan | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 843 | $ 826 |
Plan asset allocation % | 2.00% | 3.00% |
Swiss pension plan | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 8,865 | $ 8,242 |
Plan asset allocation % | 26.00% | 25.00% |
Swiss pension plan | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 4,446 | $ 3,721 |
Plan asset allocation % | 13.00% | 11.00% |
Swiss pension plan | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 5,093 | $ 6,146 |
Plan asset allocation % | 15.00% | 19.00% |
Swiss pension plan | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1,314 | $ 1,303 |
Plan asset allocation % | 4.00% | 4.00% |
Swiss pension plan | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 7,769 | $ 7,085 |
Plan asset allocation % | 23.00% | 22.00% |
Swiss pension plan | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1,349 | $ 1,136 |
Plan asset allocation % | 4.00% | 3.00% |
Swiss pension plan | Quoted in an active market | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 22,973 | $ 22,525 |
Swiss pension plan | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 187 | 219 |
Swiss pension plan | Quoted in an active market | Real estate / property - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
Swiss pension plan | Quoted in an active market | Real estate / property - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
Swiss pension plan | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 843 | 826 |
Swiss pension plan | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 6,213 | 6,284 |
Swiss pension plan | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 4,446 | 3,721 |
Swiss pension plan | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 5,093 | 6,146 |
Swiss pension plan | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 1,314 | 1,303 |
Swiss pension plan | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 4,211 | 3,363 |
Swiss pension plan | Quoted in an active market | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 668 | 663 |
Swiss pension plan | Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 11,002 | 10,065 |
Swiss pension plan | Other | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
Swiss pension plan | Other | Real estate / property - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 3,530 | 3,582 |
Swiss pension plan | Other | Real estate / property - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 580 | 331 |
Swiss pension plan | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
Swiss pension plan | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2,652 | 1,958 |
Swiss pension plan | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
Swiss pension plan | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
Swiss pension plan | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
Swiss pension plan | Other | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 3,558 | 3,722 |
Swiss pension plan | Other | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 682 | 473 |
UK pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 4,297 | $ 4,149 |
Plan asset allocation % | 100.00% | 100.00% |
UK pension plan | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 147 | $ 195 |
Plan asset allocation % | 3.00% | 5.00% |
UK pension plan | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 2,605 | $ 2,150 |
Plan asset allocation % | 61.00% | 52.00% |
UK pension plan | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 372 | $ 53 |
Plan asset allocation % | 9.00% | 1.00% |
UK pension plan | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 4 | $ 0 |
Plan asset allocation % | 0.00% | 0.00% |
UK pension plan | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 47 | $ 37 |
Plan asset allocation % | 1.00% | 1.00% |
UK pension plan | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 921 | $ 1,077 |
Plan asset allocation % | 21.00% | 26.00% |
UK pension plan | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 679 | $ 1,050 |
Plan asset allocation % | 16.00% | 25.00% |
UK pension plan | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 12 | $ 47 |
Plan asset allocation % | 0.00% | 1.00% |
UK pension plan | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 179 | $ 149 |
Plan asset allocation % | 4.00% | 4.00% |
UK pension plan | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 115 | $ 110 |
Plan asset allocation % | 3.00% | 3.00% |
UK pension plan | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 122 | $ 114 |
Plan asset allocation % | 3.00% | 3.00% |
UK pension plan | Investment funds - Real estate - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 40 | $ 37 |
Plan asset allocation % | 1.00% | 1.00% |
UK pension plan | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ (313) | $ (86) |
Plan asset allocation % | (7.00%) | (2.00%) |
UK pension plan | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 8 | $ 8 |
Plan asset allocation % | 0.00% | 0.00% |
UK pension plan | Derivative financial instruments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 54 | $ (3) |
Plan asset allocation % | 1.00% | 0.00% |
UK pension plan | Asset-backed securities | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 11 | $ 6 |
Plan asset allocation % | 0.00% | 0.00% |
UK pension plan | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ (707) | $ (794) |
Plan asset allocation % | (16.00%) | (19.00%) |
UK pension plan | Quoted in an active market | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 4,074 | $ 3,940 |
UK pension plan | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 147 | 195 |
UK pension plan | Quoted in an active market | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2,605 | 2,150 |
UK pension plan | Quoted in an active market | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 372 | 53 |
UK pension plan | Quoted in an active market | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 4 | 0 |
UK pension plan | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 44 | 34 |
UK pension plan | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 921 | 1,077 |
UK pension plan | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 532 | 919 |
UK pension plan | Quoted in an active market | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 12 | 47 |
UK pension plan | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 179 | 149 |
UK pension plan | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 115 | 110 |
UK pension plan | Quoted in an active market | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 110 | 98 |
UK pension plan | Quoted in an active market | Investment funds - Real estate - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 6 | 0 |
UK pension plan | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | (313) | (86) |
UK pension plan | Quoted in an active market | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Quoted in an active market | Derivative financial instruments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 57 | (3) |
UK pension plan | Quoted in an active market | Asset-backed securities | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Quoted in an active market | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | (717) | (803) |
UK pension plan | Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 223 | 209 |
UK pension plan | Other | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 4 | 3 |
UK pension plan | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 147 | 131 |
UK pension plan | Other | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 12 | 16 |
UK pension plan | Other | Investment funds - Real estate - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 34 | 37 |
UK pension plan | Other | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UK pension plan | Other | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 8 | 8 |
UK pension plan | Other | Derivative financial instruments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | (3) | 0 |
UK pension plan | Other | Asset-backed securities | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 11 | 6 |
UK pension plan | Other | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 10 | 9 |
US and German pension plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1,329 | $ 1,360 |
Plan asset allocation % | 100.00% | 100.00% |
US and German pension plans | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 11 | $ 38 |
Plan asset allocation % | 1.00% | 3.00% |
US and German pension plans | Equity securities - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 79 | $ 0 |
Plan asset allocation % | 6.00% | 0.00% |
US and German pension plans | Equity securities - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 31 | $ 0 |
Plan asset allocation % | 2.00% | 0.00% |
US and German pension plans | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 486 | $ 490 |
Plan asset allocation % | 37.00% | 36.00% |
US and German pension plans | Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 17 | $ 7 |
Plan asset allocation % | 1.00% | 0.00% |
US and German pension plans | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 97 | $ 99 |
Plan asset allocation % | 7.00% | 7.00% |
US and German pension plans | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 6 | $ 1 |
Plan asset allocation % | 0.00% | 0.00% |
US and German pension plans | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 3 | $ 210 |
Plan asset allocation % | 0.00% | 15.00% |
US and German pension plans | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 56 | $ 169 |
Plan asset allocation % | 4.00% | 12.00% |
US and German pension plans | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 269 | $ 195 |
Plan asset allocation % | 20.00% | 14.00% |
US and German pension plans | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 147 | $ 34 |
Plan asset allocation % | 11.00% | 2.00% |
US and German pension plans | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 11 | $ 19 |
Plan asset allocation % | 1.00% | 1.00% |
US and German pension plans | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 2 | $ 3 |
Plan asset allocation % | 0.00% | 0.00% |
US and German pension plans | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 9 | $ 14 |
Plan asset allocation % | 1.00% | 1.00% |
US and German pension plans | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 99 | $ 79 |
Plan asset allocation % | 7.00% | 6.00% |
US and German pension plans | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1 | $ 1 |
Plan asset allocation % | 0.00% | 0.00% |
US and German pension plans | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 5 | $ 0 |
Plan asset allocation % | 0.00% | 0.00% |
US and German pension plans | Quoted in an active market | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1,319 | $ 1,345 |
US and German pension plans | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 11 | 38 |
US and German pension plans | Quoted in an active market | Equity securities - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 79 | 0 |
US and German pension plans | Quoted in an active market | Equity securities - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 31 | 0 |
US and German pension plans | Quoted in an active market | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 486 | 490 |
US and German pension plans | Quoted in an active market | Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 17 | 7 |
US and German pension plans | Quoted in an active market | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 97 | 99 |
US and German pension plans | Quoted in an active market | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 6 | 1 |
US and German pension plans | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 3 | 210 |
US and German pension plans | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 56 | 169 |
US and German pension plans | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 269 | 195 |
US and German pension plans | Quoted in an active market | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 147 | 34 |
US and German pension plans | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 11 | 19 |
US and German pension plans | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2 | 3 |
US and German pension plans | Quoted in an active market | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 99 | 79 |
US and German pension plans | Quoted in an active market | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Quoted in an active market | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 5 | 0 |
US and German pension plans | Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 10 | 15 |
US and German pension plans | Other | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Equity securities - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Equity securities - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 9 | 14 |
US and German pension plans | Other | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
US and German pension plans | Other | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 1 | 1 |
US and German pension plans | Other | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | Swiss pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 19,196 | $ 18,358 |
Plan asset allocation % | 100.00% | 100.00% |
UBS AG | Swiss pension plan | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 106 | $ 123 |
Plan asset allocation % | 1.00% | 1.00% |
UBS AG | Swiss pension plan | Real estate / property - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1,994 | $ 2,018 |
Plan asset allocation % | 10.00% | 11.00% |
UBS AG | Swiss pension plan | Real estate / property - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 328 | $ 186 |
Plan asset allocation % | 2.00% | 1.00% |
UBS AG | Swiss pension plan | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 476 | $ 465 |
Plan asset allocation % | 2.00% | 3.00% |
UBS AG | Swiss pension plan | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 5,009 | $ 4,642 |
Plan asset allocation % | 26.00% | 25.00% |
UBS AG | Swiss pension plan | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 2,512 | $ 2,096 |
Plan asset allocation % | 13.00% | 11.00% |
UBS AG | Swiss pension plan | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 2,877 | $ 3,462 |
Plan asset allocation % | 15.00% | 19.00% |
UBS AG | Swiss pension plan | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 742 | $ 734 |
Plan asset allocation % | 4.00% | 4.00% |
UBS AG | Swiss pension plan | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 4,389 | $ 3,991 |
Plan asset allocation % | 23.00% | 22.00% |
UBS AG | Swiss pension plan | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 762 | $ 640 |
Plan asset allocation % | 4.00% | 3.00% |
UBS AG | Swiss pension plan | Quoted in an active market | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 12,980 | $ 12,688 |
UBS AG | Swiss pension plan | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 106 | 123 |
UBS AG | Swiss pension plan | Quoted in an active market | Real estate / property - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | Swiss pension plan | Quoted in an active market | Real estate / property - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | Swiss pension plan | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 476 | 465 |
UBS AG | Swiss pension plan | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 3,510 | 3,540 |
UBS AG | Swiss pension plan | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2,512 | 2,096 |
UBS AG | Swiss pension plan | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2,877 | 3,462 |
UBS AG | Swiss pension plan | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 742 | 734 |
UBS AG | Swiss pension plan | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2,379 | 1,894 |
UBS AG | Swiss pension plan | Quoted in an active market | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 377 | 373 |
UBS AG | Swiss pension plan | Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 6,216 | 5,670 |
UBS AG | Swiss pension plan | Other | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | Swiss pension plan | Other | Real estate / property - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 1,994 | 2,018 |
UBS AG | Swiss pension plan | Other | Real estate / property - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 328 | 186 |
UBS AG | Swiss pension plan | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | Swiss pension plan | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 1,498 | 1,103 |
UBS AG | Swiss pension plan | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | Swiss pension plan | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | Swiss pension plan | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | Swiss pension plan | Other | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2,010 | 2,097 |
UBS AG | Swiss pension plan | Other | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 385 | 266 |
UBS AG | UK pension plan | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 4,297 | $ 4,149 |
Plan asset allocation % | 100.00% | 100.00% |
UBS AG | UK pension plan | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 147 | $ 195 |
Plan asset allocation % | 3.00% | 5.00% |
UBS AG | UK pension plan | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 2,605 | $ 2,150 |
Plan asset allocation % | 61.00% | 52.00% |
UBS AG | UK pension plan | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 372 | $ 53 |
Plan asset allocation % | 9.00% | 1.00% |
UBS AG | UK pension plan | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 4 | $ 0 |
Plan asset allocation % | 0.00% | 0.00% |
UBS AG | UK pension plan | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 47 | $ 37 |
Plan asset allocation % | 1.00% | 1.00% |
UBS AG | UK pension plan | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 921 | $ 1,077 |
Plan asset allocation % | 21.00% | 26.00% |
UBS AG | UK pension plan | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 679 | $ 1,050 |
Plan asset allocation % | 16.00% | 25.00% |
UBS AG | UK pension plan | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 12 | $ 47 |
Plan asset allocation % | 0.00% | 1.00% |
UBS AG | UK pension plan | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 179 | $ 149 |
Plan asset allocation % | 4.00% | 4.00% |
UBS AG | UK pension plan | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 115 | $ 110 |
Plan asset allocation % | 3.00% | 3.00% |
UBS AG | UK pension plan | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 122 | $ 114 |
Plan asset allocation % | 3.00% | 3.00% |
UBS AG | UK pension plan | Investment funds - Real estate - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 40 | $ 37 |
Plan asset allocation % | 1.00% | 1.00% |
UBS AG | UK pension plan | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ (313) | $ (86) |
Plan asset allocation % | (7.00%) | (2.00%) |
UBS AG | UK pension plan | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 8 | $ 8 |
Plan asset allocation % | 0.00% | 0.00% |
UBS AG | UK pension plan | Derivative financial instruments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 54 | $ (3) |
Plan asset allocation % | 1.00% | 0.00% |
UBS AG | UK pension plan | Asset-backed securities | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 11 | $ 6 |
Plan asset allocation % | 0.00% | 0.00% |
UBS AG | UK pension plan | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ (707) | $ (794) |
Plan asset allocation % | (16.00%) | (19.00%) |
UBS AG | UK pension plan | Quoted in an active market | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 4,074 | $ 3,940 |
UBS AG | UK pension plan | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 147 | 195 |
UBS AG | UK pension plan | Quoted in an active market | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2,605 | 2,150 |
UBS AG | UK pension plan | Quoted in an active market | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 372 | 53 |
UBS AG | UK pension plan | Quoted in an active market | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 4 | 0 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 44 | 34 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 921 | 1,077 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 532 | 919 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 12 | 47 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 179 | 149 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 115 | 110 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 110 | 98 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Real estate - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 6 | 0 |
UBS AG | UK pension plan | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | (313) | (86) |
UBS AG | UK pension plan | Quoted in an active market | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Quoted in an active market | Derivative financial instruments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 57 | (3) |
UBS AG | UK pension plan | Quoted in an active market | Asset-backed securities | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Quoted in an active market | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | (717) | (803) |
UBS AG | UK pension plan | Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 223 | 209 |
UBS AG | UK pension plan | Other | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 4 | 3 |
UBS AG | UK pension plan | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 147 | 131 |
UBS AG | UK pension plan | Other | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 12 | 16 |
UBS AG | UK pension plan | Other | Investment funds - Real estate - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 34 | 37 |
UBS AG | UK pension plan | Other | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | UK pension plan | Other | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 8 | 8 |
UBS AG | UK pension plan | Other | Derivative financial instruments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | (3) | 0 |
UBS AG | UK pension plan | Other | Asset-backed securities | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 11 | 6 |
UBS AG | UK pension plan | Other | Other investments | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 10 | 9 |
UBS AG | US and German pension plans | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1,329 | $ 1,360 |
Plan asset allocation % | 100.00% | 100.00% |
UBS AG | US and German pension plans | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 11 | $ 38 |
Plan asset allocation % | 1.00% | 3.00% |
UBS AG | US and German pension plans | Equity securities - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 79 | $ 0 |
Plan asset allocation % | 6.00% | 0.00% |
UBS AG | US and German pension plans | Equity securities - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 31 | $ 0 |
Plan asset allocation % | 2.00% | 0.00% |
UBS AG | US and German pension plans | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 486 | $ 490 |
Plan asset allocation % | 37.00% | 36.00% |
UBS AG | US and German pension plans | Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 17 | $ 7 |
Plan asset allocation % | 1.00% | 0.00% |
UBS AG | US and German pension plans | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 97 | $ 99 |
Plan asset allocation % | 7.00% | 7.00% |
UBS AG | US and German pension plans | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 6 | $ 1 |
Plan asset allocation % | 0.00% | 0.00% |
UBS AG | US and German pension plans | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 3 | $ 210 |
Plan asset allocation % | 0.00% | 15.00% |
UBS AG | US and German pension plans | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 56 | $ 169 |
Plan asset allocation % | 4.00% | 12.00% |
UBS AG | US and German pension plans | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 269 | $ 195 |
Plan asset allocation % | 20.00% | 14.00% |
UBS AG | US and German pension plans | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 147 | $ 34 |
Plan asset allocation % | 11.00% | 2.00% |
UBS AG | US and German pension plans | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 11 | $ 19 |
Plan asset allocation % | 1.00% | 1.00% |
UBS AG | US and German pension plans | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 2 | $ 3 |
Plan asset allocation % | 0.00% | 0.00% |
UBS AG | US and German pension plans | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 9 | $ 14 |
Plan asset allocation % | 1.00% | 1.00% |
UBS AG | US and German pension plans | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 99 | $ 79 |
Plan asset allocation % | 7.00% | 6.00% |
UBS AG | US and German pension plans | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1 | $ 1 |
Plan asset allocation % | 0.00% | 0.00% |
UBS AG | US and German pension plans | Quoted in an active market | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1,319 | $ 1,345 |
UBS AG | US and German pension plans | Quoted in an active market | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 11 | 38 |
UBS AG | US and German pension plans | Quoted in an active market | Equity securities - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 79 | 0 |
UBS AG | US and German pension plans | Quoted in an active market | Equity securities - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 31 | 0 |
UBS AG | US and German pension plans | Quoted in an active market | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 486 | 490 |
UBS AG | US and German pension plans | Quoted in an active market | Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 17 | 7 |
UBS AG | US and German pension plans | Quoted in an active market | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 97 | 99 |
UBS AG | US and German pension plans | Quoted in an active market | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 6 | 1 |
UBS AG | US and German pension plans | Quoted in an active market | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 3 | 210 |
UBS AG | US and German pension plans | Quoted in an active market | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 56 | 169 |
UBS AG | US and German pension plans | Quoted in an active market | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 269 | 195 |
UBS AG | US and German pension plans | Quoted in an active market | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 147 | 34 |
UBS AG | US and German pension plans | Quoted in an active market | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 11 | 19 |
UBS AG | US and German pension plans | Quoted in an active market | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 2 | 3 |
UBS AG | US and German pension plans | Quoted in an active market | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Quoted in an active market | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 99 | 79 |
UBS AG | US and German pension plans | Quoted in an active market | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 10 | 15 |
UBS AG | US and German pension plans | Other | Cash and cash equivalents | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Equity securities - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Equity securities - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Investment funds - Equity - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Investment funds - Equity - Foreign | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Investment funds - Bonds - Domestic, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Investment funds - Bonds - Domestic, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Investment funds - Bonds - Foreign, AAA to BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Investment funds - Bonds - Foreign, below BBB- | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Investment funds - Real estate - Domestic | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 9 | 14 |
UBS AG | US and German pension plans | Other | Investment funds - Other | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | 0 | 0 |
UBS AG | US and German pension plans | Other | Insurance contracts | ||
Disclosure Of Net Defined Benefit Liability Asset [Table] | ||
Fair value | $ 1 | $ 1 |
Defined benefit plans (Detail_5
Defined benefit plans (Detail 11) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Swiss pension plan | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | $ 33,975 | $ 32,590 |
Derivative financial instruments, net of collateral | 43 | (17) |
Swiss pension plan | Bank accounts at UBS | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 194 | 231 |
Swiss pension plan | UBS debt instruments | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 28 | 34 |
Swiss pension plan | UBS shares | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 25 | 24 |
Swiss pension plan | Securities lent to UBS | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 1,079 | 1,416 |
Swiss pension plan | Property occupied by UBS | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 93 | 96 |
Swiss pension plan | Derivative financial instruments, counterparty UBS | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 128 | 149 |
UK pension plan | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 4,297 | 4,149 |
US and German pension plans | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 1,329 | 1,360 |
UBS AG | Swiss pension plan | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 19,196 | 18,358 |
Derivative financial instruments, net of collateral | (24) | 9 |
UBS AG | Swiss pension plan | Bank accounts at UBS | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 109 | 130 |
UBS AG | Swiss pension plan | UBS debt instruments | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 16 | 19 |
UBS AG | Swiss pension plan | UBS shares | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 14 | 13 |
UBS AG | Swiss pension plan | Securities lent to UBS | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 608 | 796 |
UBS AG | Swiss pension plan | Property occupied by UBS | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 52 | 54 |
UBS AG | Swiss pension plan | Derivative financial instruments, counterparty UBS | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 72 | 84 |
UBS AG | UK pension plan | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | 4,297 | 4,149 |
UBS AG | US and German pension plans | ||
Plan Assets At Fair Value By Plan [Table] | ||
Fair value | $ 1,329 | $ 1,360 |
Defined contribution plans (Det
Defined contribution plans (Detail 12) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Defined Contribution Plans [Table] | |||
Total | $ 363 | $ 343 | $ 326 |
US plan | |||
Defined Contribution Plans [Table] | |||
Total | 198 | 190 | 173 |
UK plan | |||
Defined Contribution Plans [Table] | |||
Total | 101 | 88 | 82 |
Remaining plans | |||
Defined Contribution Plans [Table] | |||
Total | 64 | 65 | 71 |
UBS AG | |||
Defined Contribution Plans [Table] | |||
Total | 303 | 291 | 278 |
UBS AG | US plan | |||
Defined Contribution Plans [Table] | |||
Total | 198 | 190 | 173 |
UBS AG | UK plan | |||
Defined Contribution Plans [Table] | |||
Total | 41 | 36 | 34 |
UBS AG | Remaining plans | |||
Defined Contribution Plans [Table] | |||
Total | $ 64 | $ 65 | $ 71 |
Related party disclosure (Detai
Related party disclosure (Detail 12) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Received by UBS | |||
Fees | $ 39 | $ 34 | $ 34 |
Paid by UBS | |||
Rent | 4 | 5 | 4 |
Dividends, capital repayments and interest | 5 | 10 | 11 |
UBS AG | |||
Received by UBS | |||
Fees | 22 | 19 | 19 |
Paid by UBS | |||
Rent | 2 | 3 | 2 |
Dividends, capital repayments and interest | $ 5 | $ 10 | $ 10 |
Related party disclosure (Det_2
Related party disclosure (Detail 13) - USD ($) shares in Thousands, $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Financial instruments bought by pension funds | ||
UBS shares (in thousands of shares) | 907 | 1,758 |
UBS debt instruments (par values) | $ 37 | $ 28 |
Financial instruments sold by pension funds or matured | ||
UBS shares (in thousands of shares) | 1,688 | 2,605 |
UBS debt instruments (par values) | $ 40 | $ 6 |
UBS shares held by post-employment benefit plans | ||
Number of shares (in thousands of shares) | 14,073 | 14,854 |
Fair value | $ 252 | $ 210 |
UBS AG | ||
Financial instruments bought by pension funds | ||
UBS shares (in thousands of shares) | 847 | 1,677 |
UBS AG debt instruments (par values) | $ 22 | $ 16 |
Financial instruments sold by pension funds or matured | ||
UBS shares (in thousands of shares) | 1,505 | 2,556 |
UBS AG debt instruments (par values) | $ 22 | $ 4 |
UBS shares held by post-employment benefit plans | ||
Number of shares (in thousands of shares) | 13,456 | 14,112 |
Fair value | $ 241 | $ 199 |
Employee benefits_ variable c_3
Employee benefits: variable compensation (Narrative) (Detail 1) - shares shares in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] | ||
Share delivery obligations | 175 | 172 |
Treasury shares available to satisfy share delivery obligations | 149 | 157 |
Employee benefits_ variable c_4
Employee benefits: variable compensation (Narrative) (Detail 2) $ in Millions | Dec. 31, 2021USD ($)yr | Dec. 31, 2020USD ($) |
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] | ||
Carrying amount of liability related to cash-settled share-based awards | $ | $ 37 | $ 36 |
Unvested share-based awards | ||
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] | ||
Weighted average remaining contractual term (years) | yr | 2.5 | |
UBS AG | ||
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] | ||
Carrying amount of liability related to cash-settled share-based awards | $ | $ 3 | $ 1 |
UBS AG | Unvested share-based awards | ||
Disclosure Of Terms And Conditions Of Sharebased Payment Arrangement [Table] | ||
Weighted average remaining contractual term (years) | yr | 2.5 |
Employee benefits_ variable c_5
Employee benefits: variable compensation - Effect on income statement (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | $ 8,280 | $ 7,520 | $ 7,045 |
Variable compensation including FA variable compensation deferred to the next and following years | 5,238 | 4,524 | 4,259 |
Variable compensation including FA variable compensation related to share-based compensation | 651 | 686 | 610 |
Variable compensation including FA variable compensation related to share-based compensation - performance awards | 435 | 517 | 461 |
Variable compensation including FA variable compensation related to share-based compensation - other variable compensation | 59 | 50 | 43 |
Variable compensation including FA variable compensation related to share-based compensation - financial advisor variable compensation | 157 | 119 | 106 |
Variable compensation including FA variable compensation related to share-based compensation recognized within other Note 6 expense categories | 85 | 100 | 61 |
Salaries related to share-based compensation | 5 | 4 | 10 |
Social security related to share-based compensation | 64 | 54 | 25 |
Personnel expenses related to share-based compensation - Equity Plus Plan | 16 | 42 | 27 |
Personnel expense related to share-based equity-settled compensation excluding social security | 643 | 691 | 619 |
Personnel expense related to share-based equity-settled compensation excluding social security, before FX effect | 641 | ||
Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 7,155 | 6,012 | 5,617 |
Variable compensation including FA variable compensation deferred to the next and following years | 2,109 | 1,760 | 1,093 |
Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 1,125 | 1,508 | 1,428 |
Variable compensation including FA variable compensation deferred to the next and following years | 3,129 | 2,764 | 3,166 |
Variable compensation - performance awards | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 3,190 | 3,209 | 2,755 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,421 | 1,044 | 1,036 |
Variable compensation - performance awards | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,788 | 2,508 | 2,193 |
Variable compensation including FA variable compensation deferred to the next and following years | 797 | 756 | 429 |
Variable compensation - performance awards | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 402 | 701 | 562 |
Variable compensation including FA variable compensation deferred to the next and following years | 624 | 288 | 608 |
Non-deferred cash | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,373 | 2,141 | 1,868 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
Non-deferred cash | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,383 | 2,167 | 1,894 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
Non-deferred cash | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | (10) | (26) | (26) |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
Deferred compensation awards | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 817 | 1,068 | 887 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,421 | 1,044 | 1,036 |
Deferred compensation awards | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 405 | 341 | 299 |
Variable compensation including FA variable compensation deferred to the next and following years | 797 | 756 | 429 |
Deferred compensation awards | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 412 | 727 | 588 |
Variable compensation including FA variable compensation deferred to the next and following years | 624 | 288 | 608 |
of which: Equity Ownership Plan | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 363 | 463 | 422 |
Variable compensation including FA variable compensation deferred to the next and following years | 577 | 376 | 424 |
of which: Equity Ownership Plan | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 183 | 137 | 122 |
Variable compensation including FA variable compensation deferred to the next and following years | 393 | 306 | 205 |
of which: Equity Ownership Plan | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 180 | 327 | 300 |
Variable compensation including FA variable compensation deferred to the next and following years | 184 | 69 | 219 |
of which: Deferred Contingent Capital Plan | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 297 | 463 | 375 |
Variable compensation including FA variable compensation deferred to the next and following years | 628 | 476 | 538 |
of which: Deferred Contingent Capital Plan | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 140 | 112 | 113 |
Variable compensation including FA variable compensation deferred to the next and following years | 299 | 280 | 173 |
of which: Deferred Contingent Capital Plan | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 158 | 351 | 262 |
Variable compensation including FA variable compensation deferred to the next and following years | 329 | 196 | 365 |
of which: Long Term Incentive Plan | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 73 | 54 | 39 |
Variable compensation including FA variable compensation deferred to the next and following years | 83 | 61 | 25 |
of which: Long Term Incentive Plan | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 54 | 42 | 39 |
Variable compensation including FA variable compensation deferred to the next and following years | 50 | 50 | 25 |
of which: Long Term Incentive Plan | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 19 | 11 | 0 |
Variable compensation including FA variable compensation deferred to the next and following years | 33 | 10 | 0 |
of which: Asset Management EOP | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 84 | 88 | 51 |
Variable compensation including FA variable compensation deferred to the next and following years | 133 | 132 | 49 |
of which: Asset Management EOP | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 29 | 49 | 25 |
Variable compensation including FA variable compensation deferred to the next and following years | 56 | 120 | 26 |
of which: Asset Management EOP | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 56 | 39 | 26 |
Variable compensation including FA variable compensation deferred to the next and following years | 78 | 12 | 23 |
Variable compensation - other | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 229 | 220 | 246 |
Variable compensation including FA variable compensation deferred to the next and following years | 397 | 374 | 349 |
Variable compensation - other | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 191 | 126 | 159 |
Variable compensation including FA variable compensation deferred to the next and following years | 215 | 181 | 117 |
Variable compensation - other | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 38 | 94 | 88 |
Variable compensation including FA variable compensation deferred to the next and following years | 182 | 192 | 232 |
Total variable compensation excluding financial advisor variable compensation | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 3,419 | 3,429 | 3,001 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,818 | 1,418 | 1,385 |
Total variable compensation excluding financial advisor variable compensation | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,979 | 2,634 | 2,352 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,012 | 938 | 545 |
Total variable compensation excluding financial advisor variable compensation | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 440 | 795 | 650 |
Variable compensation including FA variable compensation deferred to the next and following years | 806 | 480 | 840 |
Total FA variable compensation | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 4,860 | 4,091 | 4,043 |
Variable compensation including FA variable compensation deferred to the next and following years | 3,419 | 3,106 | 2,874 |
Total FA variable compensation | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 4,175 | 3,378 | 3,265 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,097 | 822 | 548 |
Total FA variable compensation | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 685 | 713 | 778 |
Variable compensation including FA variable compensation deferred to the next and following years | 2,323 | 2,284 | 2,327 |
Financial advisor variable compensation | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 4,382 | 3,589 | 3,501 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,075 | 952 | 907 |
Financial advisor variable compensation | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 4,134 | 3,356 | 3,233 |
Variable compensation including FA variable compensation deferred to the next and following years | 434 | 350 | 197 |
Financial advisor variable compensation | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 248 | 233 | 268 |
Variable compensation including FA variable compensation deferred to the next and following years | 641 | 602 | 710 |
of which: non-deferred cash | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 3,853 | 3,154 | 3,064 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
of which: non-deferred cash | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 3,858 | 3,154 | 3,064 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
of which: non-deferred cash | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | (6) | 0 | 0 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
of which: deferred share-based awards | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 157 | 119 | 106 |
Variable compensation including FA variable compensation deferred to the next and following years | 269 | 214 | 183 |
of which: deferred share-based awards | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 106 | 69 | 57 |
Variable compensation including FA variable compensation deferred to the next and following years | 123 | 79 | 54 |
of which: deferred share-based awards | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 51 | 50 | 48 |
Variable compensation including FA variable compensation deferred to the next and following years | 146 | 135 | 130 |
of which: deferred cash-based awards | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 372 | 316 | 331 |
Variable compensation including FA variable compensation deferred to the next and following years | 806 | 738 | 724 |
of which: deferred cash-based awards | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 170 | 133 | 112 |
Variable compensation including FA variable compensation deferred to the next and following years | 311 | 271 | 144 |
of which: deferred cash-based awards | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 202 | 183 | 219 |
Variable compensation including FA variable compensation deferred to the next and following years | 495 | 467 | 580 |
Compensation commitments with recruited financial advisors | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 479 | 502 | 542 |
Variable compensation including FA variable compensation deferred to the next and following years | 2,344 | 2,155 | 1,967 |
Compensation commitments with recruited financial advisors | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 41 | 22 | 32 |
Variable compensation including FA variable compensation deferred to the next and following years | 662 | 473 | 350 |
Compensation commitments with recruited financial advisors | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 438 | 480 | 510 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,682 | 1,682 | 1,617 |
UBS AG | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 7,973 | 7,246 | 6,814 |
Variable compensation including FA variable compensation deferred to the next and following years | 5,181 | 4,481 | 4,222 |
Variable compensation including FA variable compensation related to share-based compensation | 631 | 666 | 595 |
Variable compensation including FA variable compensation related to share-based compensation - performance awards | 419 | 498 | 448 |
Variable compensation including FA variable compensation related to share-based compensation - other variable compensation | 56 | 49 | 42 |
Variable compensation including FA variable compensation related to share-based compensation - financial advisor variable compensation | 157 | 119 | 106 |
Variable compensation including FA variable compensation related to share-based compensation recognized within other Note 6 expense categories | 77 | 88 | 54 |
Salaries related to share-based compensation | 5 | 4 | 10 |
Social security related to share-based compensation | 59 | 51 | 23 |
Personnel expenses related to share-based compensation - Equity Plus Plan | 13 | 34 | 22 |
UBS AG | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 6,863 | 5,765 | 5,398 |
Variable compensation including FA variable compensation deferred to the next and following years | 2,074 | 1,732 | 1,076 |
UBS AG | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 1,109 | 1,481 | 1,416 |
Variable compensation including FA variable compensation deferred to the next and following years | 3,107 | 2,749 | 3,146 |
UBS AG | Variable compensation - performance awards | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,916 | 2,953 | 2,545 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,373 | 1,011 | 1,005 |
UBS AG | Variable compensation - performance awards | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,525 | 2,278 | 1,993 |
Variable compensation including FA variable compensation deferred to the next and following years | 767 | 734 | 413 |
UBS AG | Variable compensation - performance awards | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 391 | 675 | 553 |
Variable compensation including FA variable compensation deferred to the next and following years | 606 | 277 | 592 |
UBS AG | Non-deferred cash | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,128 | 1,920 | 1,682 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
UBS AG | Non-deferred cash | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,136 | 1,948 | 1,706 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
UBS AG | Non-deferred cash | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | (8) | (29) | (24) |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
UBS AG | Deferred compensation awards | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 788 | 1,034 | 863 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,373 | 1,011 | 1,005 |
UBS AG | Deferred compensation awards | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 389 | 329 | 287 |
Variable compensation including FA variable compensation deferred to the next and following years | 767 | 734 | 413 |
UBS AG | Deferred compensation awards | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 399 | 704 | 576 |
Variable compensation including FA variable compensation deferred to the next and following years | 606 | 277 | 592 |
UBS AG | of which: Equity Ownership Plan | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 350 | 446 | 410 |
Variable compensation including FA variable compensation deferred to the next and following years | 553 | 365 | 412 |
UBS AG | of which: Equity Ownership Plan | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 175 | 131 | 115 |
Variable compensation including FA variable compensation deferred to the next and following years | 374 | 298 | 198 |
UBS AG | of which: Equity Ownership Plan | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 174 | 315 | 294 |
Variable compensation including FA variable compensation deferred to the next and following years | 180 | 67 | 213 |
UBS AG | of which: Deferred Contingent Capital Plan | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 285 | 448 | 365 |
Variable compensation including FA variable compensation deferred to the next and following years | 608 | 459 | 521 |
UBS AG | of which: Deferred Contingent Capital Plan | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 134 | 108 | 109 |
Variable compensation including FA variable compensation deferred to the next and following years | 290 | 271 | 166 |
UBS AG | of which: Deferred Contingent Capital Plan | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 151 | 339 | 256 |
Variable compensation including FA variable compensation deferred to the next and following years | 318 | 189 | 356 |
UBS AG | of which: Long Term Incentive Plan | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 69 | 52 | 38 |
Variable compensation including FA variable compensation deferred to the next and following years | 79 | 55 | 23 |
UBS AG | of which: Long Term Incentive Plan | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 51 | 41 | 38 |
Variable compensation including FA variable compensation deferred to the next and following years | 48 | 46 | 23 |
UBS AG | of which: Long Term Incentive Plan | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 17 | 11 | 0 |
Variable compensation including FA variable compensation deferred to the next and following years | 32 | 9 | 0 |
UBS AG | of which: Asset Management EOP | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 84 | 88 | 51 |
Variable compensation including FA variable compensation deferred to the next and following years | 133 | 132 | 49 |
UBS AG | of which: Asset Management EOP | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 29 | 49 | 25 |
Variable compensation including FA variable compensation deferred to the next and following years | 56 | 120 | 26 |
UBS AG | of which: Asset Management EOP | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 55 | 39 | 26 |
Variable compensation including FA variable compensation deferred to the next and following years | 77 | 12 | 23 |
UBS AG | Variable compensation - other | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 196 | 201 | 225 |
Variable compensation including FA variable compensation deferred to the next and following years | 388 | 364 | 343 |
UBS AG | Variable compensation - other | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 163 | 109 | 140 |
Variable compensation including FA variable compensation deferred to the next and following years | 210 | 176 | 115 |
UBS AG | Variable compensation - other | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 33 | 92 | 85 |
Variable compensation including FA variable compensation deferred to the next and following years | 178 | 189 | 228 |
UBS AG | Total variable compensation excluding financial advisor variable compensation | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 3,112 | 3,155 | 2,770 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,762 | 1,375 | 1,348 |
UBS AG | Total variable compensation excluding financial advisor variable compensation | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 2,688 | 2,387 | 2,133 |
Variable compensation including FA variable compensation deferred to the next and following years | 978 | 909 | 528 |
UBS AG | Total variable compensation excluding financial advisor variable compensation | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 424 | 768 | 638 |
Variable compensation including FA variable compensation deferred to the next and following years | 784 | 465 | 820 |
UBS AG | Total FA variable compensation | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 4,860 | 4,091 | 4,043 |
Variable compensation including FA variable compensation deferred to the next and following years | 3,419 | 3,106 | 2,874 |
UBS AG | Total FA variable compensation | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 4,175 | 3,378 | 3,265 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,097 | 822 | 548 |
UBS AG | Total FA variable compensation | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 685 | 713 | 778 |
Variable compensation including FA variable compensation deferred to the next and following years | 2,323 | 2,284 | 2,327 |
UBS AG | Financial advisor variable compensation | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 4,382 | 3,589 | 3,501 |
Variable compensation including FA variable compensation deferred to the next and following years | 1,075 | 952 | 907 |
UBS AG | Financial advisor variable compensation | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 4,134 | 3,356 | 3,233 |
Variable compensation including FA variable compensation deferred to the next and following years | 434 | 350 | 197 |
UBS AG | Financial advisor variable compensation | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 248 | 233 | 268 |
Variable compensation including FA variable compensation deferred to the next and following years | 641 | 602 | 710 |
UBS AG | of which: non-deferred cash | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 3,853 | 3,154 | 3,064 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
UBS AG | of which: non-deferred cash | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 3,858 | 3,154 | 3,064 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
UBS AG | of which: non-deferred cash | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | (6) | 0 | 0 |
Variable compensation including FA variable compensation deferred to the next and following years | 0 | 0 | 0 |
UBS AG | of which: deferred share-based awards | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 157 | 119 | 106 |
Variable compensation including FA variable compensation deferred to the next and following years | 269 | 214 | 183 |
UBS AG | of which: deferred share-based awards | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 106 | 69 | 57 |
Variable compensation including FA variable compensation deferred to the next and following years | 123 | 79 | 54 |
UBS AG | of which: deferred share-based awards | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 51 | 50 | 48 |
Variable compensation including FA variable compensation deferred to the next and following years | 146 | 135 | 130 |
UBS AG | of which: deferred cash-based awards | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 372 | 316 | 331 |
Variable compensation including FA variable compensation deferred to the next and following years | 806 | 738 | 724 |
UBS AG | of which: deferred cash-based awards | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 170 | 133 | 112 |
Variable compensation including FA variable compensation deferred to the next and following years | 311 | 271 | 144 |
UBS AG | of which: deferred cash-based awards | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 202 | 183 | 219 |
Variable compensation including FA variable compensation deferred to the next and following years | 495 | 467 | 580 |
UBS AG | Compensation commitments with recruited financial advisors | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 479 | 502 | 542 |
Variable compensation including FA variable compensation deferred to the next and following years | 2,344 | 2,155 | 1,967 |
UBS AG | Compensation commitments with recruited financial advisors | Related to performance year | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 41 | 22 | 32 |
Variable compensation including FA variable compensation deferred to the next and following years | 662 | 473 | 350 |
UBS AG | Compensation commitments with recruited financial advisors | Related to prior performance years | |||
Income Statement Compensation Items [Table] | |||
Variable compensation including FA variable compensation for the current year | 438 | 480 | 510 |
Variable compensation including FA variable compensation deferred to the next and following years | $ 1,682 | $ 1,682 | $ 1,617 |
Employee benefits_ variable c_6
Employee benefits: variable compensation - Movements (Detail) | 12 Months Ended | |
Dec. 31, 2021USD ($)shares | Dec. 31, 2020USD ($)shares | |
Entity [Table] | ||
Number of shares outstanding, at the beginning of the year | 174,900,395 | 156,064,763 |
Number of shares awarded during the year | 68,721,549 | 72,250,157 |
Number of share distributions during the year | (52,137,287) | (46,899,362) |
Number of shares forfeited during the year | (10,906,096) | (6,515,164) |
Number of shares outstanding, at the end of the year | 180,578,561 | 174,900,395 |
Number of shares vested for accounting purposes | 107,828,979 | 118,260,527 |
Weighted average grant date fair value of shares outstanding, at the beginning of the year | $ | $ 12 | $ 14 |
Weighted average grant date fair value of shares awarded during the year | $ | 15 | 11 |
Weighted average grant date fair value of share distributions during the year | $ | 13 | 15 |
Weighted average grant date fair value of shares forfeited during the year | $ | 13 | 13 |
Weighted average grant date fair value of shares outstanding, at the end of the year | $ | $ 13 | $ 12 |
UBS AG | ||
Entity [Table] | ||
Number of shares outstanding, at the beginning of the year | 54,557 | 90,443 |
Number of shares awarded during the year | 278,756 | 19,229 |
Number of share distributions during the year | (24,176) | (55,114) |
Number of shares forfeited during the year | (13,215) | 0 |
Number of shares outstanding, at the end of the year | 295,921 | 54,557 |
Number of shares vested for accounting purposes | 116,775 | 53,216 |
Weighted average grant date fair value of shares outstanding, at the beginning of the year | $ | $ 13 | $ 14 |
Weighted average grant date fair value of shares awarded during the year | $ | 15 | 11 |
Weighted average grant date fair value of share distributions during the year | $ | 13 | 14 |
Weighted average grant date fair value of shares forfeited during the year | $ | 15 | 0 |
Weighted average grant date fair value of shares outstanding, at the end of the year | $ | $ 15 | $ 13 |
Interests in subsidiaries (Deta
Interests in subsidiaries (Detail 1.1) SFr in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021CHF (SFr) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | |
Disclosure Of Significant Investments In Subsidiaries [Table] | |||
Share capital | $ | $ 322 | $ 338 | |
UBS AG Subsidiaries | |||
Disclosure Of Significant Investments In Subsidiaries [Table] | |||
Company | UBS AG | ||
Registered office | Zurich and Basel, Switzerland | ||
Share capital | SFr | SFr 385.8 | ||
Equity interest accumulated in % | 100.00% | ||
UBS Business Solutions AG | |||
Disclosure Of Significant Investments In Subsidiaries [Table] | |||
Company | UBS Business Solutions AG | ||
Registered office | Zurich, Switzerland | ||
Share capital | SFr | SFr 1 | ||
Equity interest accumulated in % | 100.00% | ||
UBS AG | |||
Disclosure Of Significant Investments In Subsidiaries [Table] | |||
Share capital | $ | $ 338 | $ 338 |
Interests in subsidiaries (De_2
Interests in subsidiaries (Detail 1.2) € in Millions, SFr in Millions | 12 Months Ended | |||
Dec. 31, 2021CHF (SFr) | Dec. 31, 2021EUR (€) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | |
Individually significant subsidiaries of UBS AG | ||||
Share capital | $ 322,000,000 | $ 338,000,000 | ||
UBS Americas Holding LLC | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Americas Holding LLC | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Group Functions | |||
Share capital | 4,150,000,000 | |||
Equity interest accumulated in % | 100.00% | |||
Common share capital | 1,000 | |||
Preference share capital | 4,150,000,000 | |||
UBS Americas Inc. | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Americas Inc. | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Group Functions | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100.00% | |||
UBS Asset Management AG | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Asset Management AG | |||
Registered office | Zurich, Switzerland | |||
Primary business division | Asset Management | |||
Share capital | SFr | SFr 43.2 | |||
Equity interest accumulated in % | 100.00% | |||
UBS Bank USA | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Bank USA | |||
Registered office | Salt Lake City, Utah, USA | |||
Primary business division | Global Wealth Management | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100.00% | |||
UBS Europe SE | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Europe SE | |||
Registered office | Frankfurt, Germany | |||
Primary business division | Global Wealth Management | |||
Share capital | € | € 446 | |||
Equity interest accumulated in % | 100.00% | |||
UBS Financial Services Inc. | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Financial Services Inc. | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Global Wealth Management | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100.00% | |||
UBS Securities LLC | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Securities LLC | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Investment Bank | |||
Share capital | 1,283,100,000 | |||
Equity interest accumulated in % | 100.00% | |||
Common share capital | 100,000 | |||
Preference share capital | 1,283,000,000 | |||
UBS Switzerland AG | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Switzerland AG | |||
Registered office | Zurich, Switzerland | |||
Primary business division | Personal & Corporate Banking | |||
Share capital | SFr | SFr 10 | |||
Equity interest accumulated in % | 100.00% | |||
UBS AG | ||||
Individually significant subsidiaries of UBS AG | ||||
Share capital | 338,000,000 | $ 338,000,000 | ||
UBS AG | UBS Americas Holding LLC | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Americas Holding LLC | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Group Functions | |||
Share capital | 4,150,000,000 | |||
Equity interest accumulated in % | 100.00% | |||
Common share capital | 1,000 | |||
Preference share capital | 4,150,000,000 | |||
UBS AG | UBS Americas Inc. | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Americas Inc. | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Group Functions | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100.00% | |||
UBS AG | UBS Asset Management AG | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Asset Management AG | |||
Registered office | Zurich, Switzerland | |||
Primary business division | Asset Management | |||
Share capital | 43,200,000 | |||
Equity interest accumulated in % | 100.00% | |||
UBS AG | UBS Bank USA | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Bank USA | |||
Registered office | Salt Lake City, Utah, USA | |||
Primary business division | Global Wealth Management | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100.00% | |||
UBS AG | UBS Europe SE | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Europe SE | |||
Registered office | Frankfurt, Germany | |||
Primary business division | Global Wealth Management | |||
Share capital | 446,000,000 | |||
Equity interest accumulated in % | 100.00% | |||
UBS AG | UBS Financial Services Inc. | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Financial Services Inc. | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Global Wealth Management | |||
Share capital | 0 | |||
Equity interest accumulated in % | 100.00% | |||
UBS AG | UBS Securities LLC | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Securities LLC | |||
Registered office | Wilmington, Delaware, USA | |||
Primary business division | Investment Bank | |||
Share capital | 1,283,100,000 | |||
Equity interest accumulated in % | 100.00% | |||
Common share capital | 100,000 | |||
Preference share capital | 1,283,000,000 | |||
UBS AG | UBS Switzerland AG | ||||
Individually significant subsidiaries of UBS AG | ||||
Company | UBS Switzerland AG | |||
Registered office | Zurich, Switzerland | |||
Primary business division | Personal & Corporate Banking | |||
Share capital | $ 10,000,000 | |||
Equity interest accumulated in % | 100.00% |
Interests in subsidiaries (De_3
Interests in subsidiaries (Detail 2) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Share capital | $ 322 | $ 338 |
UBS Asset Management (Americas) Inc. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Asset Management (Americas) Inc. | |
Registered office | Wilmington, Delaware, USA | |
Primary business division | Asset Management | |
Share capital | $ 0 | |
Equity interest accumulated in % | 100.00% | |
UBS Asset Management (Hong Kong) Limited | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Asset Management (Hong Kong) Limited | |
Registered office | Hong Kong SAR, China | |
Primary business division | Asset Management | |
Share capital | $ 254 | |
Equity interest accumulated in % | 100.00% | |
UBS Asset Management Life Ltd | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Asset Management Life Ltd | |
Registered office | London, United Kingdom | |
Primary business division | Asset Management | |
Share capital | $ 15 | |
Equity interest accumulated in % | 100.00% | |
UBS Asset Management Switzerland AG | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Asset Management Switzerland AG | |
Registered office | Zurich, Switzerland | |
Primary business division | Asset Management | |
Share capital | $ 0.5 | |
Equity interest accumulated in % | 100.00% | |
UBS Business Solutions US LLC | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Business Solutions US LLC | |
Registered office | Wilmington, Delaware, USA | |
Primary business division | Group Functions | |
Share capital | $ 0 | |
Equity interest accumulated in % | 100.00% | |
UBS Credit Corp. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Credit Corp. | |
Registered office | Wilmington, Delaware, USA | |
Primary business division | Global Wealth Management | |
Share capital | $ 0 | |
Equity interest accumulated in % | 100.00% | |
UBS (France) SA. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS (France) S.A. | |
Registered office | Paris, France | |
Primary business division | Global Wealth Management | |
Share capital | $ 133 | |
Equity interest accumulated in % | 100.00% | |
UBS Fund Management (Luxembourg) S.A. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Fund Management (Luxembourg) S.A. | |
Registered office | Luxembourg, Luxembourg | |
Primary business division | Asset Management | |
Share capital | $ 13 | |
Equity interest accumulated in % | 100.00% | |
UBS Fund Management (Switzerland) AG | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Fund Management (Switzerland) AG | |
Registered office | Basel, Switzerland | |
Primary business division | Asset Management | |
Share capital | $ 1 | |
Equity interest accumulated in % | 100.00% | |
UBS (Monaco) S.A. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS (Monaco) S.A. | |
Registered office | Monte Carlo, Monaco | |
Primary business division | Global Wealth Management | |
Share capital | $ 49.2 | |
Equity interest accumulated in % | 100.00% | |
UBS O'Connor LLC | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS O‘Connor LLC | |
Registered office | Wilmington, Delaware, USA | |
Primary business division | Asset Management | |
Share capital | $ 1 | |
Equity interest accumulated in % | 100.00% | |
UBS Realty Investors LLC | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Realty Investors LLC | |
Registered office | Boston, Massachusetts, USA | |
Primary business division | Asset Management | |
Share capital | $ 9 | |
Equity interest accumulated in % | 100.00% | |
UBS Securities Australia Ltd | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Securities Australia Ltd | |
Registered office | Sydney, Australia | |
Primary business division | Investment Bank | |
Share capital | $ 0.3 | |
Equity interest accumulated in % | 100.00% | |
UBS Securities Hong Kong Limited | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Securities Hong Kong Limited | |
Registered office | Hong Kong SAR, China | |
Primary business division | Investment Bank | |
Share capital | $ 4,154.2 | |
Equity interest accumulated in % | 100.00% | |
UBS Securities Japan Co., Ltd. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Securities Japan Co., Ltd. | |
Registered office | Tokyo, Japan | |
Primary business division | Investment Bank | |
Share capital | $ 34,708.7 | |
Equity interest accumulated in % | 100.00% | |
UBS SuMi TRUST Wealth Management Co., Ltd. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS SuMi TRUST Wealth Management Co., Ltd. | |
Registered office | Tokyo, Japan | |
Primary business division | Global Wealth Management | |
Share capital | $ 5,165 | |
Equity interest accumulated in % | 51.00% | |
UBS AG | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Share capital | $ 338 | $ 338 |
UBS AG | UBS Asset Management (Americas) Inc. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Asset Management (Americas) Inc. | |
Registered office | Wilmington, Delaware, USA | |
Primary business division | Asset Management | |
Share capital | $ 0 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Asset Management (Hong Kong) Limited | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Asset Management (Hong Kong) Limited | |
Registered office | Hong Kong SAR, China | |
Primary business division | Asset Management | |
Share capital | $ 254 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Asset Management Life Ltd | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Asset Management Life Ltd | |
Registered office | London, United Kingdom | |
Primary business division | Asset Management | |
Share capital | $ 15 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Asset Management Switzerland AG | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Asset Management Switzerland AG | |
Registered office | Zurich, Switzerland | |
Primary business division | Asset Management | |
Share capital | $ 0.5 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Business Solutions US LLC | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Business Solutions US LLC | |
Registered office | Wilmington, Delaware, USA | |
Primary business division | Group Functions | |
Share capital | $ 0 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Credit Corp. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Credit Corp. | |
Registered office | Wilmington, Delaware, USA | |
Primary business division | Global Wealth Management | |
Share capital | $ 0 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS (France) SA. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS (France) S.A. | |
Registered office | Paris, France | |
Primary business division | Global Wealth Management | |
Share capital | $ 133 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Fund Management (Luxembourg) S.A. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Fund Management (Luxembourg) S.A. | |
Registered office | Luxembourg, Luxembourg | |
Primary business division | Asset Management | |
Share capital | $ 13 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Fund Management (Switzerland) AG | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Fund Management (Switzerland) AG | |
Registered office | Basel, Switzerland | |
Primary business division | Asset Management | |
Share capital | $ 1 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS (Monaco) S.A. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS (Monaco) S.A. | |
Registered office | Monte Carlo, Monaco | |
Primary business division | Global Wealth Management | |
Share capital | $ 49.2 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS O'Connor LLC | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS O‘Connor LLC | |
Registered office | Wilmington, Delaware, USA | |
Primary business division | Asset Management | |
Share capital | $ 1 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Realty Investors LLC | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Realty Investors LLC | |
Registered office | Boston, Massachusetts, USA | |
Primary business division | Asset Management | |
Share capital | $ 9 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Securities Australia Ltd | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Securities Australia Ltd | |
Registered office | Sydney, Australia | |
Primary business division | Investment Bank | |
Share capital | $ 0.3 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Securities Hong Kong Limited | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Securities Hong Kong Limited | |
Registered office | Hong Kong SAR, China | |
Primary business division | Investment Bank | |
Share capital | $ 4,154.2 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS Securities Japan Co., Ltd. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS Securities Japan Co., Ltd. | |
Registered office | Tokyo, Japan | |
Primary business division | Investment Bank | |
Share capital | $ 34,708.7 | |
Equity interest accumulated in % | 100.00% | |
UBS AG | UBS SuMi TRUST Wealth Management Co., Ltd. | ||
Disclosure Of Investments In Subsidiaries With Material Group Contribution [Table] | ||
Company | UBS SuMi TRUST Wealth Management Co., Ltd. | |
Registered office | Tokyo, Japan | |
Primary business division | Global Wealth Management | |
Share capital | $ 5,165 | |
Equity interest accumulated in % | 51.00% |
Interests in associates and j_3
Interests in associates and joint ventures (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
Carrying amount at the beginning of the year | $ 1,557 | $ 1,051 | |
Additions | 1 | 388 | |
Reclassifications | (386) | 0 | |
Share of comprehensive income | 150 | 83 | |
of which: share of net profit | 105 | 84 | $ 46 |
of which: share of other comprehensive income | 45 | (1) | |
Share of changes in retained earnings | 1 | (40) | |
Dividends received | (39) | (33) | |
Foreign currency translation | (39) | 108 | |
Carrying amount at the end of the year | 1,243 | 1,557 | 1,051 |
Share of profit (loss) of associates | 79 | 64 | |
Share of profit (loss) of joint ventures | 26 | 19 | |
Share of other comprehensive income of associates | 44 | 1 | |
Share of other comprehensive income of joint ventures | 1 | ||
Associates | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
of which: associates | 1,200 | 1,513 | |
of which: joint ventures | 43 | 44 | |
SIX Group AG, Zurich | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
of which: associates | $ 1,043 | 965 | |
UBS's equity interest | 17.31% | ||
Clearstream Fund Centre AG | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
Carrying amount at the end of the year | $ 386 | ||
of which: associates | 399 | ||
UBS's equity interest | 48.80% | ||
Gains (losses) on the sale of subsidiaries | 631 | ||
Other associates | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
of which: associates | $ 157 | 150 | |
UBS AG | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
Carrying amount at the beginning of the year | 1,557 | 1,051 | |
Additions | 1 | 388 | |
Reclassifications | (386) | 0 | |
Share of comprehensive income | 150 | 83 | |
of which: share of net profit | 105 | 84 | 46 |
of which: share of other comprehensive income | 45 | (1) | |
Share of changes in retained earnings | 1 | (40) | |
Dividends received | (39) | (33) | |
Foreign currency translation | (39) | 108 | |
Carrying amount at the end of the year | 1,243 | 1,557 | $ 1,051 |
of which: associates | 1,200 | 1,513 | |
of which: joint ventures | 43 | 44 | |
UBS AG | Associates | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
Share of profit (loss) of associates | 79 | 64 | |
Share of profit (loss) of joint ventures | 26 | 19 | |
Share of other comprehensive income of associates | 44 | 1 | |
Share of other comprehensive income of joint ventures | 1 | ||
UBS AG | SIX Group AG, Zurich | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
of which: associates | $ 1,043 | 965 | |
UBS's equity interest | 17.31% | ||
UBS AG | Clearstream Fund Centre AG | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
Carrying amount at the end of the year | $ 386 | ||
of which: associates | 399 | ||
UBS's equity interest | 48.80% | ||
Gains (losses) on the sale of subsidiaries | 631 | ||
UBS AG | Other associates | |||
Disclosure Of Investments In Associates And Joint Ventures [Table] | |||
of which: associates | $ 157 | $ 150 |
Interests in unconsolidated s_3
Interests in unconsolidated structured entities (Narrative) (Detail) - USD ($) $ in Billions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Sponsored [Member] | Non Existence Of Interest [Member] | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets transferred to client vehicles by UBS, at time of transfer | $ 1 | $ 0 |
Assets transferred to client vehicles by third parties, at time of transfer | 2 | 9 |
Total closing net asset value of sponsored investment funds | 46 | 37 |
Interests in Investment funds represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 158 | 124 |
Interests in Investment funds not represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 370 | 359 |
UBS AG | Sponsored [Member] | Non Existence Of Interest [Member] | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets transferred to client vehicles by UBS, at time of transfer | 1 | 0 |
Assets transferred to client vehicles by third parties, at time of transfer | 2 | 9 |
Total closing net asset value of sponsored investment funds | 46 | 37 |
UBS AG | Interests in Investment funds represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 103 | 89 |
UBS AG | Interests in Investment funds not represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | $ 425 | $ 395 |
Interests in unconsolidated s_4
Interests in unconsolidated structured entities (Detail 1) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | $ 12,588 | $ 15,326 |
Total liabilities | 294 | 390 |
Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 7,151 | 8,101 |
Total assets | 7,151 | 8,101 |
Derivative financial instruments - assets | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 205 | 211 |
Total assets | 205 | 213 |
Loans and advances to customers | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 125 | 179 |
Total assets | 125 | 179 |
Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 257 | 208 |
Total assets | 257 | 208 |
Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 4,849 | 6,624 |
Total assets | 4,849 | 6,624 |
Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 250 | 250 |
Total assets | 1 | 0 |
Derivative financial instruments - liabilities | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 0 | |
Total liabilities | 294 | 390 |
Securitization vehicles | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 610 | 416 |
Total liabilities | 2 | 3 |
Assets held by the unconsolidated structured entities in which UBS had an interest | 30,000 | 39,000 |
Assets recognised in entity's financial statements in relation to structured entities, which was held in Non-core and Legacy Portfolio unit within Group Functions | 100 | 200 |
Securitization vehicles | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 246 | 375 |
Securitization vehicles | Derivative financial instruments - assets | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 5 | 6 |
Securitization vehicles | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 35 | 35 |
Securitization vehicles | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 324 | |
Securitization vehicles | Derivative financial instruments - liabilities | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total liabilities | 2 | 3 |
Client vehicles | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 4,732 | 6,805 |
Total liabilities | 11 | 11 |
Assets held by the unconsolidated structured entities in which UBS had an interest | 81,000 | 136,000 |
Client vehicles | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 162 | 131 |
Client vehicles | Derivative financial instruments - assets | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 45 | 49 |
Client vehicles | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 1 | |
Client vehicles | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 4,525 | 6,624 |
Client vehicles | Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 0 | 0 |
Client vehicles | Derivative financial instruments - liabilities | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total liabilities | 11 | 11 |
Investment funds | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 7,247 | 8,104 |
Total liabilities | 281 | 376 |
Investment funds | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 6,743 | 7,595 |
Investment funds | Derivative financial instruments - assets | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 155 | 158 |
Investment funds | Loans and advances to customers | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 125 | 179 |
Investment funds | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 222 | 172 |
Investment funds | Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 0 | |
Investment funds | Derivative financial instruments - liabilities | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total liabilities | 281 | 376 |
Interests in Investment funds represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 158,000 | 124,000 |
Interests in Investment funds not represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 370,000 | 359,000 |
UBS AG | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 12,466 | 15,227 |
Total liabilities | 294 | 390 |
UBS AG | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 7,151 | 8,101 |
Total assets | 7,151 | 8,101 |
UBS AG | Derivative financial instruments - assets | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 205 | 211 |
Total assets | 205 | 213 |
UBS AG | Loans and advances to customers | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 125 | 179 |
Total assets | 125 | 179 |
UBS AG | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 135 | 109 |
Total assets | 135 | 109 |
UBS AG | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 4,849 | 6,624 |
Total assets | 4,849 | 6,624 |
UBS AG | Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 250 | 250 |
Total assets | 1 | 0 |
UBS AG | Derivative financial instruments - liabilities | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Maximum exposure to loss | 0 | |
Total liabilities | 294 | 390 |
UBS AG | Securitization vehicles | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 610 | 416 |
Total liabilities | 2 | 3 |
Assets held by the unconsolidated structured entities in which UBS had an interest | 30,000 | 39,000 |
Assets recognised in entity's financial statements in relation to structured entities, which was held in Non-core and Legacy Portfolio unit within Group Functions | 100 | 200 |
UBS AG | Securitization vehicles | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 246 | 375 |
UBS AG | Securitization vehicles | Derivative financial instruments - assets | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 5 | 6 |
UBS AG | Securitization vehicles | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 35 | 35 |
UBS AG | Securitization vehicles | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 324 | |
UBS AG | Securitization vehicles | Derivative financial instruments - liabilities | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total liabilities | 2 | 3 |
UBS AG | Client vehicles | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 4,732 | 6,805 |
Total liabilities | 11 | 11 |
Assets held by the unconsolidated structured entities in which UBS had an interest | 81,000 | 136,000 |
UBS AG | Client vehicles | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 162 | 131 |
UBS AG | Client vehicles | Derivative financial instruments - assets | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 45 | 49 |
UBS AG | Client vehicles | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 1 | |
UBS AG | Client vehicles | Financial assets measured at fair value through other comprehensive income | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 4,525 | 6,624 |
UBS AG | Client vehicles | Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 0 | 0 |
UBS AG | Client vehicles | Derivative financial instruments - liabilities | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total liabilities | 11 | 11 |
UBS AG | Investment funds | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 7,124 | 8,005 |
Total liabilities | 281 | 376 |
UBS AG | Investment funds | Financial assets at fair value held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 6,743 | 7,595 |
UBS AG | Investment funds | Derivative financial instruments - assets | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 155 | 158 |
UBS AG | Investment funds | Loans and advances to customers | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 125 | 179 |
UBS AG | Investment funds | Financial assets at fair value not held for trading | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 100 | 73 |
UBS AG | Investment funds | Other financial assets measured at amortized cost | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total assets | 0 | |
UBS AG | Investment funds | Derivative financial instruments - liabilities | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Total liabilities | 281 | 376 |
UBS AG | Interests in Investment funds represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | 103,000 | 89,000 |
UBS AG | Interests in Investment funds not represented on balance sheet | ||
Disclosure Of Unconsolidated Structured Entities [Table] | ||
Assets held by the unconsolidated structured entities in which UBS had an interest | $ 425,000 | $ 395,000 |
Changes in organization and a_2
Changes in organization and acquisitions and disposals of subsidiaries and businesses (Narrative) (Detail) SFr in Millions, $ in Millions | 12 Months Ended | |||
Dec. 31, 2021CHF (SFr) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | Dec. 31, 2019USD ($) | |
Disclosure Of Changes In Organisation [Table] | ||||
Investments in subsidiaries and associates | $ 1,243 | $ 1,557 | $ 1,051 | |
Tax expense / (benefit) | 1,998 | $ 1,583 | 1,267 | |
Assets of disposal groups held for sale | 1,093 | |||
Liabilities of disposal group held for sale | 1,298 | |||
UBS Brasil Servicos | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Decrease in proportion of ownership in subsidiaries that do not result in loss of control | 49.99% | |||
UBS Austria | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Tax expense / (benefit) | $ 25 | |||
UBS SuMi TRUST Wealth Management Co., Ltd. | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Proportion of ownership interest in subsidiary | 51.00% | 51.00% | ||
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity attributable to owners of parent | $ 155 | |||
UBS Wealth Management business in Spain | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Expected future pre-tax gain upon sale of businesses | 200 | |||
Assets of disposal groups held for sale | 647 | |||
Liabilities of disposal group held for sale | 823 | |||
UBS Swiss Financial Advisers AG | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Assets of disposal groups held for sale | 446 | |||
Liabilities of disposal group held for sale | 475 | |||
Wealthfront | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Acquisition cost of subsidiaries and businesses | 1,400 | |||
Goodwill and intangible assets that will be recognized upon the acquisition of subsidiaries and businesses | $ 1,200 | |||
Clearstream Fund Centre AG [Member] | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Proportion of ownership interest in associate | 48.80% | 48.80% | ||
Gains (losses) recognised when control is lost | $ 631 | |||
Investments in subsidiaries and associates | $ 386 | |||
Proceeds from sales of interests in associates | SFr | SFr 390 | |||
UBS AG | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Investments in subsidiaries and associates | 1,243 | 1,557 | 1,051 | |
Tax expense / (benefit) | 1,903 | $ 1,488 | $ 1,198 | |
Assets of disposal groups held for sale | 1,093 | |||
Liabilities of disposal group held for sale | 1,298 | |||
UBS AG | UBS Brasil Servicos | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Decrease in proportion of ownership in subsidiaries that do not result in loss of control | 49.99% | |||
UBS AG | UBS Austria | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Tax expense / (benefit) | $ 25 | |||
UBS AG | UBS SuMi TRUST Wealth Management Co., Ltd. | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Proportion of ownership interest in subsidiary | 51.00% | 51.00% | ||
Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity attributable to owners of parent | $ 155 | |||
UBS AG | UBS Wealth Management business in Spain | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Expected future pre-tax gain upon sale of businesses | 200 | |||
Assets of disposal groups held for sale | 647 | |||
Liabilities of disposal group held for sale | 823 | |||
UBS AG | UBS Swiss Financial Advisers AG | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Assets of disposal groups held for sale | 446 | |||
Liabilities of disposal group held for sale | 475 | |||
UBS AG | Wealthfront | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Acquisition cost of subsidiaries and businesses | 1,400 | |||
Goodwill and intangible assets that will be recognized upon the acquisition of subsidiaries and businesses | $ 1,200 | |||
UBS AG | Clearstream Fund Centre AG [Member] | ||||
Disclosure Of Changes In Organisation [Table] | ||||
Proportion of ownership interest in associate | 48.80% | 48.80% | ||
Gains (losses) recognised when control is lost | $ 631 | |||
Investments in subsidiaries and associates | $ 386 | |||
Proceeds from sales of interests in associates | SFr | SFr 390 |
Events after the reporting pe_2
Events after the reporting period (Narrative) (Detail) - Russia's invasion of Ukraine $ in Millions | Dec. 31, 2021USD ($) |
Disclosure Of Nonadjusting Events After Reporting Period [Table] | |
Country risk exposure to Russia | $ 600 |
Net assets, OOO UBS Bank | 51 |
Exposure to Russia through Lombard collateral and other secured financing, as of 3 March 2022. | 200 |
Russia loans subject to sanctions, as of 3 March 2022 | 10 |
UBS AG | |
Disclosure Of Nonadjusting Events After Reporting Period [Table] | |
Country risk exposure to Russia | 600 |
Net assets, OOO UBS Bank | 51 |
Exposure to Russia through Lombard collateral and other secured financing, as of 3 March 2022. | 200 |
Russia loans subject to sanctions, as of 3 March 2022 | $ 10 |
Related parties (Narrative) (De
Related parties (Narrative) (Detail) SFr in Millions, $ in Millions | 12 Months Ended | |||||
Dec. 31, 2021CHF (SFr) | Dec. 31, 2021USD ($) | Dec. 31, 2020CHF (SFr) | Dec. 31, 2020USD ($) | Dec. 31, 2019CHF (SFr) | Dec. 31, 2019USD ($) | |
Entity [Table] | ||||||
Payments to external board members | SFr 6.9 | $ 7.5 | SFr 6.6 | $ 7 | SFr 7.3 | $ 7.3 |
UBS AG | ||||||
Entity [Table] | ||||||
Payments to external board members | SFr 6.9 | $ 7.5 | SFr 6.6 | $ 7 | SFr 7.3 | $ 7.3 |
Related parties (Detail 1)
Related parties (Detail 1) SFr in Millions, $ in Millions | 12 Months Ended | |||||
Dec. 31, 2021CHF (SFr) | Dec. 31, 2021USD ($) | Dec. 31, 2020CHF (SFr) | Dec. 31, 2020USD ($) | Dec. 31, 2019CHF (SFr) | Dec. 31, 2019USD ($) | |
Entity [Table] | ||||||
Base salaries and other cash payments | $ 31 | $ 33 | $ 32 | |||
Incentive awards - cash | 17 | 18 | 14 | |||
Annual incentive award under DCCP | 26 | 27 | 21 | |||
Employer's contributions to retirement benefit plans | 3 | 3 | 3 | |||
Benefits in kind, fringe benefits (at market value) | 1 | 1 | 1 | |||
Equity-based compensation | 45 | 47 | 37 | |||
Total | SFr 113 | $ 124 | SFr 121 | $ 129 | SFr 107 | $ 108 |
Applicable performance award currency exchange rate | 0.92 | 0.92 | 0.94 | 0.94 | 0.99 | 0.99 |
UBS AG | ||||||
Entity [Table] | ||||||
Base salaries and other cash payments | $ 30 | $ 31 | $ 30 | |||
Incentive awards - cash | 17 | 17 | 13 | |||
Annual incentive award under DCCP | 26 | 26 | 20 | |||
Employer's contributions to retirement benefit plans | 2 | 2 | 2 | |||
Benefits in kind, fringe benefits (at market value) | 1 | 1 | 1 | |||
Equity-based compensation | 45 | 45 | 34 | |||
Total | SFr 112 | $ 122 | SFr 115 | $ 122 | SFr 101 | $ 101 |
Applicable performance award currency exchange rate | 0.92 | 0.92 | 0.94 | 0.94 | 0.99 | 0.99 |
Related parties (Detail 2)
Related parties (Detail 2) - shares | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Entity [Table] | ||
Number of shares held by members of the BoD, GEB and parties closely linked to them | 4,597,006 | 5,288,317 |
UBS AG | ||
Entity [Table] | ||
Number of shares held by members of the BoD, GEB and parties closely linked to them | 4,175,515 | 4,956,640 |
Related parties (Detail 3)
Related parties (Detail 3) SFr in Millions, $ in Millions | 12 Months Ended | ||
Dec. 31, 2021CHF (SFr) | Dec. 31, 2021USD ($) | Dec. 31, 2020USD ($) | |
Entity [Table] | |||
Balance at the beginning of the year | SFr 34 | $ 38 | $ 33 |
Additions | 11 | 14 | |
Reductions | (15) | (8) | |
Balance at the end of the year | 31 | 34 | 38 |
UBS AG | |||
Entity [Table] | |||
Balance at the beginning of the year | 28 | 31 | 23 |
Additions | 11 | 13 | |
Reductions | (15) | (5) | |
Balance at the end of the year | SFr 25 | $ 28 | $ 31 |
Related parties (Detail 4)
Related parties (Detail 4) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Entity [Table] | ||
Carrying amount at the beginning of the year | $ 630 | $ 982 |
Additions | 133 | 527 |
Reductions | 497 | 1,001 |
Foreign currency translation | (14) | 123 |
Carrying amount at the end of the year | 251 | 630 |
of which: unsecured loans | 243 | 621 |
Other transactions with associates and joint ventures | ||
Payments to associates and joint ventures for goods and services received | 157 | 139 |
Fees received for services provided to associates and joint ventures | 104 | 128 |
Liabilities to associates and joint ventures | 127 | 91 |
Commitments and contingent liabilities to associates and joint ventures | 7 | 9 |
UBS AG | ||
Entity [Table] | ||
Carrying amount at the beginning of the year | 630 | 982 |
Additions | 133 | 527 |
Reductions | (497) | (1,001) |
Foreign currency translation | (14) | 123 |
Carrying amount at the end of the year | 251 | 630 |
of which: unsecured loans | 243 | 621 |
Other transactions with associates and joint ventures | ||
Payments to associates and joint ventures for goods and services received | 157 | 139 |
Fees received for services provided to associates and joint ventures | 104 | 128 |
Liabilities to associates and joint ventures | 127 | 91 |
Commitments and contingent liabilities to associates and joint ventures | $ 7 | $ 9 |
Related parties (Detail 5)
Related parties (Detail 5) - UBS AG - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
Receivables | ||
Loans and advances to customers | $ 1,049 | $ 1,470 |
Financial assets at fair value held for trading | 187 | 76 |
Other financial assets measured at amortized cost | 45 | 38 |
Payables | ||
Customer deposits | 2,828 | 3,324 |
Funding from UBS Group AG | 57,295 | 53,979 |
Other financial liabilities measured at amortized cost | 1,887 | 1,820 |
Other financial liabilities designated at fair value | $ 2,340 | $ 1,375 |
Invested assets and net new m_3
Invested assets and net new money (Detail 1) - USD ($) $ in Billions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Fund assets managed by UBS | $ 419 | $ 397 | |
Discretionary assets | 1,705 | 1,459 | |
Other invested assets | 2,472 | 2,331 | |
Total invested assets | 4,596 | 4,187 | $ 3,607 |
of which: double counts | 356 | 311 | |
Net new money | 159 | 127 | |
UBS AG | |||
Entity [Table] | |||
Fund assets managed by UBS | 419 | 397 | |
Discretionary assets | 1,705 | 1,459 | |
Other invested assets | 2,472 | 2,331 | |
Total invested assets | 4,596 | 4,187 | $ 3,607 |
of which: double counts | 356 | 311 | |
Net new money | $ 159 | $ 127 |
Invested assets and net new m_4
Invested assets and net new money (Detail 2) - USD ($) $ in Billions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Entity [Table] | ||
Total invested assets at the beginning of the year | $ 4,187 | $ 3,607 |
Net new money | 159 | 127 |
Market movements | 339 | 359 |
Foreign currency translation | (65) | 96 |
Other effects | (24) | (1) |
of which: acquisitions / (divestments) | (5) | 0 |
Total invested assets at the end of the year | 4,596 | 4,187 |
UBS AG | ||
Entity [Table] | ||
Total invested assets at the beginning of the year | 4,187 | 3,607 |
Net new money | 159 | 127 |
Market movements | 339 | 359 |
Foreign currency translation | (65) | 96 |
Other effects | (24) | (1) |
of which: acquisitions / (divestments) | (5) | 0 |
Total invested assets at the end of the year | $ 4,596 | $ 4,187 |
Currency translation rates (Det
Currency translation rates (Detail) | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
1 CHF | |||
Foreign Exchange Rates [Table] | |||
Closing exchange rate | 1.10 | 1.13 | |
Average rate | 1.09 | 1.07 | 1.01 |
1 EUR | |||
Foreign Exchange Rates [Table] | |||
Closing exchange rate | 1.14 | 1.22 | |
Average rate | 1.18 | 1.15 | 1.12 |
1 GBP | |||
Foreign Exchange Rates [Table] | |||
Closing exchange rate | 1.35 | 1.37 | |
Average rate | 1.37 | 1.29 | 1.28 |
100 JPY | |||
Foreign Exchange Rates [Table] | |||
Closing exchange rate | 0.87 | 0.97 | |
Average rate | 0.91 | 0.94 | 0.92 |
UBS AG | 1 CHF | |||
Foreign Exchange Rates [Table] | |||
Closing exchange rate | 1.10 | 1.13 | |
Average rate | 1.09 | 1.07 | 1.01 |
UBS AG | 1 EUR | |||
Foreign Exchange Rates [Table] | |||
Closing exchange rate | 1.14 | 1.22 | |
Average rate | 1.18 | 1.15 | 1.12 |
UBS AG | 1 GBP | |||
Foreign Exchange Rates [Table] | |||
Closing exchange rate | 1.35 | 1.37 | |
Average rate | 1.37 | 1.29 | 1.28 |
UBS AG | 100 JPY | |||
Foreign Exchange Rates [Table] | |||
Closing exchange rate | 0.87 | 0.97 | |
Average rate | 0.91 | 0.94 | 0.92 |
Main differences between IFRS_2
Main differences between IFRS and Swiss GAAP (Narrative) (Detail) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Goodwill, maximum useful life for justified exceptional cases (in years) | 10 years |
UBS AG [Member] | |
Entity [Table] | |
Goodwill, maximum useful life for justified exceptional cases (in years) | 10 years |
Supplemental guarantor inform_3
Supplemental guarantor information (Narrative) (Detail) - UBS AG $ in Billions | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Entity [Table] | |
Joint and several liability | $ 5.7 |
Increase decrease in joint and several liability | $ 4.4 |
Supplemental guarantor consolid
Supplemental guarantor consolidated income statement (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Condensed Income Statement [Table] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | $ 8,533 | $ 8,810 | $ 10,684 |
Interest expense from financial instruments measured at amortized cost | (3,259) | (4,247) | (7,194) |
Net interest income from financial instruments measured at fair value through profit or loss | 1,431 | 1,299 | 1,011 |
Net interest income | 6,705 | 5,862 | 4,501 |
Other net income from financial instruments measured at fair value through profit or loss | 5,850 | 6,960 | 6,842 |
Credit loss (expense) / release | 148 | (694) | (78) |
Fee and commission income | 24,372 | 20,961 | 19,110 |
Fee and commission expense | (1,985) | (1,775) | (1,696) |
Net fee and commission income | 22,387 | 19,186 | 17,413 |
Other income | 452 | 1,076 | 212 |
Total operating income | 35,542 | 32,390 | 28,889 |
Personnel expenses | 18,387 | 17,224 | 16,084 |
General and administrative expenses | 5,553 | 4,885 | 5,288 |
Depreciation, amortization and impairment of non-financial assets | 2,118 | 2,126 | 1,940 |
Total operating expenses | 26,058 | 24,235 | 23,312 |
Operating profit / (loss) before tax | 9,484 | 8,155 | 5,577 |
Tax expense / (benefit) | 1,998 | 1,583 | 1,267 |
Net profit / (loss) | 7,486 | 6,572 | 4,310 |
Profit Loss Attributable To Non-controlling Interests | 29 | 15 | 6 |
Net profit / (loss) attributable to shareholders | 7,457 | 6,557 | 4,304 |
UBS AG (consolidated) | |||
Condensed Income Statement [Table] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 8,534 | 8,816 | 10,703 |
Interest expense from financial instruments measured at amortized cost | (3,366) | (4,333) | (7,303) |
Net interest income from financial instruments measured at fair value through profit or loss | 1,437 | 1,305 | 1,015 |
Net interest income | 6,605 | 5,788 | 4,415 |
Other net income from financial instruments measured at fair value through profit or loss | 5,844 | 6,930 | 6,833 |
Credit loss (expense) / release | 148 | (695) | (78) |
Fee and commission income | 24,422 | 20,982 | 19,156 |
Fee and commission expense | (1,985) | (1,775) | (1,696) |
Net fee and commission income | 22,438 | 19,207 | 17,460 |
Other income | 941 | 1,549 | 677 |
Total operating income | 35,976 | 32,780 | 29,307 |
Personnel expenses | 15,661 | 14,686 | 13,801 |
General and administrative expenses | 9,476 | 8,486 | 8,586 |
Depreciation, amortization and impairment of non-financial assets | 1,875 | 1,909 | 1,751 |
Total operating expenses | 27,012 | 25,081 | 24,138 |
Operating profit / (loss) before tax | 8,964 | 7,699 | 5,169 |
Tax expense / (benefit) | 1,903 | 1,488 | 1,198 |
Net profit / (loss) | 7,061 | 6,211 | 3,971 |
Profit Loss Attributable To Non-controlling Interests | 29 | 15 | 6 |
Net profit / (loss) attributable to shareholders | 7,032 | 6,196 | 3,965 |
UBS AG (consolidated) | Elimination entries | |||
Condensed Income Statement [Table] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | (703) | (818) | (1,928) |
Interest expense from financial instruments measured at amortized cost | 1,025 | 1,134 | 2,298 |
Net interest income from financial instruments measured at fair value through profit or loss | (274) | (273) | (327) |
Net interest income | 48 | 43 | 42 |
Other net income from financial instruments measured at fair value through profit or loss | (83) | 118 | (322) |
Credit loss (expense) / release | (24) | 0 | 0 |
Fee and commission income | (770) | (984) | (997) |
Fee and commission expense | 755 | 961 | 986 |
Net fee and commission income | (14) | (23) | (11) |
Other income | (8,396) | (5,941) | (6,442) |
Total operating income | (8,469) | (5,803) | (6,733) |
Personnel expenses | 1 | 0 | 0 |
General and administrative expenses | (2,696) | (2,481) | (2,627) |
Depreciation, amortization and impairment of non-financial assets | (114) | (115) | (196) |
Total operating expenses | (2,809) | (2,596) | (2,823) |
Operating profit / (loss) before tax | (5,660) | (3,207) | (3,911) |
Tax expense / (benefit) | (11) | (107) | (21) |
Net profit / (loss) | (5,649) | (3,100) | (3,890) |
Profit Loss Attributable To Non-controlling Interests | 0 | 0 | 0 |
Net profit / (loss) attributable to shareholders | (5,649) | (3,100) | (3,889) |
UBS AG (consolidated) | UBS AG (standalone) | Reportable legal entities | |||
Condensed Income Statement [Table] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 3,130 | 3,386 | 4,864 |
Interest expense from financial instruments measured at amortized cost | (2,847) | (3,694) | (6,547) |
Net interest income from financial instruments measured at fair value through profit or loss | 1,229 | 1,103 | 1,177 |
Net interest income | 1,512 | 794 | (506) |
Other net income from financial instruments measured at fair value through profit or loss | 3,751 | 4,857 | 5,116 |
Credit loss (expense) / release | 65 | (352) | (51) |
Fee and commission income | 3,837 | 3,731 | 3,285 |
Fee and commission expense | (810) | (644) | (674) |
Net fee and commission income | 3,027 | 3,087 | 2,610 |
Other income | 7,555 | 4,671 | 4,899 |
Total operating income | 15,910 | 13,057 | 12,069 |
Personnel expenses | 3,401 | 3,458 | 3,251 |
General and administrative expenses | 4,255 | 3,507 | 3,467 |
Depreciation, amortization and impairment of non-financial assets | 949 | 1,013 | 954 |
Total operating expenses | 8,605 | 7,978 | 7,672 |
Operating profit / (loss) before tax | 7,305 | 5,079 | 4,396 |
Tax expense / (benefit) | 203 | 238 | 175 |
Net profit / (loss) | 7,102 | 4,840 | 4,221 |
Profit Loss Attributable To Non-controlling Interests | 0 | 0 | 0 |
Net profit / (loss) attributable to shareholders | 7,102 | 4,840 | 4,221 |
UBS AG (consolidated) | UBS Switzerland AG (standalone) | Reportable legal entities | |||
Condensed Income Statement [Table] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 3,652 | 3,636 | 4,048 |
Interest expense from financial instruments measured at amortized cost | (520) | (513) | (737) |
Net interest income from financial instruments measured at fair value through profit or loss | 254 | 164 | (228) |
Net interest income | 3,386 | 3,288 | 3,083 |
Other net income from financial instruments measured at fair value through profit or loss | 807 | 911 | 924 |
Credit loss (expense) / release | 98 | (286) | 7 |
Fee and commission income | 5,204 | 4,585 | 4,342 |
Fee and commission expense | (481) | (829) | (819) |
Net fee and commission income | 4,723 | 3,756 | 3,523 |
Other income | 221 | 233 | 259 |
Total operating income | 9,235 | 7,902 | 7,796 |
Personnel expenses | 2,098 | 2,017 | 1,936 |
General and administrative expenses | 3,442 | 3,313 | 3,181 |
Depreciation, amortization and impairment of non-financial assets | 285 | 261 | 221 |
Total operating expenses | 5,825 | 5,591 | 5,338 |
Operating profit / (loss) before tax | 3,409 | 2,311 | 2,458 |
Tax expense / (benefit) | 622 | 444 | 514 |
Net profit / (loss) | 2,788 | 1,868 | 1,944 |
Profit Loss Attributable To Non-controlling Interests | 0 | 0 | 0 |
Net profit / (loss) attributable to shareholders | 2,788 | 1,868 | 1,944 |
UBS AG (consolidated) | Other subsidiaries | Reportable legal entities | |||
Condensed Income Statement [Table] | |||
Interest income from financial instruments measured at amortized cost and fair value through other comprehensive income | 2,456 | 2,612 | 3,719 |
Interest expense from financial instruments measured at amortized cost | (1,024) | (1,261) | (2,317) |
Net interest income from financial instruments measured at fair value through profit or loss | 228 | 311 | 394 |
Net interest income | 1,660 | 1,662 | 1,796 |
Other net income from financial instruments measured at fair value through profit or loss | 1,369 | 1,044 | 1,114 |
Credit loss (expense) / release | 10 | (56) | (33) |
Fee and commission income | 16,151 | 13,651 | 12,527 |
Fee and commission expense | (1,450) | (1,263) | (1,188) |
Net fee and commission income | 14,702 | 12,388 | 11,338 |
Other income | 1,560 | 2,585 | 1,960 |
Total operating income | 19,300 | 17,623 | 16,176 |
Personnel expenses | 10,161 | 9,211 | 8,614 |
General and administrative expenses | 4,474 | 4,147 | 4,565 |
Depreciation, amortization and impairment of non-financial assets | 755 | 750 | 772 |
Total operating expenses | 15,390 | 14,108 | 13,951 |
Operating profit / (loss) before tax | 3,910 | 3,515 | 2,225 |
Tax expense / (benefit) | 1,090 | 912 | 530 |
Net profit / (loss) | 2,820 | 2,603 | 1,695 |
Profit Loss Attributable To Non-controlling Interests | 29 | 15 | 6 |
Net profit / (loss) attributable to shareholders | $ 2,792 | $ 2,588 | $ 1,689 |
Supplemental guarantor consol_2
Supplemental guarantor consolidated statement of comprehensive income (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | $ 7,486 | $ 6,572 | $ 4,310 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (2,393) | 2,230 | 1,363 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 26 | (490) | (582) |
Total other comprehensive income | (2,367) | 1,740 | 781 |
Total comprehensive income | 5,119 | 8,312 | 5,091 |
Comprehensive income attributable to shareholders | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 7,457 | 6,557 | 4,304 |
Foreign currency translation, net of tax | (535) | 1,095 | 104 |
Financial assets measured at fair value through other comprehensive income, net of tax | (157) | 136 | 117 |
Cash flow hedges, net of tax | (1,675) | 1,011 | 1,143 |
Cost of hedging, net of tax | (26) | (13) | |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (2,393) | 2,230 | 1,363 |
Defined benefit plans, net of tax | (5) | (218) | (186) |
Own credit on financial liabilities designated at fair value, net of tax | 46 | (293) | (392) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 42 | (511) | (578) |
Total other comprehensive income | (2,351) | 1,719 | 785 |
Total comprehensive income | 5,106 | 8,276 | 5,089 |
Comprehensive income attributable to non-controlling interests | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 29 | 15 | 6 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (16) | 21 | (4) |
Total other comprehensive income | (16) | 21 | (4) |
Total comprehensive income | 13 | 36 | 2 |
UBS AG (consolidated) | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 7,061 | 6,211 | 3,971 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (2,368) | 2,165 | 1,351 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 132 | (406) | (566) |
Total other comprehensive income | (2,235) | 1,759 | 785 |
Total comprehensive income | 4,826 | 7,970 | 4,756 |
UBS AG (consolidated) | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 7,032 | 6,196 | 3,965 |
Foreign currency translation, net of tax | (510) | 1,030 | 92 |
Financial assets measured at fair value through other comprehensive income, net of tax | (157) | 136 | 117 |
Cash flow hedges, net of tax | (1,675) | 1,011 | 1,143 |
Cost of hedging, net of tax | (26) | (13) | |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (2,368) | 2,165 | 1,351 |
Defined benefit plans, net of tax | 102 | (134) | (170) |
Own credit on financial liabilities designated at fair value, net of tax | 46 | (293) | (392) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 148 | (427) | (562) |
Total other comprehensive income | (2,220) | 1,738 | 789 |
Total comprehensive income | 4,813 | 7,934 | 4,754 |
UBS AG (consolidated) | Comprehensive income attributable to non-controlling interests | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 29 | 15 | 6 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (16) | 21 | (4) |
Total other comprehensive income | (16) | 21 | (4) |
Total comprehensive income | 13 | 36 | 2 |
UBS AG (consolidated) | Elimination entries | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | (5,649) | (3,100) | (3,890) |
Total comprehensive income | (5,149) | (4,088) | (4,007) |
UBS AG (consolidated) | Elimination entries | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | (5,649) | (3,100) | (3,889) |
Foreign currency translation, net of tax | 517 | (969) | (102) |
Financial assets measured at fair value through other comprehensive income, net of tax | 0 | 0 | 0 |
Cash flow hedges, net of tax | (17) | (18) | (15) |
Total other comprehensive income that may be reclassified to the income statement, net of tax | 500 | (988) | (117) |
Defined benefit plans, net of tax | 0 | 0 | 0 |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 0 | 0 | 0 |
Total other comprehensive income | 500 | (988) | (117) |
Total comprehensive income | (5,149) | (4,088) | (4,007) |
UBS AG (consolidated) | UBS AG (standalone) | Reportable legal entities | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 7,102 | 4,840 | 4,221 |
Total comprehensive income | 6,163 | 5,451 | 4,616 |
UBS AG (consolidated) | UBS AG (standalone) | Reportable legal entities | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 7,102 | 4,840 | 4,221 |
Foreign currency translation, net of tax | (1) | 81 | 5 |
Financial assets measured at fair value through other comprehensive income, net of tax | 0 | 0 | 0 |
Cash flow hedges, net of tax | (1,129) | 902 | 870 |
Cost of hedging, net of tax | (26) | (13) | |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (1,155) | 971 | 875 |
Defined benefit plans, net of tax | 170 | (67) | (89) |
Own credit on financial liabilities designated at fair value, net of tax | 46 | (293) | (392) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 217 | (360) | (481) |
Total other comprehensive income | (939) | 611 | 394 |
Total comprehensive income | 6,163 | 5,451 | 4,616 |
UBS AG (consolidated) | UBS Switzerland AG (standalone) | Reportable legal entities | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 2,788 | 1,868 | 1,944 |
Total comprehensive income | 1,954 | 3,015 | 2,228 |
UBS AG (consolidated) | UBS Switzerland AG (standalone) | Reportable legal entities | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 2,788 | 1,868 | 1,944 |
Foreign currency translation, net of tax | (419) | 1,228 | 150 |
Financial assets measured at fair value through other comprehensive income, net of tax | 0 | 0 | |
Cash flow hedges, net of tax | (279) | 26 | 140 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (699) | 1,254 | 290 |
Defined benefit plans, net of tax | (135) | (107) | (6) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | (135) | (107) | (6) |
Total other comprehensive income | (834) | 1,147 | 284 |
Total comprehensive income | 1,954 | 3,015 | 2,228 |
UBS AG (consolidated) | Other subsidiaries | Reportable legal entities | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 2,820 | 2,603 | 1,695 |
Total comprehensive income | 1,858 | 3,592 | 1,919 |
UBS AG (consolidated) | Other subsidiaries | Reportable legal entities | Comprehensive income attributable to shareholders | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Net profit / (loss) | 2,792 | 2,588 | 1,689 |
Foreign currency translation, net of tax | (607) | 690 | 39 |
Financial assets measured at fair value through other comprehensive income, net of tax | (157) | 137 | 117 |
Cash flow hedges, net of tax | (250) | 101 | 147 |
Total other comprehensive income that may be reclassified to the income statement, net of tax | (1,014) | 928 | 303 |
Defined benefit plans, net of tax | 67 | 40 | (75) |
Total other comprehensive income that will not be reclassified to the income statement, net of tax | 67 | 40 | (75) |
Total other comprehensive income | (947) | 968 | 228 |
Total comprehensive income | 1,845 | 3,556 | 1,917 |
UBS AG (consolidated) | Other subsidiaries | Reportable legal entities | Comprehensive income attributable to non-controlling interests | |||
Condensed Statement Of Comprehensive Income [Table] | |||
Total comprehensive income | $ 13 | $ 36 | $ 2 |
Supplemental guarantor consol_3
Supplemental guarantor consolidated balance sheet (Detail) - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 |
Assets | ||||
Cash and balances at central banks | $ 192,817,000,000 | $ 158,231,000,000 | ||
Loans and advances to banks | 15,480,000,000 | 15,444,000,000 | ||
Receivables from securities financing transactions | 75,012,000,000 | 74,210,000,000 | ||
Cash collateral receivables on derivative instruments | 30,514,000,000 | 32,737,000,000 | ||
Loans and advances to customers | 397,761,000,000 | 379,528,000,000 | ||
Other financial assets measured at amortized cost | 26,209,000,000 | 27,194,000,000 | ||
Total financial assets measured at amortized cost | 737,794,000,000 | 687,345,000,000 | ||
Financial assets at fair value held for trading | 130,821,000,000 | 125,397,000,000 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 43,397,000,000 | 47,098,000,000 | ||
Derivative financial instruments | 118,142,000,000 | 159,617,000,000 | ||
Brokerage receivables | 21,839,000,000 | 24,659,000,000 | ||
Financial assets at fair value not held for trading | 60,080,000,000 | 80,364,000,000 | ||
Total financial assets measured at fair value through profit or loss | 330,882,000,000 | 390,037,000,000 | ||
Financial assets measured at fair value through other comprehensive income | 8,844,000,000 | 8,258,000,000 | ||
Investments in subsidiaries and associates | 1,243,000,000 | 1,557,000,000 | $ 1,051,000,000 | |
Property, equipment and software | 12,888,000,000 | 13,109,000,000 | 12,804,000,000 | |
Goodwill and intangible assets | 6,378,000,000 | 6,480,000,000 | ||
Deferred tax assets | 8,876,000,000 | 9,212,000,000 | ||
Other non-financial assets | 10,277,000,000 | 9,768,000,000 | ||
Total assets | 1,117,182,000,000 | 1,125,765,000,000 | 972,194,000,000 | |
Liabilities | ||||
Amounts due to banks | 13,101,000,000 | 11,050,000,000 | ||
Payables from securities financing transactions | 5,533,000,000 | 6,321,000,000 | ||
Cash collateral payables on derivative instruments | 31,798,000,000 | 37,312,000,000 | ||
Customer deposits | 542,007,000,000 | 524,605,000,000 | ||
Debt issued measured at amortized cost | 139,155,000,000 | 139,232,000,000 | ||
Other financial liabilities measured at amortized cost | 9,001,000,000 | 9,729,000,000 | ||
Total financial liabilities measured at amortized cost | 740,595,000,000 | 728,250,000,000 | ||
Financial liabilities at fair value held for trading | 31,688,000,000 | 33,595,000,000 | ||
Derivative financial instruments | 121,309,000,000 | 161,102,000,000 | ||
Brokerage payables designated at fair value | 44,045,000,000 | 38,742,000,000 | ||
Debt issued designated at fair value | 73,799,000,000 | 61,243,000,000 | ||
Other financial liabilities designated at fair value | 30,074,000,000 | 30,387,000,000 | ||
Total financial liabilities measured at fair value through profit or loss | 300,916,000,000 | 325,069,000,000 | ||
Provisions | 3,518,000,000 | 2,828,000,000 | ||
Other non-financial liabilities | 11,151,000,000 | 9,854,000,000 | ||
Total liabilities | 1,056,180,000,000 | 1,066,000,000,000 | ||
Equity | ||||
Equity attributable to shareholders | 60,662,000,000 | 59,445,000,000 | ||
Equity attributable to non-controlling interests | 340,000,000 | 319,000,000 | ||
Total equity | 61,002,000,000 | 59,765,000,000 | 54,675,000,000 | $ 53,060,000,000 |
Total liabilities and equity | 1,117,182,000,000 | 1,125,765,000,000 | ||
UBS AG (consolidated) | ||||
Assets | ||||
Cash and balances at central banks | 192,817,000,000 | 158,231,000,000 | ||
Loans and advances to banks | 15,360,000,000 | 15,344,000,000 | ||
Receivables from securities financing transactions | 75,012,000,000 | 74,210,000,000 | ||
Cash collateral receivables on derivative instruments | 30,514,000,000 | 32,737,000,000 | ||
Loans and advances to customers | 398,693,000,000 | 380,977,000,000 | ||
Other financial assets measured at amortized cost | 26,236,000,000 | 27,219,000,000 | ||
Total financial assets measured at amortized cost | 738,632,000,000 | 688,717,000,000 | ||
Financial assets at fair value held for trading | 131,033,000,000 | 125,492,000,000 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 43,397,000,000 | 47,098,000,000 | ||
Derivative financial instruments | 118,145,000,000 | 159,618,000,000 | ||
Brokerage receivables | 21,839,000,000 | 24,659,000,000 | ||
Financial assets at fair value not held for trading | 59,642,000,000 | 80,038,000,000 | ||
Total financial assets measured at fair value through profit or loss | 330,659,000,000 | 389,808,000,000 | ||
Financial assets measured at fair value through other comprehensive income | 8,844,000,000 | 8,258,000,000 | ||
Investments in subsidiaries and associates | 1,243,000,000 | 1,557,000,000 | 1,051,000,000 | |
Property, equipment and software | 11,712,000,000 | 11,958,000,000 | 11,826,000,000 | |
Goodwill and intangible assets | 6,378,000,000 | 6,480,000,000 | ||
Deferred tax assets | 8,839,000,000 | 9,174,000,000 | ||
Other non-financial assets | 9,836,000,000 | 9,374,000,000 | ||
Total assets | 1,116,145,000,000 | 1,125,327,000,000 | 971,927,000,000 | |
Liabilities | ||||
Amounts due to banks | 13,101,000,000 | 11,050,000,000 | ||
Payables from securities financing transactions | 5,533,000,000 | 6,321,000,000 | ||
Cash collateral payables on derivative instruments | 31,801,000,000 | 37,313,000,000 | ||
Customer deposits | 544,834,000,000 | 527,929,000,000 | ||
Funding from UBS Group AG | 57,295,000,000 | 53,979,000,000 | ||
Debt issued measured at amortized cost | 82,432,000,000 | 85,351,000,000 | ||
Other financial liabilities measured at amortized cost | 9,765,000,000 | 10,421,000,000 | ||
Total financial liabilities measured at amortized cost | 744,762,000,000 | 732,364,000,000 | ||
Financial liabilities at fair value held for trading | 31,688,000,000 | 33,595,000,000 | ||
Derivative financial instruments | 121,309,000,000 | 161,102,000,000 | ||
Brokerage payables designated at fair value | 44,045,000,000 | 38,742,000,000 | ||
Debt issued designated at fair value | 71,460,000,000 | 59,868,000,000 | ||
Other financial liabilities designated at fair value | 32,414,000,000 | 31,773,000,000 | ||
Total financial liabilities measured at fair value through profit or loss | 300,916,000,000 | 325,080,000,000 | ||
Provisions | 3,452,000,000 | 2,791,000,000 | ||
Other non-financial liabilities | 8,572,000,000 | 7,018,000,000 | ||
Total liabilities | 1,057,702,000,000 | 1,067,254,000,000 | ||
Equity | ||||
Equity attributable to shareholders | 58,102,000,000 | 57,754,000,000 | ||
Equity attributable to non-controlling interests | 340,000,000 | 319,000,000 | ||
Total equity | 58,442,000,000 | 58,073,000,000 | $ 53,896,000,000 | $ 52,389,000,000 |
Total liabilities and equity | 1,116,145,000,000 | 1,125,327,000,000 | ||
UBS AG (consolidated) | Elimination entries | ||||
Assets | ||||
Loans and advances to banks | (51,245,000,000) | (50,678,000,000) | ||
Receivables from securities financing transactions | (21,577,000,000) | (29,735,000,000) | ||
Cash collateral receivables on derivative instruments | (10,518,000,000) | (11,671,000,000) | ||
Loans and advances to customers | (26,188,000,000) | (20,767,000,000) | ||
Other financial assets measured at amortized cost | (1,870,000,000) | (2,644,000,000) | ||
Total financial assets measured at amortized cost | (111,397,000,000) | (115,495,000,000) | ||
Financial assets at fair value held for trading | (2,156,000,000) | (1,634,000,000) | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | (10,568,000,000) | (13,617,000,000) | ||
Derivative financial instruments | (35,047,000,000) | (45,041,000,000) | ||
Brokerage receivables | (7,000,000) | (2,000,000) | ||
Financial assets at fair value not held for trading | (17,243,000,000) | (15,672,000,000) | ||
Total financial assets measured at fair value through profit or loss | (54,454,000,000) | (62,350,000,000) | ||
Investments in subsidiaries and associates | (53,038,000,000) | (52,526,000,000) | ||
Property, equipment and software | (293,000,000) | (350,000,000) | ||
Goodwill and intangible assets | 28,000,000 | 28,000,000 | ||
Deferred tax assets | (1,000,000) | |||
Other non-financial assets | (1,000,000) | (183,000,000) | ||
Total assets | (219,154,000,000) | (230,878,000,000) | ||
Liabilities | ||||
Amounts due to banks | (105,448,000,000) | (107,527,000,000) | ||
Payables from securities financing transactions | (21,615,000,000) | (29,899,000,000) | ||
Cash collateral payables on derivative instruments | (10,458,000,000) | (11,618,000,000) | ||
Customer deposits | 14,287,000,000 | 23,745,000,000 | ||
Debt issued measured at amortized cost | (73,000,000) | 3,000,000 | ||
Other financial liabilities measured at amortized cost | (2,245,000,000) | (3,175,000,000) | ||
Total financial liabilities measured at amortized cost | (125,551,000,000) | (128,470,000,000) | ||
Financial liabilities at fair value held for trading | (2,046,000,000) | (1,529,000,000) | ||
Derivative financial instruments | (35,063,000,000) | (45,043,000,000) | ||
Brokerage payables designated at fair value | (1,000,000) | (7,000,000) | ||
Debt issued designated at fair value | 14,000,000 | (54,000,000) | ||
Other financial liabilities designated at fair value | (3,167,000,000) | (2,927,000,000) | ||
Total financial liabilities measured at fair value through profit or loss | (40,263,000,000) | (49,559,000,000) | ||
Provisions | (21,000,000) | |||
Other non-financial liabilities | (33,000,000) | (49,000,000) | ||
Total liabilities | (165,868,000,000) | (178,078,000,000) | ||
Equity | ||||
Equity attributable to shareholders | (53,287,000,000) | (52,800,000,000) | ||
Total equity | (53,287,000,000) | (52,800,000,000) | ||
Total liabilities and equity | (219,154,000,000) | (230,878,000,000) | ||
UBS AG (consolidated) | UBS AG (standalone) | Reportable legal entities | ||||
Assets | ||||
Cash and balances at central banks | 53,839,000,000 | 34,426,000,000 | ||
Loans and advances to banks | 39,681,000,000 | 40,171,000,000 | ||
Receivables from securities financing transactions | 50,566,000,000 | 56,568,000,000 | ||
Cash collateral receivables on derivative instruments | 29,939,000,000 | 32,771,000,000 | ||
Loans and advances to customers | 101,458,000,000 | 99,952,000,000 | ||
Other financial assets measured at amortized cost | 8,902,000,000 | 8,411,000,000 | ||
Total financial assets measured at amortized cost | 284,385,000,000 | 272,299,000,000 | ||
Financial assets at fair value held for trading | 116,370,000,000 | 110,812,000,000 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 47,891,000,000 | 54,468,000,000 | ||
Derivative financial instruments | 113,426,000,000 | 154,313,000,000 | ||
Brokerage receivables | 14,563,000,000 | 16,898,000,000 | ||
Financial assets at fair value not held for trading | 37,532,000,000 | 46,198,000,000 | ||
Total financial assets measured at fair value through profit or loss | 281,891,000,000 | 328,221,000,000 | ||
Financial assets measured at fair value through other comprehensive income | 1,007,000,000 | 187,000,000 | ||
Investments in subsidiaries and associates | 54,204,000,000 | 53,606,000,000 | ||
Property, equipment and software | 6,501,000,000 | 6,999,000,000 | ||
Goodwill and intangible assets | 213,000,000 | 217,000,000 | ||
Deferred tax assets | 936,000,000 | 840,000,000 | ||
Other non-financial assets | 5,757,000,000 | 6,641,000,000 | ||
Total assets | 634,894,000,000 | 669,010,000,000 | ||
Liabilities | ||||
Amounts due to banks | 34,691,000,000 | 41,414,000,000 | ||
Payables from securities financing transactions | 16,711,000,000 | 17,247,000,000 | ||
Cash collateral payables on derivative instruments | 30,260,000,000 | 35,875,000,000 | ||
Customer deposits | 101,093,000,000 | 98,441,000,000 | ||
Funding from UBS Group AG | 57,295,000,000 | 53,979,000,000 | ||
Debt issued measured at amortized cost | 73,045,000,000 | 75,658,000,000 | ||
Other financial liabilities measured at amortized cost | 4,477,000,000 | 5,285,000,000 | ||
Total financial liabilities measured at amortized cost | 317,572,000,000 | 327,898,000,000 | ||
Financial liabilities at fair value held for trading | 25,711,000,000 | 28,800,000,000 | ||
Derivative financial instruments | 116,588,000,000 | 156,192,000,000 | ||
Brokerage payables designated at fair value | 30,497,000,000 | 25,045,000,000 | ||
Debt issued designated at fair value | 70,660,000,000 | 58,986,000,000 | ||
Other financial liabilities designated at fair value | 11,127,000,000 | 11,255,000,000 | ||
Total financial liabilities measured at fair value through profit or loss | 254,584,000,000 | 280,279,000,000 | ||
Provisions | 2,023,000,000 | 1,293,000,000 | ||
Other non-financial liabilities | 1,799,000,000 | 2,173,000,000 | ||
Total liabilities | 575,978,000,000 | 611,643,000,000 | ||
Equity | ||||
Equity attributable to shareholders | 58,916,000,000 | 57,367,000,000 | ||
Total equity | 58,916,000,000 | 57,367,000,000 | ||
Total liabilities and equity | 634,894,000,000 | 669,010,000,000 | ||
UBS AG (consolidated) | UBS Switzerland AG (standalone) | Reportable legal entities | ||||
Assets | ||||
Cash and balances at central banks | 91,031,000,000 | 91,638,000,000 | ||
Loans and advances to banks | 7,066,000,000 | 6,385,000,000 | ||
Receivables from securities financing transactions | 5,438,000,000 | 4,026,000,000 | ||
Cash collateral receivables on derivative instruments | 779,000,000 | 1,543,000,000 | ||
Loans and advances to customers | 230,170,000,000 | 228,279,000,000 | ||
Other financial assets measured at amortized cost | 6,828,000,000 | 8,084,000,000 | ||
Total financial assets measured at amortized cost | 341,312,000,000 | 339,956,000,000 | ||
Financial assets at fair value held for trading | 79,000,000 | 55,000,000 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 0 | 1,000,000 | ||
Derivative financial instruments | 4,199,000,000 | 6,342,000,000 | ||
Financial assets at fair value not held for trading | 5,413,000,000 | 13,068,000,000 | ||
Total financial assets measured at fair value through profit or loss | 9,691,000,000 | 19,464,000,000 | ||
Investments in subsidiaries and associates | 37,000,000 | 38,000,000 | ||
Property, equipment and software | 1,456,000,000 | 1,335,000,000 | ||
Deferred tax assets | 1,000,000 | |||
Other non-financial assets | 2,424,000,000 | 2,063,000,000 | ||
Total assets | 354,921,000,000 | 362,857,000,000 | ||
Liabilities | ||||
Amounts due to banks | 33,453,000,000 | 34,096,000,000 | ||
Payables from securities financing transactions | 526,000,000 | 566,000,000 | ||
Cash collateral payables on derivative instruments | 153,000,000 | 561,000,000 | ||
Customer deposits | 286,488,000,000 | 293,371,000,000 | ||
Debt issued measured at amortized cost | 9,460,000,000 | 9,687,000,000 | ||
Other financial liabilities measured at amortized cost | 2,477,000,000 | 2,567,000,000 | ||
Total financial liabilities measured at amortized cost | 332,556,000,000 | 340,848,000,000 | ||
Financial liabilities at fair value held for trading | 372,000,000 | 335,000,000 | ||
Derivative financial instruments | 4,053,000,000 | 5,593,000,000 | ||
Total financial liabilities measured at fair value through profit or loss | 4,425,000,000 | 5,927,000,000 | ||
Provisions | 297,000,000 | 301,000,000 | ||
Other non-financial liabilities | 1,278,000,000 | 987,000,000 | ||
Total liabilities | 338,556,000,000 | 348,063,000,000 | ||
Equity | ||||
Equity attributable to shareholders | 16,365,000,000 | 14,794,000,000 | ||
Total equity | 16,365,000,000 | 14,794,000,000 | ||
Total liabilities and equity | 354,921,000,000 | 362,857,000,000 | ||
UBS AG (consolidated) | Other subsidiaries | Reportable legal entities | ||||
Assets | ||||
Cash and balances at central banks | 47,946,000,000 | 32,167,000,000 | ||
Loans and advances to banks | 19,858,000,000 | 19,465,000,000 | ||
Receivables from securities financing transactions | 40,585,000,000 | 43,350,000,000 | ||
Cash collateral receivables on derivative instruments | 10,314,000,000 | 10,093,000,000 | ||
Loans and advances to customers | 93,252,000,000 | 73,513,000,000 | ||
Other financial assets measured at amortized cost | 12,377,000,000 | 13,368,000,000 | ||
Total financial assets measured at amortized cost | 224,332,000,000 | 191,957,000,000 | ||
Financial assets at fair value held for trading | 16,740,000,000 | 16,260,000,000 | ||
of which: assets pledged as collateral that may be sold or repledged by counterparties | 6,073,000,000 | 6,247,000,000 | ||
Derivative financial instruments | 35,567,000,000 | 44,005,000,000 | ||
Brokerage receivables | 7,283,000,000 | 7,763,000,000 | ||
Financial assets at fair value not held for trading | 33,940,000,000 | 36,444,000,000 | ||
Total financial assets measured at fair value through profit or loss | 93,531,000,000 | 104,473,000,000 | ||
Financial assets measured at fair value through other comprehensive income | 7,837,000,000 | 8,072,000,000 | ||
Investments in subsidiaries and associates | 40,000,000 | 439,000,000 | ||
Property, equipment and software | 4,048,000,000 | 3,975,000,000 | ||
Goodwill and intangible assets | 6,138,000,000 | 6,234,000,000 | ||
Deferred tax assets | 7,903,000,000 | 8,334,000,000 | ||
Other non-financial assets | 1,656,000,000 | 854,000,000 | ||
Total assets | 345,484,000,000 | 324,337,000,000 | ||
Liabilities | ||||
Amounts due to banks | 50,405,000,000 | 43,066,000,000 | ||
Payables from securities financing transactions | 9,910,000,000 | 18,407,000,000 | ||
Cash collateral payables on derivative instruments | 11,845,000,000 | 12,495,000,000 | ||
Customer deposits | 142,967,000,000 | 112,372,000,000 | ||
Debt issued measured at amortized cost | 3,000,000 | |||
Other financial liabilities measured at amortized cost | 5,057,000,000 | 5,745,000,000 | ||
Total financial liabilities measured at amortized cost | 220,184,000,000 | 192,088,000,000 | ||
Financial liabilities at fair value held for trading | 7,652,000,000 | 5,989,000,000 | ||
Derivative financial instruments | 35,731,000,000 | 44,359,000,000 | ||
Brokerage payables designated at fair value | 13,548,000,000 | 13,704,000,000 | ||
Debt issued designated at fair value | 785,000,000 | 935,000,000 | ||
Other financial liabilities designated at fair value | 24,454,000,000 | 23,445,000,000 | ||
Total financial liabilities measured at fair value through profit or loss | 82,171,000,000 | 88,433,000,000 | ||
Provisions | 1,153,000,000 | 1,197,000,000 | ||
Other non-financial liabilities | 5,528,000,000 | 3,907,000,000 | ||
Total liabilities | 309,036,000,000 | 285,625,000,000 | ||
Equity | ||||
Equity attributable to shareholders | 36,108,000,000 | 38,393,000,000 | ||
Equity attributable to non-controlling interests | 340,000,000 | 319,000,000 | ||
Total equity | 36,448,000,000 | 38,712,000,000 | ||
Total liabilities and equity | $ 345,484,000,000 | $ 324,337,000,000 |
Supplemental guarantor consol_4
Supplemental guarantor consolidated statement of cash flows (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Condensed Cash Flow Statement [Table] | |||
Net cash flow from / (used in) operating activities | $ 31,425 | $ 36,958 | $ 19,705 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (1) | (46) | (26) |
Disposal of subsidiaries, associates and intangible assets | 593 | 674 | 114 |
Purchase of property, equipment and software | (1,841) | (1,854) | (1,584) |
Disposal of property, equipment and software | 295 | 366 | 11 |
Purchase of financial assets measured at fair value through other comprehensive income | (5,802) | (6,290) | (3,424) |
Disposal and redemption of financial assets measured at fair value through other comprehensive income | 5,052 | 4,530 | 3,913 |
Net (purchase) / redemption of debt securities measured at amortized cost | (415) | (4,166) | (562) |
Net cash flow from / (used in) investing activities | (2,119) | (6,785) | (1,558) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | (3,093) | 23,845 | (17,149) |
Distributions paid on UBS shares | (1,301) | (2,607) | (2,544) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 98,272 | 80,255 | 65,047 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (79,909) | (87,098) | (68,883) |
Net cash flows from other financing activities | (282) | (575) | (526) |
Net cash flow from / (used in) financing activities | 10,345 | 12,432 | (25,614) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 173,531 | 119,873 | 126,079 |
Net cash flow from / (used in) operating, investing and financing activities | 39,651 | 42,605 | (7,467) |
Effects of exchange rate differences on cash and cash equivalents | (5,307) | 11,052 | 1,261 |
Cash and cash equivalents at the end of the year | 207,875 | 173,531 | 119,873 |
Net cash flow from / (used in) operating activities includes: | |||
of which: cash and balances at central banks | 192,706 | 158,088 | 106,957 |
of which: loans and advances to banks | 13,942 | 14,028 | 11,386 |
of which: money market paper | 1,227 | 1,415 | 1,530 |
Restricted cash and cash equivalents | 3,408 | 3,828 | 3,192 |
UBS AG (consolidated) | |||
Condensed Cash Flow Statement [Table] | |||
Net cash flow from / (used in) operating activities | 30,563 | 36,581 | 18,805 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (1) | (46) | (26) |
Disposal of subsidiaries, associates and intangible assets | 593 | 674 | 114 |
Purchase of property, equipment and software | (1,581) | (1,573) | (1,401) |
Disposal of property, equipment and software | 295 | 364 | 11 |
Purchase of financial assets measured at fair value through other comprehensive income | (5,802) | (6,290) | (3,424) |
Disposal and redemption of financial assets measured at fair value through other comprehensive income | 5,052 | 4,530 | 3,913 |
Net (purchase) / redemption of debt securities measured at amortized cost | (415) | (4,166) | (562) |
Net cash flow from / (used in) investing activities | (1,860) | (6,506) | (1,374) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | (3,093) | 23,845 | (17,149) |
Distributions paid on UBS shares | (4,539) | (3,848) | (3,250) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 98,619 | 80,153 | 65,047 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (79,799) | (87,099) | (68,883) |
Net cash flows from other financing activities | (261) | (553) | (504) |
Net activity related to group internal capital transactions and dividends | 0 | 0 | 0 |
Net cash flow from / (used in) financing activities | 10,927 | 12,498 | (24,738) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 173,430 | 119,804 | 125,853 |
Net cash flow from / (used in) operating, investing and financing activities | 39,630 | 42,573 | (7,307) |
Effects of exchange rate differences on cash and cash equivalents | (5,306) | 11,053 | 1,258 |
Cash and cash equivalents at the end of the year | 207,755 | 173,430 | 119,804 |
Net cash flow from / (used in) operating activities includes: | |||
of which: cash and balances at central banks | 192,706 | 158,088 | 106,957 |
of which: loans and advances to banks | 13,822 | 13,928 | 11,317 |
of which: money market paper | 1,227 | 1,415 | 1,530 |
Restricted cash and cash equivalents | 3,408 | 3,828 | 3,192 |
UBS AG (consolidated) | UBS AG (standalone) | Reportable legal entities | |||
Condensed Cash Flow Statement [Table] | |||
Net cash flow from / (used in) operating activities | 5,714 | (14,883) | 17,531 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | 0 | 0 | (6) |
Disposal of subsidiaries, associates and intangible assets | 16 | 14 | 100 |
Purchase of property, equipment and software | (656) | (714) | (628) |
Disposal of property, equipment and software | 294 | 361 | 10 |
Purchase of financial assets measured at fair value through other comprehensive income | (1,006) | (77) | (10) |
Disposal and redemption of financial assets measured at fair value through other comprehensive income | 189 | 79 | 10 |
Net (purchase) / redemption of debt securities measured at amortized cost | (807) | (3,021) | (1,045) |
Net cash flow from / (used in) investing activities | (1,970) | (3,357) | (1,569) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | (3,073) | 23,828 | (17,150) |
Distributions paid on UBS shares | (4,539) | (3,848) | (3,250) |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 97,250 | 78,867 | 64,285 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (78,385) | (86,204) | (67,113) |
Net cash flows from other financing activities | (280) | (290) | (262) |
Net activity related to group internal capital transactions and dividends | 5,240 | 2,984 | 3,569 |
Net cash flow from / (used in) financing activities | 16,212 | 15,336 | (19,922) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 39,400 | 39,598 | 42,895 |
Net cash flow from / (used in) operating, investing and financing activities | 19,957 | (2,905) | (3,960) |
Effects of exchange rate differences on cash and cash equivalents | (1,462) | 2,706 | 664 |
Cash and cash equivalents at the end of the year | 57,895 | 39,400 | 39,598 |
Net cash flow from / (used in) operating activities includes: | |||
of which: cash and balances at central banks | 53,729 | 34,283 | 36,275 |
of which: loans and advances to banks | 3,258 | 4,085 | 2,697 |
of which: money market paper | 908 | 1,032 | 626 |
UBS AG (consolidated) | UBS Switzerland AG | Reportable legal entities | |||
Condensed Cash Flow Statement [Table] | |||
Net cash flow from / (used in) operating activities | 2,131 | 24,661 | 8,882 |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | (1) | (3) | 0 |
Disposal of subsidiaries, associates and intangible assets | 0 | 0 | 0 |
Purchase of property, equipment and software | (276) | (162) | (173) |
Disposal of property, equipment and software | 0 | 0 | 0 |
Purchase of financial assets measured at fair value through other comprehensive income | 0 | 0 | 0 |
Disposal and redemption of financial assets measured at fair value through other comprehensive income | 0 | 0 | 0 |
Net (purchase) / redemption of debt securities measured at amortized cost | 772 | 132 | 437 |
Net cash flow from / (used in) investing activities | 495 | (33) | 264 |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | (21) | 17 | 0 |
Distributions paid on UBS shares | 0 | 0 | 0 |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 1,177 | 1,057 | 621 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (1,093) | (776) | (752) |
Net cash flows from other financing activities | 0 | 0 | 0 |
Net activity related to group internal capital transactions and dividends | (537) | (1,307) | (2,055) |
Net cash flow from / (used in) financing activities | (475) | (1,009) | (2,186) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 93,342 | 62,551 | 54,757 |
Net cash flow from / (used in) operating, investing and financing activities | 2,151 | 23,619 | 6,961 |
Effects of exchange rate differences on cash and cash equivalents | (2,693) | 7,171 | 833 |
Cash and cash equivalents at the end of the year | 92,799 | 93,342 | 62,551 |
Net cash flow from / (used in) operating activities includes: | |||
of which: cash and balances at central banks | 91,031 | 91,638 | 60,926 |
of which: loans and advances to banks | 1,588 | 1,695 | 1,127 |
of which: money market paper | 179 | 9 | 498 |
UBS AG (consolidated) | Other subsidiaries | Reportable legal entities | |||
Condensed Cash Flow Statement [Table] | |||
Net cash flow from / (used in) operating activities | 22,718 | 26,804 | (7,608) |
Cash flow from / (used in) investing activities | |||
Purchase of subsidiaries, associates and intangible assets | 0 | (43) | (20) |
Disposal of subsidiaries, associates and intangible assets | 577 | 660 | 14 |
Purchase of property, equipment and software | (650) | (697) | (600) |
Disposal of property, equipment and software | 1 | 3 | 1 |
Purchase of financial assets measured at fair value through other comprehensive income | (4,795) | (6,213) | (3,414) |
Disposal and redemption of financial assets measured at fair value through other comprehensive income | 4,863 | 4,451 | 3,904 |
Net (purchase) / redemption of debt securities measured at amortized cost | (380) | (1,277) | 45 |
Net cash flow from / (used in) investing activities | (385) | (3,117) | (70) |
Cash flow from / (used in) financing activities | |||
Net short-term debt issued / (repaid) | 0 | 0 | 0 |
Distributions paid on UBS shares | 0 | 0 | 0 |
Issuance of debt designated at fair value and long-term debt measured at amortized cost | 193 | 229 | 142 |
Repayment of debt designated at fair value and long-term debt measured at amortized cost | (320) | (118) | (1,017) |
Net cash flows from other financing activities | 20 | (263) | (242) |
Net activity related to group internal capital transactions and dividends | (4,702) | (1,677) | (1,514) |
Net cash flow from / (used in) financing activities | (4,811) | (1,829) | (2,630) |
Total cash flow | |||
Cash and cash equivalents at the beginning of the year | 40,689 | 17,655 | 28,201 |
Net cash flow from / (used in) operating, investing and financing activities | 17,523 | 21,859 | (10,308) |
Effects of exchange rate differences on cash and cash equivalents | (1,151) | 1,175 | (239) |
Cash and cash equivalents at the end of the year | 57,061 | 40,689 | 17,655 |
Net cash flow from / (used in) operating activities includes: | |||
of which: cash and balances at central banks | 47,946 | 32,167 | 9,756 |
of which: loans and advances to banks | 8,975 | 8,148 | 7,493 |
of which: money market paper | $ 139 | $ 374 | $ 406 |
MD&A - Risk management and co_7
MD&A - Risk management and control - Credit Risk (Narrative) (Detail) | 12 Months Ended |
Dec. 31, 2021 | |
Mortgage loan portfolio region Americas | |
Schedule Of Credit Risk [Table] | |
Maximum LTV ratio within the standard approval process for any type of mortgage | 80.00% |
Lowest point of maximum LTV ratio for mortgages in GWM Region Americas | 45.00% |
Mortgage loan portfolio regions EMEA and Asia Pacific | |
Schedule Of Credit Risk [Table] | |
Maximum LTV ratio within the standard approval process for any type of mortgage | 70.00% |
Lowest point of maximum LTV ratio for mortgages in GWM Region Americas | 30.00% |
UBS AG | Mortgage loan portfolio region Americas | |
Schedule Of Credit Risk [Table] | |
Maximum LTV ratio within the standard approval process for any type of mortgage | 80.00% |
Lowest point of maximum LTV ratio for mortgages in GWM Region Americas | 45.00% |
UBS AG | Mortgage loan portfolio regions EMEA and Asia Pacific | |
Schedule Of Credit Risk [Table] | |
Maximum LTV ratio within the standard approval process for any type of mortgage | 70.00% |
Lowest point of maximum LTV ratio for mortgages in GWM Region Americas | 30.00% |
MD&A - Risk management and co_8
MD&A - Risk management and control - Credit Risk (Detail) | 12 Months Ended |
Dec. 31, 2021 | |
Entity [Table] | |
Internal UBS rating scale and mapping of external ratings [text block] | Internal UBS rating scale and mapping of external ratings Internal UBS rating 1-year PD range in % Description Moody’s Investors Service mapping S&P mapping Fitch mapping 0 and 1 0.00–0.02 Investment grade Aaa AAA AAA 2 0.02–0.05 Aa1 to Aa3 AA+ to AA– AA+ to AA– 3 0.05–0.12 A1 to A3 A+ to A– A+ to A– 4 0.12–0.25 Baa1 to Baa2 BBB+ to BBB BBB+ to BBB 5 0.25–0.50 Baa3 BBB– BBB– 6 0.50–0.80 Sub-investment grade Ba1 BB+ BB+ 7 0.80–1.30 Ba2 BB BB 8 1.30–2.10 Ba3 BB– BB– 9 2.10–3.50 B1 B+ B+ 10 3.50–6.00 B2 B B 11 6.00–10.00 B3 B– B– 12 10.00–17.00 Caa1 to Caa3 13 >17 Ca to C CCC to C CCC to C Counterparty is in default Default Defaulted D D |
UBS AG | |
Entity [Table] | |
Internal UBS rating scale and mapping of external ratings [text block] | Internal UBS rating scale and mapping of external ratings Internal UBS rating 1-year PD range in % Description Moody’s Investors Service mapping S&P mapping Fitch mapping 0 and 1 0.00–0.02 Investment grade Aaa AAA AAA 2 0.02–0.05 Aa1 to Aa3 AA+ to AA– AA+ to AA– 3 0.05–0.12 A1 to A3 A+ to A– A+ to A– 4 0.12–0.25 Baa1 to Baa2 BBB+ to BBB BBB+ to BBB 5 0.25–0.50 Baa3 BBB– BBB– 6 0.50–0.80 Sub-investment grade Ba1 BB+ BB+ 7 0.80–1.30 Ba2 BB BB 8 1.30–2.10 Ba3 BB– BB– 9 2.10–3.50 B1 B+ B+ 10 3.50–6.00 B2 B B 11 6.00–10.00 B3 B– B– 12 10.00–17.00 Caa1 to Caa3 13 >17 Ca to C CCC to C CCC to C Counterparty is in default Default Defaulted D D |
MD&A - Risk management and co_9
MD&A - Risk management and control - Market Risk (Narrative) (Detail) $ in Millions | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Entity [Table] | |
Equity instruments held as financial assets at fair value not held for trading and as investments in associates | $ 3,000 |
Equity instruments held as financial assets at fair value not held for trading | $ 1,800 |
Confidence level applied for calculating VaR for internal management purpose | 95.00% |
Confidence level applied for calculating regulatory VaR | 99.00% |
Confidence level applied for calculating SVaR | 99.00% |
+1 bp | |
Entity [Table] | |
Regulatory threshold for eligible tier 1 capital | 15.00% |
Regulatory threshold for outlier test of additional tier 1 capital | 15.00% |
Total effect of economic value of equity for equity, goodwill and real estate | $ (22.1) |
Parallel up | |
Entity [Table] | |
Increase (decrease) additional tier 1 (AT1) capital instruments, immediate effect | $ (1,100) |
Percentage change in additional tier 1 (AT1) capital instruments | (10.00%) |
Percentage change in additional tier 1 (AT1) capital instruments, immediate effect | (1.80%) |
CHF | +1 bp | |
Entity [Table] | |
Total effect of economic value of equity for equity, goodwill and real estate | $ (5.5) |
USD | +1 bp | |
Entity [Table] | |
Total effect of economic value of equity for equity, goodwill and real estate | (15.6) |
UBS AG | |
Entity [Table] | |
Equity instruments held as financial assets at fair value not held for trading and as investments in associates | 3,000 |
Equity instruments held as financial assets at fair value not held for trading | $ 1,800 |
Confidence level applied for calculating VaR for internal management purpose | 95.00% |
Confidence level applied for calculating regulatory VaR | 99.00% |
Confidence level applied for calculating SVaR | 99.00% |
UBS AG | +1 bp | |
Entity [Table] | |
Regulatory threshold for eligible tier 1 capital | 15.00% |
Regulatory threshold for outlier test of additional tier 1 capital | 15.00% |
Total effect of economic value of equity for equity, goodwill and real estate | $ (22.1) |
UBS AG | Parallel up | |
Entity [Table] | |
Increase (decrease) additional tier 1 (AT1) capital instruments, immediate effect | $ (1,100) |
Percentage change in additional tier 1 (AT1) capital instruments | 10.00% |
Percentage change in additional tier 1 (AT1) capital instruments, immediate effect | (1.80%) |
UBS AG | CHF | +1 bp | |
Entity [Table] | |
Total effect of economic value of equity for equity, goodwill and real estate | $ (5.5) |
UBS AG | USD | +1 bp | |
Entity [Table] | |
Total effect of economic value of equity for equity, goodwill and real estate | $ (15.6) |
MD&A - Risk management and c_10
MD&A - Risk management and control - Market Risk (Detail 1) - USD ($) $ in Millions | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Value At Risk [Table] | ||
Management VaR | $ 12 | $ 11 |
Diversification effect | (5) | (8) |
Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 2 | 1 |
Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 11 | 10 |
Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 4 | 6 |
Minimum | ||
Value At Risk [Table] | ||
Management VaR | 4 | 8 |
Minimum | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 1 | 0 |
Minimum | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Minimum | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Minimum | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 3 | 7 |
Minimum | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 4 | 4 |
Maximum | ||
Value At Risk [Table] | ||
Management VaR | 36 | 31 |
Maximum | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 3 | 2 |
Maximum | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Maximum | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Maximum | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 36 | 32 |
Maximum | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 8 | 7 |
Average | ||
Value At Risk [Table] | ||
Management VaR | 11 | 13 |
Diversification effect | (6) | (5) |
Average | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 1 | 1 |
Average | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Average | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Average | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 11 | 12 |
Average | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 5 | 5 |
Equity prices | ||
Value At Risk [Table] | ||
Management VaR | 8 | 6 |
Diversification effect | 0 | 0 |
Equity prices | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Equity prices | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Equity prices | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Equity prices | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 7 | 10 |
Equity prices | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Equity prices | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 1 | 3 |
Equity prices | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 35 | 29 |
Equity prices | Average | ||
Value At Risk [Table] | ||
Management VaR | 7 | 10 |
Interest rate risk | ||
Value At Risk [Table] | ||
Management VaR | 11 | 8 |
Diversification effect | (5) | (4) |
Interest rate risk | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 1 | 1 |
Interest rate risk | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Interest rate risk | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Interest rate risk | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 9 | 7 |
Interest rate risk | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 4 | 4 |
Interest rate risk | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 7 | 6 |
Interest rate risk | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 13 | 11 |
Interest rate risk | Average | ||
Value At Risk [Table] | ||
Management VaR | 9 | 8 |
Credit spreads | ||
Value At Risk [Table] | ||
Management VaR | 7 | 8 |
Diversification effect | (5) | (4) |
Credit spreads | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 2 | 1 |
Credit spreads | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Credit spreads | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Credit spreads | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 7 | 6 |
Credit spreads | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 4 | 3 |
Credit spreads | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 5 | 5 |
Credit spreads | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 11 | 11 |
Credit spreads | Average | ||
Value At Risk [Table] | ||
Management VaR | 7 | 7 |
Foreign exchange | ||
Value At Risk [Table] | ||
Management VaR | 6 | 3 |
Diversification effect | (1) | (1) |
Foreign exchange | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Foreign exchange | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Foreign exchange | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Foreign exchange | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 3 | 4 |
Foreign exchange | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 1 | 1 |
Foreign exchange | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 1 | 2 |
Foreign exchange | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 9 | 7 |
Foreign exchange | Average | ||
Value At Risk [Table] | ||
Management VaR | 3 | 4 |
Commodities | ||
Value At Risk [Table] | ||
Management VaR | 3 | 3 |
Diversification effect | 0 | 0 |
Commodities | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Commodities | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Commodities | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Commodities | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 3 | 4 |
Commodities | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
Commodities | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 2 | 2 |
Commodities | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 5 | 6 |
Commodities | Average | ||
Value At Risk [Table] | ||
Management VaR | 3 | 4 |
UBS AG | ||
Value At Risk [Table] | ||
Management VaR | 12 | 11 |
Diversification effect | (5) | (8) |
UBS AG | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 2 | 1 |
UBS AG | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 11 | 10 |
UBS AG | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 4 | 6 |
UBS AG | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 4 | 8 |
UBS AG | Minimum | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 1 | 0 |
UBS AG | Minimum | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Minimum | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Minimum | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 3 | 7 |
UBS AG | Minimum | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 4 | 4 |
UBS AG | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 36 | 31 |
UBS AG | Maximum | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 3 | 2 |
UBS AG | Maximum | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Maximum | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Maximum | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 36 | 32 |
UBS AG | Maximum | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 8 | 7 |
UBS AG | Average | ||
Value At Risk [Table] | ||
Management VaR | 11 | 13 |
Diversification effect | (6) | (5) |
UBS AG | Average | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 1 | 1 |
UBS AG | Average | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Average | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Average | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 11 | 12 |
UBS AG | Average | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 5 | 5 |
UBS AG | Equity prices | ||
Value At Risk [Table] | ||
Management VaR | 8 | 6 |
Diversification effect | 0 | 0 |
UBS AG | Equity prices | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Equity prices | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Equity prices | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Equity prices | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 7 | 10 |
UBS AG | Equity prices | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Equity prices | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 1 | 3 |
UBS AG | Equity prices | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 35 | 29 |
UBS AG | Equity prices | Average | ||
Value At Risk [Table] | ||
Management VaR | 7 | 10 |
UBS AG | Interest rate risk | ||
Value At Risk [Table] | ||
Management VaR | 11 | 8 |
Diversification effect | (5) | (4) |
UBS AG | Interest rate risk | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 1 | 1 |
UBS AG | Interest rate risk | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Interest rate risk | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Interest rate risk | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 9 | 7 |
UBS AG | Interest rate risk | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 4 | 4 |
UBS AG | Interest rate risk | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 7 | 6 |
UBS AG | Interest rate risk | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 13 | 11 |
UBS AG | Interest rate risk | Average | ||
Value At Risk [Table] | ||
Management VaR | 9 | 8 |
UBS AG | Credit spreads | ||
Value At Risk [Table] | ||
Management VaR | 7 | 8 |
Diversification effect | (5) | (4) |
UBS AG | Credit spreads | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 2 | 1 |
UBS AG | Credit spreads | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Credit spreads | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Credit spreads | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 7 | 6 |
UBS AG | Credit spreads | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 4 | 3 |
UBS AG | Credit spreads | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 5 | 5 |
UBS AG | Credit spreads | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 11 | 11 |
UBS AG | Credit spreads | Average | ||
Value At Risk [Table] | ||
Management VaR | 7 | 7 |
UBS AG | Foreign exchange | ||
Value At Risk [Table] | ||
Management VaR | 6 | 3 |
Diversification effect | (1) | (1) |
UBS AG | Foreign exchange | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Foreign exchange | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Foreign exchange | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Foreign exchange | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 3 | 4 |
UBS AG | Foreign exchange | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 1 | 1 |
UBS AG | Foreign exchange | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 1 | 2 |
UBS AG | Foreign exchange | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 9 | 7 |
UBS AG | Foreign exchange | Average | ||
Value At Risk [Table] | ||
Management VaR | 3 | 4 |
UBS AG | Commodities | ||
Value At Risk [Table] | ||
Management VaR | 3 | 3 |
Diversification effect | 0 | 0 |
UBS AG | Commodities | Global Wealth Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Commodities | Personal & Corporate Banking | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Commodities | Asset Management | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Commodities | Investment Bank | ||
Value At Risk [Table] | ||
Management VaR | 3 | 4 |
UBS AG | Commodities | Group Functions | ||
Value At Risk [Table] | ||
Management VaR | 0 | 0 |
UBS AG | Commodities | Minimum | ||
Value At Risk [Table] | ||
Management VaR | 2 | 2 |
UBS AG | Commodities | Maximum | ||
Value At Risk [Table] | ||
Management VaR | 5 | 6 |
UBS AG | Commodities | Average | ||
Value At Risk [Table] | ||
Management VaR | $ 3 | $ 4 |
MD&A - Risk management and c_11
MD&A - Risk management and control - Market Risk (Detail 2) - USD ($) $ in Millions | Dec. 31, 2021 | Dec. 31, 2020 |
+1 bp | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | $ (29.9) | $ (27.2) |
Additional tier 1 (AT1) capital instruments | 4.5 | |
Total including AT1 capital instruments | (25.4) | |
+1 bp | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (5.1) | |
+1 bp | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (1.1) | |
+1 bp | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 0.1 | |
+1 bp | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (23.5) | |
+1 bp | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (0.4) | |
Parallel up | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (6,041.4) | |
Additional tier 1 (AT1) capital instruments | 853.4 | |
Total including AT1 capital instruments | (5,188) | |
Parallel up | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (724.1) | |
Parallel up | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (196.6) | |
Parallel up | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 33.3 | |
Parallel up | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (5,068.3) | |
Parallel up | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (85.8) | |
Parallel down | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 5,149.5 | |
Additional tier 1 (AT1) capital instruments | (928.4) | |
Total including AT1 capital instruments | 4,221.1 | |
Parallel down | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 806.3 | |
Parallel down | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 231.9 | |
Parallel down | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (32.8) | |
Parallel down | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 4,124.2 | |
Parallel down | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 19.9 | |
Steepener | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (1,179.6) | |
Additional tier 1 (AT1) capital instruments | (9.6) | |
Total including AT1 capital instruments | (1,189.2) | |
Steepener | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (254.3) | |
Steepener | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (69) | |
Steepener | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (31.1) | |
Steepener | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (821.4) | |
Steepener | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (3.7) | |
Flattener | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (207) | |
Additional tier 1 (AT1) capital instruments | 197.1 | |
Total including AT1 capital instruments | (10) | |
Flattener | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 117.1 | |
Flattener | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 37.4 | |
Flattener | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 35.3 | |
Flattener | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (362.3) | |
Flattener | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (34.5) | |
Short-term up | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (2,362.9) | |
Additional tier 1 (AT1) capital instruments | 531.5 | |
Total including AT1 capital instruments | (1,831.4) | |
Short-term up | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (158.7) | |
Short-term up | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (24.1) | |
Short-term up | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 45.4 | |
Short-term up | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (2,165.9) | |
Short-term up | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (59.6) | |
Short-term down | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 2,465.6 | |
Additional tier 1 (AT1) capital instruments | (553.3) | |
Total including AT1 capital instruments | 1,912.3 | |
Short-term down | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 162.5 | |
Short-term down | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 27.4 | |
Short-term down | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (43.7) | |
Short-term down | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 2,315.6 | |
Short-term down | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 3.8 | |
UBS AG | +1 bp | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (29.9) | $ (27.2) |
Additional tier 1 (AT1) capital instruments | 4.5 | |
Total including AT1 capital instruments | (25.4) | |
UBS AG | +1 bp | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (5.1) | |
UBS AG | +1 bp | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (1.1) | |
UBS AG | +1 bp | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 0.1 | |
UBS AG | +1 bp | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (23.5) | |
UBS AG | +1 bp | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (0.4) | |
UBS AG | Parallel up | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (6,041.4) | |
Additional tier 1 (AT1) capital instruments | 853.4 | |
Total including AT1 capital instruments | (5,188) | |
UBS AG | Parallel up | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (724.1) | |
UBS AG | Parallel up | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (196.6) | |
UBS AG | Parallel up | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 33.3 | |
UBS AG | Parallel up | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (5,068.3) | |
UBS AG | Parallel up | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (85.8) | |
UBS AG | Parallel down | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 5,149.5 | |
Additional tier 1 (AT1) capital instruments | (928.4) | |
Total including AT1 capital instruments | 4,221.1 | |
UBS AG | Parallel down | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 806.3 | |
UBS AG | Parallel down | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 231.9 | |
UBS AG | Parallel down | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (32.8) | |
UBS AG | Parallel down | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 4,124.2 | |
UBS AG | Parallel down | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 19.9 | |
UBS AG | Steepener | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (1,179.6) | |
Additional tier 1 (AT1) capital instruments | (9.6) | |
Total including AT1 capital instruments | (1,189.2) | |
UBS AG | Steepener | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (254.3) | |
UBS AG | Steepener | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (69) | |
UBS AG | Steepener | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (31.1) | |
UBS AG | Steepener | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (821.4) | |
UBS AG | Steepener | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (3.7) | |
UBS AG | Flattener | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (207) | |
Additional tier 1 (AT1) capital instruments | 197.1 | |
Total including AT1 capital instruments | (10) | |
UBS AG | Flattener | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 117.1 | |
UBS AG | Flattener | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 37.4 | |
UBS AG | Flattener | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 35.3 | |
UBS AG | Flattener | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (362.3) | |
UBS AG | Flattener | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (34.5) | |
UBS AG | Short-term up | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (2,362.9) | |
Additional tier 1 (AT1) capital instruments | 531.5 | |
Total including AT1 capital instruments | (1,831.4) | |
UBS AG | Short-term up | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (158.7) | |
UBS AG | Short-term up | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (24.1) | |
UBS AG | Short-term up | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 45.4 | |
UBS AG | Short-term up | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (2,165.9) | |
UBS AG | Short-term up | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (59.6) | |
UBS AG | Short-term down | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 2,465.6 | |
Additional tier 1 (AT1) capital instruments | (553.3) | |
Total including AT1 capital instruments | 1,912.3 | |
UBS AG | Short-term down | CHF | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 162.5 | |
UBS AG | Short-term down | EUR | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 27.4 | |
UBS AG | Short-term down | GBP | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | (43.7) | |
UBS AG | Short-term down | USD | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | 2,315.6 | |
UBS AG | Short-term down | Other | ||
Interest Rate Sensitivity Of Banking Book [Table] | ||
Total effect on economic value of equity as per Pillar 3 requirement | $ 3.8 |
MD&A - Capital management (Narr
MD&A - Capital management (Narrative) (Detail) - USD ($) $ in Millions | 12 Months Ended | ||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | |
Entity [Table] | |||
Increase (decrease) in CET1 capital | $ 5,400 | ||
Operating profit / (loss) before tax | 9,484 | $ 8,155 | $ 5,577 |
Increase (decrease) in CET1 capital through foreign currency translation effects before tax | 400 | ||
Increase (decrease) in CET1 capital through deferred tax assets on temporary differences | 500 | ||
Increase (decrease) in CET1 capital through capital reserve for potential share repurchases | 2,000 | ||
Increase (decrease) in CET1 capital through changes in deduction of goodwill related to associates | (400) | ||
Increase (decrease) in CET1 capital through accruals for proposed dividends | (1,700) | ||
Increase (decrease) in CET1 capital through changes in deduction of goodwill related to operatonal partnership entities | 200 | ||
Increase (decrease) in CET1 capital through changes in compensation- and own share-related capital components | (600) | ||
Current tax expense / (benefit) | 1,600 | ||
Increase (decrease) in CET1 capital through share repurchases under share repurchase program | (600) | ||
Increase (decrease) in CET1 capital through defined benefit plans | 200 | ||
Loss-absorbing AT1 capital | 15,200 | ||
Increase (decrease) in loss-absorbing AT1 capital | (1,100) | ||
Decrease in AT1 capital through issuance of capital instruments | 2,250 | ||
Increase in AT1 capital through call of capital instruments | 2,600 | ||
TLAC-eligible senior unsecured debt included in gone concern loss-absorbing capacity | 41,100 | ||
Gone concern loss-absorbing capacity | 44,300 | ||
UBS AG | |||
Entity [Table] | |||
Operating profit / (loss) before tax | $ 8,964 | $ 7,699 | $ 5,169 |
MD&A - Capital management (Deta
MD&A - Capital management (Detail 1) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Entity [Table] | ||||
Total IFRS equity | $ 61,002 | $ 59,765 | $ 54,675 | $ 53,060 |
Equity attributable to non-controlling interests | (340) | (319) | ||
Defined benefit plans, net of tax | (270) | (41) | ||
Deferred tax assets recognized for tax loss carry-forwards | (4,565) | (5,617) | ||
Deferred tax assets on temporary differences, excess over threshold | (49) | (5) | ||
Goodwill, net of tax | (5,838) | (6,319) | ||
Intangible assets, net of tax | (180) | (296) | ||
Compensation-related components (not recognized in net profit) | (1,700) | (1,349) | ||
Expected losses on advanced internal ratings-based portfolio less provisions | (482) | (330) | ||
Unrealized (gains) / losses from cash flow hedges, net of tax | (628) | (2,321) | ||
Own credit related to (gains) / losses on financial liabilities measured at fair value that existed at the balance sheet date, net of tax | 315 | 382 | ||
Own credit related to gains / losses on derivative financial instruments that existed at the balance sheet date | (50) | (45) | ||
Unrealized gains related to debt instruments at fair value through OCI, net of tax | (68) | (152) | ||
Prudential valuation adjustments | (167) | (150) | ||
Capital reserve for potential share repurchases | (2,000) | |||
Accruals for proposed dividends to shareholders | (1,700) | (1,314) | ||
Other | 1 | 0 | ||
Total common equity tier 1 capital | 45,281 | 39,890 | ||
Goodwill related to significant investments in financial institutions | 22 | 413 | ||
UBS AG | ||||
Entity [Table] | ||||
Total IFRS equity | 58,442 | $ 58,073 | $ 53,896 | $ 52,389 |
Equity attributable to non-controlling interests | (340) | |||
Defined benefit plans, net of tax | (270) | |||
Deferred tax assets recognized for tax loss carry-forwards | (4,565) | |||
Deferred tax assets on temporary differences, excess over threshold | (350) | |||
Goodwill, net of tax | (5,838) | |||
Intangible assets, net of tax | (180) | |||
Expected losses on advanced internal ratings-based portfolio less provisions | (482) | |||
Unrealized (gains) / losses from cash flow hedges, net of tax | (628) | |||
Own credit related to (gains) / losses on financial liabilities measured at fair value that existed at the balance sheet date, net of tax | 315 | |||
Own credit related to gains / losses on derivative financial instruments that existed at the balance sheet date | (50) | |||
Unrealized gains related to debt instruments at fair value through OCI, net of tax | (68) | |||
Prudential valuation adjustments | (167) | |||
Accruals for proposed dividends to shareholders | (4,200) | |||
Other | (24) | |||
Total common equity tier 1 capital | $ 41,594 |
MD&A - Capital management (De_2
MD&A - Capital management (Detail 2) - USD ($) $ in Millions | 12 Months Ended | |||
Dec. 31, 2021 | Dec. 31, 2020 | Dec. 31, 2019 | Dec. 31, 2018 | |
Reconciliation Of IFRS Equity To Swiss SRB Common Equity Tier One Capital [Table] | ||||
Total IFRS equity | $ 61,002 | $ 59,765 | $ 54,675 | $ 53,060 |
Equity attributable to non-controlling interests | (340) | (319) | ||
Defined benefit plans, net of tax | (270) | (41) | ||
Deferred tax assets recognized for tax loss carry-forwards | (4,565) | (5,617) | ||
Deferred tax assets on temporary differences, excess over threshold | (49) | (5) | ||
Goodwill, net of tax | (5,838) | (6,319) | ||
Intangible assets, net of tax | (180) | (296) | ||
Compensation-related components (not recognized in net profit) | (1,700) | (1,349) | ||
Expected losses on advanced internal ratings-based portfolio less provisions | (482) | (330) | ||
Unrealized (gains) / losses from cash flow hedges, net of tax | (628) | (2,321) | ||
Own credit related to (gains) / losses on financial liabilities measured at fair value that existed at the balance sheet date, net of tax | 315 | 382 | ||
Own credit related to gains / losses on derivative financial instruments that existed at the balance sheet date | (50) | (45) | ||
Unrealized gains related to debt instruments at fair value through OCI, net of tax | (68) | (152) | ||
Prudential valuation adjustments | (167) | (150) | ||
Accruals for proposed dividends to shareholders | (1,700) | (1,314) | ||
Capital reserve for potential share repurchases | (2,000) | |||
Other | 1 | 0 | ||
Total common equity tier 1 capital | 45,281 | 39,890 | ||
UBS AG | ||||
Reconciliation Of IFRS Equity To Swiss SRB Common Equity Tier One Capital [Table] | ||||
Total IFRS equity | 58,442 | $ 58,073 | $ 53,896 | $ 52,389 |
Equity attributable to non-controlling interests | (340) | |||
Defined benefit plans, net of tax | (270) | |||
Deferred tax assets recognized for tax loss carry-forwards | (4,565) | |||
Deferred tax assets on temporary differences, excess over threshold | (350) | |||
Goodwill, net of tax | (5,838) | |||
Intangible assets, net of tax | (180) | |||
Expected losses on advanced internal ratings-based portfolio less provisions | (482) | |||
Unrealized (gains) / losses from cash flow hedges, net of tax | (628) | |||
Own credit related to (gains) / losses on financial liabilities measured at fair value that existed at the balance sheet date, net of tax | 315 | |||
Own credit related to gains / losses on derivative financial instruments that existed at the balance sheet date | (50) | |||
Unrealized gains related to debt instruments at fair value through OCI, net of tax | (68) | |||
Prudential valuation adjustments | (167) | |||
Accruals for proposed dividends to shareholders | (4,200) | |||
Other | (24) | |||
Total common equity tier 1 capital | 41,594 | |||
Differences | ||||
Reconciliation Of IFRS Equity To Swiss SRB Common Equity Tier One Capital [Table] | ||||
Total IFRS equity | 2,559 | |||
Deferred tax assets on temporary differences, excess over threshold | 302 | |||
Compensation-related components (not recognized in net profit) | (1,700) | |||
Accruals for proposed dividends to shareholders | 2,500 | |||
Other | 25 | |||
Total common equity tier 1 capital | $ 3,687 |
MD&A - UBS shares (Narrative) (
MD&A - UBS shares (Narrative) (Detail) | Dec. 31, 2021SFr / shares |
Entity [Table] | |
Par value of shares | SFr 0.10 |
UBS AG | |
Entity [Table] | |
Par value of shares | SFr 0.10 |